Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5827995342448704,-2.0258961337830623,0.0,0.16029340955783206,0.132,17/50,9.90%,GLI3;ZIC1;FGFR2;GPC3;SMO;DCDC2;GAS1;TULP3;IFT81;CREBBP;RORA;ARMC9;EVC;MEGF8;INTU;GLI1;PTCH1
prerank,mesonephric tubule development (GO:0072164),-0.7760416177315401,-2.017830501414364,0.0,0.09076855721949527,0.151,8/15,11.66%,FGFR2;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1;PKD1
prerank,ureteric bud development (GO:0001657),-0.7398848347314017,-2.0155911909467275,0.0,0.06147799442880709,0.153,8/17,11.07%,FGFR2;GPC3;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1
prerank,vasodilation (GO:0042311),0.8993418137847106,1.996395527086259,0.0,0.18575123028928853,0.136,5/13,2.63%,NOS1;NOS3;KLF2;F2RL1;ADRB2
prerank,retinoid metabolic process (GO:0001523),-0.5329182644106096,-1.9933719808535506,0.0,0.059868622846901136,0.195,12/71,3.93%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;HSPG2;GPC3;RBP1;CYP26B1;APOE;ABCA4;RBP4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.8138558498858551,1.9779363275155017,0.0,0.14667241954536717,0.203,7/26,5.93%,NOS1;ACER2;NOS3;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,establishment of endothelial barrier (GO:0061028),0.7749111239363504,1.9720382570332498,0.0,0.11300712370969467,0.233,12/29,9.21%,PECAM1;RAPGEF2;F11R;RAPGEF1;F2RL1;SOX18;MSN;RAPGEF6;PPP1R16B;ROBO4;TJP2;TJP1
prerank,embryonic skeletal system development (GO:0048706),-0.6067738255384487,-1.9623191519272407,0.0,0.0826573244466893,0.301,15/35,7.50%,COL1A1;HOXC4;PDGFRA;SULF1;SULF2;OSR1;WNT5A;HOXA3;HOXB3;RBP4;XYLT1;HOXB4;MEGF8;SIX1;WNT9A
prerank,skeletal system morphogenesis (GO:0048705),-0.5795037910669563,-1.953565016024884,0.0,0.07724983593148534,0.328,14/42,8.09%,FGFR2;HOXC4;PDGFRA;TGFBR1;CYP26B1;HOXA3;HOXB3;FBN2;HOXB4;MEGF8;ANKRD11;SFRP4;SIX1;WWOX
prerank,regulation of glucose import (GO:0046324),-0.6148697062237783,-1.9430000502382818,0.0,0.07559448230438208,0.361,13/30,8.12%,PRKAG2;PID1;IGF1;SORBS1;APPL2;RHOQ;GRB10;ENPP1;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,mesoderm development (GO:0007498),0.8299802526718528,1.9085057334925621,0.0,0.30679404019091505,0.57,4/18,1.44%,BMX;TIE1;TBX1;TBXT
prerank,nitric oxide metabolic process (GO:0046209),0.8517236565489112,1.9034672048387757,0.0,0.26979604923985184,0.599,3/14,3.43%,NOS1;NOS3;GCH1
prerank,nitric oxide biosynthetic process (GO:0006809),0.8544164591000272,1.9019231024968704,0.0,0.23295031339558317,0.615,3/13,3.43%,NOS1;NOS3;GCH1
prerank,regulation of vasculogenesis (GO:2001212),0.8470427316868778,1.9003002394090982,0.003115264797507788,0.20648692578606315,0.631,9/14,5.43%,RAPGEF2;CEACAM1;ASB4;HEY1;EMP2;TMEM100;HEY2;RRAS;CD34
prerank,negative regulation of blood pressure (GO:0045776),0.8769699052668191,1.8953270508355733,0.0,0.19983482766777966,0.664,3/13,0.97%,NOS1;NOS3;BMPR2
prerank,B cell differentiation (GO:0030183),0.7063237327141724,1.8924385910196233,0.001321003963011889,0.18451063312281482,0.677,8/46,6.32%,PTPRJ;PLCG2;VCAM1;KLF6;HDAC9;HHEX;TPD52;ADAM17
prerank,B cell receptor signaling pathway (GO:0050853),0.7348134473017762,1.8891758267112233,0.0029154518950437317,0.1753978830272626,0.696,4/32,5.48%,BMX;PLCG2;MEF2C;PLEKHA1
prerank,activation of protein kinase A activity (GO:0034199),-0.7094119949992806,-1.8866330977820744,0.005494505494505495,0.14556765958339268,0.624,10/16,14.77%,ADCY5;ADCY9;ADCY1;ADCY2;PRRC1;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A
prerank,heterochromatin organization (GO:0070828),0.862367229838184,1.8855730268976674,0.0015748031496062992,0.16923385809764288,0.714,2/14,0.09%,PRDM16;MECOM
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6288298198941472,1.8821116062324161,0.0,0.16485844619026563,0.727,22/88,7.72%,VEGFC;PTPRM;CDH13;TEK;TIE1;PDGFB;BMPR2;FLT4;EGFL7;ACVRL1;EGR3;CAV1;PRKD1;CAV2;VEGFD;NRAS;VASH2;ANGPT1;PPP1R16B;AKT3;STAT1;ATP5F1A
prerank,collagen fibril organization (GO:0030199),-0.48058417982903934,-1.8819882073679857,0.0,0.1361528358292429,0.645,40/88,13.66%,COL1A2;COL3A1;ADAMTS2;COL4A5;COL1A1;COL4A6;COL5A1;COL12A1;COL22A1;TGFBR1;COL4A3;COL25A1;COL4A4;LOXL1;COL6A2;COL6A3;COL11A1;COL26A1;COL8A2;COL6A1;TLL1;COL13A1;COL27A1;COL23A1;LOXL3;P4HA1;COL15A1;ADAMTS3;SERPINH1;COL20A1;COL16A1;P3H1;COL9A2;PLOD2;P3H2;DPT;LUM;ADAMTS14;COL8A1;COL5A3
prerank,zinc ion homeostasis (GO:0055069),-0.6152566545777624,-1.8722648853030746,0.0,0.14156032434444688,0.698,13/28,6.94%,SLC39A14;SLC30A10;PRKN;SLC39A8;SLC39A13;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,blood vessel diameter maintenance (GO:0097746),0.7115592008094904,1.866574551835555,0.0027816411682892906,0.20214793409792683,0.812,6/34,2.44%,NOS1;NOS3;EDN1;ACE;KLF2;F2RL1
prerank,lung development (GO:0030324),-0.585305110742389,-1.8649325413003075,0.0,0.1397519759124144,0.722,13/33,11.66%,ERRFI1;GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6;PKD1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8512905209048867,1.862840772851084,0.0,0.19988920449163483,0.839,3/14,1.04%,NOS3;EDN1;ACE
prerank,peptide hormone secretion (GO:0030072),0.7523827832663792,1.8623672148782813,0.0,0.18839031880705984,0.84,3/26,0.76%,LTBP4;EDN1;EXOC3L1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6331444356279109,1.8607760979224093,0.00125,0.18073949969063624,0.843,17/75,6.91%,VEGFC;CDH13;TEK;GATA2;PDGFB;BMPR2;FLT4;EGFL7;JCAD;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B;ADAM17;AKT3
prerank,positive regulation of vasculature development (GO:1904018),0.6118045482398533,1.8596622975125652,0.0012048192771084338,0.17339169809067628,0.846,20/94,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;VEGFD;RRAS;VASH2;CD34;IL1A;ZC3H12A;ADAM12;HSPB1
prerank,respiratory system development (GO:0060541),-0.5909404496722899,-1.8575402421180045,0.0,0.14162469920772314,0.763,11/32,9.62%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,lymphocyte differentiation (GO:0030098),0.6507925645260465,1.8570146374844616,0.0012391573729863693,0.17176631677631232,0.857,11/68,6.32%,PTPRJ;PLCG2;JAG2;VCAM1;KLF6;DLL4;HDAC9;HHEX;TPD52;GATA3;ADAM17
prerank,regulation of cell-cell adhesion (GO:0022407),0.7053193718815951,1.854717351306238,0.002805049088359046,0.17004491400943497,0.872,8/39,1.06%,PODXL;JAG1;PTPRG;PTPRR;EFNA5;CEACAM1;MAGI1;SMAD7
prerank,cardiac ventricle development (GO:0003231),0.7839512963680055,1.8538317022246045,0.0,0.1645877704448532,0.875,8/20,6.03%,GJA5;ENG;NOTCH1;DAND5;HEY1;DLL4;HEY2;GATA3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.871063240608622,1.849129025736944,0.001658374792703151,0.17023570988261105,0.896,2/11,0.16%,PLCG2;CDH13
prerank,energy reserve metabolic process (GO:0006112),-0.6629107130699926,-1.8454190200344198,0.005263157894736842,0.15048862268960508,0.816,5/19,6.77%,PRKAG2;PID1;LEPR;PHKB;PYGM
prerank,regulation of plasminogen activation (GO:0010755),-0.7483318592939117,-1.8440654444690194,0.0,0.14215349272749223,0.82,5/12,11.23%,SERPINE2;THBS1;CLEC3B;RUNX1;SERPINE1
prerank,negative regulation of cell adhesion (GO:0007162),0.6273446355245188,1.843028776072179,0.0,0.17869212988336175,0.922,19/72,10.05%,CDH13;PODXL;ACER2;JAG1;PLXNA4;RND1;ACVRL1;NOTCH1;DUSP1;PDE3B;PLXND1;ANGPT1;GCNT2;ARHGDIA;PTPRO;SNAI2;PTK2;ADAM10;SPINT2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.6364994291207424,1.8404326421093264,0.003740648379052369,0.17776335367195392,0.937,14/65,7.33%,PTPRJ;CDH13;AFAP1L2;HIP1;CEACAM1;HIP1R;ITGA1;DAB2IP;CBL;SHKBP1;SH3KBP1;BCAR3;DUSP3;PTPN12
prerank,glutamine family amino acid catabolic process (GO:0009065),0.8449345344659404,1.8394202311733738,0.003436426116838488,0.17293642546741822,0.938,6/13,5.83%,NOS1;NOS3;GLS2;GLS;ARG1;GLUD1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.7391674932139001,1.8389844670240207,0.0028328611898017,0.16719640794126558,0.939,5/30,5.43%,PLCG2;NOD2;F2RL1;LGALS9;CD34
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.6488083265733228,1.8374155740677278,0.0012547051442910915,0.16463071419292344,0.941,20/69,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,ceramide biosynthetic process (GO:0046513),0.6973692586155983,1.834206320540709,0.0028735632183908046,0.16729264820630116,0.943,12/40,9.87%,SGMS1;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5;B4GALT6
prerank,negative regulation of catalytic activity (GO:0043086),0.739437622450903,1.8327796278133852,0.0029985007496251873,0.16458052020167252,0.947,2/24,1.60%,NOS1;NOTCH1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6410748718789422,1.8276016745623513,0.0012376237623762376,0.1710857383934506,0.955,20/73,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6909607197034466,1.826034154859597,0.0,0.16900316854189368,0.956,8/42,4.97%,PTPRJ;CDH13;TEK;UTRN;EMP2;PPM1F;RRAS;MAP4K4
prerank,blood vessel morphogenesis (GO:0048514),0.6533136665518257,1.8254979814474024,0.0013175230566534915,0.1650576329787244,0.959,13/54,3.58%,GJA5;SOX17;ENG;FLT1;RASIP1;FLT4;SMAD7;TBX1;EGFL7;CAV1;ID1;SOX18;HEY2
prerank,endothelial cell development (GO:0001885),0.7383190687579435,1.8239143822102004,0.0014903129657228018,0.16389627850149482,0.96,8/25,5.54%,PECAM1;RAPGEF2;RAPGEF1;F2RL1;SOX18;MSN;PPP1R16B;ROBO4
prerank,embryonic limb morphogenesis (GO:0030326),-0.5589906946364666,-1.822726709929231,0.0,0.1763227505136153,0.896,14/34,11.55%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;CREBBP;FBXW4;NIPBL;MEGF8;INTU;PTCH1;SALL1;TBX2;HDAC1
prerank,ceramide metabolic process (GO:0006672),0.6630504333757395,1.8214376474011602,0.0040650406504065045,0.16458930837522484,0.964,12/49,9.27%,SGMS1;ACER2;ST6GALNAC3;SGMS2;DEGS2;PLPP1;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5
prerank,regulation of lymphocyte migration (GO:2000401),0.8833732836032167,1.8186819426726508,0.0017094017094017094,0.16619689794607348,0.969,3/10,4.24%,STK10;JAM2;MSN
prerank,regulation of angiogenesis (GO:0045765),0.5648873798903442,1.8126150940300112,0.0,0.1756008898363219,0.975,40/192,7.36%,VEGFC;PTPRM;TEK;NOS3;GATA6;CLDN5;GATA2;FLT1;TIE1;CEACAM1;PIK3R6;FOXO4;ATP2B4;ECSCR;DAB2IP;PRKD1;TGFB2;RHOB;EMP2;CEMIP2;BTG1;HHEX;ANXA3;PDE3B;KLF4;VEGFD;PLXND1;RRAS;VASH2;PPP1R16B;CD34;TSPAN12;PGK1;WARS1;IL1A;NPR1;ZC3H12A;ADAM12;STAT1;HSPB1
prerank,regulation of interleukin-10 production (GO:0032653),0.6792467256241743,1.806564612093168,0.0013175230566534915,0.18654070121340816,0.981,10/44,10.88%,PLCG2;NOD2;F2RL1;LGALS9;FCGR2B;CD34;CD47;HMGB1;TYROBP;VSIR
prerank,cellular response to sterol (GO:0036315),-0.7183091082332765,-1.8049728809016674,0.0,0.2050138223900435,0.944,9/13,17.11%,SMO;GRAMD1C;RORA;GPLD1;PTCH1;INSIG2;GRAMD1A;OSBPL7;GRAMD1B
prerank,diterpenoid metabolic process (GO:0016101),-0.5123177397128758,-1.8039228121240927,0.0,0.194828630327202,0.945,13/55,9.62%,GPC6;ALDH1A1;LRP1;SDC2;HSPG2;GPC3;RBP1;APOE;ABCA4;RBP4;NAPEPLD;DHRS3;STRA6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7463399309932472,1.8024061710654984,0.0045385779122541605,0.19324053554242335,0.985,6/25,10.16%,PLCG2;CDH13;GPR143;LRRK2;CMKLR1;CCL4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.7804284780762222,1.80049621973139,0.0033112582781456954,0.19387150265166178,0.985,1/15,0.01%,BMX
prerank,cellular glucan metabolic process (GO:0006073),-0.7503060561648177,-1.7979515768755552,0.0022727272727272726,0.19596781295674717,0.958,3/11,6.77%,PRKAG2;PHKB;PYGM
prerank,cellular response to glucagon stimulus (GO:0071377),-0.661045330142005,-1.7976085534686261,0.0084985835694051,0.1864160514451896,0.959,10/17,17.74%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6619101623850027,1.7970495089413847,0.003952569169960474,0.19764534717904678,0.986,15/38,12.63%,EDN1;KLF2;ATP2B4;INSR;CAV1;NOS1AP;KLF4;CD34;ASS1;CD47;ZC3H12A;JAK2;RAC1;CLU;CX3CR1
prerank,positive regulation of angiogenesis (GO:0045766),0.5817491969642851,1.7966072475508226,0.002372479240806643,0.1941506370141184,0.986,22/108,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;KLF4;VEGFD;RRAS;VASH2;CD34;IL1A;JMJD8;ZC3H12A;ADAM12;HSPB1
prerank,regulation of hydrolase activity (GO:0051336),0.6189280392188673,1.794850785310603,0.0038314176245210726,0.1934753918047168,0.986,16/71,5.38%,NOS1;FGD5;EFNA5;RASIP1;RABGAP1;PLXNA4;CHN2;DAB2IP;CAV1;PRKG1;CRK;APOA1;GPR137B;PLXND1;RAPGEF6;FGD6
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7364883736516472,-1.793914816220056,0.0049261083743842365,0.18477195131862148,0.965,4/11,9.11%,EGFR;DDX5;BMP4;MAP2K2
prerank,positive regulation of vasculogenesis (GO:2001214),0.852981043200047,1.793389617279107,0.00684931506849315,0.19217977924283403,0.986,6/10,5.43%,RAPGEF2;CEACAM1;ASB4;TMEM100;RRAS;CD34
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6928130635077068,1.787654424935514,0.002751031636863824,0.20298320361641783,0.991,11/34,7.60%,VEGFC;FLT1;FLT4;NOTCH1;EGR3;DAB2IP;PRKD1;DLL4;VEGFD;HSPB1;NUS1
prerank,heart morphogenesis (GO:0003007),0.6446170164120408,1.7864797167018112,0.0013351134846461949,0.20150732694696163,0.991,14/50,4.11%,SOX17;NOS3;ENG;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;INSR;HEY1;TGFB2;FKBP1A;HEY2;ACVR1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.7965954220420441,1.7833360725731808,0.00792393026941363,0.20582634807404465,0.991,5/14,8.12%,VEGFC;FLT4;VEGFD;NUS1;MYO1C
prerank,aortic valve development (GO:0003176),0.7061149035234187,1.7827174957243417,0.0014124293785310734,0.20274201756925433,0.991,15/34,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;BMPR2;NOTCH1;HEY1;DLL4;HEY2;EFNA1;TNFRSF1B;GATA3;SNAI2;ROCK1
prerank,membrane lipid biosynthetic process (GO:0046467),0.6345253875837512,1.7778357613308573,0.0,0.21155901080268227,0.993,17/58,9.75%,SGMS1;ACER2;SGPP2;ST8SIA6;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;CERT1;ELOVL4;CERS6;CERS5;HACD4
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8507606434722199,1.7775009599790066,0.009787928221859706,0.20810312582842536,0.993,2/11,1.06%,CEACAM1;SMAD7
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6030065767908673,-1.7768007781669974,0.0,0.21331070767033364,0.977,12/26,6.94%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,regulation of cellular respiration (GO:0043457),0.7704808018518176,1.7736463026140472,0.007836990595611285,0.2142136135186275,0.994,1/17,0.01%,PRDM16
prerank,positive regulation of sodium ion transport (GO:0010765),0.8121529558086213,1.7731404368507764,0.011146496815286623,0.21135038891167024,0.994,2/12,0.99%,NOS1;CNKSR3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.6545414880068146,1.7724213940244151,0.002652519893899204,0.20891788967605934,0.994,16/45,12.46%,IRF6;VCAM1;B2M;IRF2;IFNGR1;IRF9;CAMK2D;FCGR1A;STAT1;MT2A;OAS2;JAK2;TRIM25;GBP2;TRIM8;IRF5
prerank,B cell activation (GO:0042113),0.6302635161866503,1.7722179241233522,0.0012437810945273632,0.20546631463062748,0.994,11/68,6.32%,PTPRJ;PLCG2;VCAM1;CASP8;KLF6;HDAC9;HHEX;CTPS1;MEF2C;TPD52;ADAM17
prerank,mesenchyme morphogenesis (GO:0072132),0.7686237359888741,1.7707526490147831,0.009316770186335404,0.20564972789425515,0.994,8/17,5.38%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1;SMAD2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7241748315791843,1.7697888356722615,0.0030627871362940277,0.2046421416878652,0.994,6/24,9.75%,PECAM1;VCAM1;F11R;MSN;ROCK1;GFUS
prerank,macrophage activation (GO:0042116),0.6877029078394591,1.7682604094784815,0.004201680672268907,0.205055332314385,0.995,9/34,9.10%,PLCG2;CD93;DYSF;IFNGR1;APP;ITGAM;JAK2;NMI;FOXP1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6955441000014875,1.7651813165302632,0.005633802816901409,0.20858949630846338,0.997,9/31,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;LTB;HMGB1;LAPTM5;IRF5
prerank,respiratory tube development (GO:0030323),-0.5739240186942509,-1.762844834600678,0.0,0.23763102939378503,0.987,11/28,9.62%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8236830892905489,1.7615376506737979,0.011111111111111112,0.21433245209106286,0.998,3/11,4.95%,NOS1;NOS1AP;CAMK2D
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.8080723542584233,1.7603576319015422,0.0049586776859504135,0.213752169469886,0.998,6/12,7.87%,PODXL;JAG1;MYO1E;IQGAP1;PROM1;PTPRO
prerank,response to glucagon (GO:0033762),-0.6350332409327546,-1.7597231437653913,0.008875739644970414,0.23473034385485572,0.988,11/19,17.74%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;CREB1;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,T cell mediated immunity (GO:0002456),0.8078861050334235,1.7581818352496676,0.009771986970684038,0.2165119230518381,0.998,4/13,2.80%,JAG1;CRTAM;CADM1;EMP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.6686328119890347,1.7573600709699448,0.0027247956403269754,0.21495037632565572,0.998,6/41,5.31%,NOS1;KCNN4;KCNQ1;KCNN3;NOS1AP;STAC
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.6565991149682531,1.7551757572051123,0.0054869684499314125,0.21721728569348492,0.998,12/39,10.05%,PODXL;JAG1;NOTCH4;NOTCH1;APOA1;KLF4;PPM1F;ASS1;FXYD5;PTK2;MAD2L2;SPINT2
prerank,intestinal lipid absorption (GO:0098856),0.8360115123328827,1.7536149483973518,0.008156606851549755,0.21741374389580045,0.998,1/11,0.46%,LIMA1
prerank,endocardial cushion development (GO:0003197),0.7422327397641938,1.7529162551345752,0.010703363914373088,0.2156061205422204,0.998,8/21,4.11%,NOS3;ENG;BMPR2;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,keratan sulfate catabolic process (GO:0042340),-0.7199822274048081,-1.749164683703489,0.00477326968973747,0.25106196677732734,0.991,7/11,12.71%,OGN;FMOD;GNS;PRELP;HEXA;LUM;OMD
prerank,cellular response to zinc ion (GO:0071294),-0.6787293632513794,-1.744512003497405,0.0029069767441860465,0.25322496218340895,0.994,9/15,7.34%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;P2RX4
prerank,cellular response to drug (GO:0035690),0.7030533699269721,1.7417986978162736,0.0029542097488921715,0.24357645105728254,1.0,5/25,5.32%,ACER2;KCNQ1;AIM2;PPM1F;MEF2C
prerank,regulation of cardiac conduction (GO:1903779),0.621279427715531,1.7393094249852803,0.001336898395721925,0.2470592866252067,1.0,11/54,3.81%,NOS1;ATP2A3;GJA5;NPR2;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,clathrin coat assembly (GO:0048268),0.7939649402849279,1.7376032707994677,0.011513157894736841,0.24831423780848258,1.0,5/15,8.71%,HIP1;HIP1R;PIK3C2A;FCHO2;NSG2
prerank,sphingolipid biosynthetic process (GO:0030148),0.606362548310622,1.7367155374748053,0.001218026796589525,0.24694111848261993,1.0,26/71,14.96%,SGMS1;ACER2;SGPP2;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;CERT1;A4GALT;ELOVL4;CERS6;CERS5;HACD4;B4GALT6;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.7277614176984013,1.7351124164762264,0.005908419497784343,0.24799670041998068,1.0,6/22,11.23%,PTPRJ;CEACAM1;FCGR2B;DUSP3;PRNP;LAPTM5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.716948983211911,1.734588282341699,0.01649175412293853,0.24591774109020642,1.0,8/24,10.68%,PTPRJ;TEK;PPM1F;IQSEC1;MAP4K4;DUSP3;ROCK1;RAC1
prerank,amide biosynthetic process (GO:0043604),0.6380191038752464,1.732438539510684,0.008141112618724558,0.24866884061131997,1.0,13/47,9.27%,SGMS1;SGMS2;DEGS2;CERS4;PCSK5;SPTLC2;FURIN;SPTLC1;ARG1;ASAH2;ASS1;CERS6;CERS5
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7014082308135733,1.7316592270200126,0.002932551319648094,0.247839862102294,1.0,6/25,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8057482979141856,1.7313536361323008,0.008375209380234505,0.24503203807362808,1.0,4/12,11.20%,LAMA3;LAMA5;ACTG1;ACTB
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6376498214320752,-1.7306607579448203,0.010958904109589041,0.28017921262842566,0.999,6/16,7.26%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP3
prerank,response to lipid (GO:0033993),0.5764711408522046,1.7294253447615182,0.0011668611435239206,0.24730678807734757,1.0,21/105,10.93%,NOS1;ACER2;NOS3;GATA6;SMAD6;ALPL;FOXO1;LGALS9;GCH1;TIRAP;TRIM6;IFNAR1;PCK2;RXRG;ADAM17;HNRNPA0;PAQR8;JAK2;FOXP1;STRN3;TAB2
prerank,regulation of epithelial cell migration (GO:0010632),0.6212949722465112,1.728308353484115,0.002583979328165375,0.24753114028950676,1.0,19/51,10.49%,PLCG2;PTPRG;PTPRR;CEACAM1;BMPR2;RAB11A;MACF1;DAB2IP;TGFB2;EMP2;EVL;PPM1F;ADIPOR1;CLASP1;MCC;PTK2;RTN4;CLASP2;PLCG1
prerank,response to molecule of bacterial origin (GO:0002237),0.6042714314379855,1.7280779576140097,0.0024271844660194173,0.24492094823644842,1.0,17/69,12.89%,NOS1;NOS3;SMAD6;LGALS9;GCH1;TIRAP;FCGR2B;TRIM6;IFNAR1;ADAM17;HNRNPA0;JAK2;ACOD1;FOXP1;TAB2;IRF5;RPS6KA3
prerank,aortic valve morphogenesis (GO:0003180),0.6956028085284488,1.7280372630854322,0.0057553956834532375,0.24181850558080661,1.0,13/30,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;NOTCH1;HEY1;DLL4;HEY2;EFNA1;GATA3;SNAI2;ROCK1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.7384945209016192,1.7279659798854736,0.015527950310559006,0.2388361926322709,1.0,6/19,10.68%,PTPRJ;TEK;PPM1F;MAP4K4;ROCK1;RAC1
prerank,regulation of glucose metabolic process (GO:0010906),-0.5426761542510437,-1.7274147545287213,0.006644518272425249,0.2789219770507658,1.0,12/34,15.34%,OGT;PDK1;PRKN;RORA;IRS2;IRS1;GPLD1;ZNF692;FOXK2;PDK3;SLC45A3;PDK2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6239490849230451,-1.7258725877748409,0.005917159763313609,0.27334026767542535,1.0,11/19,11.26%,TGFBR3;BMPR1A;FGFR2;TGFBR1;ZFPM2;RBPJ;RBP4;FGF2;RUNX1;GLI1;TBX2
prerank,response to prostaglandin E (GO:0034695),-0.747089553563965,-1.7253396844726663,0.0024154589371980675,0.26511344555451993,1.0,1/10,0.09%,TGFBR3
prerank,artery development (GO:0060840),0.7003051350144609,1.7251432337880683,0.009022556390977444,0.24343899853031528,1.0,6/23,1.57%,GJA5;ENG;BMPR2;SMAD7;TBX1;ACVRL1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.7455682614070365,1.7237484395498581,0.010447761194029851,0.24466175051315156,1.0,6/19,6.03%,PDGFB;KLF2;APP;SLCO1C1;KLF4;GATA3
prerank,regulation of cell junction assembly (GO:1901888),0.6968480468517549,1.7198273752181186,0.00723589001447178,0.25237552743744796,1.0,11/27,9.21%,RAPGEF2;CLDN5;F11R;OCLN;RAPGEF1;PDLIM5;MEF2C;MYO1C;SNAI2;ROCK1;TJP1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.601427567825917,1.719236514473562,0.0012674271229404308,0.2508011281798435,1.0,16/64,9.22%,CDH13;ACER2;JAG1;EFNA5;UTRN;LIMCH1;MACF1;EMP2;ADAM15;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,cardiac atrium morphogenesis (GO:0003209),0.7557382689069654,1.7163447366667852,0.014586709886547812,0.25573906555888987,1.0,6/16,3.58%,ENG;BMPR2;NOTCH1;TGFB2;DLL4;HEY2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6771838550079592,1.71629612262364,0.002797202797202797,0.2527923945822558,1.0,3/33,0.80%,PTPRJ;KCNN4;CEACAM1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7612008340455942,1.7154713683244418,0.01938610662358643,0.252018452960799,1.0,4/15,3.84%,VEGFC;CDH13;F2RL1;VEGFD
prerank,positive regulation of lyase activity (GO:0051349),0.7752079006780257,1.7147588108749032,0.011864406779661017,0.2510000070363584,1.0,4/14,5.18%,NOS1;NOS3;ORAI1;AKAP5
prerank,substrate-dependent cell migration (GO:0006929),0.798548965479956,1.714236632853022,0.008169934640522876,0.2494387152709254,1.0,4/14,4.50%,VEGFC;CD2AP;NTN1;SHTN1
prerank,embryonic digestive tract development (GO:0048566),-0.6127361936198061,-1.7138548220180174,0.005555555555555556,0.2876590765498685,1.0,10/18,11.07%,GLI3;GLI2;FGFR2;PDGFRA;RARB;NIPBL;RBPMS2;PKDCC;STRA6;SALL1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.4781063949898953,-1.713780314899063,0.004545454545454545,0.2785977953916149,1.0,23/55,18.13%,GPC6;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;FMOD;GNS;BGN;FGF2;PRELP;HEXA;VCAN;HYAL1;LUM;CSPG4;OMD;HPSE2;GPC1;SDC1;SLC9A1;IDUA
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7561066848473554,1.7135630197748657,0.008156606851549755,0.24827499406796436,1.0,2/16,0.41%,NOS1;NOS3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5698969931343447,1.713172148992549,0.0011587485515643105,0.2463879800179764,1.0,28/112,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;CD34;IL1A;NFKBIL1;CD47;ZC3H12A;HSPB1;OAS2;JAK2;CACTIN;FOXP1;HMGB1;DHX9;TYROBP;VSIR;CYBA;CLU;CX3CR1;DDT
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7481831706660823,1.7127153058906903,0.010479041916167664,0.2448398975778502,1.0,5/17,11.23%,PTPRJ;CEACAM1;DUSP3;PRNP;LAPTM5
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7639796351108712,1.7121361742893144,0.01932367149758454,0.2410984713086514,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7639796351108712,1.7121361742893144,0.01932367149758454,0.2410984713086514,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5742495888410627,1.7091703659935789,0.0036407766990291263,0.2462781517294784,1.0,11/86,4.92%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;FYN;ARHGEF2;APP;ACVR1;ANGPT1;EFNA1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5758446610682229,-1.7075755777868438,0.006535947712418301,0.28669948874415707,1.0,11/25,14.74%,ANK2;DMD;WNK1;ACTN2;WNK4;ATP1B3;SLC6A9;COX17;TRPC6;ATP1B1;ATP1B2
prerank,cellular response to interferon-gamma (GO:0071346),0.5720934207789155,1.7060083951012779,0.002336448598130841,0.2523723895633832,1.0,25/88,12.46%,IRF6;VCAM1;GBP5;B2M;IRF2;IFNGR1;LGALS9;GBP4;IRF9;CAMK2D;GBP3;FCGR1A;CD47;STAT1;MT2A;OAS2;JAK2;ACOD1;GAPDH;TRIM25;CCL4;CASP1;GBP2;TRIM8;IRF5
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7164813749788783,1.704753862527905,0.007680491551459293,0.2530242313765032,1.0,5/20,7.75%,PLCB1;GNAQ;AGRN;CHRM3;LYPD1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.684586573565544,1.7039064208444803,0.007309941520467836,0.2523908865052386,1.0,6/26,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.702621973222213,1.7008982258049414,0.0197869101978691,0.2575331691801116,1.0,7/20,12.77%,NOS1;RPS6KA5;ARRB1;PRKAA1;BRCA1;DIP2B;GLYR1
prerank,positive regulation of cyclase activity (GO:0031281),0.7678124112644493,1.7002001849997905,0.01,0.25659432808989036,1.0,4/14,5.18%,NOS1;NOS3;ORAI1;AKAP5
prerank,lamellipodium assembly (GO:0030032),0.7019879522077359,1.7001883788020082,0.010416666666666666,0.25401744858061787,1.0,10/26,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,hemidesmosome assembly (GO:0031581),0.828193386452822,1.6991465285007659,0.008532423208191127,0.2543839363419737,1.0,3/11,6.94%,LAMA3;DST;PLEC
prerank,sprouting angiogenesis (GO:0002040),0.6116357587949249,1.6986260611726594,0.01045751633986928,0.25366715826008795,1.0,10/51,4.45%,VEGFC;CDH13;TEK;ENG;FLT4;RECK;ACVRL1;EGR3;VEGFD;ANGPT1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7778910730567332,1.6985207990398026,0.01854974704890388,0.2514671473407227,1.0,3/13,2.96%,NOTCH4;ENG;DLL4
prerank,dephosphorylation (GO:0016311),0.540272242549772,1.6980388600991183,0.0,0.24993720668304784,1.0,25/147,9.03%,PTPRM;PTPRJ;PTPRB;SGPP2;PTPRG;PTPRR;ALPL;PTPN14;DUSP12;DUSP1;PLPP1;INPP5K;PPM1F;ACP6;PTPRE;CTTNBP2NL;DUSP16;THTPA;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6561941770811403,1.6971238784392317,0.008438818565400843,0.25011227252067175,1.0,5/34,3.81%,NOS1;GJA5;KCNQ1;SMAD7;SLC8A1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.6294625146266192,1.696786089056871,0.006858710562414266,0.24859550161299224,1.0,8/39,4.97%,ACER2;JAG1;EFNA5;NOTCH1;ACTN4;ADAM15;GCNT2;MAP4K4
prerank,membrane repolarization during action potential (GO:0086011),0.7661975255482008,1.6936109124117393,0.020512820512820513,0.2545318705967716,1.0,3/13,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,regulation of heart contraction (GO:0008016),0.5659017099373921,1.6930554359514691,0.0024183796856106408,0.25356699546656153,1.0,15/90,4.95%,NOS1;ATP2A3;GJA5;KCNQ1;NPR2;SMAD7;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;TGFB2;SLC8A1;CAMK2D
prerank,second-messenger-mediated signaling (GO:0019932),0.5728205982771636,1.6922912174313416,0.0024183796856106408,0.2529616621671093,1.0,6/82,1.49%,NOS1;PLCG2;NOS3;EDN1;CCR1;MCTP1
prerank,negative regulation of cell growth (GO:0030308),0.549415272148816,1.691135055389964,0.0,0.2533731743254872,1.0,19/121,7.45%,SEMA3G;PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;SH3BP4;NPR1;HSPA1B
prerank,negative regulation of receptor binding (GO:1900121),0.8301450197510383,1.690531840497897,0.008305647840531562,0.2525199835441238,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6111057958116362,1.690070925134615,0.008097165991902834,0.2514239330199823,1.0,15/51,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;TMED10;P2RX7;HSPB1;JAK2;EGR1;HMGB1;TYROBP;CASP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5681633288603408,1.6887424151481454,0.0035294117647058825,0.2523868436953854,1.0,18/86,11.83%,SYNPO;EDN1;FCHSD2;TRPV4;STMN2;OCLN;F2RL1;APP;FES;EVL;CDC42EP1;CLIP1;CLASP1;WDR1;NCKAP1;RAC1;NUMA1;CLU
prerank,response to laminar fluid shear stress (GO:0034616),0.8144746250281154,1.6887350724233026,0.013986013986013986,0.2501515153417712,1.0,6/10,8.27%,SMAD6;SMAD7;KLF2;KLF4;ASS1;NFE2L2
prerank,muscle cell differentiation (GO:0042692),0.6571058966049095,1.6875232806545464,0.01394700139470014,0.25115355669464223,1.0,8/32,5.52%,MRTFB;NEBL;GATA6;SYNE1;TBX1;HEY2;MEF2C;TMEM204
prerank,artery morphogenesis (GO:0048844),0.6663999252121832,1.686820913489135,0.016129032258064516,0.25082915868466815,1.0,9/30,3.58%,GJA5;JAG1;ENG;BMPR2;SMAD7;TBX1;NOTCH1;TGFB2;HEY2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6979214319333458,1.6838464127527897,0.015602836879432624,0.2561416347348612,1.0,4/23,2.70%,PIK3R6;CRTAM;LGALS9;CADM1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7534811466227453,1.6830872654746925,0.020338983050847456,0.2558935829366852,1.0,3/14,2.63%,RAPGEF2;ATP2B4;ADRB2
prerank,lipoprotein localization (GO:0044872),-0.7049566205264661,-1.6812714336528005,0.019559902200488997,0.35455919014462417,1.0,5/11,13.79%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,sphingolipid metabolic process (GO:0006665),0.5579596678932007,1.681183489575117,0.0011641443538998836,0.2585647409061676,1.0,29/108,15.26%,SGMS1;ACER2;SGPP2;ST6GALNAC3;SGMS2;DEGS2;ESYT2;PRKD1;PPT1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;GLTP;CERT1;ELOVL4;CERS6;CERS5;HACD4;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK;TECR
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.6877654736510433,-1.6810225143995114,0.015037593984962405,0.34489779689410216,1.0,8/12,26.82%,STX4;ANO1;GPLD1;PPP3CB;C2CD2L;PLA2G6;CFTR;BAIAP3
prerank,negative regulation of vascular permeability (GO:0043116),0.7826294396254917,1.6802675097986663,0.013266998341625208,0.2587304577494314,1.0,4/12,4.45%,PTPRJ;CLDN5;CEACAM1;ANGPT1
prerank,regulation of interleukin-12 production (GO:0032655),0.6256986996146054,1.6792756461729705,0.01171875,0.25933693372436645,1.0,12/47,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;CD47;CMKLR1;LTB;FOXP1;HMGB1;LAPTM5;IRF5
prerank,skeletal system development (GO:0001501),-0.4024810188890595,-1.6775345427597461,0.0,0.3455274804306866,1.0,38/148,10.81%,COL1A2;BMP6;IGF1;SOX5;COL1A1;GLI2;FGFR2;SULF1;TGFBR1;CDH11;BMP5;BMP7;NPR3;SULF2;MMP14;TLL1;WNT5A;COL13A1;TRIP11;GJA1;RBP4;SH3PXD2B;FBN1;ITGB8;TNFRSF11B;XYLT1;PRELP;EVC;ANKRD11;VCAN;IGF2;WWOX;P3H1;PKDCC;PTH1R;COL9A2;MMP16;HYAL1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6516352749026769,-1.6774202255232689,0.013297872340425532,0.33627819203924714,1.0,9/13,28.01%,IDH2;ADHFE1;L2HGDH;IDH1;GOT1;DLST;D2HGDH;PHYH;GOT2
prerank,negative regulation of potassium ion transport (GO:0043267),0.7551701197277417,1.67685338487961,0.02050473186119874,0.2635112967760567,1.0,4/13,10.96%,NOS1;CAV1;STK39;NEDD4L
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.719079203068252,1.6765653435503707,0.014285714285714285,0.2621723885756733,1.0,4/18,6.12%,PLCB1;GNAQ;AGRN;CHRM3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5767513615530613,1.673740187351864,0.010948905109489052,0.2674115512285238,1.0,8/67,3.24%,BMX;TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES
prerank,diol biosynthetic process (GO:0034312),0.7492952023726734,1.6728157812711268,0.022187004754358162,0.267622390967241,1.0,5/15,5.93%,ACER2;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,regulation of Notch signaling pathway (GO:0008593),0.5724238326726369,1.6724235750881598,0.004956629491945477,0.26658559478367966,1.0,21/76,11.31%,JAG1;JAG2;NOTCH4;NOS3;GATA2;EGFL7;MFNG;NOTCH1;NOD2;HEY1;TGFB2;DLL4;TSPAN14;ARRDC1;POGLUT1;ARRB1;TM2D3;FBXW7;EPN2;MAML2;HIF1AN
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7262288662524272,1.6710401307836311,0.024883359253499222,0.26774974060453377,1.0,8/19,4.92%,SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;ACVR1;EFNA1
prerank,sphingosine metabolic process (GO:0006670),0.735926442577118,1.6686674918635431,0.022292993630573247,0.27181967266984014,1.0,6/17,5.93%,ACER2;SGPP2;PLPP1;SPTLC2;SPTLC1;ASAH2
prerank,defense response to fungus (GO:0050832),0.7361310862395658,1.6645221086560182,0.0112,0.28048507705229087,1.0,4/17,14.37%,PLCG2;GAPDH;CX3CR1;FAM3A
prerank,plasma membrane tubulation (GO:0097320),0.7632050372255235,1.664195926960532,0.015126050420168067,0.2792215919448488,1.0,6/13,8.41%,CAVIN2;PACSIN2;FNBP1L;PACSIN1;WHAMM;BIN3
prerank,sphingosine biosynthetic process (GO:0046512),0.7954660439179732,1.6639117732176014,0.02138157894736842,0.27556612738965364,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.7954660439179732,1.6639117732176014,0.02138157894736842,0.27556612738965364,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,Rap protein signal transduction (GO:0032486),0.8148979520773181,1.663589997796022,0.020168067226890758,0.27434588123525794,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,endothelial cell migration (GO:0043542),0.6328815872507295,1.6634309663894336,0.0111731843575419,0.27255202046586946,1.0,10/37,7.31%,CDH13;NOS3;EGR3;EMP2;ID1;SOX18;PLXND1;PLEKHG5;MYH9;STAT1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7362949856684808,1.6620115956268484,0.029595015576323987,0.2743263064525443,1.0,2/17,1.54%,JAG1;BACH2
prerank,endocardial cushion morphogenesis (GO:0003203),0.7226526040663608,1.6619532775926746,0.018867924528301886,0.2724381677099972,1.0,7/18,4.11%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.6092443312998477,1.6616706994969466,0.013736263736263736,0.271081759030561,1.0,13/45,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;P2RX7;HSPB1;JAK2;EGR1;TYROBP;CASP1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6078055784696316,-1.6613634165501163,0.0136986301369863,0.37703661476424616,1.0,6/17,1.61%,DOCK5;IGF1;PDGFRB;IGFBP5;DOCK7;VTN
prerank,vasculogenesis (GO:0001570),0.646017756310454,1.6607784167884603,0.015804597701149427,0.271514143631229,1.0,8/32,3.58%,SOX17;ENG;RASIP1;EGFL7;NOTCH1;CAV1;SOX18;HEY2
prerank,camera-type eye development (GO:0043010),-0.5576370453459569,-1.6604783703646564,0.005813953488372093,0.37001146743367036,1.0,8/25,9.62%,CACNA1C;EFEMP1;LAMA1;FBN2;FBN1;SHROOM2;VEGFA;STRA6
prerank,cellular response to fluid shear stress (GO:0071498),0.7826363821344434,1.6580455026442615,0.02030456852791878,0.2768894331447206,1.0,5/12,8.27%,KLF2;KLF4;MEF2C;ASS1;NFE2L2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7510108578071089,1.6572445999383763,0.031007751937984496,0.276935122025105,1.0,3/15,3.48%,SMAD7;TGFB2;APOA1
prerank,lipoprotein transport (GO:0042953),-0.7130348863269319,-1.656110465120736,0.02142857142857143,0.373993196072143,1.0,5/10,13.79%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,response to growth factor (GO:0070848),0.615141729556811,1.655550879908698,0.022099447513812154,0.27939724897190976,1.0,7/41,4.11%,NOS1;GATA6;PDGFB;BMPR2;ACVRL1;KLF4;ACVR1
prerank,regulation of biomineral tissue development (GO:0070167),0.6661713525679616,1.6553520269230908,0.019943019943019943,0.2779163216022251,1.0,8/26,9.04%,NOS3;SGMS2;S1PR1;NOTCH1;HEY1;HEY2;NBR1;ROCK1
prerank,neutrophil migration (GO:1990266),0.5808909869317415,1.6553207341639327,0.00639386189258312,0.276060465028626,1.0,5/58,6.86%,PECAM1;EDN1;TGFB2;PIP5K1C;BSG
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.620855928794736,-1.6547335406581491,0.025210084033613446,0.36867484198301376,1.0,5/17,6.67%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1G
prerank,early endosome to Golgi transport (GO:0034498),-0.6793537209933203,-1.6545028562070476,0.014634146341463415,0.3602480153682926,1.0,8/11,16.06%,SURF4;TRAPPC10;LMAN1;EHD3;STX5;SNX1;SNX8;SNX2
prerank,regulation of interleukin-6 production (GO:0032675),0.5503400628885627,1.6533966711594053,0.0,0.2792201399815358,1.0,20/96,11.05%,PLCG2;AFAP1L2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;CD47;ZC3H12A;ARRB1;CD200;HMGB1;DHX9;TYROBP;CYBA
prerank,diol metabolic process (GO:0034311),0.7082974683734784,1.653146087655957,0.025954198473282442,0.27802705258898475,1.0,6/19,5.93%,SGPP2;NOS3;DEGS2;PLPP1;GCH1;ASAH2
prerank,sphingolipid catabolic process (GO:0030149),0.7299621347214531,1.6508441882722233,0.02843601895734597,0.28171424065504347,1.0,4/15,5.93%,ACER2;PPT1;SMPDL3A;ASAH2
prerank,lamellipodium organization (GO:0097581),0.6553224458240425,1.6508217940464196,0.022792022792022793,0.2798273857013009,1.0,10/29,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,eye development (GO:0001654),-0.4707417963662217,-1.648898265411983,0.004273504273504274,0.3691438588440264,1.0,13/54,6.70%,CACNA1C;SMOC1;EFEMP1;COL5A1;LAMA1;PBX3;FBN2;RBP4;SH3PXD2B;FBN1;NIPBL;MEIS1;SHROOM2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6558921018696399,1.6481769912639483,0.015220700152207,0.28481438173745355,1.0,8/25,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;RTN4;CCDC88A
prerank,lipid oxidation (GO:0034440),0.7756498090388717,1.6479111979020555,0.01935483870967742,0.2835880832675767,1.0,3/12,8.17%,ADIPOR2;ADIPOR1;ACOX1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5548850209151291,-1.6473393901737148,0.03170028818443804,0.3655668834676307,1.0,11/23,22.66%,SMO;BMP4;GJA1;FGF2;SIX1;VEGFA;MDK;PAX2;AGT;WNT5B;SIX4
prerank,polyol metabolic process (GO:0019751),0.6044803420341629,1.6438841236625108,0.019815059445178335,0.29196631312381116,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5656424228326853,1.6438806476203123,0.00902061855670103,0.29004086921174854,1.0,27/70,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.6142014070487176,-1.6428469972875075,0.016,0.3716112135874549,1.0,4/16,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,pulmonary valve morphogenesis (GO:0003184),0.72543688583466,1.6422970093413105,0.030015797788309637,0.29232980504543765,1.0,8/17,3.58%,GJA5;JAG1;NOS3;SMAD6;NOTCH1;HEY1;TGFB2;HEY2
prerank,eye morphogenesis (GO:0048592),-0.6011000174877054,-1.6403248016005483,0.011267605633802818,0.3717219188447557,1.0,9/19,8.97%,EFEMP1;COL5A1;NKD1;MFAP5;FBN2;FBN1;NIPBL;SHROOM2;VEGFA
prerank,response to lipopolysaccharide (GO:0032496),0.5278302227238786,1.6379875270597466,0.00331858407079646,0.30147855561264797,1.0,31/138,10.93%,NOS1;NOS3;SMAD6;NOD2;DAB2IP;LGALS9;VIM;GCH1;TIRAP;DEFA6;TRIM6;MEF2C;TNFRSF1B;IFNAR1;IL1A;PDCD4;ADAM17;NFKBIL1;IRGM;HNRNPA0;ZC3H12A;JAK2;NR1D1;ACOD1;CACTIN;FOXP1;STAP1;HMGB1;NFKBIB;CASP1;TAB2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5435068742967094,1.6377171818436422,0.008073817762399077,0.3000627617852636,1.0,23/109,11.66%,BMX;PLCG2;PIP5K1B;PLCB1;PITPNM3;PIK3R6;IP6K3;INPP5D;PIK3C2A;INPP5K;PLEKHA1;PIP5K1C;PGAP1;FIG4;LCLAT1;MTMR10;INPP5B;PIK3C3;ARF3;PLCG1;MTMR11;OCRL;INPP5F
prerank,positive regulation of cell migration (GO:0030335),0.5051464017850528,1.6367667859797808,0.0,0.30070217736677346,1.0,49/253,9.54%,SEMA3G;PECAM1;PLCG2;CDH13;PODXL;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;BMPR2;CCR1;NOTCH1;RAB11A;MYLK;INSR;FAM107A;ARHGEF2;DAB2IP;CAV1;F2RL1;TGFB2;NEDD9;SEMA3F;ACTN4;TNFRSF18;MGAT5;PPM1F;ACVR1;SHTN1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;CLASP1;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RTN4;RIPOR1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5717949037942737,1.6367622983366785,0.01015228426395939,0.2987561569555951,1.0,15/68,11.05%,PLCG2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;HMGB1;DHX9;TYROBP;CYBA
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6437686664934211,1.6362307939327485,0.01741654571843251,0.2984003634969861,1.0,6/29,2.67%,ENG;S1PR1;SMAD7;MYBPC3;NOTCH1;FKBP1A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6273234075409478,1.636215701980768,0.020833333333333332,0.29652658042502966,1.0,9/33,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;ADAM17;FBXW7;CCDC88A
prerank,axon extension (GO:0048675),-0.574708598420809,-1.6359169872230614,0.012121212121212121,0.3773276632794698,1.0,10/23,11.03%,ALCAM;AUTS2;NRP2;SLIT2;SEMA5A;SEMA3A;USP9X;SPG11;PPP3CB;ULK2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.559847586771622,1.6350340796382379,0.010243277848911651,0.2979868419220911,1.0,27/71,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7691589661753506,1.6342345472420075,0.019672131147540985,0.29824655413226187,1.0,4/13,8.51%,EDN1;NOD2;JAK2;NAMPT
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5259478465165018,-1.6341872511386017,0.006514657980456026,0.374435707407266,1.0,10/31,7.10%,FGFR2;HOXC4;PDGFRA;TGFBR1;OSR1;HOXA3;HOXB3;HOXB4;MEGF8;SIX1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5580420834896389,1.6340756195821429,0.007662835249042145,0.29677935680375067,1.0,27/73,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7601484977008394,1.6331697157430454,0.018487394957983194,0.297100465058332,1.0,6/12,7.07%,INSR;ADRB2;SMCR8;SETX;IRGM;FYCO1
prerank,intestinal absorption (GO:0050892),0.7637060663310586,1.6331290690409528,0.02572347266881029,0.2953496889441774,1.0,3/13,7.70%,KCNQ1;F11R;TJP2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7592788849863803,1.632980525339034,0.024232633279483037,0.2939338094626966,1.0,2/13,0.41%,NOS1;NOS3
prerank,bicellular tight junction assembly (GO:0070830),0.602034876322162,1.6328663430697834,0.01171875,0.29244189469461157,1.0,5/46,3.22%,PECAM1;CLDN5;F11R;OCLN;ESAM
prerank,negative regulation of axonogenesis (GO:0050771),0.6457090119118328,1.6320932430055386,0.016591251885369532,0.29258356355676185,1.0,9/27,18.15%,SEMA3G;ARHGDIA;RTN4;DCC;TRIM46;DIP2B;MAP2;GDI1;CDKL3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7254145067778165,1.632068198991122,0.024844720496894408,0.2908533918886425,1.0,4/16,2.53%,PTPRJ;PDGFD;PDGFB;PIK3C2A
prerank,epithelial tube morphogenesis (GO:0060562),0.630923858694176,1.6301792312738002,0.02881844380403458,0.2938156681358418,1.0,8/32,6.03%,PODXL;SOX17;RASIP1;ACVRL1;RHOB;ACVR1;MEF2C;GATA3
prerank,smooth muscle cell differentiation (GO:0051145),0.7609239960523668,1.6292782740949907,0.03257328990228013,0.2942990926542767,1.0,7/12,8.56%,MRTFB;GATA6;HEY1;HEY2;MEF2C;TMEM204;MRTFA
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6190288025022154,-1.6290784572469517,0.024193548387096774,0.38353336511296043,1.0,7/15,16.47%,GGACT;ALDH4A1;PRODH;GGT5;SARDH;ABHD12;GGT7
prerank,oogenesis (GO:0048477),0.7358030630042393,1.6265698928701304,0.019261637239165328,0.29980963926018334,1.0,2/15,0.40%,NANOS1;NANOS3
prerank,regulation of membrane depolarization (GO:0003254),0.699256751899558,1.6259785284155157,0.02450229709035222,0.2997293431744642,1.0,6/18,10.96%,GJA5;SMAD7;CAMK2D;LRRK2;SCN1B;NEDD4L
prerank,inositol phosphate metabolic process (GO:0043647),0.5988763957970319,1.6251119508841412,0.022606382978723406,0.3000619761551975,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,cellular response to calcium ion (GO:0071277),0.5641695651327137,1.6247648251063465,0.0038560411311053984,0.2992688389574365,1.0,13/67,8.29%,PLCG2;SYT15;ITPKB;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;MCOLN1;PRKAA1
prerank,regulation of axon extension (GO:0030516),0.6107119208136709,1.624552523791583,0.02401129943502825,0.2981367440022511,1.0,10/37,11.97%,SEMA3G;MACF1;NTN1;SHTN1;SEMA7A;ISLR2;NRCAM;RTN4;TRIM46;DIP2B
prerank,epithelial cell migration (GO:0010631),0.6197187896533553,1.6244819824916361,0.02074688796680498,0.29657769318876004,1.0,9/37,9.04%,NANOS1;CDH13;NOS3;PKN3;PLXND1;PKN1;PLEKHG5;STAT1;ROCK1
prerank,endothelial cell differentiation (GO:0045446),0.7703366810536824,1.622255314590689,0.025597269624573378,0.30056674798773014,1.0,5/12,3.25%,JAG1;TIE1;BMPR2;ACVRL1;SOX18
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5836633939256924,1.6216621824517532,0.01859229747675963,0.30029347215510804,1.0,10/49,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;HYAL2;HSPA1B;HMGB1
prerank,regulation of macrophage cytokine production (GO:0010935),0.7401987105481814,1.6173562317449734,0.027552674230145867,0.30984490956569877,1.0,3/13,4.67%,PLCG2;TGFB2;SEMA7A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5278201114828168,1.6169955980088506,0.005733944954128441,0.30896604100818126,1.0,14/121,6.05%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;ACE;ARHGEF2;NEDD9;TNFRSF18;ACVR1;ANGPT1;EFNA1;FGFR3;FCGR1A
prerank,filopodium assembly (GO:0046847),0.7021096813614899,1.6169592803554689,0.03475513428120063,0.30731011087124843,1.0,4/16,5.38%,SPATA13;FGD5;DNM3;FGD6
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5418752370125703,-1.6150304963701796,0.025236593059936908,0.4212283783253824,1.0,7/23,9.80%,PLCE1;AGMO;LPGAT1;MOGAT3;PLA2G4A;GK;DGAT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6961732234264137,1.6149693964917338,0.014331210191082803,0.3107932176235713,1.0,3/17,2.55%,PODXL;PIEZO1;TGFB2
prerank,metal ion transport (GO:0030001),0.5407186316955344,1.6148289795938267,0.005931198102016607,0.3094105723965687,1.0,17/86,11.28%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B2;CAV1;CACNA1A;SLC8A1;ATP2C1;NIPAL2;SLC30A1;NIPAL3;NDFIP2;NIPA2;GRIN3A;TRPM2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5949566386675137,1.6144907462271865,0.016150740242261104,0.3085815656159886,1.0,18/48,11.99%,NOS3;GATA2;PDGFB;JCAD;PRKD1;PIK3C2A;HDAC9;HDAC7;ANGPT1;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;MAP3K3;PRKD2
prerank,alcohol catabolic process (GO:0046164),-0.6945700983396124,-1.614073605880056,0.013921113689095127,0.4161448661629115,1.0,2/10,2.91%,CYP27A1;APOE
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7647419749896732,1.6127722482029556,0.018518518518518517,0.3115931434655182,1.0,3/12,11.05%,PLCG2;ADGRB1;CYBA
prerank,cellular response to cAMP (GO:0071320),0.6335870277692075,1.6126061090320352,0.026988636363636364,0.31028980634964853,1.0,4/30,3.52%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K
prerank,ameboidal-type cell migration (GO:0001667),0.5792969818838166,1.6117402716326068,0.016861219195849545,0.3110141545640234,1.0,7/51,4.99%,SEMA3G;NANOS1;TBX1;SEMA3F;PKN3;SEMA7A;PKN1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6473219650989877,1.6116619959256118,0.016058394160583942,0.30960733049754136,1.0,8/27,13.00%,NOS1;UTRN;ATP2B4;CAMK2D;FXYD5;SCN1B;NEDD4L;YWHAH
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6642845592407679,1.6114186040602831,0.02616279069767442,0.3085812641147573,1.0,8/26,11.08%,TRPV4;STMN2;OCLN;FES;CLIP1;CLASP1;RAC1;NUMA1
prerank,hemopoiesis (GO:0030097),0.5469937621163475,1.611260704505232,0.01070154577883472,0.3073110561952707,1.0,17/87,7.98%,MECOM;JAG1;TEK;NOTCH4;FLT1;PDGFB;FLT4;KITLG;TAL1;SNRK;TGFB2;TIRAP;RRAS;CD34;ZBTB16;CEBPA;TPO
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7437538587832732,1.6108976878110155,0.04695652173913043,0.3066104702039997,1.0,2/11,2.15%,KCNQ1;ATP1A1
prerank,tight junction assembly (GO:0120192),0.587914103675032,1.6106606866848339,0.014230271668822769,0.3056058058918575,1.0,6/49,3.70%,PECAM1;CLDN5;F11R;OCLN;ESAM;LSR
prerank,neurotransmitter uptake (GO:0001504),-0.6533761993617857,-1.6105312626903883,0.03864734299516908,0.4198566450442861,1.0,4/12,10.49%,ATP1A2;SLC1A3;SNAP25;SLC29A1
prerank,cellular response to copper ion (GO:0071280),-0.603838538463005,-1.6097258785817268,0.023017902813299233,0.41414082714999667,1.0,8/16,6.94%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,regulation of feeding behavior (GO:0060259),-0.6815789058253465,-1.6081041694062357,0.015424164524421594,0.4116468851499952,1.0,3/11,15.26%,LEPR;CFAP20;EIF2AK4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.7183346152375127,1.607736150107429,0.020569620253164556,0.311401760528117,1.0,7/15,12.57%,ATL2;ATL1;REEP2;RTN4;REEP1;REEP3;RTN3
prerank,negative regulation of developmental growth (GO:0048640),0.6318530601869957,1.6076681472608312,0.028400597907324365,0.3099627001359838,1.0,8/30,11.97%,SEMA3G;FGFR3;SLC6A4;WWC2;RTN4;DCC;TRIM46;DIP2B
prerank,endoderm development (GO:0007492),0.7442461582533505,1.6061713616953048,0.03691275167785235,0.31212296892872254,1.0,2/13,2.05%,SOX17;DUSP1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6976555001934063,-1.604625042820912,0.017587939698492462,0.41507481288000875,1.0,5/10,4.91%,PID1;APPL2;PRKCB;GRB10;ENPP1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6552917127128451,1.603578478366396,0.025787965616045846,0.31736380533358327,1.0,5/25,5.08%,PLCG2;NOD2;B2M;F2RL1;TRIM6
prerank,regulation of hemopoiesis (GO:1903706),-0.6735753287619842,-1.6016683360289519,0.03211009174311927,0.4169208758784051,1.0,5/10,9.65%,PTN;PRKCB;CREBBP;RUNX1;IL17D
prerank,positive regulation of histone methylation (GO:0031062),-0.543691535381711,-1.5992132456089647,0.02735562310030395,0.41733878996645973,1.0,9/24,11.91%,AUTS2;OGT;SNW1;JARID2;MTF2;PAF1;WDR5;CTR9;TET1
prerank,negative regulation of cartilage development (GO:0061037),-0.6361150614302895,-1.599004348989999,0.01990049751243781,0.41062692393492833,1.0,4/13,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,response to muramyl dipeptide (GO:0032495),0.7436715752997687,1.5980207419933288,0.032948929159802305,0.3301372071656111,1.0,4/12,2.69%,NOD1;NOD2;ARHGEF2;VIM
prerank,cytoplasmic microtubule organization (GO:0031122),0.5773148299643276,1.5977482488265453,0.015748031496062992,0.32917814354110464,1.0,17/54,11.08%,CCDC88C;TRPV4;PLK3;RAB11A;CLIP2;SLK;DST;CAMSAP2;CLIP1;CLASP1;KPNB1;HOOK1;PCM1;KATNAL2;CCDC88A;LIMK2;NUMA1
prerank,negative regulation of cell motility (GO:2000146),0.5253776353443229,1.5976675995742253,0.005733944954128441,0.3277317067477232,1.0,21/108,7.86%,PTPRJ;JAG1;ENG;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;RHOB;CRK;CLIC4;ADAM15;STK24;SPOCK3;GATA3;SRGAP1;DUSP3;PTPRU
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7474998227015105,1.5964235303144163,0.03409090909090909,0.32933475181356253,1.0,5/13,10.63%,MMRN2;DAB2IP;HHEX;EPN2;PTPN1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6919660284372351,-1.5958781050524278,0.02564102564102564,0.41396921776646184,1.0,5/10,13.91%,IRS2;IRS1;GPLD1;PTH1R;SLC45A3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6257897244208257,1.5958659668174269,0.0329512893982808,0.3291273524047277,1.0,10/32,4.05%,MMRN2;GATA2;NOTCH1;JCAD;PIK3C2A;DLL4;HDAC9;HDAC7;KLF4;CARD10
prerank,lymphocyte migration (GO:0072676),0.6241588188446339,1.5952718610329888,0.018361581920903956,0.3289730441480065,1.0,5/32,10.16%,S1PR1;CRTAM;MSN;GATA3;CCL4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5098405909058937,1.5935700424549366,0.003303964757709251,0.332185116834011,1.0,40/151,14.92%,SGMS1;ACER2;SGPP2;GCNT1;SGMS2;DEGS2;GSTA2;PRKD1;PLPP1;GCH1;APOA1;GPHN;CERS4;SLC44A1;PCSK5;SPTLC2;LCAT;SPNS2;FURIN;SPTLC1;ARG1;ASS1;ALAS1;CERT1;PCYT1A;ELOVL4;CERS6;CERS5;HACD4;CEPT1;LPCAT3;ELOVL7;ACHE;PRKD2;PPM1L;TYW1;ELOVL5;VAPA;STARD10;CSNK2B
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5847892316004785,1.5922691537955918,0.02435723951285521,0.33421384669563914,1.0,9/41,11.28%,PLCG2;TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;HTR2A;TRPM2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5493020383633574,1.5916577098194833,0.013349514563106795,0.3342275964795146,1.0,14/72,7.74%,EPS8L2;HEG1;ARHGEF3;RASIP1;ARHGEF28;F11R;ARHGEF2;F2RL1;APOA1;BCR;LPAR6;CUL3;ARHGDIA;ARRB1
prerank,regulation of cellular component organization (GO:0051128),0.5115056666799013,1.591652871297536,0.007847533632286996,0.33259115545296813,1.0,28/135,11.63%,CDH13;LTBP4;RAPGEF2;HIP1;CEACAM1;HIP1R;RAPGEF1;FAM107A;DAB2IP;RASGRP2;PACSIN2;CISH;WFDC1;CAMK2D;STK38L;CAMSAP2;PACSIN1;IRGM;ROCK1;TJP1;SGK1;STON1;TAOK2;MAD2L2;ERMN;PTPN1;SPOCK1;SNCAIP
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5663092546985125,-1.5907472731189738,0.03273809523809524,0.42410487256198726,1.0,7/20,10.06%,ATP1A2;ANK2;CACNA1C;DMD;CALM2;PRKACA;ATP2A2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6203857942430923,-1.5899143518399577,0.021447721179624665,0.41946660910796535,1.0,6/16,11.07%,FOXD1;BMP4;FGF1;FGF2;SIX1;SALL1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6151409626987905,1.5898966602616864,0.021613832853025938,0.33567772956810676,1.0,7/33,3.54%,PTPRM;PTPRG;PTPRR;ACVRL1;DAB2IP;DLL4;EVL
prerank,regulation of cell adhesion (GO:0030155),0.5126091814756155,1.5896663594574298,0.004608294930875576,0.3345601727153655,1.0,22/129,9.42%,PTPRJ;CDH13;PODXL;NUAK1;EFNA5;PLXNA4;RND1;ACVRL1;DUSP1;FES;CYTH1;TNFRSF18;PDE3B;PLXND1;ANGPT1;EFNA1;ARHGDIA;PPP3CA;RSU1;ROCK1;PTK2;ADAM10
prerank,embryonic eye morphogenesis (GO:0048048),-0.6571893903783887,-1.5896206311767955,0.02843601895734597,0.413571560152866,1.0,7/11,19.35%,EFEMP1;MFAP5;FBN2;FBN1;TBX2;RARG;MFAP2
prerank,regulation of microtubule depolymerization (GO:0031114),0.6510990062465543,1.5887347668038927,0.019402985074626865,0.33555251691603133,1.0,8/25,9.92%,TRPV4;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6241599274481155,1.5886194804077274,0.03730272596843615,0.33419628175434046,1.0,8/29,9.21%,KANK4;LIMA1;HIP1R;FKBP4;KANK3;SHANK3;CLASP1;TJP1
prerank,cardiac cell development (GO:0055006),0.7532080687429312,1.5876956765489594,0.042328042328042326,0.3348929153486947,1.0,4/11,4.18%,JAG1;NOTCH1;SLC8A1;ALPK3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6378584455094114,-1.58558498230114,0.029490616621983913,0.4193607020748335,1.0,7/13,16.35%,BMP5;DKK3;APOE;ERLIN1;REST;NFKB1;SCAP
prerank,establishment of epithelial cell polarity (GO:0090162),0.6739818559465203,1.585289417118302,0.02627511591962906,0.33972558135189745,1.0,6/19,6.73%,CYTH3;SIPA1L3;CYTH1;MSN;SYNE4;CLASP1
prerank,regulation of receptor binding (GO:1900120),0.7577790756323384,1.5847195859957581,0.043333333333333335,0.33941288426084126,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.609843131136336,-1.5846283147629994,0.0273224043715847,0.4155397424481149,1.0,6/14,14.74%,ANK2;ACTN2;ATP1B3;LRRC38;ATP1B1;ATP1B2
prerank,cholesterol homeostasis (GO:0042632),0.5560797129436297,1.584456596756821,0.02127659574468085,0.33853069116405904,1.0,10/64,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5509326908194883,1.583097699664412,0.007434944237918215,0.34050083112906826,1.0,17/73,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;CASP8;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4795525407478056,1.583051940663413,0.0,0.3390070748749249,1.0,48/348,8.22%,VEGFC;NOS1;PTPRJ;PECAM1;PLCG2;TEK;PDGFD;ENG;RAPGEF2;EFNA5;PDGFB;BMPR2;FLT4;RPS6KA5;FAS;TBX1;LIMCH1;CCND2;ACVRL1;ATP2B4;INSR;CCND3;ARHGEF2;RBPMS;CAV1;PRKD1;TGFB2;APP;IQGAP1;VEGFD;KRAS;ACVR1;ANGPT1;EFNA1;TRIM6;CSNK1D;BRAT1;BCAR3;ADAM17;MAPK1;IRGM;LRRK2;PDE8A;MAPRE3;ARRB1;THPO;TOM1L1;JAK2
prerank,regulation of cell migration (GO:0030334),0.4795712233838601,1.5829539462799285,0.0,0.33762688510423716,1.0,70/382,9.54%,SEMA3G;PTPRJ;PECAM1;CDH13;PODXL;JAG1;SPATA13;EDN1;PDGFD;ENG;CLDN5;FLT1;CEACAM1;PDGFB;LDB2;DACH1;RECK;ACE;SMAD7;PLXNA4;CCR1;LIMCH1;MCTP1;ACVRL1;NOTCH1;MYLK;INSR;FAM107A;ADARB1;MACF1;CAV1;F2RL1;RHOB;NEDD9;SEMA3F;ACTN4;CLIC4;MGAT5;PPM1F;PLXND1;ADAM15;ACVR1;SLK;STK24;LEF1;GCNT2;SEMA7A;MAP4K4;TTBK2;ROBO4;SPAG9;SRGAP1;ADAM17;KIF2A;DUSP3;PPP3CA;PRR5L;PTPRU;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;ROCK1;TJP1;PTK2;SGK1;ADAM10;RIPOR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7443117169912019,1.5828900880117605,0.04355108877721943,0.33624064995382946,1.0,5/11,9.21%,RAPGEF2;F11R;RAPGEF6;TJP2;TJP1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6964472474482163,1.5824650113478216,0.04966887417218543,0.33584469050584076,1.0,2/15,2.15%,KCNQ1;ATP1A1
prerank,sterol homeostasis (GO:0055092),0.55422234528013,1.5820380012285524,0.02,0.33533076347130025,1.0,10/65,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,vesicle transport along actin filament (GO:0030050),0.683422692267825,1.5819672117637695,0.03296703296703297,0.33396016926102223,1.0,5/19,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7665054709326742,1.579842032695942,0.03722504230118443,0.33806659024629354,1.0,3/10,4.30%,CEACAM1;LGALS9;FCGR2B
prerank,macrophage activation involved in immune response (GO:0002281),0.7208019031805557,1.5797082205081472,0.02823920265780731,0.3368528893050411,1.0,5/13,12.63%,PLCG2;DYSF;NMI;TYROBP;CX3CR1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6774951943143211,1.5795672385712862,0.03627760252365931,0.33563639334001777,1.0,6/19,11.89%,PTPRJ;VCAM1;GPR143;PRNP;TRPM2;GRM5
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5141763245296569,1.5783539873302168,0.007990867579908675,0.33719705318280757,1.0,16/119,7.29%,BMX;PLCG2;EFR3B;PIP5K1B;PITPNM3;PIK3R6;ITPKB;IP6K3;INPP5D;PIK3C2A;INPP5K;CISH;PLEKHA1;PIP5K1C;FIG4;SOCS6
prerank,bone development (GO:0060348),-0.45783643031245663,-1.5771494581997443,0.014598540145985401,0.4337759341855866,1.0,9/39,8.49%,RANBP3L;FGFR2;SULF1;SULF2;CYP26B1;GJA1;SH3PXD2B;SFRP4;P3H1
prerank,regulation of acrosome reaction (GO:0060046),0.7761468937705919,1.57696605722193,0.024054982817869417,0.33922619862701375,1.0,1/10,0.84%,PLCB1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5546520265117582,1.5761952718531378,0.015364916773367477,0.3396965500252858,1.0,28/67,16.98%,VEGFC;FLT1;FYN;FLT4;ELMO1;DAB2IP;PRKD1;CRK;VEGFD;SHB;CLEC14A;HSPB1;NCKAP1;ROCK1;PTK2;CYFIP1;RAC1;CYBA;PRKD2;WASF2;PIK3CB;DOCK1;PGF;NCF2;PAK2;NCK1;ELMO2;MAPK14
prerank,cell differentiation in spinal cord (GO:0021515),0.7483431186183116,1.575698858462866,0.0627062706270627,0.33938227212296723,1.0,3/10,12.21%,SOX13;ZC4H2;SOX6
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6616133623273774,-1.5749854266049728,0.021844660194174758,0.43424806809870153,1.0,8/11,20.22%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.596282588323271,-1.5739600030416758,0.028011204481792718,0.4312530613478147,1.0,4/15,2.70%,PIEZO2;ADGRV1;COL11A1;KIT
prerank,cGMP-mediated signaling (GO:0019934),-0.6427726668510679,-1.5737142655391763,0.022900763358778626,0.42555147491585216,1.0,3/13,2.91%,IRAG1;PDE3A;APOE
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5497768922354058,-1.5731188575047337,0.031609195402298854,0.4210826075140321,1.0,4/21,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,neuron projection regeneration (GO:0031102),-0.6746696420610344,-1.5729080866919192,0.03944315545243619,0.41556773151910453,1.0,3/10,12.77%,PTN;GAP43;NREP
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5878542353100948,1.5726711402172016,0.03443526170798898,0.3460906790374775,1.0,12/41,6.03%,JAG1;ENG;SMAD7;MYBPC3;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4;HEY2;MEF2C;GATA3
prerank,retinoic acid metabolic process (GO:0042573),-0.6207299339999581,-1.5722521871264736,0.024630541871921183,0.4118519824232904,1.0,2/14,2.57%,ALDH1A2;CYP26B1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5539730526132979,1.571862782074283,0.015151515151515152,0.3467123779921248,1.0,13/65,9.82%,PRDM16;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;WFIKKN1;SMAD2;ADAM17;UBA52;RPS27A;PMEPA1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.5327319012299958,1.5707891731932813,0.014457831325301205,0.34819229276641345,1.0,20/76,16.66%,TEK;SYNPO;EDN1;FCHSD2;F2RL1;FES;EVL;CDC42EP1;P2RX7;WDR1;NCKAP1;STAP1;PFDN2;NUMA1;SORBS3;NES;VIL1;TENM1;NCK1;PYCARD
prerank,atrioventricular valve development (GO:0003171),0.7265745118514457,1.570104662400348,0.05670103092783505,0.34850684212006583,1.0,5/14,4.11%,GJA5;BMPR2;NOTCH1;TGFB2;ACVR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5742856534873095,1.5693478142182635,0.019230769230769232,0.34892015966647705,1.0,11/51,9.50%,VEGFC;CCR1;F2RL1;LGALS9;VEGFD;ANO6;ADAM17;MAPK1;CMKLR1;PTK2;HMGB1
prerank,positive regulation of cell motility (GO:2000147),0.4919179912767624,1.5691648757256742,0.0010683760683760685,0.3479325791111689,1.0,40/205,9.54%,SEMA3G;PECAM1;CDH13;PODXL;EDN1;PDGFD;FLT1;PDGFB;CCR1;NOTCH1;MYLK;INSR;FAM107A;CAV1;F2RL1;NEDD9;SEMA3F;ACTN4;MGAT5;PPM1F;SPOCK2;NTN1;ACVR1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RIPOR1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.679009583762103,1.568085655566172,0.03815580286168521,0.3495523493490368,1.0,6/18,12.10%,PLCG2;DYSF;KARS1;NMI;TYROBP;DOCK2
prerank,positive regulation of histone modification (GO:0031058),0.592422708107821,1.5673506337074,0.03314917127071823,0.3499515016855188,1.0,7/33,12.77%,NOS1;RPS6KA5;ING2;ARRB1;BRCA1;CHTOP;GLYR1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.48043727953822146,-1.5666837689878066,0.012145748987854251,0.4234324633610677,1.0,10/40,5.55%,ARHGAP6;EGFR;NTRK3;LPAR1;PDGFRB;PDGFRA;KIT;EDNRA;NTRK2;FGF2
prerank,positive regulation of cell junction assembly (GO:1901890),0.558259924681443,1.5666634523051164,0.018915510718789406,0.3502995271879357,1.0,9/56,10.68%,PTPRJ;TEK;CLDN5;CAV1;PPM1F;MAP4K4;IL1RAP;ROCK1;RAC1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5510262170840171,1.5664733637973576,0.018963337547408345,0.3492451395768167,1.0,13/59,11.00%,PTPRM;PECAM1;CDH13;CEACAM1;CADM1;AMIGO2;ROBO4;BSG;TENM3;NECTIN4;NECTIN1;KIRREL3;CDH2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5928615146931863,1.5657172177833423,0.02710027100271003,0.34969643257156835,1.0,10/39,6.29%,JAG1;JAG2;NOTCH4;NOS3;NOTCH1;NOD2;TGFB2;DLL4;TSPAN14;POGLUT1
prerank,pulmonary valve development (GO:0003177),0.6941935756745891,1.565690805496885,0.0368,0.3483322741437462,1.0,9/18,5.71%,JAG1;NOS3;SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;TNFRSF1B
prerank,positive chemotaxis (GO:0050918),0.6917705735230694,1.565596398522429,0.03715170278637771,0.34707767075750995,1.0,2/17,4.45%,PTPRJ;ANGPT1
prerank,regulation of interleukin-1 production (GO:0032652),0.6911799326555956,1.565341453222427,0.043154761904761904,0.34633046565609465,1.0,4/15,9.50%,CEACAM1;TMED10;FOXP1;HMGB1
prerank,leukocyte tethering or rolling (GO:0050901),0.6919825975695658,1.5653203422521311,0.027331189710610933,0.3449381737514591,1.0,3/17,1.64%,GCNT1;VCAM1;JAM2
prerank,icosanoid secretion (GO:0032309),0.7371917183878927,1.5649208369019245,0.04433497536945813,0.3445387761055928,1.0,2/12,1.04%,ABCC4;ACE
prerank,positive regulation of neuron migration (GO:2001224),0.7258320393792453,1.5644714574191019,0.044293015332197615,0.3442894817112849,1.0,4/11,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,apical junction assembly (GO:0043297),0.5651160528288179,1.5640862363542274,0.03221649484536082,0.3438208530963509,1.0,8/53,8.44%,PECAM1;CLDN5;F11R;OCLN;ESAM;WDR1;CTNNA1;APC
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.5068830160413164,1.563078565585775,0.010101010101010102,0.3448619768651352,1.0,22/124,10.68%,PTPRM;LIMA1;STMN2;RAPGEF2;FRYL;RAB11A;FRY;BTG2;APP;MAP4;BLOC1S6;TTC29;EHD1;FAM161A;PLEKHA1;UHMK1;FLRT3;RAB35;ROCK1;HMGB1;CYFIP1;RAC1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7247692363075636,1.5628757635374468,0.05102040816326531,0.3439681084763665,1.0,3/14,7.72%,NOS1;ALDH9A1;SLC6A4
prerank,regulation of integrin activation (GO:0033623),0.6921238634705336,1.5608310175109408,0.03968253968253968,0.3480040098144938,1.0,3/15,2.02%,RASIP1;PIEZO1;FBLIM1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4885075983963063,1.5592419153715107,0.002150537634408602,0.35097165049638224,1.0,38/199,10.04%,LAMA4;NOS3;PTPRG;PTPRR;SMAD6;BMPR2;RPS6KA5;SMAD7;NOVA2;NOTCH1;ATP2B4;PAEP;HEY1;KLF7;DAB2IP;IFNGR1;ID1;HDAC9;APOA1;EVL;HEY2;IL17RD;FCGR2B;EFNA1;MEF2C;GATA3;ADAM17;ADIPOR1;SLC6A4;PTPRO;WWC2;ABHD6;PROC;NR1D1;MCC;ROCK1;MAD2L2;ACOT13
prerank,somite development (GO:0061053),-0.6663490938520881,-1.5589764883632775,0.025943396226415096,0.4417322649436341,1.0,5/11,9.90%,SMO;MEOX2;LOXL3;MTHFD1;PTCH1
prerank,platelet degranulation (GO:0002576),0.5010222773679002,1.55843156526425,0.006928406466512702,0.3516888322992177,1.0,14/118,4.78%,VEGFC;PECAM1;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;VEGFD;TIMP3;SELENOP;TAGLN2
prerank,positive regulation of ruffle assembly (GO:1900029),0.7238526216416159,1.5579989174531692,0.044189852700491,0.35138929600229707,1.0,2/13,7.52%,EPS8L2;PLEKHM1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4911799164257848,1.5578666715744167,0.005422993492407809,0.35030042944042045,1.0,42/163,18.86%,BMX;PTPRJ;PLCG2;FYN;INPP5D;PSMD13;MEF2C;PLEKHA1;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;CD38;PRKD2;PIK3CB;BTK;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;CD79A;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,protein hydroxylation (GO:0018126),-0.6039261261599466,-1.5567799438731915,0.036011080332409975,0.44266536976834875,1.0,10/15,18.57%,P3H3;EGLN3;VIPAS39;P3H1;PLOD2;P3H2;JMJD4;VPS33B;P3H4;PLOD3
prerank,cation transmembrane transport (GO:0098655),-0.46321096957322483,-1.5552660123000777,0.011811023622047244,0.44211177216125924,1.0,8/44,7.04%,ATP1A2;TRPM3;SLC7A2;TRPM6;SFXN2;ABCC9;SLC25A20;SLC6A9
prerank,positive regulation of immune response (GO:0050778),0.5458998193845122,1.554657270963033,0.01987577639751553,0.35742139067529827,1.0,14/64,11.05%,GBP5;NOD2;F2RL1;TGFB2;LGALS9;FCGR2B;KARS1;ITGAM;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;CYBA
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6285763249151635,-1.5532217165434998,0.031331592689295036,0.4431179338756552,1.0,6/13,4.81%,FSTL1;NBL1;LTBP1;GREM2;FBN2;FBN1
prerank,aorta morphogenesis (GO:0035909),0.680828786934482,1.552763571252186,0.04709576138147567,0.3609332171862817,1.0,8/17,3.58%,JAG1;ENG;TBX1;ACVRL1;MYLK;HEY1;DLL4;HEY2
prerank,positive regulation of phagocytosis (GO:0050766),0.5739819724033001,1.5525486009113165,0.030343007915567283,0.36008031857478423,1.0,11/47,12.10%,PTPRJ;GATA2;MERTK;F2RL1;APOA1;ANO6;FCGR2B;CD47;STAP1;CYBA;DOCK2
prerank,limb development (GO:0060173),-0.49853368674223986,-1.551890657439168,0.032362459546925564,0.4415692101912568,1.0,8/28,11.07%,GLI3;SMOC1;KAT2B;MEGF8;RSPO2;INTU;PTCH1;SALL1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5788166820312857,1.5517678214702477,0.0326530612244898,0.36076068296535885,1.0,7/43,5.57%,SOX17;ENG;NOTCH1;DAND5;SOX18;MEF2C;BBS7
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5271070926750481,1.5516698296256022,0.016624040920716114,0.35958874725476175,1.0,12/75,8.44%,PTPRJ;HEG1;RASIP1;DUSP1;DAB2IP;HHEX;INPP5K;SLC8A1;STK38;HYAL2;CEBPA;APC
prerank,protein autophosphorylation (GO:0046777),0.4927468003653981,1.5513373772503054,0.010940919037199124,0.359096048360869,1.0,34/157,12.18%,BMX;TEK;FLT1;STK10;FLT4;INSR;PRKD1;OXSR1;FES;SLK;STK24;CAMK2D;FGFR3;MEX3B;UHMK1;EEF2K;ALK;SIK2;LRRK2;LMTK2;JAK2;STK39;PASK;PIM3;CAD;PTK2;TAOK2;MAP3K11;MARK3;MINK1;MAP3K3;PRKD2;MARK2;VRK1
prerank,response to cAMP (GO:0051591),0.5915223739419402,1.5513071775986886,0.03185595567867036,0.3577817279974075,1.0,6/37,8.30%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K;STAT1;NDUFS4
prerank,female gamete generation (GO:0007292),0.6112280057386418,1.5510533708570713,0.03212290502793296,0.3570716664772276,1.0,2/29,0.40%,NANOS1;NANOS3
prerank,regulation of ruffle assembly (GO:1900027),0.6392710661825401,1.5498851130313012,0.049062049062049064,0.35900852800558186,1.0,5/23,9.11%,EPS8L2;CAV1;EVL;PLEKHM1;STAP1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6276219254552948,1.549088231775605,0.04090909090909091,0.35980224121798443,1.0,5/24,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,positive regulation of histone acetylation (GO:0035066),0.6447301701721315,1.5483148015648456,0.03886397608370702,0.36057820527881335,1.0,2/23,1.03%,NOS1;RPS6KA5
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5216699607778388,1.5466605104632294,0.017921146953405017,0.36349453931282055,1.0,29/84,13.57%,TEK;NOS3;EDN1;GATA2;PDGFB;BMPR2;FLT4;PRKD1;RHOB;ANXA3;RRAS;ANGPT1;GPI;GATA3;ADAM17;AKT3;ZC3H12A;HSPB1;NUS1;ATP5F1A;FOXP1;HMGB1;GFUS;PLCG1;RAC1;PRKD2;PIK3CB;ITGB1BP1;HIF1A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7458890349672525,1.5460987653026566,0.04482758620689655,0.36355586324296557,1.0,5/10,12.58%,GATA6;FURIN;CDH3;TYROBP;TSKU
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5909663419785263,1.5452714146417932,0.043041606886657105,0.36441644639114623,1.0,7/34,7.87%,PTPRJ;PTPRB;DUSP1;DUSP16;DUSP3;PTPN12;PTPRO
prerank,positive regulation of JNK cascade (GO:0046330),0.533131135607366,1.5447323329047964,0.018656716417910446,0.3643167856013071,1.0,17/70,10.65%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,regulation of striated muscle contraction (GO:0006942),0.6067122910521953,1.5446941033236619,0.044642857142857144,0.3630425715619504,1.0,4/27,1.45%,NOS1;GJA5;SMAD7;MYBPC3
prerank,regulation of histone acetylation (GO:0035065),0.5962899071501798,1.5440834666092451,0.03954802259887006,0.3633441719598256,1.0,2/33,1.03%,NOS1;RPS6KA5
prerank,embryonic heart tube development (GO:0035050),0.6799262474582003,1.5429513293291164,0.06200317965023847,0.36491988904601885,1.0,3/14,4.11%,SOX17;SOX18;ACVR1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5159846013953435,1.5423526924934061,0.016548463356973995,0.3652235882686379,1.0,30/92,13.57%,PLCG2;TEK;EDN1;BMPR2;FLT4;RAB11A;PRKD1;TGFB2;RHOB;ANXA3;PPM1F;RRAS;ANGPT1;IQSEC1;MAP4K4;GPI;GATA3;CLASP1;ZC3H12A;FOXP1;RTN4;GFUS;CLASP2;PLCG1;RAC1;PRKD2;PIK3CB;DOCK1;ITGB1BP1;HIF1A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5917636960863508,-1.5420824182675237,0.038560411311053984,0.46830204921906765,1.0,7/15,12.26%,UST;DSE;DCN;BGN;VCAN;B3GAT3;CSPG4
prerank,positive regulation of protein depolymerization (GO:1901881),0.7341102624899556,1.5418005563278803,0.04529616724738676,0.36536714368256173,1.0,4/11,7.47%,TRPV4;STMN2;F2RL1;WDR1
prerank,bile acid and bile salt transport (GO:0015721),0.6258453950892131,1.541120051295716,0.04985337243401759,0.36583549928509423,1.0,3/24,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,cellular response to superoxide (GO:0071451),0.7388753126334608,1.5404218093350668,0.057947019867549666,0.36636758246707635,1.0,2/10,4.38%,NOS3;ATP7A
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7398977347984045,1.5392840873729219,0.05235602094240838,0.36808555110008756,1.0,5/11,11.05%,F2RL1;TIRAP;MFHAS1;ACOD1;CYBA
prerank,positive regulation of immune effector process (GO:0002699),0.6274679601837411,1.536012206538546,0.04454022988505747,0.3755514832483188,1.0,2/27,2.67%,PTPRJ;LGALS9
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7380699841941492,1.5359819462226,0.05673758865248227,0.37426704421467594,1.0,3/11,5.32%,RAPGEF2;LGALS9;MEF2C
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5504714044966307,1.5359619323909515,0.024804177545691905,0.37296616909317154,1.0,21/54,17.40%,NOS3;GATA2;PDGFB;ACVRL1;ATP2B4;PRKD1;ANGPT1;MEF2C;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;PRKD2;HIF1A;CSNK2B;TMSB4X;MAPK14;ETS1
prerank,digestive tract development (GO:0048565),-0.47783565258215877,-1.5357627020400695,0.017421602787456445,0.48325714670215736,1.0,15/33,11.66%,GLI3;CLMP;GLI2;FGFR2;RARB;SMO;COBL;KIT;NIPBL;MEGF8;GLI1;PKDCC;STRA6;SALL1;PKD1
prerank,regulation of GTPase activity (GO:0043087),0.48080753182683855,1.5353907665339206,0.006543075245365322,0.3730708164319596,1.0,30/177,7.15%,FGD5;RAPGEF2;EFNA5;DOCK9;RASIP1;RABGAP1;F11R;PLXNA4;CHN2;RAPGEF1;DAB2IP;RASGRP2;CAV2;F2RL1;PRKG1;AGRN;CRK;GPR137B;PLXND1;TBC1D30;RAPGEF6;MAP4K4;FGD6;RAP1GDS1;BCAR3;LRCH1;SH3BP4;RGS7;RAB3GAP2;LRRK2
prerank,vasoconstriction (GO:0042310),0.7472183181230482,1.5344766700143646,0.0547945205479452,0.37413862813506693,1.0,3/11,3.81%,EDN1;PIK3C2A;SLC8A1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5735848931033751,1.5343848177259993,0.032520325203252036,0.37307048808224325,1.0,9/39,9.21%,RAPGEF2;TIE1;NOTCH1;RAPGEF1;DAB2IP;MSN;IRGM;ROCK1;TJP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.5466816807290295,1.5340509525197035,0.028314028314028315,0.37262262314999367,1.0,17/54,10.68%,PTPRJ;TEK;EFNA5;LIMCH1;ACVRL1;FAM107A;MACF1;PPM1F;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2;CLASP2;RAC1
prerank,negative regulation of platelet activation (GO:0010544),0.6983996407822867,1.5340250776754711,0.045871559633027525,0.37135435952570456,1.0,5/16,3.41%,NOS3;CEACAM1;PDGFB;PRKG1;ADAMTS18
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6547665030499197,1.5305463692494685,0.05303030303030303,0.37937077413538023,1.0,6/20,11.77%,ENTPD1;APP;ANO6;P2RX7;CASP1;SUGT1
prerank,positive regulation of heart rate (GO:0010460),0.6756243303157026,1.529681889200067,0.042789223454833596,0.3804333255000918,1.0,2/17,0.47%,KCNQ1;EDN1
prerank,ketone body metabolic process (GO:1902224),-0.6596952899927263,-1.5293764361083384,0.03773584905660377,0.4996059800416981,1.0,6/10,11.89%,OXCT1;ACSS3;HMGCS2;BDH2;BDH1;HMGCL
prerank,modulation by symbiont of host process (GO:0044003),0.7340373493042317,1.5281857912491068,0.05733558178752108,0.38320037054426703,1.0,4/10,8.54%,B2M;PGK1;UBA52;RPS27A
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6277874167592783,-1.5276347677436344,0.05569620253164557,0.49926327556781686,1.0,5/12,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.46947213388482434,-1.5274256183098114,0.007168458781362007,0.4938267289546063,1.0,9/35,5.64%,IRAG1;PDE7B;PDE3A;ADCY1;ADGRG6;APOE;NUDT4;KSR1;ADCY2
prerank,positive regulation of protein modification process (GO:0031401),0.4741834738767355,1.5263257701652184,0.006458557588805167,0.38679564019438,1.0,30/203,7.97%,VEGFC;PECAM1;TEK;ENG;EFNA5;FLT4;ACE;FAS;TBX1;LIMCH1;CCND2;INSR;CCND3;APP;NOS1AP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;PPP1R16B;FAM161A;BRAT1;ADAM17;IRGM;RAB3GAP2;LRRK2;PDE8A;ARRB1;THPO
prerank,negative regulation of developmental process (GO:0051093),0.5470592433263703,1.52620935529058,0.024360535931790498,0.3857768204743224,1.0,10/69,5.43%,NOTCH4;NOS3;TBX1;NOTCH1;ARHGEF15;HEY1;KLF7;HEY2;OMA1;FGFR3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.46988555302022383,1.5259614500554306,0.0020964360587002098,0.38514352787024675,1.0,49/260,10.78%,CDH13;SPATA13;EXOC6;EHD4;FGD5;CD2AP;ABCC4;RAPGEF2;S1PR1;ABLIM1;EMP1;NOTCH1;RAB11A;MYLK;PARVB;EMP2;DNM3;INPP5K;ANO6;NTN1;TEKT5;EHD1;SHTN1;RAPGEF6;MAP4K4;FAM161A;TTBK2;FGD6;TTC36;FNBP1L;BBS7;SNX10;RAB23;P2RX7;FXYD5;WHAMM;TMEM216;PTPRO;IFT140;CFAP43;PCM1;CFAP52;CCDC88A;CDC14A;DYNLL1;CYFIP1;MINK1;RAC1;EXOC8
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5449320551067286,1.5256030083470513,0.028423772609819122,0.38473314740511755,1.0,7/54,4.87%,KCNN4;KCNQ1;CAV1;KCNN3;NOS1AP;DPP6;DPP10
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6092594878664026,-1.524916003263444,0.03836317135549872,0.49720161169194727,1.0,8/13,20.22%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,regulated exocytosis (GO:0045055),0.4712503465417118,1.524522928112355,0.006493506493506494,0.38631352829143517,1.0,20/173,6.37%,VEGFC;PECAM1;SYT15;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;SYT7;VEGFD;TIMP3;SELENOP;TAGLN2;TMED10;MYH9;PIP5K1C;CYB5R1
prerank,regulation of protein neddylation (GO:2000434),0.7226862725326173,1.5242774150641176,0.035,0.3856219341603933,1.0,1/10,0.18%,EPAS1
prerank,negative regulation of cell migration (GO:0030336),0.48952472088610577,1.523857645134639,0.012249443207126948,0.38545133050002495,1.0,24/137,6.93%,PTPRJ;JAG1;PTPRG;ENG;PTPRR;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;DAB2IP;RHOB;CLIC4;EVL;ADAM15;STK24;HYAL2;SRGAP1;ADIPOR1;CLASP1;DUSP3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5674996917203856,1.523796535888732,0.036048064085447265,0.3842842420325353,1.0,13/44,13.27%,NANOS1;NANOS3;TNRC6C;BTG2;ZC3H12A;PRR5L;POLR2G;ROCK1;ZFP36L2;CNOT1;GTPBP1;TOB1;METTL14
prerank,amino sugar biosynthetic process (GO:0046349),-0.6206964640164729,-1.522147393277103,0.04106280193236715,0.5014724289142687,1.0,8/12,20.22%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6604365233289897,1.5214200784921956,0.04823151125401929,0.38947514531236227,1.0,6/17,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,regulation of cell aging (GO:0090342),0.7211749388742701,1.52047508044547,0.06309148264984227,0.3907259624976648,1.0,2/11,4.15%,NUAK1;ING2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.48079610389949273,1.5204593004401223,0.008602150537634409,0.3894599611968932,1.0,31/172,11.86%,BMX;PLCG2;PIP5K1B;PITPNM3;PIK3R6;INPP5D;PIK3C2A;APOA1;INPP5K;ACP6;SLC44A1;LPCAT4;LCAT;FAR1;PLEKHA1;PIP5K1C;CRLS1;FIG4;LCLAT1;PLD1;PLSCR1;PCYT1A;DGKH;PIK3C3;ARF3;CEPT1;LPCAT3;PTDSS1;OCRL;INPP5F;ACHE
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6146258341750706,1.5197973639542108,0.04512372634643377,0.3898759484660754,1.0,2/26,1.09%,PLCG2;ITPR3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6405115787298442,1.5196717053357593,0.04264705882352941,0.3888503151709199,1.0,5/21,3.58%,NOS3;CCR1;NOTCH1;HEY1;HEY2
prerank,regulation of ossification (GO:0030278),0.5824563865739788,1.51905874820142,0.047954866008462625,0.3891293101906919,1.0,10/36,8.58%,SGMS2;SMAD6;S1PR1;BMPR2;NOTCH1;TGFB2;ACVR1;MEF2C;ZBTB16;NBR1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5672948898155027,1.5190127452354232,0.043243243243243246,0.3879500858276149,1.0,9/39,10.49%,TEK;GATA2;ECSCR;ANO6;ANGPT1;GATA3;PDCD4;NFE2L2;PLCG1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5683916588796334,-1.518791548946736,0.03954802259887006,0.506687651540488,1.0,8/16,22.49%,AUTS2;OGT;ARHGAP24;CADM4;GABARAP;ARF6;KBTBD7;RASGRF1
prerank,lymphocyte mediated immunity (GO:0002449),0.721661118980939,1.5185863268763855,0.059625212947189095,0.3878208245801297,1.0,1/12,0.26%,JAG1
prerank,regulation of histone modification (GO:0031056),-0.5855427111472824,-1.5181072095423098,0.05489260143198091,0.5028737113739896,1.0,7/13,21.30%,UBE2N;IGF2;FLCN;AKAP8L;NNMT;PARG;MTHFR
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5900474561961895,-1.5175757652571988,0.03950617283950617,0.4987105687111705,1.0,4/14,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6093901378299672,1.5171235729853563,0.06149341142020498,0.39028564872576105,1.0,4/26,2.89%,PLCG2;LMCD1;ATP2B4;HOMER2
prerank,lung epithelium development (GO:0060428),-0.6576330500531467,-1.517042329780348,0.05102040816326531,0.49477631984967724,1.0,5/10,16.10%,ERRFI1;BMP4;STRA6;PKD1;RCN3
prerank,myoblast fusion (GO:0007520),0.7119544988010322,1.5155751827621349,0.05612244897959184,0.39329208215360434,1.0,2/12,1.64%,NOS1;JAM2
prerank,positive regulation of developmental growth (GO:0048639),0.5484390555026664,1.5155288141182979,0.0316622691292876,0.3921046367454894,1.0,12/49,13.94%,PLCB1;INSR;MACF1;ITSN2;AGRN;NTN1;SHTN1;SEMA7A;ISLR2;NEDD4L;SMURF1;RASAL1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6189479689330665,1.5150019055908577,0.05701754385964912,0.3923540645683061,1.0,2/24,1.09%,PLCG2;ITPR3
prerank,response to cholesterol (GO:0070723),-0.5607465388136019,-1.5147252802448457,0.03713527851458886,0.4967800883701898,1.0,9/17,17.11%,TGFBR1;SMO;GRAMD1C;GPLD1;PTCH1;GRAMD1A;OSBPL7;TGFBR2;GRAMD1B
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6279007882069881,1.5145774411165367,0.05076923076923077,0.3921326115516721,1.0,6/20,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5453574782752664,1.5144555542811404,0.029925187032418952,0.3911695744823806,1.0,10/56,10.93%,PLCG2;NOD1;NOD2;TLR3;IRAK2;HSP90B1;UBA52;RPS27A;HMGB1;TAB2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5952483710160918,-1.5141656880775038,0.0425,0.4929993391700509,1.0,5/13,2.18%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4
prerank,T cell proliferation (GO:0042098),0.7004406540470274,1.5138961224090786,0.05536912751677853,0.3913898540067836,1.0,4/13,4.64%,CRTAM;CADM1;MSN;CTPS1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5969652500739536,1.512399222286483,0.06976744186046512,0.3943308399025055,1.0,9/26,11.05%,CAV1;F2RL1;TLR3;TIRAP;MFHAS1;SLC15A4;RTN4;HMGB1;CYBA
prerank,regulation of MAPK cascade (GO:0043408),0.4832890415261538,1.5122436565038444,0.0077348066298342545,0.3934554460954624,1.0,30/157,9.50%,PTPRJ;PLCG2;TEK;FLT1;CEACAM1;PDGFB;FLT4;FAS;TBX1;JCAD;INSR;DUSP1;DAB2IP;CAV1;CAV2;ADRB2;IQGAP1;RRAS;MAP4K4;FGFR3;IAPP;BCAR3;MAPK1;P2RX7;DUSP3;THPO;NBR1;ROCK1;TAOK2;HMGB1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5389774267399569,-1.5112591187414857,0.0625,0.497617693125318,1.0,7/20,1.90%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2
prerank,positive regulation of integrin activation (GO:0033625),0.7221474565070014,1.5109117497217563,0.05537459283387622,0.3959713296769704,1.0,2/11,1.14%,RASIP1;PIEZO1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5582138276748756,-1.5108746086014067,0.05121293800539083,0.4936561630775496,1.0,7/17,9.47%,FSTL1;SULF1;CASK;SLIT2;TWSG1;SFRP4;ZDHHC17
prerank,Rac protein signal transduction (GO:0016601),0.6550851586722293,1.5108454838926377,0.05161290322580645,0.3948515073954655,1.0,6/18,13.75%,CDH13;ELMO1;NCKAP1;CYFIP1;RAC1;RHOH
prerank,negative regulation of hydrolase activity (GO:0051346),0.562868038983872,1.5108418020851895,0.03669724770642202,0.3935924643207704,1.0,8/49,7.15%,NOS1;F11R;DAB2IP;ZCCHC9;LRCH1;SH3BP4;GPATCH2;LRRK2
prerank,negative regulation of angiogenesis (GO:0016525),0.5091788439933733,1.5102354567721499,0.02031063321385902,0.39397589806709415,1.0,20/84,11.18%,PTPRM;TEK;CLDN5;KLF2;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1;EPN2;ADGRB1;ADAMTS1
prerank,adenine nucleotide transport (GO:0051503),0.6662947533302974,1.5095759538804356,0.049206349206349205,0.3945961014053265,1.0,3/17,4.76%,LRRC8C;ABCC4;SLC17A9
prerank,purine ribonucleotide transport (GO:0015868),0.6733095955854457,1.5089619579334634,0.04897314375987362,0.394999693144619,1.0,3/16,4.76%,LRRC8C;ABCC4;SLC17A9
prerank,negative regulation of protein depolymerization (GO:1901880),0.6187721518798227,1.5087580206628826,0.04328358208955224,0.39428612033582133,1.0,8/24,9.92%,LIMA1;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6710911577629846,1.508045995578336,0.0734375,0.395062777629974,1.0,2/16,3.80%,CEACAM1;STX7
prerank,positive regulation of MAPK cascade (GO:0043410),0.46904027550794664,1.50626097495872,0.005246589716684155,0.39895306683502757,1.0,44/245,9.67%,PTPRJ;PLCG2;TEK;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;FLT4;PIK3R6;TBX1;CCR1;NOTCH1;JCAD;NOD2;INSR;DAB2IP;ARL6IP5;CAV2;F2RL1;TGFB2;ADRB2;LGALS9;APP;IQGAP1;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;IAPP;BCAR3;MFHAS1;LRRK2;PDE8A;ARRB1;THPO;TPD52L1;ROCK1;HTR2A;TAOK2;HMGB1;FBXW7
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7055606581396555,1.5061079275864637,0.0755336617405583,0.39808107932579645,1.0,2/12,2.62%,PTPRJ;CBL
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6556018102032655,-1.5060788287707088,0.05489260143198091,0.5044645196161658,1.0,4/10,8.90%,MECP2;PCGF3;IGF2;DNMT3A
prerank,melanocyte differentiation (GO:0030318),-0.627498010080218,-1.504753816045896,0.06417112299465241,0.5029441939093036,1.0,5/11,6.86%,LRMDA;MITF;KIT;ENPP1;USP13
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6674186106224329,1.5045561623854982,0.0717557251908397,0.4011477986640226,1.0,4/17,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.5430378204319909,-1.5045325323613647,0.044642857142857144,0.4981381707432961,1.0,14/19,32.67%,ADK;AMPD3;GMPR;PNP;TERT;APRT;TYMS;CDA;POLD2;DCK;AMPD2;ADA;POLL;POLD3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5277119495394926,1.5040520023183417,0.028205128205128206,0.4012388473759907,1.0,16/66,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;APOA1;P2RX7;ZC3H12A;HSPB1;JAK2;FOXP1;EGR1;TYROBP;CASP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5537228760737948,1.5038375592014253,0.04685408299866131,0.4005822402924332,1.0,8/41,9.21%,PODXL;MAGI1;SMAD7;PIEZO1;GCNT2;CD47;PTPRU;TJP1
prerank,actin filament depolymerization (GO:0030042),-0.6218349272086043,-1.5036301134092454,0.0575,0.4955983553088634,1.0,3/11,1.41%,MICAL3;GSN;MICAL2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5436057798952874,1.503523525500752,0.0425531914893617,0.40019052806933,1.0,5/45,4.59%,NANOS1;NANOS3;APP;PUM2;GCNT2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5867434080662806,-1.5033511296011541,0.053475935828877004,0.4914316711073671,1.0,7/14,11.23%,LRP1;BMPR1A;IGFBP5;SLIT2;TPM1;IGFBP3;SERPINE1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4569339239755323,-1.5031076452868262,0.034482758620689655,0.4872115296596335,1.0,18/37,22.13%,IFT80;TRIP11;IFT81;KIF3C;WDR35;DYNC2LI1;IFT43;DYNLRB1;DYNC2I2;KIF3A;TTC21B;WDR19;IFT27;IFT74;IFT20;IFT88;DYNC2H1;DYNC2I1
prerank,maintenance of blood-brain barrier (GO:0035633),0.5958478506887094,1.503048547805823,0.05393586005830904,0.4000925861877663,1.0,12/30,11.60%,PECAM1;CLDN5;F11R;OCLN;JAM2;ESAM;LSR;TJP2;ACTG1;TJP1;ACTB;SLC1A1
prerank,endodermal cell fate commitment (GO:0001711),0.7292554361989291,1.5026102238314423,0.07130730050933787,0.40010768156587584,1.0,2/10,6.27%,SOX17;RTF1
prerank,phospholipid biosynthetic process (GO:0008654),0.573541558206509,1.5020452072077903,0.04722222222222222,0.4003312956258217,1.0,5/36,7.60%,SGMS1;SGMS2;FAR1;CRLS1;NUS1
prerank,epidermis development (GO:0008544),0.5499345801864666,1.5020324710975959,0.04336399474375821,0.3991225612973834,1.0,4/56,3.89%,LAMA3;GATA6;EMP1;ATP2C1
prerank,protein localization to cell-cell junction (GO:0150105),0.6624443817624704,1.501803137382521,0.06109324758842444,0.398574161274477,1.0,8/15,15.69%,F11R;LSR;TJP2;ACTG1;TJP1;DSP;ACTB;PAK2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.656777964354717,1.5017167202835335,0.05909797822706065,0.3976341881277038,1.0,3/18,1.64%,GCNT1;VCAM1;JAM2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6852140847359166,1.5017058592802315,0.061788617886178863,0.3964415394854416,1.0,5/14,4.05%,MMRN2;NOTCH1;DLL4;KLF4;CARD10
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.726880929859686,1.501535925161264,0.08514190317195326,0.3956608841702601,1.0,2/10,1.14%,PODXL;PIEZO1
prerank,regulation of DNA repair (GO:0006282),-0.44794809520848367,-1.5013314312357948,0.012,0.48806328101967644,1.0,8/44,8.58%,EYA2;EGFR;EYA1;TRIP12;EYA4;UBE2V2;UBE2N;USP1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.550463279059791,1.5013082041481287,0.059147180192572216,0.3950225115137192,1.0,10/44,12.50%,PTPRJ;DUSP1;DAB2IP;INPP5K;STK38;HYAL2;PDCD4;AIDA;PTPN1;PIK3CB
prerank,modified amino acid transport (GO:0072337),-0.5768580161242804,-1.5012232838031605,0.06077348066298342,0.48351374580752415,1.0,4/15,6.15%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5659241467618145,-1.5008179178209933,0.0443213296398892,0.47966354375757536,1.0,8/16,19.34%,PPARGC1B;DDX5;DDX17;PADI2;SAFB;TADA3;AR;TRIP4
prerank,adherens junction organization (GO:0034332),0.5364360693349179,1.500227907201941,0.06166219839142091,0.3968234450058423,1.0,21/48,20.22%,CDH13;SMAD7;CADM1;PIP5K1C;CTNNA1;CDH15;CDH3;NECTIN4;TJP1;NECTIN1;CDH12;CDH2;ACTB;CTNNB1;CDH22;PAK2;VCL;ANG;CDH18;CDH24;JUP
prerank,fat cell differentiation (GO:0045444),0.5367147906150829,1.499795859297783,0.031055900621118012,0.3968661556146426,1.0,12/57,13.92%,PRDM16;SMAD6;NR4A2;FOXO1;KLF4;BBS7;CEBPA;PSMB8;NR4A1;ALOXE3;CTBP2;SDF4
prerank,cellular response to peptide (GO:1901653),0.5412177508056121,1.4996909369151268,0.03800786369593709,0.3959723559511616,1.0,12/56,4.30%,FYN;VCAM1;NOD1;NOD2;ARHGEF2;ATP1A3;CAV1;CACNA1A;ADRB2;VIM;APP;FCGR2B
prerank,actin filament-based transport (GO:0099515),0.6372788019682829,1.4995232543571049,0.0639269406392694,0.3952198185834106,1.0,5/21,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7081420019197288,1.4989284429350562,0.06529209621993128,0.39448487344442124,1.0,6/11,17.35%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7081420019197288,1.4989284429350562,0.06529209621993128,0.39448487344442124,1.0,6/11,17.35%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5148274540273805,1.498164010424262,0.023114355231143552,0.3954410953636708,1.0,16/75,9.04%,PTPRM;TEK;CLDN5;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1
prerank,angiogenesis involved in wound healing (GO:0060055),0.6976452172265848,1.4971544676517339,0.07155025553662692,0.3969230926247566,1.0,4/11,6.22%,GATA2;ADIPOR2;CD34;MCAM
prerank,striated muscle contraction (GO:0006941),0.5343538233519947,1.4961936813216572,0.03636363636363636,0.39839342118036597,1.0,5/53,5.31%,NOS1;KCNQ1;MYBPC3;SLC8A1;STAC
prerank,circulatory system development (GO:0072359),0.49376419993406145,1.4958734631121404,0.016,0.3981307806206871,1.0,20/118,5.32%,HEG1;SOX17;TEK;NOTCH4;PDGFB;FLT4;TBX1;ACVRL1;NOTCH1;HEY1;CASP8;TGFB2;HDAC9;SOX18;HEY2;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,heart looping (GO:0001947),0.5667536196671427,1.4944091718831778,0.049723756906077346,0.40081119872615173,1.0,6/40,5.57%,SOX17;ENG;NOTCH1;SOX18;MEF2C;BBS7
prerank,toll-like receptor signaling pathway (GO:0002224),0.508423802859438,1.4942779583969814,0.030915576694411414,0.3999588220112543,1.0,17/84,12.89%,PLCG2;CASP8;LGALS9;TLR3;TIRAP;IRAK2;UBE2D1;ITGAM;HSP90B1;UBA52;NMI;RPS27A;HMGB1;PIK3C3;TAB2;BTK;RPS6KA3
prerank,negative regulation of growth (GO:0045926),0.4907846115119443,1.4924391853961518,0.011312217194570135,0.40364520534630455,1.0,21/121,7.68%,PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;NOTCH1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;FGFR3;SH3BP4;NPR1;HSPA1B;MT2A
prerank,cellular response to cadmium ion (GO:0071276),-0.5154347640928247,-1.4911751197684813,0.041916167664670656,0.5055944397976163,1.0,9/24,6.94%,EGFR;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,sphingoid metabolic process (GO:0046519),0.694154099558409,1.4911430294268078,0.0718954248366013,0.40579946353685226,1.0,4/12,5.93%,SGPP2;DEGS2;PLPP1;ASAH2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6936841680899439,1.4910201234691167,0.06851549755301795,0.4049400806701797,1.0,5/12,9.50%,F2RL1;TIRAP;KLF4;FOXP1;HMGB1
prerank,response to cadmium ion (GO:0046686),-0.5074339928746661,-1.4896910692098548,0.041791044776119404,0.5056929517098225,1.0,9/26,6.94%,EGFR;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4935964200294584,-1.4884355109276295,0.03880597014925373,0.5051708020835057,1.0,10/26,8.12%,IGF1;SORBS1;RHOQ;IRS2;C2CD5;IRS1;PIK3R1;CLIP3;OSBPL8;PRKCI
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6055928409702216,-1.4875568432104576,0.06702412868632708,0.5033866712573809,1.0,5/13,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,actin filament organization (GO:0007015),0.47123377027340263,1.4860571423812472,0.012168141592920354,0.4167064767682541,1.0,32/151,13.75%,MYO1D;CD2AP;TRPV4;NEBL;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;RND1;ARHGEF2;PLS3;RHOB;EMP2;NEDD9;FLII;EVL;WHAMM;ARHGAP25;ENAH;MYO1C;BIN3;MAD2L2;GAS2L3;ERMN;RAC1;SHROOM1;TPM4;TMOD3;RND2;CAPG;RHOH
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5703770876687373,-1.4859714865023332,0.04878048780487805,0.5035309841376925,1.0,7/15,22.66%,SMO;BMP4;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,cellular response to dsRNA (GO:0071359),0.661459351525738,1.4851234733044516,0.0642504118616145,0.41788282711251923,1.0,7/15,21.89%,CAV1;IFIH1;DHX9;NPM1;RIOK3;RALB;PQBP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4953279989122404,1.485070430127541,0.0246189917936694,0.4168106802633476,1.0,13/95,6.32%,PRDM16;LTBP4;ENG;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;ING2;WFIKKN1;SMAD2;ADAM17
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7136866542167921,1.4847193187957521,0.08421052631578947,0.41654857261158573,1.0,3/10,8.76%,ACER2;PDE3B;SNAI2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6273339584893873,1.4847168762932688,0.04930662557781202,0.41537096322374195,1.0,7/21,9.92%,STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,negative regulation of protein polymerization (GO:0032272),0.603728138613564,1.4837517224389531,0.07335329341317365,0.4169144511660279,1.0,4/27,2.97%,KANK4;STMN2;HIP1R;KANK3
prerank,regulation of DNA biosynthetic process (GO:2000278),0.604219949462315,1.4837253929188632,0.06330935251798561,0.4158055425951835,1.0,9/27,13.96%,PDGFB;DACH1;BMPR2;ACVRL1;HMBOX1;TOM1L1;TNKS;PRKD2;ATM
prerank,regulation of protein metabolic process (GO:0051246),0.548165139388036,1.4835996827016804,0.0546875,0.4150059619847423,1.0,7/44,5.65%,LTBP4;ACE;KLF2;FKBP1A;APP;KLF4;FURIN
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6369180456874864,1.4832097993075868,0.07822085889570553,0.41480392699970164,1.0,4/21,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5570011563228251,1.4831635579706344,0.04172461752433936,0.4137500540773531,1.0,7/44,5.57%,SOX17;ENG;NOTCH1;SOX18;ACVR1;MEF2C;BBS7
prerank,metal ion export (GO:0070839),0.5730468585985441,1.482039324556643,0.05702364394993046,0.41568479445527484,1.0,7/31,4.38%,KCNQ1;KCNE3;ATP2B4;ATP1A4;ATP1A1;ATP1A3;ATP7A
prerank,microvillus organization (GO:0032528),0.6968694927639234,1.4818020612248075,0.06351791530944625,0.4152196093484293,1.0,5/13,10.65%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,ganglioside metabolic process (GO:0001573),0.6346863883459536,1.4816996592506022,0.07668231611893583,0.4143340777510814,1.0,2/20,0.49%,ST6GALNAC3;ST8SIA6
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4198847775846259,-1.4804269816408004,0.011583011583011582,0.5171093085673072,1.0,20/50,14.38%,IGF1;PLCE1;OGT;PDGFRB;PDGFRA;PLCL1;ADAP2;PITPNM2;NGF;IRS2;IRS1;PIK3R1;PLCB3;PI4KB;TNFAIP8L3;PI4KA;PLCD3;PIK3R2;PLCD1;GAB2
prerank,sulfur compound catabolic process (GO:0044273),-0.4481203332217285,-1.4798231339896706,0.03383458646616541,0.5143070268382417,1.0,13/38,12.71%,DCN;OGN;FMOD;GNS;BGN;PRELP;HEXA;VCAN;GGT5;HYAL1;LUM;CSPG4;OMD
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5509681453039601,1.4797515273673711,0.05748663101604278,0.4185229989151311,1.0,14/42,12.50%,PDGFB;NOTCH1;EMP2;FBLN2;PPM1F;GCNT2;PTPRO;JAK2;RSU1;PTK2;MINK1;RAC1;SPOCK1;PIK3CB
prerank,positive regulation of cell projection organization (GO:0031346),-0.3532094734894056,-1.4789820536116929,0.007874015748031496,0.5122897973803606,1.0,24/115,5.85%,ROBO1;PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;PLXNA2;CUX1;PTK7;SLIT2;WNT5A;GRIP1;NDNF;APOE;MAGI2;DLG4;OBSL1;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1;NGF
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6085346452975838,1.4789552836108752,0.05963302752293578,0.41966891038549975,1.0,4/23,7.15%,KCNQ1;ATP2B4;MAPK1;LRRK2
prerank,Rho protein signal transduction (GO:0007266),0.5302595022848595,1.4754346723644898,0.047058823529411764,0.42805915093717267,1.0,14/53,10.19%,EPS8L2;CDH13;ARHGEF3;RHOB;CDC42EP1;NTN1;SHTN1;PLEKHG5;ARHGDIA;ARHGAP5;ROCK1;RIPOR1;TAX1BP3;ARHGEF1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6003920578539911,-1.4738909236601252,0.07804878048780488,0.5239789043393994,1.0,6/12,13.26%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5517920536624581,1.4732175665886178,0.05298913043478261,0.43275028412499406,1.0,5/39,2.96%,NOTCH4;ENG;TIE1;RASIP1;DLL4
prerank,microglial cell activation (GO:0001774),0.6187937386330382,1.4729329614825035,0.061068702290076333,0.43243787427868774,1.0,7/21,12.63%,IFNGR1;APP;ITGAM;JAK2;TYROBP;CLU;CX3CR1
prerank,T-helper cell differentiation (GO:0042093),0.6743382084010858,1.4728898427982833,0.07755775577557755,0.43138946925107996,1.0,5/14,11.95%,ATP7A;LEF1;FOXP1;HMGB1;TMEM98
prerank,regulation of cell growth (GO:0001558),0.46070068337908243,1.4708710507430198,0.008492569002123142,0.43599446021952387,1.0,37/204,10.41%,PTPRJ;SOX17;LTBP4;CEACAM1;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;FAM107A;RASGRP2;TGFB2;HNF4A;PPT1;BTG1;CISH;ADAM15;KIF26A;WFDC1;SERTAD2;CAMK2D;HYAL2;BRAT1;TAF9B;ADAM17;SH3BP4;SLC25A33;NPR1;HSPA1B;SGK1;SERTAD3;ADAM10;TAOK2;RTN4;MAD2L2;RPS6KA1;GNG4
prerank,regulation of interleukin-8 production (GO:0032677),0.505314051837168,1.4702213644078397,0.03625,0.43657772750978374,1.0,13/69,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;KLF4;HYAL2;HSPA1B;ARRB1;CACTIN;HMGB1
prerank,inositol phosphate catabolic process (GO:0071545),0.6817951621949752,1.4698534733463533,0.0865874363327674,0.43641512562169504,1.0,6/12,17.35%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,negative regulation of MAPK cascade (GO:0043409),0.4982813408551482,1.4695808542588424,0.03902439024390244,0.436011989160066,1.0,13/87,6.93%,PTPRJ;PTPRR;CNKSR3;FOXO1;DUSP1;DAB2IP;CAV1;INPP5K;TIMP3;STK38;HYAL2;P2RX7;DUSP3
prerank,regulation of membrane repolarization (GO:0060306),0.668279767202278,1.4693566337245043,0.08928571428571429,0.43548517266296427,1.0,2/13,2.28%,KCNQ1;CAV1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5525947333351386,-1.4684473466174508,0.043731778425655975,0.5372287169512467,1.0,6/16,22.28%,PID1;PPARA;FLCN;SPHK2;ANTKMT;PARP1
prerank,cAMP biosynthetic process (GO:0006171),-0.6245910807527009,-1.466933851943334,0.07304785894206549,0.5371647375109636,1.0,5/10,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6103390102148388,-1.4667345235095113,0.0851581508515815,0.5331359491624172,1.0,7/11,21.03%,FBH1;TIPIN;LIG3;DONSON;SMARCAL1;TIMELESS;ZRANB3
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5412074655938568,-1.4665129737685636,0.07065217391304347,0.5290759227723433,1.0,3/16,3.93%,PRKAG2;APPL2;PPARA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5894125697045228,-1.4663629839879107,0.06702412868632708,0.5249431285107317,1.0,8/13,11.26%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1;TBX2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4108421330136198,-1.4661580959845113,0.02564102564102564,0.5212096810625098,1.0,14/53,13.28%,EYA2;EGFR;EYA1;DDX5;PLA2R1;FXR2;EYA4;FBH1;UBE2N;SPRED1;BCLAF1;ATR;SPRED2;HMGA2
prerank,myotube differentiation (GO:0014902),0.6617505385386966,1.4658262306835168,0.06190476190476191,0.4438754794426862,1.0,5/17,7.18%,NOS1;JAM2;MEF2C;MYEF2;ADAM12
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5141954455125944,1.4656942246062616,0.043640897755610975,0.44304195124024964,1.0,10/67,4.06%,CDH13;UTRN;PDGFB;EMP2;FBLN2;NEDD9;CRK;APOA1;PPM1F;LIMS2
prerank,regulation of T cell cytokine production (GO:0002724),0.6563121860333754,1.4655631004906962,0.08012820512820513,0.442136888554221,1.0,3/15,5.71%,SMAD7;B2M;TNFRSF1B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5879345362403,1.4652195734485203,0.058333333333333334,0.44194582332216514,1.0,6/29,10.12%,CRTAM;CADM1;STX7;ITGAM;STAP1;TYROBP
prerank,atrial septum development (GO:0003283),0.6686127100562278,1.464938893646216,0.09165302782324058,0.44152901146952206,1.0,5/13,3.58%,GJA5;BMPR2;DAND5;TGFB2;HEY2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.561785582096942,1.464485967899775,0.06818181818181818,0.4417255851659178,1.0,11/36,12.63%,SGMS1;FAS;NR4A2;DAB2IP;TRAF1;ASAH2;MADD;CRADD;TPD52L1;TMBIM6;CX3CR1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4826201209292149,1.4638970393418318,0.029036004645760744,0.4421869610398044,1.0,16/104,8.54%,PRDM16;SMAD6;BMPR2;SMAD7;NOTCH1;DAND5;CAV1;FKBP1A;IL17RD;ACVR1;WFIKKN1;SMAD2;ADAM17;UBE2D1;UBA52;RPS27A
prerank,ceramide transport (GO:0035627),0.6563512783089683,1.4636291187786605,0.08673469387755102,0.44173531758084505,1.0,4/12,8.07%,PLTP;ABCB4;GLTP;CERT1
prerank,regulation of sodium ion transport (GO:0002028),0.5595540173389906,1.4629993453523655,0.07201086956521739,0.44236519265140617,1.0,7/34,8.96%,NOS1;CNKSR3;ATP2B4;ATP1A1;P2RX7;NKAIN3;SCN1B
prerank,regulation of JNK cascade (GO:0046328),0.4838325363034087,1.4627059559128952,0.03176470588235294,0.44199804029667383,1.0,21/101,10.65%,MECOM;MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;MAP4K4;TRAF1;DUSP3;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;AIDA;MINK1
prerank,alanine transport (GO:0032328),0.7106666347589762,1.4624712464914533,0.08419243986254296,0.441484009403127,1.0,1/10,0.19%,SLC6A6
prerank,negative regulation of ion transport (GO:0043271),0.5966349283559224,1.4624264509324802,0.06386066763425254,0.4404770717088404,1.0,4/24,9.06%,NOS1;INPP5K;PXK;HTR1B
prerank,response to zinc ion (GO:0010043),-0.48738189941913523,-1.4616039959069662,0.029801324503311258,0.5313090547589422,1.0,9/25,7.34%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;P2RX4
prerank,regulation of calcium ion transport (GO:0051924),0.5168286266873697,1.4615519769703402,0.05368289637952559,0.4416799055488401,1.0,10/54,8.24%,NOS1;CCR1;MYLK;HOMER2;INPP5K;ORAI1;EPB41;STIM2;CASQ1;CRACR2A
prerank,heart trabecula morphogenesis (GO:0061384),0.6290127266830386,1.461408716891489,0.06635802469135803,0.440962426701657,1.0,8/18,2.96%,TEK;ENG;S1PR1;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4
prerank,clathrin-dependent endocytosis (GO:0072583),0.6025677256039322,1.461183725518889,0.07412790697674419,0.4403696279678885,1.0,8/26,11.66%,FCHSD2;ITSN2;AP2B1;FCHO2;FNBP1L;PIP5K1C;AP2M1;INPP5F
prerank,calcium-mediated signaling (GO:0019722),0.49241952451047405,1.4609512895351777,0.027315914489311165,0.4398874287000752,1.0,22/93,13.33%,PTPRJ;PLCG2;EDN1;VCAM1;CCR1;MCTP1;SLC8A1;GPR143;CHRM3;P2RX7;IRGM;LRRK2;PPP3CA;PRKAA1;PRNP;PLCG1;TPCN2;TRPM2;GRM5;BTK;CX3CR1;KSR2
prerank,protein dephosphorylation (GO:0006470),0.46761609981466024,1.460157460346627,0.015418502202643172,0.4410061320101276,1.0,31/135,14.97%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP12;DUSP1;PPM1F;PTPRE;CTTNBP2NL;DUSP16;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C;DUSP11;PPP2R2C;RPRD1B;PTPN1;PDP1;EYA3;DUSP22;PPM1D;PPM1L;PPP1R15B;PPP4R1;PPP2CB
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.598231616408982,1.459639001258731,0.07017543859649122,0.4412397353718894,1.0,8/26,10.93%,NOD1;NOD2;CASP8;IFIH1;IRAK2;UBA52;RPS27A;TAB2
prerank,cell-cell junction assembly (GO:0007043),0.5045426790850173,1.459586177521446,0.04230769230769231,0.4402645105189302,1.0,19/63,15.69%,GJA5;TRPV4;CLDN5;SMAD7;GJB1;GJA4;PIP5K1C;WDR1;CTNNA1;ACTG1;TJP1;CDH12;CDH2;ACTB;CTNNB1;CD9;CDH22;PKN2;PAK2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5935788501761193,-1.459498943369059,0.05134474327628362,0.5335933378716156,1.0,5/13,7.80%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,cellular response to growth factor stimulus (GO:0071363),0.46419932660786933,1.4577472179783668,0.025191675794085433,0.4440890767947916,1.0,41/151,13.05%,NOS1;STMN2;RAPGEF2;FLT1;PDGFB;BMPR2;FLT4;SMAD7;TBX1;ACVRL1;NOTCH1;RAPGEF1;EGR3;DAB2IP;PRKD1;DLL4;IQGAP1;TMEM100;INPP5K;KLF4;ACVR1;EHD1;MEF2C;HYAL2;SETX;DUSP3;PTPN12;HSPB1;PDE8A;SYAP1;RAB35;SNAI2;ZFP36L2;PLCG1;NR4A1;VSTM2A;PRKD2;SOX6;RPS6KB1;DUSP22;ITGB1BP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5011624505624214,1.457604581343928,0.04854368932038835,0.4433394236363964,1.0,17/72,11.83%,KANK4;LIMA1;STMN2;HIP1R;ARHGEF2;KANK3;TTBK2;IAPP;SHANK3;CAMSAP2;CLASP1;PFDN6;VBP1;APC;CLASP2;PFDN2;CLU
prerank,negative regulation of ossification (GO:0030279),0.6028691540935603,1.4575756381951936,0.06676557863501484,0.44231206206929763,1.0,4/23,5.32%,SMAD6;CCR1;NOTCH1;MEF2C
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6285865156188537,-1.4571320647493833,0.07481296758104738,0.5367554277985155,1.0,5/10,13.84%,CPEB1;NUDT21;NCBP1;PAF1;CPEB3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5502210601062649,-1.457090083193988,0.07859078590785908,0.5323584806849818,1.0,6/16,11.02%,DPYSL3;DPYD;TET2;NT5M;NT5E;UPB1
prerank,response to calcium ion (GO:0051592),0.4799084578918291,1.4564346849049283,0.029726516052318668,0.4443504750426725,1.0,16/102,8.29%,PLCG2;SYT15;ITPR3;ITPKB;CPNE8;RASGRP2;CAV1;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;PPP3CA;MCOLN1;PRKAA1
prerank,negative regulation of cellular process (GO:0048523),0.4371530749889355,1.4560514010831411,0.0,0.44434849884710786,1.0,93/521,12.26%,NOS1;PTPRJ;CDH13;PODXL;SOX17;NOTCH4;NOS3;IRF6;RAPGEF2;SMAD6;MSX1;BMPR2;SMARCA2;PLXNA4;TBX1;PTPN14;APBB2;FOXO4;RND1;ITGA1;ACVRL1;NOTCH1;JAM2;DYSF;DUSP1;ADARB1;DAB2IP;AQP11;PRKD1;TGFB2;RHOB;HNF4A;BTG2;DLL4;APP;PPT1;BTG1;PLPP1;PPP1R13B;APOA1;PDE3B;KLF4;DDX4;PLXND1;ADAM15;TMEM109;FCGR2B;WFDC1;ANGPT1;SERTAD2;HYAL2;CTTNBP2NL;CD34;TNFRSF1B;GMNC;GATA3;MYH9;WARS1;IL1A;PDCD4;SH3BP4;ARHGDIA;NPR1;IGFBP7;VAMP8;HSPA1B;PDE8A;CEBPA;PTPRU;PLSCR1;CD200;JAK2;APC;NMI;KLF11;PPP2R5C;SERTAD3;ADAM10;RTN4;LPCAT3;CHD5;GNG4;ADGRB1;ADAMTS1;NPM1;VPS35;E2F7;TMBIM6;NR4A1;CLU;TMEM98;COPS8;TOB1
prerank,modulation by symbiont of entry into host (GO:0052372),0.6499774194834429,1.4556605180500595,0.09523809523809523,0.4443080843730374,1.0,5/16,11.57%,TRIM14;CAV1;TRIM6;TRIM25;HS3ST5
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5941554244515409,1.4556311620304117,0.08163265306122448,0.44325795297467463,1.0,3/24,1.57%,DACH1;BMPR2;ACVRL1
prerank,ganglioside biosynthetic process (GO:0001574),0.6592152178109478,1.4544130048648216,0.085,0.4453729659102798,1.0,2/15,0.49%,ST6GALNAC3;ST8SIA6
prerank,Ras protein signal transduction (GO:0007265),0.4644709168613421,1.4536604786329406,0.016816143497757848,0.4462206684592992,1.0,31/137,10.68%,EPS8L2;CDH13;ARHGEF3;RAPGEF2;ELMO1;RAPGEF1;RASGRP2;PRKD1;RHOB;KRAS;NRAS;CDC42EP1;NTN1;RRAS;SHTN1;RAPGEF6;PLEKHG5;ARHGDIA;SHOC2;ARHGAP5;PLD1;KPNB1;NCKAP1;ROCK1;JUN;RIPOR1;TAX1BP3;RRAS2;ARHGEF1;CYFIP1;RAC1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5635771830808033,1.4536508317809778,0.07375886524822695,0.4451381053946231,1.0,8/33,5.32%,MMRN2;ACVRL1;NOTCH1;ATP2B4;DLL4;KLF4;CARD10;MEF2C
prerank,microvillus assembly (GO:0030033),0.6709321961825061,1.453325001606586,0.0875796178343949,0.4449114439891716,1.0,5/14,10.65%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,cholesterol transport (GO:0030301),0.5436107032751606,1.4530889397805837,0.04911323328785812,0.44443341422123545,1.0,14/45,19.69%,LIMA1;CAV1;APOA1;LCAT;STX12;ABCG4;CLU;TSKU;VPS4A;LDLRAP1;ABCA7;SCARB1;SOAT1;RELCH
prerank,response to exogenous dsRNA (GO:0043330),0.6267778013286491,1.4510599056555107,0.06451612903225806,0.44888684273166524,1.0,4/18,9.64%,CAV1;IFIH1;TLR3;DHX9
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.4282826570038575,-1.4499732483377537,0.04,0.5518374217197293,1.0,19/39,26.57%,STEAP3;ABCA1;TANGO2;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;AFM;MON1A;PDIA4;PREB;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3
prerank,cell-cell junction organization (GO:0045216),0.48666134139211525,1.4492361977461878,0.0471584038694075,0.452710209123326,1.0,18/79,9.28%,CDH13;TRPV4;CLDN5;OCLN;F2RL1;TGFB2;CADM1;LIMS2;GJA4;CTNNA1;TJP2;CDH15;CDH3;NECTIN4;TJP1;DSP;NECTIN1;CDH12
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5999872614986924,1.4484804400344446,0.07926829268292683,0.453672599366469,1.0,6/22,7.18%,GATA2;RASSF10;DLL4;TAFA1;LRRK2;SLC16A2
prerank,regulation of endothelial cell migration (GO:0010594),0.487224848306119,1.448168777931139,0.046625766871165646,0.4534477091073666,1.0,23/85,10.68%,PTPRM;TEK;EDN1;CEACAM1;BMPR2;FLT4;ACVRL1;DAB2IP;PRKD1;RHOB;EMP2;DLL4;ANXA3;RRAS;ANGPT1;GPI;GATA3;ZC3H12A;FOXP1;PTK2;GFUS;ADGRB1;RAC1
prerank,response to peptide hormone (GO:0043434),-0.4174481252645869,-1.4479853822063808,0.03125,0.5543952584876328,1.0,9/43,8.36%,TGFBR3;OGT;ROCK2;IGFBP5;GNAI1;ANXA1;IRS1;SRC;SLC27A1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5476921401029675,1.447876742184366,0.06153846153846154,0.4531416239023759,1.0,13/41,11.89%,PDGFB;FYN;ACE;NEDD9;EFNA1;FCGR1A;ADAM17;DOCK3;STAP1;FBXW7;PRNP;PTPN1;GRM5
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.43699313660352584,-1.4469782454346307,0.035842293906810034,0.5530328418242565,1.0,13/40,8.71%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT6;FBN2;KL;CEBPB;PKDCC
prerank,cardiocyte differentiation (GO:0035051),0.7004408945100868,1.4469056596410272,0.08803986710963455,0.45464569046537684,1.0,2/10,2.55%,GATA6;TGFB2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.49289689672326786,1.4463050393755759,0.040865384615384616,0.4551894117801629,1.0,27/73,18.86%,GATA2;LMO2;KITLG;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,ruffle organization (GO:0031529),0.6456035437183154,1.4454568835338797,0.09302325581395349,0.4564335775491799,1.0,5/16,10.68%,LIMA1;INPP5K;PLEKHA1;CYFIP1;RAC1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.6816275061981705,1.445446025909979,0.09433962264150944,0.45535266959539494,1.0,2/11,3.43%,NOS3;GCH1
prerank,phasic smooth muscle contraction (GO:0014821),0.7121299437992201,1.4447070230085122,0.09572649572649573,0.4561863567896985,1.0,1/10,0.47%,EDN1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5759000669119694,1.4435484142920691,0.07391910739191074,0.4583161351112983,1.0,7/28,9.92%,STMN2;FKBP4;CAMSAP2;PRUNE1;CLASP1;MAPRE3;CLASP2
prerank,endochondral bone morphogenesis (GO:0060350),0.7048550570654959,1.4434196791043854,0.090311986863711,0.45754008066927837,1.0,4/11,5.43%,TRPV4;BMPR2;MEF2C;FGFR3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6142641615870064,1.4427012682890208,0.09567901234567901,0.45839671245147917,1.0,7/19,12.73%,LIFR;IFIH1;APOA1;KLF4;IRAK2;DHX9;CBFB
prerank,negative regulation of T cell differentiation (GO:0045581),-0.617234723813696,-1.4423162825842597,0.09285714285714286,0.5641357683130697,1.0,2/10,2.18%,GLI3;BMP4
prerank,potassium ion export across plasma membrane (GO:0097623),0.6597870892728965,1.4412364944349227,0.11221122112211221,0.4613549334585036,1.0,2/13,1.44%,KCNQ1;KCNE3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.7150679614844648,1.4409981012235207,0.10309278350515463,0.4609642022255509,1.0,2/10,2.28%,KCNE3;CAV1
prerank,regulation of B cell activation (GO:0050864),0.5857282189637141,1.4408690517719216,0.07714285714285714,0.46022566371973506,1.0,8/25,21.03%,NOD2;SH3KBP1;FCGR2B;ZFP36L2;LAPTM5;BANK1;FOXJ1;ZFP36L1
prerank,Notch signaling pathway (GO:0007219),0.5176912340437081,1.440561097222289,0.04697156983930779,0.45996304100352403,1.0,14/59,9.42%,JAG1;JAG2;NOTCH4;SORBS2;NOTCH1;HEY1;DLL4;HEY2;PLXND1;ADAM17;STAT1;SNAI2;APH1A;ADAM10
prerank,cellular response to increased oxygen levels (GO:0036295),0.6822620796032969,1.4398287150134212,0.07142857142857142,0.4607336201510609,1.0,3/11,2.28%,FAS;FOXO1;CAV1
prerank,JNK cascade (GO:0007254),0.5486947025613427,1.4398015734837617,0.062154696132596686,0.45975014733854924,1.0,10/40,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;IRAK2;UBA52;RPS27A;MAP3K11;MINK1;TAB2
prerank,cell-substrate junction assembly (GO:0007044),0.5694540130943238,1.4392439803266872,0.07766990291262135,0.460178432493155,1.0,6/33,9.44%,LAMA3;BCR;DST;PLEC;WHAMM;TAOK2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6688806201132397,1.4388911910760518,0.08631921824104234,0.4600839777940053,1.0,2/13,3.43%,NOS3;GCH1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.47271141014412776,1.4387489384775933,0.028037383177570093,0.45935317840935885,1.0,19/101,8.72%,EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;PIK3R6;CCNY;CCND2;NOD2;ATP2B4;CCND3;DAB2IP;ADRB2;ADAM17;IRGM;LRRK2;MAPRE3;SYAP1;TPD52L1
prerank,vasculature development (GO:0001944),0.632347733481598,1.4386874976855315,0.09538461538461539,0.45848013084119754,1.0,5/16,3.25%,NOTCH4;BMPR2;FLT4;ACVRL1;SOX18
prerank,glycogen metabolic process (GO:0005977),-0.48054450744028565,-1.4386678403322029,0.05993690851735016,0.5721238100857153,1.0,9/27,12.75%,PRKAG2;PHKB;PYGB;PYGM;PGM1;AGL;PHKA2;GYS1;GYG1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.47330318293971574,1.4385847725099683,0.02549246813441483,0.4576802806496793,1.0,22/108,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;ARL6IP5;CASP8;LGALS9;PPM1F;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;GRAMD4;HMGB1;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.4892112340373845,-1.4380650785434494,0.04573170731707317,0.5696789150767386,1.0,6/23,9.90%,GLI3;GPC3;TULP3;ENPP1;MEGF8;PTCH1
prerank,phosphorylation (GO:0016310),0.4349693863082686,1.4380627977703964,0.0020429009193054137,0.45807749554275573,1.0,76/385,12.62%,BMX;NUAK1;CDK19;ERG;MAP4K2;STK10;PDGFB;FYN;BMPR2;RPS6KA5;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;CDC42BPA;APP;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;MEX3B;PGK1;MAPK1;PXK;MAST1;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;GNPTAB;JAK2;PRKAA1;STK39;PASK;PIM3;DGKH;NEK7;ROCK1;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;MINK1;LIMK2;NEK11;PRKD2;MARK2;MATK;VRK1;COPS8;PIK3CB;TTBK1;BTK
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5442316853196186,1.4377376607400232,0.07327001356852103,0.45784438695034213,1.0,7/39,9.56%,MYO1D;MYO1E;TANC2;ACTN4;FNBP1L;MYO1C;PPFIA2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4661984511470473,-1.4375299724705695,0.0529595015576324,0.5669586172828657,1.0,12/29,15.79%,ZBTB20;SORBS1;LPGAT1;APOE;PPARA;GPLD1;SLC27A1;SREBF1;CREB1;SLC45A3;MFSD2A;NR1H3
prerank,cellular copper ion homeostasis (GO:0006878),0.6628727142999074,1.437343949977995,0.08603896103896104,0.4577732562886161,1.0,6/14,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,sterol transport (GO:0015918),0.6119962371251868,1.4368480782588686,0.10061919504643962,0.45799280341501797,1.0,3/19,5.21%,CAV1;APOA1;LCAT
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6618008843774675,1.4367847522852553,0.09546925566343042,0.45711151528989685,1.0,1/14,0.10%,ENTPD1
prerank,secretion (GO:0046903),0.6432768345215556,1.4365671374419242,0.09333333333333334,0.45661024573768716,1.0,3/14,6.82%,FBLN5;TPD52;NPR1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5589122706110093,-1.4364532576368685,0.07788944723618091,0.5661439747498425,1.0,6/15,6.77%,GPC3;RSPO3;NPHP3;DACT1;SFRP4;DAAM2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5965889457852189,-1.4360706297094112,0.07389162561576355,0.5630562504314718,1.0,5/12,7.80%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.47312757427074315,1.4357994447962021,0.0353356890459364,0.45761391697563814,1.0,29/91,19.49%,CDH13;HIP1;HIP1R;RAB11A;FES;PACSIN2;SYT7;PACSIN1;MAPK1;LRRK2;PLD1;STON1;PTPN1;INPP5F;CHMP3;NSF;ZFYVE16;RNF139;CPLX1;STXBP5L;RIT2;OPHN1;STXBP5;RUFY1;SCARB1;SYT1;HAP1;RAB5C;MAP2K1
prerank,protein import into peroxisome membrane (GO:0045046),-0.4915141420358994,-1.435594290786513,0.0783132530120482,0.5602185049368502,1.0,15/22,35.36%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,cellular response to interferon-beta (GO:0035458),0.652351510857889,1.4352755894346425,0.09197324414715718,0.45804229869854696,1.0,5/14,8.74%,AIM2;TRIM6;IRGM;STAT1;ACOD1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4683980169735149,-1.4345303493379784,0.06188925081433225,0.5590362646034086,1.0,7/27,9.11%,EGFR;DDX5;BMP4;LIMD1;EIF4E2;PUM1;MAP2K2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4523823653616105,1.4343663136284197,0.0231023102310231,0.4594464103100385,1.0,29/159,11.00%,PTPRM;PECAM1;CDH13;CLDN5;CEACAM1;VCAM1;CRTAM;MPZ;TGFB2;CADM1;ATP2C1;ACVR1;AMIGO2;ROBO4;MILR1;BSG;ITGAM;FLRT3;TENM3;LRRC4C;CDH15;CDH3;NECTIN4;NECTIN1;CDH12;FAT4;TENM4;KIRREL3;CDH2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6716141195359198,1.4340091791576075,0.0773109243697479,0.45937041922910865,1.0,3/12,9.64%,CAV1;IFIH1;DHX9
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.48285758204108953,1.433670487982392,0.04465334900117509,0.45916934838551476,1.0,13/90,8.44%,PRDM16;EPAS1;ADIPOR2;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,regulation of MAP kinase activity (GO:0043405),0.48424144192164886,1.4335436426147659,0.03672985781990521,0.4584825355149229,1.0,12/92,5.33%,PTPRJ;EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DUSP1;DAB2IP;INPP5K;STK38;HYAL2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4953958513302812,1.432580807215025,0.03799019607843137,0.4601341235816678,1.0,24/76,19.95%,AIM2;DAB2IP;KLF4;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;NFKBIB;NFKBIA;NWD1;HAVCR2;PTGIS;TMSB4X;PYCARD;PYDC1;ERBIN;FOXJ1
prerank,positive regulation of metabolic process (GO:0009893),0.4751265197042263,1.432546002647101,0.04100227790432802,0.4591760262410759,1.0,15/103,8.44%,PRDM16;EPAS1;ADIPOR2;FASN;INSR;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,ceramide catabolic process (GO:0046514),0.6582542408537608,1.4323141311753562,0.11004784688995216,0.4587539585130571,1.0,2/14,5.93%,ACER2;ASAH2
prerank,neural crest cell migration (GO:0001755),0.5423431438097266,1.4315800139775037,0.06233062330623306,0.45978745794822584,1.0,4/36,4.67%,SEMA3G;TBX1;SEMA3F;SEMA7A
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5885408096266395,1.43113802862814,0.08433734939759036,0.459913529815184,1.0,3/24,4.95%,NOS1;FKBP1A;CAMK2D
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.46916830024745143,-1.4301706784361485,0.048701298701298704,0.5687003188727058,1.0,10/30,12.26%,DSE;DCN;NDNF;CHST15;BGN;HEXA;VCAN;HYAL1;CHPF2;CSPG4
prerank,dicarboxylic acid transport (GO:0006835),-0.45809959292901936,-1.4297046069093953,0.046296296296296294,0.56595014742797,1.0,8/28,6.15%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;GJA1;SLC22A6;SLC19A1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.6663840694634299,1.429224172091849,0.09836065573770492,0.46415403667718735,1.0,2/12,1.60%,JAG1;NOTCH1
prerank,regulation of hormone secretion (GO:0046883),0.6428613060795072,1.4283962308137725,0.0943089430894309,0.465293887339371,1.0,2/15,4.32%,EDN1;SCG5
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5302159230637292,-1.4279133096255114,0.07975460122699386,0.5675830050544922,1.0,4/16,5.50%,PTN;SOX5;NUDT21;HOXB4
prerank,endoderm formation (GO:0001706),0.5440936438557227,1.4269621923624238,0.07965860597439545,0.468251591295183,1.0,3/35,2.05%,LAMA3;SOX17;DUSP1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6532205891626646,1.4260657237452314,0.11525974025974026,0.46969735368990456,1.0,2/14,4.67%,PLCG2;SEMA7A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5052467098276212,-1.4259660680422757,0.06970509383378017,0.570128290055161,1.0,10/19,20.22%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;PMM1;NANS;GNPNAT1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6160088499556104,1.4256644899147999,0.10339506172839506,0.46972966147096845,1.0,7/17,10.60%,CEACAM1;KLF7;CAV1;MAFF;GATA3;DSPP;APOLD1
prerank,negative regulation of axon extension (GO:0030517),0.5604904285264538,1.4254733118839433,0.07215007215007214,0.4691559698317614,1.0,8/30,11.97%,SEMA3G;SEMA3F;SEMA7A;SEMA6D;RTN4;SEMA4G;TRIM46;DIP2B
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6097577512537197,-1.4252571881353968,0.07579462102689487,0.5682869874774547,1.0,3/10,15.34%,OGT;ZNF692;PDK2
prerank,retina homeostasis (GO:0001895),0.583841832137969,1.4249162823190114,0.08358662613981763,0.469635952077858,1.0,6/23,11.20%,B2M;HSPB1;CDH3;ACTG1;POTEF;ACTB
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5397151414381149,1.4245609070645195,0.07818930041152264,0.46953089267822506,1.0,8/39,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;PTPN12;RNF115
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.46026561464658344,1.424149286333136,0.04267589388696655,0.4697159870631995,1.0,15/113,5.23%,VEGFC;CDH13;TEK;PDGFB;BMPR2;FLT4;TBX1;EGFL7;NOD2;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B
prerank,regulation of chromatin binding (GO:0035561),0.680612439241064,1.423422164059743,0.1020066889632107,0.47086152166155654,1.0,4/10,16.04%,HMBOX1;BTAF1;DTX3L;KDM4D
prerank,regulation of interleukin-2 production (GO:0032663),0.5303125338813799,1.423150233571433,0.07103825136612021,0.47055100303393516,1.0,13/43,18.78%,PLCG2;HOMER2;HDAC7;CD34;IL1A;PRNP;LAPTM5;PRKD2;NAV3;HAVCR2;PDE4D;SPTBN1;MALT1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4582593279429239,-1.422832739722214,0.05921052631578947,0.5723375022611307,1.0,12/28,21.89%,PDK1;APOE;PPARA;PRKN;RORA;EPHX2;FOXK2;PDK3;PDK2;PANK2;ACADVL;NR1H4
prerank,activation of adenylate cyclase activity (GO:0007190),-0.4383000754083728,-1.4223211670987996,0.036585365853658534,0.569816216792427,1.0,8/35,9.88%,LGR4;ADCY5;ADCY9;ADCY1;EDNRA;ADCY2;ADCY7;RAF1
prerank,protein phosphorylation (GO:0006468),0.4294615069891444,1.4211603901493723,0.0020222446916076846,0.47502477897855827,1.0,97/479,12.94%,BMX;NUAK1;CDK19;TEK;ERG;FLT1;MAP4K2;STK10;PDGFB;FYN;BMPR2;FLT4;RPS6KA5;SMAD7;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;SBK1;DAB2IP;CDK14;SNRK;PRKD1;PRKG1;TGFB2;MAST4;OXSR1;CDC42BPA;APP;MAP3K6;FES;PKN3;TLR3;CDC42BPG;BCR;ACVR1;SLK;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;SMAD2;FGFR3;MEX3B;MAPK1;PXK;UHMK1;MAST1;EEF2K;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;JAK2;PRKAA1;STK39;PASK;PIM3;CAD;NEK7;ROCK1;CSNK1G3;PTK2;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;TNKS;MAP3K3;NEK11;GTF2H3;PRKD2;MARK2;MATK;VRK1;COPS8;TTBK1;BTK;STK33;RPS6KA3;RPS6KB1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5433065047474452,1.4208712971364332,0.08725761772853186,0.47475768921712114,1.0,4/36,2.44%,MECOM;FOXO1;DUSP1;F2RL1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6889405308369285,1.420350157367698,0.13344594594594594,0.4751980721163563,1.0,3/10,8.51%,NOD2;JAK2;NAMPT
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3645735731632906,-1.420020683310766,0.026490066225165563,0.5729082940875266,1.0,28/95,12.71%,GPC6;UST;DSE;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;HS3ST3A1;FMOD;B3GNT2;CHST15;BGN;PXYLP1;XYLT1;PRELP;HEXA;ST3GAL4;B4GALT1;VCAN;B3GAT3;HS2ST1;HYAL1;CHPF2;LUM;CSPG4;OMD
prerank,ventricular septum development (GO:0003281),0.5402336777116246,1.4198877429904055,0.08547008547008547,0.475437071107567,1.0,10/37,6.03%,GJA5;BMPR2;SMAD7;NOTCH1;DAND5;HEY1;TGFB2;HEY2;ACVR1;GATA3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6080447820118594,1.4182776074121213,0.09969788519637462,0.4788528150336554,1.0,7/19,9.21%,CLDN5;F11R;OCLN;MYO1C;SNAI2;ROCK1;TJP1
prerank,aminoglycan catabolic process (GO:0006026),-0.47087047410105215,-1.4179783453205388,0.06134969325153374,0.5756988447372411,1.0,5/28,4.59%,GPC6;SDC2;HSPG2;GPC3;GNS
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5947983860381411,1.4175619012791445,0.09281437125748503,0.47971170959445286,1.0,7/22,12.62%,NOD2;F2RL1;APOA1;TRIM6;TNFRSF1B;LAPTM5;BTK
prerank,mitochondrion morphogenesis (GO:0070584),-0.597160554435396,-1.4174660349878172,0.10199004975124377,0.5731179122370457,1.0,2/11,3.16%,PID1;WASF1
prerank,regulation of platelet aggregation (GO:0090330),0.6195641135081351,1.4165486219973298,0.09062003179650238,0.4813815473388471,1.0,4/17,3.41%,CEACAM1;F11R;PRKG1;ADAMTS18
prerank,protein localization to cell junction (GO:1902414),0.5801765298418916,1.4162340746457354,0.11045655375552282,0.48111515225367574,1.0,5/22,9.23%,HEG1;TJP2;TJP1;DSP;NECTIN1
prerank,cellular response to lectin (GO:1990858),0.4661355228464834,1.4162334201594209,0.03788748564867968,0.4790457551924327,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4661355228464834,1.4162334201594209,0.03788748564867968,0.4790457551924327,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5767146069825102,1.4161441113998607,0.09433962264150944,0.47825129911006625,1.0,6/27,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6095973816539328,-1.4158145847726324,0.10396039603960396,0.5746483805860758,1.0,7/10,35.75%,PLA2G4A;PLA2G15;PLA2G6;ENPP2;PLA2G7;LIPC;PLA2G5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.46518217862518396,1.4153406311396568,0.036488027366020526,0.47952734994004165,1.0,29/105,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5343853832564376,-1.4152679125316339,0.08659217877094973,0.5721655981756317,1.0,5/17,11.42%,PID1;NUPR1;PPARA;FLCN;HDAC4
prerank,atrial septum morphogenesis (GO:0060413),0.6761142384077139,1.414815385992034,0.12157534246575342,0.4798654956156439,1.0,4/10,4.11%,BMPR2;TGFB2;HEY2;ACVR1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4501780537411726,1.4145996372857956,0.03243847874720358,0.47940404979547613,1.0,25/138,9.22%,TEK;PTPRG;FLT1;TIE1;NPR2;FYN;BMPR2;FLT4;MPZL1;MERTK;LIFR;RAPGEF1;INSR;TRIO;NEDD9;FES;FGFR3;NPR1;ALK;LMTK2;PTPRU;JAK2;YES1;STAP1;PTK2
prerank,regulation of phospholipase activity (GO:0010517),-0.6079048857481475,-1.4145537498151346,0.10294117647058823,0.5705075951349127,1.0,2/10,1.04%,LRP1;FGFR2
prerank,regulation of coagulation (GO:0050818),0.6755892308979397,1.4130496843894258,0.12116040955631399,0.4827017127051065,1.0,4/11,11.57%,CAV1;F2RL1;PROC;HS3ST5
prerank,copper ion homeostasis (GO:0055070),0.6250776320704545,1.4127750752040635,0.09233176838810642,0.48239600985068937,1.0,6/17,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,positive regulation of cell death (GO:0010942),0.4942027590403421,1.412697328582831,0.07160804020100503,0.4815916307907522,1.0,17/59,14.96%,SLC6A6;ACER2;FYN;FCGR2B;ZC3H12A;ITGAM;LRRK2;CIDEB;GRIN2B;APC;EGR1;PRNP;TYROBP;CLU;BNIP3;SARM1;EIF2S1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.47191416761961646,1.4119104876031137,0.04678362573099415,0.4827562133314952,1.0,20/93,10.65%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;ARL6IP5;F2RL1;TGFB2;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;ZC3H12A;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6294764609209424,1.4117930576423625,0.11295681063122924,0.4820746470858829,1.0,2/15,6.09%,PLCG2;CUL3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5379121664668907,1.4115105500366598,0.07377049180327869,0.4819206050461543,1.0,11/38,11.89%,PDGFB;ACE;CAV1;APP;NEDD9;EFNA1;HYAL2;FCGR1A;PRNP;PTPN1;GRM5
prerank,defense response to tumor cell (GO:0002357),-0.5990770325042598,-1.4114337768225287,0.10772833723653395,0.57646348920886,1.0,2/10,0.65%,RBMS3;DAPK1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5331877869693579,1.4112659694096463,0.0890125173852573,0.48158130010566497,1.0,7/36,5.32%,PTPRM;ACVRL1;NOTCH1;ATP2B4;DAB2IP;DLL4;MEF2C
prerank,Notch signaling involved in heart development (GO:0061314),0.6930664473307784,1.4107057241542016,0.0929853181076672,0.4820388151415972,1.0,5/11,3.58%,JAG1;NOTCH1;HEY1;DLL4;HEY2
prerank,histone modification (GO:0016570),-0.34824088503369954,-1.4104343521300287,0.006802721088435374,0.5759574620867562,1.0,26/109,14.55%,EYA2;EYA1;PRDM5;TBL1XR1;CREBBP;BAZ1B;EYA4;NSD3;NSD1;UBE2N;EHMT1;USP3;PHF20;RBM14;HDAC4;HDAC1;USP22;TAF6L;HDAC6;PADI2;ATXN7L3;MSL3;KDM4A;SIRT2;SIN3B;MTA2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6398806611041256,1.4100775071779008,0.1072,0.48263911274568094,1.0,2/15,7.42%,ENTPD1;CMPK1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.589794687586638,1.4097574855433055,0.1044776119402985,0.4825467604335942,1.0,9/21,9.22%,EFNA5;LIMCH1;MACF1;SLK;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5655305619474629,1.4096647934740372,0.0965034965034965,0.4818148348917465,1.0,6/29,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6566776579698571,1.4091901396235351,0.11093247588424437,0.4821221396275635,1.0,2/13,5.80%,ENTPD1;SMPDL3A
prerank,pyroptosis (GO:0070269),0.6129750217355924,1.4089296984421638,0.10806451612903226,0.4818309636060196,1.0,4/15,10.37%,AIM2;CASP8;DHX9;CASP1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.557330931060865,1.4088723723841083,0.10339943342776203,0.4810018905646566,1.0,7/29,9.89%,SMAD7;DAB2IP;IL17RD;EFNA1;GATA3;ADIPOR1;MAD2L2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6138407725276385,1.4076666752298328,0.11059190031152648,0.48332432714221096,1.0,1/16,0.65%,CLDN5
prerank,renal water homeostasis (GO:0003091),-0.4763248532537196,-1.4075298678337047,0.06624605678233439,0.5815497280496211,1.0,10/23,15.55%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;WFS1
prerank,endocrine system development (GO:0035270),-0.49541946666041914,-1.4074281302691027,0.10559006211180125,0.5778957751762264,1.0,11/21,20.43%,GLI2;WNT4;TGFBR1;DKK3;SIX1;STRA6;SALL1;MDK;FOXE1;NF1;SOX2
prerank,positive regulation of hormone secretion (GO:0046887),0.626724082718247,1.4072807645302647,0.0972644376899696,0.48346029633924265,1.0,3/17,8.95%,EDN1;VAMP8;VAMP7
prerank,mesenchymal cell development (GO:0014031),0.6115672026792125,1.4071766480504677,0.10873146622734761,0.4827648419190024,1.0,9/18,21.33%,NOTCH1;HEY2;SNAI2;CDH2;CYP26C1;TBX20;TCOF1;SOX11;NOLC1
prerank,muscle organ development (GO:0007517),-0.39326353871436137,-1.4071018015876333,0.01990049751243781,0.5750415151737662,1.0,16/54,9.79%,LAMA2;IGF1;DMD;CHD2;COL6A3;LARGE1;VAMP5;MRAS;ITGA11;FHL1;SGCD;SPEG;EVC;POU6F1;SMTN;SGCE
prerank,small GTPase mediated signal transduction (GO:0007264),0.46247783649317314,1.406892554361216,0.046153846153846156,0.48253799552539095,1.0,29/103,14.49%,CCDC88C;RAPGEF2;ARHGAP31;RASGRP2;RAPGEF5;ABR;PRKD1;NUCB2;KRAS;NRAS;NTN1;BCR;RRAS;SHTN1;RAPGEF6;SHOC2;TIAM2;PLD1;JUN;SIAH2;RHEBL1;RRAS2;CCDC88A;RAC1;RGS19;KSR2;RRAD;SOS1;RHEB
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6692584912818523,1.406653180517744,0.12833333333333333,0.4811864571167506,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6692584912818523,1.406653180517744,0.12833333333333333,0.4811864571167506,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,regulation of secretion (GO:0051046),0.6487541954692269,1.4063640589803457,0.13367174280879865,0.48101197208719837,1.0,3/13,9.30%,KCNQ1;OAS2;SGK1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4383321304238222,-1.406236536651291,0.05434782608695652,0.5739170277198389,1.0,6/32,3.93%,PID1;IGF1;ZBTB20;NUPR1;PRKAA2;PPARA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.48694733137951407,-1.405739085557767,0.06906077348066299,0.5717453481879059,1.0,9/21,20.34%,SMO;DCDC2;ARMC9;EVC;GLI1;KIF7;GAS8;ULK3;STK36
prerank,calcium ion import into cytosol (GO:1902656),0.6106493472220473,1.405497743047852,0.11589403973509933,0.4825285416515669,1.0,3/15,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,cellular response to osmotic stress (GO:0071470),0.5875653235766739,1.4043557037025074,0.10107197549770292,0.48467772298959716,1.0,4/21,2.77%,TRPV4;MYLK;ARHGEF2;OXSR1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5328167248773501,1.403989255531924,0.08811188811188811,0.48473239663967826,1.0,10/35,14.10%,HIP1;HIP1R;B2M;CBL;PPT1;HNRNPK;RAC1;CLU;PIK3CB;LDLRAP1
prerank,calcium ion import across plasma membrane (GO:0098703),0.6191506792249303,1.4031366495604967,0.10509031198686371,0.48611277531586666,1.0,3/14,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5578276119097038,1.4027972783429552,0.11271676300578035,0.4860204919157511,1.0,6/30,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;BCL2L1
prerank,chondrocyte differentiation (GO:0002062),-0.43933396843417993,-1.4026475269791239,0.07368421052631578,0.5779732964671835,1.0,10/32,7.53%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;RUNX2;RUNX1;CCN3;GPLD1
prerank,regulation of intracellular pH (GO:0051453),-0.4322065788148145,-1.402323426716335,0.06859205776173286,0.5753461053430017,1.0,17/34,22.63%,SLC4A10;SLC9A2;CA2;SLC9A9;SLC4A2;ATP5F1B;VPS33A;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;TMEM165;SLC4A8;CFTR
prerank,regulation of synapse maturation (GO:0090128),0.6861933447441948,1.4021948937932882,0.11892797319932999,0.48664833279179576,1.0,2/10,2.21%,ARHGEF15;DAB2IP
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.4707883076044359,-1.4014496337956686,0.06369426751592357,0.574236402946252,1.0,11/24,22.82%,PID1;LEPR;SLC25A13;COQ10A;COX10;GFPT1;GFPT2;ACADVL;LYRM7;CYCS;MTLN
prerank,endothelial cell proliferation (GO:0001935),0.6142844573870572,1.3997416996273566,0.1360655737704918,0.49257392063470795,1.0,4/17,5.43%,TEK;BMPR2;ACVRL1;CD34
prerank,cardiac conduction system development (GO:0003161),0.580501316333591,1.3982279767601276,0.11280487804878049,0.4956695125944744,1.0,5/24,3.58%,GJA5;GATA6;MSX1;HEY1;HEY2
prerank,calcium ion homeostasis (GO:0055074),0.46937703852573176,1.3976572418860422,0.04332552693208431,0.496239545996469,1.0,12/95,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4058288337223109,-1.3970988868829404,0.04,0.5844652359452607,1.0,14/45,17.81%,EGFR;DDX5;BMP4;PIK3R1;LIN28B;MAP2K2;BUD23;NFKB1;RBM20;HNRNPLL;SUPV3L1;NMD3;ZPR1;U2AF2
prerank,cAMP metabolic process (GO:0046058),-0.5533175346316012,-1.396791887388301,0.10638297872340426,0.581734873342433,1.0,5/13,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,nerve growth factor signaling pathway (GO:0038180),0.679445369856211,1.3964628466004156,0.09747899159663866,0.4984468086042856,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,regulation of phagocytosis (GO:0050764),0.5002491682992166,1.3963672756845942,0.08673469387755102,0.49768946302176703,1.0,16/53,17.97%,GATA2;MERTK;DYSF;APOA1;SYT7;FCGR2B;CD47;PLSCR1;CYBA;DOCK2;TUB;ABCA7;RACK1;PYCARD;SCARB1;RAB27A
prerank,innate immune response (GO:0045087),0.43443928654265684,1.3959354965112603,0.02006335797254488,0.49790560246691745,1.0,53/217,20.93%,PLCG2;FYN;TRIM14;NOD2;B2M;IFIH1;APP;FES;GCH1;TLR3;DEFA6;ADAM15;TRIM11;TRIM6;MFHAS1;IRGM;SERINC3;NLRC5;YES1;ADAR;PTK2;HMGB1;TRIM25;TYROBP;TRIM17;CYBA;SERINC5;CFB;CHGA;TRIM8;IRF5;BTK;CX3CR1;AKAP1;CR2;RNASE6;NCF2;SLPI;SRPK1;SLA;PYDC1;CXCL10;IFITM3;RELA;MALT1;ANG;AGER;CAPZA2;SETD2;DHX58;ANKRD17;MID2;RPL39
prerank,positive regulation of potassium ion transport (GO:0043268),0.5331327504882711,1.395773675257293,0.09439124487004104,0.4973626382350229,1.0,4/38,3.68%,KCNN4;KCNQ1;KCNN3;NOS1AP
prerank,cGMP biosynthetic process (GO:0006182),0.6713171876154602,1.3956934967855854,0.13261648745519714,0.4965816956275289,1.0,3/10,11.52%,NPR2;NPR1;NPPC
prerank,regulation of ion transport (GO:0043269),0.4795327423323997,1.3956477520890151,0.06666666666666667,0.49574746121834184,1.0,8/76,7.62%,NOS1;SYT15;B2M;ATP1A1;SYT7;PXK;P2RX7;NKAIN3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.48067349280154675,-1.3955345099295922,0.08231707317073171,0.5780329681936986,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.48067349280154675,-1.3955345099295922,0.08231707317073171,0.5780329681936986,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5970487781038346,1.395110334256199,0.10975609756097561,0.49617678089869816,1.0,7/18,14.84%,HOMER2;HDAC7;CD34;PRNP;LAPTM5;NAV3;HAVCR2
prerank,response to estrogen (GO:0043627),0.5409729092731353,1.3947310778438338,0.11218836565096953,0.49622326439730124,1.0,13/31,19.37%,CAV1;PELP1;GATA3;TRIM24;NCOA4;ARID5A;TRIM25;SFR1;BRCA1;ESR1;RARA;CD24;WBP2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6772240170099124,1.3942674886842732,0.12563667232597622,0.49649379295719837,1.0,3/10,9.97%,CRTAM;LGALS9;PRNP
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5382759514734176,1.3940751287288013,0.09523809523809523,0.49602795619073925,1.0,5/35,6.09%,HEG1;RASIP1;DAB2IP;TGFB2;CUL3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6028495383056117,1.3935627177050232,0.1166407465007776,0.4964792752205945,1.0,9/18,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,calcium-ion regulated exocytosis (GO:0017156),0.553320699238704,1.3935025439002162,0.12347560975609756,0.4956530658953619,1.0,8/27,18.29%,SYT15;DOC2B;SYT7;VAMP7;RIMS3;SDF4;SYT1;SYT2
prerank,neural crest cell development (GO:0014032),0.5188556713737069,1.392932368676284,0.07840440165061899,0.4962126023904364,1.0,10/44,13.01%,SEMA3G;TBX1;SEMA3F;SEMA7A;SEMA6D;SNAI2;CDH2;SEMA4G;SOX10;CYP26C1
prerank,regulation of oxidoreductase activity (GO:0051341),0.6386885137005915,1.3927543433897827,0.13793103448275862,0.49583025370882966,1.0,3/13,6.37%,NOD2;ATP7A;SIRT4
prerank,positive regulation of filopodium assembly (GO:0051491),-0.47392566310339057,-1.3925366823248089,0.07297297297297298,0.5843974534367478,1.0,7/24,8.24%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;PIK3R1;BCAS3
prerank,positive regulation of bone mineralization (GO:0030501),-0.4237405158661238,-1.3923401534918247,0.03691275167785235,0.5812685767825727,1.0,10/35,5.87%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;FBN2;KL
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5710213161369914,1.392301514064818,0.11225997045790251,0.49611223466179927,1.0,7/24,10.93%,NOD1;NOD2;CASP8;IRAK2;UBA52;RPS27A;TAB2
prerank,autophagy of nucleus (GO:0044804),-0.5158941460219901,-1.3921812634388064,0.08888888888888889,0.5782451976643285,1.0,7/16,21.50%,ATG3;ATG5;ATG2A;ULK2;ATG7;WIPI2;WDR45
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5462814984506115,-1.391049062054399,0.10704960835509138,0.5784501301434809,1.0,6/13,12.26%,DCN;BGN;HEXA;VCAN;HYAL1;CSPG4
prerank,epithelial cell differentiation (GO:0030855),0.4718037574825503,1.3906548665764895,0.05860805860805861,0.49966531960533417,1.0,12/88,6.23%,JAG1;IRF6;GATA6;TBX1;RHCG;GSTA2;DEUP1;TST;TAGLN2;GATA3;PGK1;PCK2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6772748497057767,1.3900841133995363,0.1360544217687075,0.5002107484620871,1.0,2/10,2.67%,RAPGEF2;LGALS9
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6398080732896945,1.3892212157303492,0.12038523274478331,0.501464193661163,1.0,1/14,0.26%,KCNN4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5785131775471453,1.3883639259982072,0.12198795180722892,0.5028364788108298,1.0,5/21,3.85%,CNKSR3;SMAD7;CAV1;INPP5K;PPM1F
prerank,phospholipid translocation (GO:0045332),0.5555017478803506,1.3856099658053527,0.12112676056338029,0.5095020216596913,1.0,10/28,15.39%,ATP10A;PLSCR4;ANO6;ABCB4;P2RX7;PLSCR1;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6118356734224897,1.3854616212896806,0.1321656050955414,0.5089427641107981,1.0,4/16,5.23%,GATA2;JCAD;DLL4;PPP1R16B
prerank,protein import (GO:0017038),-0.35247658421471195,-1.3851571003589498,0.02127659574468085,0.5944660985431246,1.0,33/84,24.74%,APPL2;APOE;ABCD3;HSPA4;NUP107;HEATR3;CSE1L;PPP1R10;ATAD1;NUP155;PEX2;TNPO3;PXMP4;RANBP6;IPO5;FAM53C;PXMP2;NUP93;TNPO2;GDAP1;RANBP17;TSC2;PHB2;TOMM22;PEX11B;SEC13;SYK;PEX13;IPO7;POM121;PEX3;IPO8;PEX16
prerank,blood circulation (GO:0008015),0.5096712418491912,1.3849243150745778,0.06298200514138817,0.5094319234145525,1.0,12/49,13.10%,ELN;NOS3;ACE;ACVRL1;DLL4;TBC1D8;NPR1;STAT1;ROCK1;MYOF;ITGB1BP1;SGCZ
prerank,regulation of transferase activity (GO:0051338),0.6114020466816362,1.3848879713616822,0.10894308943089431,0.508535953177485,1.0,5/17,8.03%,LDB2;EMP2;HMBOX1;JMJD8;NLRC5
prerank,calcium ion transport (GO:0006816),0.4517083001087304,1.384521665101264,0.03876852907639681,0.5085126115969728,1.0,20/113,8.36%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;FKBP1A;SLC8A1;ATP2C1;ANO6;ORAI1;STIM2;P2RX7;CRACR2B;MCOLN1;CRACR2A;MCUR1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5713914634654189,1.384431151653352,0.09809663250366032,0.5078314308994537,1.0,6/23,8.22%,IFNGR1;ARG1;IRGM;STAT1;NLRC5;JAK2
prerank,epidermal cell differentiation (GO:0009913),0.5240479161780776,1.384312894478213,0.10135135135135136,0.5071741580948608,1.0,4/41,4.02%,JAG1;GATA6;CLIC4;BCR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5898946030124124,1.3838218412559493,0.12363067292644757,0.5075672910010488,1.0,3/18,6.09%,HEG1;RASIP1;CUL3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5575398487877685,-1.383343258897933,0.09975669099756691,0.5967016659661702,1.0,6/13,19.55%,GLI3;RUNX1;NCKAP1L;PNP;TGFBR2;ZBTB7B
prerank,glycolipid metabolic process (GO:0006664),0.5083181655442925,1.3832883785306056,0.08432147562582346,0.5079975235557036,1.0,6/47,7.84%,ST6GALNAC3;ST8SIA6;ST3GAL6;ESYT2;PGAP1;GLTP
prerank,phagolysosome assembly (GO:0001845),0.644108857470047,1.3822652596844125,0.1399662731871838,0.5098937816841853,1.0,3/12,4.75%,SYT7;RAB39A;RAB34
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.593050846665594,1.382086074500522,0.10276073619631902,0.5093894528758273,1.0,4/20,5.27%,FASN;FAR2;PPT1;FAR1
prerank,positive regulation of telomerase activity (GO:0051973),0.5390366929697699,1.3819537603633956,0.1071932299012694,0.5087930106258761,1.0,18/33,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;CTNNB1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5727236029659853,1.3819056934701772,0.11244377811094453,0.5079690000722726,1.0,7/23,9.97%,NOS1;FYN;DIAPH1;NOS1AP;CAMK2D;CASQ1;PRNP
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.38501486552756836,-1.3818696082517006,0.028925619834710745,0.5979266835882826,1.0,13/52,9.11%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;EPB41L2;GNAI1;STX4;GPSM2;PIK3R1;CLIP3;PRKCI;STX3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6001065039834326,1.3817503591864644,0.11885895404120443,0.507450118332726,1.0,6/18,6.91%,GATA2;JCAD;PIK3C2A;HDAC9;HDAC7;AKT3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5922616147104651,-1.3817040400885283,0.10123456790123457,0.5948881115357134,1.0,4/11,4.29%,NKD1;DAB2;RSPO3;PLEKHA4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6781603692816943,1.3810468496837964,0.12333333333333334,0.5083698802014263,1.0,3/10,3.41%,CEACAM1;PRKG1;ADAMTS18
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.38829560681978115,-1.3809750525204614,0.03404255319148936,0.5937650416318099,1.0,17/52,19.92%,SHC1;LMNA;DNAJC3;SSR1;ARFGAP1;SEC31A;TSPYL2;SRPRB;EXTL2;VAPB;GFPT1;FKBP14;WFS1;TLN1;PDIA6;ADD1;ACADVL
prerank,neural tube development (GO:0021915),-0.5308892253797488,-1.3807363737787561,0.12299465240641712,0.5909959379159518,1.0,4/15,11.66%,ALDH1A2;DACT1;PTCH1;PKD1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5878402454439063,-1.3806122879212197,0.11083743842364532,0.5878517090693947,1.0,5/11,11.18%,OGT;SETD1A;SETD1B;TET2;CTR9
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5618501751594149,-1.3804687701998941,0.10804020100502512,0.584767545012717,1.0,5/12,15.79%,ABCA1;ITGAV;PPARA;PPARG;NR1H3
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.48095586734806905,-1.379779151763206,0.0764525993883792,0.5836906720823112,1.0,5/22,3.90%,NOTCH2;FGFR2;CASK;PTPRK;STXBP4
prerank,phospholipid dephosphorylation (GO:0046839),0.5264642138387401,1.3794111128617335,0.0989010989010989,0.5119199470624491,1.0,13/37,17.35%,SGPP2;PLPP1;INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;PLPP6;PLPP4;INPP5J;PLPPR1;SYNJ1
prerank,phagosome-lysosome fusion (GO:0090385),0.6749258586087719,1.3790923203145957,0.13059033989266547,0.5118204628703361,1.0,3/10,4.75%,SYT7;RAB39A;RAB34
prerank,neuron development (GO:0048666),0.44275223394657326,1.3790725915427777,0.04950495049504951,0.5109263986845873,1.0,23/141,9.87%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;TGFB2;FRY;BTG2;APP;MAP4;PPT1;BLOC1S6;EHD1;ATP7A;MEF2C;UHMK1;ALK;FLRT3;TENM3;RAB35;ROCK1;HMGB1;B4GALT6
prerank,activation of phospholipase C activity (GO:0007202),-0.4470644793327843,-1.378547785667568,0.08561643835616438,0.5841510619713766,1.0,5/29,5.53%,ARHGAP6;EGFR;LPAR1;EDNRA;NTRK2
prerank,carnitine shuttle (GO:0006853),-0.5686371958789516,-1.3785465559373327,0.12980769230769232,0.5807604489538055,1.0,6/11,20.14%,PRKAG2;PRKAA2;SLC25A20;PRKAB2;CPT2;ACACA
prerank,regulation of protein phosphorylation (GO:0001932),0.421842437316048,1.378460573852233,0.02100840336134454,0.511632076716295,1.0,43/256,10.83%,VEGFC;PECAM1;TEK;CCDC88C;ENG;EFNA5;FYN;FLT4;FAS;TBX1;LIMCH1;CCND2;OCLN;INSR;CCND3;DAB2IP;APP;INPP5K;VEGFD;KRAS;ANGPT1;WWTR1;EFNA1;CSNK1D;BRAT1;WARS1;ADAM17;IRGM;ZC3H12A;LRRK2;HSPB1;PDE8A;PRR5L;ARRB1;THPO;NDUFS4;PPP2R5C;CACTIN;PTK2;PRNP;CCDC88A;RAC1;LIMK2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5838209193767122,1.3779437708630884,0.13787878787878788,0.5121177542428397,1.0,5/18,11.93%,EDN1;NOD2;ATP7A;RFK;PDP1
prerank,chordate embryonic development (GO:0043009),-0.3930438405086894,-1.3777184695887637,0.03349282296650718,0.5801049637424279,1.0,18/55,9.90%,ALDH1A2;COL1A1;FGFR2;SULF1;TGFBR1;ARNT2;BMP5;BMP7;SULF2;WNT5A;RBP4;ZNF568;XYLT1;DACT1;IGF2;FLCN;VEGFA;PTCH1
prerank,glutamate receptor signaling pathway (GO:0007215),0.5209304911528319,1.3773879262534976,0.10857142857142857,0.5127167137799977,1.0,13/37,19.60%,PLCB1;GNAQ;HOMER2;APP;GRIN2B;GRIN2C;GRIK2;GRIN3A;GRM5;GRIK1;GRIN2A;GRM7;GRID2
prerank,embryonic organ morphogenesis (GO:0048562),-0.41185362373821777,-1.3764211221411626,0.057692307692307696,0.580977591510867,1.0,15/42,7.10%,EFEMP1;FGFR2;HOXC4;PDGFRA;MFAP5;HOXA3;HOXB3;FBN2;RBP4;FBN1;NIPBL;HOXB4;RBPMS2;MEGF8;SIX1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6312623019482912,1.3762331941595998,0.1407766990291262,0.5149480511135253,1.0,2/14,2.28%,NOTCH4;CAV1
prerank,female gonad development (GO:0008585),-0.48534876216957423,-1.3760157034175724,0.10422535211267606,0.5788716455525854,1.0,5/19,8.97%,NR2F2;KIT;NUP107;CEBPB;VEGFA
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4843808296412863,-1.3759937366859618,0.09971509971509972,0.5756648995223841,1.0,9/21,14.02%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4;CCN3;SLC2A10;SH2B1;NUP93
prerank,regulation of programmed cell death (GO:0043067),0.4351490260162852,1.375571416466435,0.039603960396039604,0.5158045876589088,1.0,36/161,15.09%,MECOM;ACER2;HIP1;FAS;ACTN4;PPP1R13B;GLS2;SLK;CASP2;OMA1;AMIGO2;TNFRSF25;APEX1;TOX3;TRIM24;MADD;ALK;FANK1;CRADD;LRRK2;STAT1;CIDEB;DCPS;JAK2;SGK1;RTN4;CASP1;CLU;NF2;BNIP3L;ATM;BNIP3;ANP32B;PSMC5;TM7SF3;DFFA
prerank,organic hydroxy compound transport (GO:0015850),0.5294638318750747,1.3751346537967397,0.10136986301369863,0.5160313008323519,1.0,3/36,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,morphogenesis of an epithelium (GO:0002009),0.5604277695756338,1.3749556584412435,0.125948406676783,0.5155998398798798,1.0,5/25,12.09%,LAMA3;LAMA5;ACTG1;ACTB;SOX10
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5291299038901685,-1.374539774100354,0.11989100817438691,0.5771915707310132,1.0,7/15,23.74%,PPARA;OSBPL8;PPARG;OSBPL11;LPL;PLIN3;FITM2
prerank,positive regulation of cell adhesion (GO:0045785),0.4711551291630234,1.3739328597973808,0.0687116564417178,0.5173178025737261,1.0,12/74,8.73%,PTPRJ;PDGFB;MAGI1;SMAD7;TGFB2;FBLN2;TNFRSF18;PPM1F;CD47;PPP3CA;JAK2;RSU1
prerank,mesoderm formation (GO:0001707),0.611961727377831,1.3730591952876083,0.1088646967340591,0.5187066534748809,1.0,6/17,17.39%,BMPR2;TBXT;SMAD2;TBX20;ITGA3;ITGA8
prerank,renal absorption (GO:0070293),0.6756496765129154,1.371746731487204,0.1289198606271777,0.5214015709193138,1.0,5/10,9.30%,KCNQ1;HNF1A;KLHL3;HYAL2;SGK1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.592257427609667,1.3716657833490986,0.12539184952978055,0.5206641302826479,1.0,3/20,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,"phagocytosis, engulfment (GO:0006911)",0.5362924289599533,1.3712882227142733,0.10393258426966293,0.5206827750274514,1.0,13/36,13.75%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;XKR6;VAMP7;ADGRB1;RAC1;DOCK1;RHOH
prerank,dendrite morphogenesis (GO:0048813),-0.42860606721214833,-1.3712424853549419,0.08992805755395683,0.5835888764045926,1.0,8/35,6.56%,PTN;SDC2;FARP1;DCDC2;PHACTR1;DOCK10;DLG4;CTNND2
prerank,protein localization to cell periphery (GO:1990778),0.4374168457514345,1.3711868845788002,0.0552423900789177,0.5200400977947721,1.0,27/133,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;PDZD11
prerank,regulation of cellular senescence (GO:2000772),0.5536748569381948,1.370174629909532,0.1282798833819242,0.5218217920626467,1.0,6/28,11.13%,NUAK1;B2M;ING2;AKT3;RBL1;MAP3K3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4448808687447511,-1.370043373738473,0.09841269841269841,0.5840292589001674,1.0,10/27,20.58%,ABCA1;ITGAV;PPARA;PPARG;NFKB1;AGTR1;NR1H3;MAPK9;LPL;AGT
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5369629489523663,1.3698139846145987,0.0899854862119013,0.5218732950817161,1.0,8/28,11.31%,GATA2;EGFL7;HEY1;DLL4;ARRDC1;ARRB1;FBXW7;HIF1AN
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4637062639360769,-1.3697252937634152,0.07062146892655367,0.5817824622870593,1.0,13/23,25.45%,CAMK1D;SLIT2;DPP4;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,negative regulation of cell activation (GO:0050866),0.6273720145825412,1.3695652763774313,0.13716814159292035,0.5216096005911958,1.0,4/14,8.68%,NOS3;PDGFB;CD200;NR1D1
prerank,protein O-linked mannosylation (GO:0035269),-0.5059889503694176,-1.3685048484584033,0.10393258426966293,0.5823133178009362,1.0,4/18,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,negative regulation of protein kinase activity (GO:0006469),0.4571773554391179,1.368408933167987,0.07980652962515115,0.5238734136499847,1.0,27/88,17.56%,PTPRB;CEACAM1;GNAQ;ADARB1;DAB2IP;CAV1;INPP5K;SLC8A1;PPM1F;WWTR1;HYAL2;WARS1;SMCR8;DUSP3;HSPB1;PTPRO;ADAR;PTPN1;NPM1;ITGB1BP1;LRP5;SH3BP5L;DUSP26;PAK2;PYCARD;TRIB3;PYDC1
prerank,stress-activated MAPK cascade (GO:0051403),0.4834498870973399,1.3683245478215493,0.09147869674185463,0.5231775479186206,1.0,13/61,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;LGALS9;IRAK2;MAPK1;UBA52;RPS27A;TAOK2;MAP3K11;MINK1;TAB2
prerank,nuclear migration (GO:0007097),-0.5443972091839556,-1.368261854803402,0.13387978142076504,0.5798990259255093,1.0,4/13,8.54%,DOCK7;SYNE2;CLMN;SYNE3
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3735926153331886,-1.367899131605322,0.030456852791878174,0.5779279733764934,1.0,10/61,6.61%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;UBE2N;USP9X;MECP2;RAD50
prerank,cellular response to mechanical stimulus (GO:0071260),0.5046963904537792,1.367802229775833,0.08147174770039421,0.5237355810760658,1.0,12/46,14.04%,F11R;PIEZO1;FAS;CASP8;TLR3;CASP2;CRADD;CASP1;TMEM150C;CASP8AP2;HABP4;BNIP3
prerank,negative regulation of cell projection organization (GO:0031345),0.49266474187360776,1.366931454731641,0.09733333333333333,0.525149352793744,1.0,12/48,13.00%,TRPV4;STMN2;RAPGEF2;FYN;FKBP4;PTPRO;GRIN2B;PRNP;SPOCK1;DCC;TSKU;YWHAH
prerank,mesonephros development (GO:0001823),-0.5800507820651409,-1.36688752438548,0.14047619047619048,0.5778990953083719,1.0,4/11,2.43%,BMP7;BMP4;OSR1;FGF1
prerank,regulation of transport (GO:0051049),0.5263597658526105,1.3668396122520203,0.11221590909090909,0.5244366908710081,1.0,8/36,11.20%,RAB11A;ARL6IP5;ICA1;FES;EPB41;LRRK2;ACTG1;ACTB
prerank,histone H3-K4 methylation (GO:0051568),-0.44671772523905157,-1.3666549906655694,0.08108108108108109,0.5753233726832461,1.0,10/26,16.36%,OGT;KMT2C;ASH2L;SETD1A;SETD1B;TET2;WDR5;CTR9;DPY30;SETD4
prerank,sulfate transport (GO:0008272),-0.5186318079724026,-1.366049526125802,0.10416666666666667,0.574343185412376,1.0,3/14,2.86%,SLC13A4;SLC26A7;SLC26A2
prerank,cellular component maintenance (GO:0043954),0.6305595414121969,1.3660056558606297,0.14424635332252836,0.525802214049598,1.0,4/12,14.23%,FYN;INSR;PRNP;ITGA3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5351907032556609,1.3655310618663885,0.11186903137789904,0.5261587231791539,1.0,8/35,7.72%,PTPRM;FLT1;CAV1;CAV2;DLL4;MEF2C;STAT1;ATP5F1A
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5235708660639359,1.3651232756196372,0.11714285714285715,0.526350534487,1.0,4/33,1.96%,PLCG2;PLCB1;CCND2;CCND3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.47805245591374707,-1.365090734583896,0.10833333333333334,0.5742203379179834,1.0,3/18,2.18%,EGFR;DDX5;BMP4
prerank,extracellular matrix assembly (GO:0085029),0.5566800839605992,1.3645983223514144,0.12556732223903178,0.5267791062186286,1.0,3/23,4.38%,FBLN5;NTN4;ATP7A
prerank,regulation of multicellular organismal development (GO:2000026),0.5453824941088319,1.3643814465919317,0.11240875912408758,0.5264697528167473,1.0,6/25,11.00%,SOX17;SPAAR;INSR;GATA3;OAS2;BAG6
prerank,regulation of trophoblast cell migration (GO:1901163),-0.5293878384762076,-1.364340183781489,0.12082262210796915,0.5732564453774699,1.0,4/14,9.45%,GJA1;SYDE1;VEGFA;ACVR1B
prerank,cGMP metabolic process (GO:0046068),0.6238639163735343,1.3636087850022676,0.14915254237288136,0.5276316741829715,1.0,3/12,11.52%,NPR2;NPR1;NPPC
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5572459016043259,-1.363438132277748,0.1330049261083744,0.5731253204554385,1.0,5/12,22.82%,PPARA;IRS2;IRS1;TWIST1;MTLN
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5645465144349517,1.3629204884156647,0.11824817518248175,0.5286668705797237,1.0,2/23,2.21%,EDN1;DAB2IP
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6316105545904571,1.362783576077406,0.1361344537815126,0.5281146550036844,1.0,2/11,5.43%,MECOM;CD34
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5506006026823204,1.3624652551261018,0.11851851851851852,0.5280781990172148,1.0,8/28,10.93%,NOD1;NOD2;CASP8;IRAK2;IRGM;UBA52;RPS27A;TAB2
prerank,embryonic axis specification (GO:0000578),0.6150114181032815,1.361832977099679,0.1260096930533118,0.5289779986555114,1.0,4/15,10.07%,SMAD6;TBXT;SMAD2;TASOR
prerank,negative regulation of heart contraction (GO:0045822),-0.5640527571500322,-1.3617390923779742,0.13493975903614458,0.5751860152224858,1.0,1/11,0.03%,ATP1A2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4639905391955662,-1.3611456333318757,0.08771929824561403,0.5710000079740357,1.0,9/23,13.86%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4639905391955662,-1.3611456333318757,0.08771929824561403,0.5710000079740357,1.0,9/23,13.86%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,vascular process in circulatory system (GO:0003018),0.6157256244581429,1.3609049687111823,0.15492957746478872,0.529636901896009,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.6157256244581429,1.3609049687111823,0.15492957746478872,0.529636901896009,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,negative regulation of dephosphorylation (GO:0035305),0.587357446277699,1.360426834169164,0.14461538461538462,0.5301421136790807,1.0,6/18,12.11%,INPP5K;ZCCHC9;PPP1R16B;GPATCH2;MFHAS1;ARPP19
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5349719499563959,1.3603678434349258,0.11220196353436185,0.5293865544207649,1.0,7/34,5.43%,TEK;FLT1;PDGFB;NOD2;DAB2IP;PRKD1;FGFR3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5026971663318697,1.3596117726759591,0.10657894736842105,0.5305463852697272,1.0,12/47,9.44%,FAS;NOD2;FOXO1;DAB2IP;ARL6IP5;F2RL1;TGFB2;LGALS9;MAP4K4;MAPK1;NBR1;TAOK2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6551184911181952,1.3594910911101004,0.16134453781512606,0.5299347238620228,1.0,3/10,8.58%,FAS;MAPK1;NBR1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4951576758669662,1.3590392592648337,0.11470985155195682,0.5302587452897228,1.0,10/47,11.66%,RAPGEF2;CEACAM1;FYN;ATP2B4;CAV1;CD34;ZC3H12A;SNAI2;FBXW7;BRCA1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6394588868780305,1.3589661952793541,0.14332784184514002,0.5295294682857036,1.0,4/11,10.96%,KCNE3;CAV1;STK39;NEDD4L
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5568908053504837,1.3587077144066602,0.12369597615499255,0.5293093622816984,1.0,12/23,25.15%,CCDC88C;TUBB;HOOK1;MYO10;CCDC88A;TUBA1A;KIF1A;HOOK2;DYNC1I2;TUBA1B;KIF5A;MAP6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5287453131279738,1.357940417555005,0.12108262108262108,0.5304945034063555,1.0,16/33,21.52%,ABR;CACNA1A;BCR;GRID1;BTBD9;PXK;LRRC4C;GRIK5;GRIK2;CX3CR1;PSMC5;GRIK1;LRP8;GRID2;BDNF;NLGN1
prerank,positive regulation of heart contraction (GO:0045823),0.5890985655074962,1.3578513868284747,0.11791730474732007,0.5298231434357844,1.0,3/19,2.55%,KCNQ1;EDN1;TGFB2
prerank,regulation of cellular pH (GO:0030641),-0.4295650045640925,-1.3574021808511354,0.0627062706270627,0.5791386177834988,1.0,16/29,22.42%,SLC4A10;SLC9A2;CA2;LACC1;SLC9A9;ATP6AP1;SLC4A2;ATP5F1B;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;SLC4A8
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5136243986558382,1.3568383016228154,0.10657894736842105,0.5316864232805402,1.0,4/46,0.88%,ELN;CDH13;EDN1;PDGFB
prerank,regulation of autophagosome maturation (GO:1901096),0.6106181180747012,1.356521326630051,0.13793103448275862,0.5316061121412851,1.0,6/13,17.72%,ADRB2;SMCR8;IRGM;FYCO1;RUBCN;UBQLN4
prerank,myoblast differentiation (GO:0045445),0.6097253381804704,1.3561167203068458,0.15384615384615385,0.5318078373874976,1.0,3/14,4.60%,EPAS1;JAG1;MBNL1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.655481888009183,1.3558226662882789,0.14680483592400692,0.5317433171511327,1.0,3/11,1.88%,NOTCH1;ATP2B4;FOXO1
prerank,establishment of spindle localization (GO:0051293),0.6133763256305358,1.3558009478271282,0.14705882352941177,0.5308785020929148,1.0,6/14,18.51%,MAP4;CLASP1;KPNB1;CLASP2;CFL1;ZBED3
prerank,negative regulation of JNK cascade (GO:0046329),0.5297933551590479,1.354981972044233,0.12285714285714286,0.5321825240543632,1.0,5/31,10.36%,MECOM;F2RL1;PDCD4;DUSP3;AIDA
prerank,neuron projection extension (GO:1990138),-0.42944808349006464,-1.3540492795932826,0.1054421768707483,0.5866557611077743,1.0,11/32,12.06%,ALCAM;AUTS2;NRP2;SEMA5A;SEMA3A;USP9X;SPG11;FLRT1;PPP3CB;ULK2;LLPH
prerank,positive regulation of DNA repair (GO:0045739),-0.3928231470523696,-1.3539572890991447,0.046413502109704644,0.5840038077294694,1.0,8/46,8.57%,EYA2;EGFR;EYA1;EYA4;UBE2N;SLF1;FMN2;XRCC1
prerank,regulation of metal ion transport (GO:0010959),-0.5153771303710432,-1.3536997918554303,0.10569105691056911,0.5819356262899903,1.0,4/16,6.07%,ANK2;BCL2;SLC30A10;CACNA2D1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6497578567363772,1.3533512609462977,0.14492753623188406,0.5357207169172145,1.0,3/10,8.23%,RAPGEF2;ATP7A;CDH3
prerank,T cell receptor signaling pathway (GO:0050852),0.43533482975691506,1.35321925040385,0.05292171995589857,0.5351745315064981,1.0,36/138,18.86%,PTPRJ;PLCG2;FYN;INPP5D;PSMD13;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;PRKD2;PIK3CB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,regulation of histone methylation (GO:0031060),-0.5395415516646548,-1.3529323714594228,0.15104166666666666,0.5813491301384489,1.0,8/13,21.30%,JARID2;NSD1;PAF1;CTR9;TET1;PIH1D1;NNMT;MTHFR
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5654382204206223,1.3526990183633056,0.1184407796101949,0.5356296549950269,1.0,9/24,14.00%,MMRN2;DAB2IP;HHEX;TMEM204;EPN2;PTPN1;PRKD2;HIF1A;ITGA5
prerank,spinal cord development (GO:0021510),-0.5574902116596986,-1.3526805520648586,0.10757946210268948,0.5791494328413895,1.0,6/12,19.92%,GLI2;VIT;LOXL3;PKD1;ZPR1;NF1
prerank,cellular response to alcohol (GO:0097306),-0.4034616365706027,-1.3515641382670998,0.09848484848484848,0.579514488408377,1.0,14/42,17.11%,ADCY5;SMO;ADCY1;GNAI1;CDH1;GRAMD1C;ADCY2;ADCY7;GPLD1;PTCH1;GRAMD1A;OSBPL7;LARP1;GRAMD1B
prerank,male gonad development (GO:0008584),0.5289565471335981,1.3515242573711599,0.1310344827586207,0.5377553537387938,1.0,7/34,8.81%,GATA6;KITLG;TGFB2;ING2;GATA3;COL9A3;NCOA4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.41002441999639333,1.3510522464866328,0.011224489795918367,0.5380008427263798,1.0,60/390,9.22%,VEGFC;PTPRJ;TEK;PTPRG;PDGFD;RAPGEF2;KALRN;FLT1;EFNA5;TIE1;PLCB1;PDGFB;ARHGEF28;FYN;FLT4;MPZL1;ELMO1;MERTK;FOXO4;ESRP2;IRS4;RAPGEF1;FOXO1;INSR;PRKD1;CAV2;PIK3C2A;CBL;ADRB2;NEDD9;FES;CRK;AP2B1;VEGFD;SHB;ANGPT1;EFNA1;FGFR3;BCAR3;MAPK1;SETX;SHOC2;ALK;LMTK2;FRS3;NUS1;FLRT3;JAK2;GRIN2B;ARPC5;POLR2G;NCKAP1;APC;NAMPT;ACTG1;APH1A;YES1;ROCK1;STAP1;PTK2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.45172451427406424,1.349611990768184,0.08343409915356712,0.5410458891768383,1.0,21/87,9.22%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2
prerank,heart process (GO:0003015),0.6151682362399515,1.3494288320538397,0.15384615384615385,0.5406002509382526,1.0,2/14,1.04%,FYN;ACE
prerank,regulation of actin filament polymerization (GO:0030833),0.4685406611495769,1.3493796868597963,0.08557457212713937,0.5398332334711752,1.0,7/69,3.93%,KANK4;FCHSD2;HIP1R;KANK3;ESAM;EVL;CDC42EP1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.43434415918870556,1.3492522224560615,0.04661487236403995,0.5392608407473535,1.0,32/149,12.80%,TRIM14;RPS6KA5;NOD1;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;TIRAP;TRIM6;TRAF1;IRAK2;ALK;IL1RAP;HSPA1B;UBA52;RPS27A;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;NPM1;CLU;PRKD2;TRIM8;BTK;CX3CR1;RTKN2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.42192192580413446,1.3490269779363275,0.04608788853161844,0.5389813663593633,1.0,27/198,7.30%,PLCG2;PTPRB;PLCB1;ALPL;ITPKB;IP6K3;PLCB4;DUSP12;INPP5D;INPP1;PLPP1;INPP5K;IPPK;MINPP1;ACP6;PGM2L1;LPCAT4;GPI;LCAT;GPD2;PGK1;DUSP16;THTPA;ALK;DUSP3;LRRK2;PPP3CA
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4552811831839235,1.3484695879209974,0.071849234393404,0.539591414955094,1.0,32/86,20.43%,EPAS1;KLF2;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;GCN1;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5305565642554699,-1.3483036092927154,0.10962566844919786,0.5862248643103136,1.0,3/15,13.03%,GLI3;CD55;PNP
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.44677206864217656,1.348228548050221,0.08757396449704143,0.5392884412359007,1.0,12/93,6.98%,NOS1;CNKSR3;SMAD7;ATP2B4;CAV1;PRKD1;APP;INPP5K;PPM1F;TRIM6;BCAR3;IRGM
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5631260241404353,1.3479531501961184,0.14759036144578314,0.5391039965377876,1.0,3/22,2.97%,KANK4;HIP1R;KANK3
prerank,cellular response to interleukin-1 (GO:0071347),0.4328105844996256,1.3476067731630232,0.05044843049327354,0.5391411989339538,1.0,46/143,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;DAB2IP;PSMD13;HYAL2;IRAK2;GBP3;IL1A;PSMD4;CD47;ZC3H12A;IL1RAP;UBA52;RPS27A;NR1D1;ACOD1;CACTIN;EGR1;PSMA5;RBX1;PSMB10;CCL4;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PYCARD;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,cellular calcium ion homeostasis (GO:0006874),0.434556813538444,1.3474988257818667,0.06229143492769744,0.5385129034195036,1.0,17/133,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;CAV2;MCUB;SLC8A1;ATP2C1;SMDT1;CAMK2D;ATP13A3;STIM2;HCRTR1;SLC30A1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6125515062428103,1.3471258683842704,0.1444991789819376,0.5385916375442393,1.0,4/16,9.87%,ST6GALNAC3;ST8SIA6;A4GALT;B4GALT6
prerank,neuron projection development (GO:0031175),0.4248252080493228,1.347010471771488,0.046994535519125684,0.5380086453690409,1.0,31/168,10.65%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;DAB2IP;FRY;BTG2;TRIO;APP;MAP4;BLOC1S6;EHD1;ATP7A;VASH2;SHTN1;MAP4K4;SHANK3;CAMSAP2;PACSIN1;UHMK1;LRRK2;FLRT3;NCKAP1;RAB35;ROCK1;SGK1;TAOK2;HMGB1;NEFH;MINK1
prerank,positive regulation of phosphorylation (GO:0042327),0.4149464004238479,1.3463792999916917,0.02931937172774869,0.5389155217100766,1.0,33/240,8.29%,VEGFC;PECAM1;TEK;ENG;FLT1;EFNA5;TIE1;FLT4;FAS;TBX1;MERTK;LIMCH1;CCND2;INSR;CCND3;APP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;BRAT1;FGFR3;ADAM17;P2RX7;ALK;IRGM;LRRK2;LMTK2;PDE8A;ARRB1;THPO;PRKAA1
prerank,negative regulation of calcium ion transport (GO:0051926),0.6010185828832728,1.3460284249099004,0.15161290322580645,0.538996566877048,1.0,3/15,7.19%,NOS1;INPP5K;SLC30A1
prerank,regulation of cell population proliferation (GO:0042127),0.40113779090820195,1.3448875986274342,0.003003003003003003,0.5411343442380798,1.0,86/691,9.42%,VEGFC;PTPRJ;ELN;CDH13;ACER2;NUAK1;JAG1;JAG2;NOS3;EDN1;PDGFD;ENG;IRF6;RAPGEF2;CLDN5;FLT1;SMAD6;PDGFB;BMPR2;FLT4;SMARCA2;KITLG;TBX1;PTPN14;FOXO4;CCND2;ITGA1;LIFR;ACVRL1;NOTCH1;INSR;ARHGEF2;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;EMP2;BTG2;DLL4;APP;FES;BTG1;HHEX;PLPP1;KLF4;VEGFD;KRAS;IER5;WWTR1;LEF1;GCNT2;SERTAD1;TBC1D8;FGFR3;GATA3;CUL3;BCL6B;WARS1;IL1A;ADAM17;SH3BP4;SLC25A33;CD47;ALK;GNAI2;IGFBP7;STAT1;HSPA1B;CNOT6L;CEBPA;PTPRU;THPO;CD200;JAK2;APC;NMI;NAMPT;TSPO;KLF11;PPP2R5C;JUN;TJP1;PTK2;SGK1;ADAM10
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.45111648064106735,1.3447951967680907,0.07656065959952886,0.5405173927600685,1.0,33/94,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;PSMD13;IRAK2;IL1A;PSMD4;IL1RAP;UBA52;RPS27A;EGR1;PSMA5;RBX1;PSMB10;NFKBIA;TAB2;PSMB8;MAP3K3;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,positive regulation of glucose import (GO:0046326),-0.46860658920638754,-1.343814332091156,0.12137203166226913,0.597528441748894,1.0,8/21,8.12%,IGF1;SORBS1;RHOQ;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,peptide cross-linking (GO:0018149),-0.44650982104809156,-1.3432000019111248,0.11513157894736842,0.5964538229380706,1.0,4/25,6.16%,COL3A1;NDNF;THBS1;ANXA1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.46203500993238855,1.342652554655379,0.07930607187112763,0.5455363391780278,1.0,25/70,18.86%,GATA2;LMO2;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,protein localization to microtubule organizing center (GO:1905508),0.6109035338298728,1.3421261256828472,0.1610305958132045,0.5461117660010119,1.0,6/15,14.33%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5358350680555186,1.341950085421882,0.14305750350631136,0.545752201306827,1.0,4/29,3.92%,CCR1;JAM2;LGALS9;ANO6
prerank,outer dynein arm assembly (GO:0036158),-0.5105421928050514,-1.3414382970403493,0.1331521739130435,0.5990762830593057,1.0,11/15,41.47%,DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAH8
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6482981909801913,1.3413077759072356,0.16083916083916083,0.546637569989508,1.0,3/10,3.85%,NOTCH4;NOTCH1;PPM1F
prerank,cellular metal ion homeostasis (GO:0006875),0.44789813715082405,1.3405972471308945,0.06752037252619325,0.5476417018050974,1.0,14/102,5.71%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2
prerank,regulation of pseudopodium assembly (GO:0031272),0.6462265172822953,1.3397945138282803,0.16415410385259632,0.5480303373171502,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6462265172822953,1.3397945138282803,0.16415410385259632,0.5480303373171502,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,calcium import into the mitochondrion (GO:0036444),0.6643268874227508,1.339655073514869,0.14802631578947367,0.5475345740289139,1.0,3/10,8.36%,MCUB;SMDT1;MCUR1
prerank,cardiac muscle tissue development (GO:0048738),0.49342271522625425,1.339545794980965,0.1081441922563418,0.5469510125157679,1.0,7/50,3.58%,GJA5;GATA6;MSX1;BMPR2;NOTCH1;HEY1;HEY2
prerank,cellular response to fatty acid (GO:0071398),-0.5409431189880405,-1.33933423963369,0.13043478260869565,0.6027049239779471,1.0,7/12,25.27%,PID1;IRS1;PDK3;LPL;NR1H4;DGAT2;PDK4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5337130408831376,-1.3383458225267157,0.13297872340425532,0.6029679419361894,1.0,9/14,21.11%,SEC24D;SEC31A;SEC24C;SAR1A;SCAP;SEC23B;TBC1D20;SEC23A;SEC13
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5632453159051097,1.3382624486014247,0.13292117465224113,0.5496855705757352,1.0,8/18,19.35%,AOAH;MANBA;BPGM;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,glucose import (GO:0046323),0.6181985784703079,1.337775115304068,0.15333333333333332,0.5500807836144358,1.0,2/13,2.68%,SLC2A1;HNF1A
prerank,negative regulation of protein binding (GO:0032091),0.46660722989886005,1.3376926410827277,0.0865265760197775,0.5494349627105074,1.0,19/71,15.64%,ATP2A3;PDGFB;B2M;CAV1;ADRB2;ADAM15;TTBK2;LRRK2;CTNNBIP1;ROCK1;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;NES;MAP2;RACK1;SLPI
prerank,long-chain fatty acid transport (GO:0015909),-0.4338536834417566,-1.3371474073452108,0.09202453987730061,0.6038190300676143,1.0,9/30,11.56%,PRKAG2;ACSL1;APOE;PRKAA2;ABCD3;SLC25A20;SLC27A1;PPARG;PRKAB2
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3802216334055496,-1.3364372867316479,0.04435483870967742,0.6030665180788946,1.0,12/49,10.38%,GPC6;B3GALT1;SDC2;HSPG2;GPC3;HS3ST3A1;B3GNT2;PXYLP1;XYLT1;HEXA;B3GAT3;HS2ST1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.43527569462687843,1.3363919432819709,0.060267857142857144,0.5522081326556697,1.0,39/136,20.17%,FZD6;SMAD7;TBXT;AIM2;DAB2IP;ID1;KLF4;NFKBIE;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CTNNBIP1;CACTIN;MAD2L2;PRNP;NFKBIA;NWD1;KEAP1;HAVCR2;PTGIS;TMSB4X;ESR1;PYCARD;MEN1;PYDC1;TBX6;ID3;TAF3;ERBIN;FOXJ1;EGLN1;SIGIRR
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6542958516697287,1.3360252912338046,0.15656565656565657,0.5523197713337699,1.0,1/10,0.07%,PTPRJ
prerank,purine-containing compound salvage (GO:0043101),-0.5487735585423755,-1.3345329416846785,0.13917525773195877,0.6060816003824041,1.0,8/12,30.32%,ADK;AMPD3;GMPR;PNP;APRT;DCK;AMPD2;ADA
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.5185412500244638,-1.3343930033130909,0.1319796954314721,0.6035928867082002,1.0,7/14,19.84%,NMNAT2;ME1;AK5;PNP;CMPK2;AK1;NME2
prerank,membrane depolarization during action potential (GO:0086010),-0.44212157034995214,-1.3341913010373208,0.11356466876971609,0.6013761781130542,1.0,5/26,6.67%,ATP1A2;CACNA1C;SCN7A;SCN2A;CACNA1G
prerank,cytosolic calcium ion transport (GO:0060401),0.536759644661873,1.3338157356641465,0.1452991452991453,0.5576324838637678,1.0,5/28,4.82%,ATP2A3;ITPR3;MCUB;SLC8A1;SMDT1
prerank,regulation of leukocyte activation (GO:0002694),0.6016090649893142,1.3336791751791808,0.14839797639123103,0.5571030729127571,1.0,4/14,8.02%,GPR137B;MFHAS1;PLSCR1;CD200
prerank,outflow tract septum morphogenesis (GO:0003148),0.5536013417176547,1.333446451258611,0.15701219512195122,0.5568875594247956,1.0,7/24,4.11%,ENG;GATA6;SMAD6;BMPR2;TBX1;TGFB2;ACVR1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4552474061981499,1.3333231817247344,0.08791208791208792,0.5563169874241353,1.0,16/76,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;ZC3H12A;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;LAPTM5;BRCA1;FBXO4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4518261541858752,1.3332972006837867,0.07797029702970297,0.5554989690913255,1.0,27/80,21.60%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;RBX1;LAPTM5;BRCA1;FBXO4;PIN1;SPRTN;BMI1;TRIB3;GSK3A;XIAP;CRY1;MALT1;ARRDC4;DCUN1D2;UBB
prerank,I-kappaB phosphorylation (GO:0007252),0.6500833167096627,1.3323335345248066,0.15608919382504288,0.5573155038385726,1.0,2/10,3.64%,DAB2IP;TLR3
prerank,T cell differentiation (GO:0030217),0.5006389225923448,1.332262212310766,0.12330623306233063,0.5566235577325453,1.0,5/40,6.32%,SOX13;JAG2;DLL4;GATA3;ADAM17
prerank,response to copper ion (GO:0046688),-0.47159530926674564,-1.3316809098238678,0.10555555555555556,0.6060405226835788,1.0,8/20,6.94%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5096695034591304,1.3316631380995971,0.12116991643454039,0.5573817862186299,1.0,10/35,21.52%,CDH13;ATP2C1;CDH12;PCDHB16;PCDHB14;CDH22;PCDHB9;CDH18;CDH24;NLGN1
prerank,regulation of tissue remodeling (GO:0034103),0.5899657708804737,1.3311951989475228,0.16150081566068517,0.557826772290569,1.0,3/18,3.73%,CEACAM1;FLT4;SYT7
prerank,monocyte chemotaxis (GO:0002548),0.5207095845118029,1.3304298366085465,0.14580467675378267,0.5590946522971536,1.0,4/32,10.16%,FLT1;PDGFB;PTPRO;CCL4
prerank,negative regulation of DNA binding (GO:0043392),0.5342427257412204,1.3299405493067655,0.1563845050215208,0.5596161866426101,1.0,10/28,13.36%,HEY1;HEY2;SUMO3;LEF1;JAK2;JUN;MAD2L2;NFKBIA;TNKS;HABP4
prerank,axon guidance (GO:0007411),0.41315232650977035,1.3299272292860564,0.04751847940865892,0.5587730196055081,1.0,35/201,11.35%,SEMA3G;LAMA3;PTPRM;EFNA5;FYN;RPS6KA5;PLXNA4;NTN4;NOTCH1;KLF7;SEMA3F;SH3KBP1;EVL;PLXND1;LAMA5;NTN1;TMEFF1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;MAPK1;BSG;PTPRO;ENAH;SEMA6D;SCN1B;PTK2;PLCG1;CYFIP1;RAC1;RANBP9;DCC;SEMA4G
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4973817236755071,1.329903869466636,0.1375515818431912,0.5579582628359161,1.0,8/43,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;GPRC5A;RNF115
prerank,positive regulation of neuron projection development (GO:0010976),-0.34790688830479805,-1.3292435815302948,0.045454545454545456,0.6106927477800607,1.0,19/85,5.83%,PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;BMP5;BMP7;PTK7;COBL;WNT5A;NDNF;APOE;MAGI2;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5454615186926624,1.3289699804297352,0.1299093655589124,0.5596499421266988,1.0,4/26,11.05%,PLCG2;SLC25A33;ADGRB1;CYBA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.601757445026662,1.3288909234037043,0.15097402597402598,0.5589390001595035,1.0,1/13,0.16%,CDH13
prerank,cellular response to type I interferon (GO:0071357),0.4991994515952618,1.3284881001343847,0.1279887482419128,0.558313482319884,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,type I interferon signaling pathway (GO:0060337),0.4991994515952618,1.3284881001343847,0.1279887482419128,0.558313482319884,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,protein localization to plasma membrane (GO:0072659),0.42630246860603777,1.328432915737664,0.08380520951302378,0.5576095911699114,1.0,26/129,10.33%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;CCDC88A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5455710705318481,1.3277276374022746,0.14774494556765164,0.5587706648256716,1.0,4/23,5.38%,LTBP4;ENG;SMAD7;SMAD2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.507293746724772,1.327144147102874,0.14410480349344978,0.5595144485142082,1.0,6/32,4.97%,ACER2;JAG1;ACVRL1;FAM107A;ADAM15;MAP4K4
prerank,T cell activation (GO:0042110),0.45954586372976186,1.326143527751595,0.1306532663316583,0.5612963538495245,1.0,10/69,7.30%,JAG2;CRTAM;CASP8;F2RL1;FKBP1A;DLL4;MSN;CTPS1;GATA3;PPP3CA
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.33049133204963577,-1.3252686603248987,0.02877697841726619,0.6201611388450352,1.0,24/108,8.82%,TRABD2B;WLS;LRP1;FGFR2;SULF1;GPC3;PTK7;RNF43;NKD1;SULF2;RSPO3;DCDC2;APCDD1;PRKN;GRB10;DACT1;RUNX1;CTNND2;SFRP4;DAAM2;RSPO2;FZD7;WWOX;TLE1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5888891577614477,1.3248456653839635,0.16925465838509315,0.564113100627097,1.0,6/17,4.11%,JAG1;NOTCH1;HEY1;DLL4;HEY2;ACVR1
prerank,synaptic membrane adhesion (GO:0099560),-0.5236070042486914,-1.3246467817869518,0.15775401069518716,0.6191357761583508,1.0,8/14,19.25%,GPC6;PTPRF;LRRC4;SLITRK1;PTPRS;NTNG1;PTPRD;GPC4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43593139378224294,1.324521312919143,0.08060747663551401,0.5640897313882177,1.0,18/100,9.22%,TEK;PDGFD;PIP5K1B;FLT1;CEACAM1;PDGFB;FBXL2;INSR;DAB2IP;F2RL1;TGFB2;CBL;PPP1R16B;PIP5K1C;MAPK1;JAK2;PPP2R5C;PTK2
prerank,protein targeting to ER (GO:0045047),0.436171669297433,1.3244163186622793,0.08665105386416862,0.5635051622309543,1.0,51/99,28.17%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SGTB;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;ZFAND2A;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;SGTA;RPL3;SPCS2;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;CHMP4A;CHMP4B;RPS13;RPL11;RPL14
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.45629839381363535,1.3238760625386226,0.09737827715355805,0.5641789698052162,1.0,31/74,20.43%,EPAS1;NOTCH1;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,oligodendrocyte differentiation (GO:0048709),0.5599441881138673,1.3228992421813444,0.16383307573415765,0.5660517033536512,1.0,4/19,12.21%,SOX13;EIF2B2;SOX10;SOX6
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5142899076357271,-1.3227615260006846,0.15485564304461943,0.6218477054398642,1.0,5/14,13.84%,CPEB1;UNK;YBX3;CPEB2;CPEB3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5803749403495339,1.3227237006720607,0.1324200913242009,0.5656776865957307,1.0,2/17,2.70%,CRTAM;CADM1
prerank,positive regulation of ossification (GO:0045778),-0.39278064745101793,-1.3225337299730127,0.05776173285198556,0.619800289528294,1.0,10/39,3.64%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT5A;FBN2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5877971516078899,1.3221870474085617,0.13608562691131498,0.5662790090662928,1.0,2/16,2.70%,CRTAM;CADM1
prerank,pancreas development (GO:0031016),-0.538809563925552,-1.3217767854014069,0.1491442542787286,0.6192046036694767,1.0,7/12,31.45%,TCF7L2;NPHP3;MET;NKX6-1;PROX1;FOXF1;CCDC39
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.49798737354890266,1.321634988589169,0.1375166889185581,0.5669694649675908,1.0,5/44,3.92%,KCNN4;KCNQ1;KCNN3;NOS1AP;ANO6
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5154213798868392,1.3210027814235192,0.13068181818181818,0.5678175637096567,1.0,7/31,2.96%,ENG;SMAD7;MYBPC3;NOTCH1;TGFB2;FKBP1A;DLL4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5328758779884866,-1.3207766353830224,0.13348946135831383,0.6193851093926256,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,cellular protein modification process (GO:0006464),0.39327164383328506,1.3194121380994839,0.0,0.5713609437008021,1.0,200/983,15.76%,BMX;PTPRM;PTPRJ;LMO7;PTPRB;EPAS1;NUAK1;CDK19;PTPRG;ST8SIA6;ERG;PTPRR;MAP4K2;STK10;PDGFB;ASB4;FYN;BMPR2;RPS6KA5;CDK17;PTPN14;MERTK;ACVRL1;IP6K3;ST3GAL6;FBXL2;RAB11A;MAP4K3;INSR;DUSP12;DUSP1;ST6GALNAC2;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;GOLM1;CDC42BPA;APP;TULP4;KLHL2;MAP3K6;PKN3;FBXO7;UBA7;APOA1;SERP2;COPS4;CDC42BPG;PPM1F;CISH;PSMD13;BCR;ACVR1;STK24;FBXL14;FBXL5;KLHL3;MANBA;GCNT2;CCNE1;PTPRE;CAMK2D;MAP4K4;PKN1;STK38;STK38L;TMEM132A;CSNK1D;NLK;ELOC;CTTNBP2NL;RHBDD1;MEX3B;GAN;CUL3;CHRM3;DUSP16;PGAP1;SIRT4;MAPK1;PGGT1B;CD247;PXK;PSMD4;MAST1;KLHL20;ZBTB16;AKT3;SIK2;LRRK2;PRKCSH;FBXL18;IGFBP7;LMTK2;SOCS6;PPP3CA;PTPN12;HSP90B1;NUS1;PTPRU;PTPRO;ASB5;TLK1;B3GNT3;STK19;UBA52;JAK2;FEM1C;PRKAA1;PROC;STK39;PASK;PIM3;PP2D1;NEK7;YES1;PPP2R5C;ROCK1;FBXL16;CSNK1G3;IGFBP4;DSP;SGK1;ADAM10;TAOK2;PSMA5;PIK3C3;MAP3K11;FBXW7;RBX1;PSMB10;CUL2;MARK3;DUSP11;PRKCG;APLP2;PTPN1;MINK1;LIMK2;FBXW2;LIPT1;TNKS;CDH2;MGAT1;PSMB8;PSMD14;NEK11;HS3ST5;PDP1;PRKD2;MARK2;MATK;VRK1;FBXO4;CP;COPS8;SETD3;METAP2;TTBK1;BTK;B3GALNT2;DCAF17;PSMA7;PSMC3;PPM1D;KEAP1;NAGPA;DCAF10;PPM1L;HIF1A;PSMA8;ST3GAL1;PSMC1;LTK;ATM;FBXO2;PSMB5;UBE2E1;ACVR2A;MAP3K20;PSMC5;PRKG2;MSRA;UBE2D3;PPP4R1;PPP2CB;EVPL;ACVR2B;ABCA7;PSMB9;MPI;DUSP26;ST3GAL2;PKN2;PAK2;KLHL25;ENGASE
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6296305403448121,1.3191982139183918,0.17084639498432602,0.5711643420609466,1.0,1/12,0.47%,EDN1
prerank,negative regulation of locomotion (GO:0040013),0.6178907665531042,1.3189640626612638,0.17320261437908496,0.5709324830021015,1.0,8/12,17.43%,CRK;SPOCK3;GATA3;DUSP3;SPINT2;PIN1;FRMD5;PTPN2
prerank,neuron remodeling (GO:0016322),0.6353865773030657,1.318874770077876,0.18664383561643835,0.5702950101891081,1.0,2/10,2.98%,RND1;APP
prerank,iron ion transmembrane transport (GO:0034755),-0.5448303709413848,-1.3187774099601923,0.1529126213592233,0.6226063403370655,1.0,3/10,4.83%,SLC39A14;SCARA5;SLC39A8
prerank,negative regulation of phagocytosis (GO:0050765),0.578304800546645,1.3185315893618517,0.16323296354992076,0.5703387698775244,1.0,5/17,9.50%,DYSF;FCGR2B;CD47;PLSCR1;HMGB1
prerank,positive regulation of protein polymerization (GO:0032273),0.46176722911482915,1.3184436884593387,0.12453300124533001,0.5697351951374003,1.0,15/65,16.66%,FCHSD2;OCLN;FES;EVL;CDC42EP1;CLIP1;CLASP1;NCKAP1;RAC1;NUMA1;TTBK1;NAV3;TENM1;NCK1;PYCARD
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4311762107191676,-1.3176566362706048,0.1180327868852459,0.6234061759670867,1.0,8/25,12.32%,ERRFI1;CBLB;PPARA;SNX6;SLC6A9;TSG101;PPARG;CNRIP1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.5209387065462561,-1.317607167511098,0.1347708894878706,0.6207732149301911,1.0,7/15,17.70%,PPARA;IRS2;IRS1;GPLD1;PPARG;SLC45A3;ADM
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4219102522294733,-1.3175155745149725,0.12709030100334448,0.6181987714863899,1.0,11/29,14.07%,TCF7L2;CREBBP;PYGO1;BCL9;ASH2L;TLE1;PYGO2;TLE2;HDAC1;AXIN2;TERT
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5481827081562638,1.3168664798767753,0.15315315315315314,0.5732695333993785,1.0,3/24,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6342722872790543,1.3166192402920995,0.1706924315619968,0.5730532528137866,1.0,2/10,3.83%,APOA1;KLF4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4599444457654057,-1.3156550459531025,0.12994350282485875,0.6210774225049817,1.0,6/22,12.50%,ZBTB20;SORBS1;APOE;PPARA;PPARG;CREB1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5849135510601238,1.3155470128846907,0.16451612903225807,0.5751318856504728,1.0,2/15,0.80%,CDH13;CEACAM1
prerank,plasma membrane invagination (GO:0099024),0.527850437075976,1.3146078964026633,0.1391304347826087,0.5769512132453626,1.0,8/29,8.95%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;VAMP7
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4799895211973687,1.31452619361197,0.1341301460823373,0.5763052175845186,1.0,11/48,15.93%,PRDM16;JMJD8;NUP54;NUP35;RANBP2;NUP153;NUP160;HIF1A;NUP42;EIF6;NUP205
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6168389691812326,1.3144222586887357,0.1658119658119658,0.5756904001633448,1.0,4/11,8.02%,GATA6;LGALS9;CD34;CD200
prerank,catecholamine biosynthetic process (GO:0042423),0.6226933800645402,1.3143745031178016,0.18718381112984822,0.5749484522959342,1.0,3/11,6.03%,TGFB2;GCH1;GATA3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6365601796547532,1.3134740728097807,0.16206896551724137,0.576497939058981,1.0,2/10,7.01%,SMAD7;ZC3H12A
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5888351335606659,1.3132610288463817,0.1685214626391097,0.5762163027608436,1.0,2/17,3.68%,KCNE3;NOS1AP
prerank,gene silencing by miRNA (GO:0035195),0.5140481071185736,1.3126056458883717,0.15070422535211267,0.5770376827567653,1.0,9/32,14.77%,NOTCH4;TNRC6C;PUM2;ZC3H7A;ADAR;CNOT1;AGO4;RAN;EIF6
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5522524451213024,1.312583442207455,0.16401273885350318,0.576232537964435,1.0,6/19,9.89%,NOTCH4;NOTCH1;PPM1F;PTPRU;TJP1;MAD2L2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.43582768883543477,-1.3123432128368537,0.12790697674418605,0.628517080290768,1.0,7/24,8.48%,IGF1;SORBS1;ENPP1;IRS2;IRS1;IGF2;PPP1R3B
prerank,negative regulation of chemokine production (GO:0032682),0.6013742025918637,1.3122441001132181,0.18066561014263074,0.5763290153587559,1.0,3/14,3.83%,F2RL1;LGALS9;KLF4
prerank,regulation of macrophage migration (GO:1905521),0.6376248605430386,1.3121347880251366,0.16831683168316833,0.5757906169634557,1.0,7/10,24.93%,MTUS1;CD200;CX3CR1;CD200R1;P2RY12;EMILIN1;CSF1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.45370669524377993,-1.3120298264167694,0.14285714285714285,0.6266721273639677,1.0,6/22,5.55%,NTRK3;PDGFRB;FGFR2;PDGFRA;KIT;FGF2
prerank,negative regulation of transport (GO:0051051),0.47886969866234363,1.3119686909827968,0.12738853503184713,0.5753936256474337,1.0,10/51,9.11%,MCTP1;DYSF;PRKD1;ARL6IP5;PPM1F;FCGR2B;CTTNBP2NL;PXK;PLSCR1;NDFIP2
prerank,heart development (GO:0007507),0.42419708631441094,1.3119189782901421,0.07977528089887641,0.5746867868027812,1.0,22/150,5.32%,HEG1;SOX17;TEK;PDGFB;BMPR2;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;DAND5;INSR;CASP8;TGFB2;FKBP1A;HDAC9;SOX18;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5298640466442445,1.3113961486455399,0.15261627906976744,0.5753152369693981,1.0,12/26,15.85%,DAB2IP;IQGAP1;INPP5K;DUSP3;PTPN12;PDE8A;SYAP1;SNAI2;ZFP36L2;PLCG1;DUSP22;VIL1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5745043806718384,1.3108182063091656,0.15987460815047022,0.5760628314330201,1.0,4/17,5.65%,HDAC9;APOA1;PCSK5;FURIN
prerank,Golgi ribbon formation (GO:0090161),-0.5125437478280168,-1.3107228720447206,0.16331658291457288,0.627894186346646,1.0,6/13,17.87%,TRIP11;GOLGA2;GCC2;OPTN;STX16;FHDC1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5024600078872735,1.310674956541303,0.14705882352941177,0.5755771700397313,1.0,7/38,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;MADD;BCL2L1
prerank,nucleus organization (GO:0006997),0.47628273472597304,1.3104302976238442,0.14586070959264127,0.5753734813882133,1.0,25/47,27.34%,SYNE1;IRAG2;SUN3;CHMP1B;NUP54;NUP35;NUMA1;REEP3;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;NUP205;RPS19;SUN1;CHMP1A;LEMD3;ATXN7;SEH1L;CTDNEP1;TPR;VPS4B;CHMP4A;CHMP4B
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4862235734964844,1.3101369966368885,0.12751677852348994,0.5753872590272381,1.0,4/38,5.48%,PTPRJ;INPP5K;HYAL2;PLEKHA1
prerank,histone H4-K16 acetylation (GO:0043984),-0.4592249752581512,-1.3096558180397855,0.13675213675213677,0.6284206091496878,1.0,6/19,13.64%,OGT;KANSL2;PHF20;WDR5;MEAF6;MSL3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5218974008533585,1.3092446227366132,0.15797101449275364,0.5770445991199387,1.0,2/26,0.49%,GCNT1;ST8SIA6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4886172597601565,-1.308679907731935,0.12202380952380952,0.6287984178041462,1.0,7/17,12.58%,ROBO1;SLIT2;EFNB2;FGF2;GPLD1;VEGFA;EPHB4
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4363066461721128,1.308252274554947,0.10250297973778308,0.5789462897619496,1.0,39/87,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5039575312416545,1.3075538638224329,0.13742690058479531,0.579990753344858,1.0,6/33,9.22%,ACER2;TGFB2;PDE3B;EFNA1;SNAI2;PTK2
prerank,regulation of vasoconstriction (GO:0019229),0.5311869236636495,1.3071768228036948,0.16422287390029325,0.5802132220163457,1.0,4/27,6.12%,BMPR2;ACE;CAV1;CHRM3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5104480948989714,-1.307034555084865,0.13695090439276486,0.631146339658999,1.0,5/14,9.66%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,peptidyl-tyrosine modification (GO:0018212),0.46202150040100287,1.3066250136437039,0.11845386533665836,0.5808835040549116,1.0,9/56,5.43%,TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES;TTL;FGFR3
prerank,positive regulation of cell cycle (GO:0045787),0.4603399697469843,1.306204321262871,0.1210592686002522,0.5811592353317272,1.0,11/62,7.56%,PDGFB;CCNY;CCND2;CCND3;TAL1;TGFB2;APP;TTL;ADAM17;DUSP3;MAPRE3
prerank,ethanol metabolic process (GO:0006067),-0.524279650965104,-1.3052039005786673,0.1564245810055866,0.6341077972599864,1.0,1/12,0.24%,ALDH1A1
prerank,positive regulation of GTPase activity (GO:0043547),0.4087265228977951,1.3038709779357933,0.05470459518599562,0.5868014660719197,1.0,42/188,13.86%,RAPGEF2;DOCK9;RABGAP1;SIPA1L2;F11R;ARHGEF15;RAPGEF1;RASGRP2;ABR;CAV2;F2RL1;AGRN;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;RAPGEF6;MAP4K4;TBC1D8;RAP1GDS1;BCAR3;TIAM2;RGS7;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;RSU1;TBC1D1;RAP1GAP2;TAX1BP3;CCL4;RALGAPB;ARHGAP27;USP6NL;PIN1;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,vesicle organization (GO:0016050),0.47286755032461586,1.3032788860088715,0.14134742404227213,0.5875037890653063,1.0,16/46,20.36%,ALS2CL;CAV1;CAV2;CD34;FNBP1L;SNX10;HOOK1;EXOC8;SNX11;CHMP2B;ZFYVE16;SRGN;PHETA1;HOOK2;SORT1;EPS15
prerank,regulation of viral entry into host cell (GO:0046596),0.510496191722835,1.3032090827643485,0.15007012622720897,0.5868234308375108,1.0,7/30,11.57%,TRIM14;LY6E;LGALS9;TRIM11;TRIM6;TRIM25;HS3ST5
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5480405002291396,1.3029933189056881,0.16224188790560473,0.5865991561394174,1.0,6/22,12.45%,PDGFD;PDGFB;ACE;TOM1L1;TAOK2;CALM3
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3379513113756838,-1.3028924577497194,0.041884816753926704,0.6385526616550814,1.0,22/82,11.08%,RANBP3L;BMP6;IGF1;BMPR1A;SMOC1;FGFR2;WNT4;BMP7;DDX5;BMP4;TMEM64;LIMD1;FBN2;RUNX2;NOCT;IL6R;ATP6AP1;PRKACA;PTCH1;PPARG;REST;IFITM1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4309185088942661,-1.3028174438948397,0.125,0.6360167122227556,1.0,4/26,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.49796959356993153,-1.3024488147306565,0.15598885793871867,0.6344018446738151,1.0,7/16,18.33%,AUTS2;SNW1;WDR5;CTR9;PIH1D1;BCOR;DNMT3B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3884763335305802,-1.3020161589528634,0.0931899641577061,0.6330401218520036,1.0,11/43,9.75%,PID1;OGT;SORBS1;PRKCB;NUCKS1;GRB10;ENPP1;IRS1;PIP4K2A;IGF2;PRKCZ
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.42700030675433,1.3016627586125946,0.10628571428571429,0.5894221201953768,1.0,17/116,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,cartilage development (GO:0051216),-0.3779137389837183,-1.3015518440573313,0.11,0.6316982062282429,1.0,17/49,13.28%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;TRIP11;RUNX2;ITGB8;FGF2;RUNX1;CCN3;GPLD1;HYAL1;PKD1;NFIB;HMGA2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6210665281496287,1.3014820616206333,0.19141914191419143,0.5890556248847184,1.0,1/12,0.06%,NOS1
prerank,odontogenesis (GO:0042476),-0.4080728135588092,-1.3012140954936469,0.12027491408934708,0.6301057989201702,1.0,7/35,2.71%,COL1A2;GLI2;FGFR2;EDA;BMP4;OSR1;WNT6
prerank,anion transport (GO:0006820),-0.4020230866618994,-1.3000357726844765,0.099644128113879,0.6311344190469833,1.0,9/33,8.42%,SLC13A4;SLC13A3;SLC26A7;SLCO2B1;SLC17A5;SLC22A6;SLC19A1;LRRC8D;SLC4A2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6114649604978362,1.2991939737601783,0.16802610114192496,0.5944789933005429,1.0,4/12,11.17%,AMD1;ATP7A;MAOA;SMS
prerank,regulation of calcium ion import (GO:0090279),0.5617694065283954,1.2990435162199663,0.17673716012084592,0.594029495587502,1.0,7/21,16.05%,PDGFB;FYN;SLC30A1;PRNP;PLPP4;CTNNB1;PSEN2
prerank,pigment granule transport (GO:0051904),0.549605684357472,1.2982121111971883,0.18408736349453977,0.5946054726709488,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,melanosome transport (GO:0032402),0.549605684357472,1.2982121111971883,0.18408736349453977,0.5946054726709488,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4603574827348946,1.2980998239099268,0.15327564894932014,0.5940402286339498,1.0,19/60,15.38%,PDGFB;HMBOX1;KLF4;MAPK1;NVL;CCT8;NEK7;DKC1;PTGES3;TNKS;POLG2;CCT2;PRKD2;FBXO4;CCT4;ATM;CTNNB1;CCT6A;RFC2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5951538816624201,1.298033535940363,0.20240137221269297,0.593359273273902,1.0,3/12,3.73%,UNC13B;DOC2B;SYT7
prerank,keratinocyte differentiation (GO:0030216),0.5138556815856825,1.2978714629064514,0.16279069767441862,0.5929629694022559,1.0,3/29,4.02%,JAG1;CLIC4;BCR
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5322910466097057,-1.2975375975009107,0.15,0.6362481497428397,1.0,6/12,22.66%,SMO;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,cellular amino acid catabolic process (GO:0009063),0.435664717864018,1.297373994649596,0.10990338164251208,0.5934672974406975,1.0,8/87,7.36%,NOS1;NOS3;BCAT2;GLS2;GLS;ARG1;GLUD1;HGD
prerank,regulation of amyloid fibril formation (GO:1905906),0.5752797380553027,1.2965655434693801,0.1752738654147105,0.5948654488081891,1.0,6/15,11.83%,APP;IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,primary alcohol metabolic process (GO:0034308),-0.4388119227950567,-1.2964627374648088,0.115625,0.6368788382525015,1.0,5/25,9.46%,IGF1;RBP4;NAPEPLD;NAAA;DHRS3
prerank,glycoprotein biosynthetic process (GO:0009101),0.43856359030866593,1.2963112238182444,0.12360939431396786,0.5947297395201476,1.0,11/79,8.01%,GCNT1;ST8SIA6;BMPR2;ST3GAL6;ST6GALNAC2;SERP2;ATP7A;GCNT2;CHST11;NUS1;B3GNT3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45616832352573516,1.295957560639905,0.14285714285714285,0.5948696584288594,1.0,7/66,2.21%,EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DAB2IP
prerank,positive regulation of immune system process (GO:0002684),0.575386234781754,1.2955427982109609,0.1907051282051282,0.5951764098266711,1.0,3/16,3.46%,TGFB2;LGALS9;TNFRSF18
prerank,regulation of intracellular signal transduction (GO:1902531),0.3913931732975344,1.2954080354197546,0.03147208121827411,0.5946734509726576,1.0,63/420,10.68%,PLCG2;RASGRF2;SGMS1;NUAK1;ARHGEF3;TEK;PIP5K1B;ARHGAP31;KALRN;CEACAM1;VWF;PLK3;CHN2;FBXL2;CASTOR1;ARHGEF2;DAB2IP;ABR;F2RL1;RHOB;TRIO;BOP1;CRK;PPP1R13B;RBBP8;ARAP3;BCR;ING2;RRAS;ARHGAP8;MAP4K4;TRIM6;AKAP5;PPP1R16B;PLEKHG5;TRAF1;TAF9B;GPR143;SRGAP1;PIP5K1C;MAPK1;PAK1IP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;LRRK2;ARHGAP25;CMKLR1;HSPB1;PRKAA1;WWC2;INPP5B;SLC15A4;PPP2R5C;SGK1;TAOK2;ARHGEF1;DIPK2A;BRIP1;MINK1;NFKBIA;RAC1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4869154815735425,-1.2953410932616944,0.16062176165803108,0.63780602819619,1.0,6/16,15.34%,PDK1;PRKN;RORA;FOXK2;PDK3;PDK2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4951632409704754,1.2952636069126484,0.15714285714285714,0.5942255809434782,1.0,9/33,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,response to interleukin-4 (GO:0070670),0.6265971964940007,1.2948554834949306,0.1969439728353141,0.594516010584933,1.0,2/10,6.03%,LEF1;GATA3
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6023047178440786,1.2946657967858768,0.19435215946843853,0.5941737468687271,1.0,7/13,19.12%,CAV1;SLC8A1;CAMK2D;CALM3;PDE4D;ANK3;IRX3
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5480404805369923,-1.2946417682228757,0.1548223350253807,0.637439361930076,1.0,2/11,4.31%,PID1;PRKN
prerank,regulation of superoxide anion generation (GO:0032928),0.5939535249048551,1.2945467670216764,0.17823343848580442,0.5936158777764731,1.0,4/14,10.12%,F2RL1;ITGAM;AATF;TYROBP
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6047387864340019,1.2944276628472644,0.17586206896551723,0.593134567645213,1.0,6/13,19.00%,HEY1;HEY2;MAD2L2;TMSB4X;SIN3A;SOX11
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5128803577248933,-1.2942772566247474,0.16113744075829384,0.635898623608321,1.0,2/13,3.22%,B3GALT1;B3GNT2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5052317310895504,1.2942438267812708,0.17073170731707318,0.5927669245718192,1.0,3/30,1.04%,FLT1;FLT4;ACE
prerank,homeostasis of number of cells (GO:0048872),0.6160163355162235,1.293979467495384,0.2134453781512605,0.5925901027167343,1.0,4/12,12.63%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.42241725837856126,1.293368356296795,0.10262257696693272,0.5934919855458471,1.0,17/117,11.03%,PLCG2;FYN;ADRB2;GPR39;HRH2;KARS1;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,defense response to bacterium (GO:0042742),0.4269623870627777,1.293223188665965,0.10665137614678899,0.5930680488983117,1.0,29/105,21.23%,NOD1;NOD2;GBP4;ANXA3;TLR3;TIRAP;DEFA6;ADAM17;IRGM;GALP;OAS2;ADGRB1;GBP2;CHGA;RPL30;RNASE6;LYST;HMGB2;SLPI;DROSHA;STAB2;PYCARD;GBP7;EPX;ANG;ANKRD17;RPL39;STAB1;RPS19
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6395521132009003,1.2928162960083165,0.18568994889267462,0.592453927858421,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6395521132009003,1.2928162960083165,0.18568994889267462,0.592453927858421,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,oligosaccharide metabolic process (GO:0009311),0.4707392882553922,1.2927433061763898,0.14728682170542637,0.5918048216192998,1.0,5/46,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;MANBA;ST6GAL2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39231123513868926,1.2923253803482213,0.012121212121212121,0.5920870361807569,1.0,75/509,11.23%,PTPRJ;PLCG2;CDH13;TEK;PDGFD;ENG;RAPGEF2;HIP1;FLT1;PDGFB;FYN;TRIM14;FLT4;VWF;KITLG;TBX1;NOD1;JCAD;NOD2;INSR;DAB2IP;CAV1;PRKD1;CASP8;CAV2;F2RL1;TGFB2;CBL;ADRB2;LGALS9;FKBP1A;APP;IQGAP1;ACTN4;TLR3;NOS1AP;TIRAP;ATP2C1;PUM2;ANGPT1;GCNT2;TRIM6;TNFSF10;PLEKHG5;FGFR3;IAPP;BCAR3;GATA3;SMCR8;PDCD4;JMJD8;BBC3;MFHAS1;WDR59;BCL2L1;THPO;JAK2;NMI;GAPDH;ROCK1;NDFIP2;PTK2;RTN4;HMGB1;TRIM25;RRAGD;CCL4;RPL37;LURAP1;CHD5;CASP1;RAC1;TAB2;MAP3K3;LAPTM5
prerank,triglyceride biosynthetic process (GO:0019432),-0.46687823557261154,-1.2923238758384354,0.18023255813953487,0.6391271533802627,1.0,5/18,9.80%,AGMO;LPGAT1;MOGAT3;GK;DGAT1
prerank,calcium ion transport into cytosol (GO:0060402),0.538599510445392,1.2923196708509577,0.16925465838509315,0.5912722792920015,1.0,7/21,11.28%,TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;TRPM2
prerank,negative regulation of chemotaxis (GO:0050922),0.5073373123041158,1.29180334639068,0.1813031161473088,0.5918615183170278,1.0,6/31,8.34%,SEMA3G;NOTCH1;SEMA3F;SEMA7A;DUSP3;SEMA6D
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5201257662591859,-1.291701382652219,0.1514360313315927,0.6384231958147103,1.0,6/13,16.03%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;PGM3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5937188057548175,1.2914989777705153,0.17627118644067796,0.5918187942732964,1.0,4/12,17.28%,CEACAM1;BRCA1;ERLIN2;TRIB3
prerank,regulation of neurotransmitter transport (GO:0051588),0.5610619784790097,1.291110769970839,0.18788819875776397,0.5920327833724227,1.0,4/16,16.46%,MCTP1;MEF2C;SNCAIP;CPLX1
prerank,ear morphogenesis (GO:0042471),-0.45331920326076036,-1.2910334434585098,0.15079365079365079,0.6379575226129562,1.0,5/20,7.10%,ZIC1;FGFR2;OSR1;NIPBL;SIX1
prerank,actin filament polymerization (GO:0030041),-0.42155397569859143,-1.2907722550595282,0.14576271186440679,0.6362473910720797,1.0,7/29,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;WASHC3;PREX1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4624244479461459,1.2902938016014969,0.1367741935483871,0.5935400962361277,1.0,8/56,4.11%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,response to alcohol (GO:0097305),-0.4229339894822287,-1.2889876302183791,0.11987381703470032,0.6393127616167844,1.0,3/27,1.90%,TGFBR3;TGFBR1;SLIT2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5265252009445491,-1.2886693211113516,0.18316831683168316,0.6377044041680745,1.0,9/12,41.85%,GOLGA2;CDC14B;FZR1;BTRC;GORASP1;PLK1;CDC20;UBE2C;RAB1A
prerank,regulation of dendrite development (GO:0050773),-0.4055100042066355,-1.2886188338355284,0.12452830188679245,0.6353100964678541,1.0,7/37,2.62%,PTN;CAMK1D;SDC2;BMP5;BMP7;MARK1;COBL
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.41926415319719035,-1.2879857658041605,0.1346153846153846,0.6347155519474561,1.0,4/26,4.62%,ANK2;ACTN2;ATP1B3;FHL1
prerank,negative regulation of inflammatory response (GO:0050728),0.40500869015598223,1.2878660721697077,0.08297413793103449,0.5995599705886843,1.0,29/182,11.41%,PLCG2;TEK;FYN;AOAH;ADRB2;APOA1;GPR39;KLF4;HRH2;IAPP;FURIN;TNFRSF1B;GATA3;FCGR1A;MYH9;ADAM17;CD247;MFHAS1;MC4R;CD200;PROC;NR1D1;ACOD1;YES1;LPCAT3;ADCY4;PLCG1;GLP1R;VPS35
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4988038690346533,1.2875089912645834,0.15650969529085873,0.5997199483318,1.0,9/35,11.35%,SEMA3G;PLXNA4;SEMA3F;PLXND1;SEMA7A;ARHGDIA;SEMA6D;RAC1;SEMA4G
prerank,regulation of potassium ion transport (GO:0043266),0.4951823817038225,1.2870332831430567,0.1671388101983003,0.6001684844413039,1.0,3/31,4.87%,NOS1;DPP6;DPP10
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4863640880814884,1.2865353563010575,0.1619047619047619,0.6007495186951687,1.0,7/36,7.60%,NOS3;ATP2B4;CAV1;GCH1;NOS1AP;IL1A;NUS1
prerank,regulation of chemokine production (GO:0032642),0.4942290855369165,1.2864702180002707,0.1587516960651289,0.6000749124546951,1.0,13/36,20.88%,F2RL1;LGALS9;APP;TLR3;ADAM17;SNAI2;FOXP1;EGR1;HIF1A;PYCARD;AGER;SIGIRR;EIF2AK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4577153926332618,1.2850323835310364,0.13745271122320302,0.6032685675879808,1.0,18/59,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;MARK2;TTBK1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.49881472281683437,1.2849595728088057,0.1717877094972067,0.6026470227996545,1.0,8/32,9.92%,STMN2;ARHGEF2;FKBP4;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,plasma membrane repair (GO:0001778),0.583749128473609,1.2838932873804754,0.20770519262981574,0.6047670845164624,1.0,4/13,10.34%,DYSF;SYT7;MYH9;MYOF
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5065747674350615,1.283874020952221,0.1681159420289855,0.6039802099145042,1.0,3/27,4.95%,NOS1;FKBP1A;CAMK2D
prerank,histone H4-K8 acetylation (GO:0043982),-0.48561586408807267,-1.2836740376067501,0.16526610644257703,0.6426220726550437,1.0,5/15,11.07%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,histone H4-K5 acetylation (GO:0043981),-0.48561586408807267,-1.2836740376067501,0.16526610644257703,0.6426220726550437,1.0,5/15,11.07%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.565260134154729,1.2835419104645234,0.17611026033690658,0.6040611411685127,1.0,4/17,9.04%,CLDN5;F11R;PROC;ROCK1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5580246350252165,1.2834867898633837,0.18633540372670807,0.6033722088847303,1.0,8/20,8.76%,ENG;ACVRL1;NOTCH1;HEY1;TGFB2;HEY2;PDCD4;SNAI2
prerank,regulation of monooxygenase activity (GO:0032768),0.5299191297948347,1.2833954839481772,0.1875945537065053,0.6028188337105722,1.0,4/23,6.22%,NOS3;CAV1;NOS1AP;IL1A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5177894783422546,1.283060961841713,0.17903930131004367,0.6029663748037191,1.0,6/26,8.27%,FYN;FBXO7;LRRK2;HSPB1;PDE8A;NFE2L2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.44506321713846353,-1.28297311714251,0.1531791907514451,0.6397023938166884,1.0,13/21,24.64%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.44506321713846353,-1.28297311714251,0.1531791907514451,0.6397023938166884,1.0,13/21,24.64%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5111606358942373,-1.2828149060971166,0.14652956298200515,0.6376898221010848,1.0,7/13,19.55%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;SNX5;ZBTB7B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4564149702971521,-1.2824844332846226,0.16519174041297935,0.6362738561573537,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4968735520010923,-1.2819333520261291,0.18974358974358974,0.6354588035790039,1.0,6/15,8.15%,FGFR2;PDGFRA;TGFBR1;NIPBL;SIX1;MTHFD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.6043122337810396,1.2818343478255911,0.21140939597315436,0.6056184662874661,1.0,3/11,3.53%,ITPKB;IP6K3;IPPK
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4960495569183807,1.2818159401021672,0.17270194986072424,0.6048493583142625,1.0,9/34,9.05%,DAB2IP;F2RL1;TLR3;NFKBIL1;MFHAS1;GRAMD4;NR1D1;ACOD1;CACTIN
prerank,anion transmembrane transport (GO:0098656),-0.3474450146485417,-1.2815933938750572,0.06965174129353234,0.6340811750971148,1.0,14/67,8.36%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A4;SLC13A3;SLC25A13;SLC25A4;SFXN2;SLC39A8;SLC19A1;SLC6A9;LRRC8D;SLC27A1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4360557589752474,1.2813291044829747,0.13878562577447337,0.6053951077638251,1.0,8/73,6.98%,NOS1;ATP2B4;CAV1;PRKD1;APP;TRIM6;BCAR3;IRGM
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6103790891063507,1.281258798843763,0.20442930153321975,0.6047680706530807,1.0,4/11,6.03%,JAG1;TGFB2;HEY2;GATA3
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5135213686527946,-1.2811628718526722,0.15405405405405406,0.63275892396022,1.0,1/12,1.29%,IL1R1
prerank,protein catabolic process (GO:0030163),0.45457588194269893,1.2804978392537907,0.14402173913043478,0.606002945016127,1.0,18/59,19.79%,CEACAM1;DENND3;DAB2IP;PPT1;MANBA;TRIM24;SOCS6;NR1D1;SIAH2;BAG6;PSMA8;FBXO2;OGA;FBXO6;LAMP2;NGLY1;NEU4;RNF5
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.37611977530665797,-1.2802698396548078,0.09386281588447654,0.6332221046385731,1.0,19/40,27.18%,NUCKS1;BOD1L1;FBH1;TIPIN;ATR;THOC1;RTEL1;DONSON;SMARCAL1;RFWD3;ATRX;TIMELESS;ZRANB3;MMS22L;EME2;SETMAR;RAD51;POLE;CENPX
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.45169748138259413,-1.280250100788822,0.16666666666666666,0.6308736601071303,1.0,7/19,20.44%,CUX1;OBSL1;DBN1;PTPRD;FBXW8;SS18L2;CUX2
prerank,SNARE complex assembly (GO:0035493),0.6227122385886579,1.280061713542069,0.21901528013582344,0.6062828693248513,1.0,2/10,7.40%,STXBP6;VAMP8
prerank,embryonic hemopoiesis (GO:0035162),0.6000193283441415,1.2798310818772285,0.20607028753993611,0.6060855051284332,1.0,3/12,7.98%,KITLG;TAL1;TPO
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39802618610687135,1.2798007032899796,0.06282722513089005,0.605359152613524,1.0,42/234,12.80%,PLCG2;EDN1;TRIM14;RPS6KA5;NOD1;NEUROG2;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;ANXA3;TIRAP;TRIM6;TRAF1;IRAK2;ALK;FANK1;IL1RAP;MBTPS2;HSPA1B;CD200;UBA52;RPS27A;TCF3;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;CRTC1;NPM1;CLU;PRKD2;ARID5B;TRIM8;BTK;CX3CR1;RTKN2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5774225571135778,1.2792748130092033,0.19032761310452417,0.6060412541817185,1.0,2/16,1.04%,BMPR2;ACE
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4318658452789183,1.2792176311721752,0.13805522208883553,0.605355331273897,1.0,14/86,8.22%,EPS8L2;ARHGEF28;DENND3;NOTCH1;RAPGEF1;ARHGEF2;DAB2IP;TGFB2;BCR;ARHGDIA;MADD;SHOC2;STK19;JAK2
prerank,regulation of cytokine production (GO:0001817),0.4182314949273155,1.278891743396442,0.10442678774120318,0.6054493154963643,1.0,19/126,10.87%,AFAP1L2;RPS6KA5;CRTAM;CASP8;IFIH1;LGALS9;CADM1;HDAC9;FCGR2B;TNFRSF1B;GATA3;BCL6B;IL1A;CD47;SNAI2;GAPDH;FOXP1;LURAP1;POLA1
prerank,presynapse organization (GO:0099172),-0.55530991968487,-1.2788548779381428,0.2034313725490196,0.6325530577807681,1.0,2/10,4.01%,WNT5A;NLGN2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5041267612232258,-1.2776494384178771,0.18045112781954886,0.6338525273545517,1.0,2/13,2.18%,GLI2;BMP4
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4890394893593412,1.277648217446614,0.17385257301808066,0.6079110031743085,1.0,6/36,9.67%,EDN1;ADRB2;SHANK3;ADAM17;JAK2;FBXW7
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5027173228475117,1.2772127999134655,0.19710144927536233,0.608397472232295,1.0,8/28,19.18%,ATP2A3;DAB2IP;BBC3;BAG6;TRIB3;SELENOK;DNAJC10;ERN1
prerank,urogenital system development (GO:0001655),-0.5363328180971005,-1.2771855006436879,0.20853080568720378,0.6328451402949651,1.0,5/11,20.47%,OSR1;ANXA1;EPHB2;EPHB3;PAX2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5733413742902567,1.277104355341454,0.1875968992248062,0.6078989782731109,1.0,11/15,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;TCP1;CCT3;RUVBL1;RUVBL2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.40927365873924604,1.2768395550357121,0.10262008733624454,0.6078432601778122,1.0,25/151,10.16%,TEK;PDGFD;RAPGEF2;PDGFB;FLT4;CCR1;NOTCH1;NOD2;F2RL1;LGALS9;APP;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5344551651336444,1.276693300165475,0.1861152141802068,0.6074584176820159,1.0,4/21,7.25%,CD2AP;DAB2IP;TGFB2;ARHGAP25
prerank,negative regulation of cell population proliferation (GO:0008285),0.38549930935008725,1.2750417530623464,0.04573170731707317,0.6111918119228199,1.0,44/351,9.03%,PTPRJ;CDH13;NOS3;IRF6;GATA6;RAPGEF2;GATA2;SMAD6;BMPR2;SMARCA2;PTPN14;FOXO4;ITGA1;ACVRL1;NOTCH1;B2M;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;BTG2;DLL4;APP;BTG1;PLPP1;KLF4;GATA3;WARS1;IL1A;SH3BP4;SLC16A2;IGFBP7;HSPA1B;CEBPA;PTPRU;CD200;JAK2;APC;NMI;MCC;KLF11;CTNNBIP1;PPP2R5C
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.61580631119126,1.2746708703635987,0.21252059308072488,0.6113232517433272,1.0,8/10,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,regulation of steroid metabolic process (GO:0019218),-0.4361562901385403,-1.274542791110492,0.16612377850162866,0.6385391273172498,1.0,10/23,28.72%,APOE;RORA;EPHX2;STUB1;PANK2;ACADVL;NR1H4;STAR;ABCG1;ARV1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4398598054649791,1.2743515208362874,0.13793103448275862,0.6114529854040399,1.0,16/67,13.12%,PODXL;RABGAP1;CAV1;PPP1R16B;TBC1D8;PLD1;IFT140;TBC1D5;TBC1D1;MYO10;RAC1;TRPM2;ATP8B1;FXR1;USP6NL;TBC1D10A
prerank,O-glycan processing (GO:0016266),0.456477332335665,1.2728649167079742,0.16622340425531915,0.61473980567856,1.0,11/54,13.79%,GCNT1;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;B3GNT3;C1GALT1C1;XXYLT1;GALNT4;ST3GAL1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5359166160632709,1.2726952719725237,0.18364197530864199,0.6143780769190815,1.0,4/22,8.29%,CEACAM1;PDE3B;ALK;PRKAA1
prerank,protein mannosylation (GO:0035268),-0.43993891021657594,-1.271900915203138,0.15561959654178675,0.644270165959221,1.0,4/22,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,positive regulation of ion transport (GO:0043270),0.46518732380604816,1.2718656114609217,0.15601023017902813,0.6158935034527965,1.0,12/48,10.16%,CNKSR3;CCR1;MYLK;ANO6;ORAI1;STIM2;P2RX7;VAMP8;CRACR2A;VAMP7;SCN1B;CCL4
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.47745794100545347,-1.2715169444293648,0.16353887399463807,0.6429349055580433,1.0,7/16,25.39%,CREBBP;KAT2B;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,dendritic cell chemotaxis (GO:0002407),0.5767705451679952,1.2713266464318331,0.18811881188118812,0.6164680541371772,1.0,4/14,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4925886684719275,1.2705826819936457,0.17450682852807284,0.6176401393690224,1.0,13/31,22.43%,LSM1;EXOSC3;DCPS;DCP1B;POLR2G;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2;DIS3L2;EXOSC1
prerank,membrane repolarization (GO:0086009),0.5537425871382775,1.2699954768092296,0.23233908948194662,0.6184931819901279,1.0,3/15,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,regulation of neuron death (GO:1901214),0.42934909947033817,1.2698030764723953,0.14009661835748793,0.6182295786550981,1.0,30/82,21.60%,FYN;SNCG;FCGR2B;LANCL1;MEF2C;CD34;TNFRSF1B;ITGAM;LRRK2;CD200;GRIN2B;EGR1;PRNP;RRAS2;TYROBP;DCC;VPS35;CLU;CHGA;TRIM2;SARM1;EIF2S1;DAXX;GRID2;NENF;GSK3B;CD200R1;SORL1;AKT1S1;UBB
prerank,actin polymerization or depolymerization (GO:0008154),-0.37111227000695585,-1.2697302651582187,0.09767441860465116,0.6459837376235174,1.0,11/50,8.27%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;WASF1;SVIL;WASHC3;PREX1;VILL
prerank,synaptic vesicle membrane organization (GO:0048499),-0.47202537002482486,-1.2696723004813224,0.18082191780821918,0.6437653845855352,1.0,10/17,27.88%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29;TOR1A;STX2;STX1A;SYNGR1
prerank,regulation of mitotic cell cycle (GO:0007346),0.39739694889106303,1.2696526344185983,0.09297297297297297,0.6178111315385829,1.0,41/171,16.08%,AFAP1L2;TAL1;TTC28;CAV2;BTG2;APP;IQGAP1;BTG1;RPRM;TTL;PSMD13;ASAH2;CDC25C;UBE2D1;PSMD4;DUSP3;PIM3;NEK7;PSMA5;PSMB10;PSMB8;ANGEL2;PSMD14;NEK11;RPS6KB1;PSMA7;PSMC3;PIN1;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;BTG3;PSMB9;PKN2;ANAPC7;PSMC6;MEIS2
prerank,cellular response to estrogen stimulus (GO:0071391),0.5756499482810244,1.2692314575642114,0.20483870967741935,0.6182842867101354,1.0,7/14,19.37%,PELP1;TRIM24;NCOA4;ARID5A;SFR1;RARA;WBP2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6024474012686215,1.2690916150673113,0.2087378640776699,0.6178441355190589,1.0,8/11,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4058005102889904,1.268988585644661,0.1122334455667789,0.6173196660694076,1.0,20/140,7.25%,RASGRF2;ARHGEF3;CD2AP;ARHGAP31;KALRN;CHN2;ARHGEF2;ABR;RHOB;TRIO;ARAP3;BCR;ARHGAP8;PLEKHG5;SRGAP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;ARHGAP25
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.5002398324595246,-1.2681032003560855,0.158311345646438,0.6458408158188556,1.0,4/15,5.79%,LRP1;PDPN;DPP4;FAP
prerank,basement membrane organization (GO:0071711),-0.5024684769475667,-1.268102680363639,0.18461538461538463,0.6434576393767195,1.0,3/14,2.97%,FLRT2;NID1;NID2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5389635758302349,1.2678727675596067,0.19290123456790123,0.619554906665187,1.0,12/18,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;EXOSC10;TCP1;CCT3;RUVBL1;RUVBL2
prerank,lipid modification (GO:0030258),0.4803983534794737,1.2675840909965996,0.17099863201094392,0.6195490742830145,1.0,9/37,15.81%,SGPP2;PLPP1;MBOAT2;DGKH;LPCAT3;PLPP6;PLPP4;DGKI;PLPPR1
prerank,rRNA metabolic process (GO:0016072),0.40409504857871165,1.266409530859804,0.11538461538461539,0.6219351722785718,1.0,68/160,26.74%,BOP1;PELP1;RPL27;DHX37;RPL7;TRIR;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;RPL21;DKC1;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;RPL30;XRN1;RPL27A;NOL8;RPL23A;RPS15;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,regulation of lymphocyte activation (GO:0051249),0.5864241825872493,1.26592427972234,0.19865319865319866,0.6224616568066159,1.0,1/12,1.39%,CRTAM
prerank,regulation of JUN kinase activity (GO:0043506),0.491013781976243,1.265794381558947,0.17185385656292287,0.6220367461117995,1.0,5/33,10.36%,EDN1;DAB2IP;PDCD4;MAP3K11;AIDA
prerank,regulation of cellular component movement (GO:0051270),-0.3587872344700759,-1.2650539503806102,0.11392405063291139,0.6500665995828159,1.0,14/49,12.80%,TGFBR3;EGFR;ROCK2;TGFBR1;PDPN;ARHGAP18;ARAP1;YTHDF1;MEMO1;VEGFA;RAF1;ERBB2;HDAC6;HBEGF
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5234053845418501,1.2648913889858622,0.18597560975609756,0.6236774657876902,1.0,7/24,13.57%,KLF2;NOTCH1;MBTPS2;NFE2L2;CHD6;GCN1;HIF1A
prerank,regulation of response to interferon-gamma (GO:0060330),0.5817262404732967,1.2645764667130708,0.21300813008130082,0.6237576098747665,1.0,3/14,8.22%,IFNGR1;STAT1;JAK2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.49228362810873944,1.263907260995624,0.1708029197080292,0.6247838530350958,1.0,3/31,3.73%,SYT15;DOC2B;SYT7
prerank,positive regulation of programmed cell death (GO:0043068),0.3873233176246742,1.2638648479970007,0.06694560669456066,0.6240967846102169,1.0,40/272,9.55%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;TRIO;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;LRRK2;GADD45G;UBA52;APC;RPS27A;KLF11;APH1A;JUN;HMGB1;MAP3K11
prerank,regulation of platelet activation (GO:0010543),0.5398441121333735,1.2637411980304338,0.21236133122028525,0.6236158258137414,1.0,2/21,0.88%,NOS3;PDGFB
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5355521408079946,-1.2636239365564403,0.1975609756097561,0.6521598099530862,1.0,5/10,21.91%,PFKP;HK2;GFPT1;GFPT2;PFKL
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5186361929515972,1.2635712466501685,0.21417797888386123,0.6232848809792783,1.0,1/25,0.08%,PLCG2
prerank,cyclooxygenase pathway (GO:0019371),-0.5282614816178699,-1.2624174248255502,0.19721577726218098,0.6535329071460965,1.0,3/10,6.51%,PTGDS;PTGES;PTGS1
prerank,cellular response to cytokine stimulus (GO:0071345),0.38020981030654644,1.2618850506888197,0.044579533941236066,0.6272450216104524,1.0,65/416,9.64%,PTPRJ;S1PR1;NPR2;FYN;VCAM1;PTPN14;CCR1;LIFR;GBP5;ST3GAL6;RAPGEF1;FOXO1;ARHGEF2;DUSP1;AIM2;MMP1;INPP5D;DAB2IP;IFNGR1;CBL;LGALS9;VIM;OXSR1;CSF2RB;GBP4;CRK;INPP5K;LAMA5;MAOA;LEF1;TRIM6;HYAL2;LRCH1;TNFRSF1B;IFNAR1;IRAK2;ASAH2;GBP3;GATA3;IL1A;CD47;IRGM;ZC3H12A;ITGAM;IL1RAP;SOCS6;STAT1;PTPN12;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;JAK2;NFE2L2;STK39;RPS27A;NR1D1;ACOD1;GAPDH;CACTIN;ZFP36L2;EGR1;DHX9
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.5323180435437753,-1.2618644034579338,0.2119700748129676,0.652880499731127,1.0,2/11,1.60%,WNT4;BMP5
prerank,integrin-mediated signaling pathway (GO:0007229),0.4316084326552557,1.261807255059358,0.14648910411622276,0.6266646865138958,1.0,13/73,6.80%,LAMA3;CEACAM1;ZYX;PRKD1;NEDD9;APOA1;LAMA5;ADAM15;DST;SEMA7A;MYH9;CUL3;CD47
prerank,positive regulation of establishment of protein localization (GO:1904951),0.534043044452875,1.261095801962344,0.22056631892697467,0.6277906885350121,1.0,11/19,25.81%,CCT8;CEP135;DKC1;CCT2;CCT4;CCT6A;CEP120;TCP1;CCT3;WRAP53;PTP4A3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5713361057461214,1.2606119944052203,0.22061191626409019,0.6283361976296533,1.0,2/15,1.73%,GBP5;NOD2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4671149106505777,1.2603199385461765,0.16843501326259946,0.6283348507770292,1.0,9/47,11.05%,PLCG2;PDGFB;F2RL1;ZC3H12A;ITGAM;ACOD1;TYROBP;ADGRB1;CYBA
prerank,protein destabilization (GO:0031648),0.4976556079728998,1.2602814352581047,0.18958031837916064,0.6276385291259592,1.0,6/32,9.97%,SOX17;CCDC88C;CUL3;IRGM;NR1D1;PRNP
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.46526302211898474,-1.2602463711217944,0.17955801104972377,0.6557209578782085,1.0,5/17,12.35%,BMP6;SASH1;CD55;PRKCA;CD180
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5178264995836026,-1.2598609449882852,0.2074468085106383,0.6545041153343066,1.0,7/13,21.10%,SEC16B;BCAP31;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4209309734598752,1.259854751083012,0.1444043321299639,0.6279746876022495,1.0,33/88,19.04%,FBXL2;PSMD13;FBXL14;FBXL5;PSMD4;FBXL18;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;CUL2;PSMB8;PSMD14;FBXO4;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;FBXL13;PSMC6;AMN1;PSMA4;FBXO6;PSMD5;PSMD9;FBXL6;PSMB6;FBXL15
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.39097896013205197,1.2598354005974675,0.07987220447284345,0.6272284961753963,1.0,34/214,10.95%,TEK;PDGFD;RAPGEF2;PTPRR;CEACAM1;PDGFB;CNKSR3;FLT4;CCR1;NOTCH1;NOD2;DAB2IP;F2RL1;LGALS9;APP;TIRAP;TIMP3;RRAS;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;DUSP3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4;PTPN1;RANBP9
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5760625009023947,1.2596170289571174,0.2031496062992126,0.6270672119730901,1.0,7/14,22.66%,BOP1;RPL7;RPL35;RPL7L1;FTSJ3;URB1;RPF2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.48249797592407584,1.2593476784896598,0.19746121297602257,0.6270012159317458,1.0,5/33,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,regulation of microtubule polymerization (GO:0031113),0.4810146153666537,1.2588592669789291,0.1912568306010929,0.6275532354884117,1.0,12/40,15.30%,STMN2;OCLN;FES;CAMSAP2;PRUNE1;CLIP1;CLASP1;MAPRE3;RAC1;NUMA1;NAV3;MAP2
prerank,positive regulation of cytokine production (GO:0001819),0.3874636382793599,1.2586093618257337,0.07068607068607069,0.6274556751449988,1.0,41/292,11.99%,PLCG2;AFAP1L2;PLCB1;FLT4;NOD1;CRTAM;GBP5;NOD2;PAEP;ARHGEF2;F2RL1;IFIH1;LRRFIP1;LGALS9;CADM1;APP;TLR3;TIRAP;TRIM6;HYAL2;DDX41;CD34;TMED10;GATA3;IL1A;ADAM17;HSPA1B;CD200;POLR3B;GAPDH;LTB;FOXP1;EGR1;HMGB1;DHX9;TYROBP;LURAP1;CYBA;LAPTM5;BRCA1;PRKD2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5150752899211919,-1.258501803256173,0.19718309859154928,0.6563005732799623,1.0,7/13,21.10%,GCC2;SEC16B;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4954854174375075,1.2583168142571406,0.18992805755395684,0.6274658226414409,1.0,12/33,18.10%,TAL1;FES;STAT1;HSPA1B;THPO;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4895081100056809,1.2580486517056626,0.18513119533527697,0.6273725013243587,1.0,2/33,1.78%,PLCG2;ATP2B4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.44832764572225614,1.2569941820638555,0.18471337579617833,0.6295070685197078,1.0,23/53,22.45%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PPM1K;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,cardiac muscle cell action potential (GO:0086001),-0.397727547826415,-1.2568312632950203,0.12987012987012986,0.6589701730144689,1.0,7/30,6.67%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;CACNA1G
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4644021071817046,1.2566793866188544,0.17615176151761516,0.6295429452577416,1.0,13/46,18.13%,PTPRR;CNKSR3;DAB2IP;TIMP3;DUSP3;PTPN1;RANBP9;ITGB1BP1;PIN1;DUSP26;PTPN2;SEMA6A;SMAD4
prerank,regulation of interleukin-13 production (GO:0032656),0.5947360446803935,1.2565148807291369,0.2152317880794702,0.6291819917426947,1.0,3/13,6.03%,LGALS9;LEF1;GATA3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6078592312423472,1.2564153483724456,0.22445561139028475,0.6286379863119987,1.0,2/11,1.73%,MERTK;NOD2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3776648964448963,1.2563909943036835,0.0371859296482412,0.6279103392462881,1.0,80/476,14.62%,PRDM16;NOS1;MECOM;SOX17;NOTCH4;AFAP1L2;IRF6;GATA6;PLCB1;PDGFB;KLF2;SMARCA2;CASZ1;TBX1;ACVRL1;NOTCH1;FOXO1;HEY1;TAL1;HNF1A;HNF4A;KLF6;SOX18;HHEX;FLI1;INPP5K;HEY2;KLF4;ACVR1;ING2;LEF1;KARS1;FOXF2;MEF2C;SMAD2;ZBTB48;GATA3;RYBP;ZBTB16;FANK1;KDM3A;STAT1;MAPRE3;EBF3;DNAJC2;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;SEC14L2;MAD2L2;RPS6KA1;SFR1;DEAF1;RAI1;NPM1;BRCA1;CD38;ILF2;DTX3L;SOX10;HINFP;MED30;SETD3;ELF2;YWHAH;PHIP;HIF1A;NFATC1;LRP5;SMARCC1;CTNNB1;MED17;MLLT3;MED4;HMGB2;PSMC5
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.36928804390847214,-1.2563432845313693,0.10830324909747292,0.6581134236820183,1.0,7/40,10.91%,SLC7A11;SLC13A3;SLC38A11;SLC19A1;SLC38A10;SLC27A1;SLC38A5
prerank,plasma membrane organization (GO:0007009),0.4390778537206777,1.2556784344894512,0.17958656330749354,0.62910552563183,1.0,14/61,8.41%,CAVIN2;DYSF;PLSCR4;PACSIN2;SYT7;ANO6;FNBP1L;MYH9;PACSIN1;P2RX7;WHAMM;PLSCR1;A4GALT;BIN3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.45476467124431424,1.254135705163852,0.16168478260869565,0.632457204433475,1.0,11/47,15.72%,NANOS3;EDN1;APP;KLF4;CYFIP1;NFKBIA;VPS35;GRM5;METTL18;EIF2A;TCOF1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4889694599282053,1.2536052211772115,0.19746121297602257,0.6331943653614411,1.0,11/32,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,actomyosin structure organization (GO:0031032),0.43784027307849904,1.2534632525174525,0.17042606516290726,0.6328277055477177,1.0,16/75,9.21%,EPB41L4A;FRMD3;F11R;ZYX;CDC42BPA;FLII;CDC42BPG;EPB41;CSRP2;MYH9;CUL3;WDR1;ARRB1;CASQ1;ROCK1;TJP1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.40935244865322584,1.2529554630142594,0.13109048723897912,0.6334106100299474,1.0,24/112,9.31%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;MEF2C;HYAL2;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2;ZFP36L2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5135151048633426,1.252816982978802,0.21220930232558138,0.6330229219451045,1.0,5/25,13.37%,TRPV4;STMN2;KIF2A;PIN1;KIF24
prerank,muscle cell development (GO:0055001),0.4868438755738327,1.2525608328659532,0.18475073313782991,0.6329698816595556,1.0,6/30,4.18%,ENG;NEBL;DYSF;HEY2;SLC8A1;ALPK3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4017177739788133,1.2523048685617926,0.13209606986899564,0.6328610075175882,1.0,17/150,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;ANGPT1;GCNT2;FGFR3;IAPP;GATA3;MFHAS1;THPO;PTK2;RTN4
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3757136794183542,1.251981584312049,0.03632694248234107,0.6329442333620084,1.0,91/532,13.97%,PTPRJ;IRF6;ADIPOR2;S1PR1;CEACAM1;PLCB1;PDGFB;FYN;VCAM1;RPS6KA5;NOD1;CCR1;LIFR;NOD2;B2M;RAPGEF1;FOXO1;GSTA2;AIM2;MMP1;INPP5D;IRF2;IFNGR1;CBL;VIM;CSF2RB;CRK;ACTN4;TNFRSF18;CISH;PSMD13;LAMA5;MSN;MAOA;IRF9;CAMK2D;TNFRSF25;TRAF1;TNFRSF1B;IFNAR1;IRAK2;COMMD7;GATA3;FCGR1A;IL1A;PDCD4;ADAM17;ADIPOR1;PSMD4;ITGAM;IL1RAP;SOCS6;STAT1;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;OAS2;JAK2;RPS27A;PITPNA;LTB;ADAR;EGR1;PSMA5;RBX1;BOLA2;PSMB10;TRIM25;CCL4;CASP1;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;TRIM8;TALDO1;IRF5;PIK3CB;PSMA7;PSMC3;HIF1A;NDN;PSMA8;PSMC1;SOS1;CFL1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4975212919803889,1.251819099313777,0.2056338028169014,0.6325920552948968,1.0,7/27,15.09%,CCDC88C;MAPK1;UBA52;RPS27A;TAOK2;MAP3K20;KAT7
prerank,protein targeting to peroxisome (GO:0006625),-0.3989777384458768,-1.2516272242417918,0.1554054054054054,0.6705340740942558,1.0,18/29,35.36%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;HACL1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;ZFAND6;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,calcium ion import (GO:0070509),0.5057643634751144,1.2508020762289978,0.19635343618513323,0.634535671250465,1.0,6/28,8.36%,TRPV4;CACNA1A;MCUB;SLC8A1;SMDT1;MCUR1
prerank,regulation of cell differentiation (GO:0045595),0.40082319804431366,1.250497173698608,0.12967032967032968,0.6346329508371829,1.0,28/148,13.00%,SLC6A6;LTBP4;NOTCH4;SMAD7;CASZ1;TBX1;HEY1;EMP2;FES;HEY2;KLF4;SPOCK2;MBOAT2;GATA3;BCL6B;CLASP1;ALK;APC;NR1D1;SNAI2;ROCK1;PTK2;CLASP2;RPS6KA1;MCRIP1;CBFB;RPS6KA3;YWHAH
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.47121001673005886,-1.2504635181527781,0.18926553672316385,0.6714469449454357,1.0,7/16,5.55%,TGFBR3;IGF1;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5292798208623147,1.2503335808291776,0.20565149136577707,0.6342521763413409,1.0,4/22,4.34%,STMN2;RAPGEF2;RAPGEF1;EHD1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6008456202468984,1.2502893721102764,0.23310810810810811,0.6336021782923873,1.0,2/10,2.28%,ENG;CAV1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.43727905780560905,1.249939414456828,0.17803030303030304,0.6337872578832336,1.0,14/66,9.67%,PTPRM;CEACAM1;B2M;DAB2IP;AQP11;CAV1;CAV2;TGFB2;GATA3;STAT1;ATP5F1A;SNAI2;MCC;FBXW7
prerank,intraciliary retrograde transport (GO:0035721),-0.5153267346270871,-1.249836193309366,0.19,0.6710533561311525,1.0,8/12,22.13%,WDR35;DYNC2LI1;IFT43;DYNC2I2;TTC21B;WDR19;DYNC2H1;DYNC2I1
prerank,protein O-linked glycosylation (GO:0006493),0.415819239294217,1.2495436178147405,0.14388489208633093,0.6341242592610518,1.0,17/96,12.68%,EOGT;GCNT1;ST8SIA6;GALNT18;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;POGLUT1;B3GNT3;DPM1;TET3;C1GALT1C1;XXYLT1;GALNT4;B3GALNT2
prerank,bicarbonate transport (GO:0015701),-0.4226524992903259,-1.2490717189918732,0.18153846153846154,0.670975346503312,1.0,10/25,22.63%,SLC4A10;SLC26A7;CA2;SLC39A8;SLC4A2;SLC4A3;SLC26A6;CYB5RL;SLC4A8;CFTR
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5647917270804912,1.2489793997051835,0.22884012539184953,0.6348817840619414,1.0,7/14,16.50%,DUSP1;PPM1F;PPP3CA;PPP2R2C;PPP1R15B;PPP2CB;NCK1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4404219209113283,1.2485356880811032,0.168,0.6353371947707176,1.0,14/57,13.12%,FYN;NOD1;AIM2;ARL6IP5;CASP8;PPM1F;TNFSF10;CIDEB;GRIN2B;GRAMD4;HMGB1;CASP1;TTBK1;TBC1D10A
prerank,tRNA metabolic process (GO:0006399),0.5433900897634494,1.2480956875364642,0.2,0.6357939889735271,1.0,4/17,10.20%,DTD2;KARS1;TRPT1;FARS2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5466435050027499,1.247590439939626,0.22705314009661837,0.6364250932725539,1.0,4/17,9.44%,NOD2;ARL6IP5;TGFB2;TAOK2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5320327050558578,1.247552609477171,0.212443095599393,0.6357317176770348,1.0,4/19,8.46%,LGALS9;TIRAP;ITGAM;NMI
prerank,pinocytosis (GO:0006907),0.6008903667636496,1.2466443305183437,0.24,0.6374851319137712,1.0,6/10,21.45%,PPT1;RAB34;DOCK2;PYCARD;MAPKAPK2;CARMIL1
prerank,peptidyl-threonine modification (GO:0018210),0.4393113066727062,1.2462191474704034,0.17506297229219145,0.6379108180859469,1.0,19/66,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;GALNT4;MARK2;TTBK1
prerank,negative regulation of GTPase activity (GO:0034260),0.5241032197331209,1.2459449561273443,0.21796759941089838,0.6379077474400866,1.0,5/22,7.15%,F11R;DAB2IP;LRCH1;SH3BP4;LRRK2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4175395146180738,1.2459253534871724,0.15758293838862558,0.6371798379315626,1.0,20/95,10.37%,NOD2;DAB2IP;VIM;TIRAP;DEFA6;FCGR2B;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,negative regulation of phosphorylation (GO:0042326),-0.32203475457255215,-1.2456204454661501,0.08771929824561403,0.6791514194136098,1.0,15/85,7.26%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;NUPR1;SLIT2;BMP4;PPARA;PRKN;NIBAN1;IRS2;XDH;IGFBP3
prerank,regulation of endocytosis (GO:0030100),0.43829785324613635,1.2451593032826769,0.16521739130434782,0.6384825366912934,1.0,17/61,17.14%,CDH13;HIP1;HIP1R;MCTP1;PRKD1;PACSIN2;PACSIN1;ROCK1;STON1;PTPN1;NEDD4L;RUBCN;ABCA7;ZFYVE16;RIT2;OPHN1;RUFY1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.48225569159042747,1.244994957352384,0.20520231213872833,0.6381483013419856,1.0,5/30,5.38%,LTBP4;ENG;SMAD7;FKBP1A;SMAD2
prerank,positive regulation of lipid transport (GO:0032370),-0.5054593546114785,-1.2442978184416387,0.22141119221411193,0.6807371687140705,1.0,3/12,10.56%,LRP1;APOE;SPP1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.46323848469404316,-1.2442650413993865,0.2032520325203252,0.6784964792586787,1.0,9/17,17.11%,ATP1A2;TFPI;BMP7;BMP4;SRC;URI1;UBE2L3;GPER1;AR
prerank,positive regulation of calcium ion transport (GO:0051928),0.48409619675778115,1.2440578491485785,0.1816958277254374,0.6398958270741705,1.0,9/36,10.16%,PDGFB;CCR1;MYLK;CAV1;ORAI1;STIM2;P2RX7;CRACR2A;CCL4
prerank,cellular response to inorganic substance (GO:0071241),0.5152781709924906,1.2439386086159834,0.20496894409937888,0.6394664911056602,1.0,4/21,9.77%,FOXO1;ADCY10;NSMCE3;SPIDR
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5560869937036332,1.2432353410034913,0.2236842105263158,0.640613980761052,1.0,3/15,11.98%,SMAD7;MAD2L2;DTX3L
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.46767355734827476,-1.2429068933070377,0.22888283378746593,0.6800936076537537,1.0,3/14,3.67%,DMD;WNK1;WNK4
prerank,regulation of stem cell differentiation (GO:2000736),0.4151867430619695,1.2426954544893432,0.15852205005959474,0.6412789756674963,1.0,29/89,18.86%,JAG1;GATA2;LMO2;NOTCH1;TAL1;PSMD13;LMO1;GATA3;PSMD4;ZFP36L2;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;NELFB;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5138081944914531,1.2420232341627344,0.20952380952380953,0.6424054155583363,1.0,6/22,8.74%,DAB2IP;F2RL1;TIRAP;MFHAS1;NR1D1;ACOD1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4715500437578855,1.2418683059845943,0.1867043847241867,0.6420577503509739,1.0,13/34,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GABRA4;GABRA2;GABRE;GRIN2A;GABRG3;GSK3A;GRID2;GSK3B;INSYN2A
prerank,mesenchyme development (GO:0060485),-0.48406633464753734,-1.241330854685642,0.19466666666666665,0.6825584335534467,1.0,4/15,2.18%,FGFR2;TGFBR1;BMP7;BMP4
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5827365180238132,1.2411293083460317,0.23946037099494097,0.6433603593148094,1.0,7/12,25.95%,CAV1;CAMK2D;CALM3;PDE4D;IRX3;SRI;CALM1
prerank,sulfation (GO:0051923),-0.5270221314662067,-1.2409251127717211,0.2010443864229765,0.6815133693653777,1.0,1/11,0.05%,UST
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4287713031701209,1.2404092529600472,0.16501240694789082,0.6445072477458638,1.0,8/72,2.62%,TEK;PDGFD;FLT1;PDGFB;INSR;F2RL1;TGFB2;CBL
prerank,actin filament capping (GO:0051693),-0.4469081443672187,-1.240299563202325,0.1842818428184282,0.6786444383571699,1.0,5/18,9.41%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,barbed-end actin filament capping (GO:0051016),-0.4469081443672187,-1.240299563202325,0.1842818428184282,0.6786444383571699,1.0,5/18,9.41%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2926400909567578,-1.240286572309705,0.0594059405940594,0.6763677934323663,1.0,43/152,17.20%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;SULF1;GPC3;PTK7;SULF2;RSPO3;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;RSPO2;PPM1A;PSMB3;SALL1;NFKB1;CSNK1G2;AXIN2;DDX3X;TERT;PPM1B;PSMA3;PSMB4;PSMC4;USP8;ZRANB1;PSMB7;GID8;AMER1;PSMD12;USP34
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5028099200816826,1.2401977896219047,0.2237442922374429,0.644263982164809,1.0,10/25,19.44%,HRK;TNFSF10;BBC3;CIDEB;BNIP3;PYCARD;PLAUR;BMF;BID;PPIF
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.41541608947998476,-1.239854183213374,0.16987179487179488,0.6754072708807276,1.0,9/27,12.26%,DCN;CHST15;BGN;PXYLP1;XYLT1;VCAN;B3GAT3;CHPF2;CSPG4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5229934437078282,1.2394750226275222,0.23318385650224216,0.6454487348737689,1.0,4/21,11.99%,KCNN4;FOXP1;STAP1;PRKD2
prerank,positive regulation of vascular permeability (GO:0043117),0.5721145722878471,1.2393041279121635,0.2159468438538206,0.6451779503253683,1.0,5/12,9.21%,TRPV4;OCLN;ANGPT1;TJP2;TJP1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5235406021798127,-1.239082999022511,0.19633507853403143,0.6754385230843278,1.0,5/11,18.18%,PDPN;RREB1;SRC;ARPIN;ENPP2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.45712145007289856,1.2372975342197934,0.2024623803009576,0.6501127765075503,1.0,10/40,11.83%,HIP1;B2M;INSR;CBL;PPT1;ANGPT1;ARRB1;TBC1D5;HNRNPK;CLU
prerank,positive regulation of protein kinase activity (GO:0045860),0.39701590056043645,1.2371039256009755,0.1527313266443701,0.6498125664730738,1.0,31/148,12.61%,RAPGEF2;PDGFB;ACE;INSR;DAB2IP;TGFB2;ADRB2;EMP2;IQGAP1;NEDD9;EFNA1;MAP4K4;FCGR1A;IRGM;MAPRE3;TOM1L1;SYAP1;PTK2;TAOK2;EGR1;PRNP;CCDC88A;PTPN1;MINK1;TAB2;MMD;CLU;GRM5;MARK2;CALM3;TTBK1
prerank,negative chemotaxis (GO:0050919),0.4855021138330342,1.236853908672599,0.2,0.6497500423890867,1.0,5/33,4.67%,SEMA3G;SEMA3F;APOA1;NTN1;SEMA7A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4457244084707702,1.2362131260468634,0.1937984496124031,0.6506880627345601,1.0,22/50,22.45%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.45347682695408786,-1.2360253568445636,0.19710144927536233,0.6823692010751965,1.0,5/17,13.84%,CPEB1;NUDT21;NCBP1;CTR9;CPEB3
prerank,peroxisomal membrane transport (GO:0015919),-0.3945518096843563,-1.2357630620146964,0.16938110749185667,0.6809592544894759,1.0,16/27,35.36%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,regulation of gluconeogenesis (GO:0006111),-0.4069866407837897,-1.235246327188443,0.1617161716171617,0.6802457238715066,1.0,7/27,16.51%,OGT;C1QTNF3;ZNF692;PDK2;SIK1;CLK2;NNMT
prerank,protein localization to nucleus (GO:0034504),-0.3074214719437155,-1.23516358858453,0.059602649006622516,0.67820317915066,1.0,42/102,24.38%,COL1A1;APPL2;BMP7;BMP4;LMNA;TOR1AIP1;NUP107;SIX1;TOR1B;INTS13;HEATR3;BANP;CSE1L;PPP1R10;NUP155;PAF1;TNPO3;RANBP6;IPO5;FAM53C;BCL3;MDM2;NUP93;TNPO2;HNRNPU;RANBP17;TOPORS;TSC2;PHB2;MORC3;SUPT7L;PML;RRS1;CHCHD10;SEC13;SYK;IPO7;SIX4;POM121;TOR1A;TBRG1;IPO8
prerank,cellular response to organonitrogen compound (GO:0071417),0.4116050169709589,1.2350961624456704,0.1536643026004728,0.6530556016424977,1.0,30/99,21.41%,KCNQ1;RAPGEF2;SPAAR;RAPGEF1;DIAPH1;INPP5K;MEF2C;SH3BP4;P2RX7;HSP90B1;CTNNA1;HTR1B;EGR1;RRAGD;ACTB;TRPM2;BRCA1;CTNNB1;GLRA2;P2RY1;CIB2;GABRB1;GOLPH3;RELA;RRAGA;RRAGC;JUP;LAMTOR3;ZFP36L1;GABRB3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5387003851802744,-1.2350915724095841,0.23076923076923078,0.6761420639629807,1.0,2/10,2.27%,ATP1A2;OSR1
prerank,regulation of embryonic development (GO:0045995),0.4708869596995179,1.235017636073436,0.2086230876216968,0.6524891993144645,1.0,7/34,11.00%,SOX17;PLCB1;INSR;POGLUT1;CLASP1;CLASP2;BAG6
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5347577771278446,1.2347401737309451,0.235202492211838,0.6523739292036957,1.0,5/16,16.27%,TUBB;TUBB4B;VAMP7;LYST;PLEKHM2
prerank,development of primary male sexual characteristics (GO:0046546),0.4847604581076641,1.2346816117433932,0.23537604456824512,0.6517635593916598,1.0,6/34,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,positive regulation of response to stimulus (GO:0048584),0.46361432737730335,1.2345821077552168,0.19471488178025034,0.6512759185451598,1.0,12/40,18.44%,B2M;IFIH1;TGFB2;IER5;FCGR2B;GATA3;DHX9;FXR1;NSMCE4A;RSAD2;EEF1E1;CDKN2AIP
prerank,regulation of multicellular organism growth (GO:0040014),-0.4619790647335762,-1.23429938046939,0.2127659574468085,0.6762504532676598,1.0,5/15,15.01%,IGF1;MBD5;GHR;PTCH1;MFSD2A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.47006151335262236,1.2333557419299876,0.20967741935483872,0.6537945721474355,1.0,7/37,13.99%,ENTPD1;DFFB;ADPRM;RNASEH2B;XRN2;RNASE6;NUDT9
prerank,positive regulation of innate immune response (GO:0045089),0.48176496635495375,1.2333509897630923,0.20249653259361997,0.6530286255471385,1.0,8/30,9.64%,GBP5;TRIM6;PLSCR1;NLRC5;NMI;POLR3B;SLC15A4;DHX9
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5724530910104014,1.232933681589809,0.23141891891891891,0.6526512009443141,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5724530910104014,1.232933681589809,0.23141891891891891,0.6526512009443141,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.47638520404806667,-1.2323127191514713,0.22715404699738903,0.6799040712875404,1.0,6/15,17.31%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;AMDHD2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5152362014374829,1.2320971548211237,0.229607250755287,0.6541701541358286,1.0,4/22,4.95%,EDN1;LMCD1;NOTCH1;CAMK2D
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4274932038306976,1.2317113660772168,0.17755856966707767,0.6543875123009933,1.0,28/70,20.52%,B2M;MFSD6;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;LNPEP
prerank,rRNA catabolic process (GO:0016075),0.5311648901817109,1.231460954257037,0.2391653290529695,0.6543554074759843,1.0,7/16,21.35%,TRIR;EXOSC3;EXOSC8;PELO;XRN1;EXOSC9;EXOSC10
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5124708307689532,1.2314313030111212,0.20902255639097744,0.6536783214998814,1.0,10/22,20.68%,INPP5K;UFM1;RAB23;LRRK2;RANGAP1;ITGB1BP1;CABP1;GDI1;BARD1;BAG4
prerank,regulation of immune response (GO:0050776),0.39742528503175206,1.23136671645382,0.15428571428571428,0.6530760242338438,1.0,19/135,10.12%,VCAM1;CLEC2D;CRTAM;B2M;ICAM2;CASP8;TGFB2;FKBP1A;SPPL2A;TIRAP;FCGR2B;CD34;FCGR1A;OSCAR;CD247;PLSCR1;CD200;FOXP1;TYROBP
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4871723835798317,1.231338329792052,0.21376281112737922,0.6523864684969446,1.0,3/30,1.57%,DACH1;BMPR2;ACVRL1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5554097091588774,1.23123127589697,0.22468354430379747,0.6519235702034294,1.0,4/13,6.78%,AZIN1;ACSL5;ANO6;P2RX7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.45029695826200933,-1.230905603191164,0.21293800539083557,0.6820484895373196,1.0,10/16,26.50%,PIGA;PIGB;PIGN;PIGH;DPM2;PIGG;PIGP;PIGZ;PIGL;PIGW
prerank,regulation of ion transmembrane transport (GO:0034765),0.47942412687080277,1.230725365352893,0.20694444444444443,0.6525102722094572,1.0,4/33,6.78%,KCNQ1;ANO6;CHRM3;P2RX7
prerank,muscle tissue morphogenesis (GO:0060415),0.5444090636564284,1.230648886260104,0.2233502538071066,0.6519503965055421,1.0,4/16,3.58%,TBX1;NOTCH1;MYLK;HEY2
prerank,positive regulation of protein binding (GO:0032092),0.4441116167969988,1.230363735651536,0.19919786096256684,0.651973900784603,1.0,15/56,14.97%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;EPB41;LRRK2;NVL;MARK3;DTX3L;PIN1;RAN;PPP2CB
prerank,cotranslational protein targeting to membrane (GO:0006613),0.41046342803806574,1.2291654160900594,0.16926770708283315,0.6545146819758162,1.0,41/91,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.466438095454449,-1.2291585160604583,0.20485175202156333,0.6826669312525597,1.0,6/16,8.24%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.466438095454449,-1.2291585160604583,0.20485175202156333,0.6826669312525597,1.0,6/16,8.24%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,metanephric mesenchyme development (GO:0072075),-0.5279442284781888,-1.2290443918692089,0.25,0.6808336030183751,1.0,6/10,22.66%,WNT4;OSR1;SIX1;BASP1;PAX2;SIX4
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.37229941327562555,-1.2290179673831538,0.14056224899598393,0.6786693749633819,1.0,15/41,23.05%,ACSL1;PTGS1;PLA2G4A;SCP2;DEGS1;FADS3;SCD;GSTM2;FADS2;ELOVL1;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,positive regulation of apoptotic process (GO:0043065),0.37554256641326467,1.2289175718092045,0.09863588667366212,0.6544280287424444,1.0,45/293,10.19%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;TGFB2;RHOB;TRIO;BTG1;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;ZC3H12A;GADD45G;UBA52;APC;RPS27A;TPD52L1;KLF11;APH1A;JUN;HMGB1;MAP3K11;PRNP;ARHGEF1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4957609769794947,1.2285644713694772,0.233587786259542,0.6546470395091991,1.0,11/26,21.58%,FYN;AIM2;EFNA1;GRIN2B;APH1A;VSIR;TTBK1;PYCARD;AGER;APH1B;EPHA4
prerank,cellular response to amyloid-beta (GO:1904646),0.47213573487445937,1.2285591290155258,0.21708683473389356,0.6538991780719713,1.0,7/35,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,neural crest cell differentiation (GO:0014033),0.5327383663404411,1.2285518625071075,0.24149108589951376,0.6531530639745501,1.0,7/18,21.33%,MEF2C;SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.43145487485191586,-1.2285110502852767,0.18518518518518517,0.6778861211354554,1.0,6/21,7.62%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2
prerank,regulation of telomerase activity (GO:0051972),0.4549972808567331,1.2283170569372566,0.19538670284938942,0.6530186590504342,1.0,21/45,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;ERCC4;ATM;CTNNB1;MEN1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,supramolecular fiber organization (GO:0097435),0.37491024921573357,1.2281376822781256,0.09034907597535935,0.6527461536910601,1.0,54/334,10.33%,LAMA3;MYO1D;FBLN5;CD2AP;CCDC88C;TRPV4;STMN2;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;PLK3;RND1;B2M;ARHGEF2;TGFB2;RHOB;FKBP1A;VIM;EMP2;APP;FLII;APOA1;EVL;CLIP2;SLK;DST;TSPAN14;ATP7A;IAPP;FURIN;CAMSAP2;COL5A2;CLIP1;KIF2A;PLEC;WHAMM;ARHGAP25;HOOK1;UBA52;MYO1C;BIN3;RPS27A;COL9A3;APH1A;PCM1;DSP;ADAM10;SIAH2;KATNAL2;MAD2L2;ERMN;CCDC88A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.41615402480014513,1.2281061120781103,0.17718446601941748,0.6520666148801045,1.0,12/78,8.44%,PDGFB;CCNY;CCND2;CCND3;HHEX;CCNE1;SERTAD1;CDC25C;ADAM17;MAPRE3;CEBPA;APC
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4398050512153526,-1.2262661378425845,0.18598382749326145,0.6824454255754677,1.0,3/19,3.41%,CAMK1D;IL34;THBS1
prerank,regulation of AMPA receptor activity (GO:2000311),0.497077963882221,1.2261756089470803,0.21145374449339208,0.6565358232193358,1.0,6/25,10.65%,ADRB2;SHISA8;MEF2C;SHANK3;SHISA6;MINK1
prerank,negative regulation of cell death (GO:0060548),0.4119511740418853,1.2259203934334708,0.179456906729634,0.6564181551584275,1.0,20/88,14.80%,MECOM;FYN;PRKD1;TMEM109;AMIGO2;CD34;TNFRSF1B;LRRK2;HSPA1B;PDE8A;DCPS;CD200;VPS35;CLU;CHGA;BNIP3L;BNIP3;RAD18;PSMC5;TM7SF3
prerank,regulation of cell motility (GO:2000145),0.3997784963976656,1.2257155786001388,0.16279069767441862,0.6562171552168993,1.0,26/121,11.66%,SPATA13;CEACAM1;LDB2;PLXNA4;MACF1;RHOB;FES;CRK;DIAPH1;SPOCK2;PLXND1;NTN1;SLK;PKN1;TTBK2;ROBO4;SPOCK3;GATA3;KIF2A;ROCK1;SGK1;SPINT2;MINK1;RAC1;CAVIN1;INPP5F
prerank,neuron projection organization (GO:0106027),0.5508477424895363,1.225445821386529,0.2145214521452145,0.6561918703073901,1.0,4/15,9.97%,INSR;ATP1A3;APP;PRNP
prerank,translation (GO:0006412),0.3775711494223019,1.225273197791327,0.1334033613445378,0.6558741167549874,1.0,90/208,28.17%,RPS21;GARS1;RPL27;VARS1;KARS1;RPL7;FARSB;WARS1;MRPL18;EEF2K;MRPL41;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;FARS2;RPS28;RPL34;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;RPS9;RPLP2;EEF2;GTPBP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS34;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;GATB;EEFSEC;RPL37A;RPL18A;RPL22L1;EEF1D;MRPS18B;COPS5;RARS1;EEF1E1;ZC3H15;EEF1G;DARS1;MRPL11;RSL24D1;RPL18;MRPS28;RPL39;RPS19;RPL31;RPS8;TSFM;EIF4G1;MRPL34;WARS2;EIF4EBP2;RPL3;PPA2;RPL28;MRPS24;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;DARS2;APEH;RPS13;MRPL13;RPL11;RPL14
prerank,regulation of cellular amide metabolic process (GO:0034248),0.477138713348306,1.225093094480206,0.21164772727272727,0.6555582713426428,1.0,9/32,15.72%,NANOS3;APP;TMED10;ROCK1;CYFIP1;GRM5;METTL18;EIF2A;TCOF1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4483826703046038,1.2249578414548896,0.19695044472681067,0.6551728296809989,1.0,10/50,12.80%,NOD1;NOD2;LGALS9;APP;ACTN4;TLR3;PDCD4;NMI;LAPTM5;RTKN2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5763928960128677,1.2243407792333334,0.2376237623762376,0.656079606514494,1.0,2/13,1.77%,SPAAR;CASTOR1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.47215107788729055,1.2239035135689658,0.2418478260869565,0.6565188751640085,1.0,10/36,14.82%,FZD6;PLCB1;TNRC6C;LEF1;NLK;PPP3CA;AGO4;NFATC1;CTNNB1;FZD3
prerank,positive regulation of hydrolase activity (GO:0051345),0.39015742398593667,1.2235490214811855,0.13785310734463277,0.6566732970812952,1.0,22/137,13.11%,RAPGEF2;DOCK9;F11R;RAPGEF1;RASGRP2;CAV2;F2RL1;AGRN;APOA1;TBC1D30;RAPGEF6;MAP4K4;RAP1GDS1;BCAR3;RGS7;CD200;RSU1;CCL4;ARHGAP27;CALM3;USP6NL;PIN1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5829400690652464,1.223538217086849,0.24342105263157895,0.655940667598283,1.0,2/11,4.89%,FYN;LANCL1
prerank,negative regulation of translational initiation (GO:0045947),-0.487488708800639,-1.2231391382819392,0.2222222222222222,0.6895388883324642,1.0,5/13,17.13%,PAIP2;EIF2AK4;EIF3E;LARP1;EIF4EBP1
prerank,neutrophil mediated immunity (GO:0002446),0.3689710743688157,1.2229201558511948,0.06072874493927125,0.6568657058963644,1.0,62/432,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;ACE;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;ADAM17;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;KMT2E;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,negative regulation of hormone secretion (GO:0046888),-0.5394415169419041,-1.2227178699838146,0.23809523809523808,0.6885357361935018,1.0,2/10,8.73%,GJA1;RAB11FIP1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4698943499242491,1.2227097416589956,0.2245762711864407,0.6566397250668038,1.0,10/36,14.74%,EDN1;TRIM6;ADAM17;IRGM;HSPA1B;NLRC5;CASP1;LAPTM5;HIF1A;CXCR4
prerank,intracellular lipid transport (GO:0032365),-0.42737944395062655,-1.22202641164724,0.20869565217391303,0.6883808396521194,1.0,4/21,6.25%,PRKAG2;PRKAA2;ABCD3;SLC25A20
prerank,regulation of fibrinolysis (GO:0051917),-0.49312886775065357,-1.2208237071732413,0.2375,0.6899483948637877,1.0,4/13,17.38%,THBS1;FAP;SERPINE1;THBD
prerank,glucose transmembrane transport (GO:1904659),0.5308748682615306,1.2203977547657092,0.24881889763779527,0.6623358752273403,1.0,3/18,8.42%,SLC2A1;HNF1A;SLC2A9
prerank,negative regulation of wound healing (GO:0061045),-0.40238486047176947,-1.2202948867160333,0.17721518987341772,0.6893071745370453,1.0,8/28,5.55%,PHLDB2;TFPI;CASK;VTN;SLC12A2;APOE;SERPINE2;FGF2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4481042253792083,-1.2202319066823684,0.2184873949579832,0.6873150878519918,1.0,3/18,9.65%,EGFR;LCOR;CCDC62
prerank,cellular response to tumor necrosis factor (GO:0071356),0.38386847019896575,1.2196432570738065,0.14331896551724138,0.663627865175534,1.0,55/175,21.03%,ARHGEF2;AIM2;DAB2IP;ACTN4;TNFRSF18;INPP5K;PSMD13;TNFRSF25;HYAL2;TRAF1;TNFRSF1B;COMMD7;GBP3;GATA3;ADAM17;PSMD4;ZC3H12A;STAT1;JAK2;NFE2L2;NR1D1;ACOD1;LTB;CACTIN;ZFP36L2;PSMA5;DHX9;PSMB10;CCL4;NFKBIA;PSMB8;GBP2;PSMD14;BRCA1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;ERBIN;TNFRSF11A;PSMB2;BAG4;ZFP36L1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5260839753389619,-1.218087806476151,0.20572916666666666,0.6914960392645443,1.0,4/10,10.37%,DSE;PXYLP1;XYLT1;B3GAT3
prerank,regulation of cell communication (GO:0010646),0.4658060674493366,1.2177376537380944,0.2134670487106017,0.6681023688477141,1.0,7/35,7.22%,GJA5;KAZALD1;CRK;SLC8A1;SCG5;CAMK2D;IGFBP7
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5300598957630044,-1.217291276907133,0.2542372881355932,0.6916632293419107,1.0,3/10,4.72%,VTN;PRKCB;GRB10
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.40306817499889885,1.2172658869165538,0.17011494252873563,0.6685957416059948,1.0,14/107,7.78%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1;MT2A;SLC39A6
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5247312720735421,1.217030904764093,0.23667711598746083,0.668509292507759,1.0,2/17,1.44%,KCNQ1;KCNE3
prerank,mRNA metabolic process (GO:0016071),-0.3091951487717254,-1.21690723955906,0.08280254777070063,0.6907665753552678,1.0,34/90,24.12%,SON;DDX5;SRSF5;SCAF11;NUDT21;HNRNPA2B1;NCBP1;PRPF8;SRSF1;PRKACA;SSB;CNOT10;PRPF3;AKAP8L;SNRPF;YTHDF2;PCF11;U2AF2;SNRPD3;AGO3;ZFP36;LSM11;SLBP;LSM6;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2;DCP2;LSM10;U2AF1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.44709758567789937,1.216872127452616,0.21837549933422104,0.6681536748054713,1.0,6/46,4.92%,TEK;NTN4;PARVB;ATRNL1;LAMA5;EFNA1
prerank,manganese ion transport (GO:0006828),-0.4714040474848572,-1.2167454433820724,0.2191780821917808,0.6890158661661687,1.0,6/14,9.42%,SLC39A14;SLC30A10;TRPC3;SLC39A8;TRPC6;TRPC4
prerank,establishment of melanosome localization (GO:0032401),0.5091437544494659,1.2165772630140639,0.24427480916030533,0.6681522228065572,1.0,4/19,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5317494699113984,-1.2164853763855488,0.22938144329896906,0.6876412250871463,1.0,4/10,22.90%,PIAS3;HDAC4;GNL3;PIAS4
prerank,regulation of stress fiber assembly (GO:0051492),-0.32322294884943353,-1.2162424642158989,0.12886597938144329,0.6861788872722532,1.0,15/74,7.14%,ARHGAP6;PHLDB2;LPAR1;ROCK2;ARHGAP28;ASAP3;TGFBR1;CCN2;ARHGEF10L;PPM1E;TPM1;ARAP1;ALMS1;PIK3R1;TMEFF2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3581046009149763,-1.2161120363710174,0.17110266159695817,0.6844407435426432,1.0,9/43,5.47%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;FBN2;RUNX2;IL6R
prerank,protein targeting to lysosome (GO:0006622),0.5198104650378859,1.2159458138927013,0.24042879019908117,0.6690839133606462,1.0,10/20,20.71%,GNPTAB;NCOA4;LAPTM5;CLU;VPS4A;NAGPA;AP3M1;ZFYVE16;LAMP2;SORL1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.437543853050988,-1.2154083218526803,0.21791044776119403,0.6844443087140031,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.555337817262,1.2149450928104495,0.2830820770519263,0.6710918905041671,1.0,2/12,5.92%,LMO2;BRD8
prerank,negative regulation of response to stimulus (GO:0048585),0.4289783332783619,1.2148364169237917,0.20859671302149177,0.670644041717111,1.0,16/60,11.83%,MCTP1;KLF7;AQP11;APOA1;KLF4;ACVR1;FCGR2B;KIF26A;CD34;AKT3;RBL1;PIM3;LPCAT3;PTPN1;MAP3K3;CLU
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4013939714144543,-1.214600448066008,0.19745222929936307,0.6846773363444414,1.0,2/25,1.58%,ANK2;CEMIP
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5050907502082449,-1.2145407086807454,0.22900763358778625,0.682739992257539,1.0,7/11,27.18%,P4HA1;EGLN3;P4HTM;P3H2;P4HB;P4HA3;OGFOD1
prerank,Golgi to plasma membrane transport (GO:0006893),0.44154508761459943,1.2143368941817498,0.21986754966887417,0.671276614975477,1.0,18/47,22.78%,EXOC6;MACF1;STXBP6;RAB34;GOPC;EXOC8;NSF;ANK3;SPTBN1;GOLPH3L;EXOC4;GOLPH3;EXOC2;STEAP2;RAB31;EXOC5;EXOC6B;OSBPL5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5285217033492938,1.2142064285946104,0.2492063492063492,0.6709122429128148,1.0,4/17,3.81%,GJA5;ATP1A1;ATP1A3;SLC8A1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.504200768389398,1.2140601993938396,0.2327718223583461,0.6705567228077145,1.0,10/25,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,autophagy of peroxisome (GO:0030242),0.577597046345639,1.212964270772523,0.26677852348993286,0.6728415520034876,1.0,4/12,13.96%,TRAPPC8;NBR1;PIK3C3;ATM
prerank,protein polyglutamylation (GO:0018095),0.5841808649992263,1.212697625458974,0.2571428571428571,0.6728359723527567,1.0,4/11,12.76%,TTLL7;TTLL1;TTLL5;TTLL11
prerank,cytoplasmic translation (GO:0002181),0.4060906683368917,1.212604032568673,0.18469015795868773,0.6723583229932352,1.0,44/91,28.17%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPS25;EIF3I;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;RPL22L1;EIF3M;ZC3H15;RPL18;RPL39;RPS19;RPL31;RPS8;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;EIF4A1;RPS13;RPL11;RPL14
prerank,midbody abscission (GO:0061952),0.529127332498962,1.212242020733934,0.22720247295208656,0.6725907877404047,1.0,11/17,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5316857179209133,1.2121184765499924,0.24437299035369775,0.6721920404015703,1.0,6/15,12.26%,TNRC6C;BTG2;TENT4A;POLR2G;CNOT1;TOB1
prerank,ephrin receptor signaling pathway (GO:0048013),0.4132597689786828,1.2116305883543543,0.19854721549636803,0.6728035261253741,1.0,18/82,11.20%,KALRN;EFNA5;ARHGEF28;FYN;CRK;AP2B1;EFNA1;GRIN2B;ARPC5;ACTG1;APH1A;YES1;ROCK1;PTK2;AP2M1;ANKS1B;RAC1;ACTB
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.40289039022966455,-1.2111156250922852,0.18849840255591055,0.690858789608427,1.0,11/26,22.20%,OGT;KMT5C;SETD1A;SETD1B;TET2;CTR9;KMT5B;SUV39H1;SETD4;ANTKMT;KMT2D
prerank,external encapsulating structure organization (GO:0045229),0.37988188980636856,1.210693560274615,0.12795698924731183,0.6746562609590616,1.0,27/205,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.42609725801748016,-1.2105944381577263,0.2699724517906336,0.690314101523983,1.0,6/21,6.74%,ERRFI1;ROCK2;BMP4;MAFG;RUNX1;SFRP4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.45745561206700897,1.2102018757012618,0.22913907284768212,0.6752761209073818,1.0,7/40,5.38%,JAG1;NOTCH1;TGFB2;WWTR1;LEF1;GCNT2;SMAD2
prerank,T cell homeostasis (GO:0043029),0.5977541594968031,1.2092722707901742,0.24196277495769883,0.6770549574489866,1.0,1/10,1.17%,FAS
prerank,positive regulation of nuclear division (GO:0051785),0.4976783676455364,1.2086661556787808,0.24962630792227206,0.6780234622818886,1.0,4/25,6.22%,EDN1;PDGFB;INSR;IL1A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5147366910093613,-1.2083425804859576,0.2413793103448276,0.6948893587498451,1.0,6/11,35.75%,AGTR1;AGT;PLA2G7;ABCG1;LIPC;PLA2G5
prerank,phosphate ion transmembrane transport (GO:0035435),0.5765745712947059,1.2083020581421056,0.2563237774030354,0.6783236891814197,1.0,5/12,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,positive regulation of developmental process (GO:0051094),-0.2783068195105662,-1.2082002250867296,0.06172839506172839,0.693173461301166,1.0,29/164,9.45%,PHLDB2;PTN;BMPR1A;SOX5;DCN;FOXD1;CCN2;BMP5;BMP7;BMP4;COBL;WNT5A;GRIP1;APOE;GJA1;ADGRL1;DLG4;LMNA;RREB1;PRKN;DDHD1;CAMK1;DAG1;SRC;KMT5C;SYDE1;CEBPB;VEGFA;ACVR1B
prerank,cellular response to interleukin-15 (GO:0071350),0.5616542462825924,1.208172668599914,0.2657580919931857,0.6771633475062294,1.0,1/13,0.84%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5616542462825924,1.208172668599914,0.2657580919931857,0.6771633475062294,1.0,1/13,0.84%,PLCB1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.48260859533155326,1.2080675923184427,0.24393939393939393,0.6767036650860636,1.0,11/28,16.16%,ECSCR;DAB2IP;PTK2;FBXW7;LAPTM5;CLU;SMURF1;PSMC3;PSMC5;PSMC6;RNF139
prerank,positive regulation of protein secretion (GO:0050714),0.4180145322935469,1.2080639545736929,0.21707317073170732,0.6759653059121274,1.0,9/69,6.22%,MYRIP;CD2AP;UNC13B;DOC2B;F2RL1;TGFB2;TMED10;GLUD1;IL1A
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.46538015226442864,-1.207977972969453,0.23652694610778444,0.6917137581634728,1.0,8/15,27.39%,SIRT3;SPHK1;PLA2G6;PRKCD;ORMDL2;SPHK2;SMPD3;TNFRSF1A
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4477180383922441,-1.2071529661928557,0.2185792349726776,0.6920249180697619,1.0,5/16,15.18%,ANK2;BCAP29;SEC16B;BCAP31;SEC16A
prerank,glycoprotein metabolic process (GO:0009100),0.43573175823983107,1.2067508016798811,0.20081411126187246,0.6787783884641376,1.0,14/53,19.35%,GCNT1;ST6GALNAC3;ST8SIA6;MANBA;PRKCSH;HIF1A;FBXO2;ST3GAL2;ENGASE;OGA;FBXO6;GOLPH3;NGLY1;NEU4
prerank,regulation of cellular catabolic process (GO:0031329),0.4168639603718085,1.2064206544290466,0.19741935483870968,0.6789204878849211,1.0,18/62,17.77%,ACER2;FBXL2;DRAM1;GPR137B;SMCR8;DEPP1;LRRK2;HSPB1;ROCK1;RRAGD;TPCN2;DRAM2;KEAP1;ATM;RMC1;LONP2;TRIB3;TYSND1
prerank,sodium ion transport (GO:0006814),-0.3228591516453653,-1.2061566600092466,0.12365591397849462,0.6929420806162871,1.0,14/85,7.04%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC12A2;SCN7A;SLC6A12;SLC8A3;ATP1B3;SLC9B2;SCN2A;SLC6A1;SLC5A5;SLC6A9
prerank,wound healing (GO:0042060),-0.3314138981033884,-1.205930288531447,0.17857142857142858,0.6915281202489801,1.0,17/62,11.79%,COL3A1;IGF1;PDGFRA;TGFBR1;FGF1;WNT5A;TPM1;AHNAK2;FGF2;SMAD3;FZD7;CFLAR;PRCP;RAF1;ERBB2;SYTL4;DCBLD2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.45089533843553187,-1.2056459782944853,0.24169184290030213,0.6902642899572499,1.0,3/18,7.80%,IGF1;IGFBP2;IGF2
prerank,response to amyloid-beta (GO:1904645),0.4420494962534477,1.2054820639741803,0.22902796271637815,0.6808146956974831,1.0,7/44,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,xenobiotic transport (GO:0042908),-0.4376760183207089,-1.2054489318064838,0.22128851540616246,0.6887802908523886,1.0,3/17,7.11%,SLC47A1;GJA1;SLC22A4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.55957041333205,1.2043566766436242,0.27099841521394613,0.683156088543877,1.0,5/13,11.83%,AQP11;FCGR2B;MBTPS2;LPCAT3;CLU
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4859561081043932,-1.2042337706309647,0.2371638141809291,0.6903428139363798,1.0,6/12,19.55%,SORBS1;IRS1;IGF2;PRKCZ;SNX5;ZBTB7B
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.31762490877226857,-1.2041672860734598,0.11518324607329843,0.688489162739363,1.0,10/78,3.14%,PID1;EGFR;LRP1;EPHA3;SORBS1;PTPN9;DAB2;MMP14;RHOQ;STX4
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5080289612455348,-1.2040976714432663,0.24266666666666667,0.6866893329820837,1.0,4/11,7.09%,ITGB5;KIT;CCN3;PLEKHA7
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5500097728397346,1.2033337201658239,0.2614173228346457,0.6852051813888469,1.0,2/14,10.12%,CCR1;TYROBP
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4517085577658327,1.2017951510807463,0.23355704697986576,0.6886871555742425,1.0,8/35,11.28%,TEK;F11R;ESAM;FES;ARHGDIA;STAP1;TJP1;TRPM2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3886347351486922,1.2017537317007014,0.17780294450736125,0.6880386453370981,1.0,24/128,9.22%,ENG;CLDN5;SMAD6;BMPR2;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;TMEM100;ACVR1;GCNT2;NLK;SMAD2;FURIN;PDCD4;UBA52;RPS27A;JUN;PTK2
prerank,rRNA processing (GO:0006364),0.38227101459570834,1.201662823912415,0.17448200654307525,0.6875391235519952,1.0,73/172,26.85%,BOP1;PELP1;RPL27;DHX37;RPL7;EXOSC3;NVL;UBA52;RPS14;MRPL1;MRM2;RPL35;WDR46;RPL21;DKC1;RRP15;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;NHP2;RPL30;RPL27A;NOL8;RIOK3;SART1;RPL23A;RPS15;EIF6;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1;ERI1
prerank,negative regulation of blood coagulation (GO:0030195),0.46032592186132554,1.2011433178071298,0.24151967435549526,0.6881908494129051,1.0,3/38,0.88%,NOS3;EDN1;PDGFB
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3945852305869406,-1.2011283363381864,0.18731117824773413,0.6934938810922988,1.0,8/28,9.75%,PID1;APPL2;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,extracellular structure organization (GO:0043062),0.3761781700380628,1.2009441168502721,0.13993541442411195,0.6879889604800474,1.0,27/204,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4297222801898874,-1.2009321108671922,0.19373219373219372,0.6920591275836968,1.0,4/18,5.47%,PTN;CAMK1D;SLIT2;IL6R
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3918319680268158,1.2006856153755774,0.19096045197740114,0.6879635579983672,1.0,35/124,18.86%,CCDC88C;FZD6;PLCB1;TNRC6C;AP2B1;PSMD13;LEF1;NLK;PSMD4;PPP3CA;PSMA5;AP2M1;PSMB10;AGO4;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;FZD9;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,protein localization to centrosome (GO:0071539),0.5331198660636112,1.1996178639574533,0.26614173228346455,0.6901797447405803,1.0,8/17,20.15%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83;NUDCD3;CEP192
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5632101073560213,1.1994903187256172,0.26570048309178745,0.6890048878392656,1.0,7/11,23.98%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5632101073560213,1.1994903187256172,0.26570048309178745,0.6890048878392656,1.0,7/11,23.98%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,cellular protein-containing complex assembly (GO:0034622),0.3807397412501282,1.199198543095234,0.16703786191536749,0.6890783255178523,1.0,41/160,20.36%,HIP1;HIP1R;STXBP6;PIK3C2A;ADRB2;FKBP1A;PSMD13;FCHO2;ANGPT1;DNAAF3;OMA1;SMAD2;PSMD4;PFDN6;VBP1;VAMP8;IMMP2L;TTC12;CASQ1;NSG2;RTN4;DHX9;AP2M1;PTGES3;CYBA;CCT2;CLU;NUP153;CHMP3;CSNK2B;SAMM50;NUP205;NCK1;SMAD4;SRP19;SHQ1;PSMG2;NSG1;HOPX;DNAJC28;EPS15
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4421021080312198,-1.1991962184879306,0.24250681198910082,0.69513808556807,1.0,6/17,20.44%,FGFR2;NPR3;PLXNB1;ATRAID;CCN1;MN1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.47786495367841925,1.198908017611788,0.23623188405797102,0.6891227918421431,1.0,7/32,12.11%,CDK17;CDK14;CCNE1;KLF11;POLA1;E2F7;HINFP
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4034610044720401,1.1985802131219925,0.21479713603818615,0.6892568206800876,1.0,5/88,2.84%,NANOS1;NANOS3;EDN1;DAB2IP;BTG2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.35236926882557507,-1.1982576858062555,0.21071428571428572,0.695813215166493,1.0,10/41,13.71%,UBE2E2;PRKN;UBE2V2;TRAF3IP2;UBE2N;RNF135;RNF4;RNF152;BFAR;ARIH2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42956197866499946,-1.1980734361260676,0.2452316076294278,0.6942716395251965,1.0,11/19,25.45%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,response to estradiol (GO:0032355),-0.389508246171693,-1.1979178923546152,0.1909722222222222,0.6927418335764344,1.0,8/31,17.02%,EGFR;LCOR;ANXA1;CCDC62;GGT5;GGT7;SOCS2;GPER1
prerank,muscle contraction (GO:0006936),0.39236153949627495,1.197615972705217,0.182648401826484,0.6910900208360552,1.0,18/126,12.98%,NOS1;UTRN;MYBPC3;ITGA1;DYSF;MYLK;VIM;SLC8A1;MYL6;MYL12B;ROCK1;CLCN1;MYOF;TPCN2;TPM4;SORBS3;GAMT;TMOD3
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4317500428272485,-1.1974892320724437,0.2558139534883721,0.6920241824053582,1.0,11/18,25.45%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,negative regulation of protein modification process (GO:0031400),-0.31482489118997165,-1.197324856141301,0.16847826086956522,0.6905125056241292,1.0,15/79,8.57%,PID1;PTPN13;NTRK3;DMD;PLPP3;FBLN1;SNTA1;SLIT2;PRKAA2;PRKN;NIBAN1;XDH;IGFBP3;P3H1;XRCC1
prerank,hepaticobiliary system development (GO:0061008),-0.4251447737148495,-1.1971826095927844,0.22282608695652173,0.6889399723006346,1.0,4/20,5.01%,TGFBR3;WNT4;COBL;NIPBL
prerank,cellular response to interleukin-12 (GO:0071349),0.43458759748373904,1.1967991395218232,0.2285336856010568,0.6926165988715406,1.0,12/48,15.69%,PLCB1;GSTA2;MSN;PDCD4;CD47;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.39153970244245057,1.196635293086312,0.18099547511312217,0.692348102509599,1.0,37/114,20.68%,AIM2;ACTN4;TNFRSF18;PSMD13;TNFRSF25;TRAF1;TNFRSF1B;COMMD7;ADAM17;PSMD4;STAT1;JAK2;LTB;PSMA5;PSMB10;NFKBIA;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;TNFRSF11A;PSMB2;BAG4
prerank,T cell migration (GO:0072678),0.5458018561146514,1.1965686676322351,0.28664495114006516,0.6917991537167922,1.0,2/13,4.24%,S1PR1;MSN
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4399561277053743,-1.1963962290778412,0.2519280205655527,0.6892661007444211,1.0,11/17,25.45%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4688374427297134,1.1960404811547793,0.2503382949932341,0.6924822070500454,1.0,4/28,10.12%,NOD2;SH3KBP1;CD47;TYROBP
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4770265462784449,1.1959241235770652,0.25139664804469275,0.6920376753680761,1.0,6/30,7.74%,ARHGEF3;F11R;F2RL1;APOA1;LPAR6;ARRB1
prerank,regulation of actin filament depolymerization (GO:0030834),0.567538593671373,1.1958694830236554,0.27692307692307694,0.6914425098821168,1.0,3/12,7.47%,LIMA1;F2RL1;WDR1
prerank,determination of bilateral symmetry (GO:0009855),0.4982930588357135,1.1958180789721635,0.2653958944281525,0.690838755233524,1.0,3/25,5.57%,TBX1;NOTCH1;BBS7
prerank,positive regulation of defense response (GO:0031349),0.4058209650673483,1.1955796000281393,0.1992797118847539,0.6907328601225301,1.0,18/89,13.70%,GBP5;APP;TLR3;MEF2C;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3
prerank,positive regulation of actin nucleation (GO:0051127),0.5570757710863324,1.1952687857626032,0.28401360544217685,0.6908286673357613,1.0,5/11,12.12%,FCHSD2;WHAMM;NCKAP1;CYFIP1;WASF2
prerank,negative regulation of protein secretion (GO:0050709),-0.35194452635019724,-1.1948395309484832,0.16483516483516483,0.6918038226049046,1.0,15/38,22.90%,APOE;PRKN;CCN3;IRS1;RAB11FIP1;REST;ADRA2A;DRD2;SERGEF;KCNB1;NR1H3;RHBDF1;CYP51A1;ERP29;INHBB
prerank,positive regulation of T cell differentiation (GO:0045582),-0.37101658519815794,-1.1946642148343336,0.19402985074626866,0.6903017749610412,1.0,8/36,13.03%,GLI3;GLI2;ZMIZ1;BCL6;DUSP10;NCKAP1L;MDK;PNP
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.413423659329245,1.1945922885397209,0.2115621156211562,0.6918780500587687,1.0,9/72,11.55%,ACER2;PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.46541159371623453,1.1940986795501267,0.23975720789074356,0.6925318342653574,1.0,10/29,18.99%,LSM1;EXOSC3;DCPS;DCP1B;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.496478981727645,1.1940162826680942,0.2594752186588921,0.6920163776150853,1.0,3/23,5.32%,EDN1;PIEZO1;MEF2C
prerank,positive regulation of locomotion (GO:0040017),0.48568711533715014,1.1937341353547049,0.2630057803468208,0.6920874990481912,1.0,5/27,4.01%,PDGFB;F2RL1;PPM1F;SPOCK2;NTN1
prerank,connective tissue development (GO:0061448),-0.3635838141194388,-1.1932580888538562,0.17857142857142858,0.692505714037795,1.0,7/35,5.82%,SOX5;SULF1;SULF2;TRIP11;SH3PXD2B;ITGB8;SLC39A13
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.41257218560771747,1.1928465360943052,0.2190132370637786,0.6938117100069344,1.0,8/70,5.32%,TEK;NTN4;PARVB;ATRNL1;SIPA1L3;LAMA5;EFNA1;MEF2C
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.33382453455915523,-1.192770816665699,0.14728682170542637,0.6921568839978999,1.0,11/52,9.69%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;STX4;PIK3R1;CLIP3;PRKCI;STX3;CNST
prerank,regulation of protein binding (GO:0043393),0.3932703479872311,1.192403649027523,0.20713463751438435,0.6943017817082844,1.0,27/114,15.64%,RAPGEF2;CLDN5;PDGFB;HIP1R;B2M;CAV1;FKBP1A;APP;CRK;EPB41;LRRK2;NVL;CTNNBIP1;ROCK1;MARK3;ACTB;TMBIM6;DTX3L;MARK2;TTBK1;ITGB1BP1;PIN1;LDLRAP1;RAN;NES;RACK1;SLPI
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5385160587495043,1.1922766342472237,0.27586206896551724,0.6939333501921378,1.0,3/15,5.63%,APOA1;LCAT;PLTP
prerank,protein modification process (GO:0036211),0.40957701016748527,1.1920197862202073,0.22441430332922319,0.6939489228268167,1.0,17/76,14.78%,ST3GAL6;FBXL2;DUSP12;UBA7;MANBA;STK38;CHRM3;UBA52;YES1;CSNK1G3;FBXW2;LIPT1;NAGPA;ST3GAL1;FBXO2;MSRA;UBE2D3
prerank,dopamine metabolic process (GO:0042417),0.5156578835360888,1.1915911474690228,0.2704791344667697,0.6944210106194024,1.0,4/18,4.43%,TGFB2;GCH1;ATP7A;MAOA
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.43620358554455535,1.1914181481230453,0.2167741935483871,0.6941760421905085,1.0,16/54,17.56%,CASP8;F2RL1;SPATA2;SPPL2A;APOA1;TRAF1;ADAM17;MADD;HSPA1B;CASP1;LAPTM5;RACK1;TRAIP;PYCARD;PTPN2;PYDC1
prerank,smoothened signaling pathway (GO:0007224),-0.38276519691920186,-1.1913685066040156,0.21739130434782608,0.6942610166280117,1.0,9/32,15.04%,GLI3;GLI2;CC2D2A;SMO;GLI1;PTCH1;TMEM231;TCTN2;IFT27
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3569925931755152,1.19130620708455,0.037,0.6937465525623737,1.0,128/834,13.29%,NOS1;LMO7;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;TGFB2;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;PELP1;HEY2;TLR3;KLF4;PLXND1;IER5;ACVR1;WWTR1;LEF1;BCLAF3;MAFF;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;ZC3H12A;PPP3CA;STAT1;GAL;AATF;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;NR1D1;JUN;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;RPS6KA1;RPRD1B;NFKBIA;TET3;TNKS;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;HELZ2;PRKD2;HINFP;MED30;GCN1;IRF5;SETD3;CTBP2;GLYR1;RPS6KA3;PSMC3;ITGB1BP1;PIN1;POU3F2;APLN;PHIP
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5482658299802274,1.1911872876392857,0.26978998384491115,0.693313653821433,1.0,7/13,27.40%,STAT1;OAS2;JAK2;IL27RA;OASL;CANX;JAK1
prerank,dendritic spine morphogenesis (GO:0060997),-0.4676303064542287,-1.1909876610486225,0.26854219948849106,0.6932354450317636,1.0,6/15,19.32%,DOCK10;DLG4;CTNND2;EPHB2;EPHB3;PAK3
prerank,regulation of phospholipase C activity (GO:1900274),-0.46556017191825394,-1.190767792690866,0.25280898876404495,0.6919218843219522,1.0,5/15,5.55%,NTRK3;PDGFRB;PDGFRA;KIT;FGF2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3863347446833684,-1.1906201441000113,0.21333333333333335,0.6903987092455346,1.0,5/27,3.24%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6
prerank,regulation of epithelial cell proliferation (GO:0050678),0.39852031058184983,1.1903291115312113,0.22011834319526627,0.6949452187592622,1.0,11/85,4.45%,SGPP2;TIE1;TBX1;ACVRL1;NOD2;B2M;DAB2IP;AQP11;PRKD1;TGFB2;ANGPT1
prerank,response to axon injury (GO:0048678),-0.42667378927453903,-1.1903201040520592,0.2303206997084548,0.6893141347267265,1.0,5/18,12.77%,DPYSL3;APOD;P2RX4;GAP43;NREP
prerank,response to peptide (GO:1901652),0.46187703126990576,1.1900826983803692,0.2370266479663394,0.694895974908237,1.0,11/33,20.02%,FYN;NOD2;CACNA1A;STAT1;EIF2B2;PRNP;IRF5;KAT7;ERBIN;AGER;STAT5A
prerank,RNA destabilization (GO:0050779),-0.4324597869259469,-1.1898586676980232,0.2694610778443114,0.6887507980077064,1.0,7/18,16.76%,ROCK2;YTHDF1;FTO;PUM1;LIN28B;YTHDF2;GIGYF2
prerank,dendritic cell migration (GO:0036336),0.5291756556189592,1.1893550347834436,0.25471698113207547,0.6960956938451108,1.0,4/16,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,central nervous system myelination (GO:0022010),0.5638737714453756,1.1892714231898076,0.2627986348122867,0.6955835638935385,1.0,4/11,12.09%,B4GALT6;TENM4;CLU;SOX10
prerank,Golgi to endosome transport (GO:0006895),0.5282092702929199,1.189220745937276,0.2736,0.6950187565665829,1.0,6/16,20.36%,DOP1B;KLHL20;KIF16B;MON2;SORT1;EPS15
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.41265951651252997,1.1886812701237979,0.22832722832722832,0.6956237763887666,1.0,25/67,18.86%,B2M;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5176217767984679,1.1884359493049041,0.26506024096385544,0.6955300835586383,1.0,7/18,20.34%,HIP1R;TMEM14A;FZD9;GSK3A;BID;GSK3B;ACAA2
prerank,negative regulation of lipid storage (GO:0010888),-0.4280533426596608,-1.1882906874448966,0.23209169054441262,0.6913537544965717,1.0,6/19,15.79%,ABCA1;ITGAV;PPARA;OSBPL8;PPARG;NR1H3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.564066448052712,1.1882406902910012,0.2878535773710483,0.6953304762777982,1.0,2/12,2.98%,JAM2;APP
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5142225062236068,-1.1881604801356267,0.2780487804878049,0.6897712954329481,1.0,3/10,9.20%,EMC2;EMC7;EMC1
prerank,regulation of cell cycle (GO:0051726),0.3648925447579422,1.187942418011363,0.14479166666666668,0.6953711293774518,1.0,32/271,9.52%,MECOM;NANOS3;AFAP1L2;IRF6;GATA6;APBB2;FOXO4;NOTCH1;DUSP1;ADARB1;DAB2IP;TTC28;TGFB2;RHOB;IQGAP1;BOP1;RPRM;PPP1R13B;GMNC;ASAH2;GATA3;PDCD4;MADD;UHMK1;WHAMM;GADD45G;APC;PIM3;NEK7;JUN;ADAM10;MLF1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4891712103659135,1.187755589808511,0.2697466467958271,0.6951250486200572,1.0,9/22,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5643905531907065,1.1872799741456654,0.2684563758389262,0.695678691680975,1.0,2/11,7.01%,SMAD7;ZC3H12A
prerank,phosphate ion transport (GO:0006817),0.5348715371537561,1.1869073485622457,0.2779552715654952,0.6959995590595044,1.0,5/16,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.48946663348602115,1.1866673053891705,0.25709779179810727,0.6959380483676838,1.0,7/21,16.66%,FYN;AIM2;GRIN2B;DELE1;TTBK1;PSMB9;PYCARD
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.29533687765103317,-1.1865875838325117,0.1,0.6924559739127146,1.0,33/117,19.81%,IGF1;ALDH1A2;PCCA;ABAT;CYP26B1;PPARA;CPT1C;ME1;GNPAT;ACOT11;ALDH4A1;AASDH;MCCC2;NAAA;SCP2;GGT5;PPARG;CKB;LDHB;ECHDC3;THEM4;GBA2;AMACR;PDHA1;PDHX;HLCS;ACOT6;DLAT;HACL1;ACSF2;LPL;PANK2;ALOX12
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.46379796157398223,1.1858414001037607,0.2514705882352941,0.6975243663111808,1.0,5/34,6.22%,EDN1;PDGFB;INSR;CUL3;IL1A
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4386291316802976,-1.1855140776951267,0.24788732394366197,0.6936747180242666,1.0,4/16,6.64%,APPL2;APOD;PPARA;ADCY7
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4564251988159673,1.1854997856230431,0.25107604017216645,0.6976890773172904,1.0,10/33,14.00%,CEACAM1;KLF2;CEMIP2;KLF4;PPP1R16B;JMJD8;TJP1;EPN2;PIK3CB;ITGA5
prerank,positive regulation of organelle organization (GO:0010638),0.46022622489726617,1.1853647925032404,0.25501432664756446,0.6973007546840635,1.0,10/32,12.53%,DOC2B;ADRB2;SMCR8;P2RX7;IRGM;FYCO1;RAB3GAP2;PFDN2;TMED9;SORBS3
prerank,BMP signaling pathway (GO:0030509),0.41664008318271933,1.1852757048344733,0.24585987261146497,0.6968410453669309,1.0,10/62,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5120557859445092,-1.1832655228354767,0.24881516587677724,0.6981161309293096,1.0,1/10,0.03%,ATP1A2
prerank,negative regulation of cytokine production (GO:0001818),0.3748235808457967,1.1832328170122197,0.18259935553168635,0.7016844443163315,1.0,30/163,11.23%,CEACAM1;RPS6KA5;F2RL1;IFIH1;LGALS9;HOMER2;HDAC9;HDAC7;UBA7;APOA1;KLF4;FCGR2B;LEF1;CD34;RNF125;PDCD4;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;HMGB1;PRNP;TRIM25;TYROBP;RAC1;VSIR;LAPTM5
prerank,peptide metabolic process (GO:0006518),-0.3097443318575253,-1.183218849344818,0.14450867052023122,0.6963573980887032,1.0,20/75,14.80%,AEBP1;CPQ;DMD;BACE2;ANPEP;GSTT1;MGAT3;CPE;BACE1;HM13;CARNMT1;CPXM2;GSTZ1;CPXM1;ENPEP;ETHE1;SPCS3;CLN5;GSTA3;GSTM1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.35765853449663765,-1.1830386401834199,0.2007168458781362,0.6949548681851353,1.0,12/33,20.79%,IGFBP5;OGN;APOD;TPM1;IGFBP3;EFEMP2;PPARG;CDKN1A;GPER1;NDRG4;TGFB3;TNFAIP3
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3954214914752298,-1.1825434244942958,0.22740524781341107,0.6945097954441325,1.0,4/24,1.40%,SOX5;ADAMTS12;EFEMP1;TGFBR1
prerank,regulation of mitotic nuclear division (GO:0007088),0.4250862915916742,1.182442713250129,0.25857519788918204,0.7031198046632634,1.0,8/55,7.99%,EDN1;PDGFB;INSR;DUSP1;CAV2;CDC25C;IL1A;TOM1L1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5489948815563188,1.1821345323202297,0.2906574394463668,0.7032301929108525,1.0,1/12,1.73%,NOD2
prerank,apoptotic process (GO:0006915),0.3703785349356223,1.1820646740451128,0.17019027484143764,0.70271441352166,1.0,37/203,11.32%,HIP1;EFNA5;ELMO1;FAS;TBX1;PLK3;PAEP;FOXO1;CASP8;RHOB;APP;ADAM15;CASP2;TNFRSF25;BRAT1;DDX41;IAPP;DAP;IL1A;PDCD4;BBC3;ZBTB16;CIDEB;PLSCR1;BCL2L1;JAK2;RFK;NCKAP1;MAL;GAPDH;TAOK2;RTN4;PRUNE2;CASP1;NFKBIA;BAG6;DCC
prerank,positive regulation of dendrite extension (GO:1903861),0.5099537570987596,1.1820202446372023,0.28314238952536824,0.7020740165543069,1.0,6/17,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4566543866040202,1.181602395737132,0.26628895184135976,0.7024879696609049,1.0,10/32,21.23%,DEFA6;GALP;GAPDH;RPL30;RNASE6;FAM3A;CXCL10;ANG;RPL39;RPS19
prerank,regulation of ERAD pathway (GO:1904292),0.5576566841239762,1.1815276842901654,0.30718954248366015,0.7019756218350173,1.0,3/11,11.00%,AQP11;RNF185;BAG6
prerank,neutrophil degranulation (GO:0043312),0.3568455498332374,1.181282359904877,0.10264227642276423,0.7018739305851381,1.0,59/425,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4482364845280799,1.1810045358043368,0.24864864864864866,0.7019123459782891,1.0,9/37,12.15%,STMN2;EFNA5;FAM107A;CLASP1;MAPRE3;PRKAA1;ROCK1;CLASP2;MARK2
prerank,regulation of urine volume (GO:0035809),0.5824982347913068,1.1808992629605932,0.2879045996592845,0.701469433810848,1.0,3/10,6.82%,INPP5K;HYAL2;NPR1
prerank,response to thyroid hormone (GO:0097066),0.5388193636316064,1.1803564606414114,0.28716216216216217,0.702227214237108,1.0,2/13,5.92%,LMO2;BRD8
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4023158542329667,-1.1802139683026125,0.23303834808259588,0.6997477474788326,1.0,9/24,21.24%,ERRFI1;ROCK2;RUNX1;SRSF6;HOXA7;CTSL;ZFP36;NME2;ETV4
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3869394843934284,-1.179616801847477,0.22658610271903323,0.6996463061626198,1.0,7/25,8.24%,ARHGAP6;PHLDB2;ROCK2;APOD;THBS1;SRC;BCAS3
prerank,regulation of dendrite extension (GO:1903859),0.5036666388394218,1.1793283842790732,0.28032786885245903,0.7043319143135734,1.0,6/18,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5174529241608121,1.179293515307435,0.26380368098159507,0.7036940876670684,1.0,2/17,2.63%,RAPGEF2;ADRB2
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4118020087960769,-1.1791479403440162,0.2420749279538905,0.699116248908664,1.0,3/20,2.40%,FMNL2;ROCK2;RHOQ
prerank,regulation of T cell mediated immunity (GO:0002709),0.5638154908549797,1.178730903145626,0.2996389891696751,0.7045330379867091,1.0,3/10,19.95%,TNFRSF1B;HMGB1;AGER
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5180295176205995,1.1783692730083473,0.25370675453047775,0.7047859101065969,1.0,3/17,9.11%,TEK;FES;STAP1
prerank,regulation of filopodium assembly (GO:0051489),-0.3670727269612129,-1.1783105600363,0.22044728434504793,0.6995572895699519,1.0,11/38,13.24%,DPYSL3;DOCK11;RHOQ;FXR2;ARAP1;RIPOR2;PIK3R1;BCAS3;CAPZB;GAP43;PALM
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.373923033780444,1.177896252476285,0.2,0.705321260088661,1.0,38/161,16.05%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;PSMC6;LZTS2
prerank,neutrophil activation involved in immune response (GO:0002283),0.3558700684645942,1.1774988200852485,0.1079429735234216,0.7056823383836921,1.0,59/428,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,protein-containing complex subunit organization (GO:0043933),0.3849618702611074,1.177325720081411,0.2149425287356322,0.7054028077871397,1.0,21/109,15.93%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;CARD10;TRAF1;CD247;IL1RAP;APC;NUP54;NUP35;RANBP9;TAPBP;CAPG;PPIH;KPNA3;CLDN14;VIL1;NUP205
prerank,amide transport (GO:0042886),0.466140548575215,1.176914078869564,0.25339366515837103,0.7058255254036365,1.0,6/26,9.87%,AQP11;SLC25A32;PLTP;GLTP;CERT1;TAP1
prerank,activation of GTPase activity (GO:0090630),0.396027194427446,1.1768143236524151,0.20665083135391923,0.7053956217923354,1.0,25/89,13.86%,RABGAP1;SIPA1L2;ARHGEF15;ABR;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;TBC1D8;TIAM2;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;TBC1D1;RAP1GAP2;TAX1BP3;RALGAPB;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,negative regulation of T cell proliferation (GO:0042130),0.4747361846419865,1.176458806791314,0.25925925925925924,0.7055972283885241,1.0,4/28,9.97%,CRTAM;LGALS9;ARG1;PRNP
prerank,negative regulation of viral process (GO:0048525),0.4269151785994523,1.1764342710198021,0.25487646293888166,0.7049411444585293,1.0,18/57,21.71%,TRIM14;IFIH1;TRIM11;TRIM6;STAT1;PLSCR1;OAS2;TRIM8;CHMP3;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;MID2;EIF2AK2;BANF1;HEXIM1
prerank,cellular response to leucine (GO:0071233),-0.5092289037284584,-1.1764121042245619,0.26811594202898553,0.7012654964912034,1.0,3/10,10.40%,KLHL22;SESN1;SESN2
prerank,response to leucine (GO:0043201),-0.5092289037284584,-1.1764121042245619,0.26811594202898553,0.7012654964912034,1.0,3/10,10.40%,KLHL22;SESN1;SESN2
prerank,protein localization to membrane (GO:0072657),0.3662417746392462,1.1761113656845728,0.18991416309012876,0.7050909630688925,1.0,31/187,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;AGRN;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;SHANK3;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;NUP54;RAB40B;CLASP2;NKD2;TM9SF1;PDZD11
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5328068509569551,1.1760228950773617,0.27860696517412936,0.7046034902761144,1.0,5/13,12.26%,TNRC6C;BTG2;POLR2G;CNOT1;TOB1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4343912112653415,1.1758417507194439,0.257516339869281,0.7043891356275755,1.0,13/48,13.11%,EDN1;AZIN1;IAPP;PFDN6;VBP1;ROCK1;MAD2L2;PRNP;PRKCG;ADGRB1;PFDN2;CLU;PIN1
prerank,protein stabilization (GO:0050821),0.3748579932530957,1.1758042428499993,0.19037199124726478,0.7037803672356494,1.0,30/168,13.44%,SOX17;HIP1;MSX1;SMAD7;HIP1R;GNAQ;TMEM88;SAXO1;APOA1;EFNA1;NLK;TAF9B;IRGM;HSPA1B;DNLZ;CCT8;STX12;GAPDH;RTN4;FBXW7;TYROBP;PTGES3;GET1;BAG6;CCT2;SUGT1;CLU;CCT4;PIN1;HYPK
prerank,central nervous system neuron development (GO:0021954),0.5284579630755246,1.175573564116321,0.2717219589257504,0.7036643493445829,1.0,3/15,9.87%,RAPGEF2;ATP7A;B4GALT6
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4674611092746144,-1.1753308817897972,0.24936386768447838,0.7024738682923752,1.0,3/13,4.84%,ROCK2;ASAP3;ALMS1
prerank,negative regulation of neurogenesis (GO:0050768),0.44538523401944174,1.175257594597594,0.25,0.7038600919387419,1.0,6/34,9.49%,RAPGEF2;NOTCH1;B2M;ARHGDIA;PCM1;RTN4
prerank,cellular response to chemokine (GO:1990869),0.43697707779648154,1.1740835257779876,0.25065963060686014,0.7062946949341611,1.0,7/46,10.16%,CCR1;DUSP1;OXSR1;LRCH1;ZC3H12A;STK39;CCL4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.41154290026351226,-1.1737357246661972,0.24431818181818182,0.7051267945155159,1.0,9/20,20.51%,LDB1;MEIS1;PAF1;HOXA5;CTR9;MAFB;HOXB8;ZFP36;CIB1
prerank,cellular response to interleukin-4 (GO:0071353),0.562030846048604,1.1737205986572874,0.30782029950083195,0.7065882585279764,1.0,2/10,6.03%,LEF1;GATA3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5404462375151192,1.1735699188320394,0.2920634920634921,0.7063145770497083,1.0,5/12,11.83%,IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3869668307363007,1.1735372543520979,0.21753986332574032,0.7056798180198334,1.0,25/107,20.26%,RASGRF2;ATP2A3;DAB2IP;RHBDD1;RNF185;UFM1;BBC3;MBTPS2;HSP90B1;JUN;BAG6;TMX1;PPP1R15B;EIF2S1;RNF139;UBXN6;NCK1;SEL1L;TRIB3;CCDC47;SELENOK;DNAJC10;ERN1;RNF5;GSK3B
prerank,positive regulation of chemokine production (GO:0032722),0.43692330584374084,1.1730252207983847,0.24592391304347827,0.7063169312509663,1.0,8/44,9.50%,F2RL1;LGALS9;APP;TLR3;TIRAP;ADAM17;EGR1;HMGB1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4602516256537916,1.1729607425573705,0.2728592162554427,0.7057675257115689,1.0,5/33,9.01%,CCR1;CASP8;FES;LEF1;CTNNBIP1
prerank,myelination in peripheral nervous system (GO:0022011),-0.4677518649131068,-1.1724631419413314,0.24739583333333334,0.7069724734832364,1.0,6/13,19.92%,ADGRG6;DICER1;PARD3;LGI4;SIRT2;NF1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5236592183240361,1.1723831887249174,0.30495356037151705,0.7066152848692634,1.0,7/18,13.22%,FLT1;MEF2C;ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4448116808020478,1.1722932983358172,0.27310924369747897,0.7061321723100671,1.0,13/40,20.93%,GBP4;TIRAP;DEFA6;ADAM17;GBP2;CHGA;RNASE6;HMGB2;DROSHA;STAB2;GBP7;ANG;RPL39
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3981628497368638,1.171894128633951,0.23785803237858033,0.706475961798925,1.0,9/79,3.31%,MMRN2;SMAD6;BMPR2;SMAD7;NOTCH1;ATP2B4;DAND5;DAB2IP;HHEX
prerank,positive regulation of secretion by cell (GO:1903532),0.40611966679528994,1.1716711825269883,0.24167694204685575,0.7064024258657925,1.0,20/70,19.57%,EDN1;CD2AP;CADPS2;UNC13B;TGFB2;TMED10;IL1A;CLASP1;CLASP2;CADPS;ACHE;RAB27B;STXBP5;GOLPH3L;RAB27A;GOLPH3;PPID;SOX11;MYO18A;ANG
prerank,polyamine metabolic process (GO:0006595),0.5300760729129907,1.1711937013126423,0.2912621359223301,0.7069890649067033,1.0,3/13,11.17%,AMD1;PAOX;SMS
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5639572380665083,1.171127778674719,0.3137254901960784,0.7057449251794539,1.0,2/10,3.83%,APOA1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5639572380665083,1.171127778674719,0.3137254901960784,0.7057449251794539,1.0,2/10,3.83%,APOA1;KLF4
prerank,chromatin disassembly (GO:0031498),-0.4585833819575405,-1.1710779195276142,0.2542372881355932,0.7070076081566257,1.0,3/14,10.18%,SET;SMARCB1;SMARCD1
prerank,nucleosome disassembly (GO:0006337),-0.4585833819575405,-1.1710779195276142,0.2542372881355932,0.7070076081566257,1.0,3/14,10.18%,SET;SMARCB1;SMARCD1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4293247294235337,1.1705449671388417,0.25033288948069243,0.7065735388900936,1.0,4/48,4.95%,NOS1;FKBP1A;DIAPH1;CAMK2D
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.46687272690083914,-1.1698387715447922,0.28720626631853785,0.7085526617937905,1.0,7/12,28.07%,GMDS;EXTL2;GFPT1;GFPT2;PARG;CSGALNACT1;GALT
prerank,protein secretion (GO:0009306),-0.329315077970377,-1.169766036286594,0.1735159817351598,0.7068767638580151,1.0,22/56,26.67%,WLS;STEAP3;ABCA1;TANGO2;ANXA1;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;MON1A;PDIA4;PREB;PORCN;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3;ADCYAP1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.47801541390726965,1.1694785509835648,0.2712842712842713,0.7088158514973069,1.0,7/24,16.38%,TTLL8;TTLL7;TTLL1;TTLL10;TTLL5;TTLL11;VKORC1
prerank,positive regulation of dendrite development (GO:1900006),-0.5080531878703461,-1.1691579145403763,0.2773892773892774,0.7067724709474893,1.0,4/10,2.62%,PTN;BMP5;BMP7;COBL
prerank,regulation of protein kinase B signaling (GO:0051896),0.3678065184170904,1.1687330748760203,0.17690677966101695,0.7102183064600267,1.0,22/193,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;INPP5K;RRAS;ANGPT1;GCNT2;HYAL2;FGFR3;PLEKHA1;IAPP;GATA3;MFHAS1;THPO;PPP2R5C;PTK2;RTN4
prerank,regulation of innate immune response (GO:0045088),0.41526465230364773,1.1686748755310108,0.25287356321839083,0.7096700268463825,1.0,12/57,10.63%,GBP5;CASP8;TIRAP;FCGR2B;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;CACTIN;DHX9;PTPN1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4518801315211558,-1.1678742728372944,0.2868020304568528,0.7086075747349054,1.0,5/14,16.51%,IRS2;IRS1;GPLD1;SLC45A3;NNMT
prerank,mammary gland epithelium development (GO:0061180),0.5083782222602293,1.1677092012759076,0.286634460547504,0.7116786608609926,1.0,2/14,8.22%,IRF6;JAK2
prerank,carbohydrate biosynthetic process (GO:0016051),0.4806944190800998,1.1676387308428748,0.29339477726574503,0.7111603784818301,1.0,2/21,1.70%,ST8SIA6;ST3GAL6
prerank,cell part morphogenesis (GO:0032990),-0.46340393128934443,-1.1672155853870354,0.25839793281653745,0.7086383264242411,1.0,2/13,3.16%,PID1;WASF1
prerank,proteoglycan metabolic process (GO:0006029),-0.3887927732700332,-1.1672094988670842,0.24188790560471976,0.7068007018506679,1.0,5/26,5.21%,IGF1;ADAMTS12;SULF1;SULF2;XYLT1
prerank,cellular response to metal ion (GO:0071248),0.378622693464303,1.1667500710579322,0.223121387283237,0.7128086692996635,1.0,19/123,9.97%,PLCG2;SYT15;ITPKB;B2M;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;MAPK1;CPNE2;LRRK2;MCOLN1;MT2A;PRKAA1;JUN;PRNP
prerank,excitatory postsynaptic potential (GO:0060079),0.49852985861663474,1.1666778202123014,0.30612244897959184,0.7122852440210913,1.0,8/19,20.26%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.28521716200715175,-1.1662630963339709,0.14285714285714285,0.7077035506414621,1.0,21/129,7.92%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;GPC3;PTK7;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;PPM1A
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49493643178744096,-1.1659474582017002,0.2967289719626168,0.7068284744384222,1.0,4/10,15.58%,BMP5;SLIT2;HOXA7;CD300A
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.38826473008165374,-1.1656940266410023,0.23255813953488372,0.7057427935171952,1.0,7/25,12.09%,EGFR;THBS1;SRC;FZD7;SDCBP;PTH1R;NCKAP1L
prerank,response to interferon-beta (GO:0035456),0.48882042020918137,1.1654133747930355,0.2936746987951807,0.7151318441180684,1.0,6/22,8.74%,AIM2;TRIM6;IRGM;STAT1;PLSCR1;ACOD1
prerank,response to tumor necrosis factor (GO:0034612),0.38861803608438444,1.1652620050849642,0.23289315726290516,0.7148188268089609,1.0,21/91,11.66%,MAP4K3;ARHGEF2;DAB2IP;CASP8;GCH1;INPP5K;HYAL2;GBP3;GATA3;ZC3H12A;JAK2;NFE2L2;NR1D1;ACOD1;CACTIN;ZFP36L2;ADAM10;DHX9;CCL4;GBP2;BRCA1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4397423284765176,-1.165090793816259,0.2602040816326531,0.7056383268981841,1.0,5/16,12.35%,SNW1;RBMX;NCBP1;DAZAP1;TRA2A
prerank,B cell homeostasis (GO:0001782),-0.4990974140948542,-1.1650115479614445,0.30493273542600896,0.704013791493893,1.0,3/10,12.09%,DOCK11;DOCK10;NCKAP1L
prerank,carbohydrate transport (GO:0008643),0.5541303951556665,1.1648176950234703,0.3132328308207705,0.7153019433593798,1.0,1/11,2.23%,AQP11
prerank,cell-matrix adhesion (GO:0007160),-0.2923232022702214,-1.164522424437971,0.16666666666666666,0.7034972767509877,1.0,22/95,10.17%,ITGBL1;COL3A1;ADAMTS12;SORBS1;VTN;ITGB5;PTPRK;ITGA10;COL13A1;NID2;ITGAV;ACTN2;ITGA11;CD63;ITGB8;ADAM9;SRC;ADAMTS9;MSLN;THBS3;SGCE;ECM2
prerank,positive regulation of protein transport (GO:0051222),0.40233494758301674,1.164364759439631,0.25461254612546125,0.7157931561172387,1.0,21/67,19.57%,CD2AP;UNC13B;PLK3;TGFB2;ATP2C1;TMED10;IL1A;PRR5L;PCM1;VPS28;RIPOR1;ACHE;ICE1;PDCD10;RACK1;TENM1;GOLPH3L;GOLPH3;PPID;MYO18A;ANG
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4677762312448485,-1.1643404032363411,0.29,0.7022208162674405,1.0,6/12,26.75%,INSIG2;RER1;KDELR1;ANKRD13C;KDELR3;GPAA1
prerank,cochlea morphogenesis (GO:0090103),0.5595829767156552,1.1642343269660966,0.2916666666666667,0.7154512692562645,1.0,1/10,1.26%,TBX1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.48011412623092736,1.1641067122087412,0.2859237536656892,0.7150277315367419,1.0,12/22,20.43%,NFE2L2;PSMA5;PSMB10;ENC1;PSMB8;PSMA7;PSMA8;PSMB5;PSMB9;PSMA4;PSMB6;PSMB2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5434691324105825,1.1638923252165072,0.3062200956937799,0.7148969032862118,1.0,3/13,10.12%,F2RL1;ITGAM;TYROBP
prerank,epithelial cell morphogenesis (GO:0003382),0.5113047618917524,1.16375023130197,0.282642089093702,0.7145689377697169,1.0,2/17,3.32%,CCDC88C;SIPA1L3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.43634741973777696,-1.163674043277599,0.2702702702702703,0.7023239958879621,1.0,9/15,35.75%,NFKB1;AGTR1;MAPK9;LPL;AGT;MSR1;IL18;CD36;PLA2G5
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5264140773620088,1.1633807571002452,0.2917316692667707,0.7148682575031122,1.0,5/14,10.16%,OXSR1;ADAM17;STK39;ADAM10;CCL4
prerank,negative regulation of histone methylation (GO:0031061),-0.48390745291487713,-1.1633138847265843,0.27053140096618356,0.7016753353076424,1.0,5/10,18.33%,JARID2;MTF2;WDR5;BCOR;DNMT3B
prerank,cAMP-mediated signaling (GO:0019933),-0.3945484775190493,-1.1632931875882373,0.2229299363057325,0.6999267577222213,1.0,6/24,5.64%,PDE7B;PDE3A;ADCY1;ADGRG6;KSR1;ADCY2
prerank,mononuclear cell differentiation (GO:1903131),-0.3942436026179304,-1.1630532550932722,0.25076452599388377,0.698838974196808,1.0,8/24,16.49%,AXL;BMP4;IL31RA;MT1G;VEGFA;PPARG;RELB;FLT3
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5237339006215517,1.1630504553433207,0.3097913322632424,0.7150539836536649,1.0,6/15,15.16%,SMAD7;FKBP1A;ACVR1;ACVR2A;CSNK2B;ACVR2B
prerank,actin cytoskeleton reorganization (GO:0031532),0.4114156713831275,1.1627488829894688,0.2576312576312576,0.7151833974431567,1.0,11/63,7.08%,TRPV4;S1PR1;PLEK2;THSD7A;PARVB;CDC42BPA;NEDD9;CDC42BPG;ATP2C1;MYH9;WHAMM
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4588012295914445,1.1623279120654058,0.27705627705627706,0.7156149710046701,1.0,9/32,14.92%,APOA1;SLC44A1;LCAT;PCYT1A;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B
prerank,arachidonic acid metabolic process (GO:0019369),-0.3558710049973275,-1.1621667284799255,0.24555160142348753,0.6995926043469836,1.0,11/35,23.05%,PTGDS;PTGES;PTGS1;PLA2G4A;EPHX2;CYP2A6;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,regulation of response to biotic stimulus (GO:0002831),0.46239816916077464,1.1621092555251875,0.2984218077474892,0.715509264150179,1.0,4/28,4.30%,GATA6;CASP8;TIRAP;FCGR2B
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5653120486751995,1.1618914987567233,0.3090277777777778,0.7154107375233877,1.0,4/11,10.12%,F2RL1;ITGAM;STAP1;TYROBP
prerank,protein N-linked glycosylation (GO:0006487),-0.3178087829616506,-1.16155394751131,0.18324607329842932,0.699584072887351,1.0,23/66,19.03%,MGAT4C;MGAT4A;ST6GAL1;TUSC3;MGAT3;MAN1C1;STT3A;SLC39A8;B4GALT1;LMAN1;UGGT2;MPDU1;GFPT1;GFPT2;DPM2;PGM3;ALG8;OST4;MAGT1;PMM1;ALG9;STT3B;ALG13
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4906200822162321,1.1614119521823525,0.29596412556053814,0.7159801372668391,1.0,8/23,16.90%,LGALS9;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;RARA
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34746538421351336,1.161303372131635,0.045,0.7155791187990749,1.0,156/1082,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;AFAP1L2;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PLCB1;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;FLI1;PELP1;INPP5K;HEY2;TLR3;KLF4;IER5;ACVR1;ING2;WWTR1;SERTAD2;LEF1;BCLAF3;SERTAD1;MAFF;KARS1;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;ZBTB48;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;RYBP;ZBTB16;FANK1;ZC3H12A;KDM3A;PPP3CA;STAT1;GAL;AATF;MAPRE3;EBF3;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;DNAJC2;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;SEC14L2;MAD2L2;ASF1A;RPS6KA1;SFR1;RPRD1B;NFKBIA;TET3;TNKS;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;CD38;ILF2;HELZ2;DTX3L;PRKD2;SOX10;HINFP;MED30;IRF5;SETD3;ELF2;CTBP2;GLYR1;RPS6KA3;YWHAH;PSMC3;ITGB1BP1;PIN1;POU3F2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.47352552604351267,-1.1600477580666415,0.28717948717948716,0.7022170617946938,1.0,3/12,2.65%,NOTCH2;DOCK11;DOCK10
prerank,glycerophospholipid metabolic process (GO:0006650),0.3989072215076996,1.1600087734903897,0.2672413793103448,0.7183471420548252,1.0,20/75,17.35%,PLCB1;IP6K3;GPCPD1;APOA1;ACP6;LCAT;FAR1;PNPLA6;CRLS1;ABHD6;GDPD1;DGKH;ENPP6;PLCG1;SERINC5;PIGF;AGK;PIGQ;PIGC;SYNJ1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.42548709973850274,1.1589522236985543,0.2792207792207792,0.7205174024840325,1.0,10/53,16.45%,CCR1;HRH2;CHRM3;HTR5A;MTNR1B;HTR1B;HTR2A;HTR1F;HRH3;HTR4
prerank,positive regulation of microtubule polymerization (GO:0031116),0.46971198152686455,1.158721711215295,0.27246376811594203,0.7204144661841942,1.0,8/28,14.42%,OCLN;FES;CLIP1;CLASP1;HSPA1B;RAC1;NUMA1;NAV3
prerank,positive regulation of axon extension (GO:0045773),0.48667715013790946,1.158647476596575,0.29545454545454547,0.7199086879489063,1.0,5/22,7.01%,MACF1;NTN1;SHTN1;SEMA7A;ISLR2
prerank,RNA transport (GO:0050658),-0.31559969592765663,-1.158563454322156,0.2146341463414634,0.7043079105494537,1.0,32/71,26.03%,SIDT1;SRSF5;HNRNPA2B1;NCBP1;CKAP5;SRRM1;ATXN2;SRSF1;NUP155;SRSF6;THOC1;SIDT2;RTRAF;TGFBR2;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;SRSF3;KIF5C;SLBP;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4138016998299159,-1.1585404202234648,0.26,0.7026056506149381,1.0,6/20,12.61%,B3GALT1;ST6GALNAC6;ST3GAL4;B4GALT1;MPDU1;ST6GALNAC5
prerank,regulation of neurotransmitter secretion (GO:0046928),0.44411242391597905,1.15846722694158,0.2777777777777778,0.7197026678404704,1.0,7/32,16.46%,MCTP1;MEF2C;LRRK2;SLC30A1;SNCAIP;RIMS3;CPLX1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.49932763011848297,1.1584658224215467,0.27768595041322314,0.7190058396694292,1.0,5/17,12.41%,FCHSD2;NCKAP1;CYFIP1;WASF2;CTNNA2
prerank,action potential (GO:0001508),0.4210685934966628,1.1581032735000367,0.2759526938239159,0.7192562841362637,1.0,4/44,4.17%,KCNQ1;KCNE3;GNAQ;SCN11A
prerank,negative regulation of secretion by cell (GO:1903531),0.4340989469467089,1.1580443908924254,0.2558139534883721,0.7187230182815249,1.0,11/38,20.16%,NOTCH1;STXBP6;TNFRSF1B;SLC30A1;VAMP8;HTR1B;CHGA;HRH3;RSAD2;GRM7;DPH3
prerank,myeloid cell differentiation (GO:0030099),0.42385689254531156,1.1576777731437724,0.2839506172839506,0.7190097134203305,1.0,9/47,8.61%,TAL1;SNRK;TIRAP;ZBTB16;MFHAS1;CEBPA;JAK2;RPS14;KMT2E
prerank,replicative senescence (GO:0090399),-0.4732584650085423,-1.157673626714924,0.2942643391521197,0.7032994047218526,1.0,6/12,20.94%,PLA2R1;SERPINE1;ATR;TERT;WNT16;ROMO1
prerank,protein modification by small protein conjugation (GO:0032446),0.3502584447088757,1.157592987815946,0.15447154471544716,0.718531869461728,1.0,73/361,16.42%,LMO7;EPAS1;TRIM14;RNF103;FBXL2;TRIM69;IFIH1;CBL;HERC2;KLHL2;FBXO7;UBA7;FBXL5;KLHL3;SUMO2;SUMO3;TRIM11;TRIM6;RNF38;ELOC;ARIH1;GAN;CUL3;ARRDC1;RTF1;UBE2D1;TRIM24;UFM1;KLHL20;RANGAP1;ARRB1;WWP1;ASB5;UBA52;NFE2L2;RPS27A;NUP54;FBXW7;RBX1;ZNRF3;CUL2;TRIM47;ENC1;TRIM17;NUP35;RANBP2;NEDD4L;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;NUP153;UBE2J2;RNF103-CHMP3;KEAP1;NUP160;HIF1A;FBXO2;UBE2E1;NUP42;RAD18;CDC27;UBE2D3;RACK1;TRAIP;KLHL25;KLHL24;NUP205;ANAPC7;RNF139;KLHL9
prerank,protein homooligomerization (GO:0051260),0.37636181059412616,1.1569888659359682,0.23103448275862068,0.7194683274517771,1.0,18/114,11.88%,EHD4;GBP5;B2M;AQP11;ATL2;GLS;EHD1;SSBP1;ATL1;ELAVL1;ALDH9A1;MCOLN1;MLKL;ACOT13;ACACB;TRPM2;TRMT61B;SLC1A2
prerank,negative regulation of viral transcription (GO:0032897),0.5392281678764108,1.1569252507728405,0.29833333333333334,0.7189310256007474,1.0,2/13,4.67%,TRIM14;TRIM11
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.463464673788774,1.1568395206941873,0.28487518355359764,0.7184507175062785,1.0,8/26,16.08%,TAL1;APP;TTL;CUL3;DUSP3;RPS6KB1;PKN2;MEIS2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3879291063086488,1.15653633762212,0.2511792452830189,0.7185921264812413,1.0,27/84,19.11%,PSMD13;CUL3;UBE2D1;PSMD4;PTTG1;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,regulation of insulin secretion (GO:0050796),0.3851325321054972,1.1559842551039132,0.24231678486997635,0.7193759867262471,1.0,13/101,8.68%,MYRIP;EFNA5;ITPR3;SLC2A1;DOC2B;CACNA1A;HNF4A;SYT7;RAPGEF4;GLUD1;SIRT4;MTNR1B;NR1D1
prerank,negative regulation of nervous system development (GO:0051961),0.4986834453888544,1.1559712150981307,0.2902711323763955,0.7187126213151361,1.0,3/17,9.16%,NOTCH1;B2M;PCM1
prerank,regulation of viral life cycle (GO:1903900),0.4813071007321372,1.1553712566667722,0.29376854599406527,0.7196464257428947,1.0,5/21,12.82%,TRIM14;TRIM6;TRIM25;HS3ST5;VPS4A
prerank,signal transduction in response to DNA damage (GO:0042770),0.4243540600684401,1.1552983869219482,0.2671957671957672,0.7191521095594994,1.0,15/49,19.45%,ACER2;MAD2L2;BRIP1;E2F7;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;MAPK14;TIPRL;ATRIP;BID;HUS1
prerank,defense response to protozoan (GO:0042832),0.5301760120329638,1.155279850220735,0.3163934426229508,0.7185250327685668,1.0,4/12,16.69%,GBP4;GBP2;LYST;GBP7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3818424911061173,1.155116581499717,0.24682814302191464,0.718277482743395,1.0,36/109,20.61%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3;PSMB2;TAB1
prerank,heart contraction (GO:0060047),0.43147952249497884,1.1550747295680417,0.2851351351351351,0.7177138185486731,1.0,4/41,3.81%,KCNQ1;ACE;MYBPC3;SLC8A1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3895730316229963,-1.155039191533013,0.2872340425531915,0.7090393528839795,1.0,6/21,14.39%,SLC30A10;PPARA;PRKN;TRAP1;HDAC6;SIRT2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.40457885402484567,1.1548858114090224,0.26108374384236455,0.7175317513243257,1.0,23/70,20.26%,FAS;DAB2IP;CASP8;TGFB2;TLR3;CASP2;FGFR3;TNFRSF1B;P2RX7;CRADD;BCL2L1;JAK2;DELE1;DCC;CASP8AP2;DAXX;SIVA1;GSK3A;DDX47;BID;MCL1;SORT1;GSK3B
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3595904257511332,1.1546394710903594,0.19873150105708245,0.7175104549351532,1.0,71/224,22.11%,UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SNCG;HRH2;AKAP5;GABRQ;CHRM3;HCRTR1;MAPK1;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK2;MINK1;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;NPTX2;PCDHB14;GRIK1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;APBA2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP;GABRB3;NLGN1;KCNIP2;PDYN
prerank,maturation of LSU-rRNA (GO:0000470),0.47202342873929315,1.1546219389876644,0.2886297376093295,0.7168656090107633,1.0,12/26,22.66%,BOP1;RPL7;MRPL1;RPL35;RRP15;NHP2;EIF6;RPL7L1;LAS1L;FTSJ3;URB1;RPF2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.29846261002716123,-1.1541472698962378,0.1781609195402299,0.7097737024218536,1.0,31/84,23.60%,CELF2;SON;DDX5;NOVA1;SNW1;FXR2;RBMX;DDX17;NCBP1;JMJD6;DAZAP1;PUF60;SRSF6;REST;TRA2A;RBM39;HNRNPL;PCBP4;HNRNPU;MAGOH;U2AF2;NCL;SRSF3;SF1;RBFOX3;SRPK2;ZC3H10;KHDRBS1;CELF1;C1QBP;CELF5
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.49417023570840346,-1.1540846939786435,0.30982367758186397,0.7081873916845475,1.0,4/10,29.25%,PRKN;HDAC6;AOC3;ETFBKMT
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3478315319791505,1.1535664501273337,0.13266331658291458,0.71899150577961,1.0,65/497,12.28%,PRDM16;NANOS1;MECOM;SOX13;NANOS3;GATA6;PLCB1;PDGFB;DACH1;BMPR2;RPS6KA5;SMARCA2;ACVRL1;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;BTG2;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;GMNC;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;PASK;GATAD2A;NR1D1;GAPDH;FOXP1;MBD1;JUN;ARID5A;ZBTB14;CNOT1;ENC1;CDAN1;DEAF1;SAMD1;DMAP1;BRCA1;CD38;ARID5B;HINFP;TOB1;SUV39H2
prerank,cardiac muscle cell development (GO:0055013),0.49159348657976226,1.1533873446849137,0.30250783699059564,0.7187749823853304,1.0,5/20,4.46%,SORBS2;HEY2;SLC8A1;ALPK3;PDLIM5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3830776085167431,-1.153382631321618,0.23795180722891565,0.7083967705200978,1.0,8/27,14.18%,SLC1A3;SLC7A2;SLC47A1;SLC25A13;SLC6A9;SLC38A5;SLC1A4;SLC25A12
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4693339166672098,1.1528433895907668,0.31457431457431456,0.7195661578974412,1.0,3/26,3.64%,CEACAM1;GPR137B;TLR3
prerank,regulation of postsynapse organization (GO:0099175),0.45830921079834364,1.1520368501063087,0.30377906976744184,0.7209954222111886,1.0,9/28,15.66%,TANC2;FCGR2B;PDLIM5;SHANK3;LRRK2;PPFIA2;VPS35;CFL1;KIF1A
prerank,ncRNA processing (GO:0034470),0.3609021903603856,1.151742456031204,0.21405405405405406,0.7210598850978404,1.0,79/200,26.74%,BOP1;PELP1;RPL27;DHX37;KARS1;SMAD2;RPL7;INTS11;TRPT1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;ADAR;WDR46;RPL21;DKC1;RPL37;FARS2;RPS28;RPL34;AGO4;RPS9;XRN2;EXOSC8;RPLP2;INTS12;RPS25;RPL30;RPL27A;NOL8;INTS5;RPL23A;RPS15;RPL19;RPL32;UTP18;DROSHA;RPL37A;RPL18A;NOB1;EXOSC9;TUT7;POP1;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;INTS6;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.42170692847450486,1.1513861048080216,0.2757697456492637,0.7213289705266706,1.0,11/46,15.69%,PLCB1;GSTA2;MSN;PDCD4;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,limb morphogenesis (GO:0035108),-0.4052374704372298,-1.1510473397565377,0.2809667673716012,0.7133640867601405,1.0,6/20,9.90%,GLI3;CYP26B1;FBXW4;NIPBL;MEGF8;PTCH1
prerank,AMP metabolic process (GO:0046033),-0.45877197613583115,-1.1510111439262913,0.29846938775510207,0.7116997892435306,1.0,8/13,33.09%,AMPD3;XDH;NT5E;NUDT2;NT5C1A;AMPD2;AK3;AK9
prerank,smooth muscle tissue development (GO:0048745),0.5472143212640305,1.1507490239828606,0.3055555555555556,0.7223559253364376,1.0,2/10,1.89%,ENG;MYLK
prerank,base conversion or substitution editing (GO:0016553),0.5583127130808778,1.1506020638513514,0.31569664902998235,0.7220699644660308,1.0,2/11,9.00%,ADARB1;ADAR
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.525922701395879,1.1504548147650215,0.33223684210526316,0.721779731063854,1.0,4/14,12.25%,TLR3;TIRAP;CARD10;COPS8
prerank,chemical synaptic transmission (GO:0007268),0.35230632495363656,1.1503517389593991,0.19542619542619544,0.7213495787007207,1.0,80/284,20.82%,FCHSD2;UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SYN3;SNCG;HRH2;AKAP5;GABRQ;GRID1;CHRM3;HCRTR1;MAPK1;SHISA6;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;GRIN2C;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK5;GRIK2;MINK1;PDZD11;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;STXBP3;NPTX2;PCDHB14;ERC2;GRIK1;SLC32A1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SNPH;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;NSG1;APBA2;GRID2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP
prerank,regulation of intracellular protein transport (GO:0033157),0.4527473304762832,1.1502325165565195,0.28690807799442897,0.7209731073766192,1.0,11/32,16.40%,PTPN14;PLK3;UHMK1;PRR5L;PCM1;RIPOR1;PTPN1;ICE1;LCP1;PDCD10;TENM1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.520530892877629,1.1501405558178126,0.2921875,0.7205330084854539,1.0,5/15,16.03%,STOX2;TGFB2;CELF4;BRCA1;RICTOR
prerank,activation of protein kinase B activity (GO:0032148),-0.371746259750129,-1.150106848377761,0.23102310231023102,0.7124517961210584,1.0,9/29,11.92%,IGF1;NTRK3;FGF1;WNT5A;OSBPL8;MAPKAP1;PPIA;TXN;ADRA2A
prerank,arachidonic acid secretion (GO:0050482),0.5644046231811672,1.1490695504900663,0.3144758735440932,0.7219518306897876,1.0,1/10,1.04%,ACE
prerank,arachidonate transport (GO:1903963),0.5644046231811672,1.1490695504900663,0.3144758735440932,0.7219518306897876,1.0,1/10,1.04%,ACE
prerank,cellular response to amino acid stimulus (GO:0071230),0.44133799021848796,1.1489816446369383,0.2936170212765957,0.7215120540376413,1.0,5/33,10.04%,FYN;SPAAR;CASTOR1;SH3BP4;RRAGD
prerank,respiratory electron transport chain (GO:0022904),0.5132366669501149,1.1488639619550416,0.3073248407643312,0.7211601639561136,1.0,5/14,11.70%,GPD2;ETFDH;ETFA;ETFB;UQCRFS1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4226086521484879,1.148277251973253,0.27249022164276404,0.7220533568379941,1.0,11/47,10.07%,NOTCH4;ENG;NOTCH1;HEY1;TGFB2;HEY2;LEF1;FOXF2;SNAI2;ROCK1;TASOR
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5478118686003628,1.1477816461800803,0.3142857142857143,0.7226163915850241,1.0,4/11,10.11%,ATL2;ATL1;RTN4;LPCAT3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.42938235007652004,1.147298312342902,0.2880658436213992,0.7232260669643574,1.0,7/39,9.53%,EFR3B;ITPKB;IP6K3;PIK3C2A;CISH;SOCS6;PIK3C3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5508417819014915,1.1471955946119416,0.3258620689655172,0.7228109856156089,1.0,7/10,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRA3;GABRB2;GABRA5
prerank,inner ear morphogenesis (GO:0042472),-0.3947309759437627,-1.1470030899007846,0.2784090909090909,0.7197535724408006,1.0,4/22,7.10%,ZIC1;FGFR2;TBX18;SIX1
prerank,interstrand cross-link repair (GO:0036297),-0.3223034377711881,-1.1467369620707883,0.2112676056338028,0.7187917802265457,1.0,36/53,39.66%,NUCKS1;FAN1;USP1;ATR;FAAP100;MSH6;POLN;DCLRE1B;RFWD3;RPA3;FANCB;RNF168;RPA1;FANCI;FANCD2;FANCG;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX;XRCC3;FANCM;SLX4;DCLRE1C;FANCC;RAD51AP1;DCLRE1A;ERCC6L2;UBC;FAAP24;XPA;ERCC1;MCM9;FANCF
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.48073050370952075,-1.146695142258631,0.28501228501228504,0.717168164328927,1.0,5/11,15.79%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.47972688510744,1.1464621984482142,0.3138138138138138,0.7241906081168008,1.0,7/21,15.15%,RASSF10;DLL4;CX3CR1;CTNNB1;FZD9;FZD3;NES
prerank,chromatin organization (GO:0006325),0.37168124118127105,1.146032036722539,0.23995535714285715,0.7246582045708454,1.0,15/132,14.54%,PRDM16;MECOM;SMARCA2;NPM3;HDAC11;CHRAC1;TCF7L1;HP1BP3;CDAN1;NPM1;SMARCAD1;SUV39H2;GATAD1;SMARCC1;HMGB2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.31612357828162635,-1.1459745948975866,0.24390243902439024,0.7173709216537715,1.0,9/57,8.23%,LPAR1;ADCY5;ADCY9;ADCY1;GNAI1;AKAP12;ADCY2;ADCY7;FLNA
prerank,regulation of exocytosis (GO:0017157),0.41866326207654586,1.1458009000874132,0.2692828146143437,0.724534722995829,1.0,14/46,18.42%,CADPS2;STXBP6;CLASP1;CLASP2;CADPS;CHMP3;NSF;CPLX1;RAB27B;STXBP5L;STXBP5;RAB27A;SYT1;HAP1
prerank,axonogenesis (GO:0007409),0.3529653691779542,1.1457212445925729,0.21875,0.7240411606775798,1.0,39/237,11.35%,SEMA3G;LAMA3;EFNA5;FYN;RPS6KA5;NTN4;NOTCH1;KLF7;APP;SEMA3F;SH3KBP1;EVL;LAMA5;SHTN1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;ATL1;MAPK1;BSG;LMTK2;PTPRO;ENAH;NRCAM;SEMA6D;SCN1B;PTK2;TAOK2;B4GALT6;PLCG1;NEFH;ADGRB1;CYFIP1;RANBP9;ACTB;DCC;SEMA4G
prerank,regulation of blood coagulation (GO:0030193),0.45439502727631953,1.1453280663764192,0.311046511627907,0.7243965960800146,1.0,6/27,8.44%,EDN1;CAV1;F2RL1;ENPP4;CD34;PROC
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4391191740737367,-1.1452953818253682,0.2927536231884058,0.7175937884249574,1.0,4/16,8.24%,ROCK2;GSN;RIPOR2;BCAS3
prerank,response to X-ray (GO:0010165),-0.44650007016692894,-1.1446402626044228,0.2845303867403315,0.7177314054147591,1.0,5/14,17.73%,NUCKS1;NIPBL;ANXA1;XRCC5;IKBIP
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4229314805457154,1.1445355449503234,0.28304405874499333,0.7258317961330873,1.0,8/46,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,N-terminal protein amino acid modification (GO:0031365),-0.45482175608070785,-1.1442527007610794,0.2864721485411141,0.7170100260778355,1.0,7/14,25.39%,METAP1D;METAP1;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3806878185005433,-1.143812309237486,0.2653061224489796,0.7164945550668136,1.0,7/27,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PRKN;PIK3R1;TMEFF2
prerank,spliceosomal complex assembly (GO:0000245),-0.32594217876394826,-1.1433781993374759,0.20425531914893616,0.7160395925071155,1.0,9/46,10.82%,CELF2;SRSF5;SCAF11;NCBP1;SRSF1;SMN1;PUF60;SRSF6;DDX1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4749382425999993,1.1432031263398228,0.29914529914529914,0.7287461546570398,1.0,6/24,13.20%,ACE;B2M;MFSD6;TAP1;SEC24B;TAPBP
prerank,MAPK cascade (GO:0000165),0.3492093217703571,1.143192697060631,0.19361483007209063,0.728095367021161,1.0,58/295,15.02%,RASGRF2;TEK;RAPGEF2;PDGFB;FYN;KITLG;DAB2IP;LGALS9;CSF2RB;APOA1;KRAS;NRAS;PSMD13;IL17RD;ANGPT1;MAP4K4;KARS1;MEF2C;FGFR3;SHANK3;CUL3;MAPK1;PSMD4;SETX;SHOC2;LRRK2;FRS3;BCL2L1;UBA52;JAK2;GRIN2B;RPS27A;PTK2;ZFP36L2;TAOK2;PSMA5;RBX1;PSMB10;MARK3;MINK1;RANBP9;PSMB8;MAP3K3;PSMD14;PIK3CB;PSMA7;PSMC3;SPTAN1;PSMA8;PSMC1;RASAL1;SOS1;PSMB5;MAP3K20;GFRA3;PSMC5;PRKG2;FGF20
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5271747576442842,1.1431400127016274,0.32978723404255317,0.7275506970336058,1.0,5/14,17.56%,F2RL1;APOA1;TRAIP;PTPN2;PYDC1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4847669823867552,-1.1429573406307159,0.27611940298507465,0.715461767323594,1.0,1/10,0.80%,ROCK2
prerank,regulation of wound healing (GO:0061041),0.4211614079883959,1.1429330931605168,0.2906666666666667,0.7274404363174609,1.0,7/42,9.22%,OCLN;MYLK;CAV1;F2RL1;CRK;ACTG1;PTK2
prerank,negative regulation of nuclear division (GO:0051784),-0.4722579233722709,-1.1428975834478996,0.3088235294117647,0.713941874829468,1.0,2/11,2.18%,BMP7;BMP4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5568804007432719,1.142533635191959,0.3292894280762565,0.7277775237973226,1.0,3/10,5.65%,DAB2IP;EFNA1;FURIN
prerank,regulation of protein ubiquitination (GO:0031396),0.3765546201475975,1.1424820628408603,0.25870069605568446,0.7272337236511242,1.0,22/108,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;FOXF2;CUL3;UBE2D1;LRRK2;HSPA1B;ARRB1;UBE3A;NDFIP2;VPS28;NSMCE3;FBXW7;PRKCG;ADGRB1;LAPTM5;NXN;BRCA1;FBXO4
prerank,regulation of viral transcription (GO:0046782),0.43392638020488206,1.1424750299975284,0.3146374829001368,0.7265732336576439,1.0,14/39,23.64%,TRIM14;TRIM11;POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;IFITM3;MID2;HEXIM1;POLR2C;POLR2B;POLR2J
prerank,receptor-mediated endocytosis (GO:0006898),0.367704291195371,1.1422983843149863,0.2505592841163311,0.7263598679620854,1.0,17/132,7.44%,FCHSD2;HIP1R;INSR;CAV1;CAV2;ADRB2;PPT1;DNM3;APOA1;AP2B1;FCHO2;FCGR2B;FNBP1L;FCGR1A;PIP5K1C;ITGAM;HSP90B1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4813297008128635,1.1422552495679172,0.30640243902439024,0.7258198308624787,1.0,4/21,8.36%,MCUB;SMDT1;RAP1GDS1;MCUR1
prerank,apoptotic cell clearance (GO:0043277),-0.3582497762649614,-1.1412701799865175,0.24573378839590443,0.7166858137722307,1.0,6/30,8.62%,LRP1;THBS1;ITGAV;ANXA1;RHOBTB2;TXNDC5
prerank,regulation of DNA metabolic process (GO:0051052),-0.33925398248475175,-1.1410203534080678,0.24015748031496062,0.7157611137458892,1.0,13/44,14.42%,NUCKS1;UBE2V2;UBE2N;USP1;KPNA1;YLPM1;HELB;THOC1;WDR70;SUB1;MPHOSPH8;MPV17;XRCC5
prerank,negative regulation of protein processing (GO:0010955),-0.47317005349972674,-1.140458871340831,0.3333333333333333,0.7157467948714823,1.0,5/12,13.58%,GAS1;SERPINE2;THBS1;SERPINE1;SNX12
prerank,regulation of cytoskeleton organization (GO:0051493),0.372114132079003,1.1402999367750464,0.27453271028037385,0.7303212209870641,1.0,25/108,13.75%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK;DIAPH1;CLIC4;MAPK1;CLASP1;P2RX7;PRKAA1;ROCK1;TJP1;PTK2;TAOK2;CCDC88A;RAC1;PFDN2;MARK2;SORBS3;RND2;RHOH
prerank,calcium ion transmembrane transport (GO:0070588),0.385012781861809,1.1401212770969573,0.26303317535545023,0.7300918494071462,1.0,18/86,11.29%,ATP2A3;TRPV4;ATP2B4;CACNA1A;FKBP1A;MCUB;SLC8A1;ATP2C1;ANO6;ORAI1;SMDT1;P2RX7;MCOLN1;MCUR1;GRIN2B;GRIN2C;TRPM2;TRPC7
prerank,response to organic cyclic compound (GO:0014070),0.41342892352870375,1.1396202166791143,0.28974358974358977,0.7307607800973613,1.0,12/52,16.29%,ALPL;ARL6IP5;TLR3;ABCB4;LRRK2;PAQR8;STRN3;TRPM2;SLC1A1;CTNNB1;CDKN2D;ESR1
prerank,inner dynein arm assembly (GO:0036159),-0.46945039267866956,-1.139371794066359,0.3176178660049628,0.7171832664887952,1.0,8/11,47.05%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3
prerank,liver development (GO:0001889),-0.3622973643847392,-1.1392707877123687,0.23208191126279865,0.715786844124372,1.0,7/32,10.94%,TGFBR3;WNT4;COBL;NPHP3;ANXA1;CEBPB;MET
prerank,neutrophil chemotaxis (GO:0030593),0.4059652232089304,1.138923864561235,0.2623376623376623,0.7319519120513591,1.0,5/53,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,cellular response to chemical stress (GO:0062197),0.3831727440546469,1.1387355081906734,0.27020506634499397,0.7317993195031788,1.0,22/96,14.96%,TRPV4;FAS;FOXO1;CAV1;PRKD1;CHCHD2;SETX;ZC3H12A;LRRK2;HSPA1B;PRR5L;NFE2L2;PRKAA1;BRF2;CYBA;RBM11;KEAP1;ATM;PYROXD1;MSRA;NCF2;EIF2S1
prerank,negative regulation of defense response (GO:0031348),0.3872140932274803,1.1385817288037514,0.25794621026894865,0.7315367188221725,1.0,13/77,11.41%,TEK;AOAH;APOA1;KLF4;GATA3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35
prerank,Wnt signaling pathway (GO:0016055),0.3792250311901478,1.1384151315215285,0.27261761158021713,0.7312970123623708,1.0,18/92,14.82%,PLCG2;CCDC88C;FZD6;NR4A2;LEF1;LRRK2;UBA52;APC;RPS27A;CSNK1G3;TCF7L1;RBX1;NXN;VPS35;LRP5;CTNNB1;FZD9;FZD3
prerank,regulation of cell size (GO:0008361),0.4579483074824999,1.1383930101947455,0.3083832335329341,0.7306836393223812,1.0,4/23,10.68%,EDN1;MSN;RAP1GAP2;RAC1
prerank,synaptonemal complex assembly (GO:0007130),0.5010212775189664,1.1381845156722519,0.30317460317460315,0.7299221566595645,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,synaptonemal complex organization (GO:0070193),0.5010212775189664,1.1381845156722519,0.30317460317460315,0.7299221566595645,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.531334565985185,1.137708206811304,0.33014354066985646,0.7304970222525086,1.0,2/11,3.64%,CASP8;TLR3
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2912781245957873,-1.1376624925583416,0.19444444444444445,0.7186876540262584,1.0,22/80,16.06%,DENND2A;SGSM2;VPS54;SNX6;VPS26B;GCC2;SNX32;SURF4;TMEM87A;TRAPPC10;LMAN1;EHD3;RHOBTB3;STX5;SNX1;STX16;TBC1D17;SNX12;CLN5;SNX8;GGA1;SNX2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3014703666107617,-1.1376001885624207,0.19047619047619047,0.7171874767879098,1.0,20/77,14.55%,IGF1;TGFBR1;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV;PRKN;NDUFS3;SRC;CFLAR;NDUFA13;BIRC6;URI1;DDX3X;QARS1;MPV17L;FXN;PIH1D1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3899816118204102,1.1371118422797133,0.2809123649459784,0.7314156862883274,1.0,22/78,17.93%,SMAD7;PLK3;CAV1;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;NFE2L2;RBX1;NKD2;RNF144B;CLU;KEAP1;RACK1;UBQLN2;CBFA2T3;TRIB3;SOCS5;GSK3A
prerank,defense response to symbiont (GO:0140546),0.380577283993174,1.1362665951906636,0.2726190476190476,0.7329028714364432,1.0,29/92,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,kidney development (GO:0001822),-0.3044059499825343,-1.1362452983736688,0.2191780821917808,0.7192916281288276,1.0,19/65,11.66%,GLI2;SULF1;WNT4;TGFBR1;BMP7;SULF2;BMP4;OSR1;GREB1L;PYGO1;NPHP3;NIPBL;KANK2;SIX1;VEGFA;PYGO2;STRA6;SALL1;PKD1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3639787379213951,1.135998861537919,0.24725274725274726,0.7329575686192038,1.0,42/153,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3862807471449218,1.135985875557739,0.28762135922330095,0.732324352874133,1.0,26/85,17.93%,SMAD7;ECSCR;DAB2IP;SUMO2;CSNK1D;BBS7;RNF185;ARIH1;LRRK2;HSPA1B;CEBPA;FBXW7;RBX1;NKD2;RNF144B;BAG6;CLU;PSMC3;KEAP1;PSMC5;RACK1;CBFA2T3;PSMC6;TRIB3;SOCS5;GSK3A
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4861250408789663,1.1359693016778583,0.30712166172106825,0.7310345515637149,1.0,10/19,25.76%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4861250408789663,1.1359693016778583,0.30712166172106825,0.7310345515637149,1.0,10/19,25.76%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,tRNA wobble base modification (GO:0002097),0.518704195147893,1.1350834852533593,0.33163265306122447,0.7326900305584109,1.0,6/14,20.60%,ADAT2;ELP4;ALKBH8;ELP3;DPH3;KTI12
prerank,response to interferon-gamma (GO:0034341),0.3920933392498029,1.1346670840655961,0.2657766990291262,0.733088250962113,1.0,12/67,11.38%,GBP5;LGALS9;GBP4;GCH1;GBP3;CD47;STAT1;ACOD1;GAPDH;CCL4;CASP1;GBP2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4246151928641446,1.134323143802409,0.31950207468879666,0.733330723947254,1.0,3/39,5.83%,MYRIP;DOC2B;GLUD1
prerank,negative regulation of histone modification (GO:0031057),-0.4342445053039631,-1.1341034785159263,0.29455445544554454,0.7234799915264787,1.0,6/14,21.81%,SET;JARID2;TAF7;TWIST1;NOC2L;SPHK2
prerank,neutrophil activation (GO:0042119),0.5226405341874176,1.1340397914028963,0.3283333333333333,0.7334676575798663,1.0,3/12,10.12%,F2RL1;KMT2E;TYROBP
prerank,acyl-CoA biosynthetic process (GO:0071616),0.49947616985391535,1.1340108012657772,0.30990415335463256,0.732887739711112,1.0,2/16,3.24%,FASN;PPT1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4463968992168528,1.1339649691235674,0.32,0.732346603557312,1.0,11/31,21.58%,TANC2;PDLIM5;EFNA1;SHANK3;LRRK2;PPFIA2;CFL1;KIF1A;LRP8;NLGN1;EPHA4
prerank,regulation of translation (GO:0006417),0.35783896104999874,1.1335704720573985,0.24060150375939848,0.732651390012149,1.0,41/173,16.16%,NANOS1;NANOS3;VIM;BTG2;APP;MTG2;YBX2;PLD1;ELAVL1;HSPB1;PASK;GAPDH;ETF1;EIF3B;EIF2B2;DHX9;EIF1;CNOT1;ENC1;RPS6KA1;CYFIP1;METTL5;NPM1;EEF2;GRM5;TOB1;RPS6KA3;RPS6KB1;FXR1;METTL14;METTL18;EIF6;EIF2A;YBX1;DDX6;RACK1;MTIF2;EIF3H;TCOF1;KLHL25;RNF139
prerank,cellular response to organic cyclic compound (GO:0071407),0.3659824553834011,1.1330618034950366,0.2779017857142857,0.7333515340241019,1.0,25/141,11.66%,KCNQ1;RAPGEF2;PDGFB;RAPGEF1;ATP1A1;ATP1A3;ARL6IP5;FES;DIAPH1;INPP5K;MSN;MEF2C;ABCB4;P2RX7;ZC3H12A;LRRK2;HSP90B1;CTNNA1;NCOA4;EGR1;SPIDR;ACTB;TRPM2;SLC1A1;BRCA1
prerank,regulation of nervous system process (GO:0031644),0.49386186160606177,1.1329928207958495,0.33076923076923076,0.7328839487778308,1.0,2/18,2.98%,NOS3;APP
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5083928570291408,1.1329488676701065,0.3300813008130081,0.732325515985004,1.0,1/13,0.24%,SOX13
prerank,regulation of muscle contraction (GO:0006937),-0.37856908648695886,-1.1328501580514958,0.270516717325228,0.7253182025099695,1.0,3/26,3.47%,ATP1A2;PLCE1;TPM1
prerank,regulation of developmental growth (GO:0048638),0.45609183128280834,1.132775421678868,0.30466472303207,0.7321116270843899,1.0,6/29,7.89%,PLCB1;SPAAR;INSR;APP;FGFR3;NRCAM
prerank,regulation of regulated secretory pathway (GO:1903305),0.4326342557374513,1.1324686040572225,0.3058659217877095,0.7322486721938302,1.0,8/34,20.26%,SYT15;SYT7;LRRK2;RIMS3;RAB27A;SYT1;SYT2;GSK3B
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4199405897302513,1.1321802413454378,0.3032345013477089,0.7323443203462816,1.0,6/45,4.11%,ENG;BMPR2;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3705829139397266,1.1319137543017688,0.29826589595375724,0.7323694474206118,1.0,25/113,16.29%,UNC13B;RASIP1;PIEZO1;GBP5;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;RBX1;SPIDR;GTF2H3;CLU;TTBK1;PSMC3;CAPG;ERCC4;ATM;ICE1;PSMC5;LCP1;RACK1;PSMC6;ESR1
prerank,positive regulation of lipid localization (GO:1905954),-0.46834940756258014,-1.1315149905855995,0.3112745098039216,0.7274877250164293,1.0,3/11,11.38%,LRP1;IKBKE;NFKB1
prerank,regulation of apoptotic process (GO:0042981),0.336333376561906,1.1313959723696387,0.1492985971943888,0.7330362279838764,1.0,117/676,14.25%,RASGRF2;ACER2;ARHGEF3;TEK;GATA6;HIP1;KALRN;UNC13B;SMAD6;FLT4;HIP1R;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;CBL;TRIO;PPT1;ACTN4;PPP1R13B;PNMA1;ANO6;GLS2;SLK;ING3;HRK;ANGPT1;CASP2;LEF1;OMA1;LANCL1;MAP4K4;TNFSF10;TNFRSF25;PLEKHG5;MEF2C;IAPP;RHBDD1;SPTLC1;TAF9B;STPG1;APEX1;TOX3;TRIM24;UFM1;ARHGDIA;MADD;SETX;RYBP;TIAM2;MCF2L;KLHL20;ALK;FANK1;CRADD;STAT1;HSPB1;HSP90B1;HSPA1B;AATF;CIDEB;GADD45G;BCL2L1;UBA52;JAK2;PRKAA1;PROC;APC;PIM3;RPS27A;KLF11;APH1A;JUN;TJP1;PTK2;SGK1;ADAM10;RTN4;HMGB1;MAP3K11;BABAM2;SIAH2;ARHGEF1;CASP1;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;CLU;TMEM14A;IRF5;NF2;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;ITGB3BP;NOL3;LTK;SOS1;ATM;CFL1;BNIP3;ANP32B;CTNNB1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.39874522002842294,-1.1308563343035816,0.27217125382262997,0.7276665068574064,1.0,6/22,12.74%,SCAF8;CCNK;CDK12;ELL;THOC1;HMGN1
prerank,neuromuscular synaptic transmission (GO:0007274),0.49401918639325376,1.1303657842864754,0.3263157894736842,0.735160978817894,1.0,1/18,0.53%,FCHSD2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.39784821587493857,-1.130048826072128,0.29508196721311475,0.728111069596913,1.0,5/19,12.65%,AXL;MMP14;ZMIZ1;NCKAP1L;MDK
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.39643116976834575,-1.1297549648203367,0.27932960893854747,0.7272414892886733,1.0,9/22,19.92%,CACNA1C;ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB;CAP2;NF1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.47663210389204724,1.12962527709482,0.31892697466467956,0.7364591360750974,1.0,2/20,2.63%,RAPGEF2;ADRB2
prerank,detection of visible light (GO:0009584),0.5001028998885646,1.1296145411076122,0.33072100313479624,0.7358286759741285,1.0,1/16,1.71%,GNAQ
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.45765260187664286,-1.1295787978606462,0.3148148148148148,0.7260347238751161,1.0,4/12,17.93%,WNK1;PPARA;MDK;SKAP1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4004026358262791,-1.1293712677771106,0.2732732732732733,0.724987040291785,1.0,10/20,40.20%,LBP;PTPN22;TICAM1;HCK;IL18;CCL2;MTDH;CD14;CCL5;BCL10
prerank,linoleic acid metabolic process (GO:0043651),-0.4100753738655333,-1.1289520802561104,0.28402366863905326,0.7244946897166245,1.0,5/17,19.81%,ACSL1;GSTM2;FADS2;ELOVL1;ALOX12
prerank,negative regulation of metabolic process (GO:0009892),0.40706827808969165,1.1289032580733098,0.2860824742268041,0.7370929845134012,1.0,8/54,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4058167808789421,1.1288372700286868,0.29658792650918636,0.7365966668264181,1.0,13/51,13.86%,SYNPO;LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4283478572753329,1.128282317747523,0.3206214689265537,0.7373432464644261,1.0,6/38,9.23%,KCNQ1;KCNE3;CAV1;CAMK2D;SCN1B;DSP
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.47831719920643495,1.1280715252524594,0.3159509202453988,0.7371804943431685,1.0,8/23,17.35%,INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;INPP5J;SYNJ1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.38168677313508903,-1.1274362233096618,0.2996941896024465,0.7270232767121818,1.0,7/23,18.48%,NUPR1;PPARA;C1QTNF3;HDAC4;SIK1;CLK2;PFKFB1
prerank,sensory perception of sound (GO:0007605),0.3748108160104395,1.1273731192810281,0.2711471610660487,0.7383430147919701,1.0,6/88,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.3757398337835806,-1.127038234142348,0.2950310559006211,0.7265550358398121,1.0,13/25,30.81%,ADK;AMPD3;PRPSAP2;MTHFD1;GMPR;PNP;APRT;PPAT;DCK;PRPSAP1;AMPD2;ADA;SHMT2
prerank,neutral amino acid transport (GO:0015804),0.4506744298367645,1.1267698027162627,0.31693198263386396,0.7393187448873927,1.0,1/28,0.19%,SLC6A6
prerank,positive regulation of mRNA processing (GO:0050685),-0.4011594321962897,-1.1264867134701129,0.2756598240469208,0.7264659228351327,1.0,6/21,12.35%,SNW1;RBMX;NCBP1;DAZAP1;PAF1;TRA2A
prerank,sensory perception of light stimulus (GO:0050953),-0.2801701438932602,-1.1263956052496342,0.1853932584269663,0.7250794537621494,1.0,14/87,10.38%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;WHRN;OAT
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.38630585643238874,-1.126029709406495,0.30944625407166126,0.724465201387796,1.0,6/24,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PIK3R1;TMEFF2
prerank,positive regulation of RNA splicing (GO:0033120),-0.36593356656202297,-1.126014029158309,0.3,0.7228552674713545,1.0,11/29,19.18%,SNW1;RBMX;NCBP1;PIK3R1;DAZAP1;TRA2A;RBM20;HNRNPLL;ZPR1;U2AF2;NCL
prerank,protein complex oligomerization (GO:0051259),0.37865768727106286,1.1260105770770885,0.2644230769230769,0.7406980255996617,1.0,9/85,9.09%,LRRC8C;EHD4;AQP11;ATL2;EHD1;ATL1;ZC3H12A;ELAVL1;KCNC1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43064801838490385,1.1258277809121244,0.3143254520166898,0.7405184040969484,1.0,7/36,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,protein polymerization (GO:0051258),-0.31277114679356804,-1.125763526678166,0.2576419213973799,0.7218621405020715,1.0,11/56,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;PRKN;WASHC3;RNF135;HDGFL3;CKAP5;PREX1
prerank,negative regulation of viral release from host cell (GO:1902187),0.527086566245683,1.1256528010312672,0.3415435139573071,0.7403156227702382,1.0,4/13,20.83%,TRIM11;TRIM8;CHMP3;MID2
prerank,negative regulation of cell differentiation (GO:0045596),0.35418015437200256,1.1255285275598441,0.2696132596685083,0.7400121496653772,1.0,22/181,6.87%,JAG1;NOTCH4;GATA2;SMAD6;SMAD7;TBX1;NOTCH1;FOXO1;HEY1;DAB2IP;CAV1;TRIO;HDAC7;IL17RD;WWTR1;EFNA1;COL5A2;GATA3;EID2B;PDCD4;ADIPOR1;ZBTB16
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4460149552905265,-1.1251748476070649,0.32281553398058255,0.7218042443527044,1.0,6/14,22.82%,PPARA;IRS2;IRS1;MFSD2A;TWIST1;MTLN
prerank,regulation of protein autophosphorylation (GO:0031952),0.43022802590687564,1.1250135781448436,0.32127955493741306,0.7406458233804744,1.0,6/36,9.44%,PDGFD;ENG;PDGFB;TOM1L1;PPP2R5C;TAOK2
prerank,histone deacetylation (GO:0016575),-0.3330949887315264,-1.124796788261238,0.25650557620817843,0.7212898954397758,1.0,11/43,14.55%,PRDM5;TBL1XR1;RBM14;REST;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.38481159081747973,1.1247930219889604,0.3155940594059406,0.7405749638774642,1.0,14/80,10.68%,EPS8L2;OCLN;SAXO1;F2RL1;AGRN;CDC42EP1;FNBP1L;P2RX7;PLEKHM1;NCKAP1;APC;CCDC88A;CYFIP1;RAC1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3520609355358376,1.1239952144540957,0.2604951560818084,0.7420159828452915,1.0,53/190,20.24%,PTPRJ;CD2AP;ATP2B4;DUSP1;DAB2IP;CAV1;CASP8;HDAC7;INPP5K;PDE3B;HYAL2;PLEKHA1;SH3BP4;ADIPOR1;P2RX7;DUSP3;ZC3H12A;ARHGAP25;STAT1;BCL2L1;PRKAA1;WWC2;NMI;NR1D1;PPP2R5C;CACTIN;MARK3;PIK3IP1;PIK3CB;RTKN2;RIOK3;RHOH;CARD19;EPM2A;PHLDA3;ABCA7;RACK1;PDE4D;TMSB4X;ESR1;PYCARD;MAPK14;TRIB3;PLAUR;GSK3A;RELA;BANK1;MAPKAPK5;PPIF;MCL1;SHANK2;NPRL3;RNF34
prerank,leukotriene biosynthetic process (GO:0019370),-0.4347938122485011,-1.1239492819188934,0.28846153846153844,0.7220863315519245,1.0,9/14,36.56%,PLA2G4A;GGT5;GGT7;GGTA1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,proteasome assembly (GO:0043248),0.5416239259690809,1.1234678796122537,0.34440559440559443,0.7427379015721646,1.0,6/11,21.80%,PSMD13;PSMD4;PSMD5;PSMD9;PSMG2;POMP
prerank,positive regulation of cellular process (GO:0048522),0.33782790039358646,1.1227159755816702,0.19698492462311556,0.7439903126152873,1.0,83/565,14.01%,VEGFC;PTPRJ;SLC6A6;ACER2;EDN1;PDGFD;CLDN5;GATA2;FLT1;PDGFB;FLT4;FASN;KITLG;TBX1;MERTK;CCND2;LIFR;NOTCH1;INSR;TAL1;AQP11;CAV1;TGFB2;EMP2;ACTN4;TNFRSF18;APOA1;VEGFD;KRAS;IER5;FCGR2B;WWTR1;LEF1;GCNT2;SERTAD1;BRAT1;TBC1D8;FGFR3;TNFRSF1B;TAF9B;CUL3;ADAM17;SLC25A33;P2RX7;CD47;GNAI2;ZC3H12A;PPP3CA;CIDEB;CNOT6L;THPO;CDH3;PRKAA1;APC;NAMPT;TJP1;PTK2;ADAM10;ACACB;RPS6KA1;RPRD1B;RAC1;TENM4;RPS9;CYBA;NUMA1;NPM1;PRKD2;DOCK2;MATK;CHTOP;RTKN2;PRC1;RPS6KA3;ITGB1BP1;MCTS1;FXR1;POU3F2;PHIP;PGF;LRP5;ATM;NSMCE4A
prerank,Fc receptor signaling pathway (GO:0038093),0.3700428643356386,1.1224026257508188,0.2899543378995434,0.7441150865983848,1.0,34/110,19.26%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4623088712775185,1.12235577176664,0.319634703196347,0.7435644452245261,1.0,12/25,19.04%,ENG;BMPR2;ACVRL1;NOTCH1;SMAD2;NUMA1;TBX20;ACVR2A;ACVR2B;SMAD4;SOX11;FBXL15
prerank,hexose transmembrane transport (GO:0008645),0.46893759505600513,1.1223047020613375,0.3157894736842105,0.74304254819149,1.0,3/21,8.42%,SLC2A1;SLC5A10;SLC2A9
prerank,cellular response to BMP stimulus (GO:0071773),0.39312479589977134,1.122092157831969,0.31443298969072164,0.7429342089088486,1.0,10/66,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.444341761703426,1.1217561644913407,0.33783783783783783,0.7431667900225275,1.0,7/26,11.18%,PLCB1;CCND2;CCND3;ADAM17;MTBP;KMT2E;ADAMTS1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.40348355174589423,-1.1215892384050594,0.29427792915531337,0.7270989251879667,1.0,10/18,21.45%,SLC25A13;MTHFD1;NAALAD2;ASPG;SLC25A12;GOT1;ADI1;ASNS;MTHFR;ASPA
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4153979908753298,-1.1210387366408328,0.31213872832369943,0.7268958974436661,1.0,4/17,4.43%,PTN;IL34;SERPINE2;DICER1
prerank,presynapse assembly (GO:0099054),-0.4204064010559584,-1.120814297280519,0.3131578947368421,0.725902741201939,1.0,7/16,31.51%,WNT5A;NLGN2;PTPRD;PCLO;NLGN3;LRP4;BSN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4042532125517727,1.1207470732874754,0.3118421052631579,0.7451511463127902,1.0,14/50,24.60%,CCND2;CCND3;CCNE1;SERTAD1;CDC25C;ACTB;TTBK1;CDKN2D;BLM;MNAT1;CAMK2N1;CDKN1B;CCND1;CCNH
prerank,protein-DNA complex disassembly (GO:0032986),-0.4294511819286881,-1.1206909163158636,0.3079019073569482,0.7245914176330669,1.0,3/16,10.18%,SET;SMARCB1;SMARCD1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3828127145858498,1.120589372352825,0.3011015911872705,0.7449287543740531,1.0,23/76,17.93%,SMAD7;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;PTK2;FBXW7;RBX1;NKD2;RNF144B;LAPTM5;CLU;SMURF1;KEAP1;RACK1;CBFA2T3;RNF139;TRIB3;SOCS5;GSK3A
prerank,carbohydrate homeostasis (GO:0033500),0.3906283711745754,1.1205072258592297,0.31841432225063937,0.7444837668927444,1.0,10/67,8.29%,ADIPOR2;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1
prerank,regulation of protein localization (GO:0032880),0.3964629254180033,1.1204725391225712,0.30711610486891383,0.7439121245444341,1.0,14/58,16.27%,TRIM14;FKBP1A;PPM1F;TRIM6;FBXW7;TRIM25;TRIM17;MMD;TRIM46;VPS4A;MAP2;RACK1;DNAJB6;PLEKHM2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.482512499494907,1.1200456326302175,0.3267175572519084,0.7444161746324129,1.0,10/20,21.00%,SPPL2A;RHBDD1;ADAM17;MBTPS2;APH1A;ADAM10;PSEN2;RELA;APH1B;SPPL2B
prerank,regulation of neuron migration (GO:2001222),0.44800946187372176,1.119983528234689,0.3135464231354642,0.7439238783603017,1.0,4/26,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,negative regulation of peptidase activity (GO:0010466),-0.3309692523894542,-1.1195486372186279,0.23018867924528302,0.7261591868998416,1.0,11/47,13.44%,LRP1;SERPING1;VTN;SERPINE2;TIMP2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1;ECM1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4131600744018704,1.1194500298236163,0.3193717277486911,0.74464479665065,1.0,4/48,3.64%,CRTAM;F2RL1;LGALS9;TLR3
prerank,monocyte differentiation (GO:0030224),-0.48849110485674857,-1.1194070679065238,0.3373493975903614,0.724951599156026,1.0,5/10,10.76%,BMP4;IL31RA;MT1G;VEGFA;PPARG
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.350676861466193,1.1192980400115289,0.266025641025641,0.7443893814166619,1.0,46/186,16.05%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;NLK;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;CTNNBIP1;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;TAX1BP3;NKD2;PSMB8;NXN;PSMD14;HMGXB4;TSKU;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;RACK1;PSMC6;LZTS2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.49042401948207126,1.1189377214987646,0.32516339869281047,0.7446800822389024,1.0,5/16,17.28%,CEACAM1;SIRT4;BRCA1;ERLIN2;TRIB3
prerank,peptide biosynthetic process (GO:0043043),0.356763737429384,1.1187485408233002,0.2661555312157722,0.7445562832351185,1.0,64/153,28.17%,RPS21;RPL27;PCSK5;RPL7;FURIN;FARSB;WARS1;MRPL18;MRPL41;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;MRPL36;MRPL52;RPS9;RPLP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;MRPS18B;COPS5;DARS1;MRPL11;RSL24D1;RPL18;RPL39;RPS19;RPL31;RPS8;EIF4G1;MRPL34;EIF4EBP2;RPL3;RPL28;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;RPS13;MRPL13;RPL11;RPL14
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4286004364284803,1.1187431466151931,0.31690140845070425,0.7439154403531096,1.0,11/35,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5098993032927989,1.118050001607281,0.3448275862068966,0.7451429527643353,1.0,6/14,24.23%,TLR3;PUM2;ZDHHC5;DHX58;ANKRD17;OASL
prerank,synaptic vesicle exocytosis (GO:0016079),0.4086981056341741,1.1180137079142065,0.3151432469304229,0.7445920170729272,1.0,11/40,18.29%,UNC13B;DOC2B;BLOC1S6;SYT7;PIP5K1C;STX19;RIMS3;CPLX1;SNPH;SYT1;SYT2
prerank,microtubule anchoring (GO:0034453),0.524969635548609,1.1178144972393547,0.3442622950819672,0.7444475239386767,1.0,4/12,9.92%,SAXO1;CLASP1;PCM1;CLASP2
prerank,melanosome localization (GO:0032400),0.46374397828362085,1.1177347908795865,0.34036144578313254,0.7440067156279468,1.0,4/21,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,response to fatty acid (GO:0070542),-0.4154122882693768,-1.1174885780294697,0.3118279569892473,0.728795375530274,1.0,7/17,21.89%,PID1;IRS1;FOXO3;PDK3;SCD;LPL;NR1H4
prerank,regulation of actin filament-based process (GO:0032970),0.383712696641826,1.11723790721543,0.3131188118811881,0.7446901775086414,1.0,8/70,3.27%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK
prerank,ribosome biogenesis (GO:0042254),0.3524360162407979,1.1170354928375994,0.2838569880823402,0.7445768141578565,1.0,77/187,26.74%,BOP1;PELP1;RPL27;DHX37;RPL7;PAK1IP1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;XPO1;RPL21;DKC1;RPL37;RPS28;RPL34;MRPL36;RPS9;XRN2;EXOSC8;RPLP2;NPM1;RPS25;RPL30;RPL27A;NOL8;RAN;RPL23A;RPS15;EIF6;EIF2A;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;LSG1;EXOSC1;FBL;RPF2;WDR43;HELQ;RPL3;UTP20;GLUL;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;NIP7;UTP15;RPS17;ESF1
prerank,lipid translocation (GO:0034204),0.4646037587347962,1.1168071938301347,0.3270893371757925,0.7445472799146213,1.0,6/21,15.39%,ATP10A;ABCB4;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,regulation of macrophage chemotaxis (GO:0010758),0.47071963494238156,1.1168053719760123,0.330804248861912,0.7439073691038389,1.0,6/21,12.70%,MTUS1;MAPK1;CMKLR1;STAP1;PTK2;DDT
prerank,pre-replicative complex assembly (GO:0036388),0.3893675161278685,1.1166409681972005,0.29115479115479115,0.743718520849605,1.0,22/64,18.86%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36550312371781934,1.116411722455999,0.29617117117117114,0.7436669762351418,1.0,31/118,15.69%,EFNA5;CEACAM1;FLT4;TBX1;TANC2;EMP2;PLXND1;VASH2;PDLIM5;MEF2C;SHANK3;TSPAN12;WARS1;POGLUT1;CLASP1;LRRK2;LZTS1;LRRC4C;PPFIA2;CLASP2;NEDD4L;CDH2;INF2;MARK2;PHIP;ADGRA2;CFL1;CTNNB1;SARM1;KIF1A;PAK2
prerank,sulfur amino acid catabolic process (GO:0000098),0.5406726524974678,1.116139819781692,0.3468013468013468,0.7437304467884941,1.0,1/10,2.88%,TST
prerank,zinc ion transport (GO:0006829),-0.38194234750821987,-1.116109617123549,0.281437125748503,0.7312536828402864,1.0,5/21,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,ATP transport (GO:0015867),0.5439632184233159,1.1156987720034668,0.3528399311531842,0.7442171768433763,1.0,3/10,11.16%,SLC17A9;CD47;ABCC6
prerank,visual perception (GO:0007601),-0.2819312043362108,-1.1155514859575628,0.2155688622754491,0.7312062801635909,1.0,13/84,10.38%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;OAT
prerank,translational elongation (GO:0006414),0.37391623594580575,1.1155046517529295,0.2895040369088812,0.7441232977540858,1.0,48/101,28.54%,MRPL4;MRPL18;EEF2K;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;EEF2;GTPBP2;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;RACK1;EEFSEC;MRPL54;EEF1D;MRPS18B;EEF1G;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;EEF1A1;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,cellular response to organic substance (GO:0071310),0.3645968425842483,1.1154430163534115,0.285385500575374,0.7436323172006694,1.0,14/116,7.95%,NOS1;PDGFB;BMPR2;PTPN14;ACVRL1;ARL6IP5;INPP5K;KLF4;ACVR1;LEF1;ASAH2;LRRK2;PTPN12;DCPS
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.47091650204102053,1.1154028286055382,0.33482142857142855,0.7431142056150888,1.0,2/22,3.80%,B2M;STX7
prerank,determination of left/right symmetry (GO:0007368),0.43143946863474775,1.114822963717089,0.3306122448979592,0.7439780260852612,1.0,4/37,5.57%,TBX1;NOTCH1;DAND5;BBS7
prerank,fatty acid transmembrane transport (GO:1902001),-0.39816110391133513,-1.114799922560269,0.3165266106442577,0.7317066258961974,1.0,6/19,11.56%,PRKAG2;PRKAA2;ABCD3;SLC25A20;SLC27A1;PRKAB2
prerank,negative regulation of immune response (GO:0050777),0.3557735381784339,1.1147597226179915,0.2855579868708972,0.743498037438833,1.0,20/154,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;NMI;ACOD1;YES1;CACTIN;ADCY4;PLCG1;GLP1R
prerank,methylguanosine-cap decapping (GO:0110156),0.5272548426831247,1.1143902355579596,0.35472370766488415,0.7438089257875351,1.0,4/10,15.18%,LSM1;DCPS;DCP1B;EDC3
prerank,positive regulation of transport (GO:0051050),0.3764874154585093,1.1141758223372162,0.28519417475728154,0.7437141380780738,1.0,15/85,12.10%,GATA2;HIP1R;DOC2B;MERTK;APOA1;INPP5K;FCGR2B;CD47;CDH3;SGK1;NEDD4L;CYBA;NUMA1;ACTB;DOCK2
prerank,glycerolipid catabolic process (GO:0046503),0.47617965279413277,1.1140083209110665,0.3453689167974882,0.7435307192389373,1.0,5/19,9.85%,GPCPD1;PNPLA6;ABHD6;GDPD1;ENPP6
prerank,cell junction organization (GO:0034330),0.3847971971970557,1.113957662867019,0.2998745294855709,0.7430327541386875,1.0,16/71,13.11%,APBB2;OCLN;FBLIM1;TGFB2;AGRN;APP;PPFIBP1;SNCG;LIMS2;TJP2;ACTG1;TJP1;PPFIA2;ACTB;GRM5;PIN1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.395205642362951,-1.1136115341461383,0.29765013054830286,0.7334202761931531,1.0,3/18,5.48%,DCN;PRKN;DDHD1
prerank,central nervous system neuron differentiation (GO:0021953),0.4367264011401418,1.1135703041871665,0.3357041251778094,0.7434098919320755,1.0,10/33,19.60%,NR4A2;ATP7A;CHD5;ZC4H2;SPOCK1;CTNNB1;MAP2;OPHN1;SIN3A;GRID2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.35572308201291136,1.1132225308416759,0.29504504504504503,0.743701291819539,1.0,31/132,14.04%,TRIM14;FOXO1;INSR;PRKD1;PIK3C2A;APP;APOA1;MSN;TRIM6;FURIN;TNFRSF1B;SH3BP4;P2RX7;IRGM;ZC3H12A;LRRK2;PRR5L;PRKAA1;ROCK1;PFKFB3;HMGB1;CNOT1;GTPBP1;PTPN1;LAPTM5;VPS35;DTX3L;TRIM8;PIK3CB;HIF1A;BNIP3
prerank,regulation of microtubule nucleation (GO:0010968),-0.4818841058581691,-1.1131795475188704,0.3425,0.7330134664250376,1.0,3/10,6.83%,EML2;MECP2;CKAP5
prerank,protein K48-linked deubiquitination (GO:0071108),-0.39040648167374825,-1.1128749410502172,0.30097087378640774,0.7322141722203421,1.0,9/23,24.71%,USP33;USP20;USP50;OTUD7B;USP8;USP34;VCPIP1;TNFAIP3;BAP1
prerank,regulation of glycolytic process (GO:0006110),-0.2958666171408212,-1.1128458474859715,0.25380710659898476,0.7306925657519319,1.0,9/68,7.46%,PRKAG2;IGF1;ZBTB20;OGT;NUPR1;PRKAA2;PPARA;NUP107;PFKFB4
prerank,negative regulation of endocytosis (GO:0045806),0.45319255959288984,1.1127658308842405,0.3338150289017341,0.7442455183236278,1.0,6/24,15.39%,MCTP1;CAV1;PRKD1;RAC1;RUBCN;ABCA7
prerank,regulation of cell development (GO:0060284),0.42685051045069955,1.1126820012115997,0.31917808219178084,0.7438171217553121,1.0,11/36,14.54%,FOXO1;HEY1;HDAC9;HEY2;PRUNE1;CX3CR1;ADGRA2;HES3;CTNNB1;RHEB;HMGB2
prerank,glucan catabolic process (GO:0009251),-0.43024854895571574,-1.1124032650932358,0.3333333333333333,0.730239760207877,1.0,5/15,11.22%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3670011918475133,1.1119396749420867,0.295662100456621,0.7450479802978152,1.0,9/110,5.50%,ADGRL4;RAPGEF2;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;IAPP
prerank,natural killer cell mediated immunity (GO:0002228),0.49211940522034947,1.1114042696114816,0.349025974025974,0.7458085957579734,1.0,4/15,16.27%,TUBB;TUBB4B;LYST;PLEKHM2
prerank,actin filament bundle organization (GO:0061572),0.4324046153628379,1.1113508421728464,0.32172701949860727,0.7453272222181991,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3703260178786564,1.111145201104973,0.294811320754717,0.7451939392599471,1.0,18/101,10.37%,NOD2;DAB2IP;VIM;DEFA6;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,cellular response to heat (GO:0034605),0.42878895239683207,1.1111194845538772,0.30995792426367463,0.7446146477681049,1.0,6/35,10.09%,TRPV4;HSBP1L1;IER5;IL1A;HSPA1B;POLR2D
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4548820996256476,-1.1102609191076984,0.33164556962025316,0.7345500058015475,1.0,6/12,17.96%,APOBEC1;TET1;RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.44316741952021854,1.1099372048030909,0.34788937409024745,0.7469848549881176,1.0,9/25,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B;INSYN2A
prerank,polyol biosynthetic process (GO:0046173),0.47831345799360436,1.1098462379078562,0.32819722650231126,0.7465825284203729,1.0,3/16,3.53%,ITPKB;IP6K3;IPPK
prerank,membrane organization (GO:0061024),0.34642880989515024,1.1096502873052807,0.2641509433962264,0.7464477720029059,1.0,49/227,15.38%,HIP1;HIP1R;DYSF;PIK3C2A;CBL;ADRB2;TTPA;PPT1;DNM3;PACSIN2;SH3KBP1;VTI1B;AP2B1;ATP2C1;FCHO2;FNBP1L;PIP5K1C;TMEM43;VAMP8;SUN3;ARRB1;GLTP;CERT1;UBA52;A4GALT;ARPC5;ACTG1;RPS27A;VAMP7;CHMP1B;AP2M1;LPCAT3;EPN2;CCDC88A;MYOF;REEP1;ACTB;OCRL;REEP3;VPS4A;CHMP3;SGCZ;ARPC3;CEP55;LDLRAP1;VAPA;CHMP2B;ARPC2;CHMP7
prerank,acute-phase response (GO:0006953),-0.45973694101381035,-1.1093512078427548,0.3484848484848485,0.7354242903280382,1.0,3/12,8.52%,LBP;IL6R;CEBPB
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5347375904845729,1.1092310813615587,0.36212624584717606,0.7469007594547377,1.0,5/10,29.41%,EGR1;CLU;SORL1;HSP90AA1;HSP90AB1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.39332074225761143,1.1092029396043521,0.2925,0.7463405241459741,1.0,12/62,8.22%,ARHGEF3;F11R;NOTCH1;RAPGEF1;F2RL1;APOA1;MAP4K4;LPAR6;SHOC2;ARRB1;STK19;JAK2
prerank,glycogen catabolic process (GO:0005980),-0.4270880906200316,-1.1090643061694778,0.3392857142857143,0.734630506425869,1.0,5/15,11.22%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5366756380071838,1.1089368768023293,0.3516666666666667,0.746405542831752,1.0,3/11,12.68%,CAV1;ADIPOR1;NF2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37064420405988824,1.1084737377062197,0.29634002361275086,0.7469569472033387,1.0,6/85,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.37589887347385614,1.108424325289146,0.3212996389891697,0.7464349475213703,1.0,20/84,16.16%,NANOS1;NANOS3;BTG2;RTN1;GAPDH;ROCK1;RTN4;PRNP;CNOT1;ENC1;CLU;TOB1;RTN3;FXR1;PIN1;YBX1;ABCA7;DDX6;RACK1;RNF139
prerank,positive regulation of autophagy (GO:0010508),0.3778201950656747,1.1083570828543439,0.3209580838323353,0.7459849240631348,1.0,19/81,14.75%,TRIM14;PLK3;FOXO1;PRKD1;PIK3C2A;FBXO7;TRIM6;SH3BP4;IRGM;ZC3H12A;LRRK2;PRKAA1;ROCK1;HMGB1;TRIM8;PIK3CB;BNIP3L;BNIP3;EPM2A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5153561438949037,1.1081004312581308,0.3548922056384743,0.7460089426571467,1.0,6/13,15.85%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3897116179269018,-1.1078514332345606,0.2964071856287425,0.7365226612074292,1.0,4/20,16.13%,WNT4;C1QTNF3;SIK1;CLK2
prerank,embryonic digit morphogenesis (GO:0042733),-0.4039091245787082,-1.107383340733291,0.3041095890410959,0.7363155329366221,1.0,7/18,11.55%,GLI3;OSR1;CREBBP;INTU;SALL1;TBX2;HDAC1
prerank,presynaptic endocytosis (GO:0140238),0.4403156020468729,1.1072974389237047,0.34277198211624443,0.7474772278605253,1.0,9/24,18.29%,SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,endothelial tube morphogenesis (GO:0061154),0.5410642107944099,1.106683851579182,0.37800687285223367,0.7484133096308307,1.0,5/10,14.92%,ACVRL1;RHOB;PRKD2;CTNNB1;CSNK2B
prerank,ion transport (GO:0006811),-0.27311866821236314,-1.1065010539032782,0.25806451612903225,0.7370645558162375,1.0,15/111,6.83%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC12A2;SLC26A7;WNK1;SLC26A2;SLC8A3;WNK4;ANO1;SLC9A2;SLC17A5;SLC9A9;SLC5A5
prerank,positive regulation of ERAD pathway (GO:1904294),0.5052151752754798,1.1061635831128707,0.3559870550161812,0.7491403708489515,1.0,5/13,15.56%,CAV1;RNF185;NFE2L2;BAG6;UBQLN2
prerank,cardiac muscle cell contraction (GO:0086003),-0.38849923821920435,-1.1059036358357062,0.3107344632768362,0.7370577225946805,1.0,4/19,6.67%,CACNA1C;GSN;CACNA2D1;CACNA1G
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.37881389357292444,-1.1050121472594066,0.2909090909090909,0.7380578074620662,1.0,7/23,18.10%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1;FBXW11;ZW10
prerank,regulation of dopamine secretion (GO:0014059),0.44785205529412864,1.1049291636782321,0.3663663663663664,0.7517376258258492,1.0,2/25,3.73%,SYT15;SYT7
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4006733170417386,-1.1046758961995218,0.3072289156626506,0.7374538641818627,1.0,6/19,6.40%,ROBO1;DCN;CCBE1;CD63;ADAMTS3;XDH
prerank,regulation of viral release from host cell (GO:1902186),0.4681283429684488,1.104558824989187,0.3535660091047041,0.7520635247402423,1.0,6/21,15.24%,TRIM11;TRIM25;TRIM8;VPS4A;CHMP3;CHMP2B
prerank,organophosphate catabolic process (GO:0046434),-0.4661170516901632,-1.1045369558397384,0.3464373464373464,0.7362772261374043,1.0,8/11,47.54%,ABHD12;ENPP2;ANGPTL3;PLBD2;PLBD1;NUDT15;PDXP;PON1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4697196153322929,1.1044037132716105,0.32565284178187404,0.7518328221198979,1.0,3/20,9.48%,EPAS1;HSPA1B;EGR1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2929492718585836,-1.1043843335802843,0.24861878453038674,0.7351383869109399,1.0,11/74,3.48%,EYA2;IGF1;EYA1;TGFBR1;BMP5;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5040053342955557,1.1041800605052872,0.35714285714285715,0.7517786270038425,1.0,6/14,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;ANGEL2;MAPK14
prerank,cellular response to retinoic acid (GO:0071300),-0.32753220719289633,-1.1038265753755248,0.28205128205128205,0.7351213862621989,1.0,8/42,9.43%,EPHA3;PTK7;WNT6;WNT5A;SNW1;WNT9A;FZD7;NDUFA13
prerank,negative regulation of response to external stimulus (GO:0032102),0.36140995126178516,1.1037875817871072,0.3087719298245614,0.7521317264421666,1.0,18/105,12.41%,TEK;AOAH;CRK;APOA1;KLF4;GATA3;NFKBIL1;DUSP3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35;INPP5F;CTNNA2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38525138003395465,-1.1035576501820712,0.3255131964809384,0.7342858215514935,1.0,3/20,1.27%,BMPR1A;GLI2;NBL1
prerank,myofibril assembly (GO:0030239),-0.32847073584998937,-1.103514582806646,0.26480836236933797,0.7328446658442216,1.0,8/42,10.20%,PDGFRB;PDGFRA;TPM1;ACTN2;OBSL1;TMOD2;CFLAR;PGM5
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.46219616954679643,-1.103232738416362,0.3374083129584352,0.732084497780171,1.0,4/10,10.77%,HNMT;SMOX;ALDH7A1;SARDH
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4942207314323536,1.1028763264163568,0.3582554517133956,0.7539061319833779,1.0,4/17,7.31%,NOTCH4;NOTCH1;PLXND1;STAT1
prerank,regulation of BMP signaling pathway (GO:0030510),0.37877621330665,1.1025783427683684,0.30544993662864384,0.7540014062114258,1.0,7/73,1.86%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;NOTCH1;DAND5
prerank,ventricular septum morphogenesis (GO:0060412),0.4474904937175498,1.1024899175117342,0.3147590361445783,0.7536012999625233,1.0,7/27,4.11%,BMPR2;SMAD7;NOTCH1;HEY1;TGFB2;HEY2;ACVR1
prerank,neuron projection morphogenesis (GO:0048812),-0.26106221074881913,-1.1019486310980346,0.2336448598130841,0.7341675911970641,1.0,28/137,12.09%,ALCAM;GAS7;SDC2;FGFR2;DOCK7;NBL1;DCLK1;BMP7;FARP1;DCDC2;DOCK10;S100A6;DLG4;DICER1;PARD3;EPB41L3;NGF;MAP1A;CTNND2;BRSK1;FLRT1;NRK;ZDHHC17;DTNBP1;PLXNB1;DBN1;SLITRK1;NCKAP1L
prerank,positive regulation of keratinocyte migration (GO:0051549),0.534082227432066,1.1015722125279863,0.3579638752052545,0.7553497008232412,1.0,2/10,4.97%,IQSEC1;MAP4K4
prerank,protein polyubiquitination (GO:0000209),0.33560397767891875,1.1015563891381934,0.2716049382716049,0.754757813276298,1.0,85/297,21.24%,LMO7;TRIM14;ZNRF1;TRIM69;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM6;TRAF1;RNF125;ARIH1;CUL3;UBE2Q1;UBE2D1;PSMD4;KLHL20;FBXL18;WWP1;UBE4A;UBA52;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF115;FBXW7;RBX1;PSMB10;SIAH2;RNF144B;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;BRCA1;DTX3L;FBXO4;SMURF1;UBE2T;CBFB;UBE2J2;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;FBXL13;ANAPC7;PSMC6;PSMA4;FBXO6;UNKL;ANAPC13;RUSC1;FBXO10;MKRN1;PSMD5;PSMD9;PSMB6;FBXL15;ANAPC4;RNF166;BARD1;RNF5;RNF34;PSMB2;LNPEP;WWP2;WSB1;TMEM129
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4772779074593057,-1.101259701583564,0.3256997455470738,0.7330855899889308,1.0,4/10,18.48%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,negative regulation of glycolytic process (GO:0045820),-0.4772779074593057,-1.101259701583564,0.3256997455470738,0.7330855899889308,1.0,4/10,18.48%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4455724714560262,1.1010441384638454,0.34323922734026746,0.755434858903516,1.0,10/24,18.66%,MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,phospholipid catabolic process (GO:0009395),0.4552593357007964,1.1008636405255292,0.3533026113671275,0.7552774518580306,1.0,5/24,9.85%,GPCPD1;SMPDL3A;PNPLA6;GDPD1;ENPP6
prerank,defense response to virus (GO:0051607),0.3655596858859844,1.1004557539201056,0.30526315789473685,0.7557004468118879,1.0,31/100,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;AKAP1;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;CXCL10;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,protein homotetramerization (GO:0051289),0.39971477634388836,1.1003550069620895,0.32847682119205296,0.7553329863573448,1.0,9/49,11.28%,GBP5;B2M;GLS;SSBP1;ALDH9A1;MCOLN1;ACOT13;ACACB;TRPM2
prerank,stabilization of membrane potential (GO:0030322),0.4857007040634993,1.1002925422633156,0.3453125,0.7548835172520295,1.0,2/16,5.82%,KCNN4;KCNK12
prerank,negative regulation of defense response to virus (GO:0050687),-0.4839783917417735,-1.1001500014815742,0.373134328358209,0.7347019821259332,1.0,6/10,39.31%,PPM1B;C1QBP;TRAF3IP1;TSPAN6;RNF26;PCBP2
prerank,glucose homeostasis (GO:0042593),0.37228646699382745,1.100091681401551,0.341047503045067,0.7547927937130723,1.0,12/83,8.68%,ADIPOR2;FOXO1;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1;NR1D1
prerank,ether lipid biosynthetic process (GO:0008611),-0.4919697552514421,-1.0993993212077005,0.3588516746411483,0.7352514657661177,1.0,7/10,21.07%,GNPAT;LPCAT2;PLA2G4A;PEDS1;CHPT1;PEX7;PLA2G4C
prerank,prostanoid metabolic process (GO:0006692),-0.4308438215262579,-1.0992898973879393,0.3596938775510204,0.7340260137901397,1.0,4/13,14.80%,PTGES;PTGS1;HPGD;GSTM1
prerank,endoplasmic reticulum organization (GO:0007029),0.377598204106916,1.0990354268226274,0.33578431372549017,0.7568972527920352,1.0,16/72,12.92%,ATL2;CAV2;APP;DOP1B;SHTN1;ATL1;LRRK2;REEP2;RTN4;PRNP;LPCAT3;GET1;REEP1;REEP3;RTN3;UBE2J2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3830224559803419,1.0990233497379314,0.3341645885286783,0.7562970737006164,1.0,20/69,19.79%,RNF103;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;PSMC6;SEL1L;ERLIN2;FBXO6;DNAJC10;RNF5
prerank,mammary gland development (GO:0030879),0.4591373312819326,1.098625159461448,0.3502994011976048,0.7567104015485728,1.0,2/21,2.28%,NOTCH4;CAV1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3514404693952773,-1.098609862691798,0.28762541806020064,0.7344564211794028,1.0,10/29,21.21%,TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;DHX34;E2F1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4604025672192369,-1.0983409072795076,0.36318407960199006,0.7321456945020893,1.0,6/10,27.39%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4604025672192369,-1.0983409072795076,0.36318407960199006,0.7321456945020893,1.0,6/10,27.39%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.35515106840169075,-1.0981181416230004,0.3164983164983165,0.7312772097497638,1.0,7/30,6.78%,IGF1;NOTCH2;ITGAV;SHC1;NGF;IRS2;SRC
prerank,regulation of myotube differentiation (GO:0010830),0.4579104326997873,1.0980625201159653,0.3570391872278665,0.7574613903266852,1.0,3/24,3.11%,PIEZO1;NOTCH1;HDAC9
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4691834415887042,1.0975490335061506,0.35987261146496813,0.7581876494099014,1.0,7/18,17.72%,VTI1B;STX7;VAMP8;ACTB;VPS4A;LDLRAP1;SPTBN1
prerank,positive regulation of axonogenesis (GO:0050772),0.40980510998334113,1.0975151886162564,0.33422103861517977,0.7576428687765272,1.0,9/43,7.01%,PLXNA4;MACF1;PLXND1;NTN1;SHTN1;SEMA7A;ARHGDIA;TIAM2;ISLR2
prerank,response to chemokine (GO:1990868),0.5113078123894872,1.0974720116487109,0.38801261829652994,0.7571241117261774,1.0,5/13,8.47%,DUSP1;OXSR1;LRCH1;ZC3H12A;STK39
prerank,granulocyte differentiation (GO:0030851),0.4830998506521427,1.0970755811998798,0.37404580152671757,0.7574932141994181,1.0,5/18,16.90%,TAL1;LEF1;CEBPA;CBFA2T3;RARA
prerank,regulation of keratinocyte migration (GO:0051547),0.5169069902346083,1.0970474924096731,0.35170178282009723,0.7569453351911172,1.0,2/12,4.97%,IQSEC1;MAP4K4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4037531743016445,-1.0969697883047809,0.31607629427792916,0.7329356346989137,1.0,4/17,6.64%,SLC12A2;SLC9A2;SLC6A1;SLC9A9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.47772009534136967,1.0969347026675713,0.3640552995391705,0.7566289336762471,1.0,3/18,9.04%,TEK;SHTN1;ROCK1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.367542506726104,-1.0968762308611417,0.30246913580246915,0.7316943456178812,1.0,8/26,23.49%,ATP1A2;CALM2;ADRA2A;DRD2;GSTM2;GSTO1;CBARP;CASQ2
prerank,response to cytokine (GO:0034097),-0.25933765315095286,-1.0967165788302633,0.2247191011235955,0.7306639322845393,1.0,19/141,7.03%,PID1;PTPN13;AFF3;COL3A1;DPYSL3;ALDH1A2;IL1R1;PTPN9;BCL2;IKBKE;PTPN4;TIMP2;IL6R;ANXA1;SMAD3;ADAM9;SRC;TBK1;CXCL16
prerank,positive regulation of signal transduction (GO:0009967),0.3392089360948558,1.0966186835726401,0.28361344537815125,0.7567579646853678,1.0,33/238,9.66%,JAG1;TEK;JAG2;NOTCH4;NOS3;KLF2;FAS;VWF;NOTCH1;JCAD;NOD2;MACF1;DAB2IP;CAV2;TGFB2;EMP2;DLL4;HHEX;MGAT5;LIMS2;TSPAN14;RAB34;SHANK3;GATA3;POGLUT1;CRADD;LRRK2;MYO1C;JAK2;CDH3;TPD52L1;GKAP1;TM2D3
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3341513174823884,1.096186942926202,0.28615702479338845,0.7572712788767921,1.0,99/306,24.07%,GCNT1;NR4A2;EXT1;RBBP8;RPS21;RPL27;RPL7;FARSB;WARS1;MRPL18;ORC3;ALAS1;EEF2K;MRPL41;POLR2G;RPS14;RPS27A;RPL35;FEN1;MLF1;RPL21;NFKBIB;POLR2D;RPL37;RPS28;RPL34;TUFM;GTPBP1;MRPL36;BRIP1;MRPL52;RPS9;POLA1;RPLP2;EEF2;GTPBP2;BRCA1;MRPL23;RPS25;ORC5;RPL30;RPS5;RPL27A;RAD1;MRPL24;ATM;MRPL32;MRPS12;TAF1B;RPL23A;RPS15;RPL19;KAT7;RPS18;RFC2;RPL32;RAD9B;ST3GAL2;POLR2I;EEFSEC;PWP1;RPL37A;RPL18A;EEF1D;MMS19;MRPS18B;COPS5;HOXD3;ATRIP;GOLPH3;MEF2A;PTMA;BARD1;EEF1G;HUS1;DARS1;RRAGC;MRPL11;RSL24D1;BLM;RPL18;RPL39;RPS19;RPL31;RPS8;RMI1;POLR2C;PAX8;ORC4;KIN;TSFM;EIF4G1;POLR2B;POLR2J;MRPL34;RNASEH2A;EIF4EBP2;WRN;RPL3
prerank,positive regulation of binding (GO:0051099),0.3736144699203809,1.095894044257195,0.32484848484848483,0.7574195713061658,1.0,23/84,17.31%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;HMBOX1;EPB41;LRRK2;NVL;HMGB1;DHX9;MARK3;DTX3L;PIN1;RAN;HMGB2;KDM4D;RARA;MEN1;TRIB3;PLAUR
prerank,cellular response to hypoxia (GO:0071456),0.35206190053143094,1.0957035635877093,0.32842582106455265,0.7572595297063202,1.0,38/126,20.43%,EPAS1;GATA6;PLK3;PSMD13;ELOC;PGK1;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;HP1BP3;CUL2;PSMB8;HIF1AN;PSMD14;SUV39H2;PSMA7;PSMC3;BNIP3L;HIF1A;PSMA8;PSMC1;BNIP3;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;ACAA2;PSMB2
prerank,inorganic anion transport (GO:0015698),-0.30775840749045735,-1.0956032738727313,0.26495726495726496,0.7322462975656868,1.0,8/53,6.83%,SLC13A4;SLC4A10;SLC26A7;ANO1;CLCN2;ENPP1;ENPP3;SLC5A5
prerank,positive regulation of cilium assembly (GO:0045724),0.48179629968384385,1.095483437714939,0.3581395348837209,0.7572178937766646,1.0,8/18,25.80%,SAXO1;CEP135;CCDC88A;CEP120;HAP1;MARK4;WRAP73;KCTD17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.34227518650252176,1.0954730874688012,0.3102310231023102,0.7566118640346445,1.0,70/168,25.82%,RPS21;RPL27;RPL7;LSM1;ZC3H12A;CNOT6L;MTPAP;DCPS;UBA52;DCP1B;POLR2G;RPS14;RPS27A;RPL35;ETF1;RPL21;POLR2D;RPL37;CNOT1;RPS28;RPL34;RPS9;XRN2;EXOSC8;PELO;RPLP2;RPS25;HELZ2;RPL30;RPS5;XRN1;RPL27A;ATM;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CNOT2;TENT2;EXOSC9;TUT7;DXO;NBDY;CTIF;SMG7;RPL18;RPL39;ZFP36L1;RPS19;EXOSC10;CSDE1;SMG9;RPL31;RPS8;DIS3L2;SMG8;EIF4G1;PATL2;RPL3;MRTO4;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3326423199868036,1.095280445264012,0.2484787018255578,0.7564944079784451,1.0,43/417,9.19%,PRDM16;MECOM;SOX13;GATA6;PLCB1;PDGFB;DACH1;RPS6KA5;SMARCA2;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;GATAD2A;NR1D1;FOXP1;MBD1;JUN
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5072103193128134,1.0950931322196393,0.3658940397350993,0.7563663545956094,1.0,6/13,17.37%,YAE1;BOLA2;ISCA2;GLRX5;GLRX3;MMS19
prerank,protein deacetylation (GO:0006476),-0.32141052750320775,-1.0947550221746822,0.2835820895522388,0.7330930603534763,1.0,12/41,14.55%,PRDM5;TBL1XR1;SIRT3;FLNA;RBM14;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,regulation of kinase activity (GO:0043549),0.36811723487811987,1.0945503242987769,0.3218116805721097,0.7570901770880067,1.0,13/89,8.03%,TEK;FLT1;TIE1;LDB2;FLT4;MERTK;INSR;EMP2;FGFR3;ALK;LMTK2;RBL1;NLRC5
prerank,hexose biosynthetic process (GO:0019319),-0.32440799461437725,-1.0942873914138245,0.2900763358778626,0.7329156849820376,1.0,15/42,21.22%,SLC39A14;SLC25A13;CHST15;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;AKR1B1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.32840501575617703,1.0940845011807154,0.236,0.7576943281408433,1.0,66/572,9.89%,PRDM16;SOX13;NOTCH4;KLF8;EDN1;GATA6;PDGFB;LDB2;DACH1;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;HEY2;HMBOX1;KLF4;MAFK;EFNA1;MEF2C;SMAD2;TAF9B;PHF6;GATA3;BCL6B;RTF1;UBE2D1;ZBTB16;GTF2IRD1;STAT1;PURA;TMPRSS6;UBA52;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;JUN;TCF3;HMGB1;ARID5A;MAD2L2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.48758579783347944,1.0940408687857586,0.35691823899371067,0.7571922159370916,1.0,8/16,25.05%,CAV1;ADIPOR1;INPP5F;NF2;PTPN2;LEPROT;PARP14;PPP2R1A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.433402899183706,1.0938264652513492,0.35050071530758226,0.7571368091732932,1.0,3/27,4.95%,GJA5;CAV1;CAMK2D
prerank,negative regulation of anoikis (GO:2000811),0.4970867681830821,1.0934922285368402,0.3836065573770492,0.7573774064825762,1.0,5/14,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,glutamate metabolic process (GO:0006536),0.4662090729183873,1.0933592803194172,0.36187399030694667,0.7570989455534011,1.0,4/19,5.83%,DGLUCY;GLS2;GLS;GLUD1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4719187622805878,-1.093024767934667,0.3686746987951807,0.7350157026426098,1.0,3/10,6.78%,DCN;BCL2;SRC
prerank,tyrosine metabolic process (GO:0006570),0.5173238620266131,1.0928601770293422,0.35978835978835977,0.7577724286698239,1.0,2/11,9.86%,HGD;TYR
prerank,muscle tissue development (GO:0060537),0.5024900971805598,1.0925217553633344,0.3590163934426229,0.7580754144519446,1.0,3/13,6.29%,ENG;CSRP2;POGLUT1
prerank,actin filament bundle assembly (GO:0051017),0.4248327399924133,1.0922517014502295,0.3484848484848485,0.7581834700341836,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5370770967972124,1.0922275824914018,0.37865748709122204,0.7576196003186719,1.0,1/10,1.04%,ACE
prerank,negative regulation of B cell proliferation (GO:0030889),0.5194332953034775,1.091853462709634,0.36394557823129253,0.7580264379604018,1.0,3/11,13.96%,FCGR2B;TYROBP;ATM
prerank,regulation of actin filament-based movement (GO:1903115),-0.45589721101602887,-1.0917290137848377,0.37740384615384615,0.7370778209531651,1.0,2/10,1.63%,ANK2;PDPN
prerank,reticulophagy (GO:0061709),-0.45017637249479414,-1.0914899575972166,0.349009900990099,0.7362347217591622,1.0,4/12,11.03%,TEX264;UBA5;ATG2A;ULK2
prerank,replication fork processing (GO:0031297),-0.3257345568888143,-1.0914498179713583,0.2967741935483871,0.7348566210791477,1.0,15/38,27.18%,NUCKS1;BOD1L1;FBH1;ATR;THOC1;RTEL1;SMARCAL1;RFWD3;ATRX;ZRANB3;MMS22L;EME2;SETMAR;RAD51;CENPX
prerank,negative regulation of myoblast differentiation (GO:0045662),0.49865123066171035,1.091428041948497,0.3739967897271268,0.7585271340959984,1.0,2/13,6.06%,NOTCH1;EID2B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5186331918112941,1.0910365491988894,0.37815126050420167,0.7589407914233205,1.0,3/10,6.58%,ETFDH;ETFA;ETFB
prerank,protein tetramerization (GO:0051262),0.3744952492339508,1.0906224911526676,0.3383458646616541,0.759341471527252,1.0,12/67,11.28%,GBP5;B2M;GLS;SSBP1;FARSB;ALDH9A1;MCOLN1;GRIN2B;KCNC1;ACOT13;ACACB;TRPM2
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3550508735697569,-1.0905782716963268,0.32335329341317365,0.7357676976586202,1.0,10/28,18.44%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,regulation of inflammatory response (GO:0050727),0.341850702636265,1.089707956636621,0.32365591397849464,0.7611025354397333,1.0,29/190,11.41%,TEK;NOD2;AOAH;SPATA2;APP;APOA1;TLR3;KLF4;SEMA7A;HYAL2;TNFRSF1B;GATA3;BCL6B;PDCD4;CD47;MFHAS1;CEBPA;CD200;JAK2;PROC;NMI;NR1D1;ACOD1;FOXP1;DHX9;LPCAT3;CASP1;NFKBIA;VPS35
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.40806087668717583,1.0895867156725705,0.3428184281842818,0.7607831728254211,1.0,7/43,9.19%,CDH13;EDN1;PDGFB;STAT1;HTR1B;FOXP1;JUN
prerank,mitochondrion transport along microtubule (GO:0047497),0.5074451090641909,1.0894984732712671,0.3745819397993311,0.76040129497219,1.0,6/13,21.60%,UXT;RHOT2;HIF1A;SYBU;LRPPRC;UBB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.39027890919439634,-1.0893819316559439,0.3494318181818182,0.7375124992640923,1.0,6/21,12.26%,DCN;CHST15;BGN;VCAN;CHPF2;CSPG4
prerank,embryonic organ development (GO:0048568),0.3866880115065534,1.0892947258569254,0.34271099744245526,0.7603202078122148,1.0,10/61,6.03%,SOX17;KITLG;HEY1;TAL1;TGFB2;SOX18;TEAD4;HEY2;PCSK5;GATA3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5182312585386442,1.0892470234363534,0.3831932773109244,0.7598363431884622,1.0,4/12,14.25%,RAD21;FEN1;BUB1;CTNNB1
prerank,cell junction assembly (GO:0034329),0.3538878726748205,1.0891653871889206,0.33791523482245134,0.7594504325314335,1.0,29/100,20.66%,TRPV4;CLDN5;FBLIM1;DNM3;SPOCK2;PLXND1;LIMS2;SHANK3;GJA4;NRCAM;FLRT3;ACTG1;TJP1;CDH12;KIRREL3;CDH2;ACTB;ACHE;PCDHB16;PCDHB14;CDH22;PCDHB9;OPHN1;DSCAM;SHANK2;CDH18;CDH24;BDNF;NRXN1
prerank,regulation of axonogenesis (GO:0050770),-0.3086369844725798,-1.0889790188446637,0.2956521739130435,0.737082489503393,1.0,13/51,11.75%,ROBO1;PLXNA2;SLIT2;SIPA1L1;NTRK2;PLXNB2;NGF;BRSK1;KIF13B;CHN1;PLXNB1;ARHGAP35;SLITRK1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.44042496800282915,1.0884546305994205,0.36142857142857143,0.7606505210474962,1.0,6/27,12.62%,TIRAP;IRAK2;UBA52;RPS27A;TAB2;BTK
prerank,regulation of interferon-gamma production (GO:0032649),0.3806730486021089,1.0882653831243234,0.32521315468940315,0.7605450355752362,1.0,14/71,16.90%,CRTAM;F2RL1;LGALS9;TLR3;CD47;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;PDE4D;PYCARD;RARA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5187594967931491,1.0881072348683603,0.39152542372881355,0.7603313730908737,1.0,4/11,12.73%,LGALS9;HMGB1;VSIR;CBFB
prerank,maintenance of protein localization in organelle (GO:0072595),-0.38847244413037335,-1.0872396646644442,0.35294117647058826,0.740284481089617,1.0,8/19,20.60%,HK2;BCL3;HNRNPU;TOPORS;MORC3;SUPT7L;PML;CHCHD10
prerank,cellular senescence (GO:0090398),-0.35041039979735084,-1.0868799158087203,0.3592233009708738,0.7397482913717002,1.0,11/27,27.52%,SMC6;TBX2;HMGA2;ECRG4;CDKN1A;PRKCD;PML;ULK3;SRF;OPA1;NSMCE2
prerank,positive regulation of cellular senescence (GO:2000774),0.5333949050374419,1.0866958550176393,0.38596491228070173,0.7633943259692118,1.0,1/10,1.74%,B2M
prerank,regulation of G0 to G1 transition (GO:0070316),0.41059277536245053,1.0866121362195547,0.34746922024623805,0.7629672573813218,1.0,7/38,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4420027919722989,-1.086126663757087,0.3527777777777778,0.7401683007341465,1.0,3/12,11.55%,DAB2;HEYL;HDAC1
prerank,electron transport chain (GO:0022900),0.48575051071566966,1.085759938985204,0.3679092382495948,0.7645554998706663,1.0,5/15,14.33%,ETFDH;ETFA;ETFB;UQCRFS1;CYB561
prerank,post-translational protein modification (GO:0043687),0.33006193533826955,1.0855824928599433,0.28294177732379977,0.7644099591043699,1.0,80/332,19.04%,LMO7;EPAS1;ASB4;RAB11A;GOLM1;APP;TULP4;KLHL2;FBXO7;APOA1;COPS4;CISH;PSMD13;FBXL14;FBXL5;KLHL3;TMEM132A;ELOC;RHBDD1;GAN;CUL3;PSMD4;KLHL20;ZBTB16;PRKCSH;FBXL18;IGFBP7;SOCS6;HSP90B1;ASB5;FEM1C;PROC;FBXL16;IGFBP4;ADAM10;PSMA5;FBXW7;RBX1;PSMB10;CUL2;APLP2;FBXW2;CDH2;PSMB8;PSMD14;FBXO4;CP;COPS8;DCAF17;PSMA7;PSMC3;KEAP1;DCAF10;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;KLHL25;FBXL13;PSMC6;CST3;KLHL9;PSMA4;FBXO6;MEN1;CALU;SOCS5;COPS5;FBXO10;PENK;PSMD5;PSMD9;FEM1A;TIMP1;DCAF13;PSMB6;FBXL15
prerank,import into nucleus (GO:0051170),-0.28934669406706587,-1.084700827870858,0.275,0.7425717420981689,1.0,29/73,26.03%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;GEMIN5;NUP155;TNPO3;SMN1;RANBP6;IPO5;FAM53C;SNRPF;NUP93;TNPO2;RANBP17;HTATIP2;SNUPN;TSC2;PHB2;SNRPD3;SEC13;SYK;IPO7;GEMIN7;POM121;IPO8;SNRPD1;NUP188
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3318557085784797,1.0841423286927765,0.31326530612244896,0.7674598581077867,1.0,36/308,10.24%,PRDM16;EPAS1;ADIPOR2;PLCB1;PDGFB;BMPR2;CRTAM;CAV1;F2RL1;TGFB2;ADRB2;CADM1;INPP5K;ACVR1;WWTR1;LEF1;GCNT2;YBX2;OMA1;SMAD2;IL1A;ADIPOR1;NPR1;ZBTB16;KDM3A;CMKLR1;VAMP8;GADD45G;JAK2;APC;GAPDH;VAMP7;ROCK1;RTN4;MAD2L2;LURAP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.433203340469595,1.0841226459152753,0.39039039039039036,0.7669020006453046,1.0,8/28,17.88%,FYN;INPP5K;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3;GDI1
prerank,synaptic vesicle recycling (GO:0036465),0.41624644285108814,1.083950803950474,0.34442836468885674,0.7667103810673825,1.0,10/31,18.29%,SNCG;SYT7;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4544812894331266,-1.0834927280713118,0.3794749403341289,0.7444895346070908,1.0,5/11,23.44%,APOE;ATG7;WIPI2;WDR45;PORCN
prerank,protein ubiquitination (GO:0016567),0.32587167797027766,1.083146001607831,0.2711693548387097,0.7681630337264248,1.0,99/471,16.16%,LMO7;EPAS1;ASB4;TRIM14;RNF103;FBXL2;ZNRF1;TRIM69;CBL;HERC2;KLHL2;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM11;TRIM6;RNF38;ELOC;RNF125;RNF185;ARIH1;GAN;CUL3;UBE2Q1;ARRDC1;RTF1;UBE2D1;TRIM24;PSMD4;KLHL20;FBXL18;ARRB1;WWP1;ASB5;UBE4A;UBA52;NFE2L2;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF141;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;ENC1;RNF144B;TRIM17;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;OBI1;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;CBFB;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;RAD18;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;RACK1;TRAIP;KLHL25;FBXL13;KLHL24;ANAPC7;PSMC6;RNF139
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4888262586774974,1.0830944275484402,0.36666666666666664,0.7676924902397321,1.0,3/14,4.06%,PRKD1;EMP2;LIMS2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5140203754970054,1.0827167645742102,0.39168110918544197,0.7680583211876014,1.0,2/11,2.67%,FAS;LGALS9
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2693618283684637,-1.0825487870518158,0.273972602739726,0.7455892832816761,1.0,29/104,17.78%,UST;DSE;DCN;OGN;FMOD;SLC26A2;B3GNT2;GSTT1;CHST15;BGN;PRELP;GCLC;ST3GAL4;B4GALT1;VCAN;GSTZ1;GGT5;CHPF2;LUM;CSPG4;OMD;GSTA3;GSTM1;B4GALT2;GSTM2;GGT7;GGTA1;PAPSS2;AKR1A1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3700668023187346,1.082381641486354,0.3281061519903498,0.7682862941803424,1.0,24/72,18.86%,TLR3;TIRAP;PSMD13;CARD10;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;COPS8;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.32924752961611653,1.0816521430089912,0.2897959183673469,0.7695394280042335,1.0,59/348,12.61%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;KLF2;OCLN;NOTCH1;INSR;HEY1;IFNGR1;TNRC6C;LGALS9;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;WARS1;IL1A;MAPK1;P2RX7;ZC3H12A;HSPA1B;ARRB1;PLSCR1;TBC1D5;CDH3;NFE2L2;PRKAA1;ACTG1;ROCK1;STAP1;EGR1;TASOR;TYROBP;AGO4;PTPN1;VSIR;LAPTM5;NWD1;VPS35;INPP5F;BRCA1;VSTM2A;CLU;DTX3L;HINFP;PIK3CB;TTBK1
prerank,protein glycosylation (GO:0006486),0.35253384943111704,1.0816026395343015,0.3333333333333333,0.7690394560187265,1.0,26/125,16.63%,EOGT;ST8SIA6;GALNT18;ST3GAL6;POMGNT1;ST6GALNAC2;AQP11;SERP2;MGAT5;GCNT2;GALNT7;POGLUT1;NUS1;B3GNT3;DPM1;TET3;C1GALT1C1;MGAT1;B3GALNT2;KRTCAP2;ST3GAL1;ALG11;MPI;ST3GAL2;OGA;DDOST
prerank,response to acidic pH (GO:0010447),-0.43024755552133187,-1.0813811968495133,0.37755102040816324,0.7474284930055043,1.0,4/13,29.93%,GPR4;SLC9A1;LGMN;IMPACT
prerank,multivesicular body organization (GO:0036257),0.42839583158561256,1.0812589131663919,0.37517241379310345,0.769275774531098,1.0,12/31,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;RAB27A;MVB12A;STAM2;CHMP1A
prerank,iron ion transport (GO:0006826),-0.3149229780248551,-1.0810658783503608,0.32677165354330706,0.7468215672580812,1.0,8/47,8.32%,STEAP3;SLC39A14;SCARA5;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.497809191096085,1.0810394807124373,0.3851132686084142,0.7692420620821696,1.0,3/13,5.58%,APP;AKAP5;SHANK3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.40203782204709776,1.0803173732218712,0.349862258953168,0.7704196877450594,1.0,9/37,10.75%,VCAM1;CRTAM;CADM1;AMIGO2;TENM3;NECTIN4;NECTIN1;FAT4;TENM4
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.33978834181657563,1.0802291001952968,0.328042328042328,0.7700339195826627,1.0,36/208,14.85%,PLCG2;TRIM14;NOD1;NOD2;DAB2IP;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;TRAF1;JMJD8;ZC3H12A;STAT1;HSPB1;NR1D1;GAPDH;CACTIN;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3;TRIM8;DDX21;RIOK3;RHOH;TMED4;CARD19;VAPA
prerank,inorganic cation transmembrane transport (GO:0098662),0.33334435822810976,1.0795324502320216,0.315625,0.7711504340160169,1.0,33/268,9.99%,ATP2A3;SLC6A6;KCNN4;KCNQ1;TRPV4;RHCG;ATP2B4;KCNH8;ATP1A4;ATP1A1;ATP1A3;CACNA1A;FKBP1A;KCNN3;KCNG3;SLC8A1;ATP2C1;ANO6;SCN11A;ORAI1;KCNK12;P2RX7;SLC30A1;MCOLN1;SLC6A4;SLC39A6;SCN1B;KCNC1;KCNH7;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,regulation of vasculature development (GO:1901342),0.43375685894905736,1.0795194779840633,0.374079528718704,0.7705753320633938,1.0,10/26,22.01%,EMP2;PLXND1;VASH2;TSPAN12;WARS1;ADGRA2;CTNNB1;ETS1;EGLN1;EPHA2
prerank,negative regulation of macrophage activation (GO:0043031),0.47444154949347855,1.0793222729758372,0.3668730650154799,0.7704717744934676,1.0,4/16,8.68%,FCGR2B;ZC3H12A;CD200;NR1D1
prerank,cellular response to unfolded protein (GO:0034620),0.43668936636322675,1.079276083976435,0.37572254335260113,0.7699950529535585,1.0,8/26,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,receptor clustering (GO:0043113),-0.35953056552606244,-1.07919236045478,0.36942675159235666,0.7506413791089924,1.0,5/27,8.23%,PTN;MAGI2;DLG4;DNAJA3;FLNA
prerank,negative regulation of interleukin-1 production (GO:0032692),0.444738297110259,1.07918062416959,0.3715925394548063,0.7696375573456555,1.0,6/23,18.49%,CEACAM1;APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2963154366813685,-1.079078832659246,0.31981981981981983,0.7495058884628051,1.0,19/62,15.76%,PRKCB;THBS1;CREBBP;TNRC6A;KAT2B;KMT2C;MEIS1;RUNX1;ASH2L;SETD1A;PAF1;MYL9;HOXA5;WDR5;CTR9;HDAC1;DPY30;TNRC6B;MAFB
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.34067619813434435,1.079075910244803,0.3336875664187035,0.7692998220279834,1.0,30/182,10.53%,ENG;CLDN5;GATA2;PDGFB;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;DLL4;APP;HEY2;KLF4;TRIM6;MEF2C;CD34;SMCR8;ANKRD13A;ZC3H12A;RBL1;PRKAA1;FOXP1;NDFIP2;ADAM10;FBXW7;TCEAL1;AGO4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.40623896360538636,-1.0788983082992258,0.3486005089058524,0.7485209360256088,1.0,7/16,20.54%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5294954528417459,1.0788318069268175,0.3969335604770017,0.7693038938032064,1.0,4/10,9.42%,OXSR1;ADAM17;STK39;ADAM10
prerank,positive regulation of protein processing (GO:0010954),-0.3942450415554358,-1.0787322331759261,0.32122905027932963,0.7475228057420047,1.0,3/19,3.88%,GSN;CCBE1;CLEC3B
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4221116280729529,-1.0785610953485727,0.3393316195372751,0.7464964575923182,1.0,4/13,9.11%,STX4;MAP1A;RIC3;STX3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.40403271096666865,1.0782792091810613,0.36723910171730517,0.7700961878122278,1.0,5/42,10.16%,CCR1;OXSR1;THPO;STK39;CCL4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4021432544203801,1.0781935540729708,0.36054421768707484,0.7696934538968921,1.0,11/38,16.66%,DAB2IP;CASP8;ZC3H12A;STAT1;NR1D1;CACTIN;RIOK3;RHOH;CARD19;ESR1;PYCARD
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3623340261646065,1.0771034918209512,0.33640552995391704,0.7718261470811864,1.0,21/87,15.83%,TBX1;ESRP2;EGR3;CBL;DLL4;HYAL2;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;ZFP36L2;POLR2D;TIAL1;NR4A1;ITGB1BP1;FGF20;KIF16B;POLR2I
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4438736736503185,1.0767720896511843,0.3637747336377473,0.7720170481001937,1.0,4/25,4.95%,GJA5;CAV1;NOS1AP;CAMK2D
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.49619020436290395,1.075922069305486,0.3832528180354267,0.773541921870479,1.0,6/13,19.42%,UFM1;RAB23;RANGAP1;NUP153;CABP1;BARD1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.42122957326767835,-1.0757453267322583,0.3689839572192513,0.752712518769023,1.0,6/13,22.38%,MOGAT3;PLA2G4A;DGAT1;ABHD12;DGAT2;FAAH
prerank,positive regulation of cell population proliferation (GO:0008284),0.32489175519099744,1.0752672639189842,0.30558375634517765,0.7746093902948,1.0,45/423,9.64%,VEGFC;CDH13;ACER2;EDN1;PDGFD;CLDN5;FLT1;PDGFB;FLT4;KITLG;TBX1;CCND2;LIFR;NOTCH1;NOD2;INSR;AQP11;TGFB2;EMP2;RASSF10;DLL4;VEGFD;KRAS;WWTR1;LEF1;GCNT2;SERTAD1;MEF2C;TBC1D8;FGFR3;CUL3;ADAM17;SLC25A33;CD47;GNAI2;STAT1;CNOT6L;THPO;NDUFS4;NAMPT;FOXP1;TJP1;PTK2;ADAM10;DHX9
prerank,response to hydrogen peroxide (GO:0042542),0.3962094826701343,1.075253358160852,0.3768913342503439,0.7740330096396916,1.0,8/45,11.28%,FYN;RHOB;STK24;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,dendrite self-avoidance (GO:0070593),0.4714064456217975,1.075169637236083,0.38827258320126784,0.7736267033296209,1.0,9/16,27.55%,ROBO4;BSG;MYPN;NPTN;DSCAM;CNTN4;CNTN6;IGSF9;CNTN2
prerank,regulation of protein import into nucleus (GO:0042306),-0.330206134022729,-1.074852885516187,0.32666666666666666,0.7537901205399256,1.0,10/36,13.70%,ZIC1;BMP4;APOD;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2
prerank,regulation of peptide hormone secretion (GO:0090276),0.37703581036015793,1.074681772198359,0.36855345911949683,0.7742463834145021,1.0,8/67,8.48%,ITPR3;SLC2A1;CACNA1A;HNF4A;SYT7;RAPGEF4;MTNR1B;PASK
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.43706753332243486,-1.0746509401945235,0.38961038961038963,0.752922890190192,1.0,4/12,18.37%,GLI2;NFIB;EPHB2;SZT2
prerank,positive regulation of chemotaxis (GO:0050921),0.4065678353732924,1.0742194141521744,0.3704206241519674,0.7747968976493325,1.0,7/43,7.36%,CDH13;PDGFB;PRKD1;F2RL1;PPM1F;ADAM17;HSPB1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4130001016752335,1.0740780118212865,0.37362637362637363,0.7745193115158884,1.0,9/35,17.21%,NUAK1;ITGA1;FKBP1A;HSP90B1;CALM3;PPP1R15B;CSNK2B;BOD1;TIPRL
prerank,regulation of microtubule-based process (GO:0032886),0.41001912412458175,1.0740535908831665,0.39603960396039606,0.7739856287690208,1.0,10/36,12.15%,EFNA5;FAM107A;MACF1;DIAPH1;CLASP1;PRKAA1;APC;ROCK1;CLASP2;MARK2
prerank,negative regulation of gene expression (GO:0010629),0.32865365270411334,1.0739792724927328,0.31794871794871793,0.7735398034738102,1.0,49/302,13.22%,NANOS1;NANOS3;ENG;CLDN5;GATA2;PDGFB;RPS6KA5;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;BTG2;DLL4;APP;HDAC9;HEY2;KLF4;FCGR2B;TRIM6;MEF2C;CD34;SMCR8;ZC3H12A;HSPA1B;RBL1;PRKAA1;GAPDH;FOXP1;NDFIP2;ZFP36L2;ADAM10;FBXW7;TCEAL1;TASOR;CNOT1;ENC1;AGO4;PTBP3;TMBIM6;HINFP;TOB1;TTBK1;PPM1D;FXR1;APLN
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3653500299120635,-1.0726573509095758,0.3577981651376147,0.7570727670767871,1.0,3/24,2.40%,PID1;DAB2;RHOQ
prerank,amino acid import (GO:0043090),0.44945815137246253,1.0718903628322962,0.39473684210526316,0.7782639153069373,1.0,5/21,7.82%,SLC6A6;SFXN1;SH3BP4;SLC16A2;SLC7A1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4212187526784392,1.0718343427799883,0.38439306358381503,0.7777799085580412,1.0,5/31,7.71%,HIP1R;CASP8;PPP1R13B;BBC3;NMT1
prerank,mRNA splice site selection (GO:0006376),-0.33383440337865755,-1.0716989385421274,0.35144927536231885,0.7584275861470037,1.0,5/30,10.78%,CELF2;SRSF5;SRSF1;PUF60;SRSF6
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4915868927302445,1.0715660777891587,0.3785594639865997,0.7766539302146671,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4915868927302445,1.0715660777891587,0.3785594639865997,0.7766539302146671,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4915868927302445,1.0715660777891587,0.3785594639865997,0.7766539302146671,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,zinc ion transmembrane transport (GO:0071577),-0.36137135565434764,-1.070487149174006,0.3352601156069364,0.760369238557139,1.0,5/22,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,granulocyte chemotaxis (GO:0071621),0.38130158833796185,1.069966658410353,0.35149156939040205,0.7800556324568074,1.0,5/55,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,positive regulation of cellular metabolic process (GO:0031325),0.353893802976437,1.0698924131078433,0.3821428571428571,0.7796193236608668,1.0,18/98,11.66%,PDGFB;FASN;INSR;SLCO1C1;APOA1;KLF4;ANGPT1;LIPT2;IFNAR1;GATA3;CHCHD2;ZC3H12A;ARRB1;TBC1D5;ACOD1;ACACB;NFKBIA;INPP5F
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.38699425340909077,1.0697927612613414,0.3763157894736842,0.7792583834566342,1.0,11/47,14.51%,EFNA5;NEDD9;CRK;ACTN4;APOA1;LIMS2;PTK2;RAC1;DOCK1;ITGB1BP1;SPRY4
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4702192958607978,1.0696011875257627,0.37645107794361526,0.7791321197430418,1.0,3/18,3.52%,SLC2A1;OCLN;INPP5K
prerank,endodermal cell differentiation (GO:0035987),0.41667394205547104,1.069546360961209,0.3880171184022825,0.7786747718533564,1.0,1/31,0.04%,LAMA3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.43288940233793693,-1.0690701280216162,0.3781094527363184,0.7627526512489797,1.0,3/12,8.97%,SDK2;NKD1;VEGFA
prerank,cardiac muscle cell differentiation (GO:0055007),0.44651407440867724,1.0688736603375597,0.40435458786936235,0.7798073572492586,1.0,4/21,5.32%,SLC8A1;ACVR1;ALPK3;MEF2C
prerank,regulation of cellular response to heat (GO:1900034),0.3619518361727373,1.0688425831534953,0.36275695284159615,0.7792851380333289,1.0,23/77,21.45%,FKBP4;IER5;CAMK2D;CD34;MAPK1;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;DNAJC7;GSK3B;BAG4;NUP50;MAPKAPK2;AKT1S1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4957104419186275,1.0687862775857908,0.392914653784219,0.7788161994651358,1.0,4/14,10.49%,ECSCR;ANO6;PDCD4;PLCG1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36069993623956814,1.068704836366582,0.37606837606837606,0.7783980705006709,1.0,31/88,24.46%,EXOC6;STXBP6;APP;AP1S2;DOP1B;BLOC1S6;GOPC;KLHL20;VAMP8;ARRB1;VAMP7;EXOC8;AP1B1;CLVS1;KIF16B;MON2;EXOC4;SORCS1;SORT1;EXOC2;STEAP2;EPS15;SORL1;SCAMP1;EXOC5;EXOC6B;OSBPL5;SCAMP3;FTH1;FTL;MYO5A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5272880237508669,1.0686757161935387,0.40134907251264756,0.7778695420165579,1.0,2/10,6.03%,LGALS9;GATA3
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4551878677236829,-1.0685287766784504,0.38392857142857145,0.762829106007148,1.0,4/10,17.31%,ST6GAL1;RENBP;NAGK;AMDHD2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.49954375271931684,1.0684575175770448,0.4075993091537133,0.7778489536035503,1.0,2/10,3.82%,F2RL1;TIRAP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4655489215277602,-1.0680071101533948,0.4019370460048426,0.7627771359710714,1.0,4/10,11.02%,DPYD;NT5M;NT5E;UPB1
prerank,response to iron ion (GO:0010039),-0.4436693624337657,-1.0678781537244866,0.38613861386138615,0.7616670723382795,1.0,3/12,5.52%,BMP6;BCL2;ACO1
prerank,V(D)J recombination (GO:0033151),0.5139214619664615,1.0675784382787503,0.39322033898305087,0.7794493281558209,1.0,5/11,22.13%,TCF3;HMGB1;LIG1;HMGB2;XRCC4
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.29532215890499713,-1.067241049854403,0.2905982905982906,0.7620355941800717,1.0,9/54,7.08%,GPC6;SDC2;HSPG2;GPC3;HS3ST3A1;GNS;PXYLP1;XYLT1;HEXA
prerank,regulation of cation channel activity (GO:2001257),0.3559451991474475,1.067121872418598,0.3684834123222749,0.7800251866831545,1.0,10/89,8.37%,NOS1;FKBP1A;APP;SHISA8;CAMK2D;STAC;MEF2C;SHISA6;GRIA1;GRIN2B
prerank,peptidyl-serine modification (GO:0018209),0.34027118258160527,1.0670892069589426,0.3574561403508772,0.7795173017343192,1.0,43/166,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;TTBK2;POGLUT1;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;GALNT4;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,amyloid fibril formation (GO:1990000),0.3924155497781422,1.067011186539506,0.39602649006622515,0.7791091290599663,1.0,13/51,11.63%,B2M;FKBP1A;APP;APOA1;TSPAN14;IAPP;FURIN;UBA52;RPS27A;APH1A;ADAM10;SIAH2;SNCAIP
prerank,positive regulation of T cell activation (GO:0050870),0.3758651824611261,1.0669588457668029,0.3527227722772277,0.7786626624002482,1.0,6/62,7.82%,VCAM1;NOD2;LGALS9;GATA3;CD47;SLC7A1
prerank,response to retinoic acid (GO:0032526),0.37861634748309264,1.066950218684358,0.35526315789473684,0.77809865379297,1.0,5/59,6.67%,ACER2;GATA6;TBX1;RXRG;SETX
prerank,regulation of gastrulation (GO:0010470),-0.4136800684278241,-1.0669177255959714,0.356234096692112,0.7615367848424531,1.0,3/14,6.11%,PHLDB2;OSR1;DAG1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38692695364465857,1.0668914028627225,0.373134328358209,0.7776520901504771,1.0,5/51,1.86%,SMAD6;BMPR2;SMAD7;NOTCH1;DAND5
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3635771376760655,-1.0665520451530641,0.38181818181818183,0.7610546216923695,1.0,10/21,22.60%,SULF1;SULF2;XYLT1;B3GAT3;HS2ST1;NDST3;GPC1;SGSH;HS3ST4;EXT2
prerank,signal transduction by p53 class mediator (GO:0072331),0.42391685487645336,1.0655700411836324,0.38549075391180654,0.780349165305689,1.0,2/30,3.46%,ACER2;PPP1R13B
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5002038645840706,1.0654665992508556,0.3938356164383562,0.7800039985360945,1.0,2/10,4.47%,MSN;SYNE4
prerank,retinol metabolic process (GO:0042572),-0.42189108716412427,-1.0652986888229912,0.38292011019283745,0.7632578075120015,1.0,2/14,9.46%,RBP4;DHRS3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.455404855613599,1.0651506311606254,0.3888888888888889,0.780199056387635,1.0,4/18,10.51%,UNC13B;GRID1;GRIK5;GRIK2
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3817826661005026,-1.065117914242943,0.3502673796791444,0.7622638575249763,1.0,4/18,13.28%,PTN;REST;TAF6L;HMGA2
prerank,"phototransduction, visible light (GO:0007603)",0.4960084599796357,1.064269460798298,0.38522012578616355,0.7818373343236675,1.0,1/14,1.71%,GNAQ
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.47301313879276563,1.0642576706137161,0.3925233644859813,0.7812734854263211,1.0,3/17,9.50%,CCR1;ANO6;HMGB1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4279633190766612,1.064005933642441,0.4003021148036254,0.7813031150171545,1.0,9/26,17.28%,ADIPOR2;CEACAM1;APOA1;ADIPOR1;BRCA1;ELOVL5;EIF6;ERLIN2;TRIB3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5156269025683706,1.0635356922136883,0.4003466204506066,0.7819333708029718,1.0,3/10,8.27%,LRRK2;PDE8A;NFE2L2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3058378989772525,-1.0633870111752395,0.3510204081632653,0.7655887499387236,1.0,15/45,16.21%,EGFR;PLCE1;EFEMP1;REPS2;SLC30A10;SHC1;PIK3R1;SRC;TGFA;GAREM1;DGKD;HBEGF;SHC3;GAB1;AAMP
prerank,positive regulation of protein import (GO:1904591),-0.3384221828823477,-1.063336524167707,0.3591331269349845,0.7642521587889285,1.0,10/30,18.44%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,cellular component assembly (GO:0022607),0.3251567804607631,1.0632425987799388,0.34679089026915116,0.7820783245659788,1.0,44/253,16.23%,LIMA1;CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;FAM107A;FBLIM1;PLS3;PARVB;NEDD9;CFAP206;STX7;CARD10;LIMS2;SYCP2;TRAF1;RAD21;CD247;IL1RAP;NCKAP1;APC;ACTG1;RTN4;CDAN1;NEFH;CYFIP1;RAC1;RANBP9;BAG6;ACTB;SHROOM1;RTN3;TAPBP;CAPG;RHOH;PPIH;LCP1;KPNA3;CLDN14;PDCD10;VIL1;ANK3
prerank,synaptic vesicle endocytosis (GO:0048488),0.4060830675226354,1.0626624751285547,0.38330975954738333,0.7829447740893101,1.0,11/33,18.29%,ITSN2;DNM3;SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3620825433260029,1.0624998185055619,0.37605804111245467,0.7827593928613186,1.0,25/85,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.38200529922200865,-1.0624822333677504,0.3631123919308357,0.7651694819220152,1.0,5/20,9.66%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,cell-cell junction maintenance (GO:0045217),0.4965815961179477,1.0623764076682407,0.41487603305785126,0.7824710171005906,1.0,2/11,9.21%,F2RL1;TJP1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.34765107076516244,1.0622360899101857,0.37990762124711314,0.7821977114448568,1.0,33/107,20.14%,MCTP1;ABR;CACNA1A;SYN3;APP;BCR;MEF2C;GRID1;BTBD9;PXK;LRRK2;LRRC4C;GRIK5;GRIK2;CDH2;SNCAIP;GRM5;CX3CR1;RIMS3;NPTX2;PSMC5;DGKI;GRIK1;NMU;CPLX1;OPHN1;LRP8;NPTX1;GRM7;SYT1;GRID2;AGER;BDNF
prerank,protein oxidation (GO:0018158),-0.4404387056601316,-1.062200002895647,0.4097560975609756,0.7645347028795579,1.0,5/11,16.38%,LOXL1;LOXL3;SUMF1;PRDX3;CHCHD4
prerank,protein import into nucleus (GO:0006606),-0.2860760654093473,-1.0621879542732997,0.3150684931506849,0.7631149046678085,1.0,22/66,24.38%,APPL2;CBLB;NUP107;HEATR3;CSE1L;KPNA1;PPP1R10;NUP155;TNPO3;RANBP6;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.37493377426433844,1.0621873626157812,0.3741851368970013,0.7817085771648493,1.0,8/56,8.61%,PLCB1;CCND2;RAB11A;CCND3;CDC25C;CUL3;ADAM17;KMT2E
prerank,nucleoside catabolic process (GO:0009164),-0.44672636983609965,-1.0621746889838009,0.42685851318944845,0.7617040742047843,1.0,4/11,11.02%,DPYD;NT5M;NT5E;UPB1
prerank,regulation of exosomal secretion (GO:1903541),-0.3744827024236679,-1.0620865741174397,0.36666666666666664,0.7605050686519446,1.0,9/19,26.71%,PRKN;SDCBP;TSG101;ATP9A;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,dopaminergic neuron differentiation (GO:0071542),0.4516455306256618,1.0618301796447926,0.38225806451612904,0.7819714629839442,1.0,3/19,14.25%,NR4A2;PHOX2A;CTNNB1
prerank,nuclear transport (GO:0051169),0.4620461052120125,1.061435483857776,0.4065934065934066,0.7823092523343037,1.0,6/16,23.15%,XPO1;NPM1;RSRC1;NUP205;BANF1;NXT2
prerank,positive regulation of cell development (GO:0010720),-0.33180534813999785,-1.0613357456204002,0.348993288590604,0.7611911677399569,1.0,10/31,17.51%,PDE3A;BMP4;SNW1;ATP6AP1;NUMBL;NAP1L1;SERPINF1;GPER1;RFX3;NKX6-1
prerank,skeletal muscle tissue development (GO:0007519),0.4179579802474976,1.0606710494262714,0.3986013986013986,0.7836746173336433,1.0,4/32,7.82%,CAV1;CAV2;MEF2C;MYL6
prerank,cellular response to acid chemical (GO:0071229),0.4255193463389959,1.0605572409366533,0.3888888888888889,0.7833646081963308,1.0,8/27,20.76%,SPAAR;KLF2;SH3BP4;RRAGD;GLRA2;RRAGA;RRAGC;LAMTOR3
prerank,negative regulation of viral genome replication (GO:0045071),0.40022469174431696,1.0605447602504228,0.39231824417009603,0.7828013088394423,1.0,16/40,24.96%,IFIH1;INPP5K;TRIM6;PLSCR1;OAS2;TASOR;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;EIF2AK2;BANF1;SETDB1;OASL;BST2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45287852895126496,-1.0604835649312248,0.4194312796208531,0.7620263137990946,1.0,4/10,18.93%,SET;KLF15;TAF7;NOC2L
prerank,regulation of DNA binding (GO:0051101),-0.30612220416258534,-1.0604602576997153,0.35471698113207545,0.7606532643696687,1.0,12/44,14.39%,IGF1;SMO;PRKN;RSF1;NGF;DOT1L;PPARG;TXN;MDFI;BCL3;HMGA2;SIRT2
prerank,positive regulation of cell differentiation (GO:0045597),0.32942741300467365,1.0602565196918017,0.35751840168243953,0.7829329132136879,1.0,40/237,11.44%,SLC6A6;RAPGEF2;CEACAM1;PLCB1;ASB4;BMPR2;KITLG;ACVRL1;ARHGEF2;PRKD1;TGFB2;FES;BTG1;TMEM100;BLOC1S6;ACVR1;RRAS;WWTR1;LEF1;GCNT2;MEF2C;SMAD2;CD34;SPAG9;ZBTB16;ZC3H12A;CMKLR1;CTNNA1;NRCAM;ZHX3;CDH15;SYAP1;CTNNBIP1;TCF3;RPS6KA1;ZC4H2;CDH2;MMD;HIF1AN;PCP4
prerank,regulation of protein localization to membrane (GO:1905475),-0.3500101870253041,-1.0599423903607461,0.35454545454545455,0.7605476514563653,1.0,5/28,4.31%,GPC6;GSN;GPC3;MMP14;PRKN
prerank,response to ethanol (GO:0045471),0.48003996874439686,1.0599182851588183,0.4073482428115016,0.7831446950886932,1.0,6/14,22.31%,GRIN2B;GRIN3A;SDF4;GLRA2;GRIN2A;SOD1
prerank,positive regulation of biosynthetic process (GO:0009891),0.39548636145355437,1.0594194246444057,0.388283378746594,0.7837554401949683,1.0,6/40,11.05%,PLCG2;VIM;APOA1;SIRT4;ADGRB1;CYBA
prerank,miRNA metabolic process (GO:0010586),-0.36777589249336434,-1.0593685179635979,0.37026239067055394,0.760738579458369,1.0,6/20,18.38%,DDX17;DICER1;LIN28B;TENT4B;TUT4;DGCR8
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.45720169393045956,1.0592480810286675,0.4230769230769231,0.7836047543032896,1.0,5/18,11.99%,RPS6KA5;PRKD1;CD200;CRTC1;PRKD2
prerank,regulation of neurogenesis (GO:0050767),0.38046220281459786,1.0590358985056199,0.39390088945362134,0.7835138682816759,1.0,13/55,16.11%,NOTCH1;B2M;HEY1;RASSF10;HEY2;PRUNE1;NUMB;PCM1;CX3CR1;HES3;CTNNB1;HMGB2;SPEN
prerank,renal filtration (GO:0097205),0.5141507157028299,1.0589592226518727,0.4079173838209983,0.7831063977812992,1.0,6/10,18.30%,MYO1E;CD34;MCAM;ITGA3;XPNPEP3;TBC1D8B
prerank,mesenchymal to epithelial transition (GO:0060231),-0.460983518775398,-1.0588562703421198,0.4061032863849765,0.7606618642777634,1.0,5/10,20.47%,BMP4;FZD7;SALL1;BASP1;PAX2
prerank,negative regulation of autophagy (GO:0010507),-0.30010839410816287,-1.0575687417918782,0.3333333333333333,0.7628993519241077,1.0,15/54,14.47%,LEPR;NUPR1;BCL2;SNRNP70;KLHL22;GOLGA2;PTPN22;TAB3;DAPL1;MET;FOXK2;ATG7;KDM4A;SIRT2;TSC1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.315343420466236,1.057421357513173,0.215,0.7863219375409976,1.0,227/1667,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;SOX13;JAG1;NOTCH4;KLF8;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;LDB2;DACH1;BMPR2;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;PLK3;BACH2;ACVRL1;NOTCH1;FOXQ1;NOD2;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;ARHGEF2;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CAV1;PRKD1;ZNF296;F2RL1;ZNF235;LRRFIP1;TNRC6C;SAP30;HNF1A;HNF4A;KLF3;AGRN;ID1;KLF6;ARID3B;DLL4;APP;HDAC9;ZGLP1;SOX18;CRK;HHEX;TEAD4;FLI1;PELP1;RBBP8;HEY2;TLR3;HMBOX1;MED26;KLF4;IER5;ACVR1;SIM2;WWTR1;LEF1;BCLAF3;MAFK;IRF9;ZBTB46;EFNA1;CAMK2D;PKN1;SP4;MAFF;ELOC;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;BBS7;ZBTB48;TAF9B;FOSL2;BRD8;APEX1;PHF6;GATA3;BCL6B;RTF1;TOX3;RXRG;RAD21;UBE2D1;CHCHD2;SRCAP;SETX;ZBTB16;GTF2IRD1;MRGBP;ZC3H12A;KDM3A;PPP3CA;LCORL;STAT1;GAL;ELP4;TOX4;AATF;PURA;EBF3;ELP2;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;ZHX3;NFE2L2;WWC2;RPS14;GATAD2A;NAMPT;RPS27A;MRTFA;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;JUN;TCF7L1;TCF3;ELOA;EGR1;HMGB1;ZNF182;DHX9;SS18;ARID5A;PLAG1;MAD2L2;ZBTB14;CNOT1;CHD5;ZXDB;RPS6KA1;HNRNPK;AGO4;RPRD1B;BRIP1;NFKBIA;TET3;ZBTB34;TNKS;NEDD4L;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;HDX;PCBP1;EAF2;DMAP1;E2F7;GTF2H3;BRCA1;TIAL1;NR4A1;HELZ2;PRKD2;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;GLYR1;RPS6KA3;TGIF1;ASCL4;PSMC3;DUSP22;PPM1D;ITGB1BP1;PIN1;POU3F2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.4523863482543415,-1.0571801744004443,0.39568345323741005,0.7625208504688044,1.0,3/11,23.05%,CAT;PRDX3;GPX1
prerank,response to muscle stretch (GO:0035994),-0.40199101633890766,-1.0566187230617687,0.38242894056847543,0.7626693153841798,1.0,2/15,0.82%,DMD;GSN
prerank,RNA processing (GO:0006396),-0.24498578210281133,-1.0561435154765038,0.3069306930693069,0.76262517586431,1.0,56/176,23.41%,CELF2;RBMS1;SON;NOVA1;SNRNP40;SRSF5;HNRNPH1;SCAF11;DDX17;DICER1;APOBEC1;NUDT21;HNRNPA2B1;NCBP1;LIN28B;PRPF8;SRRM1;FUS;SRSF1;PRKACA;CDK12;PRPF3;PABPN1;THOC1;TARDBP;AKAP8L;SNRPF;TENT4B;RBM39;WBP4;SNRPA1;TUT1;HNRNPL;SCNM1;RNASEL;HNRNPU;MAGOH;PPP2CA;BCAS2;U2AF2;SNRPD3;TUT4;MAGOHB;RNGTT;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.49720865557368377,1.056022552657277,0.41264559068219636,0.78924231284816,1.0,1/12,1.84%,PAEP
prerank,neurotrophin signaling pathway (GO:0038179),0.4505474540829718,1.0559575640771715,0.4304932735426009,0.7888017648077745,1.0,2/21,1.83%,RAPGEF2;RAPGEF1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.401959210058214,1.0557241262394257,0.3812849162011173,0.7888153707307153,1.0,6/34,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZFP36L2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.41680713731900765,1.0556277570400285,0.3955119214586255,0.7884503143567245,1.0,9/28,14.77%,ADIPOR2;NOS1AP;TNFRSF1B;ADIPOR1;CD47;JAK2;RAC1;CX3CR1;EIF6
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4326266204132634,1.055517479869489,0.4015267175572519,0.7881367081277809,1.0,6/22,14.97%,DUSP1;PPM1F;DUSP16;PDP1;PPM1D;PPP2CB
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.37893291324153355,-1.0554235018659965,0.38636363636363635,0.7632308640621355,1.0,6/18,15.28%,PRKN;CCN3;IRS1;REST;ADRA2A;KCNB1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.40064505756724816,1.055416095783677,0.38335607094133695,0.7877894075685602,1.0,6/33,11.55%,PLK3;FAM107A;KLF4;RBL1;APC;E2F7
prerank,negative regulation of cyclase activity (GO:0031280),-0.4125878461251047,-1.0553617801141904,0.40145985401459855,0.7620040754106747,1.0,6/14,16.11%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,axonal fasciculation (GO:0007413),-0.4355746329125254,-1.0528690930748492,0.41133004926108374,0.7672740915643587,1.0,6/12,18.42%,EPHA3;SEMA5A;MEGF8;ARHGAP35;EPHB2;EPHB3
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4555760670813921,1.052373618955201,0.3968,0.7948141402075949,1.0,1/16,0.24%,SOX13
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.46773162392379686,1.0523192995287316,0.4181523500810373,0.7943676147890588,1.0,2/15,1.26%,MSX1;TBX1
prerank,extracellular matrix organization (GO:0030198),0.3257081398747012,1.0518517010487267,0.3834900731452456,0.7949208826217042,1.0,30/276,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;TGFB2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;DST;ATP7A;FURIN;COL5A2;CD47;BSG;PLEC;ITGAM;ADAM12
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4085936673184971,-1.0518287147392942,0.39509536784741145,0.7687364900193782,1.0,2/15,5.69%,MOXD1;SMOX
prerank,regulation of sensory perception of pain (GO:0051930),0.4862409960117344,1.051250791108264,0.3956953642384106,0.7958192392112737,1.0,2/11,4.17%,TMEM100;SCN11A
prerank,GTP metabolic process (GO:0046039),0.4699102809032102,1.0507122439733405,0.4029363784665579,0.7965067454701977,1.0,6/15,15.85%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,nitrogen compound transport (GO:0071705),0.33490565888095386,1.0504477645241905,0.3933333333333333,0.7965462665055238,1.0,17/141,10.45%,SLC6A6;EDN1;RHCG;ARL6IP5;SLC7A7;PPT1;SLC44A1;MYH9;ARRDC1;HSP90B1;SLC6A4;SLC7A1;CERT1;SLC15A4;CHMP1B;SLC6A2;SLC22A5
prerank,positive regulation of neurogenesis (GO:0050769),-0.27822016887237283,-1.0503716217947312,0.34574468085106386,0.7711873675736803,1.0,24/68,21.77%,ROBO1;PLXNA2;CUX1;SLIT2;SNW1;OBSL1;NTRK2;PLXNB2;NGF;NUMBL;VEGFA;PLXNB1;NAP1L1;SLITRK1;SERPINF1;DRD2;GPER1;PTPRD;FBXW8;PLXNC1;SS18L2;CUX2;DISC1;FAIM
prerank,cellular response to ketone (GO:1901655),-0.32697657352327136,-1.0501807976427713,0.3795620437956204,0.7702751399929636,1.0,6/35,6.78%,ROCK2;ADCY5;ADCY1;GNAI1;ADCY2;SRC
prerank,organophosphate biosynthetic process (GO:0090407),0.3943617415978614,1.0500734368996747,0.4090909090909091,0.7968878221956478,1.0,4/37,3.81%,ITPKB;IP6K3;IPPK;GPHN
prerank,acyl-CoA metabolic process (GO:0006637),0.40907777225565106,1.0499548944460557,0.4037940379403794,0.7965926813715966,1.0,5/35,12.43%,ACSM3;GLYAT;ACOT13;ACACB;HMGCS1
prerank,epithelium development (GO:0060429),0.3475151536562667,1.0496593615078245,0.38717339667458434,0.7967300849677559,1.0,13/107,8.76%,SOX17;GATA6;TBX1;RHCG;GSTA2;TST;SOX18;TAGLN2;CD34;PGK1;STAT1;JAK2;SNAI2
prerank,amino acid import across plasma membrane (GO:0089718),-0.36081964254211263,-1.0494757389054252,0.38309859154929576,0.7708427548765945,1.0,7/24,7.11%,SLC1A3;SLC6A13;SLC7A2;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4794731802801051,1.0488933655264732,0.3973727422003284,0.7980405644372146,1.0,1/12,1.46%,PLK3
prerank,coenzyme A metabolic process (GO:0015936),0.4834241908078901,1.0488161685685735,0.44660194174757284,0.7976187225453747,1.0,6/14,22.61%,SLC25A16;PANK3;PPCS;CROT;ACAT1;ACLY
prerank,nucleotide biosynthetic process (GO:0009165),-0.36989434613661987,-1.04874804464158,0.37047353760445684,0.771360992175118,1.0,5/18,13.03%,NMNAT2;ME1;PRPSAP2;MTHFD1;PNP
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3503825020493561,1.0486643026896902,0.375,0.7973720708553823,1.0,29/87,21.23%,FAM107A;KLF4;PSMD13;PSMD4;RBL1;APC;ZFP36L2;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;E2F7;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;CDKN2D;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;ZFP36L1;USP47
prerank,regulation of establishment of protein localization (GO:0070201),0.4818879828454327,1.0485669092262273,0.41225165562913907,0.7970039804898658,1.0,8/14,32.00%,CEP135;SPIDR;CEP120;DNAJA1;PTP4A3;SCFD1;GAPVD1;CEP295
prerank,sterol metabolic process (GO:0016125),-0.2874195933937823,-1.0484902896945516,0.31627906976744186,0.7706650751650301,1.0,6/60,2.95%,PRKAG2;CYP27A1;CYP26B1;APOE;LIPA;ABCA1
prerank,positive regulation of interferon-beta production (GO:0032728),0.4079335024636171,1.0484232082638116,0.41701534170153415,0.7967769319801606,1.0,7/33,13.70%,IFIH1;TLR3;OAS2;POLR3B;DHX9;IRF5;RIOK3
prerank,regulation of blood circulation (GO:1903522),0.40386695175110277,1.0483991122994996,0.3985714285714286,0.7962491626456445,1.0,3/34,4.95%,KCNQ1;ACE;CAMK2D
prerank,regulation of defense response to virus by host (GO:0050691),0.41171208330670067,1.0481883735834785,0.40331491712707185,0.7961632969011532,1.0,6/30,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DHX9;DTX3L
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.36257004574973156,-1.0480909528917353,0.3776435045317221,0.7703261442176842,1.0,7/21,6.35%,BACE2;RBMX;BACE1;HM13;ADAM19;DAG1;ADAM9
prerank,positive regulation of endocytosis (GO:0045807),0.39035535207316746,1.0478742503120493,0.4217687074829932,0.7963092016525891,1.0,11/45,11.83%,HIP1;B2M;F2RL1;CBL;PPT1;ANO6;STAP1;VPS28;HNRNPK;NEDD4L;CLU
prerank,cognition (GO:0050890),0.3893522419827682,1.0476191938985167,0.39866666666666667,0.7963395292435242,1.0,5/42,3.48%,SHROOM4;PTCHD1;FAM107A;APP;DOP1B
prerank,regulation of organelle assembly (GO:1902115),-0.2758902881492691,-1.0475737474473266,0.32085561497326204,0.7704363882880721,1.0,27/73,20.06%,GSN;DCDC2;TBC1D24;TBC1D2B;STX18;ALMS1;TBC1D9B;ATG3;ATXN2;ATG5;RNF4;ADPRH;TBC1D16;DYNC2LI1;TSG101;TBC1D17;KIF9;CYLD;TBC1D20;CDKL1;IFT20;TRAPPC12;SDCCAG8;EZR;TBC1D19;IFT88;PDCD6IP
prerank,amino sugar metabolic process (GO:0006040),-0.4454170398917721,-1.0474852761704796,0.40425531914893614,0.7693091937909252,1.0,4/10,14.57%,ST6GAL1;EXTL2;GFPT1;GFPT2
prerank,adipose tissue development (GO:0060612),0.5006032633567594,1.047340321665061,0.4312080536912752,0.79643718161978,1.0,4/11,13.91%,SPTLC2;NAMPT;ARID5B;LRP5
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3493953210977213,-1.0470431769931812,0.3588957055214724,0.7690961014778529,1.0,7/27,9.75%,PID1;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,aorta development (GO:0035904),0.47660501464661675,1.0469937843212054,0.4074675324675325,0.796708973736494,1.0,2/14,1.26%,JAG1;TBX1
prerank,nucleic acid-templated transcription (GO:0097659),0.3900716855608084,1.0467296681877998,0.38926174496644295,0.7967979883191241,1.0,17/42,23.64%,NR4A2;POLR2G;MLF1;NFKBIB;POLR2D;TAF1B;POLR2I;PWP1;MMS19;HOXD3;MEF2A;PTMA;RRAGC;POLR2C;PAX8;POLR2B;POLR2J
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5081758335217612,1.0460923117518153,0.434412265758092,0.797740576032445,1.0,3/10,6.30%,TBX1;ACTN4;RXRG
prerank,rRNA modification (GO:0000154),0.44248119691599874,1.0450618991156218,0.4141566265060241,0.7996624795987756,1.0,10/21,25.26%,MRM2;DKC1;METTL5;NHP2;FBLL1;TFB2M;FTSJ3;NSUN4;FBL;ZCCHC4
prerank,cellular response to oxygen-containing compound (GO:1901701),0.31735398133332365,1.045014651505017,0.388659793814433,0.7992128975405692,1.0,39/291,10.37%,KCNQ1;RAPGEF2;PDGFB;SPAAR;TBX1;NOD2;ATP2B4;RAPGEF1;FOXO1;DAB2IP;PRKD1;VIM;FES;INPP5K;TIRAP;DEFA6;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;SH3BP4;MAPK1;NFKBIL1;SETX;P2RX7;IRGM;ZC3H12A;HSP90B1;NR1D1;ACOD1;CACTIN;STAP1;JUN;EGR1;HMGB1;RRAGD;NFKBIB;CASP1
prerank,positive regulation of intracellular transport (GO:0032388),0.39327210396182594,1.0449236000667437,0.40870786516853935,0.7988452081953243,1.0,10/38,16.40%,PLK3;EHD1;PGAP1;PRR5L;PCM1;RIPOR1;NUMA1;ICE1;PDCD10;TENM1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31771195564752713,1.0445193424653922,0.3757637474541752,0.7991974442106425,1.0,65/366,17.08%,SOX17;SOX13;NANOS3;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;APP;SOX18;BTG1;ING2;WWTR1;NLK;MEF2C;PPIE;ORC3;RYBP;GTF2IRD1;CEBPA;TOM1L1;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;CCDC88A;CYFIP1;NUP35;ASCC1;TRAPPC2;OBI1;TESMIN;SAP30L;GRM5;ORC5;HINFP;SOX6;HIF1A;RHOH;ELAVL2;METTL18;ATXN1;EIF2A;KAT7;ACVR2B;YBX1;TRRAP;TCOF1;ESR1;NFIL3;ESRRG;DAXX;SOX7;SOX12
prerank,regulation of cell cycle phase transition (GO:1901987),0.34759069745939736,1.0443441406690255,0.39953271028037385,0.7990185777726415,1.0,27/91,19.11%,ATP2B4;PSMD13;UBE2D1;PSMD4;PSMA5;FBXW7;PSMB10;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,regulation of macrophage activation (GO:0043030),0.4115889808075899,1.0442546674413695,0.4037089871611983,0.7986258123806702,1.0,7/30,8.02%,GPR137B;FCGR2B;KARS1;MFHAS1;ZC3H12A;CEBPA;CD200
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.36292253470517405,1.0440368775697755,0.41291108404384896,0.7985278778911304,1.0,19/72,21.00%,LIFR;IFNGR1;CASP8;SPATA2;SPPL2A;TRAF1;IRAK2;MADD;STAT1;JAK2;PTPN1;CBFB;RACK1;PYCARD;PTPN2;AGPAT1;CD24;SIGIRR;SPPL2B
prerank,ERAD pathway (GO:0036503),0.3564219479340799,1.0439877352247517,0.41606714628297364,0.7980833267006583,1.0,27/83,21.24%,RNF103;RHBDD1;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;UGGT1;PSMC6;RNF139;UBXN6;SEL1L;ERLIN2;FBXO6;CCDC47;DNAJC10;RNF5;POMT2;TMEM129
prerank,positive regulation of cell cycle process (GO:0090068),0.35393873953780375,1.0438033003403548,0.3926014319809069,0.7979725762329342,1.0,18/91,16.70%,EDN1;PDGFB;INSR;CUL3;IL1A;RAD21;PLSCR1;FEN1;CDC14A;RANBP1;NUMA1;E2F7;PHIP;LRP5;MAP3K20;PKN2;NDC80;CEP120
prerank,cellular response to hormone stimulus (GO:0032870),0.3602340261221042,1.043765856431848,0.41125,0.7974794035106901,1.0,12/69,10.55%,LMO2;ATP1A1;ATP1A3;CAV1;PELP1;INPP5K;MEF2C;BRD8;TRIM24;NCOA4;ARID5A;SFR1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4572281787810226,1.0436537567192474,0.4230769230769231,0.7971647669317423,1.0,5/19,12.46%,IFIH1;TLR3;STAT1;DHX9;IRF5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.34887794365132047,1.0434289003682413,0.3931924882629108,0.7971311859153948,1.0,15/87,11.28%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;ESAM;CRK;ARHGDIA;ROCK1;TAOK2;CCDC88A;RAC1;TRPM2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.49772038596334933,1.043373344452651,0.4181523500810373,0.7966818745991758,1.0,3/11,15.20%,STAT1;JAK2;IL27RA
prerank,regulation of lipid catabolic process (GO:0050994),0.4445168360608043,1.0428856288149508,0.40809968847352024,0.7972600803343401,1.0,5/19,17.77%,PDE3B;ALK;PRKAA1;LONP2;TYSND1
prerank,regulation of response to external stimulus (GO:0032101),0.340394166207787,1.0421014063877907,0.40358744394618834,0.7985628908882899,1.0,15/121,9.10%,GATA6;SPAAR;NOD2;CAV1;CASP8;F2RL1;SPATA2;TIRAP;STK24;FCGR2B;SEMA7A;BCL6B;NMT1;JAK2;FOXP1
prerank,striated muscle tissue development (GO:0014706),-0.3284475829328902,-1.0420639145378132,0.36610169491525424,0.7814420734883393,1.0,10/29,12.49%,BMP5;BMP7;SVIL;RBP4;SGCD;SIX1;CFLAR;PGM5;TBX2;NDUFV2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.48813962166066216,1.0418692185718297,0.44554455445544555,0.7985645628670903,1.0,2/12,2.05%,PLCB1;DUSP1
prerank,regulation of mast cell degranulation (GO:0043304),0.4817643740438876,1.0415525236184195,0.4238952536824877,0.7987454862478165,1.0,2/14,3.24%,LGALS9;FES
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5215260087280912,1.0411923907423328,0.4365482233502538,0.7990912649512623,1.0,4/10,20.91%,PPM1F;NDFIP2;DNAJA1;WWP2
prerank,positive regulation of cartilage development (GO:0061036),0.4643079533173593,1.041034048844819,0.4122257053291536,0.7989216587816533,1.0,3/17,6.87%,BMPR2;ACVRL1;ZBTB16
prerank,protein localization to cell surface (GO:0034394),0.4212253494805707,1.040999040033589,0.40922619047619047,0.7984299019960178,1.0,7/26,14.25%,FBLN5;EMP2;ANGPT1;PTPRU;SMURF1;MESD;CTNNB1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.37295506947320245,1.0406062891677914,0.41304347826086957,0.7988156119462989,1.0,9/54,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,neuron maturation (GO:0042551),0.4439988503342316,1.0404606414616635,0.4241001564945227,0.7985914488745297,1.0,3/18,9.87%,RND1;APP;B4GALT6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.35655326349825406,-1.0400490728723526,0.3941176470588235,0.7854287081965752,1.0,3/23,1.76%,PRKAG2;CEMIP;BMP7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2697187957199845,-1.0397625910547588,0.35858585858585856,0.7848009830068042,1.0,28/80,21.58%,PLPP3;KIF3C;ERGIC2;STX18;COPZ2;COPA;SURF4;PITPNB;ARFGAP1;ERGIC3;COPG1;ARCN1;COPB2;ARF5;TMED3;BICD2;COG3;ATP9A;KIF3A;NAPA;ZW10;RER1;LMAN2;PICK1;KDELR1;KIF11;RACGAP1;RINT1
prerank,RNA methylation (GO:0001510),0.3701918048925611,1.039595648182126,0.4119897959183674,0.8001354734099765,1.0,18/60,21.08%,TRDMT1;TRMT61A;MRM2;TRMT5;METTL2A;METTL2B;METTL5;ALKBH8;TRMT61B;VIRMA;FBLL1;METTL14;TFB2M;RBM15;NSUN5;FTSJ3;NSUN4;NSUN6
prerank,stem cell development (GO:0048864),0.45689726070785497,1.0391128514340588,0.4216666666666667,0.800740028296172,1.0,6/16,21.33%,SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,positive regulation of DNA replication (GO:0045740),-0.3884592989455223,-1.0390861334763903,0.42934782608695654,0.7853187282914291,1.0,2/16,0.88%,EGFR;GLI2
prerank,RNA modification (GO:0009451),0.3776975250916624,1.0388722926107035,0.41304347826086957,0.8007613851030768,1.0,13/54,21.08%,ADAT2;ADARB1;TRDMT1;TRMT61A;MRM2;ADAR;TRUB1;RBM15;NSUN5;FTSJ3;NSUN4;TRMT1;NSUN6
prerank,positive regulation of wound healing (GO:0090303),-0.3164106991918715,-1.0385146739471978,0.3911290322580645,0.785511032212403,1.0,10/36,12.80%,PLPP3;VTN;THBS1;RREB1;FOXC2;ANXA1;ST3GAL4;SERPINE1;ADRA2A;HBEGF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.42865847142217434,1.0381628355573589,0.4216691068814056,0.8019054779704734,1.0,6/24,15.60%,ING2;TAF9B;BCL2L1;SNAI2;CLU;CDKN2D
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3807067527785434,-1.0381556402985883,0.38935574229691877,0.7850772305082343,1.0,6/19,22.34%,DDO;ALDH7A1;GOT1;DLST;ASPA;HYKK
prerank,regulation of neuron projection arborization (GO:0150011),-0.4016004567222806,-1.0378113384305612,0.42857142857142855,0.7846158124866106,1.0,6/15,17.14%,WNT5A;GRIP1;DLG4;MFSD2A;MYO9A;NTNG1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4224388418089048,1.0376566750782665,0.38666666666666666,0.8025418675831549,1.0,13/25,27.34%,CHMP1B;CHMP3;LYST;CHMP2B;CHMP7;UBXN6;MVB12A;SORT1;LEPROT;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,positive regulation of proteolysis (GO:0045862),-0.2874529151162939,-1.0372163273394892,0.35784313725490197,0.7848545664495505,1.0,15/55,17.46%,OGT;CCBE1;APOE;CYFIP2;ADAM9;IST1;ATP5IF1;GPLD1;NDUFA13;ADRA2A;PACSIN3;CTSC;RCN3;STUB1;FBXW11
prerank,regulation of catecholamine secretion (GO:0050433),0.4120581473786367,1.0369770525907256,0.44345238095238093,0.8036303359952693,1.0,7/29,18.29%,SYT15;SYT7;CHGA;FGF20;HRH3;SYT1;SYT2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.417693282064316,-1.0367820355950468,0.4178743961352657,0.7846754628770621,1.0,6/13,16.11%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,inflammatory response (GO:0006954),0.32528754793266473,1.036769651848971,0.4062165058949625,0.8035493618229724,1.0,19/195,11.05%,AFAP1L2;F11R;NOD1;ADGRE5;CCR1;LGALS9;HDAC9;FCGR2B;LY75;IL1A;PXK;MFHAS1;HNRNPA0;CMKLR1;HMGB1;CCL4;GPR68;RAC1;CYBA
prerank,transport along microtubule (GO:0010970),0.47471846110604177,1.0366968898202114,0.4524207011686144,0.8031440441173656,1.0,2/13,2.98%,APBA1;APP
prerank,sodium ion export across plasma membrane (GO:0036376),0.46894553555764024,1.0365322857263668,0.4209702660406886,0.802963493381052,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,lipid catabolic process (GO:0016042),0.44556662674120695,1.0362787903505009,0.42946708463949845,0.8030254677378448,1.0,2/18,3.24%,PNLIP;PPT1
prerank,photoreceptor cell development (GO:0042461),-0.40626847330970994,-1.0362229122224704,0.43351063829787234,0.7848364956544405,1.0,7/14,32.12%,VEGFA;MFSD2A;TOPORS;ARL3;TULP1;AHI1;CDHR1
prerank,cellular response to oxidative stress (GO:0034599),-0.2538764290918447,-1.0360936708042696,0.33587786259541985,0.7837690695043281,1.0,41/118,23.05%,EGFR;DAPK1;PDGFRA;PTPRK;PRKAA2;PLA2R1;STX4;TPM1;MGAT3;CAT;FOXO3;ERMP1;SOD3;GPX8;PPIA;SESN2;NOX4;PRDX3;CPEB2;CHUK;FER;MPV17;SIRT2;WNT16;PDK2;ETV5;GPX7;NUDT2;MAPK9;PRKCD;HTRA2;ALDH3B1;ROMO1;TXNRD2;ABL1;MAPK8;PARP1;CYCS;CYBB;SRXN1;GPX1
prerank,transepithelial transport (GO:0070633),-0.39547226399008184,-1.036032755480732,0.4254742547425474,0.7825557983414967,1.0,3/15,1.69%,SLC1A3;CXADR;SLC12A2
prerank,regulation of protein modification process (GO:0031399),0.37317271031544286,1.0358029750278857,0.3989145183175034,0.8036007036026659,1.0,14/50,17.92%,CCDC88C;PPP1R16B;WARS1;HSPB1;NDUFS4;PTK2;CCDC88A;GRM5;PIN1;PHIP;ASPSCR1;KDM4D;ATG14;PPP1R16A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.3404060185943987,1.0357513604560626,0.4066193853427896,0.8031571648565686,1.0,44/110,25.82%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;HELZ2;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CTIF;SMG7;RPL18;RPL39;RPS19;SMG9;RPL31;RPS8;SMG8;EIF4G1;RPL3;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4349290640590112,-1.0355703604372315,0.42053789731051344,0.7824447848068226,1.0,6/10,35.81%,TICAM1;MYD88;CD68;TREM2;CD36;TLR6
prerank,positive regulation of leukocyte activation (GO:0002696),-0.37687747700466445,-1.0354708003302864,0.4197183098591549,0.7813261859604448,1.0,3/18,3.41%,LBP;WNT5A;THBS1
prerank,macrophage differentiation (GO:0030225),-0.41978165355813835,-1.0349748067336646,0.40664961636828645,0.7813039612346266,1.0,3/13,8.97%,BMP4;IL31RA;VEGFA
prerank,exit from mitosis (GO:0010458),0.49237684204992915,1.0341376474263104,0.44390243902439025,0.8064605681768585,1.0,3/12,15.38%,CLASP1;CLASP2;CHMP7
prerank,regulation of cellular localization (GO:0060341),0.38329616897233215,1.0340765175485231,0.43346508563899866,0.8060214362302454,1.0,12/46,16.31%,EFNA5;FES;TTL;PPM1F;CAMK2D;LRRK2;NR1D1;NUMA1;TRIM46;LRP5;MAP2;GOSR1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43234215241907,1.0339835884337285,0.4116788321167883,0.8056985425910074,1.0,7/23,15.26%,FAR2;ACSL5;FAR1;ACSBG1;ELOVL7;ELOVL5;TECR
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.258343466895173,-1.0338859996336427,0.38666666666666666,0.7830611264351178,1.0,17/91,8.32%,BMP6;SLC39A14;SCARA5;SLC30A10;SLC39A8;ACO1;SLC39A13;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;ARF1;ATP6AP1
prerank,multivesicular body assembly (GO:0036258),0.41644319386230566,1.0335267145951863,0.4110169491525424,0.806271985934682,1.0,11/30,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;MVB12A;STAM2;CHMP1A
prerank,brain morphogenesis (GO:0048854),0.4839177735289676,1.0331310862446308,0.41956882255389716,0.8066623674528511,1.0,3/12,12.41%,SHANK3;SLC6A4;CTNNA2
prerank,negative regulation of T cell activation (GO:0050868),0.40129491790165644,1.033087712517276,0.43828016643550627,0.8061996783732648,1.0,6/35,14.84%,CEACAM1;FCGR2B;ARG1;DUSP3;LAPTM5;HAVCR2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.35924079365325173,1.0326871901692674,0.4330518697225573,0.8065750533654477,1.0,14/76,11.23%,NOD1;NOD2;LGALS9;APP;HDAC7;ACTN4;TLR3;TRIM6;PDCD4;ADIPOR1;ZC3H12A;NMI;NFKBIA;LAPTM5
prerank,intermediate filament organization (GO:0045109),0.4456479515262707,1.0323764017175256,0.4364207221350079,0.8067194993238057,1.0,4/17,15.90%,VIM;DSP;DNAJB6;KLHL24
prerank,membrane lipid metabolic process (GO:0006643),0.4428158660523498,1.0322911939585622,0.4266666666666667,0.8063707020034446,1.0,7/22,17.29%,ST3GAL6;B4GALT4;SPTLC1;ALOXE3;AGK;TECR;CERKL
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3325832818495521,1.032084154890138,0.410913140311804,0.8063125149801649,1.0,14/142,7.28%,EDN1;TRPV4;ITPR3;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;CAV2;F2RL1;SLC8A1;IAPP;HCRTR1;CMKLR1
prerank,TOR signaling (GO:0031929),0.41707270690190185,1.0319499822457567,0.4158125915080527,0.8060751170813957,1.0,13/26,26.00%,GATA3;PRR5L;SYAP1;RHEBL1;CCDC88A;RPS6KB1;RICTOR;TIPRL;NPRL3;EIF4EBP2;MEAK7;MLST8;RPTOR
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4839234712313946,1.031604857877894,0.42414355628058725,0.8063148702614118,1.0,5/12,20.67%,WRNIP1;KAT7;METTL4;WDR18;BLM
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3367146038251149,1.0310353072969962,0.40288568257491675,0.8070906766343833,1.0,13/140,7.28%,EDN1;TRPV4;ITPR3;CCR1;CAV1;CACNA1A;F2RL1;SLC8A1;GPR157;IAPP;LPAR6;P2RX7;CMKLR1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3265882910954404,-1.030945578579467,0.3959731543624161,0.7897902564896563,1.0,12/32,19.40%,DDX5;SNW1;FHIT;RRP8;BCL3;MYBBP1A;BOK;PDK2;DDIT4;AEN;JMY;PML
prerank,regulation of mRNA catabolic process (GO:0061013),0.3342408624462696,1.0306147627472133,0.4425087108013937,0.8075248712929798,1.0,41/121,21.60%,VIM;PSMD13;PUM2;APEX1;PSMD4;ZC3H12A;ELAVL1;HSPB1;PRR5L;EXOSC3;UBA52;RPS27A;ZFP36L2;PSMA5;XPO1;PSMB10;CNOT1;GTPBP1;EXOSC8;PSMB8;PSMD14;XRN1;PSMA7;PSMC3;FXR1;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6;ZC3HAV1;PSMB2;ZFP36L1;MAPKAPK2;UBB
prerank,negative regulation of reproductive process (GO:2000242),-0.37603328944319525,-1.0302416921025077,0.4065934065934066,0.7902463072477185,1.0,3/17,3.09%,IGF1;SULF1;GJA1
prerank,negative regulation of lyase activity (GO:0051350),-0.38862168741971104,-1.0302389916852448,0.42930591259640105,0.7888753245323282,1.0,6/16,16.11%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,positive regulation of T cell migration (GO:2000406),0.4407023405082916,1.0301932598459664,0.4374057315233786,0.8079332175276396,1.0,5/20,9.42%,OXSR1;APP;ADAM17;STK39;ADAM10
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.47927983241399436,1.030010595999183,0.423841059602649,0.8071982657580006,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.47927983241399436,1.030010595999183,0.423841059602649,0.8071982657580006,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,positive regulation of catalytic activity (GO:0043085),0.3869119788235093,1.0299321679553146,0.416551724137931,0.8068146659380926,1.0,15/37,24.22%,NOD2;CAV1;APOA1;ATP7A;SSBP1;APH1A;CHTOP;PSEN2;MAPK14;ABL2;XRCC4;SOD1;NCSTN;WRN;NHEJ1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3430807119990886,1.0294853199509733,0.4311163895486936,0.8073194048190212,1.0,24/94,19.51%,ATP2A3;DAB2IP;ARL6IP5;PPP1R13B;PPM1F;STK24;CASP2;TNFRSF1B;CUL3;BBC3;CIDEB;BCL2L1;CUL2;BAG6;BRCA1;ATM;BNIP3;PYCARD;TRIB3;SELENOK;CD24;DNAJC10;ERN1;MCL1
prerank,negative regulation of programmed cell death (GO:0043069),0.3099166390604048,1.0293313409453035,0.4473953013278856,0.8071259076520055,1.0,62/355,14.80%,MECOM;TEK;GATA6;SMAD6;FLT4;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;CBL;PPT1;ANGPT1;CASP2;LEF1;MAP4K4;AMIGO2;RHBDD1;TAF9B;UFM1;ARHGDIA;SETX;KLHL20;FANK1;HSPB1;HSP90B1;HSPA1B;AATF;DCPS;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;TJP1;PTK2;ADAM10;BABAM2;SIAH2;RPS6KA1;RNF144B;HNRNPK;NFKBIA;LAPTM5;NPM1;TMBIM6;CD38;TMEM14A;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;BNIP3;CTNNB1;PSMC5;TM7SF3
prerank,protein localization to lysosome (GO:0061462),0.4133711892111755,1.0292480576144845,0.4206008583690987,0.8067776294669914,1.0,15/28,26.54%,SH3BP4;NCOA4;RNF128;RTN4;LAPTM5;VPS4A;NAGPA;AP3M1;ZFYVE16;SORL1;ATP13A2;SCARB2;LMBRD1;GLMP;LAMTOR4
prerank,regulation of neuron differentiation (GO:0045664),0.348635596570734,1.0290139941602443,0.4110429447852761,0.8067734487124133,1.0,24/76,21.62%,CASZ1;HEY1;ARHGEF2;MEF2C;ALK;LRRK2;NRCAM;ROCK1;TCF3;ZC4H2;MMD;PCP4;YWHAH;HES3;LTK;SIN3A;HOXD3;SOX11;MMD2;BDNF;CNTN4;CDK5RAP1;NLGN1;ECT2
prerank,regulation of neuron apoptotic process (GO:0043523),-0.26501077128499273,-1.0288041348970478,0.4161073825503356,0.7914453568343335,1.0,16/96,8.12%,EPHA7;NUPR1;BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;BACE1;NTRK2;NGF;EGLN3;FOXO3;SIX1;PRKCI
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49661045863687703,1.0284724758477515,0.46596858638743455,0.8074947077991838,1.0,3/11,4.11%,SMAD7;TGFB2;ACVR1
prerank,carboxylic acid metabolic process (GO:0019752),0.39849984554723866,1.0282791206187596,0.42329545454545453,0.8073926065456759,1.0,9/33,16.28%,SLC2A1;GLYAT;LIPT2;GLUD1;SIRT4;LIPT1;ST3GAL1;PTGIS;PON3
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4350307353170826,-1.0282585495258532,0.44919786096256686,0.7915664838946485,1.0,4/10,25.17%,DICER1;TERT;TSNAX;MRPL44
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3723192703235937,-1.0281002708134634,0.4088397790055249,0.7906146486929032,1.0,2/19,1.83%,IGF1;NUPR1
prerank,L-serine metabolic process (GO:0006563),0.4947820941844078,1.0275652543914946,0.44991212653778556,0.8085991699165048,1.0,2/10,11.61%,SERINC3;SERINC5
prerank,carboxylic acid transport (GO:0046942),-0.28859210135518765,-1.0274611513612053,0.4149377593360996,0.7909852857246227,1.0,8/55,4.67%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC16A9;SLC17A5
prerank,regulation of establishment of planar polarity (GO:0090175),0.3475209163643764,1.0273600221377892,0.4170673076923077,0.8085493676480159,1.0,25/88,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,UV protection (GO:0009650),-0.4487727179403107,-1.02734901650326,0.44801980198019803,0.7899195292111262,1.0,5/10,15.09%,CAT;SCARA3;ERCC5;MFAP4;ERCC2
prerank,regulation of RNA metabolic process (GO:0051252),-0.28068331084951514,-1.027343908108589,0.39267015706806285,0.7885749011170319,1.0,18/59,16.13%,MITF;SON;SNRNP70;NOVA1;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;CLK1;FUS;CLK4;YTHDF2;RBM20;HNRNPLL;HNRNPL;PCBP4;CLK2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4203857178755076,1.026252404152564,0.42584434654919234,0.8106376403330616,1.0,3/23,2.67%,SMAD7;MYBPC3;FKBP1A
prerank,regulation of transmembrane transport (GO:0034762),0.4036910754504638,1.025838998658158,0.42302158273381296,0.811073632823906,1.0,5/31,11.20%,SLC2A1;OCLN;CTTNBP2NL;NEDD4L;ACTB
prerank,myeloid leukocyte differentiation (GO:0002573),0.3574715000194006,1.0257827296445703,0.41605839416058393,0.8106381671429898,1.0,11/65,10.12%,CASP8;F2RL1;LGALS9;LEF1;PIR;SNX10;MYH9;OSCAR;CEBPA;FOXP1;TYROBP
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.34217766218328227,-1.0255947683133075,0.436426116838488,0.7920397804403051,1.0,2/26,1.32%,LGR4;APPL2
prerank,cardiac muscle contraction (GO:0060048),0.39441690240597205,1.025217753991732,0.4320809248554913,0.8114737109954786,1.0,4/34,4.95%,KCNQ1;MYBPC3;SLC8A1;CAMK2D
prerank,gastrulation (GO:0007369),-0.39153102484312646,-1.025126732405168,0.4086294416243655,0.7919598853053113,1.0,3/15,6.51%,GPC3;NPHP3;MEGF8
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.35490443310052405,-1.0247717507852956,0.41297935103244837,0.7915842937360249,1.0,10/21,31.36%,AMPD3;NUDT4;XDH;NT5E;PNP;NT5C1A;FITM2;PDE2A;NUDT18;NUDT11
prerank,mitotic cytokinetic process (GO:1902410),0.4326370763070247,1.0245297564541131,0.4298642533936652,0.8125368916743965,1.0,12/20,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;CNTROB;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4032350630404927,1.0244337705668725,0.4263005780346821,0.8121946278167268,1.0,3/30,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.4175764093800537,-1.024424409464378,0.42133333333333334,0.791173672215042,1.0,8/12,30.03%,TAF1;DR1;GTF2B;TAF7;GTF2A2;BDP1;TBP;POLR1E
prerank,cytoskeleton organization (GO:0007010),0.33802799184214405,1.024340293574737,0.4302191464821223,0.811837184280739,1.0,17/114,6.86%,FGD5;RND1;RHOB;MAST4;NEDD9;DIAPH1;SIPA1L3;PACSIN2;SH3KBP1;ARAP3;DST;FMNL3;FGD6;PACSIN1;LRCH3;MAST1;KLHL20
prerank,cytosolic transport (GO:0016482),0.33735722791737593,1.0242921663796796,0.4294117647058823,0.8113906171269271,1.0,25/108,20.36%,MYO1D;RAB6B;EMP2;DOP1B;VTI1B;SPAG9;KLHL20;LMTK2;HOOK1;TBC1D5;PIK3C3;HEATR5A;LAPTM5;VPS35;TBC1D10A;KIF16B;GOSR1;DENND5A;MON2;VTI1A;PHETA1;HOOK2;SORT1;CCDC91;EPS15
prerank,regulation of interferon-beta production (GO:0032648),0.3782323826388658,1.0240738326973793,0.421957671957672,0.8113278010128367,1.0,9/46,13.70%,IFIH1;TLR3;TIRAP;OAS2;POLR3B;CACTIN;DHX9;IRF5;RIOK3
prerank,positive regulation of monooxygenase activity (GO:0032770),0.40850745026884416,1.0239748593728473,0.41414141414141414,0.8109717144799365,1.0,7/26,13.57%,GCH1;NOS1AP;ATP7A;NUS1;CDH3;PIK3CB;HIF1A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.310823831509314,1.023673251381245,0.43558282208588955,0.811078924709693,1.0,84/314,20.43%,RNF103;FBXL2;ZNRF1;PSMD13;FBXL14;FBXL5;RNF185;CUL3;UBE2D1;PSMD4;KLHL20;FBXL18;PTTG1;HSP90B1;ARRB1;WWP1;UBE4A;UBA52;FEM1C;NFE2L2;TMUB2;RPS27A;PPP2R5C;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;CUL2;TRIM25;NEDD4L;BAG6;PSMB8;PSMD14;FBXO4;SMURF1;KCTD10;RMND5B;YOD1;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;FOXRED2;SGTB;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;UBQLN2;SPOPL;FBXL13;ANAPC7;PSMC6;AMN1;SEL1L;ERLIN2;PSMA4;FBXO6;GSK3A;PSMD5;PSMD9;FEM1A;FBXL6;PSMB6;DNAJC10;FBXL15;ANAPC4;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,regulation of double-strand break repair (GO:2000779),-0.31338178136638817,-1.0235640139444953,0.3735408560311284,0.7922656168198469,1.0,17/39,30.61%,TRIP12;SLF1;FMN2;ACTR2;RTEL1;DEK;TWIST1;PML;TIMELESS;SLF2;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6;MGMT;OTUB2
prerank,negative regulation of neuron differentiation (GO:0045665),0.41970249086724054,1.0231690726210823,0.4491899852724595,0.811761951308647,1.0,2/22,1.98%,B2M;HEY1
prerank,N-glycan processing (GO:0006491),0.4459330898343621,1.0226383684637788,0.44049459041731065,0.8124064563589983,1.0,3/18,8.17%,ST8SIA6;PRKCSH;GNPTAB
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3905887481652562,1.0226122126880124,0.420249653259362,0.8119146120829639,1.0,10/38,13.70%,GBP5;PUM2;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;CYBA;RIOK3
prerank,negative regulation of neuron projection development (GO:0010977),0.3624836263517791,1.0224890431739198,0.44573643410852715,0.811635804000891,1.0,10/56,12.58%,TRPV4;STMN2;FKBP4;EFNA1;ARHGDIA;PTPRO;RTN4;SPOCK1;DCC;TSKU
prerank,response to organonitrogen compound (GO:0010243),0.3980492502939912,1.0222712981805577,0.45228215767634855,0.8115900996240911,1.0,18/38,28.25%,RHBDD1;RNF185;TRPM2;IRF5;KAT7;GLRA2;RNF139;UBXN6;SEL1L;CCDC47;RNF5;RRAGC;KYNU;BRSK2;MEAK7;GLRB;DNAJB12;IRAK3
prerank,thyroid hormone generation (GO:0006590),-0.43206080862089136,-1.0216998475362276,0.4256926952141058,0.7959052570037184,1.0,2/10,6.83%,CPQ;SLC5A5
prerank,digestive tract morphogenesis (GO:0048546),0.4576355411134381,1.021446913084845,0.4582651391162029,0.8130125826573433,1.0,2/14,5.57%,SOX17;BBS7
prerank,regulation of transforming growth factor beta production (GO:0071634),0.43742704386016995,1.0209119648625173,0.4557165861513688,0.813673046484746,1.0,4/18,8.02%,TGFB2;LGALS9;CD34;CD200
prerank,relaxation of muscle (GO:0090075),-0.4167427762990185,-1.0200314638297867,0.4405940594059406,0.7991170368363978,1.0,2/13,0.82%,ATP1A2;GSN
prerank,polarized epithelial cell differentiation (GO:0030859),0.45798616051003727,1.0199501123102237,0.4323873121869783,0.8153935070036828,1.0,2/13,4.47%,MSN;SYNE4
prerank,regulation of myoblast differentiation (GO:0045661),0.39916584544043743,1.0198649395126869,0.4251748251748252,0.8150356588941651,1.0,5/32,6.06%,PLCB1;NOTCH1;BTG1;MEF2C;EID2B
prerank,response to UV (GO:0009411),-0.260493924364104,-1.0185893029024513,0.40764331210191085,0.8017391927968986,1.0,22/95,15.26%,EGFR;PTPRK;CREBBP;DDB2;CAT;SCARA3;BRSK1;DCUN1D3;TAF1;USP1;ERCC5;MAP2K7;CDC25A;ATR;REV1;BCL3;MFAP4;UVSSA;MSH6;RHNO1;ERCC2;EIF2AK4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4004348023320342,-1.0185502726254492,0.4348894348894349,0.8005030614890832,1.0,4/13,10.31%,ERRFI1;CBLB;SNX6;TSG101
prerank,cellular macromolecule catabolic process (GO:0044265),0.3671540825908087,1.018286077378355,0.4520367936925099,0.8183232668571809,1.0,15/49,21.06%,DENND3;DAB2IP;MANBA;DFFB;SIAH2;RNASEH2B;XRN2;RNASE6;FBXO2;OGA;FBXO6;NGLY1;NEU4;RNF5;RAB12
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.428188092219127,1.0181446632656095,0.4654919236417034,0.8180751767737023,1.0,6/23,9.29%,PDGFB;INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,spindle assembly (GO:0051225),0.3596881246946583,1.017792706301798,0.44726810673443457,0.8183349478045275,1.0,13/67,11.08%,RAB11A;CSNK1D;KIF2A;CLASP1;MAPRE3;KPNB1;STARD9;NEK7;HAUS3;STAG1;CLASP2;TNKS;NUMA1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3758398430969669,1.017677994666604,0.4587280108254398,0.8180428780636448,1.0,9/43,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,regulation of T cell chemotaxis (GO:0010819),0.49250726307039344,1.017531355220652,0.454242928452579,0.8178186943392654,1.0,4/11,9.42%,OXSR1;ADAM17;STK39;ADAM10
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3557969560077141,1.0171357665758347,0.43950617283950616,0.818199626656719,1.0,19/68,22.61%,ACSM3;GLYAT;SULT6B1;RAB23;LRRK2;ACOT13;GTPBP1;MFN1;BPNT1;RAN;EFL1;NT5C2;CROT;ACAT1;SULT1A1;OXSM;EPHA2;ADSS2;ACLY
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3480780353467531,-1.0171047174718135,0.41228070175438597,0.8030388401361589,1.0,2/22,1.85%,ALDH1A2;RBP1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30923633859067057,-1.016839657933491,0.42955326460481097,0.8024098350604526,1.0,8/37,8.48%,IGF1;BMPR1A;IGFBP5;GJA1;TPM1;FGF2;MMP2;EFEMP2
prerank,negative regulation of apoptotic process (GO:0043066),0.3048052123918912,1.0168248196440663,0.451417004048583,0.8183603186416605,1.0,82/444,15.80%,TEK;GATA6;SMAD6;FLT4;FAS;TBX1;TNFAIP8;NR4A2;MERTK;PLK3;CCND2;NOTCH1;FOXQ1;EGR3;FOXO1;CAV1;CBL;PPT1;KLF4;ANGPT1;CASP2;LEF1;MAP4K4;MEF2C;RHBDD1;TAF9B;ASAH2;TOX3;MAPK1;UFM1;ARHGDIA;SETX;KLHL20;FANK1;ZC3H12A;HSPB1;HSP90B1;HSPA1B;AATF;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;SNAI2;TJP1;PTK2;ADAM10;BABAM2;SIAH2;PRKCG;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;TMEM14A;CX3CR1;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;APOH;ITGA5;BNIP3;CTNNB1;FZD9;FZD3;FGF20;DFFA;PDCD10;CDKN2D;PAK2;DNAJB6;VDAC1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3143390335072181,-1.0167265929987837,0.4290909090909091,0.8013660888973444,1.0,6/37,10.19%,OGT;FHIT;MAP1A;TAF1;TRIM39;SDCBP
prerank,response to hydroxyurea (GO:0072710),0.4815102239569654,1.0166634868963031,0.47254575707154745,0.8181840806157435,1.0,5/11,25.13%,NSMCE3;SPIDR;KAT7;BLM;RTF2
prerank,regulation of interleukin-4 production (GO:0032673),0.43024919286768754,1.0166375032271688,0.45331325301204817,0.8176800225227359,1.0,5/21,16.90%,LGALS9;LEF1;GATA3;HAVCR2;RARA
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.33580710614515613,-1.0166183525334553,0.40716612377850164,0.8002754625674058,1.0,8/27,17.36%,NAPEPLD;NAAA;SLC27A1;CHKB;ETNK2;PLA2G15;SELENOI;PLA2G6
prerank,regulation of protein sumoylation (GO:0033233),-0.3774208412089182,-1.0165215345964362,0.43137254901960786,0.7991803877297599,1.0,6/17,22.90%,ZMIZ1;GNL3L;PIAS3;HDAC4;GNL3;PIAS4
prerank,regulation of protein localization to nucleus (GO:1900180),0.3757575403315569,1.016424116265534,0.4385245901639344,0.8176074717134023,1.0,18/43,26.17%,CARD10;WWTR1;SUMO3;MFHAS1;CTNNA1;NVL;LIMK2;DTX3L;PIN1;KAT7;SIN3A;GSK3B;YAP1;GLUL;ATP13A2;TPR;TGFB1;PARP9
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.38984769015645443,1.0164024739837474,0.45,0.8170947062055356,1.0,7/33,13.93%,EDN1;PIK3C2A;PLEKHA1;GATA3;HTR2A;PIK3CB;LTK
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3647109860616118,-1.0163854112542308,0.4297297297297297,0.798174856794765,1.0,7/19,20.54%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4230905755094901,-1.0162950898089158,0.43316831683168316,0.7971241707063288,1.0,3/11,6.17%,BACE2;ITM2A;NECAB1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41243923496696655,1.016277309300402,0.4515195369030391,0.8162614381742151,1.0,7/29,22.61%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41243923496696655,1.016277309300402,0.4515195369030391,0.8162614381742151,1.0,7/29,22.61%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,regulation of osteoclast differentiation (GO:0045670),0.4077605070881125,1.016224480209664,0.43854748603351956,0.8158281999265623,1.0,3/33,3.64%,CCR1;GPR137B;TLR3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3327788680238142,-1.0155198750838135,0.41254125412541254,0.7979242773035066,1.0,5/29,10.77%,DDO;ALDH4A1;PRODH;GSTZ1;SARDH
prerank,cortical cytoskeleton organization (GO:0030865),0.372531997261496,1.0154191025020705,0.4350132625994695,0.8171596504746178,1.0,10/41,14.80%,TRPV4;RND1;RHOB;FMNL3;NCKAP1;ROCK1;RAC1;RND2;RHOH;LCP1
prerank,superoxide metabolic process (GO:0006801),0.4027525074906202,1.014868065944948,0.44857142857142857,0.817884436130324,1.0,4/29,11.05%,NOS3;ATP7A;TAFA4;CYBA
prerank,regulation of proteolysis (GO:0030162),0.36879514384450873,1.0148283308691894,0.41688311688311686,0.8174349416558475,1.0,3/48,2.42%,LTBP4;CAV1;CASP8
prerank,coenzyme A biosynthetic process (GO:0015937),0.4892738871286396,1.0147508509826058,0.4677685950413223,0.8159315344293795,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4892738871286396,1.0147508509826058,0.4677685950413223,0.8159315344293795,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4892738871286396,1.0147508509826058,0.4677685950413223,0.8159315344293795,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,regulation of cilium movement (GO:0003352),0.5043140387717255,1.014432756528857,0.4557823129251701,0.8161179624856321,1.0,2/10,8.62%,CFAP206;CFAP43
prerank,membrane fusion (GO:0061025),0.3942557392436939,1.0144055400591971,0.44079885877318115,0.8156323092428329,1.0,11/33,24.61%,DYSF;DNM3;VTI1B;MYOF;NSF;VAPA;GCA;NAPG;USO1;RIMS1;UBXN2A
prerank,cellular sodium ion homeostasis (GO:0006883),0.44459474267917787,1.0138329510266106,0.43962848297213625,0.8164685308937994,1.0,4/15,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,response to amino acid (GO:0043200),0.39872465003186763,1.0136832982399206,0.43162393162393164,0.8162733116694633,1.0,16/31,28.69%,SPAAR;SH3BP4;RRAGD;TMBIM6;GLRA2;RRAGA;RRAGC;LAMTOR3;MEAK7;NSMF;RPTOR;GLRB;LAMTOR4;CAPN2;SLC38A9;LAMTOR1
prerank,regulation of dendritic spine development (GO:0060998),0.4349389284557728,1.0134704067897022,0.4391371340523883,0.8162080117107825,1.0,5/19,10.92%,TANC2;MEF2C;SHANK3;PPFIA2;GRIN3A
prerank,positive regulation of chromatin organization (GO:1905269),0.48530143582685065,1.0128969763730713,0.4683333333333333,0.8170275780154196,1.0,7/12,25.76%,TAL1;DAXX;SIN3A;TERF2IP;H3-3A;TERF2;TINF2
prerank,regulation of protein polymerization (GO:0032271),0.3929561566861842,1.0123698862758486,0.45557122708039494,0.8177767878827181,1.0,5/35,7.56%,FCHSD2;ESAM;CAMSAP2;PRUNE1;MAPRE3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3962677941340803,1.0121877221859474,0.4334763948497854,0.8176386378101665,1.0,11/29,22.61%,FASN;PPT1;ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;SLC25A1;ACSL4;ACLY
prerank,myelination (GO:0042552),0.369446948482458,1.0120143976119986,0.45026881720430106,0.8175228020357042,1.0,15/46,18.78%,MALL;MPZ;ACSBG1;CMTM8;MARVELD1;MAL;EIF2B2;NFASC;B4GALT6;SOX10;ARHGEF10;CXCR4;PLLP;MAL2;SKI
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3920800286103172,-1.0118312287184352,0.4322916666666667,0.8066723841877991,1.0,8/14,34.86%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,smooth muscle contraction (GO:0006939),0.4651068678784978,1.0115830457794412,0.47217806041335453,0.8180096492830575,1.0,5/14,10.82%,MYLK;PIK3C2A;SLC8A1;ROCK1;TPCN2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4876588578738975,1.0115439226354945,0.46677471636953,0.8175436355488064,1.0,2/11,5.32%,TGFB2;MEF2C
prerank,hexose metabolic process (GO:0019318),-0.3052809987548086,-1.0114442246889772,0.4124087591240876,0.8063370061960078,1.0,13/39,22.89%,APOD;GALK2;CHST15;IRS2;ADPGK;PGM1;GALK1;AKR1A1;PMM1;GDPGP1;SLC35A2;FUCA2;PPARD
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30169871857201,1.0102021124277676,0.459,0.8202282421029631,1.0,86/807,9.99%,PRDM16;MECOM;SOX13;NOTCH4;KLF8;EDN1;GATA6;PLCB1;PDGFB;LDB2;DACH1;RPS6KA5;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;FOXO1;ELK3;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;HNF4A;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;MAFK;EFNA1;MEF2C;SMAD2;BTAF1;DAP;TAF9B;COMMD7;PHF6;GATA3;EID2B;BCL6B;RTF1;PDCD4;UBE2D1;ZBTB16;GTF2IRD1;PHC3;STAT1;PURA;TMPRSS6;CEBPA;WWP1;UBA52;ZHX3;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;MBD1;JUN;TCF3;HMGB1;ARID5A;MAD2L2;ZBTB14
prerank,sodium ion homeostasis (GO:0055078),0.42335979982253913,1.009838807402643,0.45440729483282677,0.820506769970352,1.0,4/21,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,cellular protein metabolic process (GO:0044267),0.3056600486414091,1.0094454632743552,0.4847870182555781,0.8208434925683014,1.0,101/396,21.23%,GATA6;LMCD1;DENND3;ST3GAL6;FBXL2;DUSP12;MSRB3;MMP1;DAB2IP;GOLM1;APP;CSF2RB;UBA7;APOA1;RPS21;RPL27;MANBA;OMA1;PCSK5;STK38;TMEM132A;RPL7;FURIN;FARSB;CHRM3;WARS1;ADAM17;MRPL18;MRPL41;PRKCSH;IGFBP7;HSP90B1;UBA52;PCMT1;PROC;RPS14;RPS27A;RPL35;APH1A;YES1;CSNK1G3;IGFBP4;ADAM10;RPL21;SIAH2;RPL37;RPS28;RPL34;MRPL36;APLP2;MRPL52;RPS9;FBXW2;LIPT1;CDH2;RPLP2;MRPL23;RPS25;CP;RPL30;RPS5;RPL27A;NAGPA;MRPL24;ST3GAL1;FBXO2;MRPL32;MRPS12;RPL23A;RPS15;MSRA;UBE2D3;RPL19;RPS18;RPL32;PSEN2;CST3;RPL37A;RPL18A;MEN1;CALU;MRPS18B;COPS5;CDKL3;PENK;TIMP1;VGF;DARS1;RNF5;GNMT;MRPL11;CTSH;RSL24D1;RPL18;LCMT1;APH1B;WWP2;PNPLA2;RPL39;RAB12;RPS19
prerank,regulation of bone mineralization (GO:0030500),0.3605431785300079,1.0093501784409347,0.4480946123521682,0.8204863123651587,1.0,9/55,6.78%,SGMS2;S1PR1;BMPR2;CCR1;SLC8A1;ANO6;ACVR1;MEF2C;P2RX7
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3818976665418401,-1.0089162719889209,0.4507462686567164,0.8117016870338268,1.0,7/15,26.71%,SDCBP;TSG101;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,regulation of response to oxidative stress (GO:1902882),0.4744481283700709,1.0084919359489384,0.474025974025974,0.8219043776964069,1.0,1/11,1.49%,MCTP1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.37198113185991705,1.00834504285291,0.4620505992010652,0.8216783119769565,1.0,5/44,8.42%,FCHSD2;EVL;CDC42EP1;WHAMM;NCKAP1
prerank,gonad development (GO:0008406),0.38600529210449225,1.0082373108405163,0.4559023066485753,0.8213810807806802,1.0,6/41,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.47995376539626533,1.007926876106706,0.4496527777777778,0.8215787203388059,1.0,2/11,2.42%,ARHGEF2;CASP8
prerank,nuclear pore organization (GO:0006999),0.45446551054724416,1.007876474315404,0.46405228758169936,0.8211426400166577,1.0,5/14,15.93%,RTN4;NUP54;NUP35;NUP153;NUP205
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4717981930364566,1.0078719290140081,0.4626865671641791,0.8206001589171972,1.0,5/13,13.22%,ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,regulation of mononuclear cell migration (GO:0071675),0.41026404681163725,1.0077608026328102,0.45894428152492667,0.8203407831444495,1.0,5/23,9.22%,STK10;MSN;MAPK1;CMKLR1;PTK2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.29502603649679743,-1.0075960588320911,0.42745098039215684,0.8140682668730008,1.0,15/46,22.79%,ZIC1;TCF7L2;CDH1;CAMK1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD;EFCAB7;KHDRBS1;NCBP2
prerank,transport across blood-brain barrier (GO:0150104),0.3429055450478233,1.0074579459933601,0.45955882352941174,0.8204790041988388,1.0,8/83,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.32299473397509726,-1.0073966646732562,0.44964028776978415,0.8132594978679221,1.0,11/31,16.71%,USP33;USP20;USP13;USP50;ABRAXAS2;OTUD7B;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3879007253864151,-1.006868254682102,0.4463276836158192,0.8134030427201304,1.0,7/15,22.96%,LPGAT1;PPARA;PPARG;SLC45A3;NR1H3;PPARD;MLXIPL
prerank,lipid droplet formation (GO:0140042),-0.42954504212106426,-1.0062385520991377,0.44471744471744473,0.8138637311709753,1.0,5/10,28.24%,BSCL2;SQLE;PLA2G4C;FITM2;AUP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4336518833812753,1.0060961196114018,0.47393364928909953,0.8231549661823255,1.0,2/18,9.31%,CRTAM;ZFP36L2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.35718333865646795,1.0058050866460686,0.4320827943078913,0.8232938405460376,1.0,21/55,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,positive regulation of reproductive process (GO:2000243),-0.31425822037105045,-1.0056601385532322,0.4228187919463087,0.8140775098675798,1.0,12/31,23.56%,PDE3A;SYDE1;VEGFA;LHFPL2;ACVR1B;SIRT2;CACNA1H;INHBA;CFAP69;TACR3;INHBB;C1QBP
prerank,focal adhesion assembly (GO:0048041),-0.35187315493624954,-1.005391060183268,0.4409937888198758,0.8134872240720743,1.0,4/21,6.78%,SORBS1;PTPRK;ACTN2;SRC
prerank,prostanoid biosynthetic process (GO:0046457),0.43867528293012675,1.0050324536291741,0.46044303797468356,0.8245364201181176,1.0,1/15,0.47%,EDN1
prerank,mitochondrial translational elongation (GO:0070125),0.3405117857701978,1.0049848764394673,0.44314185228604924,0.8240751302419989,1.0,39/88,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,phosphate ion homeostasis (GO:0055062),-0.43403059521048915,-1.0048966569999471,0.4728132387706856,0.813457924871453,1.0,2/10,6.74%,ENPP1;SFRP4
prerank,organic acid transport (GO:0015849),0.3374632153980093,1.0048429545011481,0.45828295042321643,0.8238383553266128,1.0,6/94,2.99%,SLC6A6;ABCC4;CEACAM1;SLC25A32;SLC7A7;SLCO1C1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.38462417384527914,1.0048416950134194,0.44914134742404227,0.8232881112506046,1.0,5/36,8.22%,NOTCH1;CAV1;NLK;ADIPOR1;JAK2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.45573442022541627,1.004798190719754,0.4574829931972789,0.8228319975657029,1.0,4/13,10.53%,ZC3H12A;PRR5L;CNOT1;GTPBP1
prerank,pharyngeal system development (GO:0060037),0.4427277040454437,1.0043602736667896,0.4378029079159935,0.8233056950654688,1.0,4/15,6.03%,BMPR2;TBX1;TGFB2;GATA3
prerank,mesenchymal cell differentiation (GO:0048762),0.36388393696373916,1.004337657384982,0.4623243933588761,0.8228025272292487,1.0,8/51,5.32%,NOTCH4;ENG;NOTCH1;TGFB2;HEY2;LEF1;FOXF2;MEF2C
prerank,protein localization to synapse (GO:0035418),-0.41306854179338093,-1.0042998078131709,0.4270833333333333,0.813771208848855,1.0,2/12,4.01%,DLG4;NLGN2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.30662078620036254,1.0041104499068914,0.48925281473899696,0.8228014280438706,1.0,40/327,12.21%,SOX17;SOX13;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;SOX18;BTG1;ACTN4;ING2;WWTR1;NLK;MEF2C;PPIE;RYBP;GTF2IRD1;CEBPA;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;NUP35;ASCC1;TRAPPC2;TESMIN;SAP30L;HINFP;SOX6
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3870854278825743,-1.004052958700076,0.4574468085106383,0.813097263866796,1.0,5/15,16.10%,NTRK2;NGF;CASP3;ZFYVE27;DDIT4
prerank,copper ion transport (GO:0006825),0.47594172614376795,1.00402566148835,0.45408163265306123,0.8224502013735914,1.0,3/11,4.64%,ATOX1;ATP7A;SLC31A1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.35777786845418597,1.003155002391429,0.45118733509234826,0.8238828882389512,1.0,16/57,20.26%,HIP1R;FBXO7;HRK;TNFSF10;BBC3;CIDEB;VPS35;BNIP3;PYCARD;PLAUR;BMF;GSK3A;BID;PPIF;SPIRE1;GSK3B
prerank,positive regulation of cellular protein localization (GO:1903829),0.349619363356579,1.003143712287314,0.4717223650385604,0.8233596330601006,1.0,16/69,16.03%,FYN;GPR137B;CARD10;WWTR1;PRKAA1;APC;VPS28;RTN4;TYROBP;CCDC88A;LIMK2;NUMA1;DTX3L;KAT7;ABCA7;NDC80
prerank,protein trimerization (GO:0070206),-0.38948681802177093,-1.0029736676017398,0.4496124031007752,0.8133211739605911,1.0,4/14,15.73%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,protein homotrimerization (GO:0070207),-0.38948681802177093,-1.0029736676017398,0.4496124031007752,0.8133211739605911,1.0,4/14,15.73%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48796596688214466,1.0022219748397323,0.4836488812392427,0.8250069162416885,1.0,4/10,20.59%,RNF125;RIOK3;SEC14L1;DHX58
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4675948602854012,1.0020465447226912,0.47324414715719065,0.8248789097807824,1.0,5/11,19.66%,UQCC3;UQCRB;UQCRFS1;UQCRC1;UQCRC2
prerank,zymogen activation (GO:0031638),0.37658774381548826,1.0016890053856025,0.4669421487603306,0.8251589851010446,1.0,8/39,14.00%,CASP8;OMA1;FURIN;PGK1;CIDEB;VSIR;TBC1D10A;APOH
prerank,motile cilium assembly (GO:0044458),0.46694544790178105,1.0013294495222418,0.4752475247524752,0.8254244667818196,1.0,2/12,6.69%,DNAAF3;SPATA6
prerank,vascular transport (GO:0010232),0.34405099520533494,1.0011721084255816,0.4600997506234414,0.8252240322049105,1.0,8/81,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,positive regulation of nervous system process (GO:0031646),0.4282904506127849,1.0008655082375446,0.4675716440422323,0.825384976075265,1.0,3/18,10.75%,UNC13B;TNFRSF1B;TENM4
prerank,positive regulation of kinase activity (GO:0033674),0.3303637333295091,1.000815205178791,0.45886442641946695,0.8249570940193914,1.0,12/107,7.56%,TEK;RAPGEF2;FLT1;TIE1;FLT4;MERTK;INSR;IQGAP1;FGFR3;ALK;LMTK2;MAPRE3
prerank,cellular response to alkaloid (GO:0071312),0.43484390973835846,1.0007581577757911,0.4656,0.8245311320115568,1.0,6/17,23.13%,SLC8A1;HTR1B;SPIDR;CASP7;BLM;RYR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3626842708620171,1.0004508880892955,0.4489528795811518,0.8247117873552461,1.0,9/50,11.98%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;DTX3L
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3747169293282211,-0.9994530668130891,0.450261780104712,0.8213528946243779,1.0,4/18,8.48%,PDPN;RUNX1;SMAD3;EFEMP2
prerank,positive regulation of transferase activity (GO:0051347),0.3194054528847007,0.9993740313822126,0.4745011086474501,0.8266895884929744,1.0,27/142,14.25%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;HMBOX1;KLF4;FGFR3;MAPK1;ALK;LMTK2;NVL;CD200;NEK7;FBXW7;DKC1;PTGES3;TNKS;POLG2;CCT2;SERINC5;DTX3L;CCT4;PIN1;LTK;CTNNB1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3915529482723892,-0.9990047865944708,0.46134020618556704,0.8211616669945755,1.0,4/14,11.18%,AUTS2;SNW1;WDR5;CTR9
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.413103983360337,-0.998779822342562,0.4873096446700508,0.820449781862568,1.0,4/12,3.47%,DOCK5;IGFBP5;DOCK7;TPM1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3464727147293623,-0.9982466328957915,0.47023809523809523,0.8205459388833589,1.0,6/21,22.23%,SAMD4A;CNOT10;TUT4;ZFP36;PNLDC1;SAMD4B
prerank,regulation of anoikis (GO:2000209),0.4232823918189781,0.9980909931884034,0.47604790419161674,0.8291918258997241,1.0,5/19,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,retinal metabolic process (GO:0042574),-0.407577447926831,-0.99788189699681,0.4489247311827957,0.8201738405138168,1.0,8/12,45.75%,ABCA4;ALDH1A3;DHRS13;BCO2;ALDH8A1;CYP1B1;RDH10;BCO1
prerank,positive regulation of neuron death (GO:1901216),0.3584525015246375,0.9965899105311197,0.46153846153846156,0.8321022791836221,1.0,13/46,16.68%,FYN;TGFB2;FCGR2B;ITGAM;GRIN2B;EGR1;PRNP;TYROBP;CLU;CTNNB1;SARM1;EIF2S1;DAXX
prerank,antibacterial humoral response (GO:0019731),0.43510955808693563,0.9964290313739572,0.44461538461538463,0.8319395387320292,1.0,6/16,24.08%,DEFA6;RNASE6;SLPI;ANG;RPL39;RNASE7
prerank,potassium ion transmembrane transport (GO:0071805),0.3233078013389469,0.9960514923536126,0.47704367301231804,0.832268723640287,1.0,10/135,3.90%,KCNN4;KCNQ1;KCNE3;KCNH8;ATP1A4;ATP1A1;ATP1A3;KCNN3;KCNG3;SLC12A8
prerank,relaxation of cardiac muscle (GO:0055119),-0.40094677881174695,-0.9960369718043237,0.4813895781637717,0.8237951253672535,1.0,2/13,0.82%,ATP1A2;GSN
prerank,long-term synaptic potentiation (GO:0060291),-0.3492494553717618,-0.9957194844949305,0.4661016949152542,0.8233066621478194,1.0,5/21,9.75%,STX4;SLC8A3;TSHZ3;GRIN2D;PRKCZ
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4576110005864662,0.9954315445320514,0.4588235294117647,0.8332145594649464,1.0,5/13,18.13%,NOTCH1;HEY2;NPY5R;GSK3A;SMAD4
prerank,mitochondrial transcription (GO:0006390),0.4865269532805067,0.9953482149985916,0.4830508474576271,0.8328579382297848,1.0,4/10,15.48%,SLC25A33;MTERF2;TFB2M;TEFM
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4485318142397433,0.9952187428819431,0.4654895666131621,0.8325830182922103,1.0,5/13,25.31%,DUSP1;NDC80;LCMT1;GEN1;TPR
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4191659787243973,0.9947208856540114,0.48613138686131385,0.8331215624014133,1.0,3/22,4.59%,APOA1;KLF4;GCNT2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.46055620402242126,0.994593463612944,0.45171849427168576,0.8328796826777906,1.0,5/14,15.48%,SLC25A33;MTERF2;FASTKD5;TFB2M;TEFM
prerank,early endosome to late endosome transport (GO:0045022),0.4220335986189016,0.9940961102215242,0.4722222222222222,0.8335218383767377,1.0,6/20,18.81%,EMP2;LMTK2;HOOK1;PIK3C3;KIF16B;HOOK2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.41840685762574725,-0.9937771807983967,0.45323741007194246,0.827119911652618,1.0,3/10,12.69%,CREBBP;KAT2B;ESCO1
prerank,vesicle transport along microtubule (GO:0047496),-0.3375648546010977,-0.9934661249482389,0.463855421686747,0.8266587666282504,1.0,9/23,23.49%,TRAK1;NDE1;KIF13A;NDEL1;KIF3A;FBXW11;CLN3;KIF5B;KIF1C
prerank,regulation of protein secretion (GO:0050708),0.3253396292629249,0.9933972275249333,0.4791666666666667,0.8345601885858848,1.0,11/119,6.22%,CD2AP;UNC13B;ITPR3;SLC2A1;CACNA1A;TGFB2;HNF4A;SYT7;RAPGEF4;TMED10;IL1A
prerank,response to interleukin-1 (GO:0070555),0.3419674225742102,0.99338359111206,0.4680589680589681,0.8340354760645501,1.0,13/73,11.38%,DAB2IP;LGALS9;APP;HYAL2;IRAK2;GBP3;CD47;ZC3H12A;NR1D1;ACOD1;CACTIN;CCL4;GBP2
prerank,regulation of protein dephosphorylation (GO:0035304),0.38311503337486297,0.9932014361926808,0.4643835616438356,0.8339226840721352,1.0,19/37,27.96%,PPP1R16B;MFHAS1;HSP90B1;ARPP19;CDCA2;CALM3;PIN1;CNEP1R1;TIPRL;PPP1R16A;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4366477672697965,0.992898101466153,0.47235387045813587,0.8340746577584053,1.0,4/18,8.22%,CBL;STAT1;CEBPA;JAK2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.31905538131620437,-0.9928058264728923,0.45125348189415043,0.8270793426685342,1.0,8/26,12.80%,ERRFI1;CBLB;SHC1;SNX6;TGFA;TSG101;ADRA2A;HBEGF
prerank,meiosis I (GO:0007127),0.4193345229454722,0.9925577259221274,0.4917043740573152,0.8343412905949504,1.0,6/23,18.63%,DDX4;ING2;PTTG1;SYCP3;SGO1;TDRD9
prerank,microtubule depolymerization (GO:0007019),0.4364838497224866,0.9923739099856184,0.47392638036809814,0.8342285200104559,1.0,2/17,6.54%,STMN2;KIF2A
prerank,tRNA modification (GO:0006400),0.35016457194796874,0.9920977421777558,0.4810606060606061,0.8343239729235312,1.0,11/62,13.52%,ADAT2;TRDMT1;OSGEP;TRMT61A;TRMT5;TRUB1;METTL2A;METTL2B;ALKBH8;TRMT61B;TYW1
prerank,regulation of gene expression (GO:0010468),0.29751760766030466,0.9920718570679334,0.5335335335335335,0.8338414708641194,1.0,122/903,12.61%,NANOS1;PLCG2;SOX17;SOX13;NOS3;ENG;CLDN5;GATA2;PDGFB;TRIM14;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;CCR1;FOXO4;ESRP2;NOVA2;OCLN;ACVRL1;NOTCH1;ATP2B4;INSR;HEY1;IRF2;IFNGR1;CASP8;TGFB2;TNRC6C;SAP30;LGALS9;DLL4;APP;SOX18;BTG1;AFF1;HEY2;TLR3;NOS1AP;MED26;SLC8A1;KLF4;PPM1F;KRAS;ING2;PUM2;MSN;ANGPT1;WWTR1;LEF1;GCNT2;MBNL1;YBX2;TRIM11;TRIM6;NLK;NKAPL;MEF2C;CD34;PPIE;GATA3;BCL6B;WARS1;IL1A;SMCR8;MAPK1;RYBP;P2RX7;GTF2IRD1;ZC3H12A;HSPA1B;RBL1;CEBPA;PLSCR1;ZC3H7A;CDH3;NFE2L2;PRKAA1;WWC2;CAVIN4;ACTG1;SNAI2;ROCK1;CACTIN;FOXP1;STAP1;NDFIP2;SERTAD3;TCF7L1;TCF3;ADAM10;DHH;EGR1;MLF1;FBXW7;HP1BP3;PLAG1;TCEAL1;TYROBP;HNRNPK;AGO4;TRIM17;NUP35;VSIR;ASCC1;PTBP3;NWD1;TRAPPC2;VPS35;PCBP1;BRCA1;TESMIN;VSTM2A;CLU;SAP30L;HINFP;SOX6;TOB1;PIK3CB;TSKU;TTBK1
prerank,protein localization to phagophore assembly site (GO:0034497),0.47025138079721707,0.9918724111324547,0.465,0.8337891931900979,1.0,1/11,1.80%,TRAPPC8
prerank,regulation of telomere maintenance (GO:0032204),-0.3323244147415577,-0.9915952826815304,0.45222929936305734,0.829026825732534,1.0,13/26,31.46%,RAD50;PPP1R10;YLPM1;XRCC5;RTEL1;PML;GNL3;ATRX;HDAC8;HNRNPD;SMG6;SIRT6;UPF1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3475227895596767,0.9914884103204182,0.4740177439797212,0.8341063899098389,1.0,24/61,22.45%,AZIN1;CAV1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NCOR2;NQO1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4075124788718401,0.9907657412366712,0.4789915966386555,0.8351960867391441,1.0,7/24,15.49%,AQP11;LRRK2;BCL2L1;LPCAT3;TMBIM6;CLU;RACK1
prerank,tRNA methylation (GO:0030488),0.3796297704491853,0.9905343410731046,0.47404371584699456,0.8351716078084723,1.0,7/34,11.54%,TRDMT1;TRMT61A;TRMT5;METTL2A;METTL2B;ALKBH8;TRMT61B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4622176518328858,0.990377989910379,0.47797716150081565,0.8349751099904505,1.0,1/13,1.35%,DOC2B
prerank,tRNA aminoacylation (GO:0043039),0.3730817155518649,0.9903051183341257,0.5065502183406113,0.8345996283944079,1.0,10/37,19.48%,GARS1;VARS1;KARS1;FARSB;WARS1;FARS2;GATB;RARS1;EEF1E1;DARS1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3505564529988454,0.990212738897023,0.47277227722772275,0.8342491841989328,1.0,23/62,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,actin crosslink formation (GO:0051764),-0.41503207593845626,-0.9900230749380391,0.4731457800511509,0.8318919080505572,1.0,4/12,19.63%,DPYSL3;FLNA;BAIAP2;GAS2L1
prerank,nucleotide metabolic process (GO:0009117),-0.33673597097724517,-0.9899819500890618,0.4301994301994302,0.8306813907417295,1.0,10/23,19.84%,NMNAT2;FHIT;ME1;ENPP3;AK5;PNP;CMPK2;CTPS2;AK1;NME2
prerank,regulation of cell projection organization (GO:0031344),0.45895281407050953,0.9899145029883856,0.4840989399293286,0.8343738969367188,1.0,2/13,10.30%,MACF1;ERMN
prerank,cholesterol efflux (GO:0033344),0.426155995886055,0.9897614596442843,0.48989113530326595,0.834200959732068,1.0,7/20,18.32%,APOA1;STX12;ABCG4;TSKU;ABCA7;SCARB1;SOAT1
prerank,positive regulation of calcium ion import (GO:0090280),0.4820396929490539,0.9892500678709767,0.47401574803149604,0.8348267680806049,1.0,1/12,0.88%,PDGFB
prerank,neurotransmitter transport (GO:0006836),0.34039536953451455,0.9892285664207029,0.48792884371029227,0.8343381345028502,1.0,22/73,21.07%,UNC13B;APBA1;SYN3;GLS2;GLS;SLC6A4;PPFIA2;SLC6A2;PDZD11;SLC1A1;GABRA2;SLC1A2;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYNJ1;SYT1;SLC1A6;NRXN1;SLC29A4
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29434119013521537,0.9879737646966501,0.581,0.8366631374696215,1.0,229/1645,14.32%,PRDM16;NOS1;MECOM;EPAS1;SOX17;SOX13;NOTCH4;KLF8;AFAP1L2;ERG;ENG;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;PLCB1;PDGFB;DACH1;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;CDK17;TBX1;APBB2;MLF2;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;ACVRL1;NOTCH1;FOXQ1;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;INSR;KLF12;HEY1;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CDK14;ZNF296;ZNF235;LRRFIP1;SAP30;HNF1A;HNF4A;KLF3;ID1;KLF6;ARID3B;HDAC9;ZGLP1;SOX18;BTG1;CRK;HHEX;TEAD4;FLI1;INPP5K;RBBP8;HEY2;HMBOX1;MED26;KLF4;PPM1F;ACVR1;ING2;SIM2;WWTR1;LEF1;MAFK;IRF9;CCNE1;ZBTB46;CAMK2D;PKN1;SP4;MAFF;KARS1;NLK;ELOC;FOXF2;MEF2C;SMAD2;BTAF1;DAP;PPIE;BBS7;ZBTB48;FOSL2;COMMD7;PHF6;GATA3;EID2B;BCL6B;TOX3;RXRG;PDCD4;RAD21;SRCAP;RYBP;ZBTB16;FANK1;GTF2IRD1;MRGBP;PHC3;KDM3A;LCORL;STAT1;ELP4;TOX4;AATF;PURA;MAPRE3;EBF3;ELP2;TMPRSS6;ARRB1;CEBPA;WWP1;DNAJC2;ZHX3;NFE2L2;WWC2;GATAD2A;KMT2E;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;MBD1;KMT2B;JUN;BRF2;SERTAD3;TCF7L1;TCF3;ELOA;EGR1;HMGB1;MLF1;ZNF182;DHX9;HP1BP3;ARID5A;PLAG1;SEC14L2;MAD2L2;ZBTB14;CHD5;ZXDB;RPS6KA1;HNRNPK;SFR1;BRIP1;NUP35;ZBTB34;POLA1;DEAF1;ASCC1;RAI1;SAMD1;NPM1;PHOX2A;HDX;TRAPPC2;DMAP1;E2F7;BRCA1;TIAL1;NR4A1;TESMIN;CD38;SAP30L;ILF2;DTX3L;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;ATP8B1;RPS6KA3;TGIF1;ASCL4;YWHAH;POU3F2;ZNF32;PHIP;RIOX1;TBX20;HIF1A;NFATC1;IKZF5;RHOH;ETV6;MYT1L;HES3;LRP5;USF2;MED27;SMARCC1;ELAVL2;CTNNB1;MED17;MLLT3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4137186641871615,0.9879405488875882,0.4900763358778626,0.8361983952704102,1.0,5/24,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DTX3L
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4243191127433753,0.9877667603878331,0.48214285714285715,0.8360565327709405,1.0,2/19,7.30%,EDN1;PPP3CA
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.39163327708462503,0.9872341004333609,0.48807854137447404,0.836768856083963,1.0,5/29,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4542458316249298,0.9871516514844293,0.4943089430894309,0.8364137754347563,1.0,5/14,16.19%,NFKBIE;NFKBIB;NFKBIA;KEAP1;TMSB4X
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4649336265911911,0.9867107023003634,0.4739583333333333,0.8368711831654873,1.0,1/11,1.35%,NR4A2
prerank,protein K48-linked ubiquitination (GO:0070936),0.35185589792355493,0.9866468394355281,0.4682741116751269,0.8364717063573816,1.0,12/54,14.78%,ZNRF1;KLHL3;CUL3;UBE2D1;UBE3A;RNF115;RBX1;NEDD4L;DTX3L;UBE2T;UBE2E1;UBE2D3
prerank,dendritic spine organization (GO:0097061),0.39860818590250635,0.9865073906324039,0.4650817236255572,0.8362294131137356,1.0,4/26,9.97%,FYN;INSR;SHANK3;PRNP
prerank,regulation of p38MAPK cascade (GO:1900744),0.381897349378104,0.9862897019625418,0.47534246575342465,0.8361992556763586,1.0,7/35,10.65%,DUSP1;DAB2IP;LGALS9;MFHAS1;ZC3H12A;GADD45G;MINK1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3197376450608059,-0.9862434553214595,0.43870967741935485,0.8395520807194394,1.0,5/29,4.30%,SNTA1;WNK1;KCNIP3;CD63;SLMAP
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.46850208548596906,0.9859275048044113,0.4833887043189369,0.8364899511722582,1.0,6/12,15.39%,FKBP1A;TMED10;ROCK1;PRNP;RANBP9;ABCA7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.47595755216992797,0.9858027271588193,0.53156146179402,0.8362362909526257,1.0,2/10,5.58%,APP;SHANK3
prerank,transferrin transport (GO:0033572),-0.3114754353029261,-0.9856739132574308,0.44982698961937717,0.8397315897260361,1.0,6/33,8.32%,STEAP3;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.29717774669634756,-0.9851471263811279,0.476027397260274,0.8398551728661003,1.0,13/38,25.43%,PRPF8;COIL;GEMIN5;SMN1;PRPF31;PRPF3;SNRPF;SNUPN;SNRPD3;GEMIN7;CD2BP2;WDR77;SNRPD1
prerank,neuropeptide signaling pathway (GO:0007218),0.3474197442136138,0.9850704575991075,0.48484848484848486,0.8373072303382988,1.0,14/58,23.17%,RAPGEF2;HCRTR1;GAL;NXPH2;NMU;GLRA2;GPR149;PENK;SORCS1;SORT1;HCRTR2;SORL1;PDYN;NTS
prerank,regulation of cell death (GO:0010941),0.33175437748723124,0.9848012035804173,0.4860606060606061,0.8373919331494654,1.0,19/94,14.86%,ACER2;PRKD1;SNCG;TMEM109;TNFRSF1B;ZC3H12A;LRRK2;HSPA1B;PDE8A;CIDEB;APC;RRAS2;DCC;VPS35;CLU;BNIP3L;BNIP3;RAD18;SARM1
prerank,ncRNA catabolic process (GO:0034661),0.3877968727569439,0.9847479562023894,0.46628407460545196,0.8369683537960795,1.0,11/28,24.98%,RBM7;TRIR;EXOSC3;EXOSC8;XRN1;EXOSC9;POP1;EXOSC10;DIS3L2;NUDT16;NUDT16L1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3364092173346975,0.9846161294503424,0.46948941469489414,0.836736664113406,1.0,7/75,3.90%,TRPV4;ATP2B4;ATP1A4;ATP1A1;ATP1A3;SLC8A1;SLC12A8
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.2867961328136946,-0.9842067223113831,0.4666666666666667,0.8411174603972368,1.0,10/46,16.29%,ATP1A2;NLGN2;GRM3;CACNG4;TSHZ3;ATAD1;HOMER1;DRD2;CACNG8;UNC13A
prerank,regulation of lipase activity (GO:0060191),0.44818748106355166,0.9841392090896037,0.47761194029850745,0.8372924159157723,1.0,2/13,5.65%,PCSK5;FURIN
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2816879396612278,-0.983316387977958,0.459915611814346,0.8421580923191024,1.0,6/49,8.97%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,protein methylation (GO:0006479),-0.2936001913393982,-0.9831533413672179,0.4708029197080292,0.8412917254888628,1.0,10/40,18.19%,NSD3;NSD1;EHMT1;GSPT1;METTL21A;FAM98B;EEF1AKMT1;N6AMT1;EEF1AKMT2;SNRPD3
prerank,transition metal ion transport (GO:0000041),0.36731424333404056,0.9830121294416525,0.45625841184387617,0.8392957233845713,1.0,10/35,17.78%,ATOX1;ATP2C1;ATP7A;SLC31A1;SLC30A1;TRPC7;CP;TRPC5;HEPH;ATP7B
prerank,regulation of macroautophagy (GO:0016241),-0.24887664819297256,-0.9829974656486181,0.4965034965034965,0.8403517061051474,1.0,33/105,22.54%,PRKAG2;DCN;PRKAA2;GPSM1;SNX6;VPS26B;SESN1;ATP6V1B2;SNX32;TBK1;ATP6V0B;PRKACA;CASP3;SESN2;PRKAB2;HDAC6;UCHL1;TSC1;WAC;ATP6V1A;LAMTOR2;LARP1;PRKAG3;TSC2;SNX5;CLN3;MAP3K7;MAPK8;LAMTOR5;CDK5;ATP6V1H;ATP6V0D2;PAFAH1B2
prerank,acidic amino acid transport (GO:0015800),0.43190639677085574,0.9828707967824308,0.4872611464968153,0.8390767163142756,1.0,2/17,2.39%,SLC6A6;ARL6IP5
prerank,import into cell (GO:0098657),0.36783532948184217,0.9825955893801874,0.4871447902571042,0.8391455733740968,1.0,2/41,0.35%,SLC6A6;LRRC8C
prerank,cellular protein localization (GO:0034613),0.29828744414111663,0.9824725803756909,0.5216049382716049,0.838888407459193,1.0,54/285,14.48%,FBLN5;RABGAP1;OCLN;TRAPPC8;ARHGEF2;RAB6B;HERC2;EMP2;ID1;ESAM;HHEX;HEY2;STX7;TBC1D30;SCG5;EHD1;SGSM1;ANGPT1;TBC1D8;TMED10;PACSIN1;RAB23;CEP68;RAB3GAP2;LRRK2;TBC1D12;PTPRU;TLK1;TBC1D5;STX12;TBC1D1;ARF3;RRAGD;TM9SF1;REEP1;LAPTM5;NPM1;VPS35;TMED9;SMURF1;RAB19;STX19;TM9SF3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;MESD;TBC1D9;NSF;CTNNB1;TMED4
prerank,postsynaptic membrane organization (GO:0001941),-0.35958211702071097,-0.9819901019839523,0.44751381215469616,0.841719642985134,1.0,5/17,8.95%,APOE;DLG4;NLGN2;DNAJA3;LRRC4
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2958140265118437,-0.9818812913591122,0.4840989399293286,0.840676822556908,1.0,7/39,9.99%,PLPP3;PDGFRA;MEGF11;UBASH3B;FLNA;MYL9;PPIA
prerank,microtubule polymerization (GO:0046785),0.39087134695286596,0.9818138172170976,0.48787446504992865,0.8398248084681681,1.0,6/29,13.11%,TRPV4;CSNK1D;CLASP1;CLASP2;RANBP9;PIN1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.38729286690825043,0.9816953102525454,0.48450704225352115,0.8395603608837512,1.0,5/30,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,nuclear export (GO:0051168),-0.262872816068358,-0.9813934935178427,0.4789473684210526,0.8406743808565126,1.0,29/80,26.03%,RANBP3L;SRSF5;PHAX;NEMF;NCBP1;SRRM1;SRSF1;CSE1L;NUP155;SRSF6;PKD1;THOC1;RANBP17;NXF1;MAGOH;RANBP3;U2AF2;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,regulation of lipid biosynthetic process (GO:0046890),0.38115154984387223,0.9811997559848028,0.48923959827833574,0.840158086647472,1.0,5/32,6.44%,ADIPOR2;CEACAM1;APOA1;SIRT4;ADIPOR1
prerank,pore complex assembly (GO:0046931),0.4225784776124908,0.9811699683340437,0.4923547400611621,0.8396878912188162,1.0,7/19,15.93%,ANO6;P2RX7;ADAM10;RTN4;PDZD11;NUP153;NUP205
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4052945057222495,0.9810822842131974,0.49277456647398843,0.8393498171936286,1.0,6/23,21.74%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3;ABHD4
prerank,ureteric bud morphogenesis (GO:0060675),-0.37453154660478255,-0.9806691565859111,0.4777777777777778,0.8412549644640918,1.0,4/16,11.07%,BMP4;FGF2;SIX1;SALL1
prerank,entry into host (GO:0044409),-0.3841704728609202,-0.9802727617425909,0.49382716049382713,0.8409848259072509,1.0,5/13,10.94%,ITGAV;CDH1;SRC;PPIA;MET
prerank,regulation of neuron projection development (GO:0010975),0.31145547811271784,0.9802437610528469,0.5216919739696312,0.840699996028409,1.0,32/163,14.06%,TRPV4;STMN2;RAPGEF2;TANC2;RAPGEF1;FKBP4;DAB2IP;PRKD1;SERPINI1;FES;FBXO7;PDLIM5;SHANK3;CAMSAP2;SETX;LRRK2;PTPRO;TENM3;LRRC4C;SCN1B;PPFIA2;CCDC88A;CDH2;SPOCK1;DCC;CSMD3;MARK2;CTNNA2;TSKU;LTK;CFL1;EFHC2
prerank,maintenance of protein location in nucleus (GO:0051457),0.41826767900483264,0.9801997899092069,0.48657187993680884,0.8402635196344839,1.0,7/20,21.56%,SYNE1;RANGAP1;ARL2BP;TAF8;TAF3;BARD1;SUN1
prerank,positive regulation of response to external stimulus (GO:0032103),0.31840489483548173,0.9795225457108191,0.4943820224719101,0.8412052411463316,1.0,23/128,14.00%,PDGFB;GBP5;F2RL1;APP;TLR3;PPM1F;PUM2;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3;APOH
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.37171732312734285,-0.9793025030601348,0.4847715736040609,0.8422789957886218,1.0,8/15,24.79%,GPLD1;SLC27A1;SREBF1;MFSD2A;SIK1;NR1H3;FITM2;C3
prerank,histone H3 acetylation (GO:0043966),-0.29730193867958876,-0.9791638993193184,0.516260162601626,0.8413190171394171,1.0,14/40,21.86%,LDB1;TADA2A;KAT2B;DR1;WDR5;MEAF6;TAF6L;NAA60;TAF5;TADA3;BRPF3;SUPT7L;MAP3K7;TAF10
prerank,response to progesterone (GO:0032570),0.4259354189743109,0.9791316249122051,0.504601226993865,0.8416093416956464,1.0,4/18,8.74%,CAV1;TGFB2;UBE3A;ACOD1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.37088761688340033,-0.9789692406911449,0.5067385444743935,0.840503864294147,1.0,6/16,14.89%,DDX5;DDX17;SRSF1;PUF60;SRSF6;SCNM1
prerank,regulation of cellular response to stress (GO:0080135),0.3183848565401295,0.978964558864535,0.5080091533180778,0.8414385615984228,1.0,22/115,16.99%,NUAK1;FKBP4;ING2;CAMK2D;MAPK1;CHCHD2;MBTPS2;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NPM1;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;ARMT1;DNAJC7
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4045164754932058,0.97797453792101,0.4978038067349927,0.843187159967798,1.0,2/24,3.80%,RAPGEF2;PDE3B
prerank,regulation of T cell activation (GO:0050863),0.36024398573818756,0.97760384915888,0.49027777777777776,0.8435153294177302,1.0,5/42,11.23%,CRTAM;TNFRSF1B;CD47;DUSP3;LAPTM5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4028194036005877,0.9773993298138421,0.46279761904761907,0.8434259249914208,1.0,5/25,9.89%,HEY1;HEY2;TRIM6;GATA3;MAD2L2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3337031983553472,-0.977375669504951,0.48546511627906974,0.8435447080317158,1.0,9/22,23.08%,DMD;AHNAK;CACNB1;CACNB2;DRD2;PDE4B;CACNB3;STAC3;CBARP
prerank,heterochromatin assembly (GO:0031507),-0.3429488554422709,-0.9773358907523423,0.4824561403508772,0.8423480941407524,1.0,5/20,14.39%,HDAC1;RRP8;HMGA2;SUV39H1;SIRT2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31813756593501485,-0.9768604573285526,0.4716981132075472,0.8423220591911055,1.0,6/30,12.70%,DDX5;DAB2;HEYL;KLK2;HDAC1;HDAC6
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.45412627274540956,0.9767223041491716,0.4991922455573506,0.8443943932939805,1.0,8/12,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,skin development (GO:0043588),0.3453379714172427,0.9764917064234623,0.4838709677419355,0.8443731172002253,1.0,7/65,5.79%,JAG1;GATA6;CLIC4;LSR;BCR;ATP7A;COL5A2
prerank,prostaglandin biosynthetic process (GO:0001516),0.41166839067944383,0.9763524852704913,0.49767441860465117,0.8441798942887239,1.0,1/18,0.47%,EDN1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3366923776453046,0.9761955519768328,0.50625,0.843999193396754,1.0,11/66,11.55%,PLCB1;CCND2;FAM107A;CCND3;KLF4;ADAM17;RBL1;APC;KMT2E;ADAMTS1;E2F7
prerank,GPI anchor metabolic process (GO:0006505),-0.31772522607860454,-0.9761232154811289,0.48534201954397393,0.8430278193797835,1.0,14/26,26.50%,GPLD1;PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW
prerank,water transport (GO:0006833),0.4524091287235419,0.9755396748500381,0.5051369863013698,0.8449906605671231,1.0,1/12,2.23%,AQP11
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.38674458488876007,-0.9748495837957573,0.5026737967914439,0.8450054146217079,1.0,5/14,22.28%,FUS;ACTR2;FANCB;TIMELESS;PARP1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.47007734644690374,0.9747009984531778,0.49230769230769234,0.8462977022968693,1.0,5/10,22.04%,UBA52;RPS27A;TUT7;UBB;DIS3L2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4541690619516484,0.9746277430056385,0.4966887417218543,0.8459341454289742,1.0,4/12,13.01%,KLF2;CNOT1;CTBP2;CYP26C1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4561905734073185,0.9746106030259727,0.502454991816694,0.8454382902121299,1.0,2/12,6.71%,PTPN14;UHMK1
prerank,cellular response to virus (GO:0098586),0.38977368939697454,0.9742263286816757,0.4978165938864629,0.8457268817868842,1.0,8/30,17.65%,IFIH1;LGALS9;IRGM;ZC3H12A;HIF1A;RIOK3;MAPK14;CXCL10
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4418636699135835,0.9732016228907409,0.4848966613672496,0.8475553587688963,1.0,3/14,17.63%,DAB2IP;PTPN1;COPS5
prerank,regulation of fibroblast proliferation (GO:0048145),-0.27633638874475136,-0.9731554324763346,0.5217391304347826,0.8482848130989523,1.0,16/45,21.64%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6;PEX2;SPHK1;CD300A;CDKN1A;NLRC3;CD74;MORC3;NF1;AGT;E2F1;CDK4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4084444313531823,0.9728742712594892,0.48988439306358383,0.8477431838704683,1.0,2/23,3.71%,NOTCH1;MGAT5
prerank,stress granule assembly (GO:0034063),-0.3450101529667702,-0.9728392464401022,0.5074183976261127,0.8478467985891379,1.0,6/20,13.47%,YTHDF1;ATXN2;UBAP2L;YTHDF2;DDX3X;PRRC2C
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3839549801155084,0.9722726563367802,0.4940652818991098,0.8485896753724366,1.0,9/29,21.18%,SMAD7;FBXW7;DTX3L;PIN1;BMI1;TRIB3;FEM1A;ARRDC4;DCUN1D2
prerank,regulation of autophagy (GO:0010506),0.29921818736680356,0.9718131190308745,0.5396145610278372,0.8490489969729952,1.0,56/216,20.83%,ACER2;RASIP1;TRIM14;FBXL2;DRAM1;FOXO1;PRKD1;PIK3C2A;ATG101;GPR137B;TRIM6;DAP;SMCR8;SH3BP4;DEPP1;IRGM;ZC3H12A;LRRK2;HSPB1;PRKAA1;GAPDH;ROCK1;HMGB1;FBXW7;RRAGD;EXOC8;TPCN2;TAB2;VPS35;TRIM8;DRAM2;PIK3CB;KEAP1;ATM;BNIP3;RHEB;RUBCN;UBQLN2;VDAC1;RMC1;TRIB3;ATP6V1G1;BMF;GSK3A;EXOC4;ATP6V1C1;CAPN1;RRAGA;ERN1;MCL1;ATP6V0A1;RRAGC;GSK3B;LAMTOR3;ATP6V1D;MID2
prerank,intracellular protein transport (GO:0006886),-0.21043182219911927,-0.9715104200006529,0.5833333333333334,0.8500328155909165,1.0,79/304,18.39%,RANBP3L;WLS;APPL2;STX4;SGSM2;GGA2;TRAK1;TBC1D2B;SNX6;VPS26B;UNC93B1;SIL1;COPZ2;TBC1D9B;NUP107;COPA;C2CD5;SURF4;VIPAS39;CLIP3;VPS45;LMAN1;SEC31A;HEATR3;KIF13B;ARF1;CSE1L;GRTP1;PPP1R10;ARCN1;STX3;KIF13A;COPB2;NUP155;ADPRH;RAB22A;COX18;TBC1D16;TNPO3;ARF5;ARL6;EIF2D;RABGAP1L;RANBP6;STX5;ARL4A;SNX1;TMED3;HOMER3;PKD1;VPS33A;STX16;IPO5;TBC1D17;FAM53C;SAR1A;BAG3;HDAC6;NUP93;SNX8;NAPA;TRIM23;HPS4;TNPO2;IFT27;SEC16A;RANBP17;GGA1;STX17;ARL5A;TMED1;RANBP3;TSC2;GABARAP;CD74;PHB2;VPS33B;RAB29;AP1S3
prerank,regulation of type I interferon production (GO:0032479),0.3330329970653927,0.9714983155029485,0.5232419547079857,0.8492027778937834,1.0,16/84,14.25%,IFIH1;LRRFIP1;UBA7;TIRAP;DDX41;RNF125;NLRC5;POLR3B;ACOD1;GAPDH;DHX9;TRIM25;POLA1;IRF5;PIN1;CTNNB1
prerank,snRNA metabolic process (GO:0016073),0.4108999464928068,0.9714305905926003,0.49768160741885625,0.8488193331143473,1.0,4/17,14.07%,RBM7;INTS11;INTS12;INTS5
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.382221280063761,0.9712788739262663,0.5042735042735043,0.8486396360809111,1.0,6/29,20.04%,SYCP2;RAD21;MEI4;BAG6;TERB1;PRDM9
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3956501756440047,0.9711603552384519,0.5036818851251841,0.848374938962906,1.0,4/25,9.23%,VCAM1;IZUMO1;CD200;DSP
prerank,regulation of protein kinase A signaling (GO:0010738),0.41806548004548744,0.9707632168250836,0.5092879256965944,0.8487298426752082,1.0,4/20,7.15%,ADRB2;AKAP5;IAPP;LRRK2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.30123368731166184,0.9703803185664134,0.5581151832460733,0.8490542190183094,1.0,50/248,14.81%,DKK2;SOX17;SOX13;CCDC88C;FZD6;CCNY;GNAQ;TMEM88;DAB2IP;CDK14;CAV1;HHEX;LGR5;PSMD13;WWTR1;CSNK1D;CUL3;PSMD4;SHISA6;LRRK2;PTPRU;PTPRO;CDH3;APC;SNAI2;MCC;CSNK1G3;IGFBP4;AMER3;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;TNKS;PSMB8;PSMD14;PSMA7;PSMC3;PIN1;ADGRA2;PSMA8;PSMC1;PSMB5;CTNNB1;MLLT3;PSMC5;FZD9
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3685188685818897,-0.9702795664355752,0.48320413436692505,0.8519680865254176,1.0,3/15,5.02%,LACTB2;DICER1;NYNRIN
prerank,blood vessel endothelial cell migration (GO:0043534),0.403066627196902,0.9698216862175097,0.49344978165938863,0.8497517088647293,1.0,5/22,6.05%,EGR3;EMP2;ID1;SOX18;MYH9
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.38123057580714365,0.9698096355814788,0.49930843706777317,0.8492383332026859,1.0,4/34,5.16%,NOD2;F2RL1;TRIM6;GPI
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2391878403743595,-0.9697303018697954,0.5259259259259259,0.8520968873734094,1.0,30/101,19.67%,SAMD4A;OGT;CYFIP2;THBS1;FXR2;NIBAN1;DACT1;PLXNB2;YTHDF1;IST1;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;AGTR1;ATG7;RPS4X;NR1H3;EIF3E;AMER1;STUB1;FBXW11;EZR;LARP6;UPF3B;FGFR4;INHBA
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4408229447141015,0.9697163720414652,0.4991922455573506,0.8488916885683968,1.0,1/14,1.84%,PAEP
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.35131378529789453,0.9684788790780756,0.49934469200524245,0.8511883988000176,1.0,25/51,28.72%,HMBOX1;MAPK1;CCT8;NEK7;STN1;TNKS;CCT2;FBXO4;CCT4;XRN1;ATM;CTNNB1;CCT6A;CTC1;MAPKAPK5;EXOSC10;TERF2;TCP1;CCT3;TINF2;MAP3K4;TNKS2;HNRNPC;SMG5;HNRNPA1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.39187100364492855,-0.9684536146297059,0.5039370078740157,0.8542203199647225,1.0,2/12,4.04%,DPYSL3;DPYD
prerank,ncRNA transcription (GO:0098781),0.4415946433898378,0.9682674156843487,0.5042881646655232,0.8511337993262956,1.0,6/13,24.72%,CAVIN1;SPIN1;USPL1;ANG;BRF1;SNAPC3
prerank,protein-containing complex disassembly (GO:0032984),0.34830173744269094,0.9680689958849643,0.501269035532995,0.851022523451139,1.0,12/54,14.37%,CAV1;VTI1B;GABARAPL1;TECPR1;VAMP8;APC;VAMP7;LIX1;VPS4A;CHMP3;CTNNB1;MAP1LC3A
prerank,nuclear membrane organization (GO:0071763),-0.34131494714487187,-0.9679775587841616,0.5045045045045045,0.8542193849449037,1.0,7/19,17.02%,TOR1AIP1;TOR1B;UBXN2B;TARDBP;AKAP8L;SPAST;GPER1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.40877396699508484,0.967844903924986,0.4940119760479042,0.8510184341870058,1.0,10/19,27.97%,CEBPA;BRF2;ICE1;TENM1;ZC3H8;POLR3C;DHX36;RPTOR;PRDX5;ICE2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3404986344149484,0.9677227041087498,0.5097560975609756,0.8507507213869724,1.0,23/64,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.37442753671754525,0.9676240535415457,0.5152317880794702,0.8504241604737025,1.0,4/35,5.27%,FASN;FAR2;PPT1;FAR1
prerank,myeloid cell development (GO:0061515),0.427925556255511,0.9673652081954468,0.5192604006163328,0.8504789645447428,1.0,4/18,9.10%,APP;ALAS1;THPO;FOXP1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4590543333538344,0.9671054376173274,0.507537688442211,0.8505572167382216,1.0,5/11,16.01%,ZC3H12A;BCL2L1;FZD3;DFFA;PTGIS
prerank,potassium ion homeostasis (GO:0055075),0.40115377886989445,0.9669881581311971,0.512012012012012,0.8502783940644637,1.0,4/23,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3394464613805776,0.9667485090985112,0.5065274151436031,0.8502760551024331,1.0,9/55,8.72%,FAS;DAB2IP;CAV1;TNFSF10;HYAL2;BBC3;CRADD;BCL2L1;TPD52L1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3322896992978195,0.9666153719641125,0.5078219013237064,0.8500275733081205,1.0,15/74,11.14%,SMAD7;DAB2IP;TGFB2;IL17RD;WWTR1;LEF1;GCNT2;EFNA1;SMAD2;GATA3;ADIPOR1;CLASP1;MAD2L2;CLASP2;MCRIP1
prerank,cellular response to radiation (GO:0071478),0.3641179068899751,0.9665571668443966,0.5066137566137566,0.8496278759152838,1.0,12/40,21.62%,RHOB;RRH;NSMCE3;SPIDR;RAD1;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2
prerank,negative regulation of binding (GO:0051100),0.3311831021034503,0.9663800854083473,0.509090909090909,0.8494713479569878,1.0,20/81,15.64%,PDGFB;CAV1;SUMO3;LEF1;BTAF1;LRRK2;JAK2;CTNNBIP1;ROCK1;JUN;NFKBIA;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;HABP4;NES;RACK1;SLPI
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.3942986314804036,-0.9662848051296787,0.4949748743718593,0.8574436038640156,1.0,6/12,26.89%,NINL;BICD2;KIF3A;CCDC68;CCDC120;CEP19
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.2633681992742797,-0.9659272648960903,0.5471698113207547,0.857102580429342,1.0,17/63,15.29%,LEPR;NUPR1;BCL2;KLHL22;GOLGA2;TIMP2;PTPN3;PTPN22;TAB3;GPLD1;DAPL1;MET;FOXK2;KDM4A;SIRT2;MFSD2A;ATRAID
prerank,cellular response to reactive oxygen species (GO:0034614),-0.27732722984219,-0.9659005882870426,0.5188284518828452,0.85585152197833,1.0,20/59,22.60%,EGFR;PDGFRA;PTPRK;TPM1;ANXA1;PRDX3;HDAC6;CHUK;FER;MPV17;FXN;PDK2;MAPK9;PRKCD;PAX2;TNFAIP3;ROMO1;ABL1;MAPK8;NET1
prerank,protein localization to Golgi apparatus (GO:0034067),0.3861520653932493,0.9655501320254016,0.5162721893491125,0.8508030564692867,1.0,5/27,9.54%,GBP5;CSNK1D;TMED10;VPS13D;RIPOR1
prerank,DNA-dependent DNA replication (GO:0006261),0.3102543150604936,0.9654709161554191,0.5338512763596004,0.8504536154970208,1.0,33/128,18.86%,PSMD13;WRNIP1;SSBP1;ORC3;PSMD4;PURA;UBA52;RPS27A;PSMA5;PSMB10;POLA1;POLG2;POLB;PSMB8;PSMD14;WDHD1;ORC5;PSMA7;PSMC3;DDX21;PSMA8;PSMC1;PSMB5;PSMC5;RFC2;TEFM;PSMB9;PSMC6;MCMBP;PSMA4;PSMD5;PSMD9;PSMB6
prerank,monocarboxylic acid transport (GO:0015718),0.34505194193098815,0.9651996427303728,0.5172413793103449,0.8505245368225876,1.0,6/51,7.47%,ABCC4;CEACAM1;SLCO1C1;ABCB4;SLC16A2;SLC16A4
prerank,regulation of astrocyte differentiation (GO:0048710),0.45412947551997707,0.9650797238221893,0.5122349102773246,0.8502515475857059,1.0,1/12,1.60%,NOTCH1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2951545748662417,-0.9649788926310093,0.4831081081081081,0.8569888953787124,1.0,11/35,17.11%,PPARGC1B;DDX5;ZMIZ1;DDX17;SRC;CALCOCO1;PADI2;SAFB;TADA3;GPER1;AR
prerank,cellular response to insulin stimulus (GO:0032869),0.31575060808716565,0.9648475406956781,0.5501138952164009,0.8502372359486996,1.0,16/124,8.51%,CEACAM1;FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;HDAC9;INPP5K;PDE3B;BCAR3;PCK2;SLC25A33;SYAP1;APC;NAMPT
prerank,regulation of dephosphorylation (GO:0035303),0.4315631034668882,0.9646121567604465,0.4944178628389155,0.8502260983126266,1.0,8/15,28.52%,INPP5K;PPP1R16B;PPP1R16A;SMG7;IGBP1;MTMR2;MTMR9;SMG5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33104990460800476,0.9637862662932498,0.5251196172248804,0.8515271378608228,1.0,11/75,13.83%,EDN1;RGS3;PLCB1;GIT2;MRAP2;NMT1;ROCK1;GNG4;KCTD8;METAP2;RGS12
prerank,sensory perception of chemical stimulus (GO:0007606),0.4367176234945346,0.9635951126635839,0.49337748344370863,0.8514237967693411,1.0,2/15,14.01%,GNAL;SLC24A4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3999393757613681,0.9633662188025361,0.5058651026392962,0.8514069028202482,1.0,8/22,16.29%,HNF1A;MED30;PSMC3;MED17;MED4;PSMC5;PSMC6;ESR1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3598413653227355,-0.9632516256112892,0.5263157894736842,0.8603773964156024,1.0,2/15,4.31%,IGF1;PRKN
prerank,heterocycle biosynthetic process (GO:0018130),0.432134565266659,0.9631969449135482,0.5105348460291734,0.851252131285534,1.0,2/14,3.81%,GCH1;GPHN
prerank,myotube cell development (GO:0014904),-0.4209254161591336,-0.9631011748742143,0.5034965034965035,0.8594866054142972,1.0,2/10,7.10%,IGF1;SIX1
prerank,gluconeogenesis (GO:0006094),-0.28813204078583765,-0.9628505764680463,0.5320754716981132,0.8588124495155376,1.0,13/39,21.22%,SLC39A14;SLC25A13;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,negative regulation of microtubule polymerization (GO:0031115),0.45219288708982913,0.96254818499595,0.5230263157894737,0.8521780311698179,1.0,1/12,0.60%,STMN2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30736328664918305,-0.9618848545465611,0.5423728813559322,0.8600832869323238,1.0,5/30,10.19%,OGT;FHIT;MAP1A;TRIM39;SDCBP
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.35803572688706586,-0.961488814457076,0.5143603133159269,0.8598660538632349,1.0,7/17,20.54%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,membrane raft organization (GO:0031579),0.43192749205534653,0.9614617246984307,0.5089430894308943,0.8540775685822561,1.0,2/15,3.24%,EMP2;PPT1
prerank,positive regulation of viral life cycle (GO:1903902),0.3957880744587271,0.9614194654443576,0.5151975683890577,0.8536492886309653,1.0,5/22,15.24%,LGALS9;TRIM11;VPS4A;CHMP3;CHMP2B
prerank,gliogenesis (GO:0042063),0.42813201571508996,0.9613438109044904,0.5140625,0.8532944000838556,1.0,4/15,14.36%,TGFB2;CDH2;METTL14;CD9
prerank,response to nutrient levels (GO:0031667),0.4145667189296052,0.961234550760307,0.5083459787556904,0.8530102558720383,1.0,7/17,27.01%,FAM107A;PRKAA1;RPS6KB1;EIF4G1;MEAK7;RPTOR;ULK1
prerank,eye photoreceptor cell development (GO:0042462),-0.36266772099275246,-0.9612067884351959,0.5078534031413613,0.8593927555782682,1.0,8/15,41.56%,VEGFA;TOPORS;TULP1;RPGRIP1L;THY1;BBS4;CRB2;NRL
prerank,receptor signaling pathway via STAT (GO:0097696),0.3961553207482405,0.9610750767412423,0.5007451564828614,0.8528519306327073,1.0,6/25,8.46%,IFNAR1;SOCS6;STAT1;THPO;JAK2;NMI
prerank,COPII-coated vesicle budding (GO:0090114),-0.2563792266228978,-0.960819774570765,0.5514018691588785,0.8590752681970408,1.0,35/68,29.46%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;SAR1A;TRAPPC3;VAPB;NAPA;SEC16A;CTSC;F5;SCAP;SEC23B;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;SEC31B;GORASP1;TRAPPC2L;PPP6R3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4649296788346349,0.9603814341356773,0.5131578947368421,0.8538260749031258,1.0,3/10,9.11%,F2RL1;ANO6;STAP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2749901494796937,-0.9603343030965874,0.5046296296296297,0.8590728554118636,1.0,6/52,4.18%,CELF2;DDX5;NOVA1;FXR2;RBMX;DDX17
prerank,fatty acid elongation (GO:0030497),0.4466123410143137,0.9602865926738496,0.5242718446601942,0.8534982691941757,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4684132009102284,0.9600916048104916,0.5392320534223706,0.853431357855529,1.0,2/10,5.71%,NOTCH1;TNFRSF1B
prerank,regulation of cartilage development (GO:0061035),0.4124904668784648,0.9595947023117345,0.5106382978723404,0.853979682206897,1.0,4/18,12.21%,BMPR2;MBOAT2;ZBTB16;SOX6
prerank,positive regulation of gene expression (GO:0010628),0.2920347745148332,0.9595605016686818,0.6032388663967612,0.8535335606268545,1.0,74/442,13.64%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;CRTAM;OCLN;NOTCH1;HEY1;IFNGR1;TNRC6C;LGALS9;VIM;CADM1;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;TAF1A;WARS1;IL1A;MAPK1;SETX;P2RX7;ZC3H12A;PLD1;ELAVL1;HSPA1B;TENT4A;PLSCR1;MYO1C;CDH3;NFE2L2;PRKAA1;PASK;ACTG1;GAPDH;ELAVL4;ROCK1;STAP1;POLR1F;EGR1;TYROBP;LURAP1;AGO4;VSIR;METTL5;ACTB;NPM1;EEF2;NWD1;VPS35;BRCA1;VSTM2A;CLU;HINFP;PIK3CB;TTBK1;RPS6KB1;FXR1;METTL14;HABP4;HIF1A;DDX21
prerank,regulation of lamellipodium assembly (GO:0010591),-0.300485587890029,-0.9595188054816413,0.5203761755485894,0.8599416886342904,1.0,7/34,13.49%,AUTS2;PLCE1;SLIT2;PIK3R1;CAPZB;ACTR2;FER
prerank,mitotic cell cycle phase transition (GO:0044772),0.3005006318121406,0.9592313884510172,0.564983888292159,0.853744885490634,1.0,45/204,21.20%,PLCB1;CCNY;PLK3;CCND2;CCND3;CDK14;ACVR1;CCNE1;TUBB;CSNK1D;CDC25C;CUL3;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;CLASP2;CUL2;DYNLL1;CEP76;USP29;ARPP19;HINFP;RPS6KB1;TUBA1A;CDC27;NES;CHMP7;CDKN2D;ANAPC7;CACUL1;E2F3;FBXL6;FBXL15;ACTR1A;PPME1;CEP192;MAX;LCMT1;DYNC1I2;MNAT1;BCAT1
prerank,positive regulation of cell growth (GO:0030307),0.318759187525023,0.9590236055081792,0.5425531914893617,0.8536723653659261,1.0,24/96,18.71%,EDN1;MACF1;ITSN2;TGFB2;NTN1;SHTN1;SEMA7A;BRAT1;TAF9B;ADAM17;SLC25A33;ISLR2;ADAM10;RPS6KA1;NEDD4L;SMURF1;RPS6KA3;RASAL1;EXOSC9;ADNP2;SYT1;SYT2;CDKN2AIP;H3-3A
prerank,negative regulation of immune system process (GO:0002683),-0.3689215206185108,-0.9588880951657711,0.5052356020942408,0.8603207516204453,1.0,4/16,17.02%,COL3A1;IL17D;HOXA7;GPER1
prerank,cilium organization (GO:0044782),0.2969782007218535,0.9588112801467715,0.5639658848614072,0.8536242802768981,1.0,24/210,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;TEKT5;TTC29;EHD1;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;RAB23;TMEM216;IFT140;CFAP43;PCM1;CFAP52;CDC14A;DYNLL1;EXOC8
prerank,glycerophospholipid catabolic process (GO:0046475),0.38533050317002815,0.9583614876858059,0.49271137026239065,0.8541165244155317,1.0,5/27,11.66%,GPCPD1;PNPLA6;GDPD1;ENPP6;INPP5F
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.46007284810641125,0.9583480876619127,0.5331125827814569,0.8536186926830577,1.0,2/11,5.77%,ING2;TAF9B
prerank,glycosphingolipid metabolic process (GO:0006687),0.35900485816688166,0.958243809446029,0.5086092715231788,0.8533345732323246,1.0,5/42,9.87%,ST6GALNAC3;ESYT2;GLTP;A4GALT;B4GALT6
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.29648034045639093,-0.95813935165235,0.5126353790613718,0.8610026972053225,1.0,13/33,23.81%,SCAF8;NUDT21;NCBP1;PABPN1;SNRPF;CSTF2T;PCF11;SNRPD3;LSM11;SLBP;NCBP2;PAPOLA;LSM10
prerank,cellular response to starvation (GO:0009267),0.3069264577588527,0.9579202512770353,0.5523385300668151,0.8534904429072857,1.0,18/147,10.04%,NUAK1;BMPR2;FAS;CASTOR1;FOXO1;PRKD1;STK24;DAP;GABARAPL1;MAPK1;ZC3H12A;SIK2;WDR59;LRRK2;PRKAA1;PIK3C3;RIPOR1;RRAGD
prerank,regulation of mast cell activation (GO:0033003),0.46387611171142984,0.9579035061424566,0.4991624790619765,0.852997022423697,1.0,2/10,7.88%,MILR1;PLSCR1
prerank,neuromuscular junction development (GO:0007528),0.389936236840187,0.9578778352877793,0.5090361445783133,0.8525334386074468,1.0,5/24,7.15%,UNC13B;AGRN;PPFIBP1;GPHN;LRRK2
prerank,cellular response to purine-containing compound (GO:0071415),0.4563824423719948,0.9578687921191373,0.5360824742268041,0.8520337495609207,1.0,4/10,23.13%,SLC8A1;TRPM2;P2RY1;RYR2
prerank,cellular protein catabolic process (GO:0044257),0.34054593085875134,0.957851451482984,0.5450980392156862,0.8515489596338164,1.0,17/59,21.06%,DENND3;DAB2IP;CASP8;AP2B1;AP2M1;SIAH2;RSPRY1;BNIP3L;VLDLR;BNIP3;CTSK;CTSO;MALT1;PISD;RNF5;CTSH;RAB12
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4545100355766493,0.9573664424546428,0.5243506493506493,0.8521145624592815,1.0,2/12,4.67%,LY6E;TRIM11
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.391153601809771,0.9573452648555401,0.5204855842185129,0.8516427245174228,1.0,6/24,16.23%,FYN;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40156496829225735,0.9570290799923611,0.5225903614457831,0.8518194230772249,1.0,9/20,22.60%,PLSCR1;PTDSS1;GSS;GAMT;GATM;CHAC2;MTHFS;GGCT;GCLM
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.440059874717042,0.9567774484947276,0.5404120443740095,0.8518434648774038,1.0,3/13,3.97%,PLXNA4;SEMA3F;PLXND1
prerank,rRNA 3'-end processing (GO:0031125),0.46142880148214444,0.9565757153442196,0.5368782161234992,0.8517733436156639,1.0,5/10,21.35%,RPS21;EXOSC3;EXOSC8;EXOSC9;EXOSC10
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3677526306805611,-0.9561693047970459,0.5105820105820106,0.8648945983318572,1.0,5/15,13.53%,APOE;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,negative regulation of leukocyte activation (GO:0002695),0.41939840146755614,0.9560881524299475,0.51875,0.8523401798387614,1.0,4/15,8.02%,FCGR2B;MILR1;ZC3H12A;CD200
prerank,regulation of intracellular transport (GO:0032386),0.36443849101196696,0.9556182173450894,0.5191780821917809,0.8528457077078765,1.0,10/38,18.42%,MYBPC3;LRRK2;NEFH;PTPN1;NUMA1;INPP5F;LCP1;MAP2;RNF139;HAP1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.30080470361102696,-0.9549055435185368,0.5339805825242718,0.8668493921094972,1.0,5/32,6.78%,AUTS2;PLCE1;RREB1;PIK3R1;SRC
prerank,membrane lipid catabolic process (GO:0046466),0.45982843879819557,0.9546751347028357,0.49646643109540634,0.8543761627544634,1.0,1/10,3.24%,PPT1
prerank,organic anion transport (GO:0015711),0.32494891584406393,0.9544817870043342,0.5309090909090909,0.8542781055969364,1.0,8/76,9.08%,LRRC8C;ABCC4;SLCO1C1;SLC17A9;CYB5R1;SLC16A2;MFSD10;SLC4A9
prerank,positive regulation of insulin secretion (GO:0032024),0.3676562570561123,0.954452886422311,0.5104311543810849,0.853820830860305,1.0,3/36,5.83%,MYRIP;DOC2B;GLUD1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.32411990865076645,0.9543585601357021,0.5417661097852029,0.8535010953987674,1.0,12/83,12.94%,CDK17;PLK3;CDK14;ACVR1;CCNE1;CUL3;KLF11;CUL2;POLA1;USP29;HINFP;RPS6KB1
prerank,androgen metabolic process (GO:0008209),-0.35545710658429647,-0.9538523327048797,0.48255813953488375,0.8683544523708813,1.0,15/18,54.16%,SPP1;SRD5A1;HSD17B10;HSD17B11;SRD5A3;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;MED1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of interferon-alpha production (GO:0032647),0.40444666625619724,0.9530777139813821,0.5256024096385542,0.8557877835984367,1.0,6/23,14.84%,IFIH1;TLR3;STAT1;DHX9;IRF5;HAVCR2
prerank,triglyceride metabolic process (GO:0006641),-0.2767993955017327,-0.9529293110977005,0.5714285714285714,0.869459279500317,1.0,6/48,9.80%,AGMO;LPGAT1;APOE;MOGAT3;GK;DGAT1
prerank,negative regulation of cell cycle (GO:0045786),0.32543882594653156,0.9528880318891412,0.5217391304347826,0.8556952704289117,1.0,14/73,11.76%,DUSP1;RHOB;BTG2;BTG1;HHEX;PPP1R13B;GMNC;GATA3;PDCD4;CEBPA;APC;ANGEL2;NPPC;NR4A1
prerank,proteasomal protein catabolic process (GO:0010498),0.29897402364740483,0.9525661259010371,0.5731310942578548,0.855861555393709,1.0,56/201,20.43%,ZNRF1;PSMD13;RHBDD1;RNF185;CUL3;PSMD4;KLHL20;SOCS6;ARRB1;WWP1;FEM1C;NFE2L2;NR1D1;PPP2R5C;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;ENC1;NEDD4L;BAG6;PSMB8;PSMD14;SMURF1;KCTD10;RMND5B;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;SPOPL;PSMC6;RNF139;UBXN6;SEL1L;PSMA4;CCDC47;GSK3A;PSMD5;PSMD9;PSMB6;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,gene expression (GO:0010467),0.2887203266650111,0.9522638444471064,0.6146044624746451,0.8559925526019806,1.0,122/348,26.42%,NR4A2;ADARB1;RBPMS;HHEX;RPS21;RPL27;TSPAN14;DDX39A;RPL7;TSPAN32;FARSB;WARS1;MRPL18;SETX;CPSF1;MRPL41;POLR2G;RPS14;RPS27A;RPL35;ADAR;ELAVL4;MLF1;NUP54;RPL21;DKC1;DUSP11;NFKBIB;POLR2D;RPL37;RPS28;RPL34;HNRNPK;MRPL36;MRPL52;NUP35;RPS9;XRN2;RANBP2;FIP1L1;RPLP2;MRPL23;RPS25;CHTOP;RPL30;SRSF9;RPS5;NUP153;RPL27A;NUP160;MRPL24;MRPL32;MRPS12;TAF1B;RPL23A;THOC3;NUP42;ATXN1;RPS15;PRPF4;RPL19;RPS18;RPL32;POLR2I;DHX38;NUP205;DROSHA;PWP1;RPL37A;RPL18A;POLDIP3;MMS19;MRPS18B;COPS5;DDX39B;HOXD3;GOLPH3;MEF2A;HNRNPUL1;LMF2;PTMA;DARS1;SMG7;RRAGC;SYNCRIP;YTHDC1;CPSF3;MRPL11;RSL24D1;SORL1;RPL18;RPL39;RPS19;NUP50;RPL31;RPS8;POLR2C;PAX8;EIF4G1;POLR2B;POLR2J;MRPL34;EIF4EBP2;RPL3;RAE1;TESC;ALYREF;SEH1L;THOC5;RPL28;TPR;WDR33;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;HNRNPF;SYMPK;MRPS18C;MRPL27
prerank,regulation of muscle cell differentiation (GO:0051147),0.3708567319239574,0.9520411240360912,0.5197657393850659,0.8559388393811578,1.0,11/31,18.66%,HDAC9;MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,RNA biosynthetic process (GO:0032774),-0.30253895270526576,-0.9518582133030202,0.5177865612648221,0.8710809903400671,1.0,10/31,15.80%,RSF1;TAF4;SMN1;HELB;SMARCA5;TTF1;GTF2B;TERT;TAF7;TAF5
prerank,negative regulation of lipid catabolic process (GO:0050995),0.4147340149916698,0.9514246128998068,0.5131147540983606,0.8567194742075239,1.0,3/17,8.29%,PDE3B;ALK;PRKAA1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3199428543127769,-0.9513597413307284,0.5732484076433121,0.8711253368797564,1.0,7/25,15.59%,SCAF8;LDB1;CCNK;ELL;THOC1;HMGN1;HTATSF1
prerank,regulation of aerobic respiration (GO:1903715),0.42390361003328253,0.9510541502474693,0.5308641975308642,0.8570395722690388,1.0,5/15,22.21%,ATP7A;SLC25A33;CBFA2T3;UQCC2;NOP53
prerank,regulation of nuclear division (GO:0051783),0.40131700415765204,0.9510013468053771,0.5330188679245284,0.8566261005506337,1.0,3/20,13.11%,CAV2;CDC25C;PIN1
prerank,ribosome assembly (GO:0042255),0.35063807057879093,0.950800769573908,0.5360419397116645,0.856552496287178,1.0,18/47,25.04%,BOP1;DHX37;RPS14;RPS28;NPM1;RPS5;RPL23A;RPS15;EIF6;EIF2A;EFL1;PWP2;RSL24D1;RPS19;NOP53;RPF2;RPL3;MDN1
prerank,DNA double-strand break processing (GO:0000729),0.4055487027700108,0.9505335056297005,0.5204582651391162,0.856589377423529,1.0,7/18,20.67%,RBBP8;EXD2;BRCA1;SMARCAD1;ATM;BARD1;BLM
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.27751679803249074,-0.9503699024604404,0.5398550724637681,0.8725492178511159,1.0,7/41,14.02%,PRKAG2;OGT;LACC1;NUP107;NUP155;AAAS;NUP93
prerank,response to ATP (GO:0033198),-0.3351438894685065,-0.9503549055992353,0.5205479452054794,0.8712980383661886,1.0,4/18,8.20%,TRPC3;ABCC9;P2RX4;TAF1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.36238781731628994,-0.9500878147741766,0.5148247978436657,0.8706576460297166,1.0,3/15,12.68%,TCF7L2;CAMK1;BAG3
prerank,regulation of necroptotic process (GO:0060544),0.38736145278241796,0.9493776647282189,0.5220700152207002,0.8586587338810946,1.0,3/23,2.47%,ARHGEF2;CASP8;SPATA2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3211646116953658,0.949049535826491,0.5255474452554745,0.8588309032445032,1.0,14/79,13.58%,MFSD6;AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.39645738195849756,0.9488453252301059,0.52,0.858759207777541,1.0,7/21,20.26%,FKBP1A;PPP1R16B;MFHAS1;ARPP19;BOD1;TIPRL;GSK3B
prerank,negative regulation of phosphatase activity (GO:0010923),0.3884823684318616,0.948664060637554,0.5240174672489083,0.8586410992927919,1.0,4/25,6.46%,TGFB2;FKBP1A;ZCCHC9;GPATCH2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3948642143851722,-0.9484822251125106,0.543640897755611,0.8736049300282815,1.0,3/11,16.13%,C1QTNF3;SIK1;CLK2
prerank,sulfur compound transport (GO:0072348),0.3817346850457138,0.9477566889713618,0.5130813953488372,0.8599979898045639,1.0,1/27,0.19%,SLC6A6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3475251075015384,0.9465943002035909,0.5268096514745308,0.8620553982796245,1.0,7/47,11.08%,RECK;SERPINI1;SPOCK2;TIMP3;SPOCK3;GAPDH;SPOCK1
prerank,endocytic recycling (GO:0032456),0.34322503901918844,0.9464283840104145,0.5467532467532468,0.8619025402741208,1.0,6/50,13.84%,EHD4;EHD1;LMTK2;RAB35;VPS35;RAB11FIP4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3492274188725948,0.9460606263333259,0.5292517006802722,0.8621386674777967,1.0,12/44,13.86%,LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,negative regulation of type I interferon production (GO:0032480),0.34575929553418133,0.9460522720612381,0.5201072386058981,0.8616364152047796,1.0,10/40,16.66%,IFIH1;UBA7;RNF125;NLRC5;ACOD1;CACTIN;TRIM25;PIN1;HAVCR2;PYCARD
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35054184829449986,-0.9455991100783465,0.5386533665835411,0.8798377469374243,1.0,4/15,8.97%,BMPER;FGF1;FGF2;VEGFA
prerank,regulation of viral genome replication (GO:0045069),0.3417814461962177,0.9454996679477228,0.5509138381201044,0.8623003789072301,1.0,17/56,20.97%,ADARB1;IFIH1;TRIM6;PPIE;PLSCR1;OAS2;ADAR;PPIH;SLPI;PKN2;RSAD2;SRPK1;IFITM3;PPID;ZC3HAV1;EIF2AK2;BANF1
prerank,histone ubiquitination (GO:0016574),-0.32255341474191157,-0.9450728267663777,0.5165165165165165,0.8799185794379156,1.0,6/21,16.42%,UBE2N;PAF1;CTR9;USP22;ATXN7L3;WAC
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4191356941099742,0.9450030597101086,0.5419968304278923,0.8628800763482096,1.0,2/17,3.52%,SMAD7;INPP5K
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.379211932734887,0.9449733212547957,0.5466284074605452,0.862422123894755,1.0,9/28,19.74%,DAB2IP;CASP8;CRADD;DELE1;CASP8AP2;DAXX;DDX47;BID;SORT1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2487186759500863,-0.9441894405777776,0.5868263473053892,0.8809207760986909,1.0,23/80,19.42%,SAMD4A;ROCK2;SLC2A13;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;SIRT3;CASP3;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;RPS4X;EIF3E;PLA2G6;PRKCD;LARP6;UPF3B
prerank,organophosphate ester transport (GO:0015748),-0.31904579278419204,-0.9441461539047407,0.5365079365079365,0.8797548220448351,1.0,10/24,23.12%,OSBPL8;PITPNB;SCP2;TNFAIP8L3;MTTP;PITPNC1;PRELID2;PCTP;PRELID1;PITPNM1
prerank,regulation of centrosome cycle (GO:0046605),0.3969068450600245,0.9438877035277204,0.5068078668683812,0.8642248143364673,1.0,10/21,27.34%,CHMP1B;NPM1;CHMP3;CHMP2B;MARK4;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,apical protein localization (GO:0045176),0.4612097740555974,0.9437845693370389,0.5358361774744027,0.8639253370494242,1.0,4/10,12.78%,GOPC;MAL;ACTB;ATP8B1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.40846753637029865,-0.9435984755493926,0.5112219451371571,0.8798325888290403,1.0,2/10,16.85%,RPS6KA6;TFAP4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.43819694250938995,0.9435822835734105,0.498371335504886,0.8638480671762178,1.0,4/13,15.49%,LRRK2;PDE8A;NFE2L2;RACK1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40160164184299085,0.9434671537268813,0.5307086614173229,0.8635704342298808,1.0,3/17,6.31%,PRKG1;MEF2C;PDCD4
prerank,cellular response to nutrient levels (GO:0031669),0.3283934544332376,0.9431273422388231,0.5526992287917738,0.8638085424141355,1.0,8/62,10.04%,BMPR2;FOXO1;FAM107A;STK24;LRRK2;PRKAA1;RIPOR1;RRAGD
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3693207865671267,0.9430664982985667,0.5356125356125356,0.8634141690134721,1.0,6/33,11.28%,RHOB;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.32155002146377937,-0.9427459431232306,0.5202492211838006,0.8806933711041051,1.0,4/24,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,contractile actin filament bundle assembly (GO:0030038),-0.35057013877554066,-0.9427361210943097,0.5131578947368421,0.8781544259736264,1.0,5/15,8.79%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.35057013877554066,-0.9427361210943097,0.5131578947368421,0.8781544259736264,1.0,5/15,8.79%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,cranial nerve development (GO:0021545),-0.3942037640286664,-0.9426584223402206,0.5465994962216625,0.8770967204342547,1.0,7/11,44.25%,SALL1;PAX2;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.42031303386252766,0.9424484365732413,0.5384615384615384,0.8642111430511388,1.0,5/16,23.33%,FCGR2B;TYROBP;VSIR;AGER;DLL1
prerank,prostaglandin metabolic process (GO:0006693),0.37480685720406137,0.9422130110601166,0.533625730994152,0.8642393755464374,1.0,3/26,10.16%,EDN1;ACOX1;PTGES3
prerank,sodium ion transmembrane transport (GO:0035725),0.31964534079087525,0.9417151283114312,0.5603015075376885,0.8647987109013628,1.0,13/84,9.99%,SLC6A6;ATP1A4;ATP1A1;ATP1A3;SLC8A1;ANO6;SCN11A;SLC6A4;SCN1B;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,mRNA modification (GO:0016556),0.39442611784489445,0.9412993673798254,0.5204855842185129,0.8651697461818986,1.0,7/22,17.96%,TRMT61A;DKC1;TRUB1;TRMT61B;VIRMA;METTL14;RPUSD2
prerank,cellular defense response (GO:0006968),-0.28765981199972046,-0.9412601153626227,0.5465116279069767,0.8794590218824329,1.0,5/40,8.07%,DCDC2;LBP;LSP1;CCR9;TCIRG1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3259799595568794,-0.9412391881717426,0.5173410404624278,0.878217229985333,1.0,9/22,22.27%,ANK2;CALM2;ATP1B1;GSTM2;JPH2;SLC9A1;P2RY6;STAC3;GSTO1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.333002636188218,-0.9411454217452547,0.5454545454545454,0.8772144921364919,1.0,9/23,16.44%,UACA;BMP7;CCN3;PPM1A;C1QTNF3;DDX3X;PPM1B;CYLD;NLRC3
prerank,neuron migration (GO:0001764),0.3490601395351996,0.9402163297785942,0.5532467532467532,0.8669812278422527,1.0,9/48,12.15%,RAPGEF2;CEP85L;NR4A2;MEF2C;NRCAM;RAC1;SPOCK1;NAV1;MARK2
prerank,homocysteine metabolic process (GO:0050667),0.443079805271093,0.9399090080454687,0.5308848080133556,0.8671213980300728,1.0,1/11,2.88%,TST
prerank,autonomic nervous system development (GO:0048483),0.4079465526572895,0.9395740700126296,0.5395348837209303,0.8673405498366775,1.0,4/17,12.09%,KIF26A;GATA3;PHOX2A;SOX10
prerank,negative regulation of biosynthetic process (GO:0009890),0.41283228955728457,0.9390518117874707,0.5285714285714286,0.8679410598901676,1.0,1/16,0.80%,CEACAM1
prerank,negative regulation of coagulation (GO:0050819),0.4280703039938435,0.9387935263193935,0.5418006430868167,0.867967560809806,1.0,5/14,14.00%,EDN1;CD34;PROC;HS3ST5;APOH
prerank,ERK1 and ERK2 cascade (GO:0070371),0.39119480690460673,0.9387190048902444,0.5269645608628659,0.8675893434607374,1.0,5/21,9.31%,LGALS9;APOA1;KARS1;MAPK1;ZFP36L2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.38655345542072195,0.9386569666231802,0.5519287833827893,0.8672115753009197,1.0,3/24,3.92%,CCR1;DUSP1;ANO6
prerank,regulation of extracellular matrix organization (GO:1903053),0.40920077210359,0.9375555443251554,0.5566502463054187,0.8690366083315614,1.0,2/15,1.60%,TIE1;NOTCH1
prerank,fatty acid transport (GO:0015908),-0.3507375956396652,-0.9373293107039691,0.5445026178010471,0.8860444225057409,1.0,5/17,15.01%,ACSL1;APOE;SLC27A1;PPARG;MFSD2A
prerank,fatty acid metabolic process (GO:0006631),0.3125538149925505,0.9372841445452054,0.5758980301274623,0.8690810597276434,1.0,10/115,8.59%,ADIPOR2;ACSM3;FASN;AOAH;SLC27A6;ACSL5;ACSBG1;ADIPOR1;ACOX1;ELOVL4
prerank,tRNA transport (GO:0051031),0.35566939582912044,0.9371836184440574,0.5510791366906475,0.8687891193429829,1.0,10/35,15.93%,TOMM20L;NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;YBX1;NUP205
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.248079011085587,-0.9370833510711843,0.5942028985507246,0.8854273343744625,1.0,11/69,8.12%,BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;NTRK2;NGF;SIX1;PRKCI
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4340007384321377,0.9365698998292227,0.5370675453047776,0.8696286143374525,1.0,5/12,14.20%,MBTPS2;KPNB1;SEC14L2;LPCAT3;RAN
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3409264408720031,-0.9365485682799344,0.5320855614973262,0.8855362469467507,1.0,7/19,23.32%,PPARA;IRS2;IRS1;TWIST1;PRKCD;MTLN;ANGPTL3
prerank,RNA splicing (GO:0008380),-0.24084366654143413,-0.9362009939128866,0.5967741935483871,0.8851125681889992,1.0,32/95,25.43%,NOVA1;SNRNP40;SCAF11;NCBP1;PRPF8;SRRM1;FUS;CDK12;PRPF3;TARDBP;SNRPF;WBP4;SNRPA1;SCNM1;MAGOH;PPP2CA;BCAS2;SNRPD3;MAGOHB;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;NCBP2;DHX15;TCERG1;SRSF2;U2AF1;WDR83;SNRPD1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38151388455074703,-0.9361372901022252,0.515,0.8839846769273569,1.0,7/12,28.66%,NABP1;ZWILCH;ZW10;CHFR;BUB1B;ZWINT;NABP2
prerank,cation transport (GO:0006812),0.29738141347909647,0.9359300088854008,0.606430155210643,0.8704629084862706,1.0,21/167,12.72%,SLC6A6;KCNN4;PIEZO1;RHCG;ATP1A4;SLC5A10;SLC8A1;ANO6;SCN11A;MCOLN1;SLC7A1;KCNC1;NDFIP2;SGK1;SLC6A17;NEDD4L;TRPM2;SLC1A1;KCNK9;KCNC4;KCNA1
prerank,peptidyl-amino acid modification (GO:0018193),0.4497881202170737,0.9359259866000776,0.5410628019323671,0.869950844735821,1.0,3/10,12.51%,APOA1;ATP7A;METAP2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4447405653234462,0.9356397372899572,0.5283911671924291,0.8700576509996568,1.0,3/10,12.21%,ACVRL1;ZBTB16;SOX6
prerank,neuron apoptotic process (GO:0051402),0.39941560517910696,0.9355276144874293,0.5357142857142857,0.8697851930027624,1.0,5/19,14.44%,FAS;APP;GAPDH;BNIP3;TRPC5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3831584932755298,0.9348022838585615,0.5373134328358209,0.8707649122076243,1.0,5/26,10.68%,SYNPO;SHANK3;ACTG1;ROCK1;RAC1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.397880411672731,0.9348006167471966,0.5766312594840668,0.8702526809147838,1.0,4/18,14.15%,DAB2IP;MSN;VPS35;NELL1
prerank,response to glucocorticoid (GO:0051384),-0.30684855355162965,-0.9347519061838634,0.5732484076433121,0.8863223801574974,1.0,8/26,19.01%,SLIT2;ANXA1;ADAM9;REST;UBE2L3;GOT1;HNRNPU;ZFP36
prerank,negative regulation of cell communication (GO:0010648),0.3895534623192789,0.9345040229187357,0.5457364341085271,0.8703997781838384,1.0,6/21,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,canonical Wnt signaling pathway (GO:0060070),0.31982184547673875,0.9343059480387085,0.5575221238938053,0.8703192769082286,1.0,13/68,14.82%,FZD6;NR4A2;CAV1;LEF1;GATA3;LRRK2;CDH3;APC;TCF7L1;LRP5;CTNNB1;FZD9;FZD3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4059649133362467,0.9336993789750228,0.5325914149443561,0.8711091560324171,1.0,3/18,9.31%,FAM107A;PCK2;ZFP36L2
prerank,secretory granule organization (GO:0033363),-0.39234261581185037,-0.9334719705619493,0.5359801488833746,0.8883328789225337,1.0,4/10,19.43%,ABCA1;DTNBP1;VPS33B;BLOC1S2
prerank,"wound healing, spreading of cells (GO:0044319)",0.3881617205282309,0.9332120850350643,0.5446153846153846,0.8716261139264182,1.0,7/24,15.45%,CEACAM1;ACVRL1;ADAM17;MRTFA;ITGA5;LCP1;PDCD10
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3122571557370306,-0.932899918897908,0.5271565495207667,0.8885546004521644,1.0,4/26,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2932357599124759,-0.9327195827305998,0.5678571428571428,0.8876993906100284,1.0,5/32,7.04%,DAPK1;GRIA3;ACTN2;DLG4;SLC6A9
prerank,positive regulation of inflammatory response (GO:0050729),0.31555183013643956,0.9325391783705778,0.5792610250297974,0.8725451312852466,1.0,14/86,12.95%,APP;TLR3;KARS1;HYAL2;PDCD4;CD47;VAMP8;CEBPA;NMI;VAMP7;DHX9;NFKBIA;DDT;ABCC1
prerank,positive regulation of embryonic development (GO:0040019),0.39886675197171806,0.9325130044959296,0.5434439178515008,0.8720814269878786,1.0,5/19,18.51%,PLCB1;TENM4;CFL1;RACK1;ZBED3
prerank,generation of neurons (GO:0048699),0.29388612778378254,0.9324772503012093,0.6042328042328042,0.8716313959166078,1.0,32/190,16.89%,RAPGEF2;CEP85L;NR4A2;NEUROG2;ATP2B2;EML1;HEY1;OLIG2;TGFB2;TAFA1;HEY2;MEF2C;MYEF2;PRUNE1;NGRN;NRCAM;RAC1;SPOCK1;NAV1;MARK2;CX3CR1;PIN1;POU3F2;MYT1L;HES3;CTNNB1;HMGB2;FZD3;ASTN1;SNPH;OPHN1;LRP12
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4370640823409817,0.932178120528629,0.5609348914858097,0.8717651506023538,1.0,2/12,10.63%,DAB2IP;PTPN1
prerank,positive regulation of histone deacetylation (GO:0031065),0.4248572747551808,0.931788229245204,0.5463576158940397,0.8720894768589297,1.0,3/12,11.99%,PRKD1;ING2;PRKD2
prerank,chromosome organization (GO:0051276),-0.23478015830548682,-0.9317744466568524,0.6338028169014085,0.8888124094893742,1.0,33/99,24.11%,TCF7L2;LDB1;NUCKS1;TOP2B;MTF2;DDB2;EHMT1;SETD7;DOT1L;CUL4B;CUL4A;NUP155;HDAC1;HMGN1;PADI2;AXIN2;COPS7B;MSH6;HMGA2;SAFB;SUV39H1;LATS1;RFWD3;COPS6;SOX2;GPS1;MTHFR;ABL1;HDAC8;PARP1;HDAC10;TOP2A;BRWD1
prerank,regulation of presynapse organization (GO:0099174),-0.34892592944754874,-0.9315306139482334,0.5705882352941176,0.8868647578207658,1.0,1/18,0.01%,GPC6
prerank,regulation of presynapse assembly (GO:1905606),-0.34892592944754874,-0.9315306139482334,0.5705882352941176,0.8868647578207658,1.0,1/18,0.01%,GPC6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2974640424990077,0.9312987383589696,0.5968819599109132,0.8726642025759264,1.0,18/150,7.53%,ENG;SMAD6;CEACAM1;CNKSR3;SMAD7;OCLN;GNAQ;DAB2IP;CAV1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;ZC3H12A;LRRK2;HSPB1;PRR5L
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3922393470981036,-0.9310686181788027,0.5764411027568922,0.886771994817775,1.0,2/12,6.03%,ANK2;UBASH3B
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4319749926392456,0.9310142776997478,0.5523156089193825,0.8727917582135055,1.0,1/13,0.28%,KCNQ1
prerank,extracellular transport (GO:0006858),0.4365765476642227,0.930941946114138,0.5356550580431177,0.8724116472907607,1.0,3/13,14.14%,ADCY10;ARRDC1;SPA17
prerank,negative regulation of signal transduction (GO:0009968),0.28642016248851887,0.9309355317564074,0.6213080168776371,0.8719130556490854,1.0,46/249,13.93%,PTPRJ;MMRN2;GATA2;NR4A2;EGFL7;HEY1;DAB2IP;DLL4;HHEX;INPP5K;NTN1;ACVR1;KIF26A;PTPRE;NLK;ASAH2;GATA3;ARRDC1;NFKBIL1;CD47;LRRK2;PTPN12;ARRB1;SNAI2;CTNNBIP1;CACTIN;FBXW7;SIAH2;TAX1BP3;EPN2;CNOT1;NKD2;PTPN1;NXN;HIF1AN;DCC;TMBIM6;HMGXB4;PIK3CB;TSKU;CX3CR1;RPS6KB1;CYP26C1;APLN;NFATC1;GRB14
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.43757671987331903,0.9308876514801423,0.5568181818181818,0.8714994359147379,1.0,2/12,5.77%,ING2;TAF9B
prerank,phospholipid homeostasis (GO:0055091),0.43947478461472944,0.9304926999084551,0.554006968641115,0.87180139735652,1.0,2/11,3.48%,HNF4A;APOA1
prerank,kinetochore organization (GO:0051383),-0.3729479202928462,-0.9304571405912528,0.585956416464891,0.887021515798202,1.0,9/13,39.74%,CENPC;MIS12;CENPE;CENPH;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4320960603738585,0.930210603256194,0.5491525423728814,0.8713619382492973,1.0,1/12,0.75%,LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4320960603738585,0.930210603256194,0.5491525423728814,0.8713619382492973,1.0,1/12,0.75%,LMCD1
prerank,peripheral nervous system development (GO:0007422),0.39080484009920885,0.9300460117520274,0.541033434650456,0.8712075155979175,1.0,6/23,14.59%,SERPINI1;NFASC;ASIC2;ADGRB1;SOX10;GFRA3
prerank,regulation of protein processing (GO:0070613),-0.3258327768074377,-0.9297177851460149,0.5632530120481928,0.887654382494253,1.0,4/21,5.93%,CCBE1;GAS1;SERPINE2;RUNX1
prerank,glucose metabolic process (GO:0006006),-0.2528285027383722,-0.9296326656736098,0.5570175438596491,0.8865939015653617,1.0,18/58,21.22%,APOD;SLC39A14;SLC25A13;RBP4;IRS2;ENO2;ADPGK;PGM1;MDH2;SLC25A12;GOT1;AKR1A1;PFKFB1;GDPGP1;CRTC2;G6PC3;TPI1;ENO3
prerank,gas transport (GO:0015669),-0.4019387074454201,-0.929624590610712,0.5639686684073107,0.8853613543820331,1.0,7/10,46.11%,CA2;CYGB;MYC;AQP1;MB;NGB;RHAG
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.42021222554561577,0.9290812004977405,0.5512820512820513,0.8726644101762311,1.0,3/15,9.04%,EDN1;CAMK2D;ROCK1
prerank,regulation of mitochondrial fission (GO:0090140),-0.31444248748364,-0.9289633353165787,0.5222929936305732,0.8857384786026077,1.0,4/24,8.53%,DCN;PRKN;DDHD1;MYO19
prerank,positive regulation of viral transcription (GO:0050434),0.3812004504996216,0.9287923932137738,0.5451895043731778,0.8727385899454498,1.0,9/25,23.64%,POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;POLR2C;POLR2B;POLR2J
prerank,modification-dependent protein catabolic process (GO:0019941),0.2898817140360884,0.9286873269981007,0.613978494623656,0.8724409972715289,1.0,52/193,21.13%,CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PTTG1;ARRB1;UBE4A;UBA52;FEM1C;RPS27A;NDFIP2;RNF128;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMD14;DTX3L;SMURF1;KCTD10;KEAP1;UBE2E1;CDC27;UBE3B;UBQLN2;KLHL25;ANAPC7;RNF150;FBXO8;UBQLN4;FBXO10;PSMD9;FEM1A;ANAPC4;RNF166;FBXO45;RNF5;RNF34;RNF11;KCTD21;UBA1
prerank,alpha-amino acid metabolic process (GO:1901605),0.33872178143511844,0.9286277983135747,0.5369595536959554,0.8720467435264653,1.0,6/45,6.07%,HNF4A;GLS2;GLS;ATP7A;GLUD1;ASS1
prerank,renal system development (GO:0072001),0.32836441704315744,0.9277296783918376,0.5587467362924282,0.8734453679018614,1.0,7/52,7.31%,SOX17;ACE;TGFB2;PCSK5;HYAL2;GATA3;STAT1
prerank,protein-containing complex assembly (GO:0065003),0.2875103277158362,0.9277109912697467,0.6492146596858639,0.8729783172704696,1.0,48/259,16.22%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;AIM2;CASP8;ANO6;CARD10;LEF1;CSNK1D;TRAF1;TMED10;MCFD2;CUL3;CD247;P2RX7;ZC3H12A;LRRK2;IL1RAP;GRIA1;APC;TCF7L1;ADAM10;DHX9;RBX1;AP2M1;PDZD11;RANBP9;TRAPPC2;TRAPPC6B;ITGB1BP1;SEC24B;TAPBP;CAPG;NOL3;NSF;PPIH;CTNNB1;CSNK2B;TRAPPC5;KPNA3;CLDN14;TRRAP;SAMM50;VIL1;FERMT3
prerank,regulation of signal transduction (GO:0009966),0.28955423814498155,0.9276990993854636,0.6194029850746269,0.8725000004496402,1.0,35/190,14.23%,RGS3;PLCB1;FYN;MFNG;LIFR;CASTOR1;KAZALD1;PRKD1;APP;CRK;LRIT3;ACVR1;KIF26A;GIT2;WWTR1;TMEM204;TSPAN12;IRAK2;GATA3;SIK2;LRRK2;IGFBP7;PLSCR1;IGFBP4;TCF7L1;PRNP;GNG4;PTPN1;KCTD8;CLU;CBFB;ITGB1BP1;WDR11;RGS12;ITGA3
prerank,fluid transport (GO:0042044),0.4357579874965913,0.9275196339353233,0.558974358974359,0.8723692398219948,1.0,1/12,2.23%,AQP11
prerank,receptor catabolic process (GO:0032801),0.38095131522293285,0.9273964667263063,0.5334323922734027,0.8721242112782933,1.0,15/24,29.94%,AP2B1;AP2M1;ZNRF3;SMURF1;VLDLR;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;GPRASP1;AP2A1;CLTC;SH3GLB1;AP2S1
prerank,ERBB signaling pathway (GO:0038127),0.325409804264854,0.9266813714418117,0.5730478589420654,0.8730848939307121,1.0,14/64,15.85%,PTPRR;RPS6KA5;PIK3C2A;CBL;IQGAP1;ADAM17;MAPK1;PTPN12;PTK2;PLCG1;MATK;SOS1;KIF16B;VIL1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.327160408605143,0.9265135023793434,0.590851334180432,0.8729157294582942,1.0,9/63,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,anterior/posterior pattern specification (GO:0009952),0.33609096358773655,0.9265010813785153,0.5858064516129032,0.8724400137047542,1.0,7/53,5.38%,BMPR2;TBX1;HEY1;HHEX;HEY2;PCSK5;SMAD2
prerank,regulation of hippo signaling (GO:0035330),0.408691305477021,0.9259239571153346,0.5467075038284839,0.8731670028706626,1.0,7/17,19.90%,WWC2;MARK3;NF2;SCHIP1;MAPK14;SOX11;SHANK2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2916724668583378,0.9256891879989594,0.6201298701298701,0.8731815672549134,1.0,39/166,17.48%,EDN1;PDGFB;KLF2;INSR;VIM;APOA1;NOS1AP;KLF4;ATP7A;PAOX;BCAR3;ASS1;PLD1;ELAVL1;CDH3;PASK;NR1D1;STN1;EGR1;DHX9;METTL5;NPM1;EEF2;CLU;PRKD2;ARPP19;RPS6KB1;FXR1;METTL14;HIF1A;CNEP1R1;ELOVL5;EIF6;KAT7;POLDIP3;NSUN5;SCARB1;PTPN2;FABP3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.26532982963332025,-0.9252126594884328,0.5809128630705395,0.8939281729181007,1.0,16/48,21.32%,DOCK5;CUX1;RREB1;OBSL1;FLNA;MDK;TRIOBP;S100A10;PTPRD;FBXW8;SS18L2;TESK1;P4HB;CUX2;CIB1;ABL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3469779877843724,0.9250159034540554,0.5773889636608345,0.8740777309090983,1.0,10/42,15.87%,WRNIP1;USP43;POLK;UBA52;RPS27A;TRIM25;POLA1;RFC2;CDKN2D;SPRTN
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3811005915919442,0.9250047005410774,0.5308641975308642,0.8730883733601439,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3811005915919442,0.9250047005410774,0.5308641975308642,0.8730883733601439,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,mitochondrial translation (GO:0032543),0.30861199627102487,0.9249698344397145,0.5930232558139535,0.8726482377368043,1.0,46/104,29.88%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MTIF2;GATB;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40;MRPS18A;MRPS5;FASTKD2;IARS2
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.26055009193057443,-0.9247217207274667,0.625,0.8939720919764385,1.0,13/52,14.97%,ME1;IDH2;ADHFE1;SLC19A1;GCLC;L2HGDH;MTHFD1;MDH2;IDH1;MTHFD2L;ALDH18A1;GOT1;DLST
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3231963539820921,0.9245644202746942,0.5651074589127687,0.8729855720044322,1.0,22/65,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;VPS4A;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,endomembrane system organization (GO:0010256),0.28925310655955855,0.9242277833921424,0.6514657980456026,0.8732152700718151,1.0,41/178,20.01%,SYNE1;ALS2CL;DYSF;TRAPPC8;PRKD1;ATL2;CAV2;DOP1B;CSNK1D;TMED10;SNX10;ATL1;CLASP1;LRRK2;SUN3;HOOK1;A4GALT;CLASP2;MYOF;EXOC8;TMED9;REEP3;ATP8B1;VPS4A;USP6NL;TMED4;VAPA;CHMP2B;ANK3;PLEKHM2;SRGN;SPTBN1;GOLPH3L;PHETA1;GOLPH3;TOR1AIP2;HOOK2;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,response to ketone (GO:1901654),-0.3095604547758248,-0.923837872488535,0.5700325732899023,0.8949543096218076,1.0,4/24,7.08%,TGFBR3;SLIT2;THBS1;CATSPER2
prerank,regulation of gene silencing by RNA (GO:0060966),0.33245750119795264,0.923575732509496,0.5714285714285714,0.8736206026042009,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.33245750119795264,0.923575732509496,0.5714285714285714,0.8736206026042009,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,receptor internalization (GO:0031623),0.33901111324347816,0.9235280501002939,0.5535714285714286,0.8732253061752533,1.0,7/44,14.36%,CEACAM1;CAV1;DNM3;ARRB1;AP2M1;LDLRAP1;CD9
prerank,mRNA methylation (GO:0080009),0.41934272026427954,0.9234090815091786,0.5730897009966778,0.8729538362304158,1.0,4/15,13.27%,TRMT61A;TRMT61B;VIRMA;METTL14
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.44995525581960144,0.922722765970027,0.5548172757475083,0.8738999016086887,1.0,3/10,10.96%,CAMK2D;STK39;NEDD4L
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.44437424935378333,0.9225726738321699,0.5368782161234992,0.8737089512511396,1.0,5/11,21.01%,RNF185;BAG6;UGGT1;RNF5;POMT2
prerank,negative regulation of hemostasis (GO:1900047),0.43076417306077636,0.9221766904767812,0.5716612377850163,0.874049376903904,1.0,3/12,8.44%,EDN1;CD34;PROC
prerank,lipid droplet organization (GO:0034389),-0.3127325165699939,-0.9220746399198737,0.5649717514124294,0.8980334170619522,1.0,7/22,28.24%,PPIA;BSCL2;SQLE;PLA2G4C;FITM2;RAB3GAP1;AUP1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.27241052100614815,-0.9218305423585764,0.626984126984127,0.8973539491239194,1.0,16/40,25.54%,FXR2;UBE2V2;UBE2N;USP1;BCLAF1;HMGA2;WDR76;NEK4;RFWD3;PRKCD;PARG;ABL1;CASP9;FEM1B;RPA2;KMT5A
prerank,response to steroid hormone (GO:0048545),0.3617131406359002,0.9214405727831197,0.5609756097560976,0.8751156856228113,1.0,6/31,8.68%,ATP1A1;ATP1A3;CAV1;TGFB2;PAQR8;UBE3A
prerank,response to reactive oxygen species (GO:0000302),-0.2627491649604547,-0.9211647636841862,0.5905172413793104,0.8978668255171254,1.0,14/54,15.34%,EGFR;PDGFRA;APOD;PTPRK;APOE;TPM1;CAT;ADAM9;HYAL1;PRDX3;CHUK;FER;MPV17;PDK2
prerank,positive regulation of cell aging (GO:0090343),0.4378094357550254,0.9211503674061761,0.559322033898305,0.8752491069081623,1.0,1/11,1.74%,B2M
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2354494580847401,-0.9208079899419543,0.6136363636363636,0.8975559981206035,1.0,18/76,20.85%,LPAR1;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;PTH1R;HOMER1;ADRA2A;AGTR1;DRD2;ADRA1A;LPAR4;TRHR;P2RY6;AGT;OPRK1;HRH1
prerank,regulation of TORC1 signaling (GO:1903432),0.35524901606079834,0.9203507207709064,0.5600558659217877,0.8763775978300204,1.0,5/33,10.04%,SPAAR;CASTOR1;GPR137B;SMCR8;RRAGD
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.29679166216061154,0.9197444677334046,0.6355653128430296,0.8771716903263176,1.0,18/152,12.94%,ADGRL4;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;AKAP5;IAPP;GNAI2;MC4R;HTR1B;ADCY4;ADGRB1;GLP1R;HTR1F;WASF2;GPR26
prerank,axonal transport (GO:0098930),0.34749405877474243,0.9194460129882809,0.5698630136986301,0.8773130154397449,1.0,10/36,22.31%,BLOC1S6;DST;AP3S1;HIF1A;SYBU;KIF1A;AP3M1;HAP1;AP3D1;SOD1
prerank,protein processing (GO:0016485),-0.23518446015846248,-0.9192066798809109,0.6461538461538462,0.9002604043986011,1.0,21/102,14.37%,AEBP1;OGT;MMP14;CPE;BACE1;ADAMTS3;HM13;ADAM19;F3;CPXM2;TMEM208;PTCH1;YME1L1;MMP16;KLK2;CPXM1;ZMPSTE24;SPCS3;PCSK7;CLN5;FXN
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.369716822618705,-0.9190371821848531,0.5604113110539846,0.8994184371694638,1.0,3/13,10.95%,PRPF8;PRPF31;PRPF3
prerank,negative regulation by host of viral transcription (GO:0043922),0.427951670310582,0.9181881252993355,0.5391014975041597,0.8794196800310118,1.0,4/12,13.02%,INPP5K;JUN;CCL4;PSMC3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.39737974554943734,-0.9181803183176004,0.5707434052757794,0.9003565344135868,1.0,4/10,19.55%,SH3RF1;RUNX1;NCKAP1L;ZBTB7B
prerank,regulation of axon regeneration (GO:0048679),-0.3786779521320692,-0.9180572250781336,0.5697940503432495,0.8994118780680289,1.0,1/12,0.29%,PTN
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3666417320675852,-0.9176841289973685,0.5626598465473146,0.8990715171242895,1.0,4/12,18.62%,ACSL1;SCP2;FADS2;ELOVL1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4146435329585152,0.917581468255529,0.5782747603833865,0.880161832539053,1.0,8/14,24.03%,ADAM17;APH1A;ADAM10;ABCA7;PSEN2;DYRK1A;APH1B;NCSTN
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3923532332767444,0.9175656500217301,0.5396341463414634,0.8796841649371635,1.0,7/20,20.26%,FAS;CASP2;BCL2L1;DCC;GSK3A;MCL1;GSK3B
prerank,regulation of amyloid-beta formation (GO:1902003),0.3568354185781725,0.9174357889775453,0.5405797101449276,0.8794520921306512,1.0,16/34,21.58%,IFNGR1;EFNA1;TMED10;RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;GSK3A;HAP1;RELA;SORL1;EPHA4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.34523660230342934,0.9172290204951828,0.5966386554621849,0.8793700152814286,1.0,14/40,19.44%,HRK;TNFSF10;BBC3;CIDEB;BCL2L1;CLU;NOL3;BNIP3;PYCARD;PLAUR;BMF;BID;PLSCR3;PPIF
prerank,secondary alcohol biosynthetic process (GO:1902653),0.35963134242026973,0.9172180036025075,0.5806916426512968,0.8788901388885629,1.0,14/30,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40499341015900414,0.9169263626795067,0.5636070853462157,0.879016005097682,1.0,2/14,4.47%,MSN;SYNE4
prerank,acetyl-CoA metabolic process (GO:0006084),0.40934467978024736,0.9164190997896472,0.5655608214849921,0.8796202767799729,1.0,7/15,23.74%,ACACB;HMGCS1;PPCS;MVD;ACAT1;ACLY;MVK
prerank,amyloid precursor protein metabolic process (GO:0042982),0.39281312689869813,0.9160918003772367,0.558282208588957,0.879837648147616,1.0,9/18,20.86%,ADAM17;APH1A;ADAM10;ACHE;LDLRAP1;TMCC2;PSEN2;NSG1;APH1B
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4251183226278484,0.91601595370226,0.5735537190082645,0.8794818619054651,1.0,5/13,16.50%,PTPN1;PPP1R15B;ABCA7;RACK1;NCK1
prerank,transition metal ion homeostasis (GO:0055076),0.3622871445831977,0.9158684553172937,0.5734265734265734,0.8792907373392962,1.0,8/28,18.52%,B2M;FBXL5;TMPRSS6;HMOX2;CP;CYBRD1;HEPH;XIAP
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.39359062502541237,0.9156590917423421,0.5742424242424242,0.8792131258266639,1.0,7/18,24.23%,PUM2;RNF125;SEC14L1;DHX58;ANKRD17;NOP53;OASL
prerank,axon development (GO:0061564),0.313213749779566,0.9154928279335295,0.5942571785268415,0.8790483686579051,1.0,17/78,12.57%,KLF7;APP;VASH2;SHTN1;CAMSAP2;ATL1;LMTK2;NRCAM;TAOK2;RTN4;NEFH;ADGRB1;ACTB;DCC;MARK2;CTNNA2;SLITRK2
prerank,detection of mechanical stimulus (GO:0050982),0.38816987890112215,0.9151222046784372,0.5644654088050315,0.8792827685082802,1.0,4/19,14.25%,PIEZO1;PTK2;CDH2;CTNNB1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.38095359013000274,0.9151200899677132,0.5423476968796433,0.8787875084195107,1.0,1/22,1.73%,NOD2
prerank,aerobic respiration (GO:0009060),-0.31375102104909025,-0.9147274103464305,0.5652173913043478,0.9053077256826866,1.0,10/20,25.93%,SIRT3;MDH2;NDUFS7;SDHB;MTFR1L;UQCRH;ATP5F1D;SLC25A14;MTFR2;NDUFS8
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3426869330056256,0.9147080456948653,0.5912806539509536,0.8791071452580911,1.0,10/40,17.72%,FOXF2;UBE3A;PTK2;XPO1;FBXW7;LAPTM5;CLU;SMURF1;RNF139;UBQLN4
prerank,glutamine family amino acid metabolic process (GO:0009064),0.344425257650377,0.9145364888935651,0.5463483146067416,0.8789710659300268,1.0,6/33,8.75%,DGLUCY;GLS2;GLS;GLUD1;SIRT4;CAD
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4055427808846814,0.9140403169785984,0.5803432137285491,0.8795258481110242,1.0,6/16,17.41%,GCH1;NOS1AP;NUS1;PIK3CB;HIF1A;SCARB1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36193695428390277,0.9140117951829758,0.5800561797752809,0.8790914510406681,1.0,3/28,7.47%,FCHSD2;ESAM;WDR1
prerank,long-chain fatty acid import into cell (GO:0044539),0.4443427503846991,0.913994120292711,0.5637342908438061,0.8786345298389792,1.0,3/10,14.79%,SLC2A1;RPS6KB1;SLC27A2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.42389349285797,0.9139634670335035,0.5555555555555556,0.8782045805401157,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3187096977537697,-0.9138693216366861,0.5635838150289018,0.9062270931497136,1.0,5/20,13.84%,APOE;CAMK1;DBN1;LLPH;CPEB3
prerank,mRNA 3'-end processing (GO:0031124),-0.23567072825204732,-0.9136561207519758,0.6616915422885572,0.9054828284314632,1.0,33/78,26.15%,SRSF5;SCAF8;NUDT21;NCBP1;SRRM1;SRSF1;PAF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;CSTF2T;PCF11;MAGOH;AHCYL1;U2AF2;MAGOHB;PABPC1;LSM11;UPF3B;SRSF3;SLBP;PAPOLB;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7;GRSF1
prerank,protein localization to cilium (GO:0061512),-0.29456791274242067,-0.9136229733010474,0.6014234875444839,0.9043038885058358,1.0,14/32,20.70%,TULP3;INVS;BBS9;WDR35;ARL6;TCTN2;TTC21B;WDR19;ZNF423;IFT20;RAB29;ARL3;NPHP4;RABEP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32875075348498334,0.9135794939912133,0.6012987012987013,0.8785274848448146,1.0,13/54,20.23%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;CTNNB1;SPOPL;CRY1;COPS9;DNAJA1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3967311221535744,-0.913488486644495,0.5914489311163895,0.9033589411907791,1.0,7/10,34.14%,MTHFD1;MTHFD2L;TYMS;MTHFR;DHFR;SHMT2;SHMT1
prerank,regulation of actin nucleation (GO:0051125),-0.373461079227572,-0.9131170382783235,0.5751789976133651,0.9030359312081111,1.0,5/12,21.73%,GSN;ARF1;ARPIN;PICK1;ARFIP1
prerank,protein depolymerization (GO:0051261),-0.3056496666744648,-0.9127902916130625,0.578397212543554,0.9026313473922729,1.0,6/27,9.45%,MICAL3;GSN;MICAL2;NCKAP5;CKAP5;STMN4
prerank,regulation of spindle organization (GO:0090224),-0.3344902391789616,-0.9123496630314036,0.5669515669515669,0.902546651713197,1.0,8/18,29.84%,GNAI1;GPSM2;RNF4;PARP3;BORA;TPX2;FSD1;NUP62
prerank,negative regulation of organelle assembly (GO:1902116),-0.2837874460038192,-0.9118251095685314,0.625,0.902581565178051,1.0,10/35,12.88%,NUPR1;KAT2B;RBM14;ODF2L;MDM1;FEZ2;CEP97;TMEM39A;CCP110;CDK10
prerank,positive regulation of cell communication (GO:0010647),0.3590698053085712,0.9114946172224242,0.5763688760806917,0.8822822978150698,1.0,9/28,19.00%,EDN1;GATA3;GRIK2;RIMS3;NMU;ANK3;SYT1;CDKN2AIP;SOX11
prerank,regulation of smooth muscle contraction (GO:0006940),0.3842305607123287,0.9108512599632445,0.5644171779141104,0.8831479390072957,1.0,5/20,15.88%,CAV1;ADRB2;CHRM3;SETD3;NMU
prerank,organelle organization (GO:0006996),0.27724402330055464,0.9107339603369919,0.7113821138211383,0.8828879736358323,1.0,67/388,15.51%,NOS3;FGD5;SYNE1;IRAG2;TRAPPC8;CAV1;PRKD1;ATL2;CAV2;MAST4;NEDD9;DIAPH1;SIPA1L3;DOP1B;PACSIN2;SH3KBP1;ARAP3;STX7;DST;TTC29;ATP7A;RAB34;SSBP1;CSNK1D;FMNL3;FAM161A;FGD6;FNBP1L;TMED10;ATL1;PACSIN1;SIRT4;CHCHD2;SLC25A33;CLASP1;MAST1;ALAS1;KLHL20;LRRK2;MCOLN1;VPS13D;CHMP1B;HPS3;CLASP2;RANBP9;POLG2;NUMA1;SNX11;CHGA;TMED9;ATP8B1;VPS4A;TTC17;CHMP3;CYP26C1;USP6NL;RHOT2;PHIP;CEP55;CFL1;TFB2M;TMED4;VAPA;ANK1;CHMP2B;CHMP7;PTCD2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.35957696484651086,-0.9106308589462753,0.5707070707070707,0.9042813870381641,1.0,5/13,17.11%,BMP7;BMP4;CALCOCO1;GPER1;AR
prerank,B cell mediated immunity (GO:0019724),0.4481110978403064,0.9106270088803353,0.5917667238421955,0.8826116715092444,1.0,1/10,4.30%,FCGR2B
prerank,negative regulation of interleukin-17 production (GO:0032700),0.44564465795735064,0.9105471227988897,0.575809199318569,0.8822743552445459,1.0,2/10,10.88%,PRNP;VSIR
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2936014262626365,0.9105001875833595,0.6449115044247787,0.8818703999557108,1.0,35/148,20.67%,NUAK1;PLK3;BOP1;PPP1R13B;RBBP8;ING2;TAF9B;PAK1IP1;PRKAA1;PPP2R5C;SGK1;RPL37;CHD5;BRIP1;BRCA1;PIN1;RAD1;ATM;RPS15;CSNK2B;RFC2;TAF11;RAD9B;RICTOR;DAXX;MAPK14;ATRIP;TAF3;MAPKAPK5;BARD1;HUS1;RBBP4;RNF34;SMYD2;BLM
prerank,organelle disassembly (GO:1903008),-0.2834779429440879,-0.9104377750504241,0.6548387096774193,0.903505615319208,1.0,11/33,15.94%,GOLGA2;TEX264;UBA5;DENR;ATG2A;MRRF;EIF2D;ULK2;STX5;KIF9;PLK5
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3986134821207813,0.9101571507350918,0.5900621118012422,0.8820788977435816,1.0,3/17,6.44%,ADIPOR2;CAV1;ADIPOR1
prerank,negative regulation of translation (GO:0017148),0.30761032816467154,0.9101564969601551,0.603267211201867,0.8815833882759335,1.0,3/87,2.84%,NANOS1;NANOS3;BTG2
prerank,keratan sulfate metabolic process (GO:0042339),-0.2971242975936695,-0.9098006391635841,0.6143344709897611,0.9037358969310139,1.0,8/31,7.47%,OGN;FMOD;B3GNT2;GNS;PRELP;HEXA;ST3GAL4;B4GALT1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3370274570074917,-0.9097952819315865,0.5653266331658291,0.902510519149201,1.0,13/16,45.57%,TOP2B;HFM1;TOP2A;EME2;CENPX;FANCM;SLX4;MEIOB;MSH4;MUS81;EME1;SHOC1;CENPS
prerank,dendritic cell differentiation (GO:0097028),0.3805115594865605,0.9097280021669937,0.5703703703703704,0.8819467842285252,1.0,2/22,2.67%,F2RL1;LGALS9
prerank,positive regulation of exocytosis (GO:0045921),0.3558630461764305,0.9094956737940741,0.5841313269493844,0.8819331338817049,1.0,8/35,17.97%,CADPS2;CLASP1;CLASP2;CADPS;VPS4A;RAB27B;STXBP5;RAB27A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3562313022794548,0.909432733068738,0.5803183791606368,0.8815527842909979,1.0,5/29,10.51%,MCTP1;APP;SHISA8;SHISA6;GRIK2
prerank,regulation of humoral immune response (GO:0002920),0.34149092932972364,0.9093171485642715,0.5750670241286864,0.8813075914684976,1.0,7/44,13.34%,GATA6;FCGR2B;SUSD4;CR1L;CLU;CFB;CR2
prerank,positive regulation of macrophage activation (GO:0043032),-0.34066509068646833,-0.9092886238765493,0.5722379603399433,0.9025215313209516,1.0,3/17,3.41%,LBP;WNT5A;THBS1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3548886236990454,0.9086996961039413,0.5823863636363636,0.8820360571434234,1.0,10/35,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,regulation of chromosome segregation (GO:0051983),0.39507743327795747,0.9086796169398752,0.5709923664122137,0.8815821590693576,1.0,4/16,14.43%,PUM2;NUMA1;BUB1;RAD18
prerank,regulation of microglial cell activation (GO:1903978),0.40531482963400656,0.9084903781471968,0.5781758957654723,0.8814690151340849,1.0,3/15,12.61%,NR1D1;STAP1;TTBK1
prerank,regulation of primary metabolic process (GO:0080090),0.29430018474022085,0.9078451653697187,0.6312217194570136,0.8822981229377524,1.0,46/126,24.17%,AZIN1;FASN;ZFP69;HNF4A;PLPP1;PSMD13;ADIPOR1;PSMD4;NR1D1;PSMA5;PSMB10;ACACB;PSMB8;PSMD14;LACTB;HELZ2;HMGCS1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;ABCA7;PSMB9;PSMC6;PSMA4;MVD;SIN3A;NCOA6;PSMD5;PSMD9;PSMB6;PSMB2;DHCR7;SREBF2;GGPS1;OAZ2;NCOR2;NQO1;EDF1;IDI1;CERS2;MVK;NCOA2;PSMD2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3144746110032234,-0.9078188428717026,0.596875,0.904888686105199,1.0,4/22,8.48%,AEBP1;APOE;MAP1A;EFEMP2
prerank,regulation of defense response to virus (GO:0050688),-0.3583003872547822,-0.9075903956498491,0.5597014925373134,0.9042119571234758,1.0,8/14,34.09%,ZMPSTE24;PPM1B;TNFAIP3;ELMOD2;C1QBP;TRAF3IP1;RNF26;IFNLR1
prerank,tRNA wobble uridine modification (GO:0002098),0.41652396280923165,0.9074614905390388,0.576592082616179,0.8826150833559551,1.0,6/14,20.60%,ELP4;ALKBH8;ELP3;DPH3;TRMU;KTI12
prerank,lipid homeostasis (GO:0055088),-0.25471244354277356,-0.9071489061906771,0.6502242152466368,0.90411696564377,1.0,19/57,23.74%,ZBTB20;RBP1;APOE;ABCA1;PRKAA2;TLCD2;IRS2;NR1D2;PPARG;DDX3X;NR1H3;RCN3;ABHD8;ORMDL2;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.36888331438709354,-0.9068186248696928,0.5875299760191847,0.9037955660402618,1.0,3/12,9.56%,IRS2;BCL6;FNIP1
prerank,cellular response to nitrogen compound (GO:1901699),0.38389781575803394,0.9067916638982362,0.5951293759512938,0.8834118951269568,1.0,6/20,20.67%,ATP2B4;NSMCE3;SPIDR;RIOK3;DAXX;BLM
prerank,DNA strand elongation (GO:0022616),-0.32468792175006234,-0.9067624289666785,0.6111111111111112,0.9027161467737504,1.0,11/18,39.99%,RAD50;TERT;DCLRE1B;POLD2;GINS1;RFC4;MCM7;POLD3;GINS3;GINS2;MRE11
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3795592005383732,0.9066885181446649,0.5712166172106825,0.8831160127856275,1.0,4/20,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,cellular component disassembly (GO:0022411),-0.2589592957329531,-0.9063124774258103,0.6304347826086957,0.90258828515218,1.0,13/53,13.93%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.35649983390343376,0.9062967356200566,0.5945945945945946,0.8834501693507208,1.0,11/31,21.37%,MSN;SYNE4;WDR1;PDZD11;MARK2;ANK1;OPHN1;LRRC7;ERBIN;MTCL1;CRB1
prerank,membrane depolarization (GO:0051899),0.349885730042529,0.9062355718242866,0.5872576177285319,0.8830716672667197,1.0,9/32,18.28%,CAV1;CACNA1A;SCN11A;P2RX7;SCN1B;YWHAH;SCN9A;CACNA1E;SCN1A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3329142757546225,0.9062149216401642,0.5900962861072903,0.8826237623955798,1.0,11/42,19.48%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2;TARS3;RARS1;EEF1E1;DARS1
prerank,amyloid-beta metabolic process (GO:0050435),0.39371020908419324,0.9061224550917684,0.5632,0.8823227410311083,1.0,8/16,24.03%,ACE;APH1A;ABCA7;PSEN2;DYRK1A;APH1B;MME;NCSTN
prerank,proteolysis (GO:0006508),-0.20659355797720932,-0.9060605950626982,0.74,0.9019440303351802,1.0,42/252,14.05%,TRABD2B;AEBP1;ADAMTS12;CPQ;OGT;ADGRV1;BACE2;MMP14;HTRA3;ANPEP;CPE;DPP4;BACE1;ADAMTS3;HM13;CLPX;FAP;ADAM19;UFSP2;ADAMTS9;F3;MMP2;ERMP1;ADAM33;PRCP;CPXM2;CASP3;NAALAD2;PTCH1;ATG4D;YME1L1;MMP16;GGT5;CPXM1;ZMPSTE24;ENPEP;MMP19;MDM2;SENP1;RNPEP;SPCS3;PCSK7
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2912774933549709,0.9060406953248978,0.6473799126637555,0.8819965383876925,1.0,21/158,11.13%,TRIM14;NOD1;NOD2;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;JMJD8;GAPDH;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4298672941256276,0.9052756887387423,0.5966101694915255,0.8831011555854918,1.0,1/11,0.92%,FYN
prerank,positive regulation of protein catabolic process (GO:0045732),0.305882523877104,0.9052693071342623,0.6174016686531585,0.8826168499800755,1.0,14/84,13.89%,PLK3;FOXO1;DAB2IP;MSN;FURIN;TNFRSF1B;WWP1;ASB5;APC;VPS28;NEDD4L;VPS35;SMURF1;NSF
prerank,sister chromatid segregation (GO:0000819),-0.2831847789269614,-0.9052424143528249,0.6472491909385113,0.902828788481784,1.0,16/31,32.34%,KLHL22;TOP2B;NCAPG2;MIS12;LATS1;CENPK;ZW10;NUSAP1;TOP2A;ZWINT;SPAG5;KIF18B;KIFC1;NSL1;TUBG2;CDCA8
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4182130799312224,0.9051555901367351,0.5919732441471572,0.8823555655631768,1.0,4/13,17.26%,CASP8;CIDEB;TBC1D10A;GRIN2A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.31049863061191246,0.9050673257051632,0.6084788029925187,0.882048177343112,1.0,2/65,0.62%,EPAS1;GATA6
prerank,regulation of fat cell differentiation (GO:0045598),0.3132873074833175,0.9048279326898658,0.6287128712871287,0.882055537705568,1.0,11/74,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZBTB16;ZC3H12A;CMKLR1;SYAP1;NR1D1;ZFP36L2
prerank,pseudouridine synthesis (GO:0001522),0.409394707642116,0.9047094229752969,0.5751211631663974,0.8817938719398024,1.0,4/13,17.96%,DKC1;TRUB1;NHP2;RPUSD2
prerank,regulation of protein export from nucleus (GO:0046825),0.3759152792029699,0.9045669997690599,0.5799418604651163,0.8816155302342427,1.0,3/23,7.21%,PTPN14;UHMK1;RANGAP1
prerank,megakaryocyte differentiation (GO:0030219),0.4357694785118188,0.9043913809537617,0.5986733001658375,0.88148480785194,1.0,2/11,7.97%,TAL1;THPO
prerank,chemical homeostasis (GO:0048878),-0.2513145634887243,-0.9039938662848839,0.6056338028169014,0.9046468530760171,1.0,15/61,16.81%,ZBTB20;SLC4A10;RBP1;WNK1;WNK4;TLCD2;IRS2;NR1D2;SLC4A2;PPARG;DDX3X;TENT4B;SLC4A3;NR1H3;ABHD8
prerank,protein localization to chromatin (GO:0071168),0.3912692065415726,0.9039410493423509,0.5919629057187017,0.8818642868157811,1.0,6/18,19.96%,RAD21;TASOR;SGF29;CHMP7;ESR1;PPHLN1
prerank,extracellular matrix disassembly (GO:0022617),-0.2586035227851854,-0.9037476091936929,0.6394849785407726,0.9040245226017664,1.0,13/53,13.93%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,regulation of cytokinesis (GO:0032465),0.3080232273916219,0.90372810605482,0.6220858895705521,0.8817995486954133,1.0,21/78,21.88%,PLK3;RAB11A;CUL3;BCL2L1;PIK3C3;CDC14A;E2F7;CALM3;VPS4A;PRC1;PIN1;RAB11FIP4;PKN2;KLHL9;GIT1;MAP10;RAB11FIP3;GIPC1;SETD2;ECT2;KIF23
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.38204004777562806,0.9034702563259934,0.5864197530864198,0.8818639456514551,1.0,5/21,11.52%,NPR2;ADCY10;NPR1;ADCY4;NPPC
prerank,cellular response to hydroxyurea (GO:0072711),0.43507886942350227,0.9032839977778635,0.5915254237288136,0.8817423880964758,1.0,4/10,25.13%,NSMCE3;SPIDR;BLM;RTF2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3614664517300429,0.9023823878747698,0.5764705882352941,0.8830604784443992,1.0,13/27,24.62%,ZC3H12A;TRIR;RNASE1;NHP2;XRN1;RNASE6;POP1;KHNYN;ERN1;RNASE4;CPSF3;NUDT16;RNASEH1
prerank,regulation of secretion by cell (GO:1903530),0.3223033469022114,0.9022037960388047,0.6092105263157894,0.8829383923873783,1.0,11/54,18.42%,MCTP1;SCG5;MEF2C;VAMP8;SNCAIP;NSF;CPLX1;STXBP5L;STXBP5;SYT1;HAP1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3427320161254521,-0.9021301675156124,0.5890052356020943,0.9055780515032649,1.0,2/14,11.56%,SLCO2B1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.3427320161254521,-0.9021301675156124,0.5890052356020943,0.9055780515032649,1.0,2/14,11.56%,SLCO2B1;BLVRB
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.38188294668781075,0.9020021548157,0.5623003194888179,0.8828552434612379,1.0,7/18,20.26%,UFM1;RAB23;MFHAS1;CTNNA1;CABP1;SIN3A;GSK3B
prerank,protein sumoylation (GO:0016925),0.32846757729381126,0.9019578150883703,0.6175675675675676,0.8824585714457159,1.0,11/49,15.93%,IFIH1;SUMO2;SUMO3;RANGAP1;NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;NUP205
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3502952120275211,0.9014958914626459,0.5843793584379359,0.8828925655414169,1.0,9/30,15.26%,SLC27A6;ACSBG1;ACOX1;ELOVL4;HACD4;ELOVL7;ELOVL5;SLC27A2;TECR
prerank,cellular potassium ion homeostasis (GO:0030007),0.41390943297730276,0.9014741949319951,0.5958132045088567,0.8824508372561392,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,mitochondrial translational termination (GO:0070126),0.3061879326417906,0.9014391306204335,0.6165680473372781,0.8820326025321817,1.0,37/88,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,tryptophan metabolic process (GO:0006568),0.4291479308657775,0.9011596087199555,0.5946843853820598,0.882115056668916,1.0,3/11,21.84%,ATP7A;KYAT1;KYNU
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3291191913530027,0.9010847339592737,0.619550858652576,0.8817804206687238,1.0,12/49,19.51%,SGMS1;CAV1;BBC3;BCL2L1;RTKN2;RACK1;PYCARD;PLAUR;BMF;BID;PPIF;MCL1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3207115664783494,-0.900873845021045,0.6123595505617978,0.9073580888087149,1.0,10/20,22.90%,GSN;PLA2R1;THBS1;SFRP4;PRKCI;ITGA4;GPER1;CD40;RGCC;PIAS4
prerank,phosphatidylserine metabolic process (GO:0006658),0.3525843819754529,0.9008086941817519,0.5702479338842975,0.881841076210438,1.0,8/32,18.29%,MBOAT2;LPCAT4;PLSCR1;LPCAT3;PTDSS1;SERINC5;PLA2G12A;PLAAT3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3494226108722672,0.9007456120449565,0.5897810218978102,0.8814834461796646,1.0,3/31,3.11%,SMAD6;NOTCH1;HDAC7
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.43802203080109064,0.9003046523896694,0.5787728026533997,0.881911826655869,1.0,3/10,13.91%,TBX1;STAT1;LRP5
prerank,response to nitric oxide (GO:0071731),0.4065805994112338,0.8995434319062809,0.575503355704698,0.8829017787323882,1.0,1/13,1.88%,FOXO1
prerank,amino acid transmembrane transport (GO:0003333),0.32801403385949124,0.8993516155373719,0.6027210884353742,0.8827995907425129,1.0,5/45,7.82%,SLC6A6;SLC7A7;SFXN1;SLC16A2;SLC7A1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.23477412255701996,-0.8988705629480882,0.6847290640394089,0.9109935094464364,1.0,19/72,19.57%,ADCY1;STX4;SLC8A3;DLG4;NLGN2;CLSTN2;CACNG4;TSHZ3;GRIN2D;PRKCZ;DTNBP1;ADRA1A;EIF2AK4;CACNG8;GPER1;EPHB2;SLC8A2;KCTD13;LGMN
prerank,regulation of protein kinase activity (GO:0045859),0.2973155632489864,0.8987695442086389,0.6543778801843319,0.8834795998023871,1.0,14/106,11.10%,RAPGEF2;CEACAM1;GNAQ;IQGAP1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1;MAPRE3;PTK2;TAB2;MMD
prerank,ESCRT III complex disassembly (GO:1904903),0.4387659545916388,0.8986341466041127,0.5927152317880795,0.8827816380006227,1.0,6/10,26.18%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.4387659545916388,0.8986341466041127,0.5927152317880795,0.8827816380006227,1.0,6/10,26.18%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,male meiosis I (GO:0007141),0.4038380935944631,0.8985216725306765,0.618066561014263,0.8825308317704162,1.0,4/16,18.63%,DDX4;ING2;SYCP3;TDRD9
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.38547672084876095,-0.8983468076338916,0.6226851851851852,0.9110174877454066,1.0,3/10,9.95%,PRKAA2;FLCN;KLF15
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.38916334635980593,-0.8980120218581035,0.6031331592689295,0.9106172498803364,1.0,5/10,27.38%,SMARCB1;CAMK1;PIH1D1;SPHK2;CHEK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3971938392665794,0.8979498640855765,0.5830721003134797,0.8831855263101283,1.0,3/16,5.32%,PLCB1;BTG1;MEF2C
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3112254738661805,0.8977657084096865,0.6061349693251534,0.8830545499613103,1.0,14/70,18.29%,APOA1;SLC44A1;MBOAT2;LPCAT4;LCAT;PCYT1A;TMEM86B;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B;PLA2G12A;PLAAT3
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2173731210451867,-0.8977465143999793,0.7547169811320755,0.9100262422236766,1.0,38/132,24.08%,CELF2;SRSF5;SCAF11;DICER1;NUDT21;NCBP1;TRAF7;RPL24;COIL;DENR;SRSF1;EIF2S2;GEMIN5;SMN1;EIF2D;PUF60;SRSF6;DDX1;SNRPF;RRP7A;XRCC5;RPLP0;RAMAC;SNUPN;SNRPD3;MRPS11;XAB2;SF1;RRS1;LUC7L;SF3B1;SRPK2;SF3A2;GEMIN7;CELF1;NAF1;CELF5;WDR77
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.39520618685395564,-0.897681441269198,0.6068181818181818,0.9089700693004047,1.0,3/10,8.66%,APOE;ABCA1;PRKACA
prerank,positive regulation of protein metabolic process (GO:0051247),0.29570750708212,0.8974530594493961,0.6555299539170507,0.8832054546764622,1.0,15/110,12.34%,KLF2;PAEP;FOXO1;DAB2IP;APP;KLF4;WWP1;ASB5;APC;VPS28;NFKBIA;RANBP9;NEDD4L;CLU;SMURF1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3066593566462537,0.8969764960325328,0.6233128834355828,0.8836383333233769,1.0,10/86,6.32%,ENG;BMPR2;ACVRL1;NOTCH1;RBPMS;TGFB2;ACVR1;ING2;SMAD2;ADAM17
prerank,positive regulation of cholesterol transport (GO:0032376),0.3612523662652304,0.8968892405569155,0.5896296296296296,0.8833221152128871,1.0,8/27,16.84%,CAV1;APOA1;PLTP;ABCB4;LPCAT3;NFKBIA;ABCA7;EEPD1
prerank,L-amino acid transport (GO:0015807),-0.2952842324885015,-0.8967932159203164,0.6636636636636637,0.9098980300957165,1.0,3/28,3.00%,SLC1A3;SLC7A2;SLC25A13
prerank,negative regulation of cation channel activity (GO:2001258),0.3602953435069365,0.8967057164302845,0.5863570391872278,0.8832030244234577,1.0,2/26,2.67%,KCNE3;FKBP1A
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.27568646104441036,-0.8964466033338099,0.6474576271186441,0.9094513926477691,1.0,10/36,16.97%,AFDN;VAMP5;GGA2;GCC2;OPTN;KIF13A;GORASP2;GOLGA4;GGA1;NECTIN3
prerank,regulation of complement activation (GO:0030449),-0.2748137917379702,-0.8962626840108401,0.6717557251908397,0.9086704051497158,1.0,15/40,27.36%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,negative regulation of kinase activity (GO:0033673),0.3147400438123861,0.8962247100133622,0.5971867007672634,0.8836690836237798,1.0,8/62,7.36%,CEACAM1;GNAQ;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1
prerank,regulation of inclusion body assembly (GO:0090083),0.4267093236900519,0.895950418617208,0.5983870967741935,0.8837076300783504,1.0,4/11,17.60%,HSPA1B;SNCAIP;DNAJB6;DNAJB8
prerank,metanephros development (GO:0001656),0.3645318496483701,0.8958022077019797,0.6012176560121766,0.8835319172467572,1.0,1/26,0.23%,SOX17
prerank,response to sterol (GO:0036314),-0.37183693780401256,-0.8954744783722353,0.5976470588235294,0.9093200968691321,1.0,2/11,5.15%,TGFBR1;RORA
prerank,negative regulation of bone mineralization (GO:0030502),0.4070207977150495,0.8953680314857553,0.5870967741935483,0.8838983026052831,1.0,1/13,1.34%,CCR1
prerank,regulation of phosphorylation (GO:0042325),0.2891670723961624,0.8953653555458597,0.6497175141242938,0.8834211054659318,1.0,28/120,16.04%,CCDC88C;LDB2;EMP2;APP;JMJD8;HSPB1;NLRC5;NDUFS4;ROCK1;STAP1;PTK2;NUP54;PTGES3;CCDC88A;DYNLL1;NUP35;RANBP2;GRM5;NUP153;PIN1;PHIP;NUP160;HIF1A;NUP42;EIF6;CDKN2D;NUP205;KDM4D
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3120420917794109,-0.895288743718378,0.6132075471698113,0.9085720038440342,1.0,7/22,13.53%,APOE;TIMP2;PTPN3;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3726950394639217,0.8949205079047059,0.5905044510385756,0.8837827188641417,1.0,8/25,21.01%,OMA1;RNF185;CUL3;BAG6;UGGT1;NGLY1;RNF5;POMT2
prerank,regulation of organelle organization (GO:0033043),0.3036742846024121,0.8948819213114716,0.6412121212121212,0.8833769861742273,1.0,15/80,15.69%,F11R;DIAPH1;CLIC4;MSN;CAMSAP2;MAPK1;TJP1;PTK2;VPS35;MARK2;TMED9;USP6NL;RHOT2;PDCD10;PAK2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.35589028348743684,-0.8946219593106102,0.5983827493261455,0.9088884552082187,1.0,8/14,30.66%,SLC27A1;CHKB;ETNK2;SELENOI;CHKA;LPIN3;LPIN1;ETNK1
prerank,regulation of cell cycle process (GO:0010564),0.29755622684656374,0.89447954529709,0.6666666666666666,0.883686758092766,1.0,16/104,14.25%,PLK3;RAB11A;CAV2;TTL;CDC25C;BCL2L1;APC;PIK3C3;RPRD1B;NUMA1;CALM3;PRC1;PIN1;BUB1;RAB11FIP4;CTNNB1
prerank,stem cell differentiation (GO:0048863),0.3388410912902178,0.8944212176631771,0.5827538247566064,0.8833196874057272,1.0,4/39,5.32%,ACE;FOXO4;TGFB2;MEF2C
prerank,cell cycle G2/M phase transition (GO:0044839),0.2894676194345863,0.8941437122492938,0.6561443066516347,0.8833809230871162,1.0,16/130,10.48%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.380485274640442,-0.8941164116264625,0.6135265700483091,0.9089238116495273,1.0,5/10,20.73%,GALNT1;POGLUT2;POGLUT3;GALNT16;GALNT3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.35188425634427334,0.8933910324564869,0.6,0.8843858472159761,1.0,8/31,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,regulation of transposition (GO:0010528),0.4140636585048514,0.8932718259824599,0.5678807947019867,0.8841559531155376,1.0,1/13,3.85%,DDX4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.289471316679103,0.8930942874018879,0.6659142212189616,0.8840416663580396,1.0,16/129,10.48%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,protein acylation (GO:0043543),0.3419688526336861,0.8930510149065508,0.6086350974930362,0.8836560925479491,1.0,3/38,2.79%,FOXO1;ZDHHC22;NAT9
prerank,positive regulation of receptor internalization (GO:0002092),0.3664418684336362,0.8929633685204458,0.598145285935085,0.8833497805608335,1.0,4/22,8.04%,INSR;ANGPT1;ARRB1;TBC1D5
prerank,receptor recycling (GO:0001881),0.4351597318311081,0.8928222125535493,0.5954063604240283,0.8831639300535492,1.0,5/10,20.71%,LMTK2;PHETA1;NSG1;REP15;SORL1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31576230603203687,0.8922261823544027,0.6286811779769527,0.8838853680832254,1.0,13/60,14.45%,TNRC6C;HNF1A;HEY2;MED26;LEF1;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.28373563938503493,0.8921126590450223,0.6756176154672395,0.883608604070528,1.0,39/166,19.01%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;TAF1A;RXRG;POLR2G;NR1D1;POLR1F;BRF2;POLR2D;TBPL1;MAML2;CAVIN1;GTF2H3;NR4A1;GTF2A1;TFB2M;MED27;TAF1B;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8;E2F3;NCOA6;NR2C2AP;TAF3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4124442770138756,0.8921111518758558,0.5903225806451613,0.8831318840337316,1.0,14/14,58.79%,PTGER3;OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;ADAM8;CREB3L3;IL6ST;TNF;PARK7
prerank,synapse organization (GO:0050808),0.28585533810417557,0.8920983552440334,0.6603351955307263,0.8826771248679213,1.0,26/125,13.24%,UNC13B;APBB2;AGRN;APP;PPFIBP1;DNM3;SNCG;GPHN;SPOCK2;PLXND1;SHANK3;LRRK2;NRCAM;FLRT3;LRRC4C;PPFIA2;CYFIP1;KIRREL3;ZC4H2;CDH2;ACHE;GRM5;SLITRK2;CX3CR1;PIN1;PCDHB16
prerank,regulation of cellular protein localization (GO:1903827),-0.2613907973342082,-0.891910850983233,0.6745098039215687,0.9132019636409164,1.0,3/45,2.96%,GPC6;GPC3;PRKAA2
prerank,negative regulation of viral life cycle (GO:1903901),0.40872081057356935,0.8917251889786592,0.6065318818040435,0.8829273917792098,1.0,2/15,4.67%,LY6E;TRIM11
prerank,histone H3-K36 demethylation (GO:0070544),-0.3842873707835894,-0.8915892995120038,0.6044226044226044,0.9127538221214444,1.0,5/10,20.13%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,epithelial structure maintenance (GO:0010669),0.421777567731868,0.8913113093265537,0.5967741935483871,0.8832866907474203,1.0,1/11,1.73%,NOD2
prerank,regulation of T cell differentiation (GO:0045580),0.34736807407272013,0.8913090622757744,0.6028776978417266,0.8828139209343647,1.0,5/33,13.75%,CRTAM;TNFRSF18;GATA3;CBFB;RHOH
prerank,tRNA processing (GO:0008033),0.31724699708822723,0.8911879785971494,0.6332046332046332,0.8825759430548052,1.0,14/61,21.08%,ADAT2;TRDMT1;TRMT61A;KARS1;TRPT1;CPSF1;FARS2;TRUB1;TRMT10B;ELAC2;POP1;CSTF2;TRMT1;NSUN6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.31278474516506183,0.8911544334424097,0.616751269035533,0.8821572600001033,1.0,24/62,25.90%,PUM2;ELAVL1;POLR2G;NUP54;DHX9;POLR2D;NUP35;RANBP2;NUP153;FXR1;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR;TGFB1
prerank,negative regulation of cell cycle process (GO:0010948),0.3154836350610167,0.8911095042543573,0.6245306633291614,0.8817669808883923,1.0,10/61,12.82%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;TOM1L1;UXT;E2F7;BRCA1;VPS4A
prerank,regulation of RNA splicing (GO:0043484),-0.23871366512297262,-0.891079985071815,0.6956521739130435,0.9127268599438981,1.0,20/69,17.81%,SON;SNRNP70;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;PIK3R1;CLK1;FUS;JMJD6;CLK4;RBM39;RBM20;HNRNPLL;HNRNPL;RPS26;CLK2;ZPR1;U2AF2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.2969495218675623,-0.8903154962263942,0.6441176470588236,0.9133500532745744,1.0,8/25,21.13%,SNRNP40;SCAF11;PRPF8;SRRM1;PRPF3;BCAS2;MPHOSPH10;SF3B1
prerank,apoptotic DNA fragmentation (GO:0006309),0.3960137828239624,0.8902426576943381,0.5924170616113744,0.882939935823878,1.0,6/16,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,pyruvate metabolic process (GO:0006090),0.32517556041356355,0.890151545029065,0.6116129032258064,0.8826421802483346,1.0,11/52,16.13%,GPI;PGK1;PCK2;BSG;GAPDH;LDHC;DLD;ME3;LDHAL6B;VDAC1;PFKM
prerank,response to interferon-alpha (GO:0035455),0.3962414019159325,0.8899309326243837,0.5908372827804107,0.8826320194894662,1.0,4/16,9.00%,IFNAR1;GATA3;KLHL20;ADAR
prerank,myeloid dendritic cell activation (GO:0001773),0.42332052513927054,0.8899209318444142,0.5966101694915255,0.8821723233514405,1.0,4/12,22.63%,HMGB1;DOCK2;PYCARD;CAMK4
prerank,lysosome localization (GO:0032418),0.3422514434188032,0.889897056028972,0.6107954545454546,0.8817388124543435,1.0,9/37,16.27%,RAB34;MILR1;SPAG9;MYH9;PLEKHM1;KLC2;CHGA;TMEM106B;PLEKHM2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.28511089564916137,0.889665079760949,0.6601307189542484,0.8817297006104997,1.0,28/138,17.09%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;RXRG;POLR2G;NR1D1;POLR2D;MAML2;GTF2H3;NR4A1;GTF2A1;MED27;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3927629479588478,0.8889668623798263,0.5934579439252337,0.8825893017251041,1.0,3/18,9.67%,GPR137B;TLR3;FBXW7
prerank,cilium movement (GO:0003341),0.3259029556525346,0.888450401556703,0.5981675392670157,0.8831532912339612,1.0,4/48,4.33%,CFAP206;ADCY10;TEKT5;TTC29
prerank,positive regulation of translation (GO:0045727),-0.22346178349588278,-0.8883693180842234,0.7677419354838709,0.9168052038745446,1.0,24/94,17.04%,SAMD4A;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;RMND1;TRUB2;YBX3;CDC123;ERBB2;PCIF1;LARP4B;YTHDF2;DDX3X;BCL3;EIF3D;CPEB3;RCC1L;RPS4X;EIF3E;RPUSD4;JMJD4;LARP1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41105479093664243,0.8883165554536792,0.582018927444795,0.8829149013631281,1.0,2/13,7.12%,F2RL1;ITGAM
prerank,protein prenylation (GO:0018342),0.4367406011629903,0.8882061983489705,0.61082910321489,0.8826576879628409,1.0,1/10,6.42%,PGGT1B
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3132097312543527,0.8879863359822778,0.6251638269986893,0.8826121480120305,1.0,15/52,18.99%,LSM1;EXOSC3;CNOT6L;DCPS;DCP1B;POLR2D;CNOT1;EXOSC8;EDC3;NT5C3B;DDX6;CNOT2;EXOSC9;TUT7;LSM2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.33699852691838206,-0.8877917115486319,0.618421052631579,0.9169676859888144,1.0,3/15,5.29%,SNW1;NUCKS1;SMARCB1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.34073719461109464,0.8875507446146195,0.6182336182336182,0.8830104620455648,1.0,6/37,6.98%,SMAD7;APP;INPP5K;TRIM6;MAPK1;IRGM
prerank,cardiac myofibril assembly (GO:0055003),0.39715860254954943,0.8874695303479726,0.603448275862069,0.8826959202113455,1.0,1/15,0.60%,NEBL
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.35607781215508566,-0.8873017006613638,0.6295336787564767,0.9169164226878768,1.0,5/12,24.62%,PARP8;PARP3;PARP1;PARP6;PARP2
prerank,positive regulation of growth (GO:0045927),0.3118274717238136,0.8872027459564011,0.6325757575757576,0.8827086369756749,1.0,10/64,10.40%,PLCB1;INSR;TGFB2;PPM1F;BRAT1;TAF9B;ADAM17;SLC25A33;ADAM10;RPS6KA1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3661548026466881,0.887168169106143,0.6131498470948012,0.8823021696572765,1.0,8/22,21.71%,MSX1;RPL37;CHD5;ATM;RPS15;EEF1E1;UBB;HEXIM1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.38092756757166313,-0.8869754003953689,0.6155660377358491,0.9164946755482364,1.0,2/10,10.06%,ADGRV1;WHRN
prerank,regulation of mRNA processing (GO:0050684),-0.2787829734090799,-0.8865709556103599,0.6598639455782312,0.9162313982429143,1.0,16/32,25.88%,SON;NCBP1;JMJD6;PABPN1;RBM39;SAFB;AHCYL1;SRSF3;SF1;SRPK2;SLTM;KHDRBS1;CDK11B;PAPOLA;QKI;LARP7
prerank,neuron cell-cell adhesion (GO:0007158),0.40699976601232174,0.8862577621833683,0.6107491856677525,0.8835621409456859,1.0,7/14,26.00%,NCAM2;ASTN1;NRXN3;CNTN4;NRXN1;NLGN1;RET
prerank,glycerol metabolic process (GO:0006071),-0.3758645322573937,-0.8862431619067528,0.6155660377358491,0.915810384040481,1.0,5/10,23.32%,GK;GOT1;COQ2;TPI1;ANGPTL3
prerank,positive regulation of neuron differentiation (GO:0045666),0.32408559940587106,0.8862172981295816,0.6103542234332425,0.8831637982615017,1.0,13/40,21.62%,ARHGEF2;MEF2C;NRCAM;TCF3;ZC4H2;MMD;PCP4;FGF20;SIN3A;HOXD3;SOX11;MMD2;ECT2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.42063283480258434,0.886201553751071,0.6024096385542169,0.8827164869073959,1.0,5/11,22.51%,EXOSC3;DKC1;FBLL1;EXOSC10;FBL
prerank,negative regulation of cilium assembly (GO:1902018),0.4178001014267089,0.8861094538879901,0.6042780748663101,0.8824145035665464,1.0,3/12,10.83%,MAP4;TBC1D30;LIMK2
prerank,positive regulation of cellular component organization (GO:0051130),0.29182752400182294,0.8860605344762562,0.6624277456647398,0.8820331366584013,1.0,11/107,6.20%,ATP10A;INSR;TAL1;MMP1;DAB2IP;TGFB2;TIRAP;HRK;SHANK3;ABCB4;WARS1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3781516018499857,0.8856031613949393,0.6162079510703364,0.8824547746380839,1.0,3/20,8.36%,MCUB;SMDT1;MCUR1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.32760133241361467,-0.8854303788531309,0.6193029490616622,0.916549463479744,1.0,7/17,16.37%,PTPN22;ANXA1;SSC5D;OTUD7B;MAPKBP1;BCL3;ANXA4
prerank,positive regulation of response to wounding (GO:1903036),0.35837335575625556,0.8848327907555089,0.5973053892215568,0.8834538929007824,1.0,4/24,9.22%,OCLN;MYLK;ACTG1;PTK2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.41679685699247715,0.8846693402613741,0.6084033613445378,0.8833069870342395,1.0,3/11,12.50%,KLF2;EPN2;PIK3CB
prerank,vitamin transport (GO:0051180),0.3461526292901519,0.8839611294715314,0.6043795620437956,0.884227213869753,1.0,3/29,3.48%,SLC25A32;TTPA;APOA1
prerank,cell projection organization (GO:0030030),0.3447643286914745,0.883874768608979,0.6401734104046243,0.8839259317580607,1.0,8/30,13.75%,PARVB;PACSIN2;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,glycolipid biosynthetic process (GO:0009247),-0.26435917089928657,-0.8837703859845395,0.6264150943396226,0.9191764852897611,1.0,18/38,20.24%,LARGE1;ST3GAL5;ST3GAL4;PIGA;GBGT1;SCCPDH;PIGB;PIGN;ST6GALNAC5;PIGH;PGAP2;DPM2;PIGG;ST8SIA1;ST8SIA3;PIGP;PGAP4;PIGZ
prerank,negative regulation of bone remodeling (GO:0046851),0.4226878704865782,0.8835258963627495,0.601018675721562,0.884096815400238,1.0,2/11,6.78%,GPR137B;P2RX7
prerank,histone H2A acetylation (GO:0043968),0.3977767308242165,0.8833914443975769,0.5968503937007874,0.8838931592017155,1.0,4/16,15.52%,ING3;BRD8;DMAP1;TRRAP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3912003480464779,0.8833442851964219,0.6047619047619047,0.8835153281711539,1.0,4/16,15.60%,BCL2L1;SNAI2;CLU;CDKN2D
prerank,positive regulation of protein deacetylation (GO:0090312),-0.34215050388873225,-0.883294641857827,0.6322751322751323,0.9191114842118617,1.0,6/14,23.04%,NIPBL;AKAP8L;SAP30BP;NNMT;ZBTB7B;APLNR
prerank,GPI anchor biosynthetic process (GO:0006506),-0.2777921193619005,-0.8832090315567763,0.6527777777777778,0.9181335624724091,1.0,14/30,26.75%,PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW;GPAA1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.36235210298938453,0.8829721293135064,0.603448275862069,0.8837460559024798,1.0,7/23,17.63%,COPS4;UBA52;RPS27A;RBX1;COPS8;XPC;COPS5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37483619621436604,0.8825338881997804,0.6024844720496895,0.8841210810135488,1.0,2/18,6.02%,RAB11A;CDC25C
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3384162082247009,-0.8821850275736318,0.5885416666666666,0.9193355070251118,1.0,4/15,21.24%,BMP4;SFRP4;NME2;ETV4
prerank,spermatid development (GO:0007286),0.3441158121048127,0.8821120552036396,0.6205479452054794,0.8844606694474186,1.0,2/32,4.15%,JAM2;ING2
prerank,nuclear body organization (GO:0030575),-0.35494337713768154,-0.8819265460190453,0.6428571428571429,0.9187864933854948,1.0,5/12,21.59%,AFF2;USP50;ZPR1;PML;SRPK2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4197531566512449,0.881461131109244,0.5907590759075908,0.8852562316920625,1.0,2/11,11.45%,NOVA2;PCBP1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3402869240820866,-0.8814086927662858,0.6240786240786241,0.9189017499861661,1.0,6/14,19.84%,ENPP1;ENPP3;AK5;CMPK2;AK1;NME2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.42211517625333017,0.8812325199818486,0.6212624584717608,0.885232999327001,1.0,4/11,13.91%,TBX1;STAT1;CTNNBIP1;LRP5
prerank,organelle assembly (GO:0070925),0.265800989096964,0.8806986237323379,0.7606490872210954,0.8857549822072286,1.0,59/385,15.56%,EXOC6;EHD4;SYNPO;ABCC4;ABLIM1;NOTCH1;RAB11A;ATG101;FLII;STX7;TEKT5;EHD1;DHX37;CSNK1D;FAM161A;TTBK2;CD34;TTC36;FNBP1L;BBS7;SNX10;GABARAPL1;VPS36;RAB23;IRGM;MAPRE3;TMEM216;IFT140;STARD9;STX12;CFAP43;NEK7;HAUS3;PCM1;VPS28;CHMP1B;PIK3C3;CFAP52;CDC14A;DYNLL1;EXOC8;TNKS;NPM1;OCRL;RAB19;VPS4A;TMOD3;CHMP3;WDR11;KIF24;CEP83;MAP1LC3A;EIF2S1;EIF2A;EDC3;CHMP2B;CHMP7;DDX6;UBQLN2
prerank,primary neural tube formation (GO:0014020),-0.2880187123453012,-0.8805668679135451,0.6360294117647058,0.9196998628830727,1.0,10/30,22.73%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,protein deneddylation (GO:0000338),0.43898176161902497,0.880429708038803,0.6164154103852596,0.8858342507520062,1.0,3/10,17.63%,COPS4;COPS8;COPS5
prerank,cholesterol biosynthetic process (GO:0006695),0.34107260298292374,0.8796870469346824,0.620199146514936,0.8867682574296928,1.0,14/31,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,regulation of cholesterol storage (GO:0010885),-0.33047852929117405,-0.8794279387919356,0.6335877862595419,0.9212540038020949,1.0,7/15,24.32%,ABCA1;PPARA;PPARG;NR1H3;LPL;PPARD;MSR1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3797420844653557,-0.8789125094677215,0.6225490196078431,0.9212303578556258,1.0,5/10,26.89%,NINL;KIF3A;CCDC68;CCDC120;CEP19
prerank,negative regulation of transferase activity (GO:0051348),0.34958515760451975,0.878759301649238,0.6169590643274854,0.8880322762611894,1.0,7/28,20.26%,SMAD7;INPP5K;DTX3L;ERCC4;MEN1;GSK3A;GSK3B
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39954406652347085,0.8786647865100999,0.5962199312714777,0.8877348125851467,1.0,5/13,14.77%,XPO1;NPM1;RAN;RPS15;EIF6
prerank,negative regulation of response to wounding (GO:1903035),-0.31549085616807804,-0.8773778264050712,0.6556473829201102,0.9235904605909232,1.0,5/19,13.88%,CASK;FGF2;SERPINE1;MDK;PTPRS
prerank,cilium assembly (GO:0060271),0.2678278599837169,0.8769552430029753,0.7609603340292276,0.8906545323891752,1.0,34/297,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;CFAP206;TEKT5;EHD1;DNAAF3;TUBB;CSNK1D;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;TUBB4B;RAB23;SPATA6;CLASP1;TMEM216;NEDD1;IFT140;CFAP43;CEP135;HAUS3;PCM1;CFAP52;CDC14A;DYNLL1;CEP76;EXOC8
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2459086078147098,-0.8765510636124814,0.723404255319149,0.9242546716197444,1.0,17/55,21.81%,PID1;PDGFRB;THBS1;PRKN;XDH;DHRS4;PDK3;AGTR1;MPV17;SIRT2;TGFBR2;CDKN1A;ACE2;PAX2;AGT;ROMO1;SPHK2
prerank,T cell differentiation in thymus (GO:0033077),-0.3452572107977414,-0.8762997811157502,0.6314432989690721,0.9236424605197245,1.0,1/14,0.41%,GLI3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.32144541594455345,-0.8761850639617289,0.6211699164345403,0.9227317558718252,1.0,7/18,18.61%,APOE;DACT1;ATP5IF1;CD81;CTSC;AMER1;EZR
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4190159121779188,0.8756878727066294,0.6171617161716172,0.8925813466682669,1.0,2/10,11.55%,SSBP1;E2F7
prerank,tube closure (GO:0060606),-0.28365676163261627,-0.8754665619463213,0.6642066420664207,0.9232551631693301,1.0,10/31,22.73%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,negative regulation of cellular component movement (GO:0051271),0.3911321627967739,0.8754033278314339,0.5987261146496815,0.8926808870335985,1.0,7/15,15.25%,CRK;SPOCK3;GATA3;SPINT2;PIN1;CD9;FRMD5
prerank,positive regulation of interleukin-4 production (GO:0032753),0.39051939702127364,0.8753614865464101,0.6242038216560509,0.8922765567108046,1.0,4/17,16.90%,LGALS9;GATA3;HAVCR2;RARA
prerank,nervous system development (GO:0007399),0.2636388673733862,0.8753038547577259,0.7979591836734694,0.8919192536294812,1.0,68/429,14.81%,JAG1;KALRN;EFNA5;LDB2;RNF103;SLC2A1;MERTK;APBA1;MPZ;GDA;RAPGEF5;NRGN;GJB1;SERPINI1;PPT1;DNM3;EVL;SNTG2;SPOCK2;PLXND1;WWTR1;MBNL1;MEF2C;PCDH1;SHANK3;SH3GL1;CHRM3;ZBTB16;WWP1;NRCAM;FLRT3;NCKAP1;APC;MAL;EIF2B2;NFASC;ASIC2;FAT4;ADGRB1;KIRREL3;ZC4H2;CDH2;SPOCK1;NCAN;BPNT1;NAV1;GSS;ACHE;SOX10;SOX6;RPS6KA3;CYP26C1;POU3F2;PCDHB16;RBM45;SDCBP2;CAPG;ADGRA2;MYT1L;VLDLR;NELL1;NAV3;TRPC5;PCDHB14;ATXN1;GFRA3;CXCR4;FZD9
prerank,B cell activation involved in immune response (GO:0002312),0.40487141503961244,0.875146859544675,0.6036184210526315,0.8917641564770816,1.0,2/13,7.65%,FCGR2B;EXOSC3
prerank,vitamin D metabolic process (GO:0042359),-0.34810763421746505,-0.8747015770111851,0.6190476190476191,0.9239410462801527,1.0,10/13,49.38%,LGMN;PIAS4;CYP2R1;CUBN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,cellular response to UV-A (GO:0071492),0.41870547760956456,0.8741909637506762,0.6062602965403624,0.893063552065547,1.0,4/11,22.89%,MMP1;PPID;TIMP1;MME
prerank,peptidyl-proline modification (GO:0018208),-0.2894644599833948,-0.8738162927662121,0.6888217522658611,0.9247691027907563,1.0,8/25,11.69%,FKBP5;NKTR;PPIC;FKBP10;PPIA;FKBP7;P3H2;PPIL2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3808679695267286,0.8737517797496146,0.5977011494252874,0.8929204787066485,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3808679695267286,0.8737517797496146,0.5977011494252874,0.8929204787066485,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,regulation of T cell proliferation (GO:0042129),0.3166780497648215,0.8737213641280073,0.6262626262626263,0.8925066145466745,1.0,4/61,7.82%,VCAM1;TNFRSF1B;ARG1;SLC7A1
prerank,mitochondrion localization (GO:0051646),0.37467419448764416,0.8736701191075328,0.6190476190476191,0.892131630018253,1.0,7/19,18.66%,BRAT1;LRRK2;MFN1;MARK2;HAP1;ZBED3;MEF2A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3665651814312566,-0.8736347888171305,0.638961038961039,0.9240077942080842,1.0,3/11,6.10%,NBL1;SLIT2;CCN3
prerank,negative regulation of B cell activation (GO:0050869),0.36626448192498695,0.8734234287079752,0.6020864381520119,0.8921412798124764,1.0,6/21,19.95%,FCGR2B;TYROBP;LAPTM5;ATM;BANK1;FOXJ1
prerank,regulation of lipid metabolic process (GO:0019216),-0.22166994825879557,-0.8733385960653658,0.7848101265822784,0.9235293957556782,1.0,14/88,10.76%,PRKAG2;CHD9;TBL1XR1;PPARA;CREBBP;RORA;NFYC;IRS2;OPA3;NR1D2;C1QTNF2;CCDC3;TNFAIP8L3;PPARG
prerank,autophagosome assembly (GO:0000045),0.3131326259963285,0.873307903109637,0.6527415143603134,0.8919039616284755,1.0,12/52,16.99%,TRAPPC8;ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;SMURF1;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,phospholipid transport (GO:0015914),0.31605353181243184,0.873168150801507,0.6267696267696268,0.8917218026582526,1.0,8/52,12.95%,ATP10A;APOA1;PLTP;ABCB4;PITPNA;ATP11C;ATP8B1;ABCC1
prerank,substantia nigra development (GO:0021762),-0.27061321217128265,-0.8730322382344401,0.652027027027027,0.923049760692874,1.0,14/37,17.90%,NDRG2;NDUFS3;CALM2;PLP1;MAPKAP1;CKB;PADI2;YWHAQ;SIRT2;MBP;SEC16A;CNP;BASP1;FGF9
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.41927731536312196,0.8729072454345329,0.6214876033057851,0.8917556295705945,1.0,2/11,7.74%,ADRB2;ARRB1
prerank,cell cycle G1/S phase transition (GO:0044843),0.30731048848112313,0.8726533994727749,0.6517967781908303,0.8917420243298114,1.0,15/61,21.20%,PLK3;ACVR1;CCNE1;CUL3;MAP3K11;CUL2;USP29;HINFP;RPS6KB1;CDKN2D;CACUL1;E2F3;MAX;MNAT1;BCAT1
prerank,protein localization to vacuole (GO:0072665),0.4014082084254653,0.8725009412938767,0.6140065146579805,0.8915559787008823,1.0,3/13,9.49%,SH3BP4;RNF128;RTN4
prerank,activation of protein kinase activity (GO:0032147),0.29355917807196097,0.8724599828462724,0.6846424384525205,0.8911578646794922,1.0,19/106,13.05%,PDGFB;INSR;TGFB2;ADRB2;EMP2;TLR3;TIRAP;CARD10;ANGPT1;MAP4K4;TOM1L1;JAK2;TAOK2;ADCY4;CCDC88A;MINK1;MARK2;COPS8;ITGB1BP1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.41824318066206817,0.8724291236509033,0.6141215106732348,0.8907601677497956,1.0,3/11,15.49%,FBXO7;HIF1A;RACK1
prerank,positive regulation of DNA binding (GO:0043388),-0.2698708598833707,-0.872424728499962,0.7095709570957096,0.9232383433454171,1.0,6/31,14.39%,IGF1;PRKN;NGF;PPARG;TXN;SIRT2
prerank,innate immune response in mucosa (GO:0002227),0.4266328704520379,0.8723064944686529,0.616580310880829,0.8905371967681182,1.0,1/10,4.04%,DEFA6
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4268199955044121,0.8716563161628476,0.6220735785953178,0.8912684105521738,1.0,4/10,22.19%,ATP7A;KYAT1;KYNU;QDPR
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.30595535106655936,-0.8714807946755913,0.654178674351585,0.9241207192508822,1.0,3/18,6.76%,NLGN2;CACNG4;TSHZ3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.31553245080318404,-0.8713737989309776,0.6424581005586593,0.923183149109463,1.0,3/18,5.49%,WNK1;PPARA;PTPN22
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.26401120345470386,0.8713542790370666,0.784394250513347,0.8913798585807987,1.0,88/341,21.13%,ZNRF1;CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PSMD4;KLHL20;PTTG1;ARRB1;WWP1;UBE4A;TOM1L1;FEM1C;NFE2L2;PPP2R5C;NDFIP2;VPS28;RNF128;PSMA5;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMB8;PSMD14;DTX3L;SMURF1;KCTD10;RMND5B;VPS4A;PSMA7;PSMC3;KEAP1;PSMA8;PSMC1;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;PSMB9;UBQLN2;KLHL25;SPOPL;ANAPC7;PSMC6;RNF150;PSMA4;FBXO8;UBQLN4;GSK3A;FBXO10;PSMD5;PSMD9;FEM1A;PSMB6;ANAPC4;RNF166;FBXO45;ZFAND2A;MAEA;MVB12A;RNF5;KCTD2;RNF34;PSMB2;RNF11;WWP2;KCTD21;UBA1
prerank,reverse cholesterol transport (GO:0043691),0.40028440420239875,0.8713384850688253,0.6152512998266898,0.890943612918465,1.0,4/13,17.41%,APOA1;LCAT;CLU;SCARB1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.32543219469605816,-0.8710050376055836,0.6366279069767442,0.9228392687036716,1.0,10/18,39.62%,FLNA;ERBB2;MAF1;UBTF;PHF8;DHX33;POLR2L;HEATR1;POLR2K;EIF2AK3
prerank,negative regulation of transmembrane transport (GO:0034763),0.4128669051805104,0.8709068277084323,0.6085470085470085,0.8912836824596809,1.0,2/10,5.41%,INPP5K;CTTNBP2NL
prerank,cellular response to amino acid starvation (GO:0034198),0.30310884839048563,0.8705870460999112,0.6773006134969325,0.8914140295011711,1.0,19/71,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,regulation of glycogen metabolic process (GO:0070873),0.3965540461766537,0.8705106378253211,0.6254071661237784,0.8910928787865675,1.0,1/12,3.52%,INPP5K
prerank,negative regulation of mRNA processing (GO:0050686),-0.3317004935333769,-0.8701639324938618,0.6336898395721925,0.923551987109632,1.0,8/15,34.86%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3688314673798574,-0.8701631508072243,0.6363636363636364,0.9223888233979071,1.0,4/11,8.41%,IGF1;IRS1;PIK3R1;GHR
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4215270899392399,0.8699976186033475,0.6127946127946128,0.8915874791054466,1.0,3/11,10.96%,GOPC;TAX1BP3;NEDD4L
prerank,ribosomal small subunit assembly (GO:0000028),0.3889706879795953,0.8698085054762917,0.6167192429022083,0.8914888430680326,1.0,6/16,21.23%,RPS14;RPS28;RPS5;RPS15;PWP2;RPS19
prerank,lipid transport (GO:0006869),0.28816618265428795,0.8697184794499497,0.693127962085308,0.8911829657207271,1.0,10/97,8.63%,ABCC4;CEACAM1;TTPA;SLCO1C1;APOA1;SPNS2;PLTP;GLTP;CERT1;PITPNA
prerank,regulation of histone deacetylation (GO:0031063),0.39671944222813726,0.869686406635376,0.6201298701298701,0.8907859481988687,1.0,2/13,4.95%,ING2;CAMK2D
prerank,inorganic anion transmembrane transport (GO:0098661),0.3092327410651436,0.8694093539410521,0.6675,0.8908405876836357,1.0,17/63,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;SLC25A30;CLCN1;GABRA4;XPR1;SLC1A1;GABRA2;SLC37A2;GABRE;SLC37A3;GLRA2;SLC25A10;GABRG3;GABRB1
prerank,protein deubiquitination (GO:0016579),0.2691419245469872,0.8690721665509622,0.7379454926624738,0.891017692631222,1.0,53/242,18.93%,SMAD7;FOXO4;SPATA2;USP38;IFIH1;ADRB2;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;MINDY1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SMAD4;PSMD5;PSMD9;PSMB6;INO80D
prerank,membrane protein proteolysis (GO:0033619),0.3323529819000628,0.8690339576897937,0.6462395543175488,0.8906229639433684,1.0,19/37,26.00%,SPPL2A;RHBDD1;MYH9;ADAM17;MBTPS2;TMPRSS6;APH1A;ADAM10;PSEN2;RELA;CTSH;APH1B;SPPL2B;ERAP1;AFG3L2;NCSTN;PARL;TGFB1;RET
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2775777086856815,-0.8690205911846277,0.6700680272108843,0.9238460921174121,1.0,8/33,17.11%,DDX5;UBA5;RUNX1;UFSP2;KLK2;HDAC6;LATS1;AR
prerank,RNA 3'-end processing (GO:0031123),-0.23285888425924614,-0.8683578547806873,0.7428571428571429,0.9242042753337567,1.0,28/69,25.48%,SRSF5;NUDT21;NCBP1;LIN28B;SRRM1;SRSF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;SUPV3L1;CSTF2T;PCF11;MAGOH;U2AF2;TUT4;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.358942924275358,0.8681363751496259,0.6203288490284006,0.8918540717164994,1.0,5/22,12.82%,VPS36;TOM1L1;VPS28;RNF115;VPS4A
prerank,'de novo' posttranslational protein folding (GO:0051084),0.34297715378472277,0.8680735111484461,0.6212765957446809,0.8915078293717407,1.0,7/30,18.61%,HSPA1B;HSPE1;PTGES3;CCT2;UGGT1;DNAJC7;DNAJB5
prerank,sensory organ development (GO:0007423),-0.24446983019962468,-0.8680402378927445,0.7112068965517241,0.9236868046784397,1.0,6/51,6.70%,SMOC1;PBX3;RBP4;SH3PXD2B;MEIS1;SHROOM2
prerank,histone lysine methylation (GO:0034968),-0.27350052311195067,-0.8679229336788876,0.697986577181208,0.9227773634502391,1.0,9/33,17.25%,PRDM5;ASH2L;SETD1B;DOT1L;WDR5;DPY30;SUV39H1;N6AMT1;SETDB2
prerank,negative regulation of complement activation (GO:0045916),-0.37239310833201117,-0.8678970370957186,0.6272493573264781,0.9216611213612809,1.0,2/10,4.85%,SERPING1;CD55
prerank,regulation of interleukin-17 production (GO:0032660),0.3422195564922227,0.8670430448291478,0.6224066390041494,0.8930270584553278,1.0,3/31,10.88%,NOD2;PRNP;VSIR
prerank,negative regulation of myotube differentiation (GO:0010832),0.4075475478362464,0.8668137913974665,0.6566666666666666,0.8930345381533248,1.0,1/12,1.60%,NOTCH1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.33895181555099174,-0.8665563000401307,0.6462765957446809,0.9235628275362459,1.0,7/14,25.74%,RMND1;TRUB2;RCC1L;RPUSD4;MPV17L2;C1QBP;FASTKD3
prerank,histone methylation (GO:0016571),-0.2863777366984075,-0.8661574195198779,0.6795252225519288,0.9232729688646485,1.0,6/26,16.43%,CREBBP;NSD3;NSD1;EHMT1;SUV39H1;N6AMT1
prerank,positive regulation of phospholipid transport (GO:2001140),0.4301509510673219,0.8658156077327961,0.6256499133448874,0.8944350495548791,1.0,3/10,15.39%,APOA1;ABCB4;ABCA7
prerank,response to interleukin-6 (GO:0070741),-0.37737120007163677,-0.865599566472794,0.6177884615384616,0.9233101220840252,1.0,1/10,0.13%,PID1
prerank,positive regulation of cellular component movement (GO:0051272),0.35514188813611125,0.8652662708923319,0.6438356164383562,0.8949743029715616,1.0,5/24,11.30%,ACTN4;SPOCK2;NTN1;ADAM17;CAVIN1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2923757329793351,0.8643010022368767,0.6713947990543735,0.8963455358633069,1.0,14/88,15.85%,SYNPO;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;SPIDR;CLU;CHGA;VPS4A;ICE1;RACK1;VIL1
prerank,protein modification by small protein removal (GO:0070646),0.2664557589710983,0.8640643602474909,0.7625,0.8963249989385876,1.0,65/252,21.84%,SMAD7;FOXO4;USP38;IFIH1;ADRB2;COPS4;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;SENP5;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;COPS8;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SENP7;SMAD4;PSMD5;PSMD9;USPL1;PSMB6;INO80D;BARD1;STAM2;PSMB2;TAB1;SENP6;USP47;UBB;USP14;USP30
prerank,tricarboxylic acid metabolic process (GO:0072350),0.39735039216511076,0.8640478363942448,0.6182432432432432,0.8958894331205273,1.0,3/12,6.37%,GLUD1;ASS1;SIRT4
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.38046921603761735,-0.8635313167408087,0.6264775413711584,0.9267863877917105,1.0,6/10,29.69%,PIH1D1;ZNHIT6;NAF1;ZNHIT3;TAF9;PIH1D2
prerank,steroid metabolic process (GO:0008202),-0.2310239821908749,-0.863272079166623,0.7802197802197802,0.9262365822353402,1.0,21/72,29.73%,CYP27A1;CYP26B1;LIPA;SCP2;DHRS4;FDX1;GBA2;AMACR;CYP2A6;LGMN;CYP51A1;PIAS4;STAR;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP2R1;ARV1;CYP46A1
prerank,ether lipid metabolic process (GO:0046485),-0.33796448566231424,-0.8631463713509252,0.6553524804177546,0.9253666681829977,1.0,3/14,7.84%,AGMO;GNPAT;PEDS1
prerank,cellular response to interleukin-6 (GO:0071354),0.34984281136684064,0.8622241724928433,0.6337817638266069,0.8988333888819394,1.0,9/26,19.14%,ST3GAL6;CBL;STAT1;CEBPA;JAK2;PTGIS;SMAD4;RELA;SELPLG
prerank,acute inflammatory response (GO:0002526),-0.29572058447972616,-0.8621725379824227,0.6618075801749271,0.926280403204453,1.0,4/23,8.52%,LBP;IL6R;F3;CEBPB
prerank,response to histamine (GO:0034776),0.4136638476670825,0.8615333166113281,0.6306913996627319,0.8996481870275193,1.0,3/10,21.41%,DIAPH1;GABRB1;GABRB3
prerank,mitotic metaphase plate congression (GO:0007080),0.30761833383056775,0.8614894567110546,0.6463878326996197,0.8992566917196712,1.0,11/51,16.03%,RAB11A;CUL3;KPNB1;CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;BOD1;NDC80
prerank,insulin receptor signaling pathway (GO:0008286),0.2968247406470587,0.8613032417469445,0.6576354679802956,0.8991565842660356,1.0,25/69,23.28%,FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;BCAR3;APC;NAMPT;AP3S1;PHIP;GRB14;SOS1;PTPN2;ATP6V1G1;GSK3A;ATP6V1C1;ATP6V0A1;GSK3B;ATP6V1D;PIK3R3;BCAR1;ZNF106;PIK3CA;IGF1R
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3783100071192818,0.8612632385871493,0.6280193236714976,0.8987557905309889,1.0,10/17,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.252039651201531,-0.8607994001948664,0.7106227106227107,0.9282065555627498,1.0,2/41,0.78%,PRKAG2;OGT
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3879935572114081,0.8606006124412917,0.6102819237147595,0.8995548056458906,1.0,6/15,28.88%,HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.34027443546694747,0.8604307956690899,0.6276150627615062,0.8994070623543554,1.0,6/29,18.29%,MBOAT2;LPCAT4;TMEM86B;LPCAT3;PLA2G12A;PLAAT3
prerank,positive regulation of organelle assembly (GO:1902117),0.32167031074834446,0.8602992267817611,0.6532797858099063,0.8991998250449951,1.0,13/44,21.44%,SAXO1;RAB3GAP2;CNOT6L;CNOT1;CCDC88A;NUMA1;CAPG;LCP1;CEP120;CNOT2;G3BP1;MARK4;RALB
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.34788374486583135,-0.859979309958414,0.6487804878048781,0.9288193299086345,1.0,5/12,24.03%,PTPN22;RUNX1;CD300A;RC3H1;PTPRC
prerank,vesicle coating (GO:0006901),-0.23666423399974654,-0.8596458584738941,0.7703349282296651,0.9260693186003495,1.0,27/61,26.36%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23666423399974654,-0.8596458584738941,0.7703349282296651,0.9260693186003495,1.0,27/61,26.36%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,COPII vesicle coating (GO:0048208),-0.23666423399974654,-0.8596458584738941,0.7703349282296651,0.9260693186003495,1.0,27/61,26.36%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,endosome organization (GO:0007032),0.3188588641885758,0.8588853042565203,0.6639344262295082,0.901377425304502,1.0,9/41,18.81%,ALS2CL;SNX10;HOOK1;CLCN3;EXOC8;CHMP2B;PHETA1;RAB27A;HOOK2
prerank,positive regulation of macrophage migration (GO:1905523),-0.31202371993090666,-0.8588362473148079,0.6267806267806267,0.9267150037616957,1.0,4/19,12.65%,IL34;THBS1;P2RX4;MDK
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.306925740002575,0.8588143255278516,0.6483375959079284,0.9010517850350372,1.0,17/53,22.21%,ECSCR;DAB2IP;FOXF2;XPO1;FBXW7;PRKCG;PSMD14;PSMC3;PSMC5;PSMC6;OPHN1;UBQLN4;PSME3IP1;TMF1;UBB;USP14;GLMN
prerank,regulation of pH (GO:0006885),0.40801407759175,0.8587014009747924,0.6221837088388215,0.9007855117895852,1.0,3/11,9.59%,ATP1A4;CLCN3;SLC9A7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2852041225971869,0.8585574442036621,0.7099767981438515,0.9005628498467314,1.0,24/100,17.93%,SMAD7;SUMO2;CSNK1D;FOXF2;BBS7;ARIH1;RYBP;LRRK2;HSPA1B;CEBPA;XPO1;RBX1;NKD2;RNF144B;BAG6;CLU;KEAP1;RACK1;EIF3H;CBFA2T3;TRIB3;SOCS5;UBQLN4;GSK3A
prerank,negative regulation of protein catabolic process (GO:0042177),0.32633828188078656,0.8579731233882846,0.652112676056338,0.9011159133101485,1.0,9/40,14.15%,AZIN1;DAB2IP;TIMP3;ROCK1;MAD2L2;PRKCG;ADGRB1;PIN1;NELL1
prerank,DNA damage checkpoint signaling (GO:0000077),0.3455066266669913,0.8573371756647683,0.6464497041420119,0.9018029812220543,1.0,10/28,19.45%,BRIP1;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;TIPRL;ATRIP;HUS1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.32275915240417413,0.8559120063452139,0.6446280991735537,0.9040152830912072,1.0,10/42,16.66%,DEFA6;IRGM;GALP;ADGRB1;CHGA;RPL30;RNASE6;HMGB2;DROSHA;PYCARD
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.41897969939349866,0.8558943114241255,0.6496478873239436,0.9035882051313123,1.0,2/10,2.96%,NOTCH1;DLL4
prerank,positive regulation of type I interferon production (GO:0032481),0.3004919368109058,0.8553691541648042,0.6998799519807923,0.904067232025543,1.0,17/73,20.59%,IFIH1;LRRFIP1;TLR3;DDX41;STAT1;OAS2;POLR3B;GAPDH;DHX9;IRF5;RIOK3;CTNNB1;RELA;G3BP1;SETD2;POLR3C;DHX58
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3402799463597197,-0.8550408920269859,0.6641025641025641,0.9338239045956938,1.0,5/13,12.81%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,transcription by RNA polymerase II (GO:0006366),0.26242361430456773,0.8548948909306332,0.7903885480572597,0.9044879887490985,1.0,67/305,17.58%,NOTCH4;TSC22D1;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;INTS11;RTF1;RXRG;TRIM24;EAF1;SETX;CPSF1;ELP4;ELP2;POLR2G;NR1D1;MBD1;ELOA;POLR2D;ELL2;SNRPE;RPRD1B;FIP1L1;DEAF1;TBPL1;MAML2;INTS12;EAF2;GTF2H3;NR4A1;KLF13;CBFB;GTF2A1;DDX21;INTS5;MED27;MED17;MLLT3;MED4;ICE1;ELOF1;TAF11;SNAPC4;NELFB;NR2C1;POLR2I;AFF4;ESR1;ESRRG;NELFA;RARA;TAF8;RPAP1;DRAP1;RPRD2
prerank,regulation of cell killing (GO:0031341),0.3849235813512752,0.8548170236162704,0.6661341853035144,0.9041632968481992,1.0,4/16,11.05%,TGFB2;CR1L;RAC1;CYBA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3825553366403563,0.8533499563518354,0.6333333333333333,0.90639420263295,1.0,3/16,9.04%,EDN1;CAMK2D;ROCK1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.28037248569816475,0.853157395119313,0.714622641509434,0.9062653253961775,1.0,22/104,21.44%,CCND2;CCND3;DAB2IP;ADRB2;SLC8A1;CCNE1;SERTAD1;CDC25C;IRGM;SYAP1;ACTB;CALM3;LRP5;PDCD10;CDKN2D;PYCARD;TRIB3;MAP2K1;CAB39;BLM;MNAT1;RALB
prerank,lymphocyte chemotaxis (GO:0048247),-0.2626524032488477,-0.8528059858247615,0.7127272727272728,0.9374134728160065,1.0,23/34,51.87%,SLC12A2;CXCL16;CCL25;CKLF;GPR183;CCL19;HSD3B7;PIK3CG;CCL2;CCL14;CX3CL1;GAS6;CCL5;CCL11;CCL7;CCL8;MSMP;ADAM8;CCL1;CCL3;XCL1;CXCL13;CCL13
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3509611280496196,0.8527152955873687,0.6177325581395349,0.9065994231281016,1.0,4/26,8.68%,EFNA5;KLF7;PIM3;NR1D1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3507215601844986,-0.8525545124984455,0.6458923512747875,0.9368438308187849,1.0,10/12,53.71%,CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,response to amino acid starvation (GO:1990928),0.29656328418338573,0.8523735731403508,0.7027027027027027,0.906750421024011,1.0,19/72,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.34957835699932754,0.8521164870394713,0.64,0.906792807411097,1.0,8/26,15.67%,ST3GAL6;B4GALT4;SLC35D2;B3GNT3;B4GALT6;CHST1;ST3GAL1;ST3GAL2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.28702518413448747,-0.8520968100334844,0.6521739130434783,0.9366341435244859,1.0,4/25,11.06%,B3GALT1;B3GNT2;HS2ST1;NDST3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4080945606660037,0.8519264854336712,0.6502463054187192,0.9066790312941421,1.0,1/11,3.68%,NOS1AP
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.33018848881200946,0.851909518383839,0.6507246376811594,0.9062548476997105,1.0,9/29,19.37%,SRARP;UFM1;CNOT1;STRN3;BRCA1;CBFB;ESR1;CNOT2;WBP2
prerank,histone mRNA catabolic process (GO:0071044),0.3826022861556329,0.8515787239278881,0.6321070234113713,0.9064026043396592,1.0,7/15,21.35%,LSM1;MTPAP;XRN1;ATM;TENT2;TUT7;EXOSC10
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2888564752023559,0.8515029970796895,0.6805385556915544,0.9056184477958532,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2888564752023559,0.8515029970796895,0.6805385556915544,0.9056184477958532,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,bone morphogenesis (GO:0060349),0.39180923326486305,0.8504929229500032,0.6436597110754414,0.9069908622926834,1.0,2/14,5.43%,BMPR2;FGFR3
prerank,Golgi inheritance (GO:0048313),0.411050285782264,0.8503127478535991,0.650994575045208,0.9068602693027406,1.0,3/11,15.45%,PLK3;VRK1;PDCD10
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32795830820569244,0.8500538719092364,0.6835443037974683,0.9068652160815595,1.0,4/34,4.06%,NEDD9;CRK;APOA1;LIMS2
prerank,regulation of cilium assembly (GO:1902017),0.3005696915595318,0.849965502827791,0.6623544631306598,0.9065617734361545,1.0,11/62,13.12%,RABGAP1;SAXO1;TBC1D30;TBC1D8;IFT140;TBC1D5;TBC1D1;CCDC88A;LIMK2;USP6NL;TBC1D10A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.29816484858648706,-0.8491098609883652,0.6991150442477876,0.9419114098464819,1.0,12/21,41.85%,GOLGA2;CDC14B;FZR1;BTRC;BAG2;MAD2L1;GORASP1;PLK1;CDC20;UBE2C;RPL5;RAB1A
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3502607362125226,0.8489668227136911,0.6376146788990825,0.9078643138864582,1.0,3/21,11.25%,RAB11A;CDC25C;NPM1
prerank,glycogen biosynthetic process (GO:0005978),0.39736644028095847,0.8481840577297592,0.6336633663366337,0.9083755262940557,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.39736644028095847,0.8481840577297592,0.6336633663366337,0.9083755262940557,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3438651954438172,0.8479332617531973,0.6484149855907781,0.9083647412403713,1.0,3/27,5.59%,F2RL1;GPR157;LPAR6
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3654339099727349,-0.8479194135928442,0.6628959276018099,0.9433191838610256,1.0,2/10,3.00%,SLC1A3;SLC25A13
prerank,negative regulation of cell development (GO:0010721),0.33953539027112517,0.847726502061917,0.6543026706231454,0.9082746192969059,1.0,4/25,9.67%,NOTCH1;B2M;PCM1;FBXW7
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3044067104762458,0.8470918046203517,0.6809895833333334,0.9089709698197291,1.0,11/51,10.65%,DAB2IP;TRIO;ATP7A;SHTN1;MAP4K4;PACSIN1;LRRK2;NCKAP1;SGK1;TAOK2;MINK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.32878455947001384,0.8467661318505914,0.6541143654114365,0.9091158603377283,1.0,5/31,11.55%,FAM107A;KLF4;RBL1;APC;E2F7
prerank,response to hexose (GO:0009746),-0.2814842959647848,-0.8462090558355303,0.6656976744186046,0.9458294472263234,1.0,4/25,7.53%,TCF7L2;THBS1;IRS2;GPLD1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.31203380237926803,-0.8460737878953827,0.6612466124661247,0.9449209351850985,1.0,2/16,2.91%,LRP1;APOE
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3114543958016778,0.8448769415980746,0.6684280052840158,0.9121498240525598,1.0,8/42,14.17%,SMARCA2;SRCAP;ACTB;DMAP1;SMARCAD1;ACTR6;VPS72;SMARCC1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.29998089384339516,0.8441307234141838,0.6860025220680959,0.9130807143284747,1.0,10/57,11.69%,BOP1;DHX37;RPL7;PAK1IP1;NVL;XPO1;RPS28;MRPL36;NPM1;RPS25
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.40479469945582336,0.8437427023390991,0.6525573192239859,0.9133163272495808,1.0,5/10,25.05%,INPP5F;NF2;PTPN2;PARP14;PPP2R1A
prerank,establishment of protein localization to organelle (GO:0072594),-0.22723110101238528,-0.8436944497995169,0.7942583732057417,0.9486757371165147,1.0,21/72,24.38%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;NUP155;TNPO3;RANBP6;HK2;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,acylglycerol homeostasis (GO:0055090),0.3580139613000509,0.8434968989287696,0.6578538102643857,0.9133025663155191,1.0,2/20,3.48%,HNF4A;APOA1
prerank,fatty acid catabolic process (GO:0009062),-0.22795937055116938,-0.8434614735654361,0.828125,0.947992694617111,1.0,27/67,30.17%,PCCA;ABCD3;SCP2;PEX2;BDH2;ACAT2;EHHADH;ACADM;ECHDC2;PLA2G15;ECI2;HACL1;CPT2;ACAD11;ACADVL;PEX13;NUDT19;FAAH;MTLN;PPARD;PHYH;ECHS1;HSD17B10;LPIN3;PCCB;LPIN1;PECR
prerank,cell projection assembly (GO:0030031),0.34721110588791787,0.8432184794919799,0.6661442006269592,0.9133468359171111,1.0,7/22,13.75%,PARVB;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,regulation of protein transport (GO:0051223),0.3401160139357482,0.8419833734525839,0.6608946608946609,0.9151034816915803,1.0,8/27,20.91%,PPM1F;NDFIP2;PTPN1;LCP1;STXBP5L;STXBP5;DNAJA1;WWP2
prerank,translational termination (GO:0006415),0.28211539620557374,0.8417696818181745,0.7259953161592506,0.9150313934787351,1.0,39/95,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;ETF1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;APEH;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,gland development (GO:0048732),0.2954756191170009,0.841400041500327,0.7028714107365793,0.9152290285407643,1.0,7/59,7.78%,NOTCH4;TBX1;CAV1;LSR;MSN;PRKCSH;CEBPA
prerank,positive regulation of signaling (GO:0023056),0.31974467617592356,0.8411338886170334,0.6580459770114943,0.9152532780513377,1.0,10/37,19.00%,EDN1;GATA3;GRIK2;INPP5F;RIMS3;NSF;NMU;SYT1;CDKN2AIP;SOX11
prerank,mitochondrion disassembly (GO:0061726),-0.2616258358766158,-0.8410443845570471,0.7381818181818182,0.9518754350547269,1.0,13/34,22.24%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;WDR45;BECN1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.27077730647642473,-0.8409317877375742,0.7210031347962382,0.9509546209221711,1.0,6/26,14.87%,DAB2;KANK2;HEYL;HDAC1;CLOCK;CRY2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3822390754969468,0.8394450880078432,0.656140350877193,0.9177736059866107,1.0,5/13,15.33%,KPNB1;NUP54;NUP35;RANBP2;KPNA3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3427010670892183,-0.839193741031505,0.6633906633906634,0.9533624638195923,1.0,1/12,0.28%,CACNA1C
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3435546634120893,-0.8388025438982764,0.6626506024096386,0.9529938635266201,1.0,1/12,1.10%,IL34
prerank,positive regulation of coagulation (GO:0050820),-0.36275151254432625,-0.838770582571157,0.6708542713567839,0.9507607524480527,1.0,3/10,11.23%,THBS1;ST3GAL4;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.36275151254432625,-0.838770582571157,0.6708542713567839,0.9507607524480527,1.0,3/10,11.23%,THBS1;ST3GAL4;SERPINE1
prerank,ovarian follicle development (GO:0001541),-0.3418925290330084,-0.8387671869392607,0.6591549295774648,0.9496243590271771,1.0,8/13,34.16%,KIT;CEBPB;VEGFA;INHBA;INHBB;FOXL2;LHCGR;EIF2B5
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3084517891084181,-0.838744075428622,0.6983695652173914,0.9485267693391514,1.0,5/18,13.91%,PTN;IL34;DAAM2;MDK;SLC45A3
prerank,regulation of DNA replication (GO:0006275),0.30057383398849186,0.8385518567952674,0.7152145643693107,0.9189001350358591,1.0,10/49,12.09%,ACVRL1;BCAR3;GMNC;ORC3;STN1;DHX9;CCDC88A;CDAN1;OBI1;ORC5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24900201154491514,-0.8377771299650874,0.7482014388489209,0.9493038051029262,1.0,16/39,24.64%,DDB2;FAN1;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.35118472457229166,0.8375722834065678,0.6563944530046225,0.9202132893051304,1.0,9/20,23.34%,MBTPS2;KPNB1;SEC14L2;LPCAT3;LDLRAP1;RAN;FMO5;SREBF2;TTC39B
prerank,potassium ion import across plasma membrane (GO:1990573),0.3148062359802615,0.8375010479193242,0.6657458563535912,0.9198724303034004,1.0,4/41,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,regulation of cellular metabolic process (GO:0031323),-0.2427599403660143,-0.8370371503486144,0.7509881422924901,0.9497168643863401,1.0,15/45,25.27%,PID1;PPARA;PRKN;ARF1;TBC1D16;PDK3;MPV17;PDK2;STUB1;PANK2;ACACA;MKLN1;SSH1;MBOAT7;PDK4
prerank,negative regulation of transposition (GO:0010529),0.3670413224639917,0.8369853752893534,0.6461295418641391,0.9203195114737781,1.0,3/16,18.63%,DDX4;TUT7;TDRD9
prerank,regulation of endopeptidase activity (GO:0052548),0.29538709659197543,0.836258521513846,0.7104591836734694,0.9211824751728803,1.0,10/59,11.08%,SERPINI1;SPOCK2;TIMP3;SPOCK3;FURIN;GAPDH;APH1A;VSIR;PSMB8;SPOCK1
prerank,positive regulation of vasoconstriction (GO:0045907),0.3930984655662981,0.8361695277176132,0.6639477977161501,0.9208850423708425,1.0,1/13,2.28%,CAV1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3601903254371852,-0.8358333763594457,0.6538461538461539,0.9510968733023687,1.0,5/10,24.64%,THOC1;WDR76;RFWD3;FEM1B;RPA2
prerank,negative regulation of receptor internalization (GO:0002091),-0.33596709943623604,-0.8354288341462469,0.6898263027295285,0.9507495769556791,1.0,4/12,14.50%,DLG4;ATXN2;SDCBP;ANKRD13D
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3428584267007856,-0.8352750989927471,0.687041564792176,0.9499382257193342,1.0,3/12,11.28%,CENPC;RMDN1;MIS12
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3862822623796171,0.8348413186059486,0.6381909547738693,0.9227858732685011,1.0,6/12,24.49%,PPT1;LRRK2;CCDC115;ATP6AP2;TMEM199;GRN
prerank,carbohydrate catabolic process (GO:0016052),0.31467514723139617,0.8344729691860425,0.6939890710382514,0.9229602560410628,1.0,8/38,19.35%,MANBA;GPI;PGK1;GAPDH;MAN2C1;PFKM;MAN2B2;NEU4
prerank,secondary palate development (GO:0062009),0.3791488406143205,0.8342022198193626,0.6709886547811994,0.9229779516124936,1.0,3/14,5.38%,TGFB2;LEF1;SMAD2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.29123531950437986,0.8339901024905906,0.7032258064516129,0.9228595781672393,1.0,13/69,13.93%,EDN1;PLCB1;PLCB4;PIK3C2A;PLEKHA1;GATA3;GPR143;HTR2A;PIK3C3;INPP5F;PIK3CB;RPS6KB1;LTK
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3417665852528024,-0.833486870590551,0.6792452830188679,0.9524553634734272,1.0,8/11,55.79%,RTP4;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,negative regulation of immune effector process (GO:0002698),-0.329116067142193,-0.8332344360210384,0.6571428571428571,0.9517973512671791,1.0,5/13,17.98%,CD55;ENPP3;FER;CD300A;RC3H1
prerank,muscle cell migration (GO:0014812),-0.36489772154763933,-0.8331862084747692,0.6838235294117647,0.9507479770069387,1.0,4/10,16.21%,CCN3;SIX1;DDR1;AAMP
prerank,mitochondrion organization (GO:0007005),0.2633005083151598,0.8329458056284152,0.7935135135135135,0.9242493595413599,1.0,28/165,15.75%,NOS3;CAV2;DNM3;FBXO7;ATP7A;OMA1;SSBP1;CHCHD3;SIRT4;CHCHD2;SLC25A33;ALAS1;AKT3;LRRK2;IMMP2L;BCL2L1;VPS13D;TSPO;MIGA1;MFN1;POLG2;RHOT2;BNIP3L;BNIP3;TFB2M;NUBPL;PTCD2;SAMM50
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3560256273418598,0.8329453754672786,0.6609907120743034,0.9237868624042229,1.0,10/19,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3656178403242335,0.8325651903863898,0.6636085626911316,0.9239867634060362,1.0,10/18,27.90%,ZC3H12A;PTBP3;TMBIM6;ESR1;PTBP2;SHQ1;NCOR2;NUDT16;TGFB1;RPS13
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3643646350893387,0.8316391815129138,0.677115987460815,0.9251038596061016,1.0,4/15,15.24%,WHAMM;ARPC5;ARPC3;ARPC2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3267243332693265,-0.8315729432688388,0.7191283292978208,0.9529651169687384,1.0,2/14,3.41%,IL34;THBS1
prerank,regulation of lamellipodium organization (GO:1902743),-0.3267283390806852,-0.8313439682312337,0.6744791666666666,0.9523019506499052,1.0,3/14,13.49%,PDPN;CAPZB;FER
prerank,genitalia development (GO:0048806),-0.3357023266979072,-0.8311133284579513,0.7045454545454546,0.9516311759470585,1.0,3/12,11.66%,WNT5A;STRA6;PKD1
prerank,mitotic spindle assembly (GO:0090307),0.3129781210263944,0.8306914776269213,0.7032967032967034,0.9262854050797992,1.0,8/42,13.86%,RAB11A;KIF2A;CLASP1;KPNB1;STAG1;CLASP2;PRC1;ARHGEF10
prerank,cellular response to glucose starvation (GO:0042149),0.3102760064115581,0.8305109407198623,0.6886792452830188,0.9261438866511896,1.0,5/41,9.53%,NUAK1;ZC3H12A;SIK2;PRKAA1;PIK3C3
prerank,signal peptide processing (GO:0006465),0.4005408323685927,0.8305019950944976,0.6588628762541806,0.9256942928705852,1.0,2/11,5.65%,PCSK5;FURIN
prerank,B cell proliferation (GO:0042100),0.37007075960097274,0.8303233004285941,0.65086887835703,0.9255506739313958,1.0,4/17,15.90%,CTPS1;MEF2C;CR2;CD79A
prerank,ncRNA 3'-end processing (GO:0043628),-0.3228929013559246,-0.8302023957787871,0.6923076923076923,0.9524173098806356,1.0,6/14,19.73%,INTS14;SSB;INTS2;PTCD1;TOE1;TRNT1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3772118775895879,0.8299607756808242,0.6876061120543294,0.9257308325827999,1.0,1/13,0.84%,PLCB1
prerank,mitotic cytokinesis (GO:0000281),-0.23737500460053734,-0.8298670390523571,0.7821011673151751,0.951958754410075,1.0,16/47,21.92%,ROCK2;SON;JTB;KLHDC8B;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19
prerank,lymphocyte proliferation (GO:0046651),0.34809552414852685,0.8295390745394304,0.6766467065868264,0.9260218464482982,1.0,5/22,15.90%,MSN;CTPS1;MEF2C;CR2;CD79A
prerank,regulation of ATP metabolic process (GO:1903578),-0.22978969768871021,-0.8293133325397961,0.8035714285714286,0.9519669354931194,1.0,9/54,14.02%,PRKAG2;OGT;NUP107;ATP5IF1;NUP155;COX7A2;AAAS;COX7A2L;NUP93
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.29648541338705564,-0.8292554237081379,0.7388724035608308,0.9509603360542637,1.0,1/20,0.35%,IGF1
prerank,organelle transport along microtubule (GO:0072384),-0.2672152743408713,-0.8292222195920911,0.7285223367697594,0.9499138845465658,1.0,9/31,22.03%,TRAK1;COPG1;NDE1;NDEL1;BICD2;ARHGAP21;FBXW11;CLN3;KIF5B
prerank,positive regulation of translational initiation (GO:0045948),0.3532725383539429,0.82856485439677,0.6939970717423133,0.9272799686336871,1.0,5/18,13.36%,UHMK1;POLR2G;POLR2D;RPS6KB1;HABP4
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.38409117544563187,0.8283693326983739,0.6618357487922706,0.927134832095647,1.0,2/13,8.22%,MGAT5;JAK2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3695055000355933,0.8282320796078282,0.674565560821485,0.9269290901649087,1.0,4/15,11.99%,NOTCH1;PRKD1;HSPB1;PRKD2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2759749061867218,0.8281630363419914,0.7368421052631579,0.9265935116111496,1.0,10/102,6.64%,CEACAM1;NR4A2;FOXO1;INSR;CAV1;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33
prerank,autophagosome maturation (GO:0097352),0.3184673358347229,0.8281060176563699,0.689280868385346,0.92623045138555,1.0,10/32,18.43%,VTI1B;GABARAPL1;TECPR1;VAMP8;VAMP7;LIX1;CHMP3;MAP1LC3A;ATG14;LAMP2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.24834579716544242,-0.827790080410939,0.7689530685920578,0.9516698685360482,1.0,16/38,27.30%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF1;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFB11;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,regulation of cell morphogenesis (GO:0022604),0.3229865641084655,0.827752732083014,0.6816901408450704,0.9263868961823464,1.0,2/30,2.08%,EFNA5;MACF1
prerank,regulation of T cell migration (GO:2000404),0.355992361704507,0.8272002857218327,0.6871165644171779,0.9269140339107773,1.0,6/18,20.48%,APP;LRCH1;CD200;PYCARD;CXCL10;CD200R1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2473506210871732,-0.82683684531229,0.75,0.9523797947820811,1.0,12/38,19.46%,PRKN;ATP5IF1;LMAN1;RNF31;UBL5;UBE2L3;SREBF1;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.38241743664805916,0.8268275560541893,0.6823529411764706,0.9271230071168459,1.0,4/13,17.53%,RHOT2;BNIP3L;BNIP3;BMF
prerank,positive regulation of type 2 immune response (GO:0002830),0.3803524917156716,0.8265323123809074,0.6716417910447762,0.9272005398464405,1.0,3/14,16.90%,NOD2;RSAD2;RARA
prerank,respiratory chain complex IV assembly (GO:0008535),-0.29193227954080203,-0.8264577751356916,0.6882352941176471,0.9520496343319302,1.0,10/21,30.01%,COX17;COX16;COX18;COX10;SMIM20;TIMM21;COA6;FASTKD3;COX14;COX19
prerank,amino acid transport (GO:0006865),0.2996384965128473,0.8263619339205863,0.7002652519893899,0.9270403806770321,1.0,5/49,9.72%,SLC6A6;SLC7A7;SH3BP4;SLC7A1;SLC6A17
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.37950501148252247,0.826180464891362,0.6579804560260586,0.9268965162953974,1.0,2/12,2.21%,ATP2B4;DAB2IP
prerank,protein lipidation (GO:0006497),-0.22459776283708338,-0.8261273947688411,0.8384279475982532,0.9515555268150434,1.0,23/59,26.50%,GPLD1;PIGA;ATG5;PIGB;PIGN;ZDHHC17;PIGH;ATG7;PGAP2;DPM2;PIGG;WIPI2;ZDHHC1;PIGP;PGAP4;PIGZ;ZDHHC8;WDR45;ZDHHC16;PORCN;PGAP3;PIGL;PIGW
prerank,piRNA metabolic process (GO:0034587),0.359987702621895,0.8253576601808695,0.6927899686520376,0.9278837463161503,1.0,3/19,18.63%,DDX4;EXD1;TDRD9
prerank,positive regulation of fat cell differentiation (GO:0045600),0.29804718509503786,0.8243638832487451,0.7057291666666666,0.9291994417491031,1.0,5/47,8.36%,SOX13;ZBTB16;ZC3H12A;CMKLR1;SYAP1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.26643308056915194,0.8239592082892173,0.7679180887372014,0.929465064112999,1.0,24/125,16.20%,EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;DYNC1LI2;NUP160;BUB1;ITGB3BP;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,regulation of lipid kinase activity (GO:0043550),-0.3438232911969629,-0.8238025811700428,0.7009803921568627,0.9549216682582871,1.0,4/11,15.46%,PIK3R1;PIK3R2;WDR81;WDR91
prerank,myelin assembly (GO:0032288),-0.3477253875160288,-0.8235638762079278,0.6955445544554455,0.954270079329516,1.0,6/10,31.03%,DICER1;EPB41L3;GPC1;TPPP;NCMAP;CNTNAP1
prerank,mitochondrial protein processing (GO:0034982),0.3948705590021353,0.8235620970892993,0.6879310344827586,0.9296478918174221,1.0,2/11,7.63%,OMA1;IMMP2L
prerank,response to purine-containing compound (GO:0014074),0.35996736608512936,0.8235577731603334,0.6806201550387597,0.9291962677941308,1.0,6/17,19.39%,P2RX7;STAT1;NDUFS4;TRPM2;P2RY1;VGF
prerank,cellular response to ATP (GO:0071318),0.3728125869196251,0.8234275326626097,0.6585760517799353,0.9289698163643481,1.0,4/14,17.03%,P2RX7;HSP90B1;P2RY1;CIB2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.26240616516198084,-0.8231819485025457,0.7482993197278912,0.9538939698046728,1.0,13/29,24.64%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.37597527107527773,0.8230627286617572,0.6639741518578353,0.9291485977778171,1.0,1/13,0.81%,MSX1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.36415814237608524,0.8227965608996928,0.6951219512195121,0.9291368519938622,1.0,1/17,1.35%,DOC2B
prerank,neuron fate commitment (GO:0048663),0.36821539966674044,0.822589547491895,0.6629570747217806,0.9290508225565262,1.0,3/14,13.79%,DLL4;POU3F2;MYT1L
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2434651170843874,-0.822094329456549,0.8122605363984674,0.9549377771653387,1.0,8/44,12.89%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;DDX3X
prerank,proton transmembrane transport (GO:1902600),0.31390761285152,0.8220214375201047,0.696969696969697,0.929554430816718,1.0,3/36,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,protein localization to organelle (GO:0033365),0.2635959331320865,0.821476743925282,0.7819634703196348,0.9300841208891035,1.0,25/133,15.39%,MSX1;GBP5;RAB11A;APP;HHEX;PACSIN2;EHD1;CSNK1D;SNX10;CEP68;LRRK2;IFT140;RAB35;RIPOR1;DHX9;PRNP;GET1;GBP2;VPS35;UBE2J2;CNEP1R1;VAPA;TUB;YBX1;ABCA7
prerank,androgen receptor signaling pathway (GO:0030521),-0.3472124984093413,-0.8211962196203291,0.6762589928057554,0.955568047253245,1.0,3/11,4.18%,DDX5;ZMIZ1;DDX17
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29266113128706994,0.8210637629174662,0.7360931435963778,0.9303315845350191,1.0,8/59,14.79%,ACSM3;CYP39A1;OSBPL1A;ELOVL4;OSBPL9;GAMT;GATM;SLC27A2
prerank,neurogenesis (GO:0022008),-0.24205256657724486,-0.8205679468392054,0.7865612648221344,0.9557004965026008,1.0,5/43,7.80%,LPAR1;TRAK1;ANXA1;SIX1;BTBD2
prerank,fatty acid oxidation (GO:0019395),0.2883157142900889,0.8204181398610297,0.7246558197747184,0.9309590659070395,1.0,17/57,22.68%,ADIPOR2;ADIPOR1;ACOX1;ACAD10;SLC27A2;ADH5;HADHB;CROT;ECI1;ACAT1;HADHA;HADH;ILVBL;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.34729576935961737,0.8200751151886525,0.6736214605067065,0.9311001940542539,1.0,5/21,18.29%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.3973384067299107,0.8198227387435767,0.687603305785124,0.9310569953844252,1.0,5/10,16.29%,HMGB1;PSMC3;PSMC5;PSMC6;ESR1
prerank,thymus development (GO:0048538),0.3741112014974854,0.819702201244406,0.6531302876480541,0.9308137340133747,1.0,1/13,1.26%,TBX1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.323820855959486,-0.8195233494326652,0.7227979274611399,0.9565785437610983,1.0,6/14,20.35%,DPYD;NT5M;NT5E;UPB1;DHODH;NT5C1A
prerank,regulation of cholesterol transport (GO:0032374),0.34525167685834934,0.8194340453728708,0.6799387442572741,0.9308397213315418,1.0,4/20,8.90%,APOA1;ABCB4;NUS1;TSPO
prerank,negative regulation of insulin secretion (GO:0046676),0.354125115788443,0.8192387419339722,0.6809160305343511,0.9307242479852798,1.0,4/17,11.92%,KLF7;SIRT4;PIM3;CHGA
prerank,protein autoubiquitination (GO:0051865),0.2841643646322452,0.8186845068504122,0.7076537013801757,0.9312392883751679,1.0,14/61,15.90%,ASB4;RNF185;CUL3;UBE3A;RNF141;RNF115;TRIM17;OBI1;BRCA1;DTX3L;UBE2T;RAD18;UBE2D3;KLHL24
prerank,autophagy of mitochondrion (GO:0000422),-0.250695184062489,-0.818307643465489,0.7937743190661478,0.9577978018645513,1.0,14/38,22.24%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;PHB2;WDR45;BECN1
prerank,chromatin remodeling (GO:0006338),-0.20545081521187453,-0.8181205175919931,0.8712121212121212,0.9570537480477328,1.0,20/100,14.55%,CHD4;TADA2A;JARID2;BAZ1B;KAT2B;BRDT;SMARCB1;RSF1;ARID1B;DR1;SMARCD1;SMARCA5;HDAC4;HDAC1;TAF6L;HMGA2;BPTF;KDM4A;MTA2;PIH1D1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3475573605211618,-0.8180524494506386,0.6936708860759494,0.9560621591296626,1.0,5/11,12.81%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,fatty acid biosynthetic process (GO:0006633),0.29110634831102405,0.8177548173893214,0.7369727047146402,0.9323904027084763,1.0,11/63,19.38%,ACSM3;ASAH2;ACSBG1;ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;ABHD2;DECR2;HACD2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3950794540641618,0.8174698288479214,0.6905594405594405,0.9324135676303066,1.0,2/11,4.13%,ARL6IP5;STK24
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.31475438778012593,0.8174615026852121,0.7117241379310345,0.9319698440036152,1.0,4/37,7.01%,GBP5;NOD2;PDCD4;ZC3H12A
prerank,establishment of protein localization to membrane (GO:0090150),0.28231715360332804,0.8174111387289977,0.7351485148514851,0.9315983464819222,1.0,8/66,11.07%,RAB11A;AQP11;ZDHHC22;NACAD;RAB3GAP2;MYO1C;TAOK2;REEP1
prerank,steroid biosynthetic process (GO:0006694),-0.22748649456915682,-0.8172368295060328,0.8354978354978355,0.9564545779365415,1.0,19/56,31.06%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE;CYP51A1;STAR;SC5D;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP46A1;PMVK;HSD3B7;EBP
prerank,chloride transmembrane transport (GO:1902476),0.29911853465788923,0.8171904890078489,0.7126137841352406,0.9315361587801244,1.0,12/48,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;GABRB1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3258571270538991,0.8169506228637741,0.7256011315417256,0.9314969425903423,1.0,17/32,27.96%,ITGA1;PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R15B;DUSP26;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3352553636487984,0.8169219977801114,0.7049180327868853,0.9310973506200718,1.0,6/21,14.45%,HNF1A;SETX;JUN;MED30;MED17;MED4
prerank,organic substance transport (GO:0071702),0.2652055393888579,0.816347673996501,0.7900232018561485,0.9316460130812871,1.0,15/121,10.45%,RHCG;ARL6IP5;PPT1;APOA1;SPNS2;PLTP;MYH9;ARRDC1;HSP90B1;SLC6A4;CHMP1B;TAP1;SLC6A2;ABCG4;SLC22A5
prerank,regulation of peptidase activity (GO:0052547),0.35250256352752457,0.8162626086627295,0.6942277691107644,0.9313178566729605,1.0,5/19,20.46%,CAV1;FURIN;PSMB8;CST3;CTSH
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.297631539383271,0.8160999048234101,0.7243675099866844,0.9311461042817933,1.0,13/48,19.74%,NPR2;SLC25A16;ADCY10;NPR1;SLC35B3;ADCY4;NPPC;PAPSS1;PANK3;PPCS;ACAT1;ADSL;GUCY1A1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3381310776253653,-0.816044199690028,0.6901408450704225,0.9576638411926792,1.0,3/11,10.83%,KAT2B;RBM14;MDM1
prerank,neural tube closure (GO:0001843),-0.25589972800686506,-0.8157991665625712,0.7857142857142857,0.956997239624508,1.0,10/34,22.73%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,response to insulin (GO:0032868),0.2828704753639404,0.8156632971821604,0.7490820073439413,0.9314395576523395,1.0,9/80,8.36%,CEACAM1;FOXO1;INSR;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33;SYAP1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33030572510017486,0.8156222185757639,0.6934749620637329,0.9310628212802992,1.0,7/26,23.29%,DUSP1;CUL3;CDC27;ANAPC7;ANAPC4;LCMT1;ANAPC11
prerank,regulation of catabolic process (GO:0009894),-0.29228371492470673,-0.815580055419143,0.735632183908046,0.9562941820642827,1.0,13/18,36.96%,FAP;ODC1;MDM2;HPGD;SNF8;RARRES2;CENATAC;TMEM9;ZDHHC2;CHMP6;FAF1;FAM83D;HGS
prerank,metal ion homeostasis (GO:0055065),0.30527218447287824,0.8152922087509474,0.7099863201094391,0.9311530215710088,1.0,7/40,17.03%,CAV1;SLC8A1;SLC12A8;TESMIN;KCNA1;ANK3;CIB2
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.34457163595417517,-0.815136172940137,0.6919431279620853,0.9560348156057701,1.0,3/10,12.81%,APOD;RIPOR2;PADI2
prerank,epiboly involved in wound healing (GO:0090505),0.36016241299757423,0.815136091474855,0.6916932907348243,0.9309618412633481,1.0,4/16,15.45%,CEACAM1;MRTFA;LCP1;PDCD10
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.36190860253970764,0.8150126101942694,0.6959349593495935,0.9307123357692053,1.0,6/15,24.79%,SRP14;RAB3GAP2;SRPRA;ZFAND2A;RYR2;SPCS2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.28826525414139087,-0.8149872267034822,0.7616279069767442,0.9552330246168695,1.0,3/19,15.67%,APOE;RIC3;CHRNB1
prerank,signal release from synapse (GO:0099643),0.2995985921112767,0.8146593528492025,0.7270233196159122,0.930856597874161,1.0,14/43,26.91%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,Golgi organization (GO:0007030),0.2641470278379826,0.813687335815853,0.773972602739726,0.9320137716913771,1.0,25/112,20.01%,SYNE1;PLK3;TRAPPC8;PRKD1;ATL2;VTI1B;CSNK1D;TMED10;CLASP1;LRRK2;CLASP2;VRK1;TMED9;ATP8B1;USP6NL;TMED4;PDCD10;PLEKHM2;VTI1A;GOLPH3L;GOLPH3;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.36316980998645093,0.8136522726128397,0.6847826086956522,0.9316091398215642,1.0,10/16,27.33%,MAD2L2;DTX3L;KDM4D;RIF1;SHLD3;SHLD2;WRAP53;SHLD1;PARP9;SMCHD1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.31621623088366446,-0.8135793341645318,0.7318435754189944,0.9567485735279082,1.0,8/16,25.07%,SIK3;KLHL22;FLCN;PIH1D1;TELO2;GPR137;LAMTOR5;RRAGB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4024530847614022,0.813416628811886,0.6826446280991736,0.9310820238055971,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,calcineurin-mediated signaling (GO:0097720),0.4024530847614022,0.813416628811886,0.6826446280991736,0.9310820238055971,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,natural killer cell activation (GO:0030101),0.3423069756563816,0.8128317830852552,0.7076023391812866,0.9316301859838558,1.0,4/23,16.30%,CASP8;BAG6;KAT7;NFIL3
prerank,histone monoubiquitination (GO:0010390),-0.2697018498732433,-0.8126634153636296,0.7788461538461539,0.957469665048782,1.0,7/24,16.42%,DDB2;CUL4B;PAF1;CTR9;ATXN7L3;BCOR;WAC
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3134856254670701,-0.8118662671554874,0.7154929577464789,0.9578790753431277,1.0,4/14,12.30%,PRKN;TXNDC12;CREB3L1;CREB3
prerank,photoperiodism (GO:0009648),-0.2634675989944498,-0.811557024145887,0.7849829351535836,0.9573918459356947,1.0,13/28,36.84%,CLOCK;CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3594945624814565,0.8112045494122293,0.6726094003241491,0.9339845157109211,1.0,7/17,28.88%,RHBDD1;HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,embryonic appendage morphogenesis (GO:0035113),0.38430676456402235,0.8111964529849209,0.6935749588138386,0.9335418764415178,1.0,2/12,4.60%,TGFB2;MBNL1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.341931389076231,0.810966847351525,0.7073170731707317,0.9335148640741734,1.0,4/20,14.77%,TNRC6C;CNOT1;AGO4;EIF6
prerank,cardiolipin metabolic process (GO:0032048),0.37176800283624833,0.8108813939909248,0.6896551724137931,0.9332154915861344,1.0,5/13,19.20%,CRLS1;LCLAT1;HADHB;HADHA;PLSCR3
prerank,regulation of myelination (GO:0031641),-0.265844270739451,-0.8108581885943265,0.7398119122257053,0.9575465275769642,1.0,3/25,4.46%,PTN;DICER1;PARD3
prerank,positive regulation of glycolytic process (GO:0045821),0.34418117351583505,0.8107191238772071,0.7022222222222222,0.9325929702781783,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.34418117351583505,0.8107191238772071,0.7022222222222222,0.9325929702781783,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,necroptotic process (GO:0070266),0.3616650402276784,0.8106824888369882,0.6710097719869706,0.9322023398507168,1.0,2/16,9.55%,TLR3;MLKL
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.28692509041009284,-0.8101970071455465,0.7362637362637363,0.9576964249807576,1.0,3/18,9.75%,DLG4;NLGN2;PRKCZ
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3378760315347484,0.8101717973914636,0.6921898928024502,0.9325862920433723,1.0,6/21,16.84%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1
prerank,synaptic vesicle transport (GO:0048489),-0.334001165442187,-0.8095979804569575,0.7135802469135802,0.9577209899812739,1.0,5/11,23.83%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,potassium ion transport (GO:0006813),0.2665851781064291,0.8091496303552363,0.7782909930715936,0.9338623338673263,1.0,6/120,3.68%,KCNN4;KCNQ1;KCNH8;ATP1A4;KCNN3;KCNG3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3181422269545571,-0.8089734620800272,0.721763085399449,0.9577731195627143,1.0,5/15,11.63%,DAB2;BMP2K;AAK1;SNAP91;DGKD
prerank,brain development (GO:0007420),0.2591258193110284,0.8085731875859825,0.7948139797068771,0.9343818903092259,1.0,29/136,18.42%,RAPGEF2;SHROOM4;EML1;PPT1;DHX37;AMIGO2;SHANK3;UFM1;MAST1;SLC6A4;NDUFS4;GRIN2B;UBE3A;GRIN2C;SLC6A17;CDH2;BAG6;SOX6;CTNNA2;CX3CR1;ATXN1;CXCR4;NES;MEIS2;ADGRG1;GRIN2A;SYNJ1;NCOA6;HAP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.22414035076905672,-0.8085580008008972,0.8450704225352113,0.9574068773077109,1.0,6/57,8.97%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3465897301187699,0.8084398924282887,0.7255813953488373,0.9341450773516562,1.0,8/22,21.58%,IFNGR1;EFNA1;RANBP9;CLU;GSK3A;RELA;AGER;EPHA4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.30187403706648874,-0.8080537953923738,0.736,0.9572476030618399,1.0,4/17,12.14%,EMC2;EMC7;EMC1;GET4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.33946038947138224,-0.8080161681264141,0.7421686746987952,0.9562199617026477,1.0,3/11,22.83%,PARP8;PARP3;PARP6
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3559178436393238,0.8075557244522182,0.7012779552715654,0.9351791295916685,1.0,5/16,24.47%,SSBP1;PURA;BLM;WRN;MCMDC2
prerank,rRNA methylation (GO:0031167),0.33358763066117086,0.8075168239261523,0.7029850746268657,0.9347903470632546,1.0,9/22,22.51%,MRM2;METTL5;FBLL1;TFB2M;NSUN5;MRM3;FTSJ3;NSUN4;FBL
prerank,acylglycerol metabolic process (GO:0006639),0.30698474472150544,0.8071787932846067,0.7134986225895317,0.9348998819450912,1.0,12/37,22.82%,CAV1;ABHD6;DGKH;APOH;DGKI;GK5;ABHD2;SEL1L;PLAAT3;DGKA;PNPLA2;MGLL
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32633317564694003,0.8070998117757298,0.6971935007385525,0.9345881797473202,1.0,10/27,23.94%,FBXO7;FCGR2B;CCDC88A;VPS35;CTNNA2;EFHC2;GSK3A;GSK3B;IL1RAPL1;BRSK2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3440926628589961,0.8070322079564279,0.7098765432098766,0.9342640234747392,1.0,7/20,19.44%,FKBP4;FKBP1A;PPIE;PIN1;PPIH;PPID;PPIF
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2782710937946168,-0.8069589955647452,0.7365269461077845,0.957044522032724,1.0,10/24,23.19%,APOE;ATP5IF1;PRKACA;PKD1;CTSC;NUB1;LATS1;RHBDF1;GPX1;PSME1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28551864045713055,0.8068800594998861,0.7626262626262627,0.9340774796877755,1.0,21/58,25.41%,HERC2;HMGB1;BABAM2;POLA1;POLB;PSMD14;BRCA1;ERCC4;ATM;HMGB2;KDM2A;BARD1;NSD2;MDC1;RIF1;CYREN;XRCC4;PAXIP1;NHEJ1;UVRAG;BABAM1
prerank,regulation of receptor recycling (GO:0001919),-0.3070086125342671,-0.8068583066035363,0.7357512953367875,0.9561150235180406,1.0,3/16,9.50%,ANXA2;OPTN;TBC1D16
prerank,central nervous system development (GO:0007417),0.24614839560705729,0.8063098227976624,0.856694560669456,0.93457630078874,1.0,65/250,21.97%,SHROOM4;RNF103;SLC2A1;NR4A2;EML1;SERPINI1;PPT1;LSR;SNTG2;DHX37;AMIGO2;SH3GL1;UFM1;MAST1;ZBTB16;ITGAM;WWP1;NRCAM;NDUFS4;GRIN2B;NCKAP1;MAL;UBE3A;GRIN2C;EIF2B2;ASIC2;SLC6A17;CDH2;BAG6;SPOCK1;NCAN;SOX10;SOX6;CX3CR1;RPS6KA3;CYP26C1;CAPG;ADGRA2;ATXN1;CXCR4;NES;GRIK1;MEIS2;ADGRG1;SOX12;GRIN2A;SYNJ1;NPTX1;TBX6;NCOA6;HAP1;SOX11;ELP3;FOXJ1;POU3F3;DCX;CNTN4;EEF1AKMT4-ECE2;CNTN6;CIC;CDK5RAP1;SMG9;BCAN;BTD;ATP6AP2
prerank,regulation of vacuole organization (GO:0044088),-0.28352756869893725,-0.8057001658089252,0.7666666666666667,0.9571945970158717,1.0,8/20,27.90%,ANXA2;ENO2;ADPRH;IFT20;IFT88;ENO3;NPRL2;MTM1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.31131089646945015,0.805410494038926,0.7301136363636364,0.9356277163853307,1.0,4/37,7.97%,MSX1;CAV1;BBC3;BCL2L1
prerank,glial cell differentiation (GO:0010001),-0.26602175791014326,-0.8048188060504355,0.7565217391304347,0.9577215009706087,1.0,9/28,21.91%,ADGRG6;SLC8A3;NFIB;GPC1;PICK1;SOX2;PAX2;TPPP;CDK5
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3725391765956217,0.8044407674585532,0.689935064935065,0.936850472624831,1.0,4/13,13.18%,NFKBIE;GOPC;NFKBIA;KEAP1
prerank,glycine metabolic process (GO:0006544),0.37373722654123465,0.8040770471321761,0.6815181518151815,0.9370066065745096,1.0,2/12,14.38%,GLYAT;DLD
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3209417089378681,0.803888485712537,0.7075606276747504,0.9368676186942061,1.0,5/29,8.46%,IFNAR1;SOCS6;STAT1;JAK2;NMI
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3504335193893854,-0.803498599336845,0.7172236503856041,0.959013577551753,1.0,4/10,16.44%,PTPRS;PPM1B;RELB;NLRC3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3055819810444025,-0.8034179719490635,0.7580174927113703,0.9580641883004406,1.0,3/17,7.03%,PDGFRB;MAGI2;CALM2
prerank,positive regulation of cellular respiration (GO:1901857),-0.33485622511005525,-0.8032784106172453,0.6940298507462687,0.9572108876827582,1.0,1/11,1.83%,NUPR1
prerank,oxoacid metabolic process (GO:0043436),0.3324273506510882,0.8030775495658394,0.7292263610315186,0.9378166504316992,1.0,5/27,11.49%,MINPP1;SULT6B1;LIPT2;LIPT1;BPNT1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2881039757154311,0.8025916526443607,0.7452471482889734,0.9381749050116821,1.0,9/59,10.93%,DAB2IP;TLR3;IRAK2;NFKBIL1;UBA52;RPS27A;ROCK1;NFKBIA;TAB2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.37601618177355844,0.8019339834900489,0.7163461538461539,0.9388371296114246,1.0,1/13,0.88%,PDGFB
prerank,cell chemotaxis (GO:0060326),0.2841831349428733,0.8017027165346371,0.7537878787878788,0.9387888280201804,1.0,5/60,5.26%,PDGFB;CCR1;EGR3;LEF1;PLEKHG5
prerank,positive regulation of ATPase activity (GO:0032781),0.2989756422884087,0.8011789434358109,0.7353723404255319,0.9391958742017462,1.0,11/41,19.72%,MYBPC3;SSBP1;PLSCR1;DHX9;DYNLL1;CHTOP;AHSA1;TOR1AIP2;DYNLL2;DNAJC10;DNAL4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.32330639332484934,0.8010703156094912,0.72,0.9389099062378604,1.0,7/23,17.42%,CAV1;CBL;HYAL2;GPRC5A;DUSP22;SH3BP5L;SOCS5
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29986817345154065,0.8005319047418399,0.725201072386059,0.9393233286471174,1.0,7/39,13.00%,UTRN;CHRM3;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.39236327275669014,0.8004038831986922,0.7412587412587412,0.9390765576131914,1.0,3/10,15.85%,F2RL1;WDR1;VIL1
prerank,cellular response to lipid (GO:0071396),0.25081059961027885,0.8003450819616407,0.8347732181425486,0.9387170253717603,1.0,27/191,10.37%,TBX1;NOD2;ATP1A1;ATP1A3;DAB2IP;VIM;FES;DEFA6;ADAM15;MSN;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;NFKBIL1;SETX;IRGM;ZC3H12A;NR1D1;ACOD1;NCOA4;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,modulation by host of symbiont process (GO:0051851),0.3165799008052212,0.799532393709197,0.7184325108853411,0.9396162854907965,1.0,7/31,15.42%,SAP30;INPP5K;LEF1;JUN;CCL4;CX3CR1;TAF11
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.339083382764126,0.7992862105784616,0.7007633587786259,0.9395852898347825,1.0,12/20,31.26%,PFDN6;PTGES3;CCT2;CLU;PSMG2;HOPX;MKKS;HSP90AA1;HSP90AB1;HSPA1A;TMEM35A;LONP1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.349639011200773,0.7991676658810087,0.7001594896331739,0.9393325435638462,1.0,9/17,22.31%,MBTPS2;KPNB1;PRKAA1;SEC14L2;LPCAT3;RAN;ERLIN2;SREBF2;SOD1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3066900662566897,-0.7990412984151803,0.772020725388601,0.9636033241956969,1.0,7/16,18.05%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,inner mitochondrial membrane organization (GO:0007007),-0.23203915434242237,-0.7989145813874474,0.796,0.9627380688429086,1.0,21/47,27.60%,MICOS10;ATP5PD;NDUFA13;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;MICOS13;ATP5MG;MTX3;ATP5F1D;MTX1;MTX2;ROMO1;TIMM29;IMMT;SPG7;APOO;ATP5F1E;OPA1;ATP5MC3
prerank,ganglion development (GO:0061548),-0.33518020521379377,-0.798547495256043,0.7034120734908137,0.962298245099954,1.0,2/11,5.38%,NRP2;SEMA3A
prerank,regulation of chemotaxis (GO:0050920),0.32089247726909004,0.7980773863402038,0.7450142450142451,0.9406521754514495,1.0,8/30,14.74%,PDGFB;F2RL1;PPM1F;DUSP3;ZSWIM6;ZSWIM4;ADGRA2;CXCR4
prerank,cell junction maintenance (GO:0034331),0.359577211281574,0.7973677598061544,0.7205651491365777,0.9413612319649137,1.0,1/14,2.44%,F2RL1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2537201030235444,0.7973146688576237,0.8262806236080178,0.9410021243900575,1.0,38/146,21.23%,RAB11A;PSMD13;TUBB;CSNK1D;CDC25C;TUBB4B;PSMD4;CLASP1;NEDD1;CEP135;HAUS3;PCM1;PSMA5;RBX1;PSMB10;DYNLL1;CEP76;PSMB8;PSMD14;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;KCNH5;PSMD5;PSMD9;PSMB6;ACTR1A;CEP192;PSMB2;DYNC1I2;USP47
prerank,regulation of synapse assembly (GO:0051963),-0.23317502623277941,-0.7968164952726895,0.8842975206611571,0.9642223609020162,1.0,13/46,20.71%,GPC6;NLGN2;CLSTN2;SLITRK1;MDGA1;SRPX2;EPHB2;EPHB3;PTPRD;GPC4;LHFPL4;CUX2;IL1RAPL2
prerank,response to organophosphorus (GO:0046683),0.34860233186681416,0.7966672834308587,0.7398496240601504,0.9416001427446274,1.0,3/16,8.30%,P2RX7;STAT1;NDUFS4
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.2929579944634996,-0.7963125372483203,0.7657430730478589,0.9640132154983128,1.0,7/17,18.05%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,neurotransmitter secretion (GO:0007269),0.290792631519254,0.7962917477589998,0.75,0.941747325711652,1.0,14/44,26.91%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3358745752097772,0.7961856534035524,0.7166921898928025,0.9414811769192277,1.0,6/21,19.95%,FCGR2B;DUSP3;LAPTM5;SOX11;BANK1;FOXJ1
prerank,protein-DNA complex assembly (GO:0065004),0.2625931174060495,0.7960068499426786,0.8128587830080367,0.9413340422809019,1.0,36/116,21.60%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;ASF1A;PSMB8;NPM1;PSMD14;GTF2H3;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;ANP32B;HMGB2;PSMC5;XPC;PSMB9;PSMC6;DAXX;PSMA4;PSMD5;PSMD9;H3-3A;NAP1L4;PSMB6;PSMB2;MNAT1;NAP1L3;UBB
prerank,cell differentiation in hindbrain (GO:0021533),0.37218098983076137,0.7957575436388918,0.6956521739130435,0.9412960613081935,1.0,3/11,19.60%,ATP7A;OPHN1;GRID2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.38482256082280153,0.7957477636280067,0.6868852459016394,0.9408648877387124,1.0,4/10,20.71%,HSPA1B;DNAJB6;DNAJB8;SORL1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3876039296330908,0.7955246821653834,0.7171717171717171,0.9408019965829485,1.0,3/11,13.08%,PUM2;DHX9;FXR1
prerank,ERBB2 signaling pathway (GO:0038128),-0.24886927713711535,-0.7954686945013234,0.8071895424836601,0.9643632994312569,1.0,9/31,17.08%,EGFR;SHC1;PIK3R1;SRC;PRKCA;ERBB2;HBEGF;GAB1;STUB1
prerank,peptidyl-lysine methylation (GO:0018022),-0.26057044660746354,-0.795427903627033,0.7707006369426752,0.9633481538907582,1.0,16/26,35.02%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2;ANTKMT;KMT5A;TRMT112;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,centromere complex assembly (GO:0034508),-0.24216248972039198,-0.7952299907792432,0.8061224489795918,0.9626308170455478,1.0,18/36,31.92%,RSF1;CENPC;SMARCA5;RBBP7;MIS12;CENPK;CENPQ;MIS18BP1;KNL1;CENPE;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPF;CENPA
prerank,engulfment of apoptotic cell (GO:0043652),0.3597362647751924,0.7950425597102264,0.7138157894736842,0.9411402441335057,1.0,4/15,13.75%,XKR6;ADGRB1;RAC1;RHOH
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.329087118706887,0.7947024417927455,0.7329286798179059,0.941273131545756,1.0,8/22,24.24%,RPS21;EXOSC3;EXOSC8;EXOSC9;FTSJ3;EXOSC10;URB1;UTP20
prerank,mitotic spindle organization (GO:0007052),0.2530763829350935,0.7942897848940876,0.8220994475138121,0.9415160960949124,1.0,28/153,16.20%,RAB11A;EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;STAG1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;PRC1;DYNC1LI2;NUP160;BUB1;ITGB3BP;ARHGEF10;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.26127440491864595,-0.7942883386154882,0.7955271565495208,0.963193212562687,1.0,9/31,23.32%,GOLGA2;UBE2N;DCUN1D3;UBE2L3;CDC14B;TOPORS;DCUN1D4;FZR1;BTRC
prerank,negative regulation of DNA replication (GO:0008156),0.36055797074101553,0.7941841896679965,0.7032258064516129,0.9412491382990491,1.0,2/13,10.41%,GMNC;CDAN1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.23595739090455153,-0.7941454750148889,0.8223140495867769,0.9623620814886847,1.0,7/44,16.15%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2038322569252533,-0.7940526576005049,0.9305555555555556,0.9614540473832419,1.0,44/95,32.09%,NUCKS1;RAD51B;SMC6;ZFYVE26;NIPBL;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;CDC7;POLN;RFWD3;RPA3;RECQL;RAD54L;FANCB;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;CDC45;RAD51AP2;ZSWIM7;NSMCE2;NABP2;XRCC3;FANCM;AP5S1;MCM7;SLX4;MORF4L1;MCM5;POLL;MCM2
prerank,secondary alcohol metabolic process (GO:1902652),-0.23551811502236064,-0.7934697293702295,0.8609022556390977,0.9613703284322714,1.0,9/42,16.35%,CYP27A1;APOE;ABCA1;IDH2;FDX1;IDH1;GBA2;SQLE;SCAP
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.34830637850135693,0.7931902444290676,0.7072419106317411,0.9424634570648018,1.0,2/17,6.77%,LPCAT4;CRLS1
prerank,positive regulation of B cell activation (GO:0050871),0.28848350382634036,0.7929656842591528,0.7542262678803641,0.9423850227431814,1.0,7/50,12.62%,NOD2;SH3KBP1;TIRAP;MEF2C;MAD2L2;CD38;BTK
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.33319952507506023,0.7928371432247351,0.7095761381475667,0.9421595216367834,1.0,5/21,12.73%,FCGR2B;FOXP1;STAP1;ELF2;CBFB
prerank,P-body assembly (GO:0033962),-0.3216161130062998,-0.7925209164961533,0.735,0.9619025557074016,1.0,2/12,7.56%,LIMD1;ATXN2
prerank,DNA geometric change (GO:0032392),-0.2655808660733852,-0.7924195803235794,0.7863501483679525,0.9609797866776403,1.0,8/24,21.03%,HNRNPA2B1;ANXA1;RAD50;DDX1;SUPV3L1;RTEL1;RECQL;ZRANB3
prerank,protein acetylation (GO:0006473),0.3190505434329451,0.7918851308142154,0.7090395480225988,0.9432853632368624,1.0,2/30,2.79%,FOXO1;NAT9
prerank,DNA conformation change (GO:0071103),0.34319314264908596,0.7918761317766098,0.7154471544715447,0.942852882575045,1.0,3/17,14.54%,HHEX;HMGB1;HMGB2
prerank,striated muscle cell differentiation (GO:0051146),0.35472847349402103,0.7917428360059403,0.7106518282988871,0.9426245900302112,1.0,5/16,19.74%,MEF2C;MYEF2;POPDC3;SKI;SORT1
prerank,monosaccharide transmembrane transport (GO:0015749),0.34707908194625736,0.7914174867662704,0.7540983606557377,0.9427253889645172,1.0,2/16,8.42%,SLC5A10;SLC2A9
prerank,erythrocyte development (GO:0048821),0.39070971110859576,0.7912786459485054,0.71499176276771,0.9425045926687965,1.0,1/10,6.79%,ALAS1
prerank,integrated stress response signaling (GO:0140467),0.3599939004852227,0.7912230182811982,0.7285714285714285,0.9421497902564662,1.0,6/14,26.28%,OMA1;NFE2L2;EIF2S1;EIF2AK1;DDIT3;HERPUD1
prerank,positive regulation of catabolic process (GO:0009896),0.2764569201714625,0.790268861874537,0.7675,0.9432397400359386,1.0,15/65,20.91%,FOXO1;DAB2IP;WWP1;ASB5;APC;VPS28;VSIR;NEDD4L;SMURF1;NSF;GSK3A;BARD1;GSK3B;SORL1;WWP2
prerank,ncRNA metabolic process (GO:0034660),0.30384485236600495,0.7901141442506479,0.7559274755927475,0.9430387185667675,1.0,7/37,18.63%,DTD2;DDX4;RAN;DROSHA;EXD1;TUT7;TDRD9
prerank,cellular response to DNA damage stimulus (GO:0006974),0.24037258166812606,0.7900776608861861,0.8990731204943357,0.9426490996830847,1.0,68/336,19.51%,ACER2;PLK3;FOXO1;HERC2;BTG2;UBA7;RBBP8;CASP2;BRAT1;TNFRSF1B;APEX1;SIRT4;SETX;ENDOV;ZC3H12A;AATF;CIDEB;POLK;BCL2L1;APC;FEN1;ZBTB40;FOXP1;TAOK2;NSMCE3;BABAM2;SPIDR;ASF1A;POLA1;POLB;ALKBH8;NPM1;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;UBE2T;STK33;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;TRAIP;SPRTN;CBX1;FBXO6;MAPK14;MEN1;MMS19;UBQLN4;NCOA6;ATRIP;CDKN2AIP;XIAP;CRY1;BID;FBXO45;BARD1;HUS1;MCL1
prerank,positive regulation of dephosphorylation (GO:0035306),0.32085476510513344,0.7899221052022476,0.7205240174672489,0.9424293418475367,1.0,14/27,27.96%,PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R7;CDH5;NSMF;TGFB1;CALM1;SYMPK;MTMR9;SPPL3;SMPD1
prerank,positive regulation of telomere capping (GO:1904355),0.3429024401735744,0.7895428517240333,0.7158218125960062,0.9426042873221093,1.0,3/17,10.95%,MAPK1;NEK7;TNKS
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.26685542916085453,-0.7892298712132386,0.8,0.9653587186146576,1.0,5/24,15.07%,LPGAT1;PLA2G4A;SLC27A1;PGS1;PLA2G15
prerank,sympathetic nervous system development (GO:0048485),0.3578574035288281,0.7891950230852839,0.734789391575663,0.9427157477376421,1.0,5/15,19.00%,SEMA3F;GATA3;CTNNB1;FZD3;SOX11
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34040367756272716,0.7888159777876258,0.7600644122383253,0.9428961462645077,1.0,7/18,19.75%,CAV1;CAMK2D;STK39;NEDD4L;EPO;PPIF;CAB39
prerank,response to metal ion (GO:0010038),0.2764040463101852,0.7884952746244359,0.7898009950248757,0.9429762129157734,1.0,12/67,14.97%,ITPR3;CAV1;GPHN;IL1A;PPP3CA;MT2A;PLSCR1;NEDD4L;TESMIN;CALM3;HIF1A;PPP2CB
prerank,positive regulation of rRNA processing (GO:2000234),-0.34061867206108737,-0.7881751513463903,0.7310344827586207,0.9659855942066895,1.0,5/10,33.89%,BUD23;RIOK2;TRMT112;DIMT1;HEATR1
prerank,microtubule-based transport (GO:0099111),0.372304960087902,0.788101749005019,0.7211221122112211,0.9431874542697802,1.0,3/13,21.10%,ADCY10;SPA17;DYNC1I2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2745262367746022,-0.7875871417299324,0.801829268292683,0.9658340786896059,1.0,10/25,20.16%,SLIT2;ARHGAP24;CAPZB;ODF2L;CEP97;CCP110;CDK10;PFN2;PRKCD;TESK1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.33307258933218864,0.7875527174789982,0.7205438066465257,0.9436139516792944,1.0,5/19,14.99%,EXT1;HS3ST5;EXTL3;NDST4;GLCE
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.35631565105473095,0.7872665497162306,0.6964586846543002,0.9436193892488112,1.0,6/13,30.41%,NAMPT;PTGIS;NAXE;PARP9;NUDT12;PARP16
prerank,negative regulation of innate immune response (GO:0045824),0.3044396719800258,0.7871453298971182,0.7523680649526387,0.9433354269726427,1.0,12/34,24.80%,SUSD4;NLRC5;NMI;ACOD1;CACTIN;FAM3A;PTPN2;DHX58;RPS19;A2M;GRN;TTLL12
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.20799424517400725,-0.7870756523457462,0.8947368421052632,0.9656828991271056,1.0,23/68,23.81%,SCAF8;NUDT21;NCBP1;TAF1D;SMN1;PABPN1;SNRPF;TTF1;ERCC2;CSTF2T;PCF11;GTF2H5;UBTF;GTF2H1;SNRPD3;LSM11;SLBP;GTF2H4;POLR1A;POLR1H;NCBP2;PAPOLA;LSM10
prerank,cellular glucose homeostasis (GO:0001678),0.2999950625604339,0.7864377068655939,0.7686170212765957,0.9439974398571666,1.0,5/41,8.68%,UNC13B;FOXO1;PCK2;PRKAA1;NR1D1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3758134586092243,0.7863954741253164,0.7197986577181208,0.9436179893817915,1.0,4/11,19.49%,MAPK1;LRRK2;CHMP3;MAP2K1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3386533952833035,0.7862805679405837,0.7158218125960062,0.9433602224586309,1.0,5/17,22.31%,HSPB1;NFE2L2;NOL3;NME5;SOD1
prerank,mitochondrial membrane organization (GO:0007006),-0.24405202500059386,-0.7862695080949702,0.839041095890411,0.9659491008595011,1.0,14/32,29.08%,BCL2;MICOS10;SLC25A4;RCC1L;MICOS13;MTX3;MTX1;MTX2;IMMT;SPG7;APOO;OPA1;BAD;TIMM50
prerank,positive regulation of leukocyte migration (GO:0002687),0.3214705669453824,0.7862613254334105,0.7399425287356322,0.9429427561604337,1.0,3/27,6.32%,F2RL1;TNFRSF18;ADAM17
prerank,negative regulation of cellular protein localization (GO:1903828),0.30134136976842063,0.785929724993475,0.7471910112359551,0.9430300975342979,1.0,7/34,10.96%,GOPC;TTBK2;ANKRD13A;MFHAS1;CTNNA1;TAX1BP3;NEDD4L
prerank,response to UV-A (GO:0070141),-0.30587361692862086,-0.785404297425134,0.7362637362637363,0.9662702583329263,1.0,2/14,7.62%,EGFR;MMP2
prerank,superoxide anion generation (GO:0042554),0.3593805797066476,0.7845209519486709,0.7026143790849673,0.9448521682972583,1.0,3/13,14.82%,TAFA4;CYBA;NCF2
prerank,positive regulation of TOR signaling (GO:0032008),0.2938569738877387,0.784062946894565,0.7925824175824175,0.94514878441001,1.0,22/40,28.69%,GPR137B;SMCR8;WDR59;RRAGD;RHEB;RICTOR;MIOS;GPR137C;GOLPH3;RRAGA;HTR6;RRAGC;LAMTOR3;WDR24;PIK3CA;SEH1L;MLST8;RPTOR;LAMTOR4;CLEC16A;SLC38A9;LAMTOR1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.27172676352362546,-0.784049462180297,0.7724550898203593,0.9673322618115535,1.0,10/22,24.98%,NFU1;NFS1;CIAPIN1;FXN;CIAO3;NDOR1;CIAO1;CIAO2A;NUBP1;LYRM4
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3100311133448361,0.7837700216358331,0.7142857142857143,0.9451634858030454,1.0,4/28,5.58%,FAM107A;APP;AKAP5;SHANK3
prerank,regulation of protein kinase C signaling (GO:0090036),0.3591428972821905,0.7834473448056819,0.7317829457364341,0.94524819217115,1.0,1/14,1.01%,FLT4
prerank,regulation of response to stress (GO:0080134),0.37561986064904906,0.7831408357283582,0.7235772357723578,0.9452933032116301,1.0,10/10,62.46%,EIF4G1;ADCY8;MLC1;OPRM1;STOX1;IL10;SLC38A2;CRHBP;DYRK3;CORO2B
prerank,histone H3-K9 demethylation (GO:0033169),-0.3225727271091796,-0.7829965565141374,0.7387862796833773,0.9679485443698705,1.0,4/11,20.13%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3280309261019434,-0.782887154965734,0.75,0.9670335890637599,1.0,4/11,18.61%,DAB2;PRKN;PTPN23;EZR
prerank,regulation of monocyte differentiation (GO:0045655),0.35342512704825846,0.7825644627638222,0.7512437810945274,0.9457638011318165,1.0,3/14,9.10%,FES;CTNNBIP1;FOXP1
prerank,positive regulation of macroautophagy (GO:0016239),0.2847548112159149,0.78217524591992,0.7792378449408672,0.9459346751483798,1.0,12/48,15.80%,ADRB2;SPTLC2;SPTLC1;SMCR8;IRGM;FYCO1;RAB3GAP2;VPS13D;BNIP3L;BNIP3;EPM2A;VDAC1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2823604072616151,0.7820977197667209,0.7655259822560203,0.9456080937272789,1.0,19/54,26.14%,BOP1;RPL7;PAK1IP1;NVL;MRPL1;RRP15;NPM1;NHP2;RPL23A;EIF6;LAS1L;RSL24D1;NOP53;RPF2;RPL3;MRTO4;MDN1;RPL26;NIP7
prerank,proteoglycan biosynthetic process (GO:0030166),0.3063279337338019,0.7820554404528448,0.7475177304964539,0.9452385746023951,1.0,8/31,19.30%,BMPR2;EXT1;CHST11;B3GAT2;EXTL3;GLCE;CSGALNACT2;CHST9
prerank,regulation of nervous system development (GO:0051960),0.2988299224234447,0.7818282633260901,0.7581081081081081,0.9451591396169036,1.0,9/37,14.54%,HEY1;HEY2;TNFRSF1B;PRUNE1;TENM4;CX3CR1;HES3;CTNNB1;HMGB2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24937996135420343,0.7812973661422578,0.8485523385300668,0.9455792250643505,1.0,38/144,21.67%,FYN;PLK3;CASP8;PPP1R13B;AKAP5;HYAL2;BBC3;ZC3H12A;ITGAM;PRR5L;NMT1;MYO1C;PCM1;RIPOR1;FBXW7;PRNP;DMAP1;UBE2J2;YWHAH;ITGB1BP1;RAN;ANP32B;ICE1;UBE2D3;PDCD10;ANK3;TENM1;GSK3A;BID;TOMM7;JUP;GSK3B;SORL1;MTCL1;PPP3CC;SREBF2;ECT2;LEPROT
prerank,muscle filament sliding (GO:0030049),0.29224019421190983,0.7811515072438248,0.75,0.9449165369405091,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.29224019421190983,0.7811515072438248,0.75,0.9449165369405091,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,telomere maintenance via recombination (GO:0000722),-0.3323276420210462,-0.7807988856137523,0.7475490196078431,0.9693269851918784,1.0,2/11,6.61%,SMC6;RAD50
prerank,hippo signaling (GO:0035329),0.3150785984296785,0.7807439780172829,0.7557471264367817,0.9451109526891325,1.0,5/26,10.55%,TEAD4;WWTR1;TJP2;TJP1;FAT4
prerank,in utero embryonic development (GO:0001701),0.32229137435076294,0.7807224858568963,0.7514970059880239,0.9447085819323747,1.0,5/25,12.11%,PTPRR;MBNL1;EGFL8;ADAM10;HINFP
prerank,positive regulation of protein maturation (GO:1903319),0.3660736434664904,0.7800176333424322,0.7251655629139073,0.9453751433024035,1.0,2/11,10.31%,RHBDD1;NKD2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24444419885334626,0.7799427843760934,0.8809523809523809,0.9450686575400721,1.0,44/185,19.11%,PSMD13;TUBB;CSNK1D;CUL3;UBE2D1;TUBB4B;PSMD4;CLASP1;NEDD1;UBA52;RPS27A;CEP135;HAUS3;PCM1;ZFP36L2;PSMA5;PSMB10;CDC14A;DYNLL1;CEP76;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;KCNH5;PPP1R9B;PSMD5;PSMD9;PSMB6;ACTR1A;ANAPC4
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2661360188775989,0.779674661291041,0.7938271604938272,0.9450544277112946,1.0,19/75,16.64%,KLF7;APP;SHTN1;MEF2C;ATL1;LMTK2;NRCAM;TAOK2;NEFH;ADGRB1;MINK1;ACTB;DCC;CTNNA2;SLITRK2;MAP2;TMEM106B;ANK3;OPHN1
prerank,mitochondrion distribution (GO:0048311),-0.3233234596091325,-0.7795707625905632,0.7727272727272727,0.9702725989217862,1.0,4/12,17.99%,TRAK1;CLUH;ATCAY;DNM1L
prerank,positive regulation of secretion (GO:0051047),0.36026312697520535,0.7789549320416476,0.7099494097807757,0.945791317418206,1.0,1/11,6.82%,NPR1
prerank,glutathione metabolic process (GO:0006749),-0.23306566298699297,-0.7784682456681321,0.8415492957746479,0.9710452933964498,1.0,9/38,16.47%,GSTT1;GCLC;GSTZ1;GGT5;ETHE1;GSTA3;GSTM1;GSTM2;GGT7
prerank,neuromuscular process controlling balance (GO:0050885),0.36115813230618776,0.7783617236069406,0.713128038897893,0.9463166659217567,1.0,3/12,21.03%,PCDH15;NRXN1;MYO7A
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.20989105116854515,-0.7776780304292991,0.9152542372881356,0.9712587528983377,1.0,14/73,13.56%,JARID2;BAZ1B;MTF2;KAT2B;MECP2;TAF1D;IGF2;DNMT3A;SMARCA5;RBBP7;HDAC4;HDAC6;MYBBP1A;MPHOSPH8
prerank,regulation of protein catabolic process (GO:0042176),0.2607369119512604,0.7776086976425924,0.8203033838973163,0.9470990641728302,1.0,15/99,13.89%,AZIN1;FOXO1;DAB2IP;FURIN;WWP1;ASB5;APC;VPS28;MAD2L2;PRKCG;ADGRB1;NEDD4L;SMURF1;PIN1;NSF
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2412848106917424,-0.777506911141835,0.8450184501845018,0.9704500050921913,1.0,6/36,10.19%,OGT;FHIT;MAP1A;PSMF1;TRIM39;SDCBP
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.35962649713249156,0.777060465506347,0.7357910906298003,0.9474783103517329,1.0,1/15,1.56%,GBP5
prerank,negative regulation of TOR signaling (GO:0032007),0.2961790666013958,0.7764022945607542,0.7760778859527121,0.9480828717777493,1.0,10/36,21.45%,SPAAR;CASTOR1;SH3BP4;PRKAA1;ATM;EPM2A;GSK3A;MAPKAPK5;NPRL3;AKT1S1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3038553909428025,-0.7762364652940863,0.7534246575342466,0.9713891882659443,1.0,1/13,1.89%,AXL
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3649084801874915,0.7750997949751577,0.7495961227786753,0.9497118148046639,1.0,6/12,27.34%,SGTB;SEC62;SEC63;SGTA;CHMP4A;CHMP4B
prerank,regulation of acute inflammatory response (GO:0002673),-0.2827430418071343,-0.7746493870074173,0.8067226890756303,0.9728682907028957,1.0,13/18,54.88%,PTGES;KLKB1;IL4;GSTP1;IL6ST;CREB3L3;ADAM8;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2877310928291165,-0.7738401779195466,0.7943661971830986,0.9730872673067279,1.0,8/18,30.01%,COX17;COX16;COX18;SMIM20;TIMM21;FASTKD3;COX14;COX19
prerank,nuclear pore complex assembly (GO:0051292),0.3733410545946515,0.7738074030209807,0.7332185886402753,0.9512812285222731,1.0,3/10,15.93%,RTN4;NUP153;NUP205
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.25278080109848344,0.7735276443355981,0.8481012658227848,0.9512844384202005,1.0,22/122,13.27%,PDGFB;NOD2;INSR;TGFB2;VIM;KLF4;BCAR3;PLD1;ELAVL1;NLRC5;JAK2;PASK;NAMPT;STN1;DHX9;METTL5;NPM1;EEF2;PRKD2;RPS6KB1;FXR1;METTL14
prerank,recombinational repair (GO:0000725),-0.2048415763068878,-0.773469372822927,0.9005847953216374,0.9725984153602512,1.0,30/77,27.52%,NUCKS1;RAD51B;SMC6;ZFYVE26;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;RHNO1;POLN;RFWD3;RPA3;RECQL;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;RAD51AP2;ZSWIM7;NSMCE2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3264293440741511,-0.773443315950894,0.7427055702917772,0.9715799055484796,1.0,5/11,23.24%,NCBP1;PAF1;AHCYL1;NCBP2;PAPOLA
prerank,immunoglobulin mediated immune response (GO:0016064),0.379972873710312,0.7734015398310565,0.7206132879045997,0.9510152731565786,1.0,1/10,4.30%,FCGR2B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33659725644552085,0.7732664165788958,0.7629513343799058,0.9507845097900315,1.0,7/17,20.38%,NUS1;ALG14;DOLK;MVD;DPAGT1;DOLPP1;ALG1
prerank,peptidyl-methionine modification (GO:0018206),0.36240995450411445,0.7731921209125704,0.735973597359736,0.9504612138723758,1.0,4/12,21.28%,APOA1;METAP2;NAA30;NAA25
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.32080581783215784,0.7719719430043668,0.7246835443037974,0.9518986453331576,1.0,5/20,17.28%,CEACAM1;FBXW7;BRCA1;ERLIN2;TRIB3
prerank,macroautophagy (GO:0016236),0.2528713898726294,0.7716161909492352,0.8362168396770473,0.9519899891208976,1.0,31/118,19.88%,ATG101;VTI1B;KLHL3;GABARAPL1;VPS36;TECPR1;VAMP8;PLEKHM1;TBC1D5;PRKAA1;NBR1;VAMP7;VPS28;PIK3C3;DYNLL1;MFN1;LIX1;YOD1;VPS4A;CHMP3;MAP1LC3A;CSNK2B;CHMP2B;VDAC1;UBXN6;ATG14;LAMP2;DYNLL2;TOMM7;MVB12A;STAM2
prerank,positive regulation of viral process (GO:0048524),0.2720371152482607,0.7715852389859246,0.8081180811808119,0.9515960629585116,1.0,14/60,18.64%,ADARB1;PPIE;POLR2G;ADAR;DHX9;POLR2D;VPS4A;PPIH;NELFB;PKN2;POLR2I;NELFA;SRPK1;PPID
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.28176347091801357,-0.7715160496893113,0.7933884297520661,0.9736077463188921,1.0,9/18,25.04%,EHMT1;SETD7;SETD1A;SETD1B;SUV39H1;SETD4;EEF1AKMT2;KMT2D;SETMAR
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3269294640960637,0.7713991082299824,0.7447129909365559,0.9514449818978377,1.0,3/21,14.25%,CAV1;APC;CTNNB1
prerank,actin filament network formation (GO:0051639),0.36811451952327995,0.7713922048024608,0.7123287671232876,0.9510131566460642,1.0,4/11,21.45%,PLS3;LCP1;SPIRE1;CARMIL1
prerank,toxin transport (GO:1901998),-0.33307144122470494,-0.7713342870019666,0.7831325301204819,0.9728278202668282,1.0,4/10,18.81%,ANTXR2;ANTXR1;RAB29;SLC22A2
prerank,regulation of receptor internalization (GO:0002090),0.29367757029112906,0.7710324251424141,0.770949720670391,0.9511282154272366,1.0,5/35,8.04%,INSR;ANGPT1;ANKRD13A;ARRB1;TBC1D5
prerank,regulation of defense response (GO:0031347),0.2627870503374335,0.7710239482844723,0.8077858880778589,0.9507049135206984,1.0,10/76,10.37%,NOD2;CASP8;SPATA2;TIRAP;FCGR2B;SEMA7A;BCL6B;JAK2;FOXP1;CASP1
prerank,protein alkylation (GO:0008213),-0.2670984302233837,-0.7709286142107589,0.796923076923077,0.9723728634761126,1.0,6/22,18.19%,GSPT1;METTL21A;FAM98B;EEF1AKMT1;EEF1AKMT2;SNRPD3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2944386998677707,-0.7708886589560223,0.7945205479452054,0.9713789426189176,1.0,5/16,17.72%,AMPD3;LHPP;ATIC;NUDT2;IMPDH2
prerank,regulation of neutrophil migration (GO:1902622),0.3694585004855946,0.7706841352597695,0.7225130890052356,0.950821884622455,1.0,2/10,13.75%,RAC1;RHOH
prerank,sodium-independent organic anion transport (GO:0043252),0.3723889547180569,0.7703907632362632,0.7371134020618557,0.950824351221091,1.0,3/10,9.08%,SLCO1C1;SLC16A2;MFSD10
prerank,regulation of activated T cell proliferation (GO:0046006),0.30596345446845963,0.77018139051254,0.7719546742209632,0.9506857604878565,1.0,8/30,19.95%,CRTAM;LGALS9;HMGB1;PRNP;IL27RA;PYCARD;CD24;AGER
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.27132767076329534,0.7701658691502189,0.7926675094816688,0.9502681281720053,1.0,8/63,6.59%,FAS;CAV1;CASP8;ACVR1;TNFSF10;HYAL2;TRAF1;MADD
prerank,cellular response to hexose stimulus (GO:0071331),0.31800470328048325,0.7692086040117464,0.7460545193687231,0.9512999264995234,1.0,3/23,8.29%,UNC13B;PCK2;PRKAA1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3367956890005409,0.7689191589345755,0.7397476340694006,0.9512853211138801,1.0,7/18,25.39%,FCGR2B;RNF185;BAG6;NCK1;ERN1;RNFT1;DDIT3
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3250830906587523,0.7689141394713594,0.7469879518072289,0.9499793356697863,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3250830906587523,0.7689141394713594,0.7469879518072289,0.9499793356697863,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3250830906587523,0.7689141394713594,0.7469879518072289,0.9499793356697863,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,DNA replication checkpoint signaling (GO:0000076),-0.28068401180069247,-0.7688038328479985,0.7969151670951157,0.9734788469109483,1.0,9/16,38.30%,TIPIN;ORC1;TIMELESS;RAD9A;CDC45;DNA2;HUS1B;CDC6;TICRR
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2680078202912776,-0.767689934535348,0.8092307692307692,0.9741963836703614,1.0,6/22,15.31%,RELL1;SASH1;XDH;VEGFA;GADD45B;SPHK1
prerank,regulation of mRNA stability (GO:0043488),0.24473862361601179,0.767671619214859,0.8659217877094972,0.9514068720587208,1.0,36/145,18.86%,VIM;PSMD13;PUM2;APEX1;PSMD4;ELAVL1;HSPB1;EXOSC3;UBA52;RPS27A;ROCK1;ZFP36L2;PSMA5;XPO1;PSMB10;EXOSC8;PSMB8;NPM1;PSMD14;XRN1;PSMA7;PSMC3;FXR1;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;YBX1;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3661644695543002,0.7675549143668906,0.7307692307692307,0.9511489977419685,1.0,11/11,63.41%,MALT1;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ;NFKBID
prerank,negative regulation of catabolic process (GO:0009895),0.2831507385226439,0.7673933670094275,0.7709720372836218,0.9509641629928942,1.0,10/47,16.35%,AZIN1;PDE3B;ALK;PRKAA1;MAD2L2;PRKCG;ADGRB1;PIN1;CBFA2T3;CST3
prerank,purine nucleotide catabolic process (GO:0006195),0.3554741710556566,0.7671037888004467,0.736,0.9509544235730867,1.0,1/13,1.85%,GDA
prerank,regulation of isotype switching (GO:0045191),0.34641473262570455,0.7665855382724912,0.7515723270440252,0.9512990458222111,1.0,7/14,25.96%,SLC15A4;MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,membrane assembly (GO:0071709),-0.2401745687988293,-0.7664562288316085,0.8210526315789474,0.9750743495245779,1.0,11/34,24.95%,ANXA2;STX4;NLGN2;TLCD2;UBXN2B;SPAST;S100A10;PTPRD;TLCD1;STX2;NLGN3
prerank,neuronal action potential (GO:0019228),-0.2644305058087154,-0.765993591448495,0.8136645962732919,0.9747112879492358,1.0,6/22,17.39%,SCN7A;SCN2A;CACNA1G;KCNMB2;GPER1;CACNA1H
prerank,negative regulation of cellular metabolic process (GO:0031324),0.29153327110646887,0.7659244208155029,0.7780859916782247,0.9518973431448842,1.0,3/37,7.48%,EDN1;ANKRD13A;AATF
prerank,modulation by host of viral genome replication (GO:0044827),0.35574111044360696,0.7657851623201042,0.743421052631579,0.9516752382122254,1.0,2/13,7.01%,FBXL2;ZC3H12A
prerank,phagosome acidification (GO:0090383),-0.257367664858631,-0.7656578513126877,0.8082191780821918,0.974197806066685,1.0,8/26,22.19%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2
prerank,motor neuron axon guidance (GO:0008045),0.3332487442831009,0.7656426825718302,0.7233704292527822,0.951467771015929,1.0,6/15,21.58%,NTN1;TMEFF1;RAC1;RHOH;SLIT1;EPHA4
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.23242507490365233,-0.7655623232326351,0.8659420289855072,0.9732875161983653,1.0,3/40,6.52%,PID1;BCL2;ATP5IF1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2997042583122881,0.7654355016336144,0.7753120665742025,0.9513307692369789,1.0,4/32,10.49%,CAV1;P2RX7;CASQ1;PLCG1
prerank,cell proliferation in forebrain (GO:0021846),-0.3274029751130566,-0.7654334587302997,0.7761557177615572,0.9724249720083851,1.0,2/10,8.51%,DOCK7;NUMBL
prerank,peptidyl-arginine modification (GO:0018195),-0.2959845192706113,-0.7652538740268369,0.7802197802197802,0.9716245712192986,1.0,3/15,12.81%,ART3;NDUFAF5;PADI2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.27294461875899384,0.7649147146263297,0.8144853875476493,0.9516930367220807,1.0,13/57,18.45%,APP;SHISA8;MEF2C;SHISA6;GRIA1;GRIN2B;MINK1;LYNX1;NPTX2;GRIN2A;NPTX1;LRRC7;CAPN1
prerank,protein deacylation (GO:0035601),0.30808115191120944,0.7646849839336678,0.7567954220314735,0.9516267330250074,1.0,2/23,3.24%,HDAC7;PPT1
prerank,carboxylic acid catabolic process (GO:0046395),-0.30971280305474724,-0.7642577877189111,0.7469879518072289,0.972022018214074,1.0,7/12,39.87%,RENBP;NAGK;AMDHD2;NPL;GNPDA1;IL4I1;ACOT8
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2800221247003502,0.764054125299243,0.7953667953667953,0.952120989614574,1.0,12/49,22.21%,SMAD6;IAPP;HMGB1;PMEPA1;AIDA;CLU;RIOK3;PYDC1;GSK3B;SORL1;LCMT1;NOP53
prerank,glial cell development (GO:0021782),0.308497576602709,0.7640494414487333,0.7474452554744525,0.9516898817659875,1.0,5/25,19.00%,APP;EIF2B2;SOX10;NSUN5;SOX11
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26397893470249445,0.7633526283545737,0.8323424494649228,0.9523452454854,1.0,14/72,15.83%,ESRP2;CBL;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;POLR2D;TIAL1;FGF20;KIF16B;POLR2I
prerank,lytic vacuole organization (GO:0080171),0.29632722357807395,0.7629881994279157,0.7706821480406386,0.9524449203865165,1.0,9/32,21.03%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,negative regulation of signaling (GO:0023057),0.3120472458446215,0.7626495578401362,0.7670196671709532,0.9525208447912379,1.0,6/25,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.31213976106633273,-0.762508637172442,0.7728395061728395,0.9735532961566191,1.0,7/12,40.83%,CDC7;CDC45;MCM7;MCM5;MCM2;GINS2;MUS81
prerank,positive regulation of T cell proliferation (GO:0042102),-0.21492876819244405,-0.7624467767081111,0.8834080717488789,0.9726009218500923,1.0,7/55,13.15%,IGF1;IGFBP2;ANXA1;IGF2;NCKAP1L;PNP;CD80
prerank,nucleic acid metabolic process (GO:0090304),0.2627587294899724,0.7622970299923173,0.8274173806609547,0.9526277675660942,1.0,16/69,17.70%,LSM1;EXD2;HNRNPA0;POLR2G;FEN1;DUSP11;POLR2D;HNRNPK;XRN2;PCBP1;METTL14;HNRNPH2;RAN;POLR2I;MMS19;DXO
prerank,mitotic recombination (GO:0006312),0.34486851855820017,0.7621455501553028,0.7483870967741936,0.9524059812159893,1.0,1/15,1.69%,RAD54B
prerank,regulation of cell division (GO:0051302),0.2644092817068665,0.761688593400065,0.8145859085290482,0.9526722251819034,1.0,16/72,20.67%,PLK3;RAB11A;TAL1;BCL2L1;PIK3C3;CALM3;PRC1;PIN1;RAB11FIP4;MLLT3;RACK1;KLHL9;GIT1;RAB11FIP3;SETD2;BLM
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23081474990480585,-0.7613749774823794,0.8723404255319149,0.973120240294259,1.0,15/37,24.64%,DDB2;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3704709387199101,0.7613035649784085,0.7455830388692579,0.952817829850505,1.0,2/10,7.72%,ATP5MC1;ATP5F1A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2925094505296568,0.7612164897150853,0.7703081232492998,0.952522666794319,1.0,7/39,13.00%,UTRN;CAMK2D;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3196122101119573,0.7610220075906545,0.7477744807121661,0.9523656397780649,1.0,5/21,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.32217544778928087,0.7610124696326226,0.7554858934169278,0.9519488701288155,1.0,4/20,10.96%,GOPC;CAMK2D;STK39;NEDD4L
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3109554211899041,0.7609837207196378,0.7668711656441718,0.9515615998803643,1.0,6/24,15.24%,OCLN;NCKAP1;CYFIP1;RAC1;WASF2;ARPC2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3133923972947803,0.759301108263043,0.7553956834532374,0.9536039261501954,1.0,2/24,8.22%,NOTCH1;JAK2
prerank,synapse assembly (GO:0007416),0.26356043046111194,0.7590834454325825,0.8366834170854272,0.9534799424915258,1.0,22/67,21.52%,DNM3;SPOCK2;PLXND1;SHANK3;NRCAM;FLRT3;CBLN4;KIRREL3;CDH2;GABRA2;ACHE;PCDHB16;LGI2;PCDHB14;PCDHB9;DSCAM;GRID2;SHANK2;BDNF;NRXN1;GABRB3;NLGN1
prerank,establishment of vesicle localization (GO:0051650),0.32982183910367124,0.7589837931427821,0.7647058823529411,0.9531972850064507,1.0,4/18,17.97%,RAB11A;LIMK2;SYNJ1;RAB27A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.29945277772994633,0.7586818800332231,0.7798561151079136,0.9532092443558622,1.0,7/29,17.69%,RAB6B;VTI1B;COG5;NSF;COG6;GOSR1;VTI1A
prerank,snRNA 3'-end processing (GO:0034472),0.31933604236988217,0.7580357602763058,0.7488151658767772,0.9537377026657611,1.0,6/19,17.49%,EXOSC3;EXOSC8;INTS12;INTS5;INTS6L;EXOSC9
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.3077842465908194,-0.757741783567047,0.7810810810810811,0.9774657873474635,1.0,4/12,20.23%,DGAT1;MTTP;MFSD2A;P4HB
prerank,regulation of immune effector process (GO:0002697),-0.2282039661854467,-0.7570140024203,0.8876404494382022,0.977437629933088,1.0,15/41,27.36%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,protein maturation (GO:0051604),0.25492793294791966,0.7569746414675532,0.8501742160278746,0.9548852113118358,1.0,27/95,21.25%,CPD;TSPAN14;CASP2;LIPT2;PCSK5;FURIN;TSPAN32;ADAM17;APH1A;ADAM10;BOLA2;LIPT1;GLRX3;METAP2;CPM;PSEN2;SRGN;LONP2;XPNPEP3;MMS19;TYSND1;LMF2;ECE2;EEF1AKMT4-ECE2;SORL1;APH1B;CCS
prerank,skeletal muscle organ development (GO:0060538),0.30533891590298623,0.756598163800636,0.7650429799426934,0.9550134188878253,1.0,5/26,15.28%,CAV1;MEF2C;MYL6;FXR1;POPDC3
prerank,regulation of cholesterol efflux (GO:0010874),0.29648403586552313,0.7563206873486484,0.7789165446559297,0.9549849259236365,1.0,7/30,17.06%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1;NAXE
prerank,microtubule nucleation (GO:0007020),-0.26836045764506766,-0.7560308486908486,0.8228228228228228,0.9777654513993571,1.0,5/20,9.84%,SLAIN2;GOLGA2;TUBGCP4;NDE1;NDEL1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.33346475620439997,-0.7558075453974324,0.75,0.9770290481842508,1.0,1/10,2.84%,WNT5A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.30866400227395446,0.7550559976245658,0.7833089311859444,0.9564240000897579,1.0,5/25,17.03%,CAV1;SLC8A1;KCNA1;ANK3;CIB2
prerank,positive regulation of cell division (GO:0051781),-0.22791658102145773,-0.7547250964031061,0.8768656716417911,0.977522347511531,1.0,7/38,15.68%,FGFR2;FGF1;SVIL;SPAST;DRD2;SIRT2;CDC14B
prerank,"transcription, DNA-templated (GO:0006351)",0.2367263188711229,0.7543983067726315,0.9065817409766455,0.9569525640918547,1.0,49/207,19.85%,TSC22D1;NR4A2;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;RTF1;TRIM24;EAF1;SLC25A33;SETX;POLR2G;MBD1;BRF2;ELOA;MLF1;NFKBIB;POLR2D;DEAF1;TBPL1;EAF2;GTF2H3;KLF13;CBFB;GTF2A1;DDX21;TFB2M;TAF1B;MLLT3;MED4;TAF11;TEFM;NELFB;POLR2I;AFF4;PWP1;NELFA;MMS19;RPAP1;DRAP1;HOXD3;NCOA6;MEF2A;PTMA;TAF3;PKNOX1;RRAGC
prerank,regulation of cellular component size (GO:0032535),0.2988071318177002,0.7543819577703815,0.7834302325581395,0.9565520792197069,1.0,13/30,27.18%,MSN;RAP1GAP2;AP2M1;HP1BP3;RAC1;PEX11A;PEX11G;PPP1R15A;ATP13A2;RDX;RPTOR;LAMTOR4;RIN3
prerank,nucleotide catabolic process (GO:0009166),0.3345056954090159,0.7537059493648895,0.7550387596899225,0.9571246980656712,1.0,1/16,1.85%,GDA
prerank,magnesium ion transport (GO:0015693),-0.3081105931078688,-0.7534731748123129,0.7788944723618091,0.9782963647189079,1.0,5/12,18.08%,SLC41A1;TUSC3;NIPA1;MAGT1;NIPAL4
prerank,regulation of centriole replication (GO:0046599),-0.28599545196657744,-0.7533667294158387,0.7939560439560439,0.9774138217076836,1.0,4/18,10.83%,ALMS1;KAT2B;RBM14;MDM1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2650184819729882,-0.7533083212660561,0.8306010928961749,0.9764551657760422,1.0,5/19,15.34%,GNL3L;SRC;TENT4B;TEN1;HNRNPU
prerank,response to unfolded protein (GO:0006986),0.27629485875542353,0.7526305081684355,0.8110236220472441,0.9582302772053873,1.0,12/48,20.23%,DAB2IP;RHBDD1;HSPB1;HSPA1B;HSPE1;PTPN1;TMBIM6;TM7SF3;DAXX;DNAJB5;ERN1;DNAJA1
prerank,negative regulation of cell aging (GO:0090344),0.32979857467836216,0.7517851952997024,0.7481031866464339,0.9590569845099524,1.0,4/16,15.28%,AKT3;RBL1;MAP3K3;YBX1
prerank,histone exchange (GO:0043486),0.2849548986839493,0.7514494133938512,0.7927170868347339,0.9591236195732104,1.0,8/37,13.98%,CENPU;SRCAP;NPM1;DMAP1;ACTR6;CENPI;ITGB3BP;VPS72
prerank,positive regulation of myelination (GO:0031643),-0.3073068863778867,-0.7506016184791072,0.7760814249363868,0.9792370026335623,1.0,2/11,4.46%,DICER1;PARD3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.29180340131753923,-0.7504588468048442,0.8089330024813896,0.9784064453228969,1.0,4/14,15.03%,CD55;PTPN22;CD81;TGFBR2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.34959196604550685,0.7498047651717393,0.7546218487394958,0.9610812230047057,1.0,2/13,9.53%,IRAK2;PIK3C3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.34601150936592,0.7496874399580997,0.7649842271293376,0.9608019642086395,1.0,1/13,3.80%,STX7
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2636386515276532,0.7493646612713214,0.8507653061224489,0.9608480069734168,1.0,14/66,15.09%,CARD10;WWTR1;HYAL2;ZC3H12A;CCT8;DKC1;LIMK2;CCT2;DMAP1;DTX3L;CCT4;RAN;CCT6A;KAT7
prerank,mRNA transport (GO:0051028),-0.18786199734043124,-0.7490440644107397,0.9933333333333333,0.9793073811495441,1.0,35/101,26.03%,SRSF5;HNRNPA2B1;NUP107;NCBP1;UPF2;SRRM1;SRSF1;NUP155;SRSF6;THOC1;AGFG1;AAAS;NUP93;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;MCM3AP;SRSF3;KIF5C;SLBP;SEC13;SRSF11;NCBP2;DDX25;SRSF2;POM121;EIF4A3;DDX19B;U2AF1;ZC3H11A;THOC7;NUP188
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3206221767438835,0.7488301183457251,0.7760736196319018,0.9612386156598798,1.0,7/18,22.41%,ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;ACSL4
prerank,cellular response to gamma radiation (GO:0071480),0.3235064989067897,0.7487084366147357,0.7774390243902439,0.960981650193194,1.0,6/17,25.80%,TMEM109;ATM;MAP3K20;WRN;YAP1;RPL26
prerank,cellular respiration (GO:0045333),0.27902305457291027,0.7484888631448534,0.794973544973545,0.9608750884693098,1.0,10/41,16.39%,ETFDH;ETFA;ETFB;NDUFS4;UQCRB;UQCRFS1;UQCRC1;COX15;ME3;SDHC
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2616417964605264,-0.7474068930728336,0.8271954674220963,0.9794366651803108,1.0,8/20,22.27%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,glutathione derivative metabolic process (GO:1901685),-0.2616417964605264,-0.7474068930728336,0.8271954674220963,0.9794366651803108,1.0,8/20,22.27%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.352723385684858,0.7472899635958481,0.787828947368421,0.9621904942396476,1.0,5/12,25.90%,ZC3H12A;ELAVL1;ESR1;NCOR2;TGFB1
prerank,negative regulation of cell division (GO:0051782),0.3625382508160965,0.7469001466323358,0.7819314641744548,0.9623547389458048,1.0,3/11,20.67%,E2F7;VPS4A;BLM
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.29447344994569064,-0.7467101003403989,0.8070175438596491,0.9793374461509385,1.0,4/13,15.73%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.22523323731555206,-0.7466786691057088,0.872,0.9783369846406237,1.0,24/43,38.30%,BRSK1;TRIM39;NABP1;HMGA2;CDC14B;CDKN1A;DONSON;ORC1;TAOK1;CHFR;FZR1;TAOK3;RINT1;CHEK1;NABP2;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;CDK1;CDC6;TICRR
prerank,homologous chromosome segregation (GO:0045143),0.31551987674126813,0.7462364351454602,0.774390243902439,0.9628718114868977,1.0,5/20,20.04%,PTTG1;MEI4;SGO1;TERB1;PRDM9
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.2977025784055617,-0.7461921585653749,0.8221649484536082,0.9779460888032905,1.0,2/13,2.84%,AXL;WNT5A
prerank,anterior/posterior axis specification (GO:0009948),0.33252804006562287,0.7455492439944852,0.7463651050080775,0.9634226946575785,1.0,6/15,25.39%,TBXT;TASOR;SKI;TBX3;RIPPLY2;DDIT3
prerank,peptidyl-asparagine modification (GO:0018196),0.29235760933627836,0.7453645975142998,0.7749287749287749,0.9632325913504163,1.0,13/31,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;HIF1AN;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.23533595829118728,0.7452354626958194,0.9116379310344828,0.9629773644886598,1.0,31/170,16.78%,TRIM14;NOVA2;APP;AFF1;SLC8A1;YBX2;TRIM11;TRIM6;NKAPL;ZC3H12A;CAVIN4;CACTIN;FOXP1;DHH;HNRNPK;TRIM17;PCBP1;HINFP;TOB1;TSKU;PIN1;TAPBP;UNCX;HIF1A;NELL1;ATXN7L3B;YBX1;KIF16B;AFF4;ZNF711;BMI1
prerank,T cell activation involved in immune response (GO:0002286),0.34093781040963433,0.745099502573516,0.7465034965034965,0.9627351463530687,1.0,1/12,2.44%,F2RL1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.29488283351908995,0.7450608558947363,0.8005865102639296,0.9623517254679176,1.0,10/30,25.98%,BCL2L1;SNAI2;CLU;CDKN2D;DDX39B;DYRK1A;YJU2;TMEM161A;THOC5;PSMD10
prerank,regulation of RNA export from nucleus (GO:0046831),0.35741393265514865,0.7448671601203416,0.7628524046434494,0.962208499888066,1.0,5/11,25.31%,DHX9;NUP153;SETD2;IWS1;TPR
prerank,regulation of endocytic recycling (GO:2001135),0.35401414346671994,0.7448197143810421,0.7367491166077739,0.9618448028098918,1.0,4/11,21.72%,EHD1;INPP5F;SORL1;ARHGAP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2509470421792995,0.7448141540036664,0.8498168498168498,0.9614194732200464,1.0,18/80,18.78%,NOD1;ARL6IP5;KLF4;PPM1F;TNFSF10;GRAMD4;DELE1;HMGB1;SIAH2;CASP1;RPS6KA1;RPS6KA3;CDKN2D;DNAJB6;PYCARD;SOX7;XIAP;MALT1
prerank,cristae formation (GO:0042407),0.29480621959647807,0.7445127508515237,0.7807807807807807,0.9614266774876106,1.0,6/27,15.75%,CHCHD3;UQCC3;ATP5MC1;ATP5F1A;ATP5ME;SAMM50
prerank,regulation of protein localization to centrosome (GO:1904779),0.3593651803275109,0.7438679331487316,0.7411347517730497,0.9619004268170106,1.0,5/10,27.60%,APC;GSK3B;MARK4;CEP72;BICD1
prerank,regulation of store-operated calcium entry (GO:2001256),0.3593021779818705,0.7437312866653608,0.7591623036649214,0.9616567215726564,1.0,2/10,7.79%,HOMER2;CASQ1
prerank,negative regulation of cellular senescence (GO:2000773),0.34202400696265106,0.7436285260943964,0.7612903225806451,0.9613727606743848,1.0,4/13,15.28%,AKT3;RBL1;MAP3K3;YBX1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3290022257013295,0.7431896366742899,0.7823343848580442,0.9615717975718597,1.0,3/16,14.04%,INSR;ETF1;BNIP3
prerank,axoneme assembly (GO:0035082),0.29306131811746705,0.7431769250645399,0.7917241379310345,0.9611586370956509,1.0,3/31,7.77%,CFAP206;DNAAF3;TTC12
prerank,cellular response to ionizing radiation (GO:0071479),0.27132197993283436,0.7431319337332021,0.8167330677290837,0.9608107903507306,1.0,15/47,24.11%,RHOB;TMEM109;SPIDR;RAD1;ATM;MAP3K20;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2;WRN;YAP1
prerank,mitochondrial gene expression (GO:0140053),0.27975642264325234,0.7428805697491199,0.7942386831275721,0.9607710333983867,1.0,10/42,17.63%,SLC25A33;MRPL47;MRPL23;FASTKD5;MRPS34;MRPS12;TFB2M;TEFM;GATB;MRPS18B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.27403068420417065,-0.7428066068106178,0.8433048433048433,0.9814022445777822,1.0,2/17,6.88%,LPGAT1;PLA2G4A
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.23809005170438605,-0.7422095872284046,0.8582375478927203,0.9811653155815694,1.0,6/31,18.01%,STX4;RBP4;KMT5C;KMT5B;EPHB2;PHB2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.32821459676579573,0.7419655902369265,0.7586726998491704,0.9616723851290333,1.0,3/15,17.43%,NLRC5;CACTIN;PTPN2
prerank,protein targeting to membrane (GO:0006612),-0.18890257046943165,-0.741535946834528,0.9482758620689655,0.9809714853478109,1.0,17/83,15.21%,ABCD3;PARD3;SIL1;ATG3;RAB3IP;SSR1;PRKCI;ATAD1;TRAM1;PEX2;PXMP4;SDCBP;ARL6;SSR2;PXMP2;RABGEF1;GDAP1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3187416873373449,-0.7411763761540467,0.7839080459770115,0.980429505445597,1.0,2/10,7.76%,ANXA2;PIP4K2A
prerank,peroxisome organization (GO:0007031),-0.24276149989144083,-0.740044561553295,0.8785942492012779,0.9809089426215186,1.0,8/25,24.74%,ABCD3;PEX2;SEC16B;DNM1L;PEX7;PEX11B;PEX3;PEX16
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2909840534260993,0.7394224933904376,0.8,0.9648737659071905,1.0,7/29,17.51%,PUM2;SMAD2;ZC3H7A;ADAR;AGO4;DROSHA;TUT7
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.31234699642207014,-0.7383104719121256,0.8090692124105012,0.981131500148954,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.31234699642207014,-0.7383104719121256,0.8090692124105012,0.981131500148954,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33364756460160383,0.738165467599165,0.775974025974026,0.9662466764477572,1.0,2/16,4.25%,AOAH;PGM2L1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.349314043828343,0.7381543820526173,0.7714285714285715,0.9658307230911017,1.0,2/10,8.73%,PLPP1;DGKH
prerank,response to UV-B (GO:0010224),-0.295829753961939,-0.7380752255536212,0.7922077922077922,0.9804120145203663,1.0,4/12,16.08%,HYAL1;CRIP1;MFAP4;CDKN1A
prerank,diacylglycerol metabolic process (GO:0046339),-0.25665987717512906,-0.7379875650703728,0.8769230769230769,0.9794954633910228,1.0,5/23,15.07%,PLCE1;DGAT1;DGKD;PGS1;PLA2G15
prerank,regulation of exit from mitosis (GO:0007096),0.2839462210176657,0.7375389637069796,0.8305084745762712,0.9662326940354166,1.0,11/38,23.29%,UBE2D1;UBA52;RPS27A;CDC14A;UBE2E1;CDC27;ANAPC7;PPP1R9B;ANAPC4;UBB;ANAPC11
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.26371175077895986,0.7373947991719053,0.8512820512820513,0.9659873466957808,1.0,17/62,20.23%,ARHGEF2;LRRK2;HSPB1;BCL2L1;NFE2L2;SNAI2;TMBIM6;CLU;RTKN2;NOL3;ARMC10;CDKN2D;PLAUR;EPO;PPIF;MCL1;DNAJA1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2629216670036305,0.7371497164773894,0.8562091503267973,0.9658861239754419,1.0,13/59,14.45%,TNRC6C;MED26;LEF1;SETX;JUN;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,quinone biosynthetic process (GO:1901663),0.3341077193417017,0.7370187740282513,0.7855973813420621,0.9656311984342654,1.0,5/14,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,negative regulation of DNA recombination (GO:0045910),0.2774191862270758,0.7369518700682558,0.8154050464807437,0.9652937600292993,1.0,18/43,25.96%,POLR2G;PARPBP;MAD2L2;POLR2D;POLR2I;DAXX;UBQLN4;TERF2IP;BLM;RIF1;SHLD3;POLR2C;SHLD2;TERF2;POLR2B;POLR2J;TINF2;SHLD1
prerank,mitochondrial fusion (GO:0008053),0.31647281309518865,0.7369391177488707,0.8028616852146264,0.964882957567088,1.0,8/18,27.67%,CHCHD3;MIGA1;MFN1;USP30;AFG3L2;STOML2;FIS1;MIEF1
prerank,protein autoprocessing (GO:0016540),0.32194344913913286,0.7362326296983464,0.7948717948717948,0.9654455440405657,1.0,3/17,15.87%,OMA1;CASP1;SPRTN
prerank,nuclear membrane disassembly (GO:0051081),-0.2907920442314257,-0.7360239516183311,0.8190954773869347,0.981093054451848,1.0,4/14,15.83%,PRKCB;PRKCA;AKAP8L;NEK6
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3257714423731033,0.7359073476419931,0.7954911433172303,0.9654522510439981,1.0,2/17,3.51%,BTG1;TMEM100
prerank,positive regulation of chromosome organization (GO:2001252),-0.28595913405256534,-0.7355819622415491,0.8093922651933702,0.9806283274303622,1.0,6/15,20.26%,RAD50;PPP1R10;RTEL1;PML;GNL3;ATRX
prerank,catecholamine metabolic process (GO:0006584),0.33527796042144686,0.735502000445227,0.7792207792207793,0.965578553693494,1.0,2/14,11.63%,ATP7A;SNCAIP
prerank,protein localization to condensed chromosome (GO:1903083),0.3471339849190982,0.7352719810078502,0.7689822294022617,0.9654588802718851,1.0,2/12,8.02%,IK;MTBP
prerank,cellular response to misfolded protein (GO:0071218),0.31469491553365314,0.7351295315330689,0.7782874617737003,0.9652274835733369,1.0,6/20,21.01%,RNF185;CUL3;BAG6;UGGT1;RNF5;POMT2
prerank,sensory perception of taste (GO:0050909),0.3559098612767561,0.735104444185756,0.7606837606837606,0.9648286224558486,1.0,10/10,64.43%,ASIC2;PKD1L3;PKD2L1;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;CD36
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2878031967189035,0.7349980421495875,0.8069444444444445,0.9645490541524718,1.0,8/33,14.81%,OMA1;IAPP;BCL2L1;CLU;TMEM14A;NOL3;BNIP3;FZD9
prerank,mitotic sister chromatid segregation (GO:0000070),0.24435532823126976,0.7347629695882112,0.8811188811188811,0.9644458112476388,1.0,19/98,16.20%,RAB11A;CUL3;RAD21;KPNB1;TENT4A;DSN1;CHMP1B;VPS4A;PRC1;CHMP3;NCAPG;CEP55;RAN;CSNK2B;CHMP2B;CHMP7;BOD1;NDC80;SGO1
prerank,mRNA destabilization (GO:0061157),-0.22177848089920385,-0.7346234712406088,0.9198473282442748,0.9808016174783875,1.0,11/38,19.01%,ROCK2;YTHDF1;FTO;PUM1;TARDBP;YTHDF2;CPEB3;GIGYF2;RC3H1;TUT4;ZFP36
prerank,regulation of fibroblast migration (GO:0010762),0.31320764873004575,0.7340688654162193,0.7758620689655172,0.9649557314716323,1.0,5/20,13.05%,HYAL2;PRR5L;PTK2;RAC1;ITGB1BP1
prerank,aggrephagy (GO:0035973),0.2955562399643142,0.7338319250624294,0.7879656160458453,0.9648636479903909,1.0,8/27,21.60%,VIM;UBA52;RPS27A;DYNLL1;DYNC1LI2;DYNLL2;DYNC1I2;UBB
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2886015084369112,-0.733712329716593,0.810880829015544,0.9808962535034093,1.0,6/13,30.35%,BCAP31;UBE2G2;ERLEC1;SVIP;EDEM2;DERL2
prerank,iron ion homeostasis (GO:0055072),0.26172793206408773,0.7336365753561486,0.8477157360406091,0.9647127318582984,1.0,20/58,24.89%,B2M;FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2724855669861835,-0.7335828667451478,0.8179419525065963,0.9800280782062837,1.0,5/16,15.79%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2564084627247433,0.733397083860426,0.849079754601227,0.9646042050231598,1.0,14/72,15.83%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;GTF2H3;COPS8;LIG1;ERCC4;RFC2;POLR2I
prerank,regulation of neuroblast proliferation (GO:1902692),0.3276987204577389,0.7332907198877472,0.7752808988764045,0.9643376104898034,1.0,5/15,14.82%,TAFA1;LRRK2;CX3CR1;CTNNB1;FZD3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.2581447510594082,-0.7332888564269211,0.8459302325581395,0.9794041115235639,1.0,4/20,13.05%,IL1R1;CD55;PRKCZ;CD81
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.29127674965657413,-0.7331017304528494,0.8333333333333334,0.9786203341035935,1.0,3/13,11.81%,NUPR1;FEZ2;TMEM39A
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.28287349392468436,0.7330363640772155,0.821376281112738,0.9642576408758561,1.0,3/29,5.33%,CAV1;TNFSF10;HYAL2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2662029617485153,-0.7329032695432057,0.824607329842932,0.9778521739466954,1.0,3/18,12.51%,BCL2;SLC25A4;THEM4
prerank,mitotic nuclear membrane organization (GO:0101024),0.2619870717176858,0.7323604815893403,0.8408215661103979,0.9643523453797771,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2619870717176858,0.7323604815893403,0.8408215661103979,0.9643523453797771,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,oligodendrocyte development (GO:0014003),0.3326718354441593,0.732172498433813,0.7833876221498371,0.9641854595347934,1.0,4/15,17.24%,EIF2B2;B4GALT6;SOX10;NSUN5
prerank,regulation of translational initiation (GO:0006446),0.25669888565133325,0.7321217233105392,0.8765281173594132,0.9638254880441237,1.0,15/63,16.50%,UHMK1;HSPB1;POLR2G;EIF3B;EIF2B2;POLR2D;EIF1;NPM1;RPS6KB1;HABP4;PPP1R15B;MTIF2;EIF3H;KLHL25;NCK1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2930462567228078,-0.7312569807359236,0.8426395939086294,0.978949943848086,1.0,4/14,17.72%,ADK;LHPP;ATIC;IMPDH2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3138231814015115,0.7312205245118608,0.7762962962962963,0.9646623646081662,1.0,7/19,21.37%,CLIC4;MARK2;LRRC7;ERBIN;FOXJ1;MTCL1;CRB1
prerank,activin receptor signaling pathway (GO:0032924),0.3269760965081134,0.7311578719019004,0.7757774140752864,0.9643320644700552,1.0,4/15,15.16%,ACVR1;SMAD2;ACVR2A;ACVR2B
prerank,covalent chromatin modification (GO:0016569),-0.2916782389711787,-0.7305594305681203,0.8108108108108109,0.978835424310309,1.0,4/14,27.78%,HDAC1;HLCS;PARP2;HELLS
prerank,regulation of phosphatase activity (GO:0010921),0.3014229831130225,0.7300471963711074,0.7964601769911505,0.9654097606436727,1.0,3/24,7.44%,ZCCHC9;GPATCH2;HSP90B1
prerank,protein monoubiquitination (GO:0006513),0.27989511336317763,0.7299201311281711,0.8251748251748252,0.9651550574887606,1.0,9/36,14.78%,CUL3;RBX1;TRIM25;OBI1;DTX3L;UBE2T;UBE2E1;RAD18;UBE2D3
prerank,neuron differentiation (GO:0030182),0.23095331844105735,0.7292106712271946,0.9148230088495575,0.9657013328915353,1.0,23/165,16.64%,NR4A2;NEUROG2;ATP2B2;OLIG2;TGFB2;PPT1;MEF2C;MYEF2;ALK;NGRN;TENM3;TENM4;SPOCK1;PHOX2A;PIN1;POU3F2;MYT1L;CTNNB1;FZD3;TENM2;TENM1;SNPH;OPHN1
prerank,positive regulation of cell killing (GO:0031343),-0.2867084016298096,-0.7291441844198261,0.8238213399503722,0.979544262455781,1.0,5/13,27.34%,WNT5A;FZD7;MAPK8;SYK;NOXO1
prerank,regulation of immunoglobulin production (GO:0002637),0.30552518304834597,0.7291011795484068,0.799410029498525,0.9654261567269221,1.0,2/23,5.16%,FCGR2B;GPI
prerank,regulation of myoblast fusion (GO:1901739),0.35409294051621776,0.7288836001064936,0.7890070921985816,0.9653206187197271,1.0,3/11,16.98%,EHD1;ADGRB1;MAPK14
prerank,regulation of programmed necrotic cell death (GO:0062098),0.30693297612454146,0.7287081341627554,0.8119266055045872,0.9651164401104212,1.0,2/20,2.47%,CASP8;SPATA2
prerank,negative regulation of neuron death (GO:1901215),0.24438761745885337,0.7285010697897236,0.8752969121140143,0.9649673682080179,1.0,33/93,27.53%,FOXQ1;PPT1;FBXO7;MEF2C;CD34;TNFRSF1B;TOX3;LRRK2;CD200;PRKCG;VPS35;CHGA;FZD9;FGF20;KDM2B;UNC5B;NENF;BDNF;GSK3B;CD200R1;SORL1;SOD1;EIF4G1;GRN;ATP13A2;CSF1;CLCF1;GDNF;SNCA;CHMP4A;CHMP4B;TRAF2;RASA1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24581217034292935,0.7284211983182088,0.8722891566265061,0.9646550578197864,1.0,22/87,23.04%,OMA1;TMEM126B;SCO1;UQCC3;SLC25A33;IMMP2L;NDUFS4;NDUFA12;NDUFB5;NDUFB7;UQCRFS1;TIMMDC1;ACAD9;NUBPL;SAMM50;PET100;NDUFB4;UQCC2;NDUFA9;NDUFV1;BCS1L;NDUFC1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33927501679127964,0.7278439648052607,0.8003472222222222,0.9649797048836052,1.0,3/13,10.51%,SHISA8;SHISA6;GRIK2
prerank,synaptic vesicle cycle (GO:0099504),0.2879649647136913,0.7276433168700731,0.8325925925925926,0.9648407009512947,1.0,8/30,26.91%,SYT7;PIP5K1C;SLC32A1;CPLX1;NLGN1;RIMS1;PLD2;SNCA
prerank,RNA metabolic process (GO:0016070),0.23509710072847068,0.7275902901120838,0.8937853107344633,0.9644762559917309,1.0,31/127,19.86%,ADARB1;RBPMS;LSM1;SETX;HNRNPA0;ZC3H12A;POLR2G;ADAR;ELAVL4;DHX9;DKC1;DUSP11;POLR2D;HNRNPK;AGO4;RNASE1;RNASEH2B;XRN2;PCBP1;METTL14;RNASE6;HNRNPH2;ATXN1;PRPF4;POLR2I;DROSHA;TENT2;DDX39B;HNRNPUL1;RNASE4;SYNCRIP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2001230244913984,-0.7271865690099768,0.9213973799126638,0.9809176202679397,1.0,23/56,28.67%,ROCK2;SON;IST1;JTB;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;DCTN3;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19;NUSAP1;CKAP2;RHOA;SNX33;CIT;ALKBH4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.21093313796725938,-0.7270941631079704,0.9367588932806324,0.9800167973061867,1.0,10/50,14.55%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;BCL2L12;DDX3X;PIH1D1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.27722390919642875,0.7268895570613447,0.8355614973262032,0.9649970553271092,1.0,8/41,16.90%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR;HAVCR2;RARA
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3232104490457936,0.7268634938305568,0.7788309636650869,0.9646097015326124,1.0,2/15,9.31%,FAM107A;ZFP36L2
prerank,positive regulation of peptidase activity (GO:0010952),0.3109426467020633,0.7267961245442736,0.7968253968253968,0.9642890208873868,1.0,8/20,27.71%,APH1A;VSIR;CTSH;APH1B;NCSTN;GRN;TANK;DDRGK1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3215863139984614,0.7267662870982555,0.7981072555205048,0.9638987571716565,1.0,3/14,8.68%,TNFRSF1B;CD200;NR1D1
prerank,myelin maintenance (GO:0043217),-0.31768399873628284,-0.7265829968262179,0.7965686274509803,0.9795867312147211,1.0,2/10,9.10%,EPB41L3;DEGS1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.29525952653124954,0.7264542851517695,0.7936962750716332,0.963896701262644,1.0,5/25,18.61%,HSPA1B;HSPE1;PTGES3;DNAJC7;DNAJB5
prerank,regulation of biosynthetic process (GO:0009889),0.34486005246681734,0.7258085233696765,0.7913188647746243,0.9643490338363787,1.0,1/11,6.64%,SLC25A33
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.25139644039053666,-0.7249376769424972,0.8861538461538462,0.9805320483881543,1.0,12/23,37.33%,HSPA4;NDUFA13;COX18;TOMM22;ROMO1;TIMM29;BAD;BAX;TIMM10;TIMM9;PMAIP1;TIMM13
prerank,regulation of mitotic spindle assembly (GO:1901673),0.30998923620083807,0.7246238625658659,0.7889221556886228,0.9655013615897279,1.0,10/19,29.78%,HSPA1B;CHMP1B;CHMP3;CHMP2B;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A
prerank,aminoglycan metabolic process (GO:0006022),-0.31121932858939433,-0.724442703343239,0.8321167883211679,0.9801429837566639,1.0,4/10,23.66%,XYLT1;B3GAT3;B3GAT1;CLN6
prerank,cellular response to glucose stimulus (GO:0071333),0.2836648434407688,0.7237793603512203,0.8261494252873564,0.9662431133932872,1.0,3/30,8.29%,UNC13B;PCK2;PRKAA1
prerank,UV-damage excision repair (GO:0070914),-0.29318261939545304,-0.7234837414251007,0.8364611260053619,0.9802944756754773,1.0,2/12,7.98%,DDB2;CUL4B
prerank,positive regulation of DNA recombination (GO:0045911),-0.23426365341598188,-0.7232587760961108,0.8774193548387097,0.9795750135173603,1.0,8/27,22.28%,KMT5C;FUS;KMT5B;ACTR2;ERCC2;FANCB;TIMELESS;PARP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2907502305825812,-0.7231964584974802,0.8037825059101655,0.9786623181999139,1.0,1/12,1.83%,NUPR1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.29390858604895054,0.7225496321862867,0.8220858895705522,0.9674788566329152,1.0,6/24,14.25%,TGFB2;ITGAM;FBXW7;PRNP;TYROBP;CTNNB1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3304513214210728,0.7224603042749261,0.7895595432300163,0.9671796505297254,1.0,2/12,11.61%,SERINC3;SERINC5
prerank,histone H4 acetylation (GO:0043967),0.2648285349617999,0.7223254921160456,0.8406374501992032,0.966927731149004,1.0,9/47,15.52%,ING3;LEF1;BRD8;JADE2;CHD5;DMAP1;KANSL1;KAT7;TRRAP
prerank,erythrocyte differentiation (GO:0030218),0.27044503192986974,0.7219732684050917,0.8373655913978495,0.966969145688205,1.0,6/44,8.61%,TAL1;ALAS1;MFHAS1;JAK2;RPS14;KMT2E
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.34340539996483505,0.7215442463678671,0.7879799666110183,0.9666752713943955,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.34340539996483505,0.7215442463678671,0.7879799666110183,0.9666752713943955,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.31663709313992494,-0.7215101708692984,0.8325242718446602,0.9797814696862239,1.0,2/10,6.40%,DCN;XDH
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2597850637870473,0.7214132135538628,0.85359477124183,0.9664372975101911,1.0,15/52,22.72%,CASP8;PPP1R13B;BBC3;NMT1;FBXW7;UBE2J2;YWHAH;UBE2D3;GSK3A;BID;TOMM7;PPP3CC;SREBF2;LEPROT;PPP3R1
prerank,tRNA export from nucleus (GO:0006409),0.2785191922264484,0.7211152015060391,0.8213256484149856,0.9659801135775116,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2785191922264484,0.7211152015060391,0.8213256484149856,0.9659801135775116,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.32024591391528134,0.7204330872080146,0.791869918699187,0.9664477489951252,1.0,4/15,16.98%,EHD1;TYROBP;ADGRB1;MAPK14
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2720221262527751,0.7203413120201048,0.8447368421052631,0.9661590065868276,1.0,6/43,10.88%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR
prerank,regulation of chromosome organization (GO:0033044),-0.2477626015936114,-0.7199973604794493,0.8558282208588958,0.9804939370947798,1.0,11/22,37.71%,YLPM1;XRCC5;HDAC8;SETMAR;RMI2;LIG4;HNRNPD;SMG6;UPF1;MYC;PIF1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.28046739027126893,0.7199768772172516,0.8085991678224688,0.9662425916277925,1.0,4/31,13.96%,FCGR2B;ARG1;TYROBP;ATM
prerank,purine nucleotide metabolic process (GO:0006163),0.29334699703584416,0.7199597195665363,0.8328611898016998,0.9658411137654427,1.0,2/24,3.76%,GDA;GART
prerank,protein import into mitochondrial matrix (GO:0030150),0.3153261231102953,0.7198279109073678,0.7990654205607477,0.9655998121884873,1.0,3/18,15.95%,TOMM20L;DNLZ;PAM16
prerank,protein transport (GO:0015031),0.21814480254463622,0.7198190550366573,0.9580777096114519,0.9651910191619413,1.0,79/332,22.04%,RABGAP1;ARHGEF2;MACF1;RAB6B;ARL6IP5;HERC2;PPT1;STX7;TBC1D30;SCG5;EHD1;SGSM1;RAB34;TBC1D8;TMED10;MYH9;ARRDC1;RAB23;RAB3GAP2;LMTK2;HSP90B1;MCOLN1;TBC1D12;TLK1;TBC1D5;STX12;TBC1D1;CHMP1B;ARF3;LAPTM5;NPM1;VPS35;CLU;TMED9;RAB19;STX19;CHMP3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;TBC1D9;NSF;VLDLR;TMED4;RUNDC1;TANGO6;CHMP2B;ARL5B;ANK3;ARFIP2;SEL1L;RUFY1;ATP6V1G1;SPTBN1;GOLPH3L;ARL4C;ATP6V1C1;TBC1D8B;GOLPH3;LAMP2;RAB5C;TVP23A;TMED7;ATP6V0A1;REP15;RAB31;LRP1B;ARRDC4;ATP6V1D;SCAMP1;RAB12;AP3D1;MYO6;ARHGAP1;CHMP1A;TBC1D14
prerank,triglyceride homeostasis (GO:0070328),0.29095796862373646,0.7193591934974067,0.8411078717201166,0.9653719276002233,1.0,2/26,3.48%,HNF4A;APOA1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2539822911270891,-0.719264979946108,0.8909657320872274,0.980368405708805,1.0,5/21,14.79%,PRKN;TXNDC12;CREB3L1;CREB3;BOK
prerank,postreplication repair (GO:0006301),0.26972877155907454,0.718576470579076,0.8845637583892617,0.9659402613681921,1.0,9/45,15.87%,USP43;POLK;UBA52;RPS27A;TRIM25;BRCA1;RAD18;RFC2;SPRTN
prerank,sensory perception of pain (GO:0019233),0.3048611212950807,0.7176612943089844,0.8208955223880597,0.9667496294345921,1.0,4/21,13.50%,NIPSNAP1;P2RX7;ALOXE3;SCN9A
prerank,ribosomal large subunit assembly (GO:0000027),0.29769296799975725,0.7174816974139235,0.8111587982832618,0.9665674912926563,1.0,14/24,32.17%,BOP1;DDX28;RPL23A;RSL24D1;NOP53;RPF2;RPL3;MDN1;RPL11;FASTKD2;NOP2;RPL10;NLE1;RPL6
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.29623645561945705,0.7172163113450242,0.7966867469879518,0.9665079317801681,1.0,3/21,12.42%,PGM2L1;GPI;TALDO1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2897721033489949,0.7168200087973258,0.8113207547169812,0.9665976418515396,1.0,3/23,13.49%,PLK3;VPS4A;BUB1
prerank,organonitrogen compound catabolic process (GO:1901565),0.2542589429513502,0.7167261385605328,0.8595360824742269,0.9663044914809732,1.0,4/57,6.51%,ACE;TST;PPT1;TRIM24
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.307297800993569,0.7164296369144973,0.8366718027734977,0.9662816258610798,1.0,6/20,18.51%,NOTCH1;NFE2L2;CHD6;HIF1A;SMAD4;RELA
prerank,negative regulation of protein transport (GO:0051224),-0.2411137232792392,-0.716356230175458,0.8984615384615384,0.9827206765917053,1.0,8/25,21.97%,APOE;PKDCC;SNX12;DRD2;SERGEF;RHBDF1;CYP51A1;ERP29
prerank,rRNA transcription (GO:0009303),0.3141755034403297,0.7161450531261274,0.7941653160453809,0.9662394376917047,1.0,6/17,21.04%,CAVIN1;TAF1B;TCOF1;SPIN1;ANG;BRF1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2955116601433705,-0.7153360769842618,0.7963446475195822,0.9828714136557127,1.0,1/12,1.76%,BMP7
prerank,negative regulation of histone acetylation (GO:0035067),-0.30402663179338374,-0.7151971188539111,0.8465227817745803,0.9820257690874113,1.0,3/11,18.93%,SET;TAF7;NOC2L
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.34841710207892856,0.7150673795994931,0.7917355371900826,0.9672435181102906,1.0,4/10,23.10%,APEX1;TERF2IP;RIF1;TERF2
prerank,ubiquinone biosynthetic process (GO:0006744),0.3226351429744513,0.7149390620147199,0.8207236842105263,0.96698924689213,1.0,6/15,22.40%,COQ3;PDSS2;PDSS1;COQ5;COQ7;NDUFA9
prerank,positive regulation of transporter activity (GO:0032411),0.3261695860465087,0.7149083036838789,0.8019966722129783,0.9666184140331334,1.0,2/13,9.30%,STK39;SGK1
prerank,ion homeostasis (GO:0050801),0.2844931484397907,0.7143594277555293,0.8345428156748912,0.9669228358336198,1.0,5/30,10.96%,RHCG;KLHL3;CAMK2D;SLC4A9;NEDD4L
prerank,programmed necrotic cell death (GO:0097300),0.3117519756654207,0.714063433339131,0.7948717948717948,0.9668734433367382,1.0,2/18,9.55%,TLR3;MLKL
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2363890857173514,0.7139703379085032,0.9138134592680047,0.9665654023293893,1.0,22/98,18.54%,FYN;ATP2B4;CASP8;PPP1R13B;DPP10;AKAP5;STAC;BBC3;ITGAM;NMT1;MYO1C;PRNP;NKD2;YWHAH;ITGB1BP1;ITGA3;CNPY4;ZDHHC5;ANK3;SPTBN1;NECAB2;BID
prerank,chloride transport (GO:0006821),0.2486046370942705,0.713907392111804,0.8983050847457628,0.9662278249519776,1.0,16/74,18.08%,CLIC4;SLC12A8;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;CLIC5;GABRB1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25444486697727503,-0.7137287094336697,0.8849315068493151,0.9826705120221462,1.0,1/20,0.19%,NR2F2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2743440733210831,0.7133739950923832,0.8426183844011143,0.9664902720729543,1.0,13/33,26.87%,ZBTB48;STN1;DKC1;PTGES3;NHP2;CTC1;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1
prerank,camera-type eye morphogenesis (GO:0048593),-0.2969955671663921,-0.7125220880322775,0.7938388625592417,0.9829727917364021,1.0,3/10,11.26%,SHROOM2;VEGFA;TBX2
prerank,organelle fission (GO:0048285),-0.24417535507213445,-0.7122826671846566,0.8858024691358025,0.9822794553494832,1.0,10/24,29.48%,PRKN;SEC16B;TMCC1;GDAP1;MTFR1L;DNM1L;PEX11B;MTFR2;OPA1;MTFP1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.30051065459422577,-0.7106401570906875,0.8251928020565553,0.983159718508712,1.0,3/10,20.26%,JARID2;DNMT3B;ATRX
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.28055134381254176,0.7104813523356535,0.8236994219653179,0.9697700076805132,1.0,6/30,17.43%,CAV1;HYAL2;INPP5F;NF2;SH3BP5L;PTPN2
prerank,response to light stimulus (GO:0009416),-0.19735270884388173,-0.7101859735821427,0.9365853658536586,0.9826650213745549,1.0,12/55,15.09%,DDB2;BRSK1;USP1;ERCC5;MAP2K7;CLOCK;REV1;UVSSA;MSH6;DRD2;CRY2;ERCC2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.286736351452476,0.7099860254192177,0.828080229226361,0.9699484127672139,1.0,6/27,15.52%,BRD8;MRGBP;BAG6;SGF29;KAT7;TRRAP
prerank,release of cytochrome c from mitochondria (GO:0001836),0.30933965159343035,0.7095367437019175,0.8180379746835443,0.9700894753090767,1.0,6/17,21.53%,BBC3;BCL2L1;CLU;FZD9;BID;GGCT
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.27877420301245415,0.7084623853510318,0.8433048433048433,0.9710359711065849,1.0,2/31,3.81%,GCH1;GPHN
prerank,lipid phosphorylation (GO:0046834),0.34510623117809974,0.7082715020090907,0.8209459459459459,0.9708625788129844,1.0,4/10,25.02%,DGKH;DGKI;DGKA;DGKB
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.28948338293674164,0.7082167645207479,0.8221574344023324,0.9705053799982979,1.0,4/26,9.05%,NFKBIL1;NMI;ACOD1;CACTIN
prerank,histone deubiquitination (GO:0016578),-0.25767675522365513,-0.7078273847093404,0.8709677419354839,0.9843037013032874,1.0,3/18,13.63%,USP3;USP22;ATXN7L3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.23294243631267325,-0.7077518685816476,0.9112627986348123,0.983386509900943,1.0,12/27,36.84%,CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,RNA stabilization (GO:0043489),-0.21424148537378804,-0.7076394906646702,0.9209621993127147,0.9825130684174865,1.0,11/33,23.53%,PHAX;TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;E2F1;NAF1
prerank,glycine transport (GO:0015816),-0.30136133298841494,-0.7068773771050295,0.8403755868544601,0.9823364028096907,1.0,2/10,10.91%,SLC6A9;SLC38A5
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2421520842911902,-0.7068411440112022,0.898360655737705,0.9813831214867387,1.0,5/24,13.56%,JARID2;MTF2;DNMT3A;RBBP7;MPHOSPH8
prerank,visual system development (GO:0150063),0.2708274929214741,0.7066075256691824,0.8546195652173914,0.9720907675851018,1.0,4/37,7.12%,TGFB2;SIPA1L3;ADAMTS18;ITGAM
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2941071878599321,0.7060558765325501,0.8313253012048193,0.9723598311634725,1.0,6/24,15.38%,POLK;UBA52;RPS27A;POLB;LIG1;RFC2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.30654621110857133,0.705900587660348,0.8154311649016641,0.9721290013157806,1.0,5/19,18.49%,APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3119528775141955,0.7054597213330227,0.8415213946117274,0.9722800435993006,1.0,6/18,21.58%,IFNGR1;EFNA1;CLU;GSK3A;RELA;EPHA4
prerank,transcription by RNA polymerase III (GO:0006383),-0.22755642187665742,-0.7052780474808937,0.9049180327868852,0.9821580278330764,1.0,11/27,31.26%,GTF3C3;ELL;CRCP;GTF3C2;GTF3A;TBP;GTF3C1;POLR3K;GTF3C4;POLR2L;SNAPC2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2606986029557125,0.705191960103199,0.8770053475935828,0.9721833017667143,1.0,12/49,18.71%,TNRC6C;MEF2C;THPO;KMT2E;KMT2B;AGO4;CBFB;HMGB2;EIF6;RBM15;SIN3A;H3-3A
prerank,body fluid secretion (GO:0007589),-0.26455474077318253,-0.705083180299735,0.8487179487179487,0.9813708522548759,1.0,4/15,19.55%,SLC22A4;VEGFA;SLC22A2;ZBTB7B
prerank,protein localization to kinetochore (GO:0034501),0.32549664114897425,0.7049743477116089,0.8051529790660226,0.9720221410612045,1.0,2/14,8.02%,IK;MTBP
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2526979550020048,0.7042632147987836,0.8886107634543179,0.9725093464418804,1.0,4/63,7.82%,VCAM1;TIRAP;MEF2C;SLC7A1
prerank,fatty acid beta-oxidation (GO:0006635),0.251702646877528,0.7041649463324255,0.8733681462140992,0.9722158073266604,1.0,18/51,22.68%,ETFDH;ETFA;ETFB;ACOX1;ACAD10;SLC27A2;HADHB;ACOX3;CROT;ECI1;ACAT1;DECR2;HADHA;HADH;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,positive regulation of blood coagulation (GO:0030194),0.3067547476887291,0.7038006693789854,0.8325434439178515,0.9722502732347418,1.0,2/17,4.92%,ANO6;ENPP4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2564690628125693,-0.7034217217799889,0.8575342465753425,0.9821432453819265,1.0,5/17,17.88%,PRKN;MDM2;SNAI1;TWIST1;CD74
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2521196557842852,-0.7031556769716774,0.8698060941828255,0.9814467683442765,1.0,6/18,18.61%,DAB2;SRC;MAP2K2;SNX12;PTPN23;EZR
prerank,positive regulation of synapse assembly (GO:0051965),0.28140351611243675,0.7031135366207637,0.8569384835479256,0.9726632263642516,1.0,9/27,22.78%,AGRN;IL1RAP;SLITRK2;LRRC4B;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3329780483162389,0.7030037857016148,0.8148148148148148,0.9723891337937686,1.0,3/11,22.21%,IPPK;PWP1;NOP53
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.34031129216736833,0.7029816439124544,0.7923211169284468,0.9720026876333111,1.0,1/10,2.67%,LGALS9
prerank,nucleotide-excision repair (GO:0006289),0.2360432858253308,0.7028365360301817,0.9154929577464789,0.9717599632739106,1.0,27/101,23.64%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;BRIP1;POLA1;POLB;GTF2H3;COPS8;LIG1;ERCC4;XPC;RFC2;POLR2I;MMS19;COPS5;HUS1;MNAT1;UBB;POLR2C;POLR2B;CETN2;POLR2J
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.28082403359042113,0.7028261916035025,0.8486171761280932,0.971357178104071,1.0,10/29,25.51%,RPS21;DHX37;RPS14;WDR46;DCAF13;PWP2;RPS19;RPS8;UTP20;RPS16
prerank,eosinophil chemotaxis (GO:0048245),0.31970867081057314,0.7025371079443427,0.8234323432343235,0.9708776775424792,1.0,14/14,68.06%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,eosinophil migration (GO:0072677),0.31970867081057314,0.7025371079443427,0.8234323432343235,0.9708776775424792,1.0,14/14,68.06%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,axonemal dynein complex assembly (GO:0070286),-0.23136740893586744,-0.7017139444366424,0.9108910891089109,0.9819824209112213,1.0,20/28,43.45%,DNAI4;DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;DRC1;CCDC39;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH8;DNAH1;SPAG1
prerank,response to gamma radiation (GO:0010332),0.2889136791832011,0.7015589522399504,0.8560830860534124,0.9716816809568986,1.0,8/24,25.80%,TMEM109;PRKAA1;ATM;MAP3K20;MEN1;WRN;YAP1;RPL26
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.31153948767527784,0.7012028921941781,0.7925117004680188,0.9717032348239026,1.0,2/15,5.77%,ING2;TAF9B
prerank,sensory perception (GO:0007600),0.25641957766534995,0.7004196204983163,0.8669301712779973,0.9722205853775361,1.0,7/45,13.50%,GNAL;NIPSNAP1;P2RX7;PCDH15;TMEM150C;ALOXE3;SCN9A
prerank,bile acid biosynthetic process (GO:0006699),0.28485558458136373,0.7001450613975665,0.8333333333333334,0.9721431167202199,1.0,4/24,14.79%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23413628674258616,0.6982657023616543,0.9097387173396675,0.9739411887572276,1.0,16/95,14.33%,RAB11A;TUBB;CSNK1D;TTBK2;TUBB4B;CLASP1;TMEM216;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;KIF24;TUBA1A;CEP83
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24192316146917794,0.6982040407447369,0.9076354679802956,0.9736076707383805,1.0,16/72,15.38%,EXD2;ZC3H12A;POLK;UBA52;DCP1B;MEI4;RPS27A;FEN1;RBX1;RNASE1;XRN2;GTF2H3;ERCC4;RNASE6;EDC3;RFC2
prerank,regulation of stem cell proliferation (GO:0072091),0.30969791543760933,0.697896094118464,0.8507692307692307,0.9735677844837062,1.0,1/17,1.04%,ACE
prerank,positive regulation of macrophage differentiation (GO:0045651),0.33191041501085694,0.6978414367128498,0.7931034482758621,0.9732096258452102,1.0,1/11,2.42%,CASP8
prerank,sterol biosynthetic process (GO:0016126),-0.2176968484658564,-0.6974050214925491,0.9273356401384083,0.9853974379259282,1.0,1/33,0.11%,PRKAG2
prerank,pentose-phosphate shunt (GO:0006098),-0.2891594771186902,-0.6973825242994193,0.8557213930348259,0.9844390779305783,1.0,5/11,27.73%,RPIA;H6PD;PGD;PGLS;SHPK
prerank,synaptic vesicle localization (GO:0097479),-0.26746249598136385,-0.697209035375265,0.8730569948186528,0.9836273314840418,1.0,5/13,23.83%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,inorganic ion transmembrane transport (GO:0098660),-0.28725853083842207,-0.6966204190709461,0.8556962025316456,0.9832402676398676,1.0,3/12,20.01%,ABCC9;CACNA1H;KCNJ8
prerank,establishment of spindle orientation (GO:0051294),-0.2279037980273525,-0.6964379620971022,0.9208860759493671,0.9824409624023793,1.0,5/28,9.84%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3004610932715287,-0.6963211675387795,0.8317073170731707,0.9815634220112016,1.0,1/10,2.70%,KIT
prerank,macromolecule catabolic process (GO:0009057),0.2796219945901991,0.6959206605814424,0.8427299703264095,0.9750703219928044,1.0,9/26,25.93%,PPT1;TRIM24;SMURF1;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;CLN8
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3082353092655604,0.695806222470987,0.8194888178913738,0.974790041149952,1.0,4/15,16.19%,PRKD1;HSPB1;PRKD2;TMSB4X
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.29507054803002974,-0.6957210823711567,0.8242574257425742,0.981151703475963,1.0,4/10,18.11%,EHMT1;SETD7;SETD4;EEF1AKMT2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.22056127102892154,-0.6956632656976076,0.9174603174603174,0.9802387947167368,1.0,11/29,27.27%,BCL2;IRS2;NCKAP1L;CD81;EPHB2;CD74;CD40;GPR183;PTPRC;CD320;NFATC2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2776797670720527,0.6952849089531418,0.8637015781922525,0.975008013420254,1.0,7/27,20.39%,MSX1;SNAI2;ATM;EEF1E1;DYRK1A;YJU2;SMYD2
prerank,response to glucose (GO:0009749),0.2589268972698906,0.6949308307704968,0.8929539295392954,0.9750297877317703,1.0,5/46,9.40%,UNC13B;HNF4A;PCK2;PRKAA1;EIF2B2
prerank,intracellular sterol transport (GO:0032366),-0.27593199014163255,-0.6943570991269377,0.8726790450928382,0.9805359264077979,1.0,1/13,2.95%,ABCA1
prerank,mRNA catabolic process (GO:0006402),0.2569329633909801,0.6940338445653577,0.8734693877551021,0.9756548673352514,1.0,18/44,25.69%,HSPA1B;ZFP36L2;AGO4;XRN2;XRN1;EXOSC9;TUT7;DXO;NBDY;LSM2;ERN1;EXOSC10;DIS3L2;NUDT16;MRTO4;RNH1;NUDT16L1;LSM5
prerank,snRNA transcription (GO:0009301),0.24160965695647374,0.6932089533285931,0.9021065675340768,0.9761797671581673,1.0,23/70,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;USPL1;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,protein targeting to mitochondrion (GO:0006626),0.2529759939617339,0.6931517797628544,0.8836265223274695,0.9758357934182652,1.0,8/52,15.95%,FBXO7;TOMM20L;IMMP2L;DNLZ;TSPO;AGK;SAMM50;PAM16
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2251697712885254,-0.6927572022528019,0.935064935064935,0.9811246461307108,1.0,5/28,9.84%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,selective autophagy (GO:0061912),0.24430469317263406,0.6927044085652656,0.8900126422250316,0.9759507089232359,1.0,14/56,21.84%,VIM;KLHL3;UFM1;UBA52;RPS27A;NBR1;DYNLL1;DYNC1LI2;ATM;ATG14;DYNLL2;DYNC1I2;UBB;USP30
prerank,cellular response to leucine starvation (GO:1990253),-0.298072204720746,-0.6925853947598635,0.8627450980392157,0.9803283626584727,1.0,3/10,15.26%,SESN1;SESN2;EIF2AK4
prerank,regulation of mitochondrion organization (GO:0010821),0.2553554570007498,0.6925684627740716,0.8869908015768725,0.9757010452120221,1.0,17/47,24.90%,OMA1;IAPP;LRRK2;FBXW7;VPS35;INF2;RHOT2;VDAC1;GSK3A;GOLPH3;PISD;PLSCR3;GSK3B;SREBF2;PARL;ATP13A2;CSNK2A2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.29880204873890504,0.6924795295005167,0.8302469135802469,0.9753925947647949,1.0,1/18,2.21%,DAB2IP
prerank,negative regulation of proteolysis (GO:0045861),0.26604535332854873,0.6923640865526497,0.8762169680111266,0.9751287437270503,1.0,6/34,11.00%,TIMP3;EFNA1;LRRK2;ROCK1;PRNP;BAG6
prerank,protein insertion into ER membrane (GO:0045048),0.264722130116284,0.6921472925761794,0.8532763532763533,0.9749550452189975,1.0,12/37,23.42%,APP;PRNP;GET1;BAG6;UBE2J2;VAPA;CCDC47;EMC3;CYB5A;EMC10;EMD;SGTA
prerank,regulation of centrosome duplication (GO:0010824),0.2753716961551167,0.6920292621305961,0.8540145985401459,0.9746683778309035,1.0,11/30,27.34%,CHMP1B;CEP76;NPM1;CHMP3;CHMP2B;CEP120;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,mitochondrial transport (GO:0006839),0.24628386880569658,0.6919844321291762,0.8978288633461047,0.9743071477197661,1.0,22/53,30.64%,SLC25A16;FBXO7;BCL2L1;TSPO;TMEM14A;BNIP3;TOMM7;PPIF;BCS1L;TIMM17A;MAIP1;PITRM1;HSP90AA1;FIS1;TIMM22;FLVCR1;TOMM70;SLC25A5;MFF;TOMM34;TIMM8B;STARD3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.34088362391615123,0.691577299361766,0.8312159709618875,0.9743471662218736,1.0,2/10,9.67%,ADAM17;FBXW7
prerank,retrograde axonal transport (GO:0008090),0.3066052105821039,0.6914581959232833,0.8409090909090909,0.9740594018151508,1.0,5/16,24.68%,DST;KIF1A;HAP1;SOD1;KIF5A
prerank,iron-sulfur cluster assembly (GO:0016226),0.2817990059480277,0.6912062285311162,0.8438880706921944,0.9739569399474874,1.0,8/24,19.32%,BOLA2;ISCA2;GLRX5;GLRX3;HSCB;NUBPL;MMS19;IBA57
prerank,canonical glycolysis (GO:0061621),0.28465293406030595,0.6905094933701361,0.8586156111929307,0.9739045740554769,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,glucose catabolic process to pyruvate (GO:0061718),0.28465293406030595,0.6905094933701361,0.8586156111929307,0.9739045740554769,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.30623307712085157,0.6904453641861035,0.8465189873417721,0.9735715984138351,1.0,3/16,13.96%,DCPS;CACTIN;SART1
prerank,maturation of SSU-rRNA (GO:0030490),0.271889758100895,0.6902516782544813,0.8599439775910365,0.9733872155639821,1.0,10/34,21.86%,DHX37;RPS14;WDR46;RPS28;RIOK3;NOB1;DCAF13;PWP2;RPS19;RPS8
prerank,melanosome organization (GO:0032438),-0.2231026072587149,-0.6901149781002253,0.9230769230769231,0.9816809719691265,1.0,9/26,22.24%,SHROOM2;AP1M1;KIF13A;DTNBP1;HPS4;RAB29;BLOC1S2;RAB32;TRAPPC6A
prerank,mitotic DNA replication (GO:1902969),0.3306374239480272,0.6900739049394048,0.8241206030150754,0.9731751381395218,1.0,2/10,13.14%,POLA1;LIG1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.22835019341043034,-0.6898223205445393,0.9066265060240963,0.9809936416466007,1.0,4/27,12.44%,UBE2E2;PRKN;RNF4;UBE2L3
prerank,regulation of B cell proliferation (GO:0030888),0.25871553964067506,0.6896817753171437,0.8842530282637954,0.9732133577772144,1.0,6/44,13.96%,TIRAP;FCGR2B;MEF2C;TYROBP;CD38;ATM
prerank,rRNA pseudouridine synthesis (GO:0031118),0.33443738020063773,0.6894974778347351,0.8399339933993399,0.9730310717326618,1.0,3/10,17.96%,DKC1;NHP2;RPUSD2
prerank,mitochondrial genome maintenance (GO:0000002),0.3340303460112639,0.6893115976087165,0.8406040268456376,0.9728480835397106,1.0,2/11,6.91%,SLC25A33;AKT3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2543993801908334,0.6893108764599124,0.8896366083445492,0.9724381180599215,1.0,4/46,8.90%,FBXO7;TOMM20L;DNLZ;TSPO
prerank,protein kinase B signaling (GO:0043491),0.2830535239286628,0.6891073674561403,0.8354430379746836,0.9722512581692473,1.0,2/23,6.67%,PLK3;SETX
prerank,intracellular pH reduction (GO:0051452),-0.2157121160278339,-0.6880141698012606,0.9397163120567376,0.981771370874106,1.0,16/33,34.14%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2;ATP6V0C;GPR89B;GPR89A;DMXL1;ATP6V0E2;SLC11A1;TMEM9;RAB20
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22334060136390704,0.6877206185100181,0.940628637951106,0.9734185042050074,1.0,9/110,6.98%,FBLIM1;TAL1;MMP1;DAB2IP;TIRAP;HRK;IAPP;WARS1;IRGM
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.27014951440897134,0.687589191677417,0.8555240793201133,0.9731510748417409,1.0,12/30,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,peptidyl-lysine modification (GO:0018205),0.22642565085372693,0.6875402511770329,0.9166666666666666,0.9727997469306423,1.0,16/99,14.41%,IFIH1;HDAC9;ATP7A;SUMO2;SUMO3;LIPT2;SIRT4;RANGAP1;SENP5;NUP54;NUP35;RANBP2;LIPT1;NUP153;NUP160;NUP42
prerank,nucleocytoplasmic transport (GO:0006913),0.2532324702663355,0.6873725906898619,0.8781163434903048,0.9725784749512478,1.0,11/40,23.15%,BACH2;XPO1;SNRPE;NPM1;RSRC1;ATXN1;NUP205;MALT1;GEMIN8;LSG1;NXT2
prerank,telomere organization (GO:0032200),0.25294516167950143,0.6866706276615471,0.8803191489361702,0.972958985463584,1.0,16/43,26.09%,APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;H3-3A;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,regulation of leukocyte migration (GO:0002685),0.29814507610273555,0.6864221095399456,0.8242811501597445,0.9728265413778229,1.0,3/16,13.75%,TNFRSF18;RAC1;RHOH
prerank,regulation of TOR signaling (GO:0032006),0.23578020784805354,0.686406531539399,0.9096612296110415,0.9724371461618047,1.0,27/67,26.69%,SMCR8;SH3BP4;WDR59;PRKAA1;RRAGD;RHEB;EPM2A;RICTOR;MIOS;GSK3A;GOLPH3;RRAGA;MAPKAPK5;HTR6;RRAGC;NPRL3;LAMTOR3;AKT1S1;WDR24;PIK3CA;ITFG2;SEH1L;MLST8;RPTOR;TBC1D7;LAMTOR4;PDCD6
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.27568909790662943,0.6861767679749439,0.8663729809104258,0.9722815953820813,1.0,3/26,7.15%,APP;SHANK3;LRRK2
prerank,glutathione biosynthetic process (GO:0006750),0.3214493444350516,0.6850997813142781,0.8531353135313532,0.9730883916480502,1.0,6/11,29.63%,GSS;CHAC2;GGCT;GCLM;OPLAH;CNDP2
prerank,sarcomere organization (GO:0045214),0.2791174175588278,0.6849942219127254,0.8704819277108434,0.9727947489326715,1.0,3/27,7.79%,CSRP2;WDR1;CASQ1
prerank,nuclear membrane reassembly (GO:0031468),0.2430161528839041,0.6842224455398412,0.9021879021879022,0.9732308150806339,1.0,12/54,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.28246861149561764,0.6840638118957476,0.8480620155038759,0.9726143820278637,1.0,3/22,18.22%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.28246861149561764,0.6840638118957476,0.8480620155038759,0.9726143820278637,1.0,3/22,18.22%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,protein heterooligomerization (GO:0051291),0.29750708607579307,0.6833390763047605,0.8407224958949097,0.9730180966745966,1.0,5/17,20.81%,FARSB;GRIN2B;KCNC2;MAT2A;TMEM120B
prerank,regulation of dendrite morphogenesis (GO:0048814),0.26823210166613315,0.6824337271591705,0.8704512372634643,0.9736164924420904,1.0,5/32,14.86%,RAPGEF2;LZTS1;NEDD4L;YWHAH;SARM1
prerank,protein targeting (GO:0006605),0.22073428189024913,0.6823532739228985,0.9456398640996603,0.9732978839161593,1.0,21/118,21.52%,AQP11;ZDHHC22;NACAD;FBXO7;SRP14;RASSF9;MYO1C;TSPO;TAOK2;SRPRA;ZDHHC14;LONP2;ZDHHC23;HAP1;LAMP2;TOMM7;ZFAND2A;GIPC1;PEX1;SORL1;NLGN1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2367973694129353,-0.6820191655492417,0.8765060240963856,0.9863890853203611,1.0,8/21,29.58%,CYP26B1;PLA2G15;AGXT;NUDT19;FAAH;PPARD;LPIN3;LPIN1
prerank,mucosal immune response (GO:0002385),0.30657160711572673,0.6806411912278124,0.8421875,0.9747778205315618,1.0,1/15,4.04%,DEFA6
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.253476071638698,0.6800307394502944,0.8849104859335039,0.9750670797631027,1.0,6/48,9.11%,F2RL1;APOA1;ARG1;NLRC5;CACTIN;STAP1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.26267666696181957,-0.6798492263090711,0.8903394255874674,0.9874161258606777,1.0,4/14,15.73%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,histone H4 deacetylation (GO:0070933),0.32443391839993385,0.6795491513733606,0.8542024013722127,0.9751690391482419,1.0,2/10,11.79%,HDAC9;SMARCAD1
prerank,positive regulation of phosphatase activity (GO:0010922),0.2868230817086071,0.6792306470857143,0.8318181818181818,0.9751072528941769,1.0,4/21,14.73%,ITGA1;MEF2C;CALM3;PPP1R15B
prerank,RNA interference (GO:0016246),-0.2464036990571422,-0.6787774818300256,0.9030303030303031,0.9874317575043225,1.0,6/17,25.17%,DICER1;TERT;AGO3;TSNAX;CELF1;MRPL44
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2909717325885801,0.678679122248724,0.8569230769230769,0.9752938731215534,1.0,4/18,13.65%,HSPB1;NFE2L2;HIF1A;NOL3
prerank,RNA catabolic process (GO:0006401),0.24920404204844607,0.6776317559581624,0.8985507246376812,0.9760069182562123,1.0,17/46,25.69%,HSPA1B;FEN1;ZFP36L2;AGO4;RNASEH2B;XRN2;RNASE6;DXO;LSM2;ERN1;DIS3L2;NUDT16;RNASEH2A;RNASEH1;RNH1;NUDT16L1;LSM5
prerank,positive regulation of behavior (GO:0048520),0.32388750885634215,0.6768843456248154,0.8608837970540099,0.976451318150595,1.0,1/10,5.32%,MEF2C
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3070900860928571,0.6764157030597042,0.8523274478330658,0.976538096054144,1.0,4/15,22.19%,HGD;KYAT1;KYNU;QDPR
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2855455735523569,0.6762849594489537,0.8630952380952381,0.9762605063591907,1.0,3/23,12.22%,ASAH2;ACSBG1;ALOXE3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.23640048018779974,-0.676072424891777,0.9202279202279202,0.988784594094973,1.0,1/22,0.19%,NR2F2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.2734299943489562,-0.6758561069390068,0.8844086021505376,0.988013627989883,1.0,6/13,30.29%,DDO;GOT1;QPRT;ASPA;GOT2;ACSF3
prerank,negative regulation of synaptic transmission (GO:0050805),0.2747941004432317,0.6754661960763746,0.9011976047904192,0.9767490757623296,1.0,6/23,23.24%,LRRK2;SLC30A1;ACHE;SLC24A2;SHANK2;MTMR2
prerank,purine-containing compound catabolic process (GO:0072523),0.312253538510739,0.675379409417462,0.855072463768116,0.9764289311990325,1.0,1/13,1.85%,GDA
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2857722032157094,-0.6741616496127217,0.8674418604651163,0.9885370489298744,1.0,3/10,19.47%,MFSD2A;PHB2;MTMR4
prerank,protein heterotetramerization (GO:0051290),0.3065989657550819,0.6738443572841926,0.8289036544850499,0.9776869620788096,1.0,2/13,8.37%,FARSB;GRIN2B
prerank,chromatin remodeling at centromere (GO:0031055),-0.21345465222021512,-0.6736141312643805,0.9433333333333334,0.9880218006145249,1.0,15/31,31.92%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPA
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.33075189843142777,0.6735916247871034,0.8373287671232876,0.9771298704570697,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,DNA dealkylation (GO:0035510),0.33075189843142777,0.6735916247871034,0.8373287671232876,0.9771298704570697,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,positive regulation of nervous system development (GO:0051962),0.25489354799233205,0.6734675691213995,0.9128065395095368,0.9768561036461616,1.0,14/42,22.89%,RASSF10;IL1RAP;NUMB;SLITRK2;CX3CR1;LRRC4B;SPEN;SOX11;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1;MME
prerank,actin nucleation (GO:0045010),0.27951846416978926,0.6734107067817271,0.8588410104011887,0.976510845457831,1.0,8/21,27.87%,WHAMM;ARPC5;ARPC3;ARPC2;SPIRE1;ARPC1B;WASHC1;ARPC1A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2327789842334218,0.673211051441668,0.9116915422885572,0.9763092524509618,1.0,15/71,18.78%,CASP8;OMA1;RHBDD1;SOCS6;UBA52;RPS27A;NR1D1;BAG6;RSPRY1;VPS4A;PSMA8;CTSK;CTSO;NGLY1;MALT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24548843781516244,0.6721322165219434,0.900131406044678,0.9770023045562742,1.0,10/48,16.66%,TMEM109;CASP2;TNFRSF1B;CIDEB;BCL2L1;BAG6;BRCA1;ATM;PHLDA3;PYCARD
prerank,double-strand break repair (GO:0006302),0.21376021119341812,0.6716760110656594,0.9703296703296703,0.9770775023732634,1.0,26/158,14.54%,RAD54B;HERC2;RBBP8;RAD21;SETX;EXD2;TENT4A;FEN1;HMGB1;BABAM2;SPIDR;MAD2L2;SFR1;BRIP1;POLA1;POLB;PSMD14;BRCA1;SMARCAD1;DTX3L;AP5Z1;EYA3;ERCC4;RAD51D;ATM;HMGB2
prerank,regulation of synapse organization (GO:0050807),0.2753323042422387,0.6709158745636841,0.8740849194729137,0.9774478821280616,1.0,7/26,22.78%,PDLIM5;MEF2C;CTNNA2;SLITRK2;ABHD17B;EPHA4;IL1RAPL1
prerank,regulation of cholesterol esterification (GO:0010872),0.3240549218210613,0.6699873692741267,0.8392226148409894,0.977979619126279,1.0,1/10,3.48%,APOA1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.29109406327574505,0.6698767440027178,0.8669590643274854,0.9776924072471753,1.0,4/19,13.09%,SULT6B1;SLC35B3;BPNT1;PAPSS1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.2748643291689237,-0.6695448272230278,0.8933002481389578,0.9905114073131592,1.0,2/11,7.94%,EFNB2;FZD7
prerank,histone H2A monoubiquitination (GO:0035518),-0.25274180441025146,-0.6691547845298877,0.8951841359773371,0.9898741770200988,1.0,3/17,7.98%,DDB2;PCGF3;CUL4B
prerank,cellular amide metabolic process (GO:0043603),0.2216960244896074,0.6691051080228069,0.9509345794392523,0.9780986684432508,1.0,7/102,5.93%,ACSM3;SLC25A32;CPD;PLPP1;GLYAT;DNPEP;ASAH2
prerank,positive regulation of bone resorption (GO:0045780),0.3197448476796537,0.6686420265539735,0.8523489932885906,0.9782047921924792,1.0,2/11,7.52%,MC4R;PLEKHM1
prerank,positive regulation of protein acetylation (GO:1901985),0.3162330804177589,0.6683888429767794,0.8444846292947559,0.9780586456830425,1.0,4/12,18.35%,FAM161A;PRKAA1;DIP2B;TERF2IP
prerank,DNA methylation or demethylation (GO:0044728),0.28641135417618485,0.6682749157730552,0.8605769230769231,0.9773639775005848,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,DNA alkylation (GO:0006305),0.28641135417618485,0.6682749157730552,0.8605769230769231,0.9773639775005848,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,t-circle formation (GO:0090656),-0.28447861390074153,-0.6682642244694508,0.8756218905472637,0.9877087451317419,1.0,6/10,38.40%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.28447861390074153,-0.6682642244694508,0.8756218905472637,0.9877087451317419,1.0,6/10,38.40%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.28447861390074153,-0.6682642244694508,0.8756218905472637,0.9877087451317419,1.0,6/10,38.40%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,osteoclast differentiation (GO:0030316),0.28283257994085076,0.6680826592937061,0.8624813153961136,0.9771663070178659,1.0,7/22,22.01%,SNX10;OSCAR;FOXP1;TYROBP;MAPK14;TNFRSF11A;EPHA2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2784522547248955,-0.667565651638864,0.8830845771144279,0.9863377260545315,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,cellular response to interleukin-2 (GO:0071352),-0.2784522547248955,-0.667565651638864,0.8830845771144279,0.9863377260545315,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,hyaluronan catabolic process (GO:0030214),0.2890533645446644,0.6666455883546877,0.8660436137071651,0.9782930858067143,1.0,2/18,5.33%,CEMIP2;HYAL2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23284987152120332,0.6663579341020255,0.9256505576208178,0.9782034091324026,1.0,22/69,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2529541402992756,0.6661596290138196,0.8916666666666667,0.9779976708813877,1.0,10/39,21.23%,RPS14;RPS28;NPM1;RPS25;RPS5;RIOK3;RPS15;NOB1;PWP2;RPS19
prerank,steroid hormone biosynthetic process (GO:0120178),-0.21907028748683083,-0.6659682830161011,0.951310861423221,0.9867322001963634,1.0,9/29,28.27%,FDX1;AKR1B1;HSD17B8;STAR;SRD5A1;HSD17B11;HSD17B2;TSPOAP1;SRD5A3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.28960530735606754,0.6659096844812731,0.8608562691131498,0.977857899526167,1.0,1/18,1.60%,NOTCH1
prerank,peptide catabolic process (GO:0043171),0.27211513371663426,0.6656890332212205,0.8916544655929722,0.9776675546766127,1.0,1/23,1.04%,ACE
prerank,ncRNA export from nucleus (GO:0097064),0.25239323227306526,0.6647642914302291,0.8939828080229226,0.9781674560301721,1.0,9/36,15.93%,NUP54;NUP35;RANBP2;NPM1;NUP153;NUP160;RAN;NUP42;NUP205
prerank,cellular lipid catabolic process (GO:0044242),0.2699509424735757,0.6639364121027146,0.875748502994012,0.9786142051806742,1.0,2/27,8.17%,AOAH;ACOX1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.32259177299913033,0.663528732932169,0.8189368770764119,0.9786262886933694,1.0,2/10,10.36%,PDCD4;AIDA
prerank,negative regulation of double-strand break repair (GO:2000780),-0.21048393595171855,-0.6632390417678777,0.9435215946843853,0.9880652288137399,1.0,10/30,25.09%,TRIP12;FBH1;HELB;HMGA2;TWIST1;KLHL15;FANCB;CGAS;POLQ;RMI2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3255818726559375,0.6630783799858717,0.8524305555555556,0.978663455797203,1.0,3/10,14.82%,CX3CR1;CTNNB1;FZD3
prerank,placenta development (GO:0001890),0.30745464900290626,0.662927643114761,0.8382838283828383,0.978412553382331,1.0,4/12,22.31%,PTK2;E2F7;ANG;SOD1
prerank,carnitine metabolic process (GO:0009437),-0.2618620196123974,-0.6628274506054789,0.8955613577023499,0.9874306378852066,1.0,5/12,21.85%,CPT1C;ACADM;TMLHE;CPT2;BBOX1
prerank,glycolytic process (GO:0006096),0.2631578626415653,0.6627752413615073,0.8945868945868946,0.9781585145049095,1.0,3/28,8.83%,GPI;PGK1;GAPDH
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24829067854968703,0.6626910124544173,0.916445623342175,0.9778449522568203,1.0,5/46,8.73%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2957990194871706,0.662297297800642,0.8380952380952381,0.9778456362969086,1.0,3/15,18.07%,HOMER2;GRM5;GRM7
prerank,positive regulation of double-strand break repair (GO:2000781),-0.19812130944526932,-0.6622841595876556,0.9616858237547893,0.9869491538495063,1.0,11/39,22.28%,KMT5C;SLF1;FMN2;FUS;KMT5B;ACTR2;FANCB;TIMELESS;PARP3;SLF2;PARP1
prerank,chromosome condensation (GO:0030261),-0.20927712341799393,-0.6622393770814509,0.9501779359430605,0.9860293437274076,1.0,15/36,29.09%,SET;NCAPG2;AKAP8L;GPER1;NCAPH2;INCENP;NCAPD2;PHF8;H1-0;NUSAP1;TOP2A;KMT5A;ACIN1;NCAPH;TTN
prerank,apoptotic mitochondrial changes (GO:0008637),-0.20636057562416713,-0.6621800062277033,0.9559322033898305,0.9851122518642172,1.0,7/32,14.79%,BCL2;IFIT2;ATG3;AIFM2;HK2;THEM4;BOK
prerank,Golgi localization (GO:0051645),-0.2737791968606739,-0.6619343128680808,0.8943488943488943,0.9843380866699978,1.0,3/11,15.51%,COPG1;ARCN1;ARHGAP21
prerank,response to ionizing radiation (GO:0010212),0.22848179522835735,0.6615131553879823,0.9325980392156863,0.9782323832990936,1.0,25/70,26.40%,RHOB;BRAT1;PRKAA1;BABAM2;SPIDR;BRCA1;EYA3;RAD1;ATM;RAD9B;KDM4D;MAPK14;MEN1;EEF1D;HUS1;BLM;ECT2;XRCC4;PAXIP1;NHEJ1;XRRA1;BABAM1;COP1;MTA1;RNF8
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2640562319107283,0.6609960912468374,0.8798842257597684,0.9783689129206221,1.0,4/29,10.63%,TRIM6;NLRC5;CACTIN;PTPN1
prerank,regulation of DNA recombination (GO:0000018),-0.2096471809286314,-0.6603327835469083,0.9547038327526133,0.9847336919204275,1.0,12/32,29.63%,RAD50;KPNA1;THOC1;MSH6;RTEL1;ZRANB3;H1-0;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6
prerank,icosanoid biosynthetic process (GO:0046456),-0.2779448798473867,-0.6602911722503514,0.8959810874704491,0.9838158452868513,1.0,5/10,36.56%,PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3103401199690538,0.6602277187531783,0.8646003262642741,0.9787184291230477,1.0,4/12,21.72%,CAD;UMPS;UPP2;TK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2030130677594069,0.660039606286992,0.987434554973822,0.9785032409600785,1.0,62/241,23.91%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20299324469180627,-0.6599158703247467,0.9469964664310954,0.983179391103092,1.0,14/32,30.04%,RRN3;TAF1D;TAF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP;POLR1E;POLR2L
prerank,negative regulation of hippo signaling (GO:0035331),0.31664908035398165,0.6598011072382571,0.8548387096774194,0.9783423979540117,1.0,4/12,19.90%,WWC2;MARK3;MAPK14;SHANK2
prerank,autophagosome organization (GO:1905037),0.23841136813934025,0.6596632786101216,0.9118421052631579,0.9780721449077723,1.0,10/50,16.99%,ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2586896009052725,0.659619270058645,0.9040114613180515,0.9777155150874026,1.0,8/30,20.46%,MACF1;RAB34;NSF;ANK3;SPTBN1;GOLPH3L;GOLPH3;RAB31
prerank,regulation of telomere capping (GO:1904353),0.27276628761913,0.6592524188976008,0.9042553191489362,0.9776817079996061,1.0,4/23,13.96%,MAPK1;NEK7;TNKS;ATM
prerank,DNA duplex unwinding (GO:0032508),0.23881143908922473,0.6589578458748022,0.918809201623816,0.9775447612277693,1.0,8/50,11.56%,SSBP1;PURA;UBA52;RPS27A;DHX9;RBX1;ASCC3;GTF2H3
prerank,transcription by RNA polymerase I (GO:0006360),-0.20215773733034034,-0.658197304196398,0.940959409594096,0.983611284853842,1.0,13/34,26.27%,RRN3;TAF1D;TAF1;TTF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.264446282824408,-0.6577444552373155,0.8691099476439791,0.982994859502244,1.0,4/13,17.88%,MDM2;SNAI1;TWIST1;CD74
prerank,mRNA polyadenylation (GO:0006378),0.2674405030685888,0.6574273022153377,0.8930635838150289,0.9782234740225095,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,RNA polyadenylation (GO:0043631),0.2674405030685888,0.6574273022153377,0.8930635838150289,0.9782234740225095,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,establishment of skin barrier (GO:0061436),0.2961475182994459,0.6571558934738456,0.8651315789473685,0.9776804601763716,1.0,2/15,12.22%,LSR;ALOXE3
prerank,regulation of water loss via skin (GO:0033561),0.2961475182994459,0.6571558934738456,0.8651315789473685,0.9776804601763716,1.0,2/15,12.22%,LSR;ALOXE3
prerank,regulation of Golgi organization (GO:1903358),0.2866317416426584,0.6567575635199024,0.8681318681318682,0.9776567139125117,1.0,7/17,24.46%,CAMSAP2;MAPK1;USP6NL;PDCD10;MAP2K1;PDE4DIP;MYO5A
prerank,negative regulation of ATPase activity (GO:0032780),0.28957239334169455,0.6566220531963902,0.8516819571865444,0.9773898104703949,1.0,3/16,19.44%,PXK;PAM16;PPIF
prerank,apoptotic nuclear changes (GO:0030262),0.26726170813406475,0.6565730862862185,0.885670731707317,0.9770414080907878,1.0,6/24,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.24407586663774142,0.6565004883282864,0.9092055485498108,0.9767019977535457,1.0,10/48,15.35%,SERTAD2;SERTAD1;TAF1A;MYO1C;POLR1F;ASF1A;ACTB;DDX21;TAF1B;ELOF1
prerank,negative regulation of cellular component organization (GO:0051129),0.2255984554673273,0.6563798568861495,0.9474327628361858,0.9764266927914163,1.0,19/74,23.24%,MCTP1;PRKD1;APOA1;IAPP;HSPA1B;AIDA;CLU;RIOK3;RUBCN;ABCA7;DNAJB6;DNAJB8;GSK3B;SORL1;LCMT1;CARMIL1;NOP53;TERF2;MTMR2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.20670234576981877,-0.6561996302522017,0.9517241379310345,0.9831723795080306,1.0,10/32,21.58%,BRSK1;TRIM39;HMGA2;CDC14B;CDKN1A;DONSON;TAOK1;FZR1;TAOK3;RINT1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2662423436571441,-0.6561652934841979,0.8876712328767123,0.9822613753441943,1.0,5/12,28.17%,FDX1;AKR1B1;CACNA1H;STAR;TSPOAP1
prerank,histone lysine demethylation (GO:0070076),-0.2199907305093377,-0.655975854354086,0.9565217391304348,0.9814587944728453,1.0,7/25,20.13%,KDM7A;JMJD1C;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,positive regulation of cation channel activity (GO:2001259),0.2501032098785924,0.6554593855124924,0.9168975069252078,0.9769180668471329,1.0,9/40,18.42%,ADRB2;STAC;SHANK3;GAL;CASQ1;CALM3;TMSB4X;ANK3;HAP1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3016187866220794,0.6550419844998279,0.8521594684385382,0.9769124973824815,1.0,3/14,10.63%,JAK2;PTK2;PTPN1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.2824681438704412,-0.6550269665586158,0.8705583756345178,0.9811989477320553,1.0,10/10,71.78%,PDE6A;PDE6G;PDE6B;RHO;GNAT1;CNGB1;GRK1;CNGA1;GNB1;SAG
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.250924374724756,-0.6544774424196306,0.9005524861878453,0.9806850006868234,1.0,2/16,5.01%,MAU2;NIPBL
prerank,histone H3 deacetylation (GO:0070932),0.2968064634886968,0.6541700540694774,0.8768472906403941,0.9773473876907195,1.0,2/15,11.79%,HDAC9;SMARCAD1
prerank,negative regulation of macroautophagy (GO:0016242),0.2636915707158359,0.6540683853763092,0.9073806078147613,0.9770350271908138,1.0,11/26,27.63%,SMCR8;LRRK2;LZTS1;RUBCN;UBQLN4;FEZ1;PIK3CA;CHMP4A;CHMP4B;SCFD1;CLEC16A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.24371174498203396,-0.6535449502163573,0.9224806201550387,0.980411594099368,1.0,11/16,47.41%,ST3GAL4;MDK;RHOA;ITGB2;NFAT5;SELP;ALOX5;FUT4;TNF;SELE;IL6
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2949486474333339,0.6524005372438195,0.8676236044657097,0.9782289273591739,1.0,2/14,6.83%,TRPT1;CPSF1
prerank,translesion synthesis (GO:0019985),0.24418439910792522,0.6517964532566928,0.9395161290322581,0.9783968979150588,1.0,8/42,15.87%,USP43;POLK;UBA52;RPS27A;MAD2L2;TRIM25;RFC2;SPRTN
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3167775058506076,0.6516236902290224,0.8735042735042735,0.978155577084154,1.0,3/10,16.50%,JUN;HIF1AN;NCK1
prerank,skeletal muscle contraction (GO:0003009),-0.23649122856508878,-0.651048955917444,0.8862973760932945,0.981294686193782,1.0,8/19,35.64%,RCSD1;STAC3;TNNT3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78
prerank,cytoplasmic translational initiation (GO:0002183),-0.23623435962320716,-0.6489828898190951,0.9189944134078212,0.9819212982517214,1.0,4/17,13.69%,DENR;EIF2S2;EIF2D;EIF3D
prerank,cellular iron ion homeostasis (GO:0006879),0.2320852691211284,0.6483633465109049,0.9357682619647355,0.9808298353738515,1.0,19/55,24.89%,FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,microtubule bundle formation (GO:0001578),0.2437799430124623,0.6474778446387989,0.9114927344782034,0.9812339897199575,1.0,9/42,21.12%,CFAP206;CLIP1;CLASP1;NUMA1;NAV1;FOXJ1;DCX;MTCL1;MARK4
prerank,negative regulation by host of viral process (GO:0044793),0.3228921931368518,0.6461820812472331,0.8519163763066202,0.9820291338856033,1.0,3/10,14.85%,ZC3H12A;PSMC3;VAPA
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.250206732161387,-0.6461438564711409,0.9197994987468672,0.9830272191276052,1.0,3/14,13.15%,ANXA1;PRKCZ;CD80
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.271468560005748,0.6453382385648114,0.8900293255131965,0.9823965745857154,1.0,4/20,16.55%,PUM2;ZC3H7A;AGO4;DROSHA
prerank,error-prone translesion synthesis (GO:0042276),0.2779225662509,0.6452727600005362,0.8940092165898618,0.9820642051995928,1.0,5/21,15.38%,POLK;UBA52;RPS27A;MAD2L2;RFC2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3102437569287674,0.6450617466988406,0.8592,0.9818582635781465,1.0,4/10,26.28%,NFE2L2;EIF2S1;DDIT3;HERPUD1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2680791399297676,0.6447342213428119,0.8982300884955752,0.9817410934560837,1.0,6/23,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,inhibitory synapse assembly (GO:1904862),0.3111566020983846,0.6441514469534536,0.8710217755443886,0.9818707738751642,1.0,3/11,13.78%,CBLN4;GABRA2;LGI2
prerank,regulation of axon guidance (GO:1902667),-0.27773009366825685,-0.643256094968005,0.8921568627450981,0.9841015447972635,1.0,2/10,8.97%,YTHDF1;VEGFA
prerank,regulation of mRNA metabolic process (GO:1903311),0.3029654669128381,0.6431694611556827,0.8648208469055375,0.9823404781322068,1.0,5/11,21.40%,DHX9;PTCD2;SRPK1;SAFB2;IWS1
prerank,epithelial cell development (GO:0002064),0.2713167793548708,0.6431156863204329,0.8724727838258165,0.981986989986548,1.0,1/20,3.32%,SIPA1L3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.27848754670967396,0.6422931492108425,0.8679245283018868,0.9823188438196934,1.0,6/18,24.45%,LRRK2;RIMS3;GSK3B;NLGN1;RAP1B;RIMS1
prerank,lipoprotein catabolic process (GO:0042159),0.30847105474166503,0.641909460387633,0.8672268907563025,0.9822461424769098,1.0,4/11,23.73%,PPT1;ABHD17B;LYPLA1;LYPLAL1
prerank,primary miRNA processing (GO:0031053),-0.2789589759337049,-0.6412516010532265,0.9143518518518519,0.984534062458348,1.0,2/10,6.30%,HNRNPA2B1;SMAD3
prerank,phosphatidic acid metabolic process (GO:0046473),0.2375048608389259,0.640912597809054,0.9388020833333334,0.9827182226297534,1.0,5/48,8.73%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,heme biosynthetic process (GO:0006783),0.2667327967314018,0.6401850976145057,0.900887573964497,0.9829441754468101,1.0,5/22,17.30%,ALAS1;TSPO;COX15;NFE2L1;CPOX
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.18041265908017307,-0.6401243788330833,1.0,0.9843587932796638,1.0,30/57,38.30%,TIPIN;BRSK1;TRIM39;ATF2;HMGA2;CDC14B;CDKN1A;WAC;DONSON;RFWD3;TAOK1;FZR1;TAOK3;RINT1;FANCD2;RPA2;EME2;RAD9A;CHEK1;FBXO31;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;TP53;PRKDC;CDK1;TICRR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.27190091784207926,-0.639642915315969,0.8961352657004831,0.9837327435779805,1.0,6/11,37.33%,NDUFA13;ROMO1;TIMM29;TIMM10;TIMM9;TIMM13
prerank,protein export from nucleus (GO:0006611),0.25619448023997937,0.6392889465889688,0.9110105580693816,0.9833510987650171,1.0,6/27,14.41%,DUSP16;XPO6;XPO1;SMURF1;RAN;NUP42
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2659470377561222,0.6386387490890368,0.8944193061840121,0.9835121465954717,1.0,4/22,10.38%,INPP5K;ROCK1;STAP1;DYNLL1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.26024708978268263,0.6383698330730221,0.911976911976912,0.9833479906008007,1.0,3/27,8.02%,ZC3H12A;ARRB1;CD200
prerank,lipid biosynthetic process (GO:0008610),0.21731875167140513,0.6383659402065625,0.9616306954436451,0.9829542102110701,1.0,18/77,25.93%,ACSM3;ACSL5;PRKAA1;ELOVL4;ACSS2;PDSS2;PDSS1;MVD;DOLPP1;AGPAT5;OXSM;GGPS1;AGPS;ACLY;MVK;HMGCR;FDFT1;CLN8
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2592647476660199,0.6380824296741023,0.9092240117130308,0.9828027157395234,1.0,3/23,9.59%,SLC12A8;CLCN3;SLC9A7
prerank,bile acid metabolic process (GO:0008206),0.25620576114145904,0.6377925530703777,0.9245852187028658,0.9826550331804769,1.0,4/27,14.79%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,positive regulation of viral genome replication (GO:0045070),0.25256812148061947,0.6377312672077745,0.918918918918919,0.9823181498286129,1.0,7/29,18.64%,ADARB1;PPIE;ADAR;PPIH;PKN2;SRPK1;PPID
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3087271654005866,0.6369381264685235,0.8493150684931506,0.9825951465278214,1.0,2/10,15.62%,PDE3B;PDE4D
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2579819317940282,0.6362954083086911,0.9082969432314411,0.9827314773654187,1.0,3/25,8.83%,GPI;PGK1;GAPDH
prerank,regulation of rRNA processing (GO:2000232),-0.23998835502551297,-0.635305103642982,0.887468030690537,0.9857798692606701,1.0,6/16,29.33%,KAT2B;BUD23;YTHDF2;RIOK2;TRMT112;DIMT1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20023842687186386,0.6351724251697135,0.9879253567508233,0.9832667539822452,1.0,37/173,20.03%,TRAPPC8;ATL2;VTI1B;GOPC;COG5;TMED10;MCFD2;CUL3;PGAP1;WHAMM;GRIA1;ERGIC1;PROC;VAMP7;DYNLL1;TRAPPC2;TRAPPC6B;TMED9;TEX261;DYNC1LI2;SEC24B;SPTAN1;NSF;TMED4;VAPA;ANK1;TRAPPC5;COG6;ANK3;GOSR1;VTI1A;SPTBN1;DYNLL2;SEC24A;ACTR1A;TMED7;CAPZA2
prerank,regulation of B cell differentiation (GO:0045577),-0.23427808527710264,-0.6348809547607221,0.9301075268817204,0.9851362356913597,1.0,4/17,21.62%,MMP14;NCKAP1L;INHBA;SYK
prerank,snRNA processing (GO:0016180),0.27660695515192374,0.6348185699243251,0.8863636363636364,0.9831605034317142,1.0,4/16,16.29%,INTS11;INTS12;INTS5;INTS6L
prerank,protein ADP-ribosylation (GO:0006471),-0.2063999265533824,-0.6346162467457632,0.9714285714285714,0.9843857176430546,1.0,10/28,29.63%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2;HPF1;SIRT6
prerank,carbohydrate derivative transport (GO:1901264),0.2726709727212654,0.6339336380076978,0.904320987654321,0.983516461169776,1.0,6/18,22.67%,PLTP;SLC15A4;VLDLR;SCARB1;SLC25A19;SLC10A7
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2850600424097076,0.6338732410290926,0.8819776714513556,0.9831780009761459,1.0,4/15,19.18%,TRPT1;CPSF1;CSTF2;ERN1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.295522132519631,0.633439969352834,0.8966101694915254,0.9831372950922438,1.0,1/12,3.76%,GART
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.21283873776266315,-0.6333134805953322,0.9557522123893806,0.9843139313658044,1.0,6/22,20.13%,SMARCB1;ERBB2;PIH1D1;UBTF;NCL;PHF8
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3062600796268574,0.6331600215270597,0.8764607679465777,0.9829589694652842,1.0,4/10,25.95%,CALM3;GNB5;CRHR1;CALM1
prerank,ubiquinone metabolic process (GO:0006743),0.28357493803133693,0.6331279929989428,0.8925619834710744,0.9825868447553552,1.0,5/15,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3086086472760716,0.6330263849695953,0.8542372881355932,0.9822709339230401,1.0,3/10,20.02%,JAK2;PTPN1;STAT5A
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19333279558306554,-0.6325833154179195,0.9636363636363636,0.9838691994534253,1.0,18/38,31.92%,RSF1;CENPC;HAT1;SMARCA5;RBBP7;CABIN1;CENPK;ATRX;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;HIRA;CENPA
prerank,regulation of oxidative phosphorylation (GO:0002082),0.28201469365601495,0.6324080074085371,0.9042386185243328,0.9823942547846172,1.0,2/16,6.64%,ATP7A;SLC25A33
prerank,pre-miRNA processing (GO:0031054),0.28988329713571453,0.6323786918035998,0.8963317384370016,0.9820179117863261,1.0,4/14,17.51%,ADAR;AGO4;DROSHA;TUT7
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.30304395274378415,0.6321163967118855,0.893581081081081,0.9818628142252027,1.0,2/10,12.45%,NOS1AP;CALM3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.24126619891223447,0.6317570820083401,0.9328571428571428,0.9817591837394827,1.0,10/36,19.45%,BRIP1;HINFP;RAD1;ATM;MAP3K20;RAD9B;FBXO6;TIPRL;ATRIP;HUS1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.19303004840424226,0.631717910398614,0.9937759336099585,0.9813973974256139,1.0,67/264,23.91%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;DCPS;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;CELF4;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;CLNS1A;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;SRPK1;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;GEMIN8;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2715315507758896,0.6313590637104047,0.9221183800623053,0.9812964796884068,1.0,4/19,16.66%,TMEM109;BAG6;PHLDA3;PYCARD
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.28562456000359465,0.6308077360326482,0.8938640132669984,0.9813592530184345,1.0,1/13,3.44%,UBA7
prerank,global genome nucleotide-excision repair (GO:0070911),0.257339630777372,0.6308075857517702,0.9018126888217523,0.9809659226565033,1.0,6/26,15.10%,UBA52;RPS27A;RBX1;GTF2H3;ERCC4;XPC
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23195947607257536,0.6298599246152339,0.9420485175202157,0.9813488229112186,1.0,9/45,15.41%,BTG2;BTG1;TOM1L1;ZFP36L2;ANGEL2;BUB1;CTNNB1;FZD3;BTG3
prerank,positive regulation of isotype switching (GO:0045830),0.2817815421522774,0.6298579252916767,0.8966049382716049,0.9809582507772021,1.0,8/15,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;CLCF1;TGFB1;SHLD1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.26619584029991006,-0.6290133916397227,0.8940886699507389,0.9851637957681465,1.0,2/11,9.66%,CEBPB;CREB3L1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.26164202519071084,-0.6276848188649572,0.897172236503856,0.9850504067007216,1.0,4/11,17.96%,RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,histone mRNA metabolic process (GO:0008334),0.252432814766202,0.6276189774036977,0.9035087719298246,0.9823847316298906,1.0,9/27,21.35%,LSM1;MTPAP;SNRPE;XRN1;ATM;TENT2;TUT7;CPSF3;EXOSC10
prerank,positive regulation of lipid storage (GO:0010884),0.2639719760100536,0.6267245377614472,0.9086826347305389,0.9826865877802998,1.0,5/21,21.40%,EHD1;ZC3H12A;VSTM2A;SCARB1;SREBF2
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.20334535331215792,-0.6266333262813115,0.9680511182108626,0.9837957908534393,1.0,14/29,31.92%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.20334535331215792,-0.6266333262813115,0.9680511182108626,0.9837957908534393,1.0,14/29,31.92%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,DNA metabolic process (GO:0006259),0.19304831583197637,0.6264397375624432,0.9937565036420395,0.9825265649619878,1.0,68/270,24.65%,BTG2;RBBP8;APEX1;RAD21;ORC3;EXD2;ENDOV;PURA;POLK;UBA52;RPS27A;DFFB;FEN1;STN1;HMGB1;NSMCE3;ASF1A;PTGES3;POLA1;POLB;NPM1;WDHD1;GTF2H3;BRCA1;SMARCAD1;ORC5;HINFP;UBE2T;LIG1;DDX21;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAN;RAD18;HMGB2;XPC;RFC2;TRRAP;RAD9B;FBXO6;MEN1;MMS19;ATRIP;CTC1;TERF2IP;BARD1;HUS1;UHRF2;BLM;MNAT1;RIF1;UBB;GEN1;NOP53;MUTYH;TOP3B;TERF2;ORC4;CNBP;RNASEH2A;PRIM2;WRN;PRIMPOL;RNASEH1;UVRAG
prerank,protein kinase A signaling (GO:0010737),0.2882226055906123,0.6263983860131958,0.9086460032626428,0.9821669912821607,1.0,6/12,29.65%,GAL;LCP1;RDX;PRKACB;MYOM1;RAB13
prerank,mismatch repair (GO:0006298),-0.2037181229807887,-0.6261212043858416,0.9585987261146497,0.9831816329869474,1.0,17/27,38.86%,MLH3;MLH1;MSH6;PMS1;RPA3;ABL1;RPA1;POLD2;RPA2;EXO1;POLD3;PMS2;TDG;MSH4;ERCC1;POLD1;MCM9
prerank,receptor metabolic process (GO:0043112),0.2224115669000788,0.6260584962898184,0.9491525423728814,0.982049495715186,1.0,13/53,20.46%,CAV1;DNM3;LMTK2;AP2M1;SMURF1;LDLRAP1;CD9;KIF16B;PHETA1;NSG1;MVB12A;REP15;RAB31
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2731652594532327,0.6259923210187485,0.8837920489296636,0.9817090541898493,1.0,8/19,26.91%,FBXO7;FBXW7;VDAC1;GSK3A;SREBF2;ATP13A2;CSNK2A2;HAX1
prerank,nuclear envelope organization (GO:0006998),0.2654532128406513,0.6252885623990075,0.9096385542168675,0.9818561333536093,1.0,9/20,24.78%,TMEM43;SUN3;REEP3;VPS4A;SUN1;NEMP1;LEMD3;EMD;CTDNEP1
prerank,lysosome organization (GO:0007040),0.23863638843806056,0.6249255977435532,0.919831223628692,0.9817413338141399,1.0,9/36,21.03%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.1945624378479716,-0.6246594431786187,0.9644128113879004,0.9831487328956781,1.0,16/32,38.87%,CEMIP;CALM2;GSTM2;JPH2;GPER1;P2RY6;GSTO1;APLNR;NPSR1;THY1;F2R;PKD2;CAPN3;TRDN;HTT;CX3CL1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.27724488703527017,0.6242475038627776,0.9107981220657277,0.9818741062622026,1.0,3/17,15.47%,IK;MTBP;BOD1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.25433604013256084,0.6238280439184403,0.9304964539007092,0.9818075718513972,1.0,11/25,29.80%,EFNA1;PRKCG;OPHN1;PSME3IP1;EPHA4;SGTA;CSNK2A2;RPL11;F8A1;HSP90AB1;RPS7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.28949448319284077,0.6235825813016741,0.8818635607321131,0.9816099616982257,1.0,5/12,26.40%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,hyaluronan metabolic process (GO:0030212),0.25825139018209825,0.6234693021038021,0.9051851851851852,0.9813044922904555,1.0,2/23,5.33%,CEMIP2;HYAL2
prerank,negative regulation of RNA splicing (GO:0033119),-0.2216640032015486,-0.6231029864841847,0.9301675977653632,0.983173123534398,1.0,5/19,17.81%,RBMX;SRSF6;PCBP4;RPS26;U2AF2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.27996332058979523,0.6230908297889807,0.9,0.9811751785593864,1.0,1/13,3.66%,RPS21
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2432141281814339,-0.6227562033791526,0.9444444444444444,0.9824469324435887,1.0,1/14,3.41%,THBS1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.22008810939148654,-0.6225567152704837,0.9215116279069767,0.9816513834111348,1.0,6/20,29.73%,FDX1;AKR1B1;STAR;HSD17B10;TSPOAP1;CYP46A1
prerank,telomere maintenance (GO:0000723),0.22673066043632267,0.6208630816493289,0.9590488771466315,0.982476959670138,1.0,16/50,26.09%,ZBTB48;APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29687892686062334,0.6206920309510873,0.9141494435612083,0.9822252517823822,1.0,3/13,18.46%,SULT6B1;BPNT1;SULT1A1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2585578726152802,0.6202723458432767,0.9031296572280179,0.9821522738841991,1.0,6/22,20.26%,FKBP1A;MGAT5;ROCK1;BOD1;TIPRL;GSK3B
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.19759540384746244,-0.6198136519826961,0.9548872180451128,0.9813715626027948,1.0,13/31,30.04%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,7-methylguanosine RNA capping (GO:0009452),-0.19759540384746244,-0.6198136519826961,0.9548872180451128,0.9813715626027948,1.0,13/31,30.04%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,mRNA stabilization (GO:0048255),0.23101409512772278,0.6196645629520475,0.9388297872340425,0.9822008835768796,1.0,8/40,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;DHX9;ANGEL2;YBX1;MAPK14
prerank,chromatin assembly or disassembly (GO:0006333),0.28314978565737337,0.6188990437766664,0.8766447368421053,0.9823592316556179,1.0,4/11,23.76%,CDAN1;SUV39H2;RBBP4;HIRIP3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.18291754061135446,-0.6182910726961782,0.98046875,0.9813251717632074,1.0,14/42,25.12%,FBH1;FUS;HELB;ACTR2;RTEL1;KLHL15;FANCB;TIMELESS;CGAS;PARP1;POLQ;RPA2;RMI2;RAD51
prerank,estrogen metabolic process (GO:0008210),-0.23962777622601547,-0.6179878277930775,0.9307479224376731,0.9805688774097309,1.0,9/15,45.96%,HSD17B8;HSD17B10;HSD17B11;HSD17B2;HSD17B14;HSD17B1;CYP1B1;HSD17B7;CYP1A1
prerank,lipoxygenase pathway (GO:0019372),0.2853411112138893,0.6174633481126279,0.8922829581993569,0.9830286017690275,1.0,3/14,16.28%,ALOXE3;PON2;PON3
prerank,neuromuscular process (GO:0050905),0.2734532636223144,0.6164516533180493,0.9162640901771336,0.9833784523472539,1.0,2/16,12.72%,GCH1;KCNA1
prerank,mRNA processing (GO:0006397),0.18824543461396293,0.6163039220286481,0.9968911917098445,0.9831032026588533,1.0,76/287,24.60%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;RPRD1B;FIP1L1;PCBP1;GTF2H3;CHTOP;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;THOC3;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;POLDIP3;ZMAT5;RPRD2;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;ERN1;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;MNAT1;CWC25;RPRD1A;PQBP1;PRCC;SF3B3;POLR2C;TBRG4;KIN;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1;PRPF6;ALYREF;CCNH
prerank,DNA biosynthetic process (GO:0071897),0.27325620113360255,0.6161609468506454,0.8951486697965572,0.9828180977295813,1.0,3/16,15.60%,WRNIP1;POLA1;CDKN2D
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21546347653380174,0.6156274503765545,0.968019680196802,0.9828200064709877,1.0,9/64,14.79%,ACSL5;ASAH2;ACSBG1;ACOX1;ALOXE3;ACAD9;CPT1A;ELOVL5;SLC27A2
prerank,positive regulation of telomere maintenance (GO:0032206),-0.18978184352692412,-0.6153487481258193,0.9672727272727273,0.9811812104923845,1.0,13/31,31.42%,HNRNPA2B1;RAD50;PPP1R10;MAP2K7;RTEL1;PML;GNL3;ATRX;NAF1;HNRNPD;NABP2;SIRT6;SLX4
prerank,non-motile cilium assembly (GO:1905515),0.24111998613666674,0.613366301198352,0.9213161659513591,0.9840680582321125,1.0,3/30,9.16%,CSNK1D;TMEM216;PCM1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.27860067959622803,0.6121872654344008,0.8961474036850922,0.9844936751835732,1.0,5/13,26.40%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,C-terminal protein amino acid modification (GO:0018410),0.29005809045823994,0.6115279641623336,0.903114186851211,0.9845612990711532,1.0,4/11,22.33%,TTL;LCMT1;AGBL4;FOLH1
prerank,protein palmitoylation (GO:0018345),0.23941370073685425,0.6108977456190154,0.9197622585438335,0.9846043380440982,1.0,6/30,21.35%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;SELENOK;ZDHHC13
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24317505088619085,0.6093523964189297,0.9252199413489736,0.985281688955868,1.0,12/28,27.33%,MAD2L2;DTX3L;KDM4D;RIF1;CYREN;SHLD3;SHLD2;NUDT16L1;WRAP53;SHLD1;PARP9;SMCHD1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2571105634034916,0.6081174120612901,0.9231950844854071,0.9857708468347885,1.0,4/22,17.08%,TNFRSF18;VSIR;CBFB;SOX12
prerank,C4-dicarboxylate transport (GO:0015740),0.27162375781179815,0.6077139314658817,0.9230769230769231,0.9856631294176966,1.0,5/14,19.25%,SLC25A30;SLC1A1;SLC1A2;SLC25A10;SLC1A6
prerank,regulation of lipid storage (GO:0010883),0.2511955819592466,0.6075137684258016,0.9230769230769231,0.9854213906650451,1.0,4/22,11.81%,ZC3H12A;FBXW7;NFKBIA;VSTM2A
prerank,cellular response to oxygen levels (GO:0071453),-0.26206403286471797,-0.607172413103763,0.925,0.9846856625084056,1.0,4/10,27.30%,ATP6AP1;ATP6V1A;PICK1;NDUFS2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25893245672534354,0.6066281910097411,0.9186746987951807,0.9856193299499992,1.0,4/17,19.00%,CCNE1;THPO;KAT7;SOX11
prerank,DNA repair (GO:0006281),0.18666143295950693,0.6065383293730494,1.0,0.9852979609609679,1.0,45/284,15.87%,HERC2;BTG2;RBBP8;WRNIP1;APEX1;RAD21;SETX;EXD2;ENDOV;TENT4A;POLK;UBA52;RPS27A;FEN1;NSMCE3;BABAM2;MAD2L2;ASF1A;BRIP1;POLA1;POLB;ASCC1;NPM1;ASCC3;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;EYA3;UBE2T;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;CDKN2D;TRAIP;SPRTN
prerank,mitotic chromosome condensation (GO:0007076),-0.20368468119698147,-0.6064229894944956,0.9552238805970149,0.9841679540661114,1.0,14/26,37.53%,SET;NCAPG2;AKAP8L;NCAPH2;NCAPD2;PHF8;NUSAP1;KMT5A;NCAPH;TTN;PHF13;SMC2;PLK1;CDK1
prerank,anterograde axonal transport (GO:0008089),0.22763462285362335,0.604272299031151,0.9621848739495799,0.9864238008116868,1.0,14/37,28.93%,BLOC1S6;HSPB1;AP3S1;KIF1A;AP3M1;RAB27B;HAP1;AP3D1;SOD1;KIF5A;AP3B1;BLOC1S5;AP3M2;RAB21
prerank,platelet aggregation (GO:0070527),0.23050889367748312,0.6021254867140697,0.9482758620689655,0.9874910243187154,1.0,8/33,19.18%,MYH9;HSPB1;ACTG1;ACTB;PIK3CB;STXBP3;FERMT3;VCL
prerank,mitotic nuclear division (GO:0140014),0.20806287148642263,0.6007525297602458,0.9757281553398058,0.988028449410108,1.0,12/71,16.20%,RAB11A;KIF2A;CLASP1;KPNB1;DSN1;STAG1;CLASP2;ARHGEF10;RAN;CHMP7;NDC80;SGO1
prerank,regulation of chromatin organization (GO:1902275),-0.2353935552123676,-0.6002273800180553,0.9268929503916449,0.9863239973254395,1.0,6/14,29.50%,SETD1A;IGF2;HNRNPU;PARG;ALKBH4;HPF1
prerank,mitochondrial fission (GO:0000266),0.26517997437913243,0.5996805920416449,0.9209302325581395,0.9883094887062651,1.0,1/16,3.29%,DNM3
prerank,NAD biosynthetic process (GO:0009435),-0.21365798575798384,-0.5988917979100861,0.94750656167979,0.9860628673240414,1.0,1/20,1.34%,NMNAT2
prerank,regulation of macrophage differentiation (GO:0045649),0.26877791964767017,0.5981165820983466,0.9180327868852459,0.9889398623783399,1.0,1/15,2.42%,CASP8
prerank,regulation of autophagosome assembly (GO:2000785),0.23120738911404579,0.5977255817230689,0.9415204678362573,0.9888240731270189,1.0,15/33,29.83%,SMCR8;RAB3GAP2;LRRK2;TBC1D12;UBQLN2;NPRL3;RALB;TBC1D14;FEZ1;CHMP4A;CHMP4B;SCFD1;PIP4K2B;PIKFYVE;SH3GLB1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.24561304203959075,0.5975828267233845,0.9416909620991254,0.9885319344726732,1.0,6/24,21.42%,ALAS1;TSPO;COX15;NFE2L1;CPOX;RSAD1
prerank,regulation of spindle assembly (GO:0090169),0.24565779390496345,0.5965642034317434,0.9416058394160584,0.9888047337022,1.0,13/25,30.80%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;SENP6;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A;DYNC1H1
prerank,protein import into peroxisome matrix (GO:0016558),-0.23580216056461917,-0.595922042320464,0.9516539440203562,0.9865405878567819,1.0,5/12,29.67%,PEX2;PEX7;PEX13;PEX16;PEX12
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.20079966248550546,0.5958597009850741,0.9805352798053528,0.9888358526789428,1.0,11/83,11.25%,TUBB;CSNK1D;TUBB4B;CLASP1;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;NPM1
prerank,histone acetylation (GO:0016573),0.20976609058380583,0.5955779331837338,0.9741060419235512,0.9886155863594474,1.0,11/69,15.52%,ING3;LEF1;BRD8;MRGBP;JADE2;CHD5;BRD1;DMAP1;SGF29;KAT7;TRRAP
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.24791291242740246,0.5943153537874951,0.9336349924585219,0.9889918908240002,1.0,5/22,15.10%,UBA52;RPS27A;RBX1;GTF2H3;XPC
prerank,negative regulation of telomere maintenance (GO:0032205),0.2688707359412642,0.5941309309753149,0.9108589951377634,0.9887150350710121,1.0,5/15,23.10%,TNKS;ERCC4;ATM;TERF2IP;TERF2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.23809017700123566,0.5937282420917032,0.9406657018813314,0.9885840861752947,1.0,4/25,15.56%,APP;ANKRD13A;RAC1;UBQLN2
prerank,cholesterol metabolic process (GO:0008203),0.20659027456780182,0.5927996066267592,0.9786163522012579,0.9887484938406271,1.0,21/68,26.49%,APOA1;LCAT;OSBPL1A;PLPP6;HMGCS1;TSKU;LDLRAP1;MVD;SOAT1;ACAA2;DHCR7;GGPS1;ACLY;OSBPL5;IDI1;MVK;INSIG1;HMGCR;FDFT1;CLN8;LBR
prerank,regulation of protein acetylation (GO:1901983),0.2779315708788158,0.5926346098362526,0.9130434782608695,0.9884553090245114,1.0,3/12,20.26%,FAM161A;TERF2IP;GSK3B
prerank,intracellular cholesterol transport (GO:0032367),-0.22518252000192135,-0.5924520142902119,0.9472295514511874,0.9872489545603527,1.0,1/15,2.95%,ABCA1
prerank,organic cation transport (GO:0015695),0.25099948783011566,0.592235287760277,0.9274924471299094,0.9883154468490186,1.0,6/20,22.38%,SLC44A1;SLC22A5;SEC14L1;SLC29A4;SLC25A19;SLC25A42
prerank,mRNA export from nucleus (GO:0006406),0.19480395516654675,0.5910523781059027,0.981242672919109,0.9886523261115022,1.0,23/102,21.40%,HHEX;DDX39A;CPSF1;NUP54;POLR2D;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3;NUP50;IWS1
prerank,chromatin assembly (GO:0031497),0.2240985540017683,0.590948001807048,0.9500693481276006,0.9883256632060328,1.0,11/38,21.46%,ASF1A;CDAN1;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;PRDM9;NAP1L3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2403700900768635,0.590521166159939,0.9449404761904762,0.9882103072326224,1.0,10/25,27.63%,EAF1;EAF2;EAPP;NELFB;NELFA;HEXIM1;WDR43;ZMYND11;RNF8;CDC73
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.23106679046345913,-0.5901033463130544,0.9425287356321839,0.987480815324784,1.0,6/14,30.09%,ATR;TERT;XRCC5;ATRX;NABP2;PINX1
prerank,aerobic electron transport chain (GO:0019646),0.2045718886442552,0.5896362735097577,0.9788557213930348,0.9883406401681905,1.0,19/68,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,base-excision repair (GO:0006284),-0.16867829069536722,-0.5896200449976645,0.9955555555555555,0.986796785202802,1.0,24/48,38.63%,RFC1;XRCC1;ERCC5;LIG3;HMGA2;RPA3;PARG;RPA1;PARP1;POLQ;NEIL1;POLD2;RPA2;POLE;RFC4;APEX2;POLL;POLD3;RFC5;TDG;DNA2;NEIL2;XPA;POLD1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.24728608189282947,-0.5892353753064024,0.9455445544554455,0.9860639072356782,1.0,3/12,15.83%,PRKCB;PRKCA;NEK6
prerank,macrophage chemotaxis (GO:0048246),0.2870614084570604,0.5892107907938114,0.9203389830508475,0.9882066676267108,1.0,1/10,7.50%,TAFA4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2719466215597031,0.5882423557637858,0.9122203098106713,0.9883683213551133,1.0,6/12,27.60%,BRCA1;RBM15;YTHDC1;LRIF1;SMCHD1;CDYL
prerank,organelle fusion (GO:0048284),0.24198311941400547,0.587942670597297,0.9433681073025335,0.9881596969779033,1.0,4/22,13.01%,CHCHD3;MIGA1;MFN1;CYP26C1
prerank,nucleosome assembly (GO:0006334),0.23071480714410056,0.5864636573277443,0.9479015918958031,0.9886713775884898,1.0,10/31,21.46%,ASF1A;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;IPO4;NAP1L3
prerank,intracellular protein transmembrane transport (GO:0065002),-0.17596617109045362,-0.5859749165016518,1.0,0.9866002136183875,1.0,15/42,29.67%,C2CD5;PEX2;TIMM17B;CHCHD4;TIMM21;PEX7;GRPEL2;SEC61A2;ROMO1;DNAJC15;ZFAND2B;PEX16;SEC61G;TIMM50;PEX12
prerank,cellular response to pH (GO:0071467),0.2540458355044569,0.5824879335714341,0.9259259259259259,0.9905802661873863,1.0,2/17,10.66%,MCOLN1;GPR68
prerank,RNA export from nucleus (GO:0006405),0.19222984451401287,0.5815525191855452,0.9882629107981221,0.9906966581816329,1.0,21/100,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;RAN;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,striated muscle cell development (GO:0055002),0.2672282812692413,0.5811226460533588,0.9243421052631579,0.9905565211272872,1.0,4/14,23.89%,FLII;TMOD3;TMOD1;KLHL41
prerank,protein insertion into membrane (GO:0051205),0.2280800570652328,0.5804951347250467,0.9561527581329562,0.9905295838293992,1.0,10/32,23.42%,APP;PRNP;GET1;REEP1;UBE2J2;VAPA;CCDC47;CYB5A;EMD;SGTA
prerank,regulation of microtubule-based movement (GO:0060632),0.27643570436346043,0.5774939296377617,0.9224283305227656,0.9918140011342254,1.0,4/11,22.01%,NEFH;MAP2;HAP1;IGBP1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.25861192457909055,0.5769709016131566,0.9322834645669291,0.9916906412408791,1.0,6/16,27.34%,VPS36;VPS28;CHMP7;LEPROT;CHMP4A;CHMP4B
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.28299622573779654,0.5769013377798806,0.9236111111111112,0.9913378951732101,1.0,2/10,14.25%,APOA1;ELOVL5
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.1991850987747222,0.5761871540052133,0.9851668726823238,0.991308317817115,1.0,19/69,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.23363470947365828,-0.5714425371957004,0.9644670050761421,0.9916929822339969,1.0,2/12,9.62%,GCLC;BDH2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2045157614954575,-0.5713421082773481,0.9607843137254902,0.9908085732173011,1.0,4/20,17.72%,AMPD3;LHPP;ATIC;IMPDH2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.24043029631079246,0.5707434649355231,0.940625,0.9937321915204524,1.0,5/19,23.71%,ACOX1;CYBA;MAOB;SOD1;NOX1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.24937591681940868,-0.5703846304653897,0.9521531100478469,0.9902548047234746,1.0,4/10,41.65%,NFKB1;APOC1;SHH;ABCA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.25470412702561324,0.5695951083236589,0.9231950844854071,0.9939119152316027,1.0,6/14,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,long-term memory (GO:0007616),-0.20470741798958644,-0.5689650583034469,0.9761273209549072,0.9898704184015814,1.0,3/19,15.26%,APOE;CPEB3;EIF2AK4
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2634598873903762,0.5684697685775627,0.9520661157024793,0.994086750110018,1.0,1/12,3.76%,GART
prerank,regulation of protein localization to cell surface (GO:2000008),0.22185557822981494,0.5663376226223953,0.9608938547486033,0.9947404846607236,1.0,9/33,21.67%,GOPC;TAX1BP3;TYROBP;NEDD4L;CTNNB1;ABCA7;BDNF;KCNAB2;LEPROT
prerank,maturation of 5.8S rRNA (GO:0000460),0.24757355811958265,0.5661427930250355,0.9437689969604863,0.994445105793522,1.0,7/17,22.64%,RRP15;EIF6;LAS1L;FTSJ3;C1D;EXOSC10;URB1
prerank,DNA packaging (GO:0006323),-0.21091966691008557,-0.5652182402680155,0.9590163934426229,0.9902218600323486,1.0,5/16,25.77%,HAT1;NOC2L;H1-0;NAA10;CHAF1A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.18777181334131393,0.5650887883289647,0.9905660377358491,0.9945724925618953,1.0,20/96,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,phospholipid metabolic process (GO:0006644),0.19687032645962016,0.5650635096672069,0.9860583016476553,0.994197992210353,1.0,4/71,5.21%,PLPP1;ACP6;LPCAT4;LCAT
prerank,DNA catabolic process (GO:0006308),0.2701767150538171,0.5635890226458059,0.9320388349514563,0.9945189038901043,1.0,2/11,10.88%,DFFB;XRN2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2508472637132497,0.5628604151646327,0.9355828220858896,0.9944826655891839,1.0,8/16,28.52%,TNKS;ERCC4;ATM;TERF2;DHX36;TINF2;TNKS2;SMG5
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.23932138965301225,0.5619168405147171,0.9483282674772037,0.9945273582586707,1.0,5/20,19.77%,CAMK2D;RAP1GDS1;CCDC47;SELENOK;PACS2
prerank,protein localization to chromosome (GO:0034502),0.22029068500995178,0.5597242786486116,0.9640387275242047,0.995120363379624,1.0,12/34,28.20%,RAD21;TNKS;CHMP7;BOD1;ESR1;TERF2IP;XRCC4;TERF2;CTCF;TINF2;WAPL;TNKS2
prerank,sulfur amino acid metabolic process (GO:0000096),0.2282426373840064,0.5590317717717557,0.9446870451237264,0.9950535693809278,1.0,3/24,14.70%,TST;SMS;MSRA
prerank,nucleosome organization (GO:0034728),0.1994711336326979,0.5578472308881252,0.9861111111111112,0.9952111202209777,1.0,15/55,21.46%,SRCAP;ASF1A;NPM1;DMAP1;ACTR6;VPS72;SMARCC1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;PRDM9;SETD2;NAP1L3
prerank,histone H2B ubiquitination (GO:0033523),0.26780844205454013,0.5576348413393413,0.9344262295081968,0.9949244713441295,1.0,6/10,27.63%,DTX3L;UBE2E1;RNF20;RNF40;RNF8;CDC73
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.20059015032346306,-0.556399280480055,0.967551622418879,0.9923829751817111,1.0,11/20,39.61%,GRK3;MET;STMN1;PLEK;RPGRIP1L;GRK2;ADA;RGS2;YWHAB;CCL5;MGRN1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.24881065009843328,0.5561455674286765,0.9199372056514914,0.9951855409852154,1.0,8/16,27.33%,PARPBP;MAD2L2;UBQLN4;RIF1;SHLD3;SHLD2;SHLD1;SMCHD1
prerank,regulation of mitochondrial translation (GO:0070129),0.23259924385468078,0.5549930033172925,0.9648854961832061,0.9953026969079866,1.0,2/21,7.26%,MTG2;NGRN
prerank,phagosome maturation (GO:0090382),0.21439546659816586,0.5542712693130948,0.9604904632152589,0.9952418653548678,1.0,8/35,20.77%,RAB39A;RAB34;MCOLN1;ATP6V1G1;ATP6V1C1;ATP6V0A1;RAB31;ATP6V1D
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2658554242742942,0.5541720743656703,0.9305555555555556,0.9949001761873169,1.0,4/10,27.70%,APC;ECT2;KNSTRN;RCC2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23705252064972426,0.553672224214873,0.9609984399375975,0.9947207796989588,1.0,1/19,2.70%,SLC25A32
prerank,axonal transport of mitochondrion (GO:0019896),0.26443652971133724,0.5519973738566506,0.939297124600639,0.9950604396524166,1.0,3/11,18.42%,HIF1A;SYBU;HAP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.19821732117760654,-0.5513996652040273,0.9733727810650887,0.9930574786177165,1.0,10/19,35.12%,NPHP3;OFD1;RFX3;CABYR;CFAP53;ROPN1L;SPAG17;CCDC39;DNAAF2;ODAD4
prerank,neuron projection fasciculation (GO:0106030),0.2676497495918975,0.550223452137198,0.9424083769633508,0.9954143763924672,1.0,4/10,21.58%,NRCAM;RTN4;CNTN4;EPHA4
prerank,positive regulation of cytokinesis (GO:0032467),0.21300351382997804,0.5499232442635634,0.975609756097561,0.9951615327767058,1.0,7/32,21.88%,CUL3;CDC14A;PKN2;MAP10;GIPC1;ECT2;KIF23
prerank,glycoprotein catabolic process (GO:0006516),0.23645897616378395,0.5496072996228653,0.9564516129032258,0.9949151673938096,1.0,6/17,19.35%,MANBA;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17756178856437982,-0.5472418503246945,0.993421052631579,0.9934218848173487,1.0,8/30,19.46%,RNF31;UBL5;UBE2L3;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2636121795561676,0.5471797577860006,0.9252173913043479,0.9955250595451584,1.0,4/11,20.99%,ASF1A;H3-3A;RBBP4;IPO4
prerank,insulin secretion (GO:0030073),0.23077859582484245,0.5465846445595134,0.9573170731707317,0.995379188139685,1.0,6/19,29.09%,GAL;SNX19;RAB11FIP2;PTPRN2;SELENOT;MAFA
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24869044946039873,0.5461698266244417,0.9405144694533762,0.9951671463281667,1.0,1/15,2.87%,SYN3
prerank,acylglycerol catabolic process (GO:0046464),0.21553560878623676,0.5461259318538506,0.9807976366322009,0.9948031504316922,1.0,5/30,22.82%,ABHD6;ABHD2;FABP3;PNPLA2;MGLL
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.23586588389406749,0.5459560719881654,0.9426751592356688,0.9944907751729498,1.0,1/18,3.31%,HHEX
prerank,tryptophan catabolic process (GO:0006569),0.2606403013182672,0.5455532074125279,0.9370860927152318,0.9942801052666775,1.0,11/11,73.95%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;AFMID;KMO
prerank,vacuolar acidification (GO:0007035),-0.1901667288431112,-0.5445213320510953,0.9916434540389972,0.9933334016538382,1.0,11/21,33.66%,ATP6V0A4;TCIRG1;CLN5;CLN3;ATP6V1H;ATP6V0D2;CLN6;DMXL1;ATP6V0E2;SLC11A1;TMEM9
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21804789479343298,0.5442510734656928,0.9698216735253772,0.9944145998410064,1.0,5/30,14.18%,TAF1A;POLR1F;CAVIN1;GTF2H3;TAF1B
prerank,branched-chain amino acid catabolic process (GO:0009083),0.22589700874770813,0.5399398910106075,0.959214501510574,0.9953285327727208,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.22589700874770813,0.5399398910106075,0.959214501510574,0.9953285327727208,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,DNA replication (GO:0006260),0.17589874895769714,0.5388523368931302,1.0,0.9953721122119082,1.0,26/105,24.06%,RBBP8;WRNIP1;ORC3;FEN1;BRIP1;POLA1;POLG2;POLB;WDHD1;BRCA1;ORC5;RAD1;ATM;KAT7;RFC2;RAD9B;MCMBP;ATRIP;BARD1;HUS1;BLM;RMI1;ORC4;KIN;RNASEH2A;WRN
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.23094767967940596,0.5384095461066954,0.9536,0.9951529065827914,1.0,2/18,11.00%,CMKLR1;BAG6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.22127952090155736,0.5380307097717038,0.9546120058565154,0.9948928306558317,1.0,11/24,28.72%,STN1;TNKS;XRN1;ERCC4;CTC1;EXOSC10;TERF2;TINF2;TNKS2;HNRNPC;HNRNPA1
prerank,folic acid metabolic process (GO:0046655),0.23221784382830887,0.536175135766106,0.9569377990430622,0.9951908720377779,1.0,1/18,2.70%,SLC25A32
prerank,DNA recombination (GO:0006310),0.20363164392438565,0.5352804479040184,0.9873060648801129,0.995118444640307,1.0,3/37,9.50%,RAD54B;RAD21;HMGB1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.23883220591986748,0.5343238979639521,0.9650793650793651,0.9951018998287101,1.0,4/16,17.93%,MRAP2;CHGA;NECAB2;GSK3A
prerank,isotype switching (GO:0045190),0.2613263497142511,0.5332580941270668,0.9369676320272572,0.9951021483864215,1.0,1/10,7.65%,EXOSC3
prerank,indolalkylamine catabolic process (GO:0046218),0.26062394074446066,0.5328885393374277,0.9435897435897436,0.9948422016307861,1.0,10/10,73.95%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,water-soluble vitamin metabolic process (GO:0006767),0.1827967856014167,0.5270488144899007,0.9900124843945068,0.996435096458983,1.0,6/68,10.72%,SLC2A1;SLC25A32;THTPA;RFK;MMAA;PDZD11
prerank,negative regulation of secretion (GO:0051048),0.25679648096631613,0.5268931024606752,0.944153577661431,0.99610545342277,1.0,1/10,7.40%,VAMP8
prerank,DNA methylation (GO:0006306),0.21776284059908205,0.5252990430229679,0.9653543307086614,0.9962194833345878,1.0,4/23,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.19012149464679343,-0.5236580620978692,0.991869918699187,0.9979163925978147,1.0,3/17,12.92%,AFG1L;COX10;COX7A2L
prerank,cellular response to arsenic-containing substance (GO:0071243),0.23696878426778814,0.5233039575232971,0.9669811320754716,0.9964802668055971,1.0,6/15,28.72%,ZC3H12A;DAXX;PPIF;DHX36;ZFAND1;HNRNPA1
prerank,regulation of adaptive immune response (GO:0002819),0.22641365259434237,0.5222037836847997,0.968798751950078,0.9964375469823109,1.0,1/18,4.30%,FCGR2B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.2344813015566386,0.518395658659739,0.9570063694267515,0.9972285266853561,1.0,5/14,22.68%,ACOX1;ACOX3;CROT;DECR2;HSD17B4
prerank,telomere maintenance via telomerase (GO:0007004),0.20400291369284512,0.5161129683533056,0.9798850574712644,0.9975146899521765,1.0,12/28,29.41%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.18970172684458397,-0.5160112093999666,0.9840425531914894,0.9987656777903403,1.0,16/16,81.06%,SIRT2;SRPX2;TIGAR;PSEN1;SMG6;MCM7;GNB3;IL4;RAD17;IKBKB;SMG5;PGAM1;IGBP1;SMG7;BARD1;CD24
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.18299353225886653,0.5154516472519672,0.991128010139417,0.9969632515158966,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.18299353225886653,0.5154516472519672,0.991128010139417,0.9969632515158966,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.226469786984698,0.5128902755850916,0.9672386895475819,0.9973230224603491,1.0,2/16,9.31%,ZC3H12A;ZFP36L2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.18671775643823055,-0.5127069600691742,0.9817708333333334,0.9985894227397399,1.0,10/18,37.64%,LIG3;POLD2;GINS1;POLE;RFC4;MCM7;POLE3;POLD3;GINS3;GINS2
prerank,cilium-dependent cell motility (GO:0060285),-0.17550867623982885,-0.5111281299438643,0.9971910112359551,0.9980415530949146,1.0,11/22,36.50%,CFAP44;EFHC1;RFX3;GAS8;RSPH9;DRC1;CCDC39;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,cellular response to UV (GO:0034644),0.17406929626962525,0.5080830516630089,1.0,0.9982795740346264,1.0,21/76,26.25%,MMP1;HYAL2;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;XPC;BMF;PPID;TIMP1;COPS9;USP47;MME;TMEM161A;DHX36;CARD16;RPL26;PCNA;RUVBL2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.22899513191808918,0.5076802642655093,0.9728,0.9980083441680904,1.0,3/15,15.98%,PTTG1;CDC27;ANAPC7
prerank,detection of calcium ion (GO:0005513),0.22485279763481394,0.507515916202997,0.9712,0.9976728874595712,1.0,5/13,25.95%,CALM3;SYT1;KCNIP2;RYR2;CALM1
prerank,DNA modification (GO:0006304),0.21094289842326777,0.5065139767010037,0.9748148148148148,0.9975681651303804,1.0,22/22,78.93%,EXOSC3;TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1;SMUG1;NEIL3;MPG;MBD4;UNG;NEIL2;TDG;EXOSC4;EXOSC5;PARP2;NEIL1;PARP1;PARP3
prerank,protein localization to mitochondrion (GO:0070585),-0.20868792099222577,-0.5059259147306786,0.9830097087378641,0.9981999252011451,1.0,2/11,11.09%,COX18;HK2
prerank,Golgi to lysosome transport (GO:0090160),0.2382916204240699,0.504773176747049,0.9684908789386402,0.9976275883288239,1.0,3/11,19.92%,LAPTM5;SORT1;CCDC91
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.20569444771158024,0.5046780319756912,0.9801526717557252,0.9972732757852015,1.0,2/27,7.42%,CTPS1;CMPK1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2364921254774684,0.5025824436849178,0.9604612850082372,0.9974296575763417,1.0,1/11,9.89%,MAD2L2
prerank,cellular response to light stimulus (GO:0071482),0.17259994879650659,0.4979175841021422,0.9975216852540273,0.9981875794853303,1.0,18/66,28.24%,RRH;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;BMF;COPS9;USP47;TMEM161A;DHX36;RPL26;PCNA;RUVBL2;SMPD1;ZBTB1;SAG
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.2091155666780602,-0.49753714702040536,0.9771573604060914,0.9988800617290017,1.0,7/11,42.16%,SIRT2;STMN1;MST1R;HPN;PAK1;HGF;NRP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.20702682541801784,-0.49486301476309746,0.9683698296836983,0.9984735123568578,1.0,4/10,30.35%,UBE2G2;ERLEC1;SVIP;DERL2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.23621378259495196,0.4944364517496099,0.973421926910299,0.998644401713675,1.0,1/11,8.22%,JAK2
prerank,steroid catabolic process (GO:0006706),-0.2108051780187437,-0.4917172539643862,0.9825436408977556,0.9980817880220253,1.0,3/10,26.87%,SPP1;HSD11B1;HSD17B11
prerank,tRNA 5'-end processing (GO:0099116),-0.18713284604495867,-0.48938547288565637,0.9924812030075187,0.997535996118541,1.0,8/15,41.18%,SSB;RPP14;POP4;HSD17B10;RPP25L;POP7;RPP40;POP5
prerank,macrophage migration (GO:1905517),-0.19685720082271185,-0.4887582475905872,0.9920844327176781,0.9967232129360014,1.0,7/13,39.28%,P2RX4;EDNRB;CKLF;CCR2;CCL2;CXCL17;CCL5
prerank,DNA replication initiation (GO:0006270),0.1850985129118935,0.48742593413928215,0.9765840220385675,0.999802727786286,1.0,4/37,12.09%,ORC3;PURA;POLA1;ORC5
prerank,lysine metabolic process (GO:0006553),0.22465404012179704,0.4838905158003533,0.9865996649916248,0.9997725597063046,1.0,4/12,22.87%,DLD;AASS;PHYKPL;PIPOX
prerank,lysine catabolic process (GO:0006554),0.22465404012179704,0.4838905158003533,0.9865996649916248,0.9997725597063046,1.0,4/12,22.87%,DLD;AASS;PHYKPL;PIPOX
prerank,leukotriene metabolic process (GO:0006691),-0.1690485626520459,-0.4813526024250233,1.0,0.996982871175571,1.0,9/19,36.56%,PLA2G4A;GGT5;ALOX12;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,glycerolipid metabolic process (GO:0046486),-0.19981167608286252,-0.4802751253879747,0.9885321100917431,0.99624486128648,1.0,11/11,80.04%,PLA2G15;GAL3ST1;PDXP;PNPLA3;DGKZ;PGP;DGKQ;PIP5K1A;DGKG;DGKB;DGKA
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.2264320395110514,0.4759731119236241,0.9728813559322034,1.0,1.0,3/10,26.67%,NUMA1;PRKCH;NCOA3
prerank,nucleoside salvage (GO:0043174),0.2302429226037287,0.4746055605964989,0.9785123966942149,1.0,1.0,10/10,76.99%,UPP2;TK1;UCK2;HPRT1;UCKL1;UPP1;TK2;DCK;UCK1;CDA
prerank,"base-excision repair, gap-filling (GO:0006287)",0.18372716912065867,0.4735008434856283,0.9958041958041958,1.0,1.0,5/35,15.38%,APEX1;FEN1;POLB;LIG1;RFC2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.20329444987777184,0.47099453229291016,0.9838449111470113,1.0,1.0,4/15,20.01%,NEK11;RAD9B;HUS1;MDC1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.21141737419333903,0.46980806770552264,0.9841521394611727,1.0,1.0,1/16,5.71%,TNFRSF1B
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.19052254842042884,-0.4687501889268516,0.98989898989899,0.9969049267156406,1.0,4/13,29.92%,MDK;RHOA;ITGB2;NFAT5
prerank,error-free translesion synthesis (GO:0070987),0.19806523354019684,0.4662196883404882,0.9907120743034056,1.0,1.0,4/22,15.87%,UBA52;RPS27A;RFC2;SPRTN
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2177226905325475,0.46333162308744125,0.9739837398373984,1.0,1.0,5/12,30.05%,STK33;HUS1;CHEK2;NAE1;TOPBP1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.21782033970815337,0.4593078725795474,0.979933110367893,1.0,1.0,3/11,22.32%,THTPA;NT5C3A;SLC25A19
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18756957897705615,0.4580464554432553,0.991304347826087,1.0,1.0,7/23,26.28%,HSP90B1;TMED9;SEL1L;TECPR2;TMEM129;SELENOS;HERPUD1
prerank,sensory perception of smell (GO:0007608),0.21544909097791998,0.4551724033097645,0.9813242784380306,1.0,1.0,3/11,29.46%,SLC24A4;MKKS;ADCY3
prerank,serine family amino acid metabolic process (GO:0009069),0.2045209433102837,0.45332005746518045,0.9885245901639345,1.0,1.0,3/16,19.72%,GLYAT;SEPSECS;CDO1
prerank,cellular response to interleukin-7 (GO:0098761),0.20101376571116547,0.45212095811356706,0.9869494290375204,1.0,1.0,1/17,3.95%,CISH
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.20101376571116547,0.45212095811356706,0.9869494290375204,1.0,1.0,1/17,3.95%,CISH
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.206139980835196,0.4510335922325569,0.9850249584026622,0.9998389317701952,1.0,4/13,20.38%,ALG14;ALG11;DPAGT1;ALG1
prerank,tRNA 5'-leader removal (GO:0001682),-0.1793271815131265,-0.4484572813515184,0.9974424552429667,0.9981731094990581,1.0,9/13,47.19%,SSB;RPP14;POP4;RPP25L;POP7;RPP40;POP5;PRORP;RPP25
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.21346547698955884,0.4482792916372039,0.9854132901134521,0.999810457758636,1.0,4/12,25.90%,ZC3H12A;ESR1;NCOR2;TGFB1
prerank,histone H2A ubiquitination (GO:0033522),0.19498048929911158,0.44792266965503186,0.9902912621359223,0.9994740347613723,1.0,3/17,16.94%,RYBP;DTX3L;KDM2B
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1744851815519668,0.44409045805280883,0.9943181818181818,0.9995587155602444,1.0,12/29,29.41%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,triglyceride catabolic process (GO:0019433),0.18779047858309253,0.44401404745560247,0.9953703703703703,0.9991872968990994,1.0,19/19,81.24%,FABP3;PNPLA2;PNPLA5;PNLIPRP2;PNPLA1;LIPI;FABP2;FABP6;APOC3;FABP5;CPS1;LIPG;PNPLA3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL
prerank,icosanoid metabolic process (GO:0006690),0.1659950988663503,0.44363432423417826,0.998639455782313,0.9988580203296153,1.0,12/40,27.51%,ALOXE3;ABCC1;ABCC10;PON2;PTGIS;PON3;MAPKAPK2;MGLL;TBXAS1;LTA4H;EPHX1;DPEP2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.17508163876829108,0.44177073791894444,0.9929178470254958,0.9986994448453245,1.0,9/31,28.30%,TOMM20L;DNLZ;PAM16;PEX1;TIMM17A;PEX26;PEX6;PEX10;TOMM70
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19561784234904642,0.4416362178095103,0.988835725677831,0.9983375987020396,1.0,8/17,32.43%,TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1
prerank,protein neddylation (GO:0045116),0.20100224870985717,0.4409972076186977,0.9866888519134775,0.998037787393819,1.0,5/13,32.12%,RBX1;DCUN1D2;RNF7;NAE1;UBE2M
prerank,fibrinolysis (GO:0042730),-0.17315419387242592,-0.43598762314283224,0.9925925925925926,0.9982660778437361,1.0,13/13,82.70%,SERPINE1;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;SERPINF2;FGG;PLAT;PLAUR
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.17275742454247534,0.426707064368814,0.9955686853766618,0.9991631616295871,1.0,4/27,18.51%,CD47;PYCARD;ETS1;RELA
prerank,cobalamin metabolic process (GO:0009235),0.18525092449551167,0.4233423139442229,0.9889937106918238,0.9990982407781096,1.0,2/17,12.95%,MMAA;ABCC1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17708793433073586,0.4189038112800487,0.9956896551724138,0.9991004247962543,1.0,2/23,12.51%,NMT1;METAP2
prerank,telomere capping (GO:0016233),0.18453902636971997,0.41409265219895386,0.996875,0.9990957125952099,1.0,5/16,25.76%,STN1;CTC1;TERF2IP;TERF2;TINF2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.16153942742340535,-0.4073950795911852,1.0,0.9988928106094436,1.0,13/13,83.87%,NT5M;NEIL1;TDG;NEIL2;DCTPP1;UNG;DUT;MBD4;SMUG1;NTHL1;OGG1;NT5C;UPP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.18996783372964043,0.4071242334369089,0.9913793103448276,0.9991982123734505,1.0,4/11,27.40%,ANK3;PLAUR;RDX;JAK1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.1903018781445306,0.4009744540550155,0.9966722129783694,0.9992106902813288,1.0,6/12,31.49%,B4GALT6;HSP90AA1;MYCBP2;HSP90AB1;SPTBN4;B4GALT5
prerank,regulation of mitotic spindle organization (GO:0060236),0.15725171867972149,0.40065089049045427,1.0,0.9988558641412235,1.0,14/35,29.78%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;CHMP1A;RAE1;TPR;VPS4B;CHMP4B;EML3;DCTN1;CLTC;HSPA1A
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.19394754167578032,0.3966004310780876,0.9966996699669967,0.9987009466009393,1.0,2/10,17.53%,NPTX2;NPTX1
prerank,tetrapyrrole metabolic process (GO:0033013),0.17188923388989552,0.39313111854573923,0.9952755905511811,0.9984975923417577,1.0,2/18,12.95%,MMAA;ABCC1
prerank,serine family amino acid catabolic process (GO:0009071),0.1817211725566506,0.37676762732003943,0.9982964224872232,0.9988363032123764,1.0,10/10,81.84%,DLD;CBS;THNSL2;SDS;AMT;DAO;SHMT1;GLDC;SHMT2;GCSH
